PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Izaddoost, S; Nam, SC; Bhat, MA; Bellen, HJ; Choi, KW				Izaddoost, S; Nam, SC; Bhat, MA; Bellen, HJ; Choi, KW			Drosophila Crumbs is a positional cue in photoreceptor adherens junctions and rhabdomeres	NATURE			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; EXPRESSION; EPITHELIA; MUTATIONS; MEMBRANE; PROTEIN; DOMAIN	Drosophila Crumbs (Crb) is required for apical-basal polarity and is an apical determinant in embryonic epithelia(1,2). Here, we describe properties of Crb that control the position and integrity of the photoreceptor adherens junction and photosensitive organ, or rhabdomere(3). In contrast to normal photoreceptor adherens junctions and rhabdomeres, which span the depth of the retina, adherens junctions and rhabdomeres of Crb-deficient photoreceptors initially accumulate at the top of the retina and fail to maintain their integrity as they stretch to the retinal floor. We show that Crb controls localization of the adherens junction through its intracellular domain containing a putative binding site for a protein 4.1 superfamily protein (FERM)(4,5). Although loss of Crb or overexpression of the FERM binding domain causes mislocalization of adherens junctions, they do not result in a significant loss of photoreceptor polarity. Mutations in CRB1, a human homologue of crb, are associated with photoreceptor degeneration in retinitis pigmentosa 12 (RP12) and Leber congenital amaurosis (LCA)(6-10). The intracellular domain of CRB1 behaves similarly to its Drosophila counterpart when overexpressed in the fly eye. Our studies may provide clues for mechanisms of photoreceptor degeneration in RP12 and LCA.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Mt Sinai Sch Med, Inst Cardiovasc Res, Dept Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai	Choi, KW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	kchoi@bcm.tmc.edu	Choi, Kwang-Wook/C-1707-2011; Nam, Sang-Chul/J-5518-2014; BHAT, MANZOOR/S-9273-2018	Choi, Kwang-Wook/0000-0002-8997-3065; Nam, Sang-Chul/0000-0001-7176-601X; Bellen, Hugo/0000-0001-5992-5989; BHAT, MANZOOR/0000-0003-0989-1498				Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Littleton JT, 1997, J CELL BIOL, V137, P793, DOI 10.1083/jcb.137.4.793; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; MIZUNO K, 1977, AM J OPHTHALMOL, V83, P32, DOI 10.1016/0002-9394(77)90188-X; NOBLE KG, 1978, ARCH OPHTHALMOL-CHIC, V96, P818, DOI 10.1001/archopht.1978.03910050424004; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223	23	208	209	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					178	182		10.1038/nature720	http://dx.doi.org/10.1038/nature720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11850624				2022-12-28	WOS:000174348100038
J	Stowers, L; Holy, TE; Meister, M; Dulac, C; Koentges, G				Stowers, L; Holy, TE; Meister, M; Dulac, C; Koentges, G			Loss of sex discrimination and male-male aggression in mice deficient for TRP2	SCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MUS-MUSCULUS; OLFACTORY CONTROL; MULTIGENE FAMILY; BEHAVIOR; CHANNEL; TESTOSTERONE; ORGANIZATION; NEURONS; VISION	The mouse vomeronasal organ (VNO) is thought to mediate social behaviors and neuroendocrine changes elicited by pheromonal cues. The molecular mechanisms underlying the sensory response to pheromones and the behavioral repertoire induced through the VNO are not fully characterized. Using the tools of mouse genetics and multielectrode recording, we demonstrate that the sensory activation of VNO neurons requires TRP2, a putative ion channel of the transient receptor potential family that is expressed exclusively in these neurons. Moreover, we show that mate mice deficient in TRP2 expression fail to display mate-mate aggression, and they initiate sexual and courtship behaviors toward both males and females. Our study suggests that, in the mouse, sensory activation of the VNO is essential for sex discrimination of conspecifics and thus ensures gender-specific behavior.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Stowers, Lisa/K-6137-2015; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Dulac, Catherine/0000-0001-5024-5418; Meister, Markus/0000-0003-2136-6506; Stowers, Lisa/0000-0002-4403-1269	NIDCD NIH HHS [DC03903] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALBERTS JR, 1971, PHYSIOL BEHAV, V6, P619, DOI 10.1016/0031-9384(71)90218-6; BARKLEY MS, 1977, HORM BEHAV, V9, P32, DOI 10.1016/0018-506X(77)90048-4; BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CONNOR J, 1972, PSYCHON SCI, V27, P1; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DRIVER PM, 1970, NATURE, V226, P968, DOI 10.1038/226968a0; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; EDWARDS DA, 1973, PHYSIOL BEHAV, V11, P867, DOI 10.1016/0031-9384(73)90282-5; FARBMAN AI, 1992, CELL BIOL OLFACTION; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hofmann T, 2000, BIOCHEM J, V351, P115, DOI 10.1042/0264-6021:3510115; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; LEE CT, 1972, PSYCHON SCI, V27, P287; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liman ER, 1996, J NEUROSCI, V16, P4625; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARUNIAK JA, 1986, PHYSIOL BEHAV, V37, P655, DOI 10.1016/0031-9384(86)90300-8; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MEREDITH M, 1986, PHYSIOL BEHAV, V36, P737, DOI 10.1016/0031-9384(86)90362-8; Meredith M, 2001, CHEM SENSES, V26, P433, DOI 10.1093/chemse/26.4.433; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; POWERS JB, 1973, PHYSIOL BEHAV, V10, P361; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SIPOS ML, 1995, PHYSIOL BEHAV, V58, P529, DOI 10.1016/0031-9384(95)00089-2; VANNIER B, 1996, P NATL ACAD SCI USA, V93, P571; VANOORTMERSSEN GA, 1971, BEHAVIOUR, V38, P1, DOI 10.1163/156853971X00014; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1979, NEUROSCI BIOBEHAV R, V3, P301, DOI 10.1016/0149-7634(79)90015-0; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	45	618	635	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1493	1500		10.1126/science.1069259	http://dx.doi.org/10.1126/science.1069259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11823606				2022-12-28	WOS:000173981300044
J	Vajkoczy, P; Hartmann, M				Vajkoczy, P; Hartmann, M			An unusual saccular aneurysm.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Heidelberg, Med Ctr Mannheim, D-68135 Mannheim, Germany; Univ Heidelberg, Med Ctr, D-69115 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Vajkoczy, P (corresponding author), Univ Heidelberg, Med Ctr Mannheim, D-68135 Mannheim, Germany.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					497	497		10.1056/NEJMicm010008	http://dx.doi.org/10.1056/NEJMicm010008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844851				2022-12-28	WOS:000173815300006
J	Chou, KM; Cheng, YC				Chou, KM; Cheng, YC			An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3 ' mispaired DNA	NATURE			English	Article							BASE EXCISION-REPAIR; HUMAN APURINIC ENDONUCLEASE; POLYMERASE-BETA; L-CONFIGURATION; CELLS; MUTAGENESIS; EXPRESSION; MUTATIONS; HOMOLOGY; ANALOGS	Human apurinic/apyrimidinic endonuclease (APE1) is an essential enzyme in DNA base excision repair that cuts the DNA backbone immediately adjacent to the 5' side of abasic sites to facilitate repair synthesis by DNA polymerase beta (ref. 1). Mice lacking the murine homologue of APE1 die at an early embryonic stage(2). Here we report that APE1 has a DNA exonuclease activity on mismatched deoxyribonucleotides at the 3' termini of nicked or gapped DNA molecules. The efficiency of this activity is inversely proportional to the gap size in DNA. In a base excision repair system reconstituted in vitro, the rejoining of nicked mismatched DNA depended on the presence of APE1, indicating that APE1 may increase the fidelity of base excision repair and may represent a new 3' mispaired DNA repair mechanism. The exonuclease activity of APE1 can remove the anti-HIV nucleoside analogues 3'-azido-3'-deoxythymidine and 2',3'-didehydro-2', 3'-dideoxythymidine from DNA, suggesting that APE1 might have an impact on the therapeutic index of antiviral compounds in this category.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Cheng, YC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,Sterling Hall Med B-315, New Haven, CT 06520 USA.							Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bhagwat AS, 1999, NUCLEIC ACIDS RES, V27, P4028, DOI 10.1093/nar/27.20.4028; Bouayadi K, 1997, CANCER RES, V57, P110; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; CHENG YC, 1990, ANN NY ACAD SCI, V616, P217; Chou KM, 2000, J BIOL CHEM, V275, P31009, DOI 10.1074/jbc.M004082200; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; GROVE KL, 1995, CANCER RES, V55, P3008; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; HUSAIN I, 1995, J BIOL CHEM, V270, P9683, DOI 10.1074/jbc.270.16.9683; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P1087, DOI 10.1093/nar/19.5.1087; SKALSKI V, 1995, BIOCHEM PHARMACOL, V50, P815, DOI 10.1016/0006-2952(95)00205-E; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Zhu QY, 1996, AIDS RES HUM RETROV, V12, P507, DOI 10.1089/aid.1996.12.507	25	182	195	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					655	659		10.1038/415655a	http://dx.doi.org/10.1038/415655a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832948				2022-12-28	WOS:000173709100050
J	Golz, J; MacLeod, DIA				Golz, J; MacLeod, DIA			Influence of scene statistics on colour constancy	NATURE			English	Article							MUTUAL ILLUMINATION; NATURAL IMAGES; APPEARANCE; CHROMATICITY; PERCEPTION; MECHANISMS; MODEL	The light reflected from an object depends not only on the surface properties of this object but also on the illuminant. The same is true for the excitations of the photoreceptors, which serve as the basis for the perceived colour. However, our visual system has the ability to perceive constant surface colours despite changes in illumination(1). The average chromaticity of the retinal image of a scene depends on the illumination, and thus might be used by the visual system to estimate the illumination and to modulate the correction that subserves colour constancy(2-4). But this measure is not sufficient: a reddish scene under white light can produce the same mean stimulation as a neutral scene in red light. Higher order scene statistics-for example, the correlation between redness and luminance within the image-allow these cases to be distinguished. Here we report that the human visual system does exploit such a statistic when estimating the illuminant, and gives it a weight that is statistically appropriate for the natural environment.	Univ Kiel, Dept Psychol, D-24098 Kiel, Germany; Univ Calif San Diego, Dept Psychol, La Jolla, CA 93093 USA	University of Kiel; University of California System; University of California San Diego	Golz, J (corresponding author), Univ Kiel, Dept Psychol, Olshaussenstr 40, D-24098 Kiel, Germany.							BAUML KH, 1994, J OPT SOC AM A, V11, P531, DOI 10.1364/JOSAA.11.000531; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; Brown RO, 1997, CURR BIOL, V7, P844, DOI 10.1016/S0960-9822(06)00372-1; BUCHSBAUM G, 1980, J FRANKLIN I, V310, P1, DOI 10.1016/0016-0032(80)90058-7; DZMURA M, 1986, J OPT SOC AM A, V3, P1662, DOI 10.1364/JOSAA.3.001662; DZMURA M, 1995, GEOMETRIC REPRESENTATIONS OF PERCEPTUAL PHENOMENA, P187; Eskew Jr R.T., 1999, COLOR VISION GENES P, P345, DOI DOI 10.1016/B978-012370880-9.00302-9; FORSYTH DA, 1990, INT J COMPUT VISION, V5, P5, DOI 10.1007/BF00056770; FORSYTH DA, 1990, AI AND THE EYE, P201; FUNT BV, 1993, IEEE T PATTERN ANAL, V15, P1319, DOI 10.1109/34.250838; FUNT BV, 1991, INT J COMPUT VISION, V6, P5, DOI 10.1007/BF00127123; GERSHON R, 1989, COLOR RES APPL, V14, P325, DOI 10.1002/col.5080140610; GILCHRIST AL, 1992, INVEST OPHTH VIS SCI, V33, P756; Golz J, 1999, INVEST OPHTH VIS SCI, V40, pS749; JENNESS JW, 1995, VISION RES, V35, P797, DOI 10.1016/0042-6989(94)00169-M; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; LAND EH, 1986, VISION RES, V26, P7, DOI 10.1016/0042-6989(86)90067-2; LEE HC, 1986, J OPT SOC AM A, V3, P1694, DOI 10.1364/JOSAA.3.001694; MACLEOD DI, IN PRESS COLOUR PERC; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; MALONEY TM, IN PRESS COLOUR PERC; Mausfeld R, 1998, PERCEPTION, V27, P42; MAUSFELD R, IN PRESS PERCEPTION; Mausfeld R., 1998, COLOR VISION PERSPEC, P219; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; TOMINAGA S, 1989, J OPT SOC AM A, V6, P576, DOI 10.1364/JOSAA.6.000576; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; WYSZECKI G, 1982, COLOR SCI CONCEPTS M, P145	30	93	95	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					637	640		10.1038/415637a	http://dx.doi.org/10.1038/415637a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832945				2022-12-28	WOS:000173709100045
J	Spillane, SM; Kippenberg, TJ; Vahala, KJ				Spillane, SM; Kippenberg, TJ; Vahala, KJ			Ultralow-threshold Raman laser using a spherical dielectric microcavity	NATURE			English	Article							GALLERY-MODE RESONANCES; SILICA-MICROSPHERE; SCATTERING	The ability to confine and store optical energy in small volumes has implications in fields ranging from cavity quantum electrodynamics to photonics. Of all cavity geometries, micrometresized dielectric spherical resonators are the best in terms of their ability to store energy for long periods of time within small volumes(1). In the sphere, light orbits near the surface, where long confinement times (high Q) effectively wrap a large interaction distance into a tiny volume. This characteristic makes such resonators uniquely suited for studies of nonlinear coupling of light with matter. Early work(2,3) recognized these attributes through Raman excitation in microdroplets-but microdroplets have not been used in practical applications. Here we demonstrate a micrometre-scale, nonlinear Raman source that has a highly efficient pump-signal conversion (higher than 35%) and pump thresholds nearly 1,000 times lower than shown before. This represents a route to compact, ultralow-threshold sources for numerous wavelength bands that are usually difficult to access. Equally important, this system can provide a compact and simple building block for studying nonlinear optical effects and the quantum aspects of light.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology	Vahala, KJ (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	vahala@caltech.edu	Kippenberg, T. J./B-3133-2013	Kippenberg, T. J./0000-0002-3408-886X				BACHOR HA, 1988, PHYS REV A, V38, P180, DOI 10.1103/PhysRevA.38.180; Braunstein D, 1996, PHYS REV A, V53, P3565, DOI 10.1103/PhysRevA.53.3565; Cai M, 2000, PHYS REV LETT, V85, P74, DOI 10.1103/PhysRevLett.85.74; Chang R.K., 1996, OPTICAL PROCESSES MI, VVolume 3; COLLOT L, 1993, EUROPHYS LETT, V23, P327, DOI 10.1209/0295-5075/23/5/005; Fan XD, 2000, OPT LETT, V25, P1600, DOI 10.1364/OL.25.001600; Gorodetsky ML, 1996, OPT LETT, V21, P453, DOI 10.1364/OL.21.000453; Il'chenko VS, 1992, LASER PHYS, V2, P1004; Knight JC, 1997, OPT LETT, V22, P1129, DOI 10.1364/OL.22.001129; LAI HM, 1990, PHYS REV A, V41, P5187, DOI 10.1103/PhysRevA.41.5187; LIN HB, 1990, J OPT SOC AM B, V7, P2079, DOI 10.1364/JOSAB.7.002079; LIN HB, 1994, PHYS REV LETT, V73, P2440, DOI 10.1103/PhysRevLett.73.2440; QIAN SX, 1986, PHYS REV LETT, V56, P926, DOI 10.1103/PhysRevLett.56.926; Silberhorn C, 2001, PHYS REV LETT, V86, P4267, DOI 10.1103/PhysRevLett.86.4267; Treussart F, 1998, EUR PHYS J D, V1, P235, DOI 10.1007/s100530050087; Vernooy DW, 1998, OPT LETT, V23, P247, DOI 10.1364/OL.23.000247; WEISS DS, 1995, OPT LETT, V20, P1835, DOI 10.1364/OL.20.001835; ZHANG JZ, 1989, J OPT SOC AM B, V6, P151, DOI 10.1364/JOSAB.6.000151	18	883	928	15	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					621	623		10.1038/415621a	http://dx.doi.org/10.1038/415621a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832940				2022-12-28	WOS:000173709100040
J	Zhang, YX; Perry, K; Vinci, VA; Powell, K; Stemmer, WPC; del Cardayre, SB				Zhang, YX; Perry, K; Vinci, VA; Powell, K; Stemmer, WPC; del Cardayre, SB			Genome shuffling leads to rapid phenotypic improvement in bacteria	NATURE			English	Article							STREPTOMYCES-FRADIAE; PROTOPLAST FUSION; GENETIC-RECOMBINATION; REGENERATION; BIOSYNTHESIS; EVOLUTION; TYLOSIN	For millennia, selective breeding, on the basis of biparental mating, has led to the successful improvement of plants and animals to meet societal needs(1). At a molecular level, DNA shuffling mimics, yet accelerates, evolutionary processes, and allows the breeding and improvement of individual genes and subgenomic DNA fragments. We describe here whole-genome shuffling; a process that combines the advantage of multi-parental crossing allowed by DNA shuffling with the recombination of entire genomes normally associated with conventional breeding. We show that recursive genomic recombination within a population of bacteria can efficiently generate combinatorial libraries of new strains. When applied to a population of phenotypically selected bacteria, many of these new strains show marked improvements in the selected phenotype. We demonstrate the use of this approach through the rapid improvement of tylosin production from Streptomyces fradiae. This approach has the potential to facilitate cell and metabolic engineering and provide a non-recombinant alternative to the rapid production of improved organisms.	Maxygen, Redwood City, CA 94063 USA; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA	Eli Lilly	del Cardayre, SB (corresponding author), Maxygen, 515 Galveston Dr, Redwood City, CA 94063 USA.							AHARONOWITZ Y, 1981, SCI AM, V245, P141, DOI 10.1038/scientificamerican0981-140; BALTZ RH, 1981, ANTIMICROB AGENTS CH, V20, P214, DOI 10.1128/AAC.20.2.214; BALTZ RH, 1988, ANNU REV MICROBIOL, V42, P547; BALTZ RH, 1978, J GEN MICROBIOL, V107, P93, DOI 10.1099/00221287-107-1-93; Christians FC, 1999, NAT BIOTECHNOL, V17, P259, DOI 10.1038/7003; Hamlyn P.F., 1979, GENETICS IND MICROOR, P185; HOPWOOD DA, 1980, PHILOS T R SOC B, V290, P313, DOI 10.1098/rstb.1980.0097; HOPWOOD DA, 1979, J GEN MICROBIOL, V111, P137, DOI 10.1099/00221287-111-1-137; HOPWOOD DA, 1978, MOL GEN GENET, V162, P307, DOI 10.1007/BF00268856; HOPWOOD DA, 1977, NATURE, V268, P171, DOI 10.1038/268171a0; IKEDA H, 1983, J ANTIBIOT, V36, P283, DOI 10.7164/antibiotics.36.283; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Vinci V, 1999, MANUAL IND MICROBIOL, V2, P103; [No title captured]; [No title captured]; [No title captured]	17	409	518	8	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					644	646		10.1038/415644a	http://dx.doi.org/10.1038/415644a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832946				2022-12-28	WOS:000173709100047
J	Schwetz, BA				Schwetz, BA			Congenital heart defect devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					578	578		10.1001/jama.287.5.578-a	http://dx.doi.org/10.1001/jama.287.5.578-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829678				2022-12-28	WOS:000173686700006
J	Nicolas, JM; Fernandez-Sola, J; Estruch, R; Pare, JC; Sacanella, E; Urbano-Marquez, A; Rubin, E				Nicolas, JM; Fernandez-Sola, J; Estruch, R; Pare, JC; Sacanella, E; Urbano-Marquez, A; Rubin, E			The effect of controlled drinking in alcoholic cardiomyopathy	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; LEFT-VENTRICULAR MASS; NATURAL-HISTORY; NUTRITIONAL-STATUS; HEART-FAILURE; LIVER-DISEASE; MYOPATHY; ETHANOL; CONSUMPTION; MEN	Background: Cardiomyopathy is a potentially fatal complication of alcohol abuse. In alcoholic persons who develop cardiac dysfunction, abstinence is thought to be essential to halt further deterioration of cardiac contractility. Some evidence indicates that reducing alcohol intake may also be beneficial. Objective: To evaluate the effect of moderate "controlled" drinking on cardiac function in patients with alcoholic cardiomyopathy. Design: 4-year prospective cohort study. Setting: A university hospital in Barcelona, Spain. Patients: 55 alcoholic men with cardiomyopathy who had been drinking a minimum of 100 g of ethanol per day for at least 10 years. Measurements: Evaluation of ethanol intake and nutrition, clinical assessment of cardiac status, and sequential echocardiography and radionuclide cardiac angiography. Results: After the first year of evaluation, all patients with cardiomyopathy who abstained from alcoholic beverages demonstrated significant improvement in left ventricular function (average increase in left ventricular ejection fraction, 0.131 [95% Cl, 0.069 to 0.193]). Patients who drank 20 to 60 g of ethanol per day showed a comparable mean improvement of 0.125 (CI, 0.082 to 0.168). In contrast, left ventricular election fraction deteriorated further in most patients who continued to abuse alcohol (>80 g/d). After 4 years, left ventricular ejection fraction had continued to improve in both abstinent patients and those who controlled their drinking. Ten patients who had continued to consume more than 80 g of ethanol per day died during the study. Conclusion: In patients with alcoholic cardiomyopathy, both abstinence and controlled drinking of up to 60 g of ethanol per day (four standard drinks) were comparably effective in promoting improvement in cardiac function.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	Jefferson University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Rubin, E (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 279, Philadelphia, PA 19107 USA.		SOLA, JOAQUIM FERNANDEZ/K-3991-2019	SOLA, JOAQUIM FERNANDEZ/0000-0002-3218-0582				ASKANAS A, 1980, AM HEART J, V99, P9, DOI 10.1016/0002-8703(80)90309-9; BORY M, 1977, NOUV PRESSE MED, V6, P3295; Christakis GT, 1996, ANN THORAC SURG, V62, P1084, DOI 10.1016/0003-4975(96)00533-4; Cohn JN, 1996, NEW ENGL J MED, V335, P490, DOI 10.1056/NEJM199608153350707; De Vries JHM, 1999, HLTH ISSUES RELATED, P27; DEMAKIS JG, 1974, ANN INTERN MED, V80, P293, DOI 10.7326/0003-4819-80-3-293; ESTRUCH R, 1993, ALCOHOL ALCOHOLISM, V28, P543; ESTRUCH R, 1989, MED CLIN-BARCELONA, V92, P69; ESTRUCH R, 1995, HEPATOLOGY, V22, P532, DOI 10.1016/0270-9139(95)90576-6; Estruch R, 1998, ALCOHOL CLIN EXP RES, V22, P2023, DOI 10.1111/j.1530-0277.1998.tb05911.x; Fernandez-Sola J, 2000, QJM-MON J ASSOC PHYS, V93, P35, DOI 10.1093/qjmed/93.1.35; FERNANDEZSOLA J, 1994, ANN INTERN MED, V120, P529, DOI 10.7326/0003-4819-120-7-199404010-00001; FernandezSola J, 1997, ADDICT BIOL, V2, P9, DOI 10.1080/13556219772822; FILLMORE KM, 1991, BRIT J ADDICT, V86, P1203, DOI 10.1111/j.1360-0443.1991.tb01700.x; FOY A, 1988, ALCOHOL CLIN EXP RES, V12, P360, DOI 10.1111/j.1530-0277.1988.tb00208.x; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOULD L, 1971, J AMER MED ASSOC, V218, P1799, DOI 10.1001/jama.218.12.1799; Guillo P, 1997, AM J CARDIOL, V79, P1276, DOI 10.1016/S0002-9149(97)00101-X; JOHNSON RA, 1982, NEW ENGL J MED, V307, P1119, DOI 10.1056/NEJM198210283071804; KALANT H, 1999, HLTH ISSUES RELATED, P1; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; KUPARI M, 1991, AM J CARDIOL, V67, P274, DOI 10.1016/0002-9149(91)90559-4; KUPARI M, 1984, POSTGRAD MED J, V60, P151, DOI 10.1136/pgmj.60.700.151; LANGER RD, 1992, CIRCULATION, V85, P910, DOI 10.1161/01.CIR.85.3.910; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MOUSHMOUSH B, 1991, ARCH INTERN MED, V151, P36, DOI 10.1001/archinte.151.1.36; NICOLAS JM, 1993, ALCOHOL ALCOHOLISM, V28, P551; Nie N.H., 1975, STAT PACKAGE SOCIAL; Oren S, 1996, AM J CARDIOL, V77, P93, DOI 10.1016/S0002-9149(97)89144-8; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; REDFIELD MM, 1993, J AM COLL CARDIOL, V22, P1921, DOI 10.1016/0735-1097(93)90780-5; SAVOLAINEN VT, 1993, ALCOHOL CLIN EXP RES, V17, P1112, DOI 10.1111/j.1530-0277.1993.tb05673.x; Sobell LC, 1996, AM J PUBLIC HEALTH, V86, P966, DOI 10.2105/AJPH.86.7.966; SOBELL LC, 1979, BEHAV RES THER, V17, P157, DOI 10.1016/0005-7967(79)90025-1; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; VANDENBERG BF, 1989, CURR OPIN CARDIOL, V4, P815, DOI 10.1097/00001573-198912000-00011; WYNNE J, 1998, HARRISONS PRINCIPLES, P1328	39	79	81	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					192	200		10.7326/0003-4819-136-3-200202050-00007	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827495				2022-12-28	WOS:000173637400002
J	Albers, L; Williams, D				Albers, L; Williams, D			Lessons for US postpartum care	LANCET			English	Editorial Material									Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; Amer Coll Nurse Midwives, Washington, DC USA	University of New Mexico; University of New Mexico's Health Sciences Center	Albers, L (corresponding author), Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA.							Albers LL, 2000, J MIDWIFERY WOM HEAL, V45, P55, DOI 10.1016/S1526-9523(99)00003-3; *AM AC PED AM COLL, 1997, GUID PER CAR, P176; HODNETT ED, 2001, COCHRANE DATABASE SY, V3; PAGE LA, 2000, NEW MIDWIFERY SCI SE, P185; ROOKS JP, 1997, MIDWIFERY CHILDBIRTH, P338; WOLMAN WL, 1993, AM J OBSTET GYNECOL, V168, P1388, DOI 10.1016/S0002-9378(11)90770-4; YARDLEY J, 2001, NY TIMES        0623	7	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					370	371		10.1016/S0140-6736(02)07587-6	http://dx.doi.org/10.1016/S0140-6736(02)07587-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844503				2022-12-28	WOS:000173686500003
J	Shahbazi, M; Pravica, V; Nasreen, N; Fakhoury, H; Fryer, AA; Strange, RC; Hutchinson, PE; Osborne, JE; Lear, JT; Smith, AG; Hutchinson, IV				Shahbazi, M; Pravica, V; Nasreen, N; Fakhoury, H; Fryer, AA; Strange, RC; Hutchinson, PE; Osborne, JE; Lear, JT; Smith, AG; Hutchinson, IV			Association between functional polymorphism in EGF gene and malignant melanoma	LANCET			English	Article							EPIDERMAL GROWTH-FACTOR; RECEPTOR; SUSCEPTIBILITY	Background Malignant melanoma, the most serious cutaneous malignancy, has attracted substantial attention because of its rapidly increasing incidence and the poor prognosis of some tumours. Little is known of the genetic factors that mediate susceptibility to, and outcome of, sporadic malignant melanoma. Because of its role in mitogenesis, which is especially relevant to wound healing, tumorigenesis, and proliferation of epidermal tissues, epidermal growth factor (EGF) is an attractive candidate in which to look for genetic polymorphisms. Methods We enrolled 135 white European patients with malignant melanoma and 99 healthy white European controls, and screened a selection of DNA samples for polymorphisms in the promoter and 5' untranslated region of the EGF gene by single-stranded conformational polymorphism (SSCP) analysis. We then screened DNA samples from all participants for the identified polymorphism by restriction-fragment-length polymorphism (RFLP) analysis. In-vitro EGF production was measured in peripheral-blood mononuclear cells from 34 controls, and the results were compared with the individuals' EGF genotypes. Findings We identified a single nucleotide substitution (G to A) at position 61 of the EGF gene. Allele frequencies in the controls were 56% EGF 61*A and 44% EGF 61*G. Cells from individuals homozygous for the 61*A allele produced significantly less EGF than cells from 61*G homozygotes (p=0.0004) or heterozygous A/G individuals (p=0.001). Compared with the A/A genotype, G/G was significantly associated with Breslow thickness (p=0.045) and with risk of malignant melanoma (odds ratio 4.9 [95% Cl 2.3-10.2], P<0.0001). Interpretation This study suggests that high EGF production might be important in the development of malignant melanoma.	Univ Manchester, Sch Biol Sci, Immunol Res Grp, Manchester M13 9PT, Lancs, England; Keele Univ, N Staffordshire Hosp, Postgrad Med Sch, Ctr Cell & Mol Med, Stoke On Trent, Staffs, England; Leicester Royal Infirm, Dept Dermatol, Leicester, Leics, England; N Staffordshire Hosp, Dept Dermatol, Stoke On Trent, Staffs, England	University of Manchester; Keele University; University Hospital of North Staffordshire NHS Trust; University of Leicester; Keele University; University Hospital of North Staffordshire NHS Trust	Pravica, V (corresponding author), Univ Manchester, Sch Biol Sci, Immunol Res Grp, Stopford Bldg, Manchester M13 9PT, Lancs, England.		Fakhoury, Hana/F-6457-2017; Shahbazi, Majid/E-1452-2012; lear, john/I-5465-2015	Fakhoury, Hana/0000-0001-9974-2108; Fryer, Anthony/0000-0001-8678-0404; lear, john/0000-0002-2969-9922; Shahbazi, Majid/0000-0002-4143-8282				BOYLE P, 1995, BRIT MED BULL, V51, P523, DOI 10.1093/oxfordjournals.bmb.a072978; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Hutchinson PE, 2000, CLIN CANCER RES, V6, P498; Ichii-Jones F, 1998, J INVEST DERMATOL, V111, P218, DOI 10.1046/j.1523-1747.1998.00287.x; LAFUENTE A, 1995, BRIT J CANCER, V72, P324, DOI 10.1038/bjc.1995.332; LAURENCE DJR, 1990, TUMOR BIOL, V11, P229, DOI 10.1159/000217659; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Lear JT, 1998, INT J CLIN PRACT, V52, P145; Ma D, 1998, INVEST OPHTH VIS SCI, V39, P1067; MACKIE RM, 1995, BRIT J CANCER, V71, P173, DOI 10.1038/bjc.1995.35; MORTON CC, 1986, CYTOGENET CELL GENET, V41, P245, DOI 10.1159/000132237; Rivers JK, 1996, LANCET, V347, P803, DOI 10.1016/S0140-6736(96)90873-9; Rodeck U, 1988, Cancer Treat Res, V43, P3; RODECK U, 1993, CANCER METAST REV, V12, P219, DOI 10.1007/BF00665954; Strange RC, 1999, PHARMACOGENETICS, V9, P269, DOI 10.1097/00008571-199906000-00001; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Wagner SN, 1998, BRIT J DERMATOL, V138, P13; WOLF CR, 1992, TOHOKU J EXP MED, V168, P73, DOI 10.1620/tjem.168.73; WORM M, 1995, EXP DERMATOL, V4, P305	20	226	242	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					397	401		10.1016/S0140-6736(02)07600-6	http://dx.doi.org/10.1016/S0140-6736(02)07600-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844511				2022-12-28	WOS:000173686500011
J	Svendsen, AJ; Holm, NV; Kyvik, K; Petersen, PH; Junker, P				Svendsen, AJ; Holm, NV; Kyvik, K; Petersen, PH; Junker, P			Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population	BRITISH MEDICAL JOURNAL			English	Article							CONGENITAL HEART-DEFECTS; IN-HOSPITAL MORTALITY; TRANSPLANTATION CENTERS; LIVER-TRANSPLANTATION; FAMILIAL AGGREGATION; VOLUME; SURGERY; ASSOCIATION; PERFORMANCE; CONCORDANCE	Objective To determine the relative importance of environmental and genetic effects in the development of rheumatoid arthritis. Design Historical cohort study with record linkage between a twin registry and the Danish discharge registry as well as the Danish national registry of deaths used to estimate completeness. Setting Two population based nationwide twin birth cohorts. Participants 37 338 twins were sent a questionnaire about rheumatic diseases. Self reported rheumatoid arthritis was verified by clinical examination and from medical records. Main outcome measures The probandwise concordance rate of rheumatoid arthritis in monozygotic and dizygotic twins. Results The response rate was 84.7%. Rheumatoid arthritis was verified in 13 monozygotic and 36 dizygotic twins. There were no concordant monozygotic twin pairs and two concordant dizygotic twin pairs. Based on capture-recapture methods the probability of ascertainment was 78.3%. The probandwise concordance rate was 0 (95% confidence interval 0 to 24.7) in monozygotic twins and 8.8 (1.9 to 23.7) in dizygotic twins. Conclusion Genes are of minor importance in the development of rheumatoid arthritis.	Odense Univ Hosp, Dept Rheumatol, DK-5000 Odense C, Denmark; Odense Univ Hosp, Dept Radiotherapy & Clin Oncol, Odense, Denmark; Univ So Denmark, Dept Publ Hlth, Danish Twin Registry, Odense, Denmark; Odense Univ Hosp, Dept Clin Chem, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Svendsen, AJ (corresponding author), Odense Univ Hosp, Dept Rheumatol, DK-5000 Odense C, Denmark.		Kyvik, Kirsten O/K-5680-2016	Kyvik, Kirsten O/0000-0003-2981-0245; Svendsen, Anders/0000-0002-3481-9001				AHO K, 1986, J RHEUMATOL, V13, P899; Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; Barrera P, 1999, RHEUMATOLOGY, V38, P415, DOI 10.1093/rheumatology/38.5.415; BELLAMY N, 1992, ANN RHEUM DIS, V51, P588, DOI 10.1136/ard.51.5.588; *BRIST ROYAL INF I, 2001, ISS LIST 1; DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003; Hannan EL, 1999, NEW ENGL J MED, V340, P1677, DOI 10.1056/NEJM199905273402112; Hannan EL, 1998, PEDIATRICS, V101, P963, DOI 10.1542/peds.101.6.963; HARVALD B, 1965, DHEW PUBLICATION, V1163, P61; HOLM NV, 1983, ACTA GENET MED GEMEL, V32, P37, DOI 10.1017/S000156600000814X; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627, DOI 10.1136/ard.45.8.627; JENKINS KJ, 1995, PEDIATRICS, V95, P323; Kennedy I, 2001, INQUIRY MANAGEMENT C; Kyvik KO, 1996, DAN MED BULL, V43, P467; Laks MP, 2000, NEW ENGL J MED, V342, P1527; LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357, DOI 10.1136/ard.29.4.357; LYKKEN DT, 1978, SOC BIOL, V25, P1, DOI 10.1080/19485565.1978.9988312; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; MACGREGOR AJ, 1994, J RHEUMATOL, V21, P1420; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; MURRAY GD, 2000, BRISTOL ROYAL INFIRM; Posnett J, 1999, BRIT MED J, V319, P1063, DOI 10.1136/bmj.319.7216.1063; SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903; SMITH C, 1974, AM J HUM GENET, V26, P454; Sollano JA, 1999, J THORAC CARDIOV SUR, V117, P419, DOI 10.1016/S0022-5223(99)70320-X; SPIEGELHALTER DJ, 2000, BRISTOL ROYAL INFIRM; Stark J, 2000, LANCET, V355, P1004, DOI 10.1016/S0140-6736(00)90001-1	31	72	76	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					264	+		10.1136/bmj.324.7332.264	http://dx.doi.org/10.1136/bmj.324.7332.264			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823356	Green Published, Bronze			2022-12-28	WOS:000173728300014
J	Rood, RT; Bania, TM; Balser, DS				Rood, RT; Bania, TM; Balser, DS			Cosmology - The saga of (3)He	SCIENCE			English	Editorial Material							INTERSTELLAR-MEDIUM; PLANETARY-NEBULAE; MILKY-WAY; ABUNDANCE; EVOLUTION		Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; Boston Univ, Inst Astrophys Res, Boston, MA USA; Natl Radio Astron Observ, Green Bank, WV 24944 USA	University of Virginia; Boston University; National Radio Astronomy Observatory (NRAO)	Rood, RT (corresponding author), Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA.	rtr@veris.astro.virginia.edu; bania@ninkasi.bu.edu; dbalser@nrao.edu	Bania, Thomas M/H-2318-2014	Bania, Thomas M/0000-0003-4866-460X				ANDERSON DL, 1993, SCIENCE, V261, P170, DOI 10.1126/science.261.5118.170; Balser DS, 1999, ASTROPHYS J, V510, P759, DOI 10.1086/306598; Balser DS, 1997, ASTROPHYS J, V483, P320, DOI 10.1086/304248; BANIA TM, 1987, ASTROPHYS J, V323, P30, DOI 10.1086/165805; Bania TM, 2002, NATURE, V415, P54, DOI 10.1038/415054a; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Charbonnel C, 1998, SPACE SCI REV, V84, P199, DOI 10.1023/A:1005027519798; Fields BD, 2001, SCIENCE, V294, P529, DOI 10.1126/science.1066158; Galli D, 1997, ASTROPHYS J, V477, P218, DOI 10.1086/303708; Gloeckler G, 1998, SPACE SCI REV, V84, P275, DOI 10.1023/A:1005095907503; Gloeckler G, 2000, IAU SYMP, P224; GOTT JR, 1974, ASTROPHYS J, V194, P543, DOI 10.1086/153273; HALL DNB, 1975, ASTROPHYS J, V197, P509, DOI 10.1086/153536; ROOD RT, 1984, ASTROPHYS J, V280, P629, DOI 10.1086/162036; Rood RT, 1998, SPACE SCI REV, V84, P185, DOI 10.1023/A:1005023402960; Rood RT, 1995, ESO ASTROPHY SYMP, P201; ROOD RT, 1976, ASTROPHYS J, V207, pL57, DOI 10.1086/182178; TOSI M, 1990, LIGHT ELEMENTS THEIR, P525; [No title captured]	20	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					804	805		10.1126/science.1069134	http://dx.doi.org/10.1126/science.1069134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823625				2022-12-28	WOS:000173733000027
J	Sisodia, SS				Sisodia, SS			Biomedicine - A cargo receptor mystery APParently solved?	SCIENCE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; AXONAL-TRANSPORT; GAMMA-SECRETASE; KINESIN; APP; PHOSPHORYLATION; LOCALIZATION; PRESENILIN-1; MICE		Ctr Mol Neurobiol, Chicago, IL 60637 USA		Sisodia, SS (corresponding author), Ctr Mol Neurobiol, Chicago, IL 60637 USA.	ssisodia@drugs.bsd.uchicago.edu						Ando K, 1999, J NEUROSCI, V19, P4421; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Heber S, 2000, J NEUROSCI, V20, P7951; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Matsuda S, 2001, J NEUROSCI, V21, P6597; Mattson M P, 2001, Trends Neurosci, V24, P441, DOI 10.1016/S0166-2236(00)01936-6; Muresan V, 2001, MOL BIOL CELL, V12, p311A; SCHEINFELD MH, 2001, J BIOL CHEM     1127; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6	27	25	27	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					805	807		10.1126/science.1069661	http://dx.doi.org/10.1126/science.1069661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823626				2022-12-28	WOS:000173733000028
J	Urnezius, E; Brennessel, WW; Cramer, CJ; Ellis, JE; Schleyer, PV				Urnezius, E; Brennessel, WW; Cramer, CJ; Ellis, JE; Schleyer, PV			A carbon-free sandwich complex [(P-5)(2)Ti](2-)	SCIENCE			English	Article							HEXA-PHOSPHORUS ANALOGS; PENTAPHOSPHACYCLOPENTADIENIDE ION; STRUCTURAL CHARACTERIZATION; MOLECULAR-STRUCTURES; CHEMISTRY; LIGANDS; REACTIVITY; METALLOCENES; AROMATICITY; CRYSTAL	Reactions of highly reduced titanium complexes with white phosphorus, P, at or below 25degreesC yielded brown to deep red-brown salts of the first entirety inorganic metallocene, [(eta(5)-P-5)(2)Ti](2-)(1). Like ferrocene and other carbon-based metallocenes, the structure of 1 has parallel and planar five-membered rings symmetrically positioned about the central metal atom. Despite its electron-deficient (16 electron) and formally zerovalent titanium character, salts of 1 are highly stable toward heat and air, both in solution and in the solid state. Computational studies show that the pentaphosphacyclopentadienyl unit, P-5, functions as an unusually effective acceptor ligand, and this results in substantial stabilization of 1.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Georgia, Athens, GA 30602 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia	Urnezius, E (corresponding author), Michigan Technol Univ, Dept Chem, Houghton, MI 49931 USA.		Cramer, Christopher J/B-6179-2011	Cramer, Christopher J/0000-0001-5048-1859; Ellis, John/0000-0002-4711-3104				Adamo C, 1998, J CHEM PHYS, V108, P664, DOI 10.1063/1.475428; Al-Ktaifani M, 2001, J CHEM SOC DALTON, P1726, DOI 10.1039/b101014j; BARTSCH R, 1988, J ORGANOMET CHEM, V356, pC1, DOI 10.1016/0022-328X(88)80681-8; Bartsch R, 2001, J CHEM SOC DALTON, P1013, DOI 10.1039/b009481l; Bartsch R, 1997, J ORGANOMET CHEM, V529, P375, DOI 10.1016/S0022-328X(96)06617-X; BARTSCH R, 1987, J CHEM SOC CHEM COMM, P1146, DOI 10.1039/c39870001146; BAUDLER M, 1988, ANGEW CHEM INT EDIT, V27, P280, DOI 10.1002/anie.198802801; BAUDLER M, 1987, Z ANORG ALLG CHEM, V544, P87, DOI 10.1002/zaac.19875440108; BAUDLER M, 1991, ANGEW CHEM INT EDIT, V30, P580, DOI 10.1002/anie.199105801; BENFIELD FW, 1973, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39730000866; BLACKBURN DW, 1992, ANGEW CHEM INT EDIT, V31, P1495, DOI 10.1002/anie.199214951; BOCHMANN M, 1994, ORGANOMETALLICS, V2; Burke K., 1998, ELECT DENSITY FUNCTI; Clark T, 2000, ANGEW CHEM INT EDIT, V39, P2087, DOI 10.1002/1521-3773(20000616)39:12<2087::AID-ANIE2087>3.0.CO;2-B; Cloke FGN, 1999, CHEM COMMUN, P1731, DOI 10.1039/a905469c; Cloke FGN, 2000, J CHEM SOC DALTON, P3534, DOI 10.1039/b005657j; Dillon K. B., 1998, PHOSPHORUS CARBON CO; Dransfeld A, 1998, INORG CHEM, V37, P4413, DOI 10.1021/ic971385y; ELLIS JE, 1993, J AM CHEM SOC, V115, P11616, DOI 10.1021/ja00077a078; ELSCHENBROICH E, 1989, ORGANOMETALLICS; EVANS DF, 1959, J CHEM SOC, P2003, DOI 10.1039/jr9590002003; FRYZUK MD, 1990, COORDIN CHEM REV, V99, P137, DOI 10.1016/0010-8545(90)80063-Y; Garnovskii AD, 1998, COORDIN CHEM REV, V173, P31, DOI 10.1016/S0010-8545(98)00084-8; HAALAND A, 1979, ACCOUNTS CHEM RES, V12, P415, DOI 10.1021/ar50143a006; HAMILTON TP, 1989, ANGEW CHEM INT EDIT, V28, P485, DOI 10.1002/anie.198904851; Hehre W. J., 1986, AB INITIO MOL ORBITA; HITCHCOCK PB, 1995, J ORGANOMET CHEM, V490, P155, DOI 10.1016/0022-328X(94)05212-T; KEALY TJ, 1951, NATURE, V168, P1039, DOI 10.1038/1681039b0; Lein M, 2001, CHEM-EUR J, V7, P4155, DOI 10.1002/1521-3765(20011001)7:19<4155::AID-CHEM4155>3.0.CO;2-M; LONG NJ, 1998, METALLOCENES; MALAR EJP, 1992, J ORG CHEM, V57, P3694, DOI 10.1021/jo00039a034; MILLER SA, 1952, J CHEM SOC, P632, DOI 10.1039/jr9520000632; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Scherer OJ, 1998, ORGANOMETALLICS, V17, P4110, DOI 10.1021/om9801148; Scherer OJ, 1999, ACCOUNTS CHEM RES, V32, P751, DOI 10.1021/ar970317c; SCHERER OJ, 1990, ANGEW CHEM INT EDIT, V29, P1104, DOI 10.1002/anie.199011041; SCHERER OJ, 1987, ANGEW CHEM INT EDIT, V26, P1153, DOI 10.1002/anie.198711531; Stowasser R, 1999, J AM CHEM SOC, V121, P3414, DOI 10.1021/ja9826892; TOGNI A, 1998, METALLOCENES SYNTHES; WEBER L, 1992, CHEM REV, V92, P1839, DOI 10.1021/cr00016a008; Winter RF, 1999, ORGANOMETALLICS, V18, P1827, DOI 10.1021/om9809724; WONG KLT, 1975, J AM CHEM SOC, V97, P5143, DOI 10.1021/ja00851a020; WOODWARD RB, 1952, J AM CHEM SOC, V74, P3458, DOI 10.1021/ja01133a543	43	183	187	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					832	834		10.1126/science.1067325	http://dx.doi.org/10.1126/science.1067325			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823635				2022-12-28	WOS:000173733000038
J	Schwartz, RS				Schwartz, RS			Perspective - A needle in a haystack of genes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	1	2	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					302	304		10.1056/NEJM200201313460502	http://dx.doi.org/10.1056/NEJM200201313460502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821505				2022-12-28	WOS:000173545300001
J	Lamptey, PR				Lamptey, PR			Reducing heterosexual transmission of HIV in poor countries	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEXUALLY-TRANSMITTED-DISEASES; PREVENTION; INFECTION; AIDS		Family Hlth Int, AIDS Inst, Arlington, VA 22201 USA		Lamptey, PR (corresponding author), Family Hlth Int, AIDS Inst, 2101 Wilson Blvd,Suite 700, Arlington, VA 22201 USA.	Plamptey@fhi.org						*AIDS CONS, 1999, VULN GIRL CHILD HIV; *CAMB MIN HLTH, 2000, UNPUB CAMB SENT SURV; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; COLEBUNDERS R, 2002, HIV AIDS PREV CAR RE; DELAY P, 2002, HIV AIDS PREVENTION; FLANAGAN D, 2001, FHI UNAIDS BEST PRAC; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; LAMPTEY P, 2000, 13 INT AIDS C DURB S; LARIVEE C, 2001, STRATEGIES EXPANDED; Mhalu FS, 1996, E AFR MED J, V73, P13; OVER M, 1993, DIS CONTROL PRIORITI, P445; *U NAIR MAN, 2001, STD PROJ SEX WORK IN; *UNAIDS, 2002, BEST PRACT DIG STI H; *UNAIDS, 2002, AIDS EP UPD DEC 2001; *UNAIDS, 1996, RED WOM VULN HIV INF; *UNICEF INN RES CT, 2000, DOM VIOL WOM GIRLS; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	19	35	35	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2002	324	7331					207	211		10.1136/bmj.324.7331.207	http://dx.doi.org/10.1136/bmj.324.7331.207			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809643	Green Published			2022-12-28	WOS:000173604800018
J	Makgoba, MW; Solomon, N; Tucker, TJP				Makgoba, MW; Solomon, N; Tucker, TJP			Science, medicine, and the future - The search for an HIV vaccine	BRITISH MEDICAL JOURNAL			English	Review							RESPONSES; VIRUS; PROSTITUTES; INFECTION; NAIROBI		S African MRC, ZA-7505 Cape Town, South Africa	South African Medical Research Council	Makgoba, MW (corresponding author), S African MRC, Fransie van Zijl Dr,Parow Valley, ZA-7505 Cape Town, South Africa.							Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2001, IMMUNOL LETT, V79, P57, DOI 10.1016/S0165-2478(01)00266-8; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Cohen J, 2001, IAPAC Mon, V7, P268; Hulskotte EGJ, 1998, VACCINE, V16, P904, DOI 10.1016/S0264-410X(97)00292-2; Joy A K, 1999, Drugs R D, V1, P431, DOI 10.2165/00126839-199901060-00001; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PU R, 1997, LEUKEMIA S3, V11, pS98; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; ROWLANDJONES SL, 1995, CURR OPIN IMMUNOL, V7, P448, DOI 10.1016/0952-7915(95)80087-5; *UNAIDS, 2002, AIDS EP UPD DEC 2001	12	13	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					211	213		10.1136/bmj.324.7331.211	http://dx.doi.org/10.1136/bmj.324.7331.211			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809644	Green Published			2022-12-28	WOS:000173604800019
J	Ruitenberg, A; van Swieten, JC; Witteman, JCM; Mehta, KM; van Duijn, CM; Hofman, A; Breteler, MMB				Ruitenberg, A; van Swieten, JC; Witteman, JCM; Mehta, KM; van Duijn, CM; Hofman, A; Breteler, MMB			Alcohol consumption and risk of dementia: the Rotterdam Study	LANCET			English	Article							APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; ACETYLCHOLINE; VALIDATION; DIAGNOSIS; DRINKING; ETHANOL; HEALTH; WINE	Background Light-to-moderate alcohol consumption reduces the risk of coronary heart disease and stroke. Because vascular disease is associated with cognitive impairment and dementia, we hypothesised that alcohol consumption might also affect the risk of dementia. Methods We examined the relation between alcohol consumption and risk of dementia in individuals taking part in the Rotterdam Study-a prospective population-based study of 7983 individuals aged 55 years and older. We studied all participants who did not have dementia at baseline (1990-93) and who had complete data on alcohol consumption (n=5395). Through follow-up examinations in 1993-94 and 1997-99 and an extensive monitoring system, we obtained nearly complete follow-up (99.7%) until the end of 1999. We used proportional hazards regression analysis, adjusted for age, sex, systolic blood pressure, education, smoking, and body-mass index, to compare the risk of developing dementia between individuals who regularly consumed alcohol and individuals who did not consume alcohol. Findings The average follow-up was 6.0 years. During this period, 197 individuals developed dementia (146 Alzheimer's disease, 29 vascular dementia, 22 other dementia). The median alcohol consumption was 0.29 drinks per day. Light-to-moderate drinking (one to three drinks per day) was significantly associated with a lower risk of any dementia (hazard ratio 0.58 [95% CI 0.38-0.90]) and vascular dementia (hazard ratio 0.29 [0.09-0.93]). We found no evidence that the relation between alcohol and dementia varied by type of alcoholic beverage. Interpretation These findings suggest that light-to-moderate alcohol consumption is associated with a reduced risk of dementia in individuals aged 55 years or older. The effect seems to be unchanged by the source of alcohol.	Eramus Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Eramus Med Ctr, Dept Neurol, NL-3000 DR Rotterdam, Netherlands; Eramus Med Ctr, Netherlands Inst Hlth Sci, NL-3000 DR Rotterdam, Netherlands		Breteler, MMB (corresponding author), Eramus Med Ctr, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	breteler@epib.fgg.eur.nl	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305; Van Duijn, Cornelia/0000-0002-2374-9204; van Swieten, John/0000-0001-6278-6844				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; BYERS T, 1987, AM J EPIDEMIOL, V125, P999, DOI 10.1093/oxfordjournals.aje.a114638; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; FENN CG, 1982, THROMB HAEMOSTASIS, V48, P49; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; GOLDBERG DM, 1995, CLIN CHIM ACTA, V237, P155, DOI 10.1016/0009-8981(95)06069-P; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Hebert R, 2000, STROKE, V31, P1487, DOI 10.1161/01.STR.31.7.1487; Henn C, 1998, N-S ARCH PHARMACOL, V357, P640, DOI 10.1007/PL00005219; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; JOYCE EM, 1994, BRIT MED BULL, V50, P99, DOI 10.1093/oxfordjournals.bmb.a072888; KLATSKY AL, 1986, CIRCULATION, V73, P628, DOI 10.1161/01.CIR.73.4.628; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER NE, 1988, J EPIDEMIOL COMMUN H, V42, P220, DOI 10.1136/jech.42.3.220; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; RUITENBERG A, IN PRESS NEUROBIOL A; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Skoog I, 1998, NEUROEPIDEMIOLOGY, V17, P2, DOI 10.1159/000026147; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; 1993, NEVO TABLE DUTCH FOO	34	359	367	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					281	286		10.1016/S0140-6736(02)07493-7	http://dx.doi.org/10.1016/S0140-6736(02)07493-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830193				2022-12-28	WOS:000173588100007
J	Condit, R; Pitman, N; Leigh, EG; Chave, J; Terborgh, J; Foster, RB; Nunez, P; Aguilar, S; Valencia, R; Villa, G; Muller-Landau, HC; Losos, E; Hubbell, SP				Condit, R; Pitman, N; Leigh, EG; Chave, J; Terborgh, J; Foster, RB; Nunez, P; Aguilar, S; Valencia, R; Villa, G; Muller-Landau, HC; Losos, E; Hubbell, SP			Beta-diversity in tropical forest trees	SCIENCE			English	Article							PATTERNS; SIMILARITY; DISPERSAL; DECAY	The high alpha-diversity of tropical forests has been amply documented, but beta-diversity-how species composition changes with distance has seldom been studied. We present quantitative estimates of beta-diversity for tropical trees by comparing species composition of plots in lowland terra firme forest in Panama, Ecuador, and Peru. We compare observations with predictions derived from a neutral model in which habitat is uniform and only dispersal and speciation influence species turnover. We find that beta-diversity is higher in Panama than in western Amazonia and that patterns in both areas are inconsistent with the neutral model. In Panama, habitat variation appears to increase species turnover relative to Amazonia, where unexpectedly tow turnover over great distances suggests that population densities of some species are bounded by as yet unidentified processes. At intermediate scales in both regions, observations can be matched by theory, suggesting that dispersal limitation, with speciation, influences species turnover.	Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Unit 0948, APO, AA 34002 USA; Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA; Univ Toulouse 2, CNRS, UMR 5552, Lab Ecol Terr, F-31029 Toulouse, France; Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Nacl San Antonio de Abad, Herbario Vargas, Cuzco, Peru; Pontificia Univ Catolica del Ecuador, Dept Biol Sci, Quito, Ecuador; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Smithsonian Inst, Ctr Trop Forest Sci, Washington, DC 20560 USA; Univ Georgia, Dept Bot, Athens, GA 30602 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Duke University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Field Museum of Natural History (Chicago); Pontificia Universidad Catolica del Ecuador; Princeton University; Smithsonian Institution; University System of Georgia; University of Georgia	Condit, R (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Unit 0948, APO, AA 34002 USA.		Pitman, Nigel C A/A-7681-2008	Pitman, Nigel C A/0000-0002-9211-2880; Muller-Landau, Helene C./0000-0002-3526-9021; Valencia, Renato/0000-0001-9770-6568				Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrison S, 1997, ECOLOGY, V78, P1898, DOI 10.1890/0012-9658(1997)078[1898:HNHPAT]2.0.CO;2; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; Hubbell Stephen P., 2001, V32, pi; Malecot G., 1969, MATH HEREDITY; Muller-Landau HC, 2001, THESIS PRINCETON U P; NAGYLAKI T, 1974, P NATL ACAD SCI USA, V71, P2932, DOI 10.1073/pnas.71.8.2932; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Wright SJ, 1995, J ECOL, V83, P937, DOI 10.2307/2261176; [No title captured]	17	974	1064	12	419	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					666	669		10.1126/science.1066854	http://dx.doi.org/10.1126/science.1066854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809969				2022-12-28	WOS:000173560900041
J	Ivell, R				Ivell, R			Endocrinology - This hormone has been relaxin' too long!	SCIENCE			English	Editorial Material							ENDOTHELIAL GROWTH-FACTOR; FACTOR EXPRESSION; CRYPTORCHIDISM; ACTIVATION; SECRETION; MARKER		Univ Hamburg, Inst Hormone & Fertil Res, D-22529 Hamburg, Germany	University of Hamburg	Ivell, R (corresponding author), Univ Hamburg, Inst Hormone & Fertil Res, Grandweg 64, D-22529 Hamburg, Germany.	ivell@ihf.de		Ivell, Richard/0000-0001-6513-2109				Balvers M, 1998, ENDOCRINOLOGY, V139, P2960, DOI 10.1210/en.139.6.2960; Bartsch O, 2001, MOL HUM REPROD, V7, P799, DOI 10.1093/molehr/7.9.799; Bullesbach EE, 1999, ENDOCRINE, V10, P167, DOI 10.1385/ENDO:10:2:167; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Einspanier A, 1999, BIOL REPROD, V61, P512, DOI 10.1095/biolreprod61.2.512; Garber SL, 2001, KIDNEY INT, V59, P876, DOI 10.1046/j.1523-1755.2001.059003876.x; Hisaw FL, 1926, P SOC EXP BIOL MED, V23, P661; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; IRVINGRODGERS HF, IN PRESS BIOL REPROD; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; Palejwala S, 1998, ENDOCRINOLOGY, V139, P1208, DOI 10.1210/en.139.3.1208; STEWART DR, 1993, CLIN ENDOCRINOL, V38, P379, DOI 10.1111/j.1365-2265.1993.tb00518.x; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Unemori EN, 2000, WOUND REPAIR REGEN, V8, P361, DOI 10.1111/j.1524-475X.2000.00361.x; Unemori EN, 1999, HUM REPROD, V14, P800, DOI 10.1093/humrep/14.3.800; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	17	20	21	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					637	638		10.1126/science.1069234	http://dx.doi.org/10.1126/science.1069234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809958				2022-12-28	WOS:000173560900030
J	Van Dyke, T; Jacks, T				Van Dyke, T; Jacks, T			Cancer Modeling in the modern era: Progress and challenges	CELL			English	Review							REPORTER GENE-EXPRESSION; TRANSGENIC MOUSE MODELS; SUPPRESSES TUMORIGENESIS; CONDITIONAL EXPRESSION; TELOMERE DYSFUNCTION; NEURAL PROGENITORS; TUMOR PROGRESSION; RETINOIC ACID; MICE; GROWTH	Genetically engineered mouse models have contributed extensively to the field of cancer research. The ability to manipulate the mouse germline affords numerous approaches toward understanding the complexities of this disease, possibly providing accurate preclinical models for therapeutic and diagnostic advances. This review highlights some of the current strategies for modeling cancer in the mouse, recent accomplishments, and key remaining challenges.	Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Ctr Canc, Cambridge, MA 02139 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Van Dyke, T (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	tvdlab@med.unc.edu						ADAMS JM, 1991, SCIENCE, V254, P1161, DOI 10.1126/science.1957168; Alexander J, 2000, TOXICOL LETT, V112, P507, DOI 10.1016/S0378-4274(99)00213-1; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Bearss DJ, 2000, ONCOGENE, V19, P1114, DOI 10.1038/sj.onc.1203275; Benaron DA, 1997, PHILOS T ROY SOC B, V352, P755, DOI 10.1098/rstb.1997.0059; Bergers G, 1998, INT J DEV BIOL, V42, P995; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Berns A, 1999, NAT MED, V5, P989, DOI 10.1038/12421; Berns A, 2001, NATURE, V410, P1043, DOI 10.1038/35074238; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Cavallaro U, 2000, J NEURO-ONCOL, V50, P63, DOI 10.1023/A:1006414621286; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Clarke AR, 2000, CARCINOGENESIS, V21, P435, DOI 10.1093/carcin/21.3.435; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Edelmann W, 1999, CANCER RES, V59, P1301; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Ewald D, 1996, SCIENCE, V273, P1384, DOI 10.1126/science.273.5280.1384; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Gambhir SS, 2000, P NATL ACAD SCI USA, V97, P2785, DOI 10.1073/pnas.97.6.2785; Giovannini M, 2000, GENE DEV, V14, P1617; Graveel CR, 2001, ONCOGENE, V20, P2704, DOI 10.1038/sj.onc.1204391; Green JE, 2001, CANCER RES, V61, P7449; Hann B, 2001, CURR OPIN CELL BIOL, V13, P778, DOI 10.1016/S0955-0674(00)00283-0; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Herschman HR, 2000, J NEUROSCI RES, V59, P699, DOI 10.1002/(SICI)1097-4547(20000315)59:6<699::AID-JNR1>3.3.CO;2-T; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Hoffman RM, 2001, BIOTECHNIQUES, V30, P1016, DOI 10.2144/01305bi01; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hsu CX, 1998, J UROLOGY, V160, P1500, DOI 10.1016/S0022-5347(01)62603-X; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Jacks T, 1996, ANNU REV GENET, V30, P603, DOI 10.1146/annurev.genet.30.1.603; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kennel SJ, 2000, MED PHYS, V27, P1101, DOI 10.1118/1.598974; KOHL NE, 1995, NAT MED, V1, P792, DOI 10.1038/nm0895-792; KUMAR TR, 1995, J INTERN MED, V238, P233, DOI 10.1111/j.1365-2796.1995.tb00928.x; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lenferink AEG, 2000, P NATL ACAD SCI USA, V97, P9609, DOI 10.1073/pnas.160564197; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Liao MJ, 1999, MOL CELL BIOL, V19, P3095; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lozano G, 1998, SEMIN CANCER BIOL, V8, P337, DOI 10.1006/scbi.1998.0096; Lu XD, 2001, MOL CELL BIOL, V21, P6017, DOI 10.1128/MCB.21.17.6017-6030.2001; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Macleod KF, 1999, J PATHOL, V187, P43, DOI 10.1002/(SICI)1096-9896(199901)187:1<43::AID-PATH246>3.0.CO;2-P; Mahgoub N, 1999, BLOOD, V94, P2469, DOI 10.1182/blood.V94.7.2469.419a01_2469_2476; Marino S, 2000, GENE DEV, V14, P994; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Norgaard P, 1999, CLIN CANCER RES, V5, P35; Omer CA, 2000, CANCER RES, V60, P2680; ORSULIC S, 2002, IN PRESS CANC CELL; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; PARANGI S, 1995, CANCER RES, V55, P6071; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; Reichert A, 2001, BLOOD, V97, P1399, DOI 10.1182/blood.V97.5.1399; Resor L, 2001, HUM MOL GENET, V10, P669, DOI 10.1093/hmg/10.7.669; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Seitz U, 2001, CANCER RES, V61, P3853; Shi YP, 1997, GENE CHROMOSOME CANC, V19, P104, DOI 10.1002/(SICI)1098-2264(199706)19:2<104::AID-GCC6>3.3.CO;2-S; Shoemaker AR, 2000, ONCOGENE, V19, P2774, DOI 10.1038/sj.onc.1203574; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Tien PC, 1999, J ACQ IMMUN DEF SYND, V20, P147, DOI 10.1097/00042560-199902010-00006; TOLBERT D, 2002, IN PRESS MOL CELL BI; Tung CH, 2000, CANCER RES, V60, P4953; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang XJ, 1999, P NATL ACAD SCI USA, V96, P8483, DOI 10.1073/pnas.96.15.8483; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang WS, 2001, TRANSGENIC RES, V10, P423, DOI 10.1023/A:1012042506002	88	264	280	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					135	144		10.1016/S0092-8674(02)00621-9	http://dx.doi.org/10.1016/S0092-8674(02)00621-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832204	Bronze			2022-12-28	WOS:000173521300001
J	Muller-Oerlinghausen, B; Berghofer, A; Bauer, M				Muller-Oerlinghausen, B; Berghofer, A; Bauer, M			Bipolar disorder	LANCET			English	Review							MAJOR MOOD DISORDERS; DOUBLE-BLIND; MAINTENANCE TREATMENT; LITHIUM PROPHYLAXIS; SUICIDAL-BEHAVIOR; DRUG-TREATMENT; MANIA; CARBAMAZEPINE; DEPRESSION; THERAPY	Bipolar, or manic-depressive, disorder is a frequent, severe, mostly recurrent mood disorder associated with great morbidity. The lifetime prevalence of bipolar disorder is 1.3 to 1.6%. The mortality rate of the disease Is two to three times higher than that of the general population. About 10-20% of individuals with bipolar disorder take their own life, and nearly one third of patients admit to at least one suicide attempt. The clinical manifestations of the disease are exceptionally diverse. They range from mild hypomania or mild depression to: severe forms of mania or depression accompanied by profound psychosis. Bipolar disorder is equally prevalent across sexes, with the exception of rapid cycling, a severe and difficult to treat variant of the disorder, which arises mostly in women. Because of the high risk of recurrence and suicide, long-term prophylactic pharmacological treatment is indicated. Lithium salts are the first choice long-term preventive treatment for bipolar disorder. They also possess dwell documented antisuicidal effects. Second choice prophylactic treatments are carbamazepine and valproate, although evidence of their effectiveness Is weaker.	Free Univ Berlin, Dept Psychiat, Res Grp Clin Psychopharmacol, D-1000 Berlin, Germany; Humboldt Univ, Charite Hosp, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; Univ Calif Los Angeles, Neuropsychiat Inst & Hosp, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles	Muller-Oerlinghausen, B (corresponding author), Jebensstr 3, D-10623 Berlin, Germany.	bmoe@zedat.fu-berlin.de		Berghofer, Anne/0000-0002-7897-6500				Alda M, 1999, J PSYCHIATR NEUROSCI, V24, P154; Alda M, 2000, AM J MED GENET, V96, P178, DOI 10.1002/(SICI)1096-8628(20000403)96:2<178::AID-AJMG11>3.0.CO;2-C; Altshuler LL, 1998, ARCH GEN PSYCHIAT, V55, P663, DOI 10.1001/archpsyc.55.7.663; [Anonymous], 1994, Am J Psychiatry, V151, P1; Baldessarini R J, 1999, Bipolar Disord, V1, P17, DOI 10.1034/j.1399-5618.1999.10106.x; Bauer M, 1999, J CLIN PSYCHOPHARM, V19, P164, DOI 10.1097/00004714-199904000-00012; Bauer M, 1998, NEUROPSYCHOPHARMACOL, V18, P444, DOI 10.1016/S0893-133X(97)00181-4; BAUER M, 2001, WORLD J BIOL PSYCHIA, V2, P57; BAUER MS, 1990, ARCH GEN PSYCHIAT, V47, P435; BAUMGARTNER A, 1994, NEUROPSYCHOPHARMACOL, V10, P183, DOI 10.1038/npp.1994.20; Bearden CE, 2001, BIPOLAR DISORD, V3, P106, DOI 10.1034/j.1399-5618.2001.030302.x; BERGHOFER A, 1997, BIOL PSYCHIAT, V42, pS78; BERKY M, 1998, EUR ARCH PSY CLIN N, V248, pS119; Bowden CL, 1998, NEUROPSYCHOPHARMACOL, V19, P194, DOI 10.1016/S0893-133X(98)00025-6; Calabrese JR, 1999, J CLIN PSYCHIAT, V60, P79, DOI 10.4088/JCP.v60n0203; CALABRESE JR, 1993, CAN J PSYCHIAT, V38, pS57; Chengappa KNR, 2000, BIPOLAR DISORD, V2, P47, DOI 10.1034/j.1399-5618.2000.020107.x; Chou JCY, 1996, ANN PHARMACOTHER, V30, P1396, DOI 10.1177/106002809603001206; Compton MT, 2000, J CLIN PSYCHIAT, V61, P57; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drevets WC, 1999, BIOL PSYCHIAT, V46, P1375, DOI 10.1016/S0006-3223(99)00189-4; Duffy A, 2000, J CLIN PSYCHIAT, V61, P630, DOI 10.4088/JCP.v61n0906; ELLICOTT A, 1990, AM J PSYCHIAT, V147, P1194; Ernst E, 1998, ARCH GEN PSYCHIAT, V55, P1026, DOI 10.1001/archpsyc.55.11.1026; FAEDDA GL, 1993, ARCH GEN PSYCHIAT, V50, P448; Fava GA, 1999, PSYCHOTHER PSYCHOSOM, V68, P171, DOI 10.1159/000012329; Frank E., 1994, BEHAV THERAPIST, V17, P143; Freeman MP, 1998, AM J PSYCHIAT, V155, P12, DOI 10.1176/ajp.155.1.12; Frye MA, 1998, J AFFECT DISORDERS, V48, P91, DOI 10.1016/S0165-0327(97)00160-2; Gelenberg AJ, 1996, J CLIN PSYCHIAT, V57, P49; GHAEMI SN, 1999, J CLIN PSYCHOPHARM, V19, P453; GITLIN MJ, 1995, AM J PSYCHIAT, V152, P1635; GOODALE LC, 2001, BIPOLAR DISORD S, V3, P19; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Goodwin FK, 1999, J CLIN PSYCHIAT, V60, P89; Greil W, 1997, EUR ARCH PSY CLIN N, V247, P42, DOI 10.1007/BF02916252; Greil W, 1997, J AFFECT DISORDERS, V43, P151, DOI 10.1016/S0165-0327(96)01427-9; Greil W, 1998, J CLIN PSYCHOPHARM, V18, P455, DOI 10.1097/00004714-199812000-00007; Grof P, 1998, NEUROPSYCHOPHARMACOL, V19, P183, DOI 10.1016/S0893-133X(98)00023-2; GUSCOTT R, 1994, BRIT J PSYCHIAT, V164, P741, DOI 10.1192/bjp.164.6.741; Jamison K. R., 1993, TOUCHED FIRE MANIC D, DOI [10.4135/9781483349985.n388, DOI 10.4135/9781483349985.N388]; Janowsky David S., 1995, P945; JOHNSON FN, 1980, HDB LITHIUM THERAPY; KECK PE, 2000, SCHIZOPHRENIA MOOD D, P199; Lambert PA, 1992, NERVURE, V5, P57; Licht RW, 1998, ACTA PSYCHIAT SCAND, V97, P387, DOI 10.1111/j.1600-0447.1998.tb10020.x; Looney S W, 1997, Depress Anxiety, V5, P53, DOI 10.1002/(SICI)1520-6394(1997)5:2<53::AID-DA1>3.0.CO;2-6; Maj M, 2000, BIPOLAR DISORD, V2, P93, DOI 10.1034/j.1399-5618.2000.020202.x; Manji HK, 2000, BIOL PSYCHIAT, V48, P740, DOI 10.1016/S0006-3223(00)00979-3; Manji HK, 2000, BIOL PSYCHIAT, V48, P518, DOI 10.1016/S0006-3223(00)00929-X; MCELROY SL, 1992, J CLIN PSYCHOPHARM, V12, pS42, DOI 10.1097/00004714-199202001-00007; Miklowitz DJ, 1996, J CLIN PSYCHOPHARM, V16, pS56, DOI 10.1097/00004714-199604001-00007; MUKHERJEE S, 1994, AM J PSYCHIAT, V151, P169; Muller-Oerlinghausen B, 2000, J CLIN PSYCHOPHARM, V20, P195, DOI 10.1097/00004714-200004000-00012; Nemeroff CB, 2001, AM J PSYCHIAT, V158, P906, DOI 10.1176/appi.ajp.158.6.906; POST RM, 1992, AM J PSYCHIAT, V149, P1727; Post RM, 1998, NEUROPSYCHOPHARMACOL, V19, P206, DOI 10.1016/S0893-133X(98)00020-7; Sachs GS, 2000, BIPOLAR DISORD, V2, P256, DOI 10.1034/j.1399-5618.2000.20306.x; Schou M, 2000, SUICIDE LIFE-THREAT, V30, P289; Schou M, 1997, ARCH GEN PSYCHIAT, V54, P9; Soares JC, 1997, J PSYCHIATR RES, V31, P393, DOI 10.1016/S0022-3956(97)00016-2; Stoll AL, 1996, HARVARD REV PSYCHIAT, V4, P77, DOI 10.3109/10673229609030527; Strakowski SM, 1999, ARCH GEN PSYCHIAT, V56, P254, DOI 10.1001/archpsyc.56.3.254; Strakowski SM, 2000, BIPOLAR DISORD, V2, P148, DOI 10.1034/j.1399-5618.2000.020302.x; Tohen M, 2000, ARCH GEN PSYCHIAT, V57, P841, DOI 10.1001/archpsyc.57.9.841; Tondo L, 1997, ANN NY ACAD SCI, V836, P339, DOI 10.1111/j.1749-6632.1997.tb52369.x; Turecki G, 1998, MOL PSYCHIATR, V3, P534, DOI 10.1038/sj.mp.4000447; Vawter MP, 2000, BIOL PSYCHIAT, V48, P486, DOI 10.1016/S0006-3223(00)00978-1; Willner Paul, 1995, P921; WOLF T, IN PRESS BIPOLAR DIS; WYATT RJ, 1995, SOC PSYCH PSYCH EPID, V30, P213; Young LT, 2000, AM J PSYCHIAT, V157, P124, DOI 10.1176/ajp.157.1.124; Yurgelun-Todd DA, 2000, BIPOLAR DISORD, V2, P237, DOI 10.1034/j.1399-5618.2000.20304.x	75	267	282	2	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2002	359	9302					241	247		10.1016/S0140-6736(02)07450-0	http://dx.doi.org/10.1016/S0140-6736(02)07450-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512YH	11812578				2022-12-28	WOS:000173350800033
J	Pepperell, JCT; Ramdassingh-Dow, S; Crosthwaite, N; Mullins, R; Jenkinson, C; Stradling, JR; Davies, RJO				Pepperell, JCT; Ramdassingh-Dow, S; Crosthwaite, N; Mullins, R; Jenkinson, C; Stradling, JR; Davies, RJO			Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial	LANCET			English	Article							BRITISH-HYPERTENSION-SOCIETY; LEFT-VENTRICULAR HYPERTROPHY; CORONARY HEART-DISEASE; APNEA SYNDROME; SYSTEMIC HYPERTENSION; DAYTIME SLEEPINESS; ASSOCIATION; VARIABILITY; COMMUNITY; STROKE	Background Obstructive sleep apnoea is associated with raised blood pressure. If blood pressure can be reduced by nasal continuous positive airway pressure (nCPAP), such treatment could reduce risk of cardiovascular disease in patients with obstructive sleep apnoea. Our aim was to see whether nCPAP for sleep apnoea reduces blood pressure compared with the most robust control intervention subtherapeutic nCPAP. Methods We did a randomised parallel trial to compare change in blood pressure in 118 men with obstructive sleep apnoea (Epworth score >9, and a >4% oxygen desaturation index of >10 per h) who were assigned to either therapeutic (n=59) or subtherapeutic (59) nCPAP (about 1 cm H2O pressure) for 1 month. The primary outcome was the change in 24-h mean blood pressure. Secondary outcomes were changes in systolic, diastolic, sleep, and wake blood pressure, and relations between blood pressure changes, baseline blood pressure, and severity of sleep apnoea. Findings Therapeutic nCPAP reduced mean arterial ambulatory blood pressure by 2.5 mm Hg (SE 0.8), whereas subtherapeutic nCPAP increased blood pressure by 0.8 mm Hg (0.7) (difference -3.3 [95% CI -5.3 to -1.3]; p=0.0013, unpaired t test). This benefit was seen in both systolic and diastolic blood pressure, and during both sleep and wake. The benefit was larger in patients with more severe sleep apnoea than those who had less severe apnoea, but was independent of the baseline blood pressure. The benefit was especially large in patients taking drug treatment for blood pressure. Interpretation In patients with most severe sleep apnoea, nCPAP reduces blood pressure, providing significant vascular risk benefits, and substantially improving excessive daytime sleepiness and quality of life.	Oxford Radcliffe Hosp, Oxford Ctr Resp Med, Oxford Sleep Unit, Oxford OX3 7LJ, England; Oxford Radcliffe Hosp, Oxford Ctr Resp Med, Resp Trials Unit, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Pepperell, JCT (corresponding author), Oxford Radcliffe Hosp, Oxford Ctr Resp Med, Oxford Sleep Unit, Churchill Hosp Site, Oxford OX3 7LJ, England.			Stradling, John/0000-0003-4971-5018				AKASHIBA T, 1995, INTERNAL MED, V34, P528, DOI 10.2169/internalmedicine.34.528; Argod J, 1998, AM J RESP CRIT CARE, V158, P1778, DOI 10.1164/ajrccm.158.6.9804157; Bennett LS, 1998, AM J RESP CRIT CARE, V158, P778, DOI 10.1164/ajrccm.158.3.9711033; Bennett LS, 1997, J SLEEP RES, V6, P142, DOI 10.1046/j.1365-2869.1997.00039.x; Brooks D, 1997, J CLIN INVEST, V99, P106, DOI 10.1172/JCI119120; Chin K, 1996, AM J RESP CRIT CARE, V153, P1972, DOI 10.1164/ajrccm.153.6.8665063; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Davies CWH, 2000, THORAX, V55, P736, DOI 10.1136/thorax.55.9.736; DAVIES RJO, 1993, THORAX, V48, P1242, DOI 10.1136/thx.48.12.1242; Engleman HM, 1998, THORAX, V53, P341, DOI 10.1136/thx.53.5.341; Faccenda JF, 2001, AM J RESP CRIT CARE, V163, P344, DOI 10.1164/ajrccm.163.2.2005037; Fagard RH, 1997, J HYPERTENS, V15, P1493, DOI 10.1097/00004872-199715120-00018; FLETCHER EC, 1995, AM J MED, V98, P118, DOI 10.1016/S0002-9343(99)80395-7; FLORAS JS, 1978, CLIN SCI MOL MED, V55, P395; GUILLEMINAULT C, 1983, AM J CARDIOL, V52, P490, DOI 10.1016/0002-9149(83)90013-9; HEDNER J, 1995, EUR RESPIR J, V8, P222, DOI 10.1183/09031936.95.08020222; Jenkinson C, 1999, LANCET, V353, P2100, DOI 10.1016/S0140-6736(98)10532-9; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kiely JL, 2000, EUR RESPIR J, V16, P128, DOI 10.1034/j.1399-3003.2000.16a23.x; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MARRONE O, 1993, CHEST, V103, P722, DOI 10.1378/chest.103.3.722; MAYER J, 1991, CARDIOLOGY, V79, P84, DOI 10.1159/000174864; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; OBRIEN E, 1991, J HYPERTENS, V9, P571; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P711, DOI 10.1164/ajrccm.152.2.7633731; Parati G, 1998, J HYPERTENS, V16, pS25; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PHILLIPSON EA, 1993, NEW ENGL J MED, V328, P1271, DOI 10.1056/NEJM199304293281712; PICKERING TG, 1987, CIRCULATION, V76, P77; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Stradling JR, 2000, J SLEEP RES, V9, P381, DOI 10.1046/j.1365-2869.2000.00218.x; SUZUKI M, 1993, SLEEP, V16, P545, DOI 10.1093/sleep/16.6.545; Suzuki M, 1996, SLEEP, V19, P382, DOI 10.1093/sleep/19.5.382; Verdecchia P, 2000, HYPERTENSION, V35, P844, DOI 10.1161/01.HYP.35.3.844; VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528; VERDECCHIA P, 1990, AM J CARDIOL, V66, P583, DOI 10.1016/0002-9149(90)90485-J; WILCOX I, 1993, SLEEP, V16, P539, DOI 10.1093/sleep/16.6.539; Wright J, 1997, BRIT MED J, V314, P851; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; 1997, BMJ, V314, P833	42	722	746	0	22	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					204	210		10.1016/S0140-6736(02)07445-7	http://dx.doi.org/10.1016/S0140-6736(02)07445-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812555				2022-12-28	WOS:000173350800011
J	Winston, WM; Molodowitch, C; Hunter, CP				Winston, WM; Molodowitch, C; Hunter, CP			Systemic RNAi in C-elegans requires the putative transmembrane protein SID-1	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE	Double-stranded RNA-mediated gene interference (RNAi) in Caenorhabditis elegans systemically inhibits gene expression throughout the organism. To investigate how gene-specific silencing information is transmitted between cells, we constructed a strain that permits visualization of systemic RNAi. We used this strain to identify systemic RNA interference-deficient (sid) loci required to spread gene-silencing information between tissues but not to initiate or maintain an RNAi response. One of these loci, sid-1, encodes a conserved protein with predicted transmembrane domains. SID-1 is expressed in cells sensitive to RNAi, is localized to the cell periphery, and is required cell-autonomously for systemic RNAi.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Hunter, CP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.							BUCH JP, 1985, UROL CLIN N AM, V12, P3; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fagard M, 2000, PLANT MOL BIOL, V43, P285, DOI 10.1023/A:1006404016494; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marathe R, 2000, PLANT MOL BIOL, V43, P295, DOI 10.1023/A:1006456000564; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Parrish S, 2001, RNA, V7, P1397; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; WINSTON WM, UNPUB	21	593	657	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2456	2459		10.1126/science.1068836	http://dx.doi.org/10.1126/science.1068836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11834782				2022-12-28	WOS:000174712600057
J	Weimerskirch, H; Bonadonna, F; Bailleul, F; Mabille, G; Dell'Omo, G; Lipp, HP				Weimerskirch, H; Bonadonna, F; Bailleul, F; Mabille, G; Dell'Omo, G; Lipp, HP			GPS tracking of foraging albatrosses	SCIENCE			English	Editorial Material							SEABIRDS; FLIGHT		Ctr Etud Biol Chize, CNRS, F-79360 Villiers En Bois, France; Inst Francais Rech & Technol Polaire, F-29280 Plouzane, France; Univ Zurich, Inst Anat, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); University of Zurich	Weimerskirch, H (corresponding author), Ctr Etud Biol Chize, CNRS, F-79360 Villiers En Bois, France.		Weimerskirch, Henri/K-7306-2019; Bonadonna, Francesco/A-7456-2008; Weimerskirch, Henri/F-5562-2013	Weimerskirch, Henri/0000-0002-0457-586X; Bonadonna, Francesco/0000-0002-2702-5801; Dell'Omo, Giacomo/0000-0002-9601-9675				ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; Batschelet E., 1981, CIRCULAR STAT BIOL; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1994, P ROY SOC B-BIOL SCI, V255, P91, DOI 10.1098/rspb.1994.0013	8	174	182	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1259	1259		10.1126/science.1068034	http://dx.doi.org/10.1126/science.1068034			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847332				2022-12-28	WOS:000173926000032
J	Xu, X; Norell, MA; Wang, XL; Makovicky, PJ; Wu, XC				Xu, X; Norell, MA; Wang, XL; Makovicky, PJ; Wu, XC			A basal troodontid from the Early Cretaceous of China	NATURE			English	Article							REPUBLIC-OF-CHINA; INNER-MONGOLIA; THEROPOD; DINOSAUR; BIRDS; SKULL	Troodontid dinosaurs form one of the most avian-like dinosaur groups(1-5). Their phylogenetic position is hotly debated, and they have been allied with almost all principal coelurosaurian lineages(6-13). Here we report a basal troodontid dinosaur, Sinovenator changii gen. et sp. nov., from the lower Yixian Formation of China. This taxon has several features that are not found in more derived troodontids, but that occur in dromaeosaurids and avialans. The discovery of Sinovenator and the examination of character distributions along the maniraptoran lineage indicate that principal structural modifications toward avians were acquired in the early stages of maniraptoran evolution.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Amer Museum Nat Hist, New York, NY 10024 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.	xxu@midwest.com.cn						BARSBOLD R, 1987, Acta Palaeontologica Polonica, V32, P121; Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Chatterjee S., 1997, THE RISE OF BIRDS; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, J PALEONTOL, V70, P536; KURZANOV S M, 1976, Paleontologicheskii Zhurnal, P127; Li JL, 2001, CHINESE SCI BULL, V46, P782, DOI 10.1007/BF03187223; MAKIVICKY P, 1998, AM MUS NOVIT, P1; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Osmolska H., 1990, P259; Perle A., 1999, NEW MANIRAPTORAN THE; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; Saurornithoididae BarsboldR., 1974, PALAENTOL POL, V30, P5; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Walker A., 1985, P123; Wang Xiaolin, 1998, Vertebrata Palasiatica, V36, P81; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; XU X, 2000, SPECIAL PUBLICATION, P179; Xu Xing, 2000, Vertebrata Palasiatica, V38, P318	30	161	177	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					780	784		10.1038/415780a	http://dx.doi.org/10.1038/415780a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845206				2022-12-28	WOS:000173833900043
J	Rauschecker, JP; Shannon, RV				Rauschecker, JP; Shannon, RV			Sending sound to the brain	SCIENCE			English	Editorial Material							COCHLEAR; STIMULATION; SPEECH; CORTEX		Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA; House Ear Res Inst, Dept Auditory Implants & Percept, Los Angeles, CA 90057 USA	Georgetown University; House Research Institute	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA.		Rauschecker, Josef P/A-4120-2013	Rauschecker, Josef P./0000-0003-4353-9084				BRACKMANN DE, 1993, OTOLARYNG HEAD NECK, V108, P624, DOI 10.1177/019459989310800602; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; BUI Q, 2000, IEEE T BIOMED ENG, V47, P281; DeLong MR, 2001, ANN NEUROL, V49, P142, DOI 10.1002/1531-8249(20010201)49:2<142::AID-ANA32>3.0.CO;2-O; EDGERTON BJ, 1982, ANN OTO RHINOL LARYN, V91, P117; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; FU Q, UNPUB; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Helmholtz H., 1863, LEHRE TONEMPFINDUNGE; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Kohler I, 1964, FORMATION TRANSFORMA; LOEB GE, 1990, ANNU REV NEUROSCI, V13, P357, DOI 10.1146/annurev.neuro.13.1.357; Matthies C, 2000, J LARYNGOL OTOL, V114, P32; McCreery D B, 1998, IEEE Trans Rehabil Eng, V6, P391, DOI 10.1109/86.736153; MOORE JK, 1979, AM J ANAT, V154, P393, DOI 10.1002/aja.1001540306; Moore JK, 2001, JARO-J ASSOC RES OTO, V2, P297, DOI 10.1007/s101620010052; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; OTTO SR, IN PRESS J NEUROSURG; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Rauschecker JP, 1999, SCIENCE, V285, P1686, DOI 10.1126/science.285.5434.1686; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Rosen S, 1999, J ACOUST SOC AM, V106, P3629, DOI 10.1121/1.428215; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; YOUNG ED, 1992, PHILOS T ROY SOC B, V336, P407, DOI 10.1098/rstb.1992.0076	28	139	155	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1025	+		10.1126/science.1067796	http://dx.doi.org/10.1126/science.1067796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834822				2022-12-28	WOS:000173793000050
J	Li, SP; Lew, WS; Bland, JAC; Lopez-Diaz, L; Natali, M; Vaz, CAF; Chen, Y				Li, SP; Lew, WS; Bland, JAC; Lopez-Diaz, L; Natali, M; Vaz, CAF; Chen, Y			Microstructures - Spin-engineering magnetic media	NATURE			English	Article									Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; CNRS, Microstruct & Microelect Lab, F-92225 Bagneux, France	University of Cambridge; Centre National de la Recherche Scientifique (CNRS)	Li, SP (corresponding author), Univ Cambridge, Cavendish Lab, Madingley Rd, Cambridge CB3 0HE, England.		Vaz, Carlos AF/A-7240-2012; natali, marco/F-8174-2013; Lew, Wen Siang/C-2910-2008; Lew, Wen Siang/O-2794-2019; Chen, Yong/A-1700-2009	Vaz, Carlos AF/0000-0002-6209-8918; Lew, Wen Siang/0000-0002-5161-741X; Lew, Wen Siang/0000-0002-5161-741X; Chen, Yong/0000-0002-2903-8753; Lopez Diaz, Luis/0000-0002-9773-1875				Bochi G, 1996, PHYS REV B, V53, pR1729, DOI 10.1103/PhysRevB.53.R1729; Chappert C, 1998, SCIENCE, V280, P1919, DOI 10.1126/science.280.5371.1919; Chou SY, 1997, P IEEE, V85, P652, DOI 10.1109/5.573754; Hope S, 1997, PHYS REV B, V55, P11422, DOI 10.1103/PhysRevB.55.11422; Krusin-Elbaum L, 2001, NATURE, V410, P444, DOI 10.1038/35068515; Lew WS, 2000, J APPL PHYS, V87, P5947, DOI 10.1063/1.372575; OBRIEN WL, 1994, PHYS REV B, V49, P15370, DOI 10.1103/PhysRevB.49.15370	7	36	36	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					600	601		10.1038/415600a	http://dx.doi.org/10.1038/415600a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832931				2022-12-28	WOS:000173709100031
J	Gallivan, S; Utley, M; Treasure, T; Valencia, S				Gallivan, S; Utley, M; Treasure, T; Valencia, S			Booked inpatient admissions and hospital capacity: mathematical modelling study	BRITISH MEDICAL JOURNAL			English	Article							SYSTEM; DESIGN	Objectives To investigate the variability of patients' length of stay in intensive care after cardiac surgery. To investigate potential interactions between such variability, booked admissions, and capacity requirements. Design Mathematical modelling study using routinely collected data. Setting A cardiac surgery department. Source of data Hospital records of 7014 people entering intensive care after cardiac surgery. Main outcome measures Length of stay in intensive care; capacity requirements of an intensive care unit for a hypothetical booked admission system. Results Although the vast majority of patients (89.5%) had a length of stay in intensive care of less than or equal to48 hours, there was considerable overall variability and the distribution of stays has a lengthy tail. A mathematical model of the operation of a hypothetical booking system indicates that such variability has a considerable impact on intensive care capacity requirements, indicating that a high degree of reserve capacity is required to avoid high rates of operation cancellation because of unavailability of suitable postoperative care. Conclusion Despite the considerable enthusiasm for booked admissions systems, queuing theory suggests that caution is required when considering such systems for inpatient admissions. Such systems may Well result in frequent operational difficulties if there is a high degree of variability in length of stay and where reserve capacity is limited. Both of these are common in the NHS.	UCL, Clin Operat Res Unit, London WC1E 6BT, England; Guys Hosp, Cardiothorac Unit, London SE1 9RT, England; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; St Georges University London	Gallivan, S (corresponding author), UCL, Clin Operat Res Unit, Mortimer St, London WC1E 6BT, England.	s.gallivan@ucl.ac.uk		Utley, Martin/0000-0001-9928-1516				BAILEY NTJ, 1952, J ROY STAT SOC B, V14, P185; Goodyear OM., 1998, CURRENT PERSPECTIVES, P345; GOODYEAR OM, 1997, CURRENT PERSPECTIVES, P316; HARRIS RA, 1986, EUR J OPER RES, V25, P121, DOI 10.1016/0377-2217(86)90121-9; JACKSON RRP, 1964, OPER RES QUART, V15, P219, DOI 10.2307/3007209; KIPPING R, 2000, BOOKING PATIENTS HOS; Mackay M, 1999, Aust Health Rev, V22, P118; Millard PH, 2000, ANN ROY COLL SURG, V82, P75; VISSERS J, 1979, EUR J OPER RES, V3, P459, DOI 10.1016/0377-2217(79)90245-5; WORTHINGTON D, 1991, J OPER RES SOC, V42, P833, DOI 10.2307/2583411; WORTHINGTON DJ, 1987, J OPER RES SOC, V38, P413, DOI 10.1057/jors.1987.69	11	64	64	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					280	282		10.1136/bmj.324.7332.280	http://dx.doi.org/10.1136/bmj.324.7332.280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823362	Green Published, Bronze			2022-12-28	WOS:000173728300021
J	Schulz, KF; Grimes, DA				Schulz, KF; Grimes, DA			Case-control studies: research in reverse	LANCET			English	Article							BREAST-CANCER; RISK-FACTORS; ORAL-CONTRACEPTIVES; WOMEN	Epidemiologists benefit greatly from having case-control study designs in their research armamentarium. Case-control studies can yield important scientific findings with relatively little time, money, and effort compared with other study designs. This seemingly quick road to research results entices many newly trained epidemiologists. Indeed, investigators implement case-control studies more frequently than any other analytical epidemiological study. Unfortunately, case-control designs also tend to be more susceptible to biases than other comparative studies. Although easier to do, they are also easier to do wrong. Five main notions guide investigators who do, or readers who assess, case-control studies. First, investigators must explicitly define the criteria for diagnosis of a case and any eligibility criteria used for selection. Second, controls should come from the same population as the cases, and their selection should be independent of the exposures of Interest. Third, investigators should blind the data gatherers to the case or control status of participants or, if impossible, at least blind them to the main hypothesis of the study. Fourth, data gatherers need to be thoroughly trained to elicit exposure in a similar manner from cases and controls; they should use memory aids to facilitate and balance recall between cases and controls. Finally, investigators should address confounding in case-control studies, either In the design stage or with analytical techniques. Devotion of meticulous attention to these points enhances the validity of the results and bolsters the reader's confidence in the findings.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.							Abdel-Salam G, 2000, EPIDEMIOLOGY, V11, P571, DOI 10.1097/00001648-200009000-00013; Amal N. M., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P301; Avidan B, 2001, AM J GASTROENTEROL, V96, P41; CHENG KK, 1992, LANCET, V339, P1314, DOI 10.1016/0140-6736(92)91960-G; Collins JW, 1999, AM J IND MED, V36, P522, DOI 10.1002/(SICI)1097-0274(199911)36:5<522::AID-AJIM4>3.0.CO;2-F; Cramer DW, 1998, LANCET, V351, P104, DOI 10.1016/S0140-6736(97)08064-1; FRENITITULAER LWJ, 1989, AM J EPIDEMIOL, V130, P404, DOI 10.1093/oxfordjournals.aje.a115348; FRIEDMAN GD, 1991, LANCET, V337, P1526, DOI 10.1016/0140-6736(91)93207-P; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Hernandez J, 2001, J AM VET MED ASSOC, V218, P83, DOI 10.2460/javma.2001.218.83; Ingram D, 1997, LANCET, V350, P990, DOI 10.1016/S0140-6736(97)01339-1; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kelsey JL., 1996, METHODS OBSERVATIONA; LINDEFORSHARRIS BM, 1991, AM J EPIDEMIOL, V134, P1003, DOI 10.1093/oxfordjournals.aje.a116173; MOSS AR, 1987, AM J EPIDEMIOL, V125, P1035, DOI 10.1093/oxfordjournals.aje.a114619; Naghavi M, 2000, CIRCULATION, V102, P3039; Osaki Y, 2001, AM J EPIDEMIOL, V153, P153, DOI 10.1093/aje/153.2.153; Rothman K, 1986, MODERN EPIDEMIOLOGY; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Silverman DT, 2001, TERATOGEN CARCIN MUT, V21, P7, DOI 10.1002/1520-6866(2001)21:1<7::AID-TCM3>3.0.CO;2-A; Slattery ML, 2000, CANCER CAUSE CONTROL, V11, P555, DOI 10.1023/A:1008924115604; STADEL BV, 1985, LANCET, V2, P970; STROM BL, 1994, AM J EPIDEMIOL, V140, P632, DOI 10.1093/oxfordjournals.aje.a117302; Torrey EF, 2000, SCHIZOPHR RES, V46, P17, DOI 10.1016/S0920-9964(99)00237-6; TRAVERSO HP, 1989, LANCET, V1, P486; Verloop J, 2000, J NATL CANCER I, V92, P128, DOI 10.1093/jnci/92.2.128; Wen LM, 1999, SEX TRANSM INFECT, V75, P312, DOI 10.1136/sti.75.5.312	29	267	274	2	43	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					431	434		10.1016/S0140-6736(02)07605-5	http://dx.doi.org/10.1016/S0140-6736(02)07605-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844534				2022-12-28	WOS:000173686500034
J	Knapp, S				Knapp, S			Fact and fantasy - The zoology created by our imagination is far outstripped by that of reality.	NATURE			English	Editorial Material									Nat Hist Museum, Dept Bot, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.		Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945				Borges J. L., 1969, BOOK IMAGINARY BEING; Borges J.L., 2000, THIS CRAFT OF VERSE; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; LINNEAUS C, 1735, SYSTEMANATURAE	4	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					479	479		10.1038/415479a	http://dx.doi.org/10.1038/415479a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823837	Bronze			2022-12-28	WOS:000173564300025
J	Farrell, RJ; Peppercorn, MA				Farrell, RJ; Peppercorn, MA			Ulcerative colitis	LANCET			English	Review							INFLAMMATORY-BOWEL-DISEASE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; ORAL MICROEMULSION CYCLOSPORINE; PRIMARY SCLEROSING CHOLANGITIS; PREDNISOLONE RETENTION ENEMAS; RESIDENT INTESTINAL FLORA; DOUBLE-BLIND; CROHNS-DISEASE; COLORECTAL-CANCER; INTRAVENOUS CYCLOSPORINE	Ulcerative colitis is a chronic inflammatory disease of the rectum and colon. Results from many studies in people and animals of intestinal inflammation suggest that ulcerative colitis results from environmental factors triggering a loss of tolerance for normal intestinal flora in genetically susceptible individuals. Although progress has been made in the overall management of the disease, no innovative treatment has been developed. By contrast with Crohn's disease, there are few clinical data on biological agents. Probiotics seem the most promising of several experimental and traditional agents that have been investigated in controlled clinical trials.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis,Div Gastroenterol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Farrell, RJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis,Div Gastroenterol, Boston, MA 02215 USA.	rfarrell@caregroup.harvard.edu						Actis GC, 1998, INFLAMM BOWEL DIS, V4, P276, DOI 10.1002/ibd.3780040404; ADLER DJ, 1990, AM J GASTROENTEROL, V85, P717; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; Ang YS, 2000, ALIMENT PHARM THERAP, V14, P1015, DOI 10.1046/j.1365-2036.2000.00802.x; Ardizzone S, 1997, J CLIN GASTROENTEROL, V25, P330, DOI 10.1097/00004836-199707000-00007; Askling J, 2001, GASTROENTEROLOGY, V120, P1356, DOI 10.1053/gast.2001.24052; ASLAN A, 1992, AM J GASTROENTEROL, V87, P432; BERNSTEIN CN, 1994, LANCET, V343, P71; BHAGAT S, 1994, GASTROENTEROLOGY, V107, P103, DOI 10.1016/0016-5085(94)90066-3; Boirivant M, 1996, J CLIN INVEST, V98, P2616, DOI 10.1172/JCI119082; BOYKO EJ, 1994, AM J EPIDEMIOL, V140, P268, DOI 10.1093/oxfordjournals.aje.a117246; Breslin NP, 1997, GUT, V41, P557, DOI 10.1136/gut.41.4.557; Breuer RI, 1997, GUT, V40, P485, DOI 10.1136/gut.40.4.485; BROBERGER O, 1959, J EXP MED, V110, P657, DOI 10.1084/jem.110.5.657; BURKE DA, 1988, BMJ-BRIT MED J, V297, P102, DOI 10.1136/bmj.297.6641.102; Bus PJ, 1999, ALIMENT PHARM THERAP, V13, P1397; Carbonnel F, 1996, DIGEST DIS SCI, V41, P2471, DOI 10.1007/BF02100145; Cohavy O, 2000, INFECT IMMUN, V68, P1542, DOI 10.1128/IAI.68.3.1542-1548.2000; Cohen RD, 1999, INFLAMM BOWEL DIS, V5, P1; Cohen RD, 1999, AM J GASTROENTEROL, V94, P1587; COPE GF, 1986, BRIT MED J, V293, P481, DOI 10.1136/bmj.293.6545.481; Corrao G, 1998, INT J EPIDEMIOL, V27, P397, DOI 10.1093/ije/27.3.397; Coulie B, 2001, ALIMENT PHARM THERAP, V15, P653, DOI 10.1046/j.1365-2036.2001.00959.x; D'Haens G, 2001, GASTROENTEROLOGY, V120, P1323, DOI 10.1053/gast.2001.23983; D'Haens G, 2000, GASTROENTEROLOGY, V118, pA786, DOI 10.1016/S0016-5085(00)85286-5; dAlbasio G, 1997, AM J GASTROENTEROL, V92, P1143; DANIELSSON A, 1987, SCAND J GASTROENTERO, V22, P987, DOI 10.3109/00365528708991947; Day R, 1999, LANCET, V354, P62, DOI 10.1016/S0140-6736(98)09267-8; Dichi I, 2000, NUTRITION, V16, P87, DOI 10.1016/S0899-9007(99)00231-2; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Duchmann R, 1999, GUT, V44, P812, DOI 10.1136/gut.44.6.812; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; DUERR RH, 1991, GASTROENTEROLOGY, V100, P1385; Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145; Eaden JA, 2000, GASTROINTEST ENDOSC, V51, P123, DOI 10.1016/S0016-5107(00)70405-6; Ekbom A, 1998, INFLAMM BOWEL DIS, V4, P235, DOI 10.1097/00054725-199808000-00007; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Engelsgjerd M, 1999, GASTROENTEROLOGY, V117, P1288, DOI 10.1016/S0016-5085(99)70278-7; Evans JMM, 1997, GUT, V40, P619, DOI 10.1136/gut.40.5.619; Evans RC, 1997, ALIMENT PHARM THERAP, V11, P1031, DOI 10.1046/j.1365-2036.1997.00251.x; Evans RC, 1997, ALIMENT PHARM THERAP, V11, P1037, DOI 10.1046/j.1365-2036.1997.00252.x; Farrell RJ, 2000, GUT, V47, P514, DOI 10.1136/gut.47.4.514; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Fellermann K, 2000, GASTROENTEROLOGY, V118, pA786, DOI 10.1016/S0016-5085(00)85287-7; Fernandez-Banares F, 1999, AM J GASTROENTEROL, V94, P427, DOI 10.1111/j.1572-0241.1999.872_a.x; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Fuss IJ, 1996, J IMMUNOL, V157, P1261; FUTAMI S, 1995, DIGEST DIS SCI, V40, P814, DOI 10.1007/BF02064985; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 1999, DIGEST DIS SCI, V44, P1220; Gordon LK, 2000, CLIN IMMUNOL, V94, P42, DOI 10.1006/clim.1999.4805; Gordon LK, 1999, INVEST OPHTH VIS SCI, V40, P1250; Green JT, 1997, ALIMENT PHARM THER, V11, P859, DOI 10.1046/j.1365-2036.1997.00220.x; GREENFIELD SM, 1993, ALIMENT PHARM THERAP, V7, P159; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; HALSTENSEN TS, 1995, ADV EXP MED BIOL, V371, P1273; HAMILTON MI, 1995, CLIN EXP IMMUNOL, V99, P404; Hanauer SB, 1998, GASTROENTEROLOGY, V115, P525, DOI 10.1016/S0016-5085(98)70131-3; Hanauer SB, 2001, ANNU REV MED, V52, P299, DOI 10.1146/annurev.med.52.1.299; Hawkey CJ, 1997, GASTROENTEROLOGY, V112, P718, DOI 10.1053/gast.1997.v112.pm9041232; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Heuschen UA, 2001, GASTROENTEROLOGY, V120, P841, DOI 10.1053/gast.2001.22434; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Jayaram H, 2001, GUT, V48, P430, DOI 10.1136/gut.48.3.430; Kornbluth A, 1997, AM J GASTROENTEROL, V92, P204; Koutroubakis IE, 2000, AM J GASTROENTEROL, V95, P171; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kyo K, 1999, HUM MOL GENET, V8, P307, DOI 10.1093/hmg/8.2.307; Lashner BA, 1997, GASTROENTEROLOGY, V112, P29, DOI 10.1016/S0016-5085(97)70215-4; LEMANN M, 1995, ALIMENT PHARM THERAP, V9, P557; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; LINDBERG E, 1988, GUT, V29, P352, DOI 10.1136/gut.29.3.352; Lipsky JJ, 1996, LANCET, V348, P1357, DOI 10.1016/S0140-6736(96)10310-X; Liu ZJ, 2000, J IMMUNOL, V164, P6005, DOI 10.4049/jimmunol.164.11.6005; Lofberg R, 1996, GASTROENTEROLOGY, V110, P1713, DOI 10.1053/gast.1996.v110.pm8964395; LOFBERG R, 1994, ALIMENT PHARM THER, V8, P623; Louis E, 2001, ACTA GASTRO-ENT BELG, V64, P1; MADARA JL, 1985, GASTROENTEROLOGY, V88, P13, DOI 10.1016/S0016-5085(85)80126-8; Madretsma S, 1996, EUR J GASTROEN HEPAT, V8, P1017, DOI 10.1097/00042737-199610000-00016; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Maunder RG, 2000, DIGEST DIS SCI, V45, P2127, DOI 10.1023/A:1026471303921; McCartney SA, 1999, ALIMENT PHARM THERAP, V13, P1115; McGarrity TJ, 2000, AM J GASTROENTEROL, V95, P1824; MILLER LG, 1982, CHEST, V82, P526, DOI 10.1378/chest.82.5.526; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi A, 1996, J EXP MED, V184, P707, DOI 10.1084/jem.184.2.707; Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9; Moum B, 1996, GUT, V38, P376, DOI 10.1136/gut.38.3.376; Navazo L, 2001, SCAND J GASTROENTERO, V36, P610, DOI 10.1080/003655201750163051; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Okazaki K, 2000, GASTROENTEROLOGY, V119, P502, DOI 10.1053/gast.2000.9368; Orchard TR, 2000, GASTROENTEROLOGY, V118, P274, DOI 10.1016/S0016-5085(00)70209-5; Oren R, 1996, GASTROENTEROLOGY, V110, P1416, DOI 10.1053/gast.1996.v110.pm8613046; Orholm M, 1999, AM J GASTROENTEROL, V94, P3236; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Orth T, 2000, AM J GASTROENTEROL, V95, P1201; Panes J, 2000, GASTROENTEROLOGY, V119, P903, DOI 10.1053/gast.2000.18159; Papa A, 2000, ALIMENT PHARM THER, V14, P1403, DOI 10.1046/j.1365-2036.2000.00860.x; Papo M, 1996, AM J GASTROENTEROL, V91, P1512; Papo M, 1999, EUR J GASTROEN HEPAT, V11, P413, DOI 10.1097/00042737-199904000-00010; PINCZOWSKI D, 1994, GASTROENTEROLOGY, V107, P117, DOI 10.1016/0016-5085(94)90068-X; PODOLSKY DK, 1984, GASTROENTEROLOGY, V87, P991; Provenzale D, 2001, J CLIN GASTROENTEROL, V32, P99, DOI 10.1097/00004836-200102000-00003; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Qiu BS, 1999, NAT MED, V5, P1178, DOI 10.1038/13503; Quan VA, 1997, BRIT MED J, V314, P363, DOI 10.1136/bmj.314.7077.363; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; RHODES JM, 1989, GUT, V30, P1660, DOI 10.1136/gut.30.12.1660; Roberts WG, 1997, GASTROENTEROLOGY, V112, P725, DOI 10.1053/gast.1997.v112.pm9041233; Roussomoustakaki M, 1997, GASTROENTEROLOGY, V112, P1845, DOI 10.1053/gast.1997.v112.pm9178675; Rubin PH, 1999, GASTROENTEROLOGY, V117, P1295, DOI 10.1016/S0016-5085(99)70279-9; RUTGEERTS P, 1994, GASTROENTEROLOGY, V106, P1251, DOI 10.1016/0016-5085(94)90016-7; Safdi M, 1997, AM J GASTROENTEROL, V92, P1867; SANDBORN W, 2000, COCHRANE LIB; Sandborn WJ, 1996, AM J GASTROENTEROL, V91, P423; Sandborn WJ, 1997, ANN INTERN MED, V126, P364, DOI 10.7326/0003-4819-126-5-199703010-00004; SANDBORN WJ, 1994, GASTROENTEROLOGY, V106, P1429, DOI 10.1016/0016-5085(94)90394-8; SANDBORN WJ, 1995, AM J GASTROENTEROL, V90, P740; Sandborn WJ, 1996, MAYO CLIN PROC, V71, P431, DOI 10.4065/71.5.431; Sands BE, 2000, GASTROENTEROLOGY, V118, pS68, DOI 10.1016/S0016-5085(00)70007-2; Sands BE, 2001, INFLAMM BOWEL DIS, V7, P83, DOI 10.1097/00054725-200105000-00001; Sartor R, 2000, INFLAMM BOWEL DIS, P153; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SAXON A, 1990, J ALLERGY CLIN IMMUN, V86, P202, DOI 10.1016/S0091-6749(05)80067-3; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Schreiber S, 1998, GASTROENTEROLOGY, V114, pA1080; Shanahan F, 2000, INFLAMM BOWEL DIS, V6, P107, DOI 10.1097/00054725-200005000-00007; Sher ME, 1999, INFLAMM BOWEL DIS, V5, P73, DOI 10.1097/00054725-199905000-00001; SRIVASTAVA ED, 1991, GUT, V32, P1016, DOI 10.1136/gut.32.9.1016; Stack WA, 1998, ALIMENT PHARM THERAP, V12, P973; Stack WA, 1998, GASTROENTEROLOGY, V115, P1340, DOI 10.1016/S0016-5085(98)70011-3; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stein R, 1997, GASTROENTEROLOGY, V112, pA1096; Steinhart AH, 1996, ALIMENT PHARM THER, V10, P729, DOI 10.1046/j.1365-2036.1996.d01-509.x; STENSON WF, 1992, ANN INTERN MED, V116, P609, DOI 10.7326/0003-4819-116-8-609; Sternthal M, 1996, GASTROENTEROLOGY, V110, pA1019; SUTHERLAND L, 2000, COCHRANE LIB; TAKAHASHI F, 1985, J CLIN INVEST, V76, P311, DOI 10.1172/JCI111963; Targan SR, 1998, GASTROENTEROLOGY, V114, P1099, DOI 10.1016/S0016-5085(98)70331-2; THEIS MK, 1994, AM J GASTROENTEROL, V89, P1920; Thomas GAO, 1996, EUR J GASTROEN HEPAT, V8, P769; Thomas GAO, 2000, POSTGRAD MED J, V76, P273, DOI 10.1136/pmj.76.895.273; THOMAS GAO, 1995, NEW ENGL J MED, V332, P988, DOI 10.1056/NEJM199504133321503; Turunen UM, 1998, GASTROENTEROLOGY, V115, P1072, DOI 10.1016/S0016-5085(98)70076-9; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Ueyama H, 1998, GUT, V43, P48, DOI 10.1136/gut.43.1.48; Van Gossum A, 1997, ACTA GASTRO-ENT BELG, V60, P197; VASHISHTHA A, 1993, J IMMUNOL, V150, P4693; Vasiliauskas EA, 1996, GASTROENTEROLOGY, V110, P1810, DOI 10.1053/gast.1996.v110.pm8964407; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; Walmsley RS, 1998, J CLIN PATHOL, V51, P657, DOI 10.1136/jcp.51.9.657; WURZELMANN JI, 1994, DIGEST DIS SCI, V39, P555, DOI 10.1007/BF02088342; YANG H, 1993, GUT, V34, P517, DOI 10.1136/gut.34.4.517; Zack M M, 1997, J Med Screen, V4, P137	159	427	474	2	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					331	340		10.1016/S0140-6736(02)07499-8	http://dx.doi.org/10.1016/S0140-6736(02)07499-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830216				2022-12-28	WOS:000173588100030
J	Katoh, E; Yamawaki, H; Fujihisa, H; Sakashita, M; Aoki, K				Katoh, E; Yamawaki, H; Fujihisa, H; Sakashita, M; Aoki, K			Protonic diffusion in high-pressure ice VII	SCIENCE			English	Article							HCL-DOPED ICE; HYDROGEN-BONDS; DENSE H2O; GPA; TRANSITIONS; DIFFRACTION; DEFECTS; AMMONIA; MOTION; STATES	Near ambient pressures, molecular diffusion dominates protonic diffusion in ice. Theoretical studies have predicted that protonic diffusion will dominate at high pressures in ice. We measured the protonic diffusion coefficient for the highest temperature molecular phase of ice VII at 400 kelvin over its entire stable pressure region. The values ranged from 10(-17) to 10(-15) square meters per second at pressures of 10 to 63 gigapascals. The diffusion coefficients extrapolated to high temperatures close to the ice VII melting curve were less by a factor of 10(2) to 10(1) than a superionic criterion of similar to10(-8) square meters per second, at which protons would diffuse freely.	Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Aoki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 5, Tsukuba, Ibaraki 3058565, Japan.		Fujihisa, Hiroshi/L-6219-2018; Fujihisa, Hiroshi/AAH-3720-2020; YAMAWAKI, Hiroshi/L-9412-2016; Sakashita, Mami/M-2784-2018	Fujihisa, Hiroshi/0000-0001-9308-153X; Fujihisa, Hiroshi/0000-0001-9308-153X; YAMAWAKI, Hiroshi/0000-0002-0145-9935; Sakashita, Mami/0000-0002-6726-4794				Benoit M, 1998, NATURE, V392, P258, DOI 10.1038/32609; Benoit M, 1999, SOLID STATE IONICS, V125, P23, DOI 10.1016/S0167-2738(99)00154-X; BJERRUM N, 1952, SCIENCE, V115, P385, DOI 10.1126/science.115.2989.385; BLICKS H, 1966, PHYS KONDENS MATER, V4, P375, DOI DOI 10.1007/BF02422755; CAMPLIN GC, 1978, J GLACIOL, V21, P123; Cavazzoni C, 1999, SCIENCE, V283, P44, DOI 10.1126/science.283.5398.44; COLLIER WB, 1984, J PHYS CHEM-US, V88, P363, DOI 10.1021/j150647a008; Crank J., 1975, MATH DIFFUSION, P44; DEMONTIS P, 1988, PHYS REV LETT, V60, P2284, DOI 10.1103/PhysRevLett.60.2284; Goncharov AF, 1999, PHYS REV LETT, V83, P1998, DOI 10.1103/PhysRevLett.83.1998; HEMLEY RJ, 1987, NATURE, V330, P737, DOI 10.1038/330737a0; Holzapfel WB, 1999, PHYSICA B, V265, P113, DOI 10.1016/S0921-4526(98)01340-4; Hubmann M., 1978, J GLACIOL, V21, P161; ITAGAKI K, 1967, J PHYS SOC JPN, V22, P427, DOI 10.1143/JPSJ.22.427; Johannsen PG, 1998, J PHYS-CONDENS MAT, V10, P2241, DOI 10.1088/0953-8984/10/10/008; Kawada S, 1997, J PHYS CHEM B, V101, P6223, DOI 10.1021/jp963178+; KUHS WF, 1984, J CHEM PHYS, V81, P3612, DOI 10.1063/1.448109; LETOULLEC R, 1989, PHYS REV B, V40, P2368, DOI 10.1103/PhysRevB.40.2368; Nellis WJ, 1997, J CHEM PHYS, V107, P9096, DOI 10.1063/1.475200; NELLIS WJ, 1988, SCIENCE, V240, P779, DOI 10.1126/science.240.4853.779; PETRENKO VF, 1983, J PHYS CHEM-US, V87, P4022, DOI 10.1021/j100244a003; Pruzan P, 1997, J PHYS CHEM B, V101, P6230, DOI 10.1021/jp963182l; RAMSEIER RO, 1967, J APPL PHYS, V38, P2553, DOI 10.1063/1.1709948; SCHWEIZER KS, 1984, J CHEM PHYS, V80, P1230, DOI 10.1063/1.446800; Shimizu H, 1996, PHYS REV B, V53, P6107, DOI 10.1103/PhysRevB.53.6107; Song M, 1999, PHYS REV B, V60, P12644, DOI 10.1103/PhysRevB.60.12644; STEVENSON DJ, 1983, REP PROG PHYS, V46, P555, DOI 10.1088/0034-4885/46/5/001; TAKEI I, 1987, J PHYS-PARIS, V48, P121, DOI 10.1051/jphyscol:1987118	28	42	42	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1264	1266		10.1126/science.1067746	http://dx.doi.org/10.1126/science.1067746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847334				2022-12-28	WOS:000173926000034
J	Kurz, T; Pintard, L; Willis, JH; Hamill, DR; Gonczy, P; Peter, M; Bowerman, B				Kurz, T; Pintard, L; Willis, JH; Hamill, DR; Gonczy, P; Peter, M; Bowerman, B			Cytoskeletal regulation by the Nedd8 ubiquitin-like protein modification pathway	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; CELL-CYCLE; CENTROSOME DUPLICATION; SPINDLE COMPONENT; C-ELEGANS; GENE; FAMILY; LIGASE; SCF; TRANSITION	The Nedd8 ubiquitin-like protein modification pathway regulates cell-cycle progression. Our analysis of Nedd8 requirements during Caenorhabditis elegans embryogenesis indicates that the cytoskeleton is another target. Nedd8 conjugation negatively regulated contractility of the microfilament-rich cell cortex during pronuclear migration and again during cytokinesis. The Nedd8 pathway also was required after meiosis to negatively regulate katanin, a microtubule-severing complex, permitting the assembly of a large mitotic spindle. We propose that Nedd8-modified cullin, as part of an E3 ubiquitin ligase complex, targets katanin for degradation during the transition from meiosis to mitosis.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Ohio Wesleyan Univ, Dept Zool, Delaware, OH 43015 USA	University of Oregon; Ohio Wesleyan University	Bowerman, B (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		PINTARD, Lionel/AAP-7361-2020; pintard, lionel/AAD-8356-2020; PINTARD, Lionel/H-3756-2018; Kurz, Thimo/E-4116-2012	PINTARD, Lionel/0000-0003-0286-4630; PINTARD, Lionel/0000-0003-0286-4630; Gonczy, Pierre/0000-0002-6305-6883; Kurz, Thimo/0000-0003-0700-6993; Peter, Matthias/0000-0002-2160-6824	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058017] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM58017] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dow MR, 1998, GENETICS, V150, P119; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; MAINS PE, 1990, GENETICS, V126, P593; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SEVERSON A, COMMUNICATION; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Srayko M, 2000, GENE DEV, V14, P1072; Wojcik EJ, 2000, CURR BIOL, V10, P1131, DOI 10.1016/S0960-9822(00)00703-X; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	34	160	167	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1294	1298		10.1126/science.1067765	http://dx.doi.org/10.1126/science.1067765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847342				2022-12-28	WOS:000173926000044
J	Van Dover, CL; German, CR; Speer, KG; Parson, LM; Vrijenhoek, RC				Van Dover, CL; German, CR; Speer, KG; Parson, LM; Vrijenhoek, RC			Marine biology - Evolution and biogeography of deep-sea vent and seep invertebrates	SCIENCE			English	Review							MID-ATLANTIC RIDGE; ALVINELLID POLYCHAETE DISPERSAL; HYDROTHERMAL-VENT; EASTERN PACIFIC; GENETIC DIFFERENTIATION; MOLECULAR SYSTEMATICS; COMMUNITIES; PATTERNS; BIVALVIA; OCEAN	Deep-sea hydrothermal vents and cold seeps are submarine springs where nutrient-rich fluids emanate from the sea floor. Vent and seep ecosystems occur in a variety of geological settings throughout the global ocean and support food webs based on chemoautotrophic primary production. Most vent and seep invertebrates arrive at suitable habitats as larvae dispersed by deep-ocean currents. The recent evolution of many vent and seep invertebrate species (<100 million years ago) suggests that Cenozoic tectonic history and oceanic circulation patterns have been important in defining contemporary biogeographic patterns.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	William & Mary; NERC National Oceanography Centre; University of Southampton; State University System of Florida; Florida State University; Monterey Bay Aquarium Research Institute	Van Dover, CL (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	cindy_vandover@wm.edu		Van Dover, Cindy/0000-0001-9845-8391				Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; Baker ET, 1996, EARTH PLANET SC LETT, V142, P137, DOI 10.1016/0012-821X(96)00097-0; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Black MB, 1998, DEEP-SEA RES PT II, V45, P365, DOI 10.1016/S0967-0645(97)00076-3; Black MB, 1997, MAR BIOL, V130, P141, DOI 10.1007/s002270050233; Burton KW, 1997, NATURE, V386, P382, DOI 10.1038/386382a0; BUTTERFIELD DA, 1990, J GEOPHYS RES-SOLID, V95, P12895, DOI 10.1029/JB095iB08p12895; CAMPBELL KA, 1995, GEOLOGY, V23, P321, DOI 10.1130/0091-7613(1995)023<0321:BACBIP>2.3.CO;2; Cannat M, 1999, EARTH PLANET SC LETT, V173, P257, DOI 10.1016/S0012-821X(99)00234-4; Chevaldonne P, 1997, LIMNOL OCEANOGR, V42, P67, DOI 10.4319/lo.1997.42.1.0067; CRADDOCK C, 1995, MAR BIOL, V121, P477, DOI 10.1007/BF00349456; Desbruyeres D, 2000, HYDROBIOLOGIA, V440, P201, DOI 10.1023/A:1004175211848; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; EDMONDS HN, 2001, EOS, V82, P647; FRANCE SC, 1992, MAR BIOL, V114, P551, DOI 10.1007/BF00357252; German CR, 1998, EARTH PLANET SC LETT, V160, P327, DOI 10.1016/S0012-821X(98)00093-4; German CR, 1996, EARTH PLANET SC LETT, V138, P93, DOI 10.1016/0012-821X(95)00224-Z; German CR, 2000, EARTH PLANET SC LETT, V184, P241, DOI 10.1016/S0012-821X(00)00319-8; German CR, 1998, NATURE, V395, P490, DOI 10.1038/26730; GOEDERT JL, 1995, PALAEOGEOGR PALAEOCL, V118, P151, DOI 10.1016/0031-0182(94)00139-Y; Harasewych MG, 2000, MAR BIOL, V137, P183, DOI 10.1007/s002270000332; Hashimoto J, 2001, ZOOL SCI, V18, P717, DOI 10.2108/zsj.18.717; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; HECKER B, 1985, BIOL SOC WASH B, V6, P465; HESSLER RR, 1991, DEEP-SEA RES, V38, P185, DOI 10.1016/0198-0149(91)90079-U; Hillis David M., 1996, P515; HURTADO LA, UNPUB; Jollivet D, 1999, EVOLUTION, V53, P1128, DOI 10.1111/j.1558-5646.1999.tb04527.x; JOLLIVET D, 1995, HEREDITY, V74, P376, DOI 10.1038/hdy.1995.56; Juniper SK, 1997, PHILOS T R SOC A, V355, P459, DOI 10.1098/rsta.1997.0017; KARL DM, 1988, NATURE, V335, P532, DOI 10.1038/335532a0; KLINKHAMMER G, 1986, EARTH PLANET SC LETT, V79, P241, DOI 10.1016/0012-821X(86)90182-2; LaCasce JH, 1999, J MAR RES, V57, P245, DOI 10.1357/002224099321618218; LITTLE CC, COMMUNICATION; LITTLE CG, UNPUB; Little CTS, 1998, GEOL SOC SPEC PUBL, V148, P259, DOI 10.1144/GSL.SP.1998.148.01.14; Little CTS, 1997, NATURE, V385, P146, DOI 10.1038/385146a0; Little CTS, 1999, GEOLOGY, V27, P1027, DOI 10.1130/0091-7613(1999)027<1027:LCHVCF>2.3.CO;2; LUPTON JE, 1981, SCIENCE, V214, P13, DOI 10.1126/science.214.4516.13; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; MACDONALD KC, 1987, GEOLOGY, V15, P993, DOI 10.1130/0091-7613(1987)15<993:TEORDB>2.0.CO;2; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; MCLEAN JH, 1985, B BIOL SOC WASH, V6, P159; NEWMAN WA, 1985, B BIOL SOC WASH, V6, P231; O'Dwyer J, 2000, J PHYS OCEANOGR, V30, P721, DOI 10.1175/1520-0485(2000)030<0721:DTPVDC>2.0.CO;2; OMULLAN GD, IN PRESS MOL ECOL; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Peek AS, 2000, J MOL EVOL, V50, P141, DOI 10.1007/s002399910016; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Pradillon F, 2001, NATURE, V413, P698, DOI 10.1038/35099674; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; SEARLE RC, 1986, J GEOL SOC LONDON, V143, P743, DOI 10.1144/gsjgs.143.5.0743; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; SIBUET M, COMMUNICATION; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; SOMERO GN, 1992, EXPERIENTIA, V48, P537, DOI 10.1007/BF01920236; SPEER K, IN PRESS ENERGY MASS; SQUIRES RL, 1991, J PALEONTOL, V65, P412, DOI 10.1017/S0022336000030389; STOMMEL H, 1960, DEEP-SEA RES, V6, P140; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; TUNNICLIFFE V, 1988, PROC R SOC SER B-BIO, V233, P347, DOI 10.1098/rspb.1988.0025; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; TUNNICLIFFE V, 1992, Palaios, V7, P338, DOI 10.2307/3514820; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover Cindy Lee, 1995, Geological Society Special Publication, V87, P257; Van Dover CL, 2001, J MAR BIOL ASSOC UK, V81, P823, DOI 10.1017/S0025315401004659; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; VanDover CL, 1996, DEEP-SEA RES PT I, V43, P1509; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; Waren A, 2001, VELIGER, V44, P116; WELANDER P, 1969, DEEP-SEA RES, VS, P369; ZUKERKANDL E, 1965, EVOLVING GENES PROTE, P97; [No title captured]	80	409	425	11	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1253	1257		10.1126/science.1067361	http://dx.doi.org/10.1126/science.1067361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847331				2022-12-28	WOS:000173926000031
J	Chatterton, JE; Awobuluyi, M; Premkumar, LS; Takahashi, H; Talantova, M; Shin, Y; Cui, JK; Tu, SC; Kevin, ASK; Nakanishi, N; Tong, G; Lipton, SA; Zhang, DX				Chatterton, JE; Awobuluyi, M; Premkumar, LS; Takahashi, H; Talantova, M; Shin, Y; Cui, JK; Tu, SC; Kevin, ASK; Nakanishi, N; Tong, G; Lipton, SA; Zhang, DX			Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits	NATURE			English	Article							RAT SPINAL-CORD; BINDING-SITE; XENOPUS OOCYTES; AMINO-ACIDS; ANTAGONIST; POTENT; IDENTIFICATION; MEMANTINE; RESPONSES; CLONING	The N-methyl-D-aspartate subtype of glutamate receptor (NMDAR) serves critical functions in physiological and pathological processes in the central nervous system, including neuronal development, plasticity and neurodegeneration(1,2). Conventional heteromeric NMDARs composed of NR1 and NR2A-D subunits(3,4) require dual agonists, glutamate and glycine, for activation. They are also highly permeable to Ca2+, and exhibit voltage-dependent inhibition by Mg2+. Coexpression of NR3A with NR1 and NR2 subunits modulates NMDAR activity(5-7). Here we report the cloning and characterization of the final member of the NMDAR family, NR3B, which shares high sequence homology with NR3A. From in situ and immunocytochemical analyses, NR3B is expressed predominantly in motor neurons, whereas NR3A is more widely distributed(5,6). Remarkably, when co-expressed in Xenopus oocytes, NR3A or NR3B co-assembles with NR1 to form excitatory glycine receptors that are unaffected by glutamate or NMDA, and inhibited by D-serine, a co-activator of conventional NMDARs. Moreover, NR1/NR3A or -3B receptors form relatively Ca2+-impermeable cation channels that are resistant to Mg2+, MK-801, memantine and competitive antagonists. In cerebrocortical neurons containing NR3 family members, glycine triggers a burst of firing, and membrane patches manifest glycine-responsive single channels that are suppressible by D-serine. By itself, glycine is normally thought of as an inhibitory neurotransmitter. In contrast, these NR1/NR3A or -3B 'NMDARs' constitute a type of excitatory glycine receptor.	Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; Kanazawa Univ, Grad Sch Med, Dept Mol Pharmacol, Kanazawa, Ishikawa 9208640, Japan; Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06030 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Southern Illinois University System; Southern Illinois University; Kanazawa University; University of Connecticut; University of California System; University of California San Diego	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Tong, Gary/AAC-9426-2022	Lipton, Stuart/0000-0002-3490-1259				Anson LC, 1998, J NEUROSCI, V18, P581; BARON BM, 1990, MOL PHARMACOL, V38, P554; BORMANN J, 1989, EUR J PHARMACOL, V166, P591, DOI 10.1016/0014-2999(89)90385-3; CHEN HSV, 1992, J NEUROSCI, V12, P4427; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; CURTIS DR, 1967, NATURE, V215, P1502, DOI 10.1038/2151502a0; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Ishimaru H, 1996, RECEPTOR CHANNEL, V4, P31; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCBAIN CJ, 1989, MOL PHARMACOL, V36, P556; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Palecek J, 1999, EUR J NEUROSCI, V11, P827, DOI 10.1046/j.1460-9568.1999.00489.x; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Soloviev MM, 1997, J MOL BIOL, V273, P14, DOI 10.1006/jmbi.1997.1272; Souverbie F, 1996, EUR J PHARMACOL, V307, P347, DOI 10.1016/0014-2999(96)00273-7; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; vonEuler M, 1997, J NEUROTRAUM, V14, P53, DOI 10.1089/neu.1997.14.53; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	30	484	529	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					793	798		10.1038/nature715	http://dx.doi.org/10.1038/nature715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11823786				2022-12-28	WOS:000173833900047
J	Beeching, NJ; Dance, DAB; Miller, ARO; Spencer, RC				Beeching, NJ; Dance, DAB; Miller, ARO; Spencer, RC			Biological warfare and bioterrorism	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTHRAX; WEAPON; SMALLPOX; RESPONSES; PLAGUE		Univ Liverpool, Liverpool Sch Trop Med, Div Trop Med, Liverpool L3 5QA, Merseyside, England; Derriford Hosp, Publ Hlth Lab, Plymouth PL6 8DH, Devon, England; Kidderminster Hosp, Worcestershire Acute Hosp NHS Trust, Kidderminster DY11 6RJ, England; Royal Infirm, Bristol Publ Hlth Lab, Bristol BS2 8HW, Avon, England	Liverpool School of Tropical Medicine; University of Liverpool; Derriford Hospital; Bristol Royal Infirmary	Beeching, NJ (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Div Trop Med, Liverpool L3 5QA, Merseyside, England.	NicholasBeeching@rlbuh-tr.nwest.nhs.uk	Beeching, Nicholas J/L-5363-2017	Dance, David/0000-0001-9189-7244; Beeching, Nicholas/0000-0002-7019-8791				ALIBECK K, 1998, BIOHAZARD; British Medical Association, 1999, BIOT WEAP HUM; Carter G. B., 2000, CHEM BIOL DEFENCE PO; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P909; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P962; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DERBES VJ, 1966, J AMER MED ASSOC, V196, P59, DOI 10.1001/jama.196.1.59; FRIEDLANDER AM, 1993, J INFECT DIS, V167, P1239, DOI 10.1093/infdis/167.5.1239; Gani R, 2001, NATURE, V414, P748, DOI 10.1038/414748a; Harris S., 1992, ANN N Y ACAD SCI, V666, P21; Hart CA, 2001, BMJ-BRIT MED J, V323, P1017, DOI 10.1136/bmj.323.7320.1017; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; HOPKINS DR, 1983, PRINCES PRESANTS SMA; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Lightfoot N, 2001, BMJ-BRIT MED J, V323, P877, DOI 10.1136/bmj.323.7318.877; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; MILLER J, 2001, GERMS AM SECRET WAR; NEWMAN NJ, 2000, ASYMMETRIC THREATS B; Olson KB, 1999, EMERG INFECT DIS, V5, P513, DOI 10.3201/eid0504.990409; ROTZ LD, 2002, IN PRESS EMERG INFEC; Spencer R. C., 1993, Reviews in Medical Microbiology, V4, P138; Spencer RC, 2001, J INFECTION, V43, P104, DOI 10.1053/jinf.2001.0906; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Turnbull PCB, 2000, CURR OPIN INFECT DIS, V13, P113, DOI 10.1097/00001432-200004000-00004; Wessely S, 2001, BRIT MED J, V323, P878, DOI 10.1136/bmj.323.7318.878; Wheelis M., 1999, BIOL TOXIN WEAPONS R, P8; World Health Organization, 1970, HLTH ASP CHEM BIOL W	32	53	59	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2002	324	7333					336	339		10.1136/bmj.324.7333.336	http://dx.doi.org/10.1136/bmj.324.7333.336			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834562	Green Published			2022-12-28	WOS:000173866300020
J	Rubenstein, DR; Chamberlain, CP; Holmes, RT; Ayres, MP; Waldbauer, JR; Graves, GR; Tuross, NC				Rubenstein, DR; Chamberlain, CP; Holmes, RT; Ayres, MP; Waldbauer, JR; Graves, GR; Tuross, NC			Linking breeding and wintering ranges of a migratory songbird using stable isotopes	SCIENCE			English	Article							CARBON; GROUNDS; POPULATIONS; BEHAVIOR; RATIOS; TRENDS	We used the natural abundance of stable isotopes (carbon and hydrogen) in the feathers of a neotropical migrant songbird to determine where birds from particular breeding areas spend the winter and the extent to which breeding populations mix in winter quarters. We show that most birds wintering on western Caribbean islands come from the northern portion of the species' North American breeding range, whereas those on more easterly islands are primarily from southern breeding areas. Although segregated by breeding latitude, birds within local wintering areas derive from a wide range of breeding longitudes, indicating considerable population mixing with respect to breeding Longitude. These results are useful for assessing the effects of wintering habitat Loss on breeding population abundances and for predicting whether the demographic consequences will be concentrated or diffuse.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; Smithsonian Inst, Dept Systemat Biol, Washington, DC 20560 USA; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Dartmouth College; Dartmouth College; Smithsonian Institution; Smithsonian Institution; Smithsonian National Museum of Natural History	Rubenstein, DR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	drr24@cornell.edu	Ayres, Matthew/AAI-6873-2020; Rubenstein, Dustin R./N-9302-2019; Graves, Gary R/P-1003-2017; Rubenstein, Dustin R/A-3451-2015	Ayres, Matthew/0000-0001-6120-9068; Rubenstein, Dustin R./0000-0002-4999-3723; Graves, Gary R/0000-0003-1406-5246; Rubenstein, Dustin R/0000-0002-4999-3723				Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P365, DOI 10.1016/0016-7037(94)90470-7; DANSGAARD W, 1964, TELLUS, V16, P436; DEWOLFE BB, 1995, CONDOR, V97, P376, DOI 10.2307/1369024; GREENBERG R, 1980, MIGRANT BIRDS NEOTRO, P593; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2001, AUK, V118, P16, DOI 10.1642/0004-8038(2001)118[0016:LBAWGO]2.0.CO;2; Hobson KA, 2001, ECOL APPL, V11, P1545, DOI 10.2307/3060938; HOLMES RT, 1994, BIRDS N AM, V87; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; James FC, 1996, ECOLOGY, V77, P13, DOI 10.2307/2265650; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Lajtha K, 1994, STABLE ISOTOPES ECOL, P1; MIZUTANI H, 1990, AUK, V107, P400, DOI 10.2307/4087626; PELLEK R, 1990, J FOREST, V88, P15; Ramos M.A., 1980, P173; SAUER JR, 2001, N AM BREEDING BIRD S; Sharp ZD, 2001, CHEM GEOL, V178, P197, DOI 10.1016/S0009-2541(01)00262-5; Sherry Thomas W., 1995, P85; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove D.S., 1984, American Birds, V38, P10; ZIEGLER H, 1988, STABLE ISOTOPES ECOL, P105	25	208	216	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1062	1065		10.1126/science.1067124	http://dx.doi.org/10.1126/science.1067124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834833				2022-12-28	WOS:000173793000063
J	Garrigue, S; Bordier, P; Jais, P; Shah, DC; Hocini, M; Raherisson, C; De Lara, MT; Haissaguerre, M; Clementy, J				Garrigue, S; Bordier, P; Jais, P; Shah, DC; Hocini, M; Raherisson, C; De Lara, MT; Haissaguerre, M; Clementy, J			Benefit of atrial pacing in sleep apnea syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; TRAFFIC ACCIDENTS; HEART-FAILURE; NASAL CPAP; CARDIOVASCULAR-DISEASE; DAYTIME SLEEPINESS; UVULOPALATOPHARYNGOPLASTY; PREVENTION; MORTALITY; ARRHYTHMIAS	Background: Many patients with sleep apnea syndrome have nocturnal bradycardia, paroxysmal tachyarrhythmias, or both, which can be prevented by permanent atrial pacing. We evaluated the effect of using cardiac pacing to increase the heart rate during sleep in patients with sleep apnea syndrome. Methods: We studied 15 patients (11 men and 4 women; mean [+/-SD] age, 69+/-9 years) with central or obstructive sleep apnea who had received permanent atrial-synchronous ventricular pacemakers for symptomatic sinus bradycardia. All patients underwent three polysomnographic evaluations on consecutive nights, the first night for base-line evaluation and then, in random order, one night in spontaneous rhythm and one in dual-chamber pacing mode with atrial overdrive (basic rate, 15 beats per minute faster than the mean nocturnal sinus rate). The total duration and number of episodes of central or obstructive sleep apnea or hypopnea were analyzed and compared. Results: The mean 24-hour sinus rate during spontaneous rhythm was 57+/-5 beats per minute at base line, as compared with 72+/-3 beats per minute with atrial overdrive pacing (P<0.001). The total duration of sleep was 321&PLUSMN;49 minutes in spontaneous rhythm, as compared with 331&PLUSMN;46 minutes with atrial overdrive pacing (P=0.48). The hypopnea index (the total number of episodes of hypopnea divided by the number of hours of sleep) was reduced from 9&PLUSMN;4 in spontaneous rhythm to 3&PLUSMN;3 with atrial overdrive pacing (P<0.001). For both apnea and hypopnea, the value for the index was 28+/-22 in spontaneous rhythm, as compared with 11+/-14 with atrial overdrive pacing (P<0.001). Conclusions: In patients with sleep apnea syndrome, atrial overdrive pacing significantly reduces the number of episodes of central or obstructive sleep apnea without reducing the total sleep time.	Hop Cardiol Haut Leveque, Cardiac Pacing & Clin Electrophysiol Dept, F-33604 Pessac, France; Univ Bordeaux, Hop Haut Leveque, Dept Lung & Resp Dis, Bordeaux, France	CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Garrigue, S (corresponding author), Hop Cardiol Haut Leveque, Cardiac Pacing & Clin Electrophysiol Dept, 19 Ave Magellan, F-33604 Pessac, France.							Abe H, 1998, PACE, V21, P1473, DOI 10.1111/j.1540-8159.1998.tb00220.x; Becker HF, 1998, THORAX, V53, pS29, DOI 10.1136/thx.53.2008.S29; Cassel W, 1996, EUR RESPIR J, V9, P2606, DOI 10.1183/09031936.96.09122606; COCCAGNA G, 1972, B PHYSIO-PATHOL RESP, V8, P1159; COUMEL P, 1983, PACE, V6, P552, DOI 10.1111/j.1540-8159.1983.tb05295.x; DAVIES RJO, 1993, AM REV RESPIR DIS, V147, P630, DOI 10.1164/ajrccm/147.3.630; Deharo JC, 1998, PACE, V21, P2688, DOI 10.1111/j.1540-8159.1998.tb00050.x; Findley L, 2000, AM J RESP CRIT CARE, V161, P857, DOI 10.1164/ajrccm.161.3.9812154; Finkelstein Y, 1997, ARCH OTOLARYNGOL, V123, P265; FRANKLIN KA, 1995, LANCET, V345, P1085, DOI 10.1016/S0140-6736(95)90820-X; FUJITA S, 1981, OTOLARYNG HEAD NECK, V89, P923, DOI 10.1177/019459988108900609; Garrigue S, 1998, PACE, V21, P1751, DOI 10.1111/j.1540-8159.1998.tb00275.x; Garrigue S, 2000, HEART, V83, P172, DOI 10.1136/heart.83.2.172; Grimm W, 1996, AM J CARDIOL, V77, P1310, DOI 10.1016/S0002-9149(96)00197-X; GUILLEMINAULT C, 1984, LANCET, V1, P126; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Hillarp B, 1996, ACTA RADIOL, V37, P307; HUDGEL DW, 1986, J APPL PHYSIOL, V61, P1403, DOI 10.1152/jappl.1986.61.4.1403; Isono S, 1999, EUR RESPIR J, V14, P1258, DOI 10.1183/09031936.99.14612589; ISSA FG, 1986, CHEST, V90, P165, DOI 10.1378/chest.90.2.165; Javaheri S, 1996, NEW ENGL J MED, V335, P562, DOI 10.1056/NEJM199608223350805; Javaheri S, 1996, SLEEP, V19, pS229; Javaheri S, 2000, CIRCULATION, V101, P392, DOI 10.1161/01.CIR.101.4.392; KRIEGER J, 1991, CHEST, V100, P917, DOI 10.1378/chest.100.4.917; Kuna ST, 2000, RESP PHYSIOL, V119, P155, DOI 10.1016/S0034-5687(99)00110-3; Langin T, 1998, CHEST, V113, P1595, DOI 10.1378/chest.113.6.1595; Mooe T, 1996, CHEST, V109, P659, DOI 10.1378/chest.109.3.659; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Newman AB, 2000, J AM GERIATR SOC, V48, P115, DOI 10.1111/j.1532-5415.2000.tb03901.x; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; Powell NB, 1998, CHEST, V113, P1163, DOI 10.1378/chest.113.5.1163; Roux F, 2000, AM J MED, V108, P396, DOI 10.1016/S0002-9343(00)00302-8; Sheldon R, 1999, AM J CARDIOL, V84, p26Q; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Sin DD, 2000, NEW ENGL J MED, V342, P293; Stegman SS, 1996, PACE, V19, P899, DOI 10.1111/j.1540-8159.1996.tb03385.x; SULLIVAN CE, 1981, LANCET, V1, P862; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Veale D, 2000, EUR RESPIR J, V15, P326, DOI 10.1034/j.1399-3003.2000.15b18.x; WOODSON BT, 1994, OTOLARYNG HEAD NECK, V111, P38, DOI 10.1177/019459989411100109; Yamamoto H, 2000, RESP MED, V94, P87, DOI 10.1053/rmed.1999.0698	41	237	276	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					404	412		10.1056/NEJMoa011919	http://dx.doi.org/10.1056/NEJMoa011919			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832528				2022-12-28	WOS:000173686400003
J	Brugha, R; Starling, M; Walt, G				Brugha, R; Starling, M; Walt, G			GAVI, the first steps: lessons for the Global Fund	LANCET			English	Article								The Global Alliance for Vaccines and Immunization (GAVI) Is seen as a model for the new Global Fund to Fight AIDS, Tuberculosis and Malaria, to be launched early in 2002. We did an assessment in four African countries to report the experiences of ministries of health and their partners in applying to GAVI for funds to strengthen health systems and for new vaccines. Countries welcomed the introduction of hepatitis B vaccine, safe Injection equipment, and the financial support to strengthen Immunisation programmes. All reported that the pace of the application process was too rapid. District visits revealed low staffing levels, insufficient transport and fuel, poorly functioning cold chains, and infrequent supervision. Information systems were unreliable, which will be an obstacle to GAVI when monitoring and rewarding improvements in Immunisation coverage. Also, the high cost of expensive new vaccines will be difficult to sustain if GAVI funding stops at the end of its 5 year commitment. Our study suggests that applications for support and planning for AIDS, tuberculosis, and malaria control under the new Global Fund, will be more complex and demanding on already overstretched ministries of health. Further, the rapid onset of activities, coupled with uncertainty about the time-scale of donor commitment, could be problematic. A limited and carefully assessed set of initial activities, focusing on where and how to strengthen existing country systems, is more likely to be successful and could provide useful models for scaling-up to larger programmes in different contexts.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Brugha, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England.		Ayres, Jose Ricardo C. M./G-2618-2012; Brugha, Ruairi/C-8420-2012	Ayres, Jose Ricardo C. M./0000-0002-5225-6492; Brugha, Ruairi/0000-0003-0729-0197				Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; *GAVI, 2002, UPD COUNTR LEV GAV V; *GAVI, 2002, PROP CALC GAVI REW S; *LATH CONS, 2001, IMM DAT QUAL AUD EV; LEVIN A, 2001, CASE STUDY COSTS FIN; Starling M., 2002, NEW PRODUCTS OLD SYS; *TRANS WORK GROUP, 2002, IN PRESS FRAM DOC GL; Walt G, 2000, TROP MED INT HEALTH, V5, P467, DOI 10.1046/j.1365-3156.2000.00596.x; WHO, 2002, MACR HLTH INV HLTH E	9	76	78	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					435	438		10.1016/S0140-6736(02)07607-9	http://dx.doi.org/10.1016/S0140-6736(02)07607-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844535				2022-12-28	WOS:000173686500035
J	McConnell, R; Berhane, K; Gilliland, F; London, SJ; Islam, T; Gauderman, WJ; Avol, E; Margolis, HG; Peters, JM				McConnell, R; Berhane, K; Gilliland, F; London, SJ; Islam, T; Gauderman, WJ; Avol, E; Margolis, HG; Peters, JM			Asthma in exercising children exposed to ozone: a cohort study	LANCET			English	Article							AIR-POLLUTION; BRONCHIAL RESPONSIVENESS; SCHOOL CHILDREN; PREVALENCE; POLLUTANTS; CHILDHOOD; ASSOCIATION; SYMPTOMS	Background Little is known about the effect of exposure to air pollution during exercise or time spent outdoors on the development of asthma. We investigated the relation between newly-diagnosed asthma and team sports in a cohort of children exposed to different concentrations and mixtures of air pollutants. Methods 3535 children with no history of asthma were recruited from schools in 12 communities in southern California and were followed up for up to 5 years. 265 children reported a new diagnosis of asthma during follow-up. We assessed risk of asthma in children playing team sports at study entry in six communities with high daytime ozone concentrations, six with lower concentrations, and in communities with high or low concentrations of nitrogen dioxide, particulate matter, and inorganic-acid vapour. Findings In communities with high ozone concentrations, the relative risk of developing asthma in children playing three or more sports was 3.3 (95% CI 1.9-5.8), compared with children playing no sports. Sports had no effect in areas of low ozone concentration (0.8, 0.4-1.6). Time spent outside was associated with a higher incidence of asthma in areas of high ozone (1.4, 1.0-2.1), but not in areas of low ozone. Exposure to pollutants other than ozone did not alter the effect of team sports. Interpretation Incidence of new diagnoses of asthma is associated with heavy exercise in communities with high concentrations of ozone, thus, air pollution and outdoor exercise could contribute to the development of asthma in children.	Univ So Calif, Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; NIEHS, Res Triangle Pk, NC 27709 USA; Calif Air Resources Board, Sacramento, CA USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McConnell, R (corresponding author), Univ So Calif, Sch Med, Dept Prevent Med, 1540 Alcazar St,CHP 236, Los Angeles, CA 90089 USA.	rmcconne@hsc.usc.edu	London, Stephanie/C-3734-2019; , Talat/AAV-6834-2020	London, Stephanie/0000-0003-4911-5290; , Talat/0000-0002-2837-865X	NHLBI NIH HHS [1R01HL61768] Funding Source: Medline; NIEHS NIH HHS [5P30ES07048-05, 1PO1ES0939581-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049019, P30ES007048] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Asher MI, 1998, EUR RESPIR J, V12, P315; Avol EL, 1998, ENVIRON SCI TECHNOL, V32, P463, DOI 10.1021/es970351m; Baldi I, 1999, EUR RESPIR J, V14, P132, DOI 10.1034/j.1399-3003.1999.14a22.x; Becklake MR, 1997, LANCET, V350, P10; BRUNEKREEF B, 1994, AM J RESP CRIT CARE, V150, P962, DOI 10.1164/ajrccm.150.4.7921470; BURR ML, 1992, CLIN EXP ALLERGY, V22, P509, DOI 10.1111/j.1365-2222.1992.tb00158.x; Clark NM, 1999, ENVIRON HEALTH PERSP, V107, P421, DOI 10.1289/ehp.99107s3421; Corrao W, 1996, CHEST, V109, P298, DOI 10.1378/chest.109.2.298; Ehrlich RI, 1995, INT J EPIDEMIOL, V24, P1138, DOI 10.1093/ije/24.6.1138; Gauderman WJ, 2000, AM J RESP CRIT CARE, V162, P1383; Guo YLL, 1999, ENVIRON HEALTH PERSP, V107, P1001, DOI 10.1289/ehp.991071001; Heir T., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P94; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; HORSTMAN DH, 1990, AM REV RESPIR DIS, V142, P1158, DOI 10.1164/ajrccm/142.5.1158; Jenkins HS, 1999, AM J RESP CRIT CARE, V160, P33, DOI 10.1164/ajrccm.160.1.9808119; Kehrl HR, 1999, J ALLERGY CLIN IMMUN, V104, P1198, DOI 10.1016/S0091-6749(99)70013-8; KOREN HS, 1995, ENVIRON HEALTH PERSP, V103, P235, DOI 10.2307/3432379; MCARDLE WD, 1996, EXERCISE PHYSL ENERG, P228; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; McDonnell WF, 1999, ENVIRON RES, V80, P110, DOI 10.1006/enrs.1998.3894; Miller FJ, 1995, TOXICOL LETT, V82-3, P277, DOI 10.1016/0378-4274(95)03562-1; OSEBOLD JW, 1988, P SOC EXP BIOL MED, V188, P259; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Rasmussen F, 2000, EUR RESPIR J, V16, P866, DOI 10.1183/09031936.00.16586600; RUPP NT, 1992, AM J DIS CHILD, V146, P941, DOI 10.1001/archpedi.1992.02160200063028; SAMET JM, 1987, CHEST, V91, pS74, DOI 10.1378/chest.91.6.74S; Sears MR, 1997, LANCET, V350, P1015, DOI 10.1016/S0140-6736(97)01468-2; SueChu M, 1996, RESP MED, V90, P99, DOI 10.1016/S0954-6111(96)90206-1; TAGER IB, 1998, RES REP HLTH EFF I, V81, P27; Wang TN, 1999, ENVIRON RES, V81, P239, DOI 10.1006/enrs.1999.3985; WICHMANN HE, 1995, ENVIRON HEALTH PERSP, V103, P29, DOI 10.2307/3432446	32	533	544	6	89	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					386	391		10.1016/S0140-6736(02)07597-9	http://dx.doi.org/10.1016/S0140-6736(02)07597-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844508				2022-12-28	WOS:000173686500008
J	McDonald, JW; Sadowsky, C				McDonald, JW; Sadowsky, C			Spinal-cord injury	LANCET			English	Review							FUNCTIONAL ELECTRICAL-STIMULATION; HIGH-DOSE METHYLPREDNISOLONE; NEUROLOGIC RECOVERY; ROOT STIMULATORS; MOTOR RECOVERY; BRAIN-INJURY; TRAUMA; PATHOPHYSIOLOGY; NEUROPROSTHESIS; DECOMPRESSION	More than a decade ago, spinal-cord injury meant confinement to a wheelchair and a lifetime of medical comorbidity. The physician's armamentarium of treatments was very limited, and provision of care for individuals with spinal-cord injury was usually met with frustration. Advances in the neurosclences have drawn attention to research into spinal-cord injury. Nowadays, advanced interventions provide high hope for regeneration and functional restoration. As scientific advances become more frequent, scepticism is giving way to the ideas that spinal-cord injury will eventually be repairable and that strategies to restore function are within our grasp. We address the present understanding of spinal-cord injury, its cause, pathophysiology, diagnosis, and treatment, and look at promising research avenues. We also discuss new treatment options, including functional electric stimulation and part-weight-supported walking.	Washington Univ, Sch Med, Dept Neurol, Restorat Treatment & Res Program, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, Spinal Cord Injury Neurorehabil Sect, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	McDonald, JW (corresponding author), Washington Univ, Sch Med, Dept Neurol, Restorat Treatment & Res Program, Campus Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	mcdonald@neuro.wustl.edu			NINDS NIH HHS [NS40520, NS01931, NS37927] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040520, K08NS001931, R29NS037927] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*AM SPIN INJ ASS, 1996, INT STAND NEUR CLASS; Atkinson PP, 1996, MAYO CLIN PROC, V71, P384, DOI 10.4065/71.4.384; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Barbeau H, 1999, BRAIN RES REV, V30, P27, DOI 10.1016/S0165-0173(99)00008-9; Barbeau H, 1999, ARCH PHYS MED REHAB, V80, P225, DOI 10.1016/S0003-9993(99)90126-0; Barker GJ, 2001, J NEUROL SCI, V186, pS45, DOI 10.1016/S0022-510X(01)00490-7; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BONDURANT FJ, 1990, SPINE, V15, P161, DOI 10.1097/00007632-199003000-00002; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brevig T, 2000, TRENDS NEUROSCI, V23, P337, DOI 10.1016/S0166-2236(00)01605-2; BRINDLEY GS, 1995, PARAPLEGIA, V33, P5, DOI 10.1038/sc.1995.3; BRINDLEY GS, 1994, PARAPLEGIA, V32, P795, DOI 10.1038/sc.1994.126; BUNGE RP, 1993, ADV NEUROL, V59, P75; CHARLIFUE SW, 1992, PARAPLEGIA, V30, P192, DOI 10.1038/sc.1992.54; Chen TY, 1998, SPINE, V23, P2398, DOI 10.1097/00007632-199811150-00007; Creasey GH, 2001, ARCH PHYS MED REHAB, V82, P1520, DOI 10.1053/apmr.2001.25912; Creasey GH, 2001, ARCH PHYS MED REHAB, V82, P1512, DOI 10.1053/apmr.2001.25911; Curt A, 1997, ARCH PHYS MED REHAB, V78, P39, DOI 10.1016/S0003-9993(97)90007-1; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Dimar JR, 1999, SPINE, V24, P1623, DOI 10.1097/00007632-199908150-00002; Ditunnio John F. Jr., 1995, P170; DUCKER TB, 1994, SPINE, V19, P2281, DOI 10.1097/00007632-199410150-00006; Egon G, 1998, WORLD J UROL, V16, P342, DOI 10.1007/s003450050078; Falci S, 1997, J NEUROTRAUM, V14, P875, DOI 10.1089/neu.1997.14.875; Fishman RA., 1992, CEREBROSPINAL FLUID; FLANDERS AE, 1990, RADIOLOGY, V177, P25, DOI 10.1148/radiology.177.1.2399326; GEILSER FH, 1998, ANN NY ACAD SCI, V19, P374; Go Bette K., 1995, P21; HALL M, 1841, DIS DERANGEMENTS NER, P256; HEIDEN JS, 1975, J NEUROSURG, V43, P732, DOI 10.3171/jns.1975.43.6.0732; Hoggard N, 2001, CLIN RADIOL, V56, P171, DOI 10.1053/crad.2000.0619; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; JOHNSTONE BR, 1988, PARAPLEGIA, V26, P317, DOI 10.1038/sc.1988.47; KATOH S, 1995, PARAPLEGIA, V33, P506, DOI 10.1038/sc.1995.110; Keith MW, 1996, J HAND SURG-AM, V21A, P89, DOI 10.1016/S0363-5023(96)80160-2; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Liu XZ, 1997, J NEUROSCI, V17, P5395; LYNSEMEYER TA, 2000, PHYS MED REH CLIN N, V11, P141; MACDONELL RAL, 1995, NEUROLOGY, V45, P303, DOI 10.1212/WNL.45.2.303; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; MARSHALL LF, 1987, J NEUROSURG, V66, P400, DOI 10.3171/jns.1987.66.3.0400; Matheson L N, 1996, J Back Musculoskelet Rehabil, V6, P249, DOI 10.3233/BMR-1996-6306; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; McDonald JW, 1999, SCI AM, V281, P64, DOI 10.1038/scientificamerican0999-64; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Melton L, 2000, LANCET, V355, P2142, DOI 10.1016/S0140-6736(05)72774-4; Mirza SK, 1999, CLIN ORTHOP RELAT R, P104, DOI 10.1097/00003086-199902000-00011; Nash MS, 1996, ARCH PHYS MED REHAB, V77, P1260, DOI 10.1016/S0003-9993(96)90190-2; National SCI Statistical Center, 1999, FACTS FIG GLANC; PENROD LE, 1990, ARCH PHYS MED REHAB, V71, P963; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Qian T, 2000, MED HYPOTHESES, V55, P452, DOI 10.1054/mehy.2000.1165; ROTH EJ, 1990, ARCH PHYS MED REHAB, V71, P18; SADOWSKY CL, 1999, SPINE, V13, P593; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; Schaefer PW, 2001, J NEUROL SCI, V186, pS25, DOI 10.1016/S0022-510X(01)00488-9; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Scremin AME, 1999, ARCH PHYS MED REHAB, V80, P1531; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Short DJ, 2000, SPINAL CORD, V38, P273, DOI 10.1038/sj.sc.3100986; Sipski ML, 1998, INT J IMPOT RES, V10, pS128; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; STAUFFER ES, 1984, SPINE, V9, P532, DOI 10.1097/00007632-198407000-00024; Stein RB, 1999, J NEUROTRAUM, V16, P713, DOI 10.1089/neu.1999.16.713; Stover S L, 1995, J Spinal Cord Med, V18, P175; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006; WATERS RL, 1995, ARCH PHYS MED REHAB, V76, P440, DOI 10.1016/S0003-9993(95)80573-7; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P306, DOI 10.1016/0003-9993(94)90034-5; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012	79	609	637	11	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					417	425		10.1016/S0140-6736(02)07603-1	http://dx.doi.org/10.1016/S0140-6736(02)07603-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844532				2022-12-28	WOS:000173686500032
J	Auslaender, OM; Yacoby, A; de Picciotto, R; Baldwin, KW; Pfeiffer, LN; West, KW				Auslaender, OM; Yacoby, A; de Picciotto, R; Baldwin, KW; Pfeiffer, LN; West, KW			Tunneling Spectroscopy of the Elementary Excitations in a One-Dimensional Wire	SCIENCE			English	Article							QUANTUM WIRES; LUTTINGER-LIQUID; CLEAVED EDGE; ELECTRON-GAS; TRANSPORT; SYSTEMS; OVERGROWTH	The collective excitation spectrum of interacting electrons in one dimension has been measured by controlling the energy and momentum of electrons tunneling between two closely spaced, parallel quantum wires in a GaAs/AlGaAs heterostructure while measuring the resulting conductance. The excitation spectrum deviates from the noninteracting spectrum, attesting to the importance of Coulomb interactions. An observed 30% enhancement! of the excitation velocity relative to noninteracting electrons with the same density, a parameter determined experimentally, is consistent with theories on interacting electrons in one dimension. In short wires, 6 and 2 micrometers long, finite size effects, resulting from the breaking of translational invariance, are observed.	Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Weizmann Institute of Science; Alcatel-Lucent; Lucent Technologies; AT&T	Auslaender, OM (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel.	ophir.auslaender@weizmann.ac.il						Altshuler B. L., 1985, Electron-electron interactions in disordered systems, P1; Auslaender OM, 2000, PHYS REV LETT, V84, P1764, DOI 10.1103/PhysRevLett.84.1764; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Boese D, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.085315; de Picciotto R, 2001, NATURE, V411, P51, DOI 10.1038/35075009; de Picciotto R, 2000, PHYS REV LETT, V85, P1730, DOI 10.1103/PhysRevLett.85.1730; EISENSTEIN JP, 1991, APPL PHYS LETT, V58, P1497, DOI 10.1063/1.105157; Emery V. J., 1979, HIGHLY CONDUCTING 1, P247; GONI AR, 1991, PHYS REV LETT, V67, P3298, DOI 10.1103/PhysRevLett.67.3298; Imry Y., 1997, INTRO MESOSCOPIC PHY; Kang W, 2000, NATURE, V403, P59, DOI 10.1038/47436; Kleimann T, 2000, PHYS REV B, V62, P8144, DOI 10.1103/PhysRevB.62.8144; MASLOV DL, 1995, PHYS REV B, V52, pR5539; Nozieres P., 1997, THEORY INTERACTING F; Oreg Y, 1996, PHYS REV B, V54, P14265, DOI 10.1103/PhysRevB.54.R14265; Pfeiffer L, 1997, MICROELECTR J, V28, P817, DOI 10.1016/S0026-2692(96)00120-6; PONOMARENKO VV, 1995, PHYS REV B, V52, pR8666, DOI 10.1103/PhysRevB.52.R8666; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Raichev OE, 2000, J PHYS-CONDENS MAT, V12, P6859, DOI 10.1088/0953-8984/12/30/315; Safi I, 1995, PHYS REV B, V52, P17040, DOI 10.1103/PhysRevB.52.R17040; Sassetti M, 1998, PHYS REV LETT, V80, P1485, DOI 10.1103/PhysRevLett.80.1485; SASSETTI M, COMMUNICATION; Yacoby A, 1997, SOLID STATE COMMUN, V101, P77, DOI 10.1016/S0038-1098(96)00377-8; YUE DX, 1994, PHYS REV B, V49, P1966, DOI 10.1103/PhysRevB.49.1966	24	275	275	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					825	828		10.1126/science.1066266	http://dx.doi.org/10.1126/science.1066266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823634				2022-12-28	WOS:000173733000036
J	Lobachev, KS; Gordenin, DA; Resnick, MA				Lobachev, KS; Gordenin, DA; Resnick, MA			The Mre11 complex is required for repair of hairpin-capped double-strand breaks and prevention of chromosome rearrangements	CELL			English	Article							DNA DOUBLE-STRAND; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENE AMPLIFICATION; MEIOTIC RECOMBINATION; PROTEIN COMPLEX; INVERTED REPEAT; HUMAN GENOME; YEAST-CELLS; MEIOSIS	Inverted repeats (IRs) that can form a hairpin or cruciform structure are common in the human genome and may be sources of instability. An IR involving the human Alu sequence (Alu-IR) has been studied as a model of such structures in yeast. We found that an Alu-IR is a mitotic recombination hotspot requiring MRE11/RAD50/XRS2 and SAE2. Using a newly developed approach for mapping rare double-strand breaks (DSBs), we established that induction of recombination results from breaks that are terminated by hairpins. Failure of the mre11, rad50, xrs2, and sae2 mutants to process the hairpins blocks recombinational repair of the DSBs and leads to generation of chromosome inverted duplications. Our results suggest an additional role for the Mre11 complex in maintaining genome stability.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.		Dmitry, Gordenin/C-3907-2018; resnick, Michael/F-1668-2019	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065073, Z01ES065073, Z01ES021122] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; BRISON O, 1993, BIOCHIM BIOPHYS ACTA, V1155, P25, DOI 10.1016/0304-419X(93)90020-D; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Catasti P, 1999, GENETICA, V106, P15, DOI 10.1023/A:1003716509180; CHALKER AF, 1988, GENE, V71, P201, DOI 10.1016/0378-1119(88)90092-3; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; DASGUPTA U, 1987, GENETICS, V115, P41; Delidakis C, 1989, CURR OPIN CELL BIOL, V1, P488, DOI 10.1016/0955-0674(89)90010-0; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; ERLICH DS, 1989, MOBILE DNA, P799; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Galli A, 1998, GENETICS, V149, P1235; GIBSON FP, 1992, J BACTERIOL, V174, P1222, DOI 10.1128/jb.174.4.1222-1228.1992; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; HUANG T, 1995, J BIOL CHEM, V270, P9607, DOI 10.1074/jbc.270.16.9607; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jankowski C, 2000, P NATL ACAD SCI USA, V97, P2134, DOI 10.1073/pnas.040460297; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lin CT, 2001, NUCLEIC ACIDS RES, V29, P3529, DOI 10.1093/nar/29.17.3529; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Malagon F, 1998, MOL GEN GENET, V259, P639, DOI 10.1007/s004380050858; Malkova A, 1996, GENETICS, V143, P741; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; McKee AHZ, 1997, GENETICS, V146, P797; MEUTH M, 1989, MOBILE DNA, P833; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nasar F, 2000, MOL CELL BIOL, V20, P3449, DOI 10.1128/MCB.20.10.3449-3458.2000; OUELLETTE M, 1991, RES MICROBIOL, V142, P737, DOI 10.1016/0923-2508(91)90089-S; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Prinz S, 1997, GENETICS, V146, P781; Qin ZJ, 2000, GENE DEV, V14, P1789; Rattray AJ, 2001, GENETICS, V158, P109; Schar P, 2001, CELL, V104, P329, DOI 10.1016/S0092-8674(01)00220-3; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; TIMME TL, 1988, AM J MED SCI, V295, P40, DOI 10.1097/00000441-198801000-00009; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WINDLE BE, 1992, MUTAT RES, V276, P199, DOI 10.1016/0165-1110(92)90009-X; YASUDA LF, 1991, CELL, V67, P505, DOI 10.1016/0092-8674(91)90525-4	64	319	324	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					183	193		10.1016/S0092-8674(02)00614-1	http://dx.doi.org/10.1016/S0092-8674(02)00614-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832209	Bronze			2022-12-28	WOS:000173521300006
J	Park, YD; Hanbicki, AT; Erwin, SC; Hellberg, CS; Sullivan, JM; Mattson, JE; Ambrose, TF; Wilson, A; Spanos, G; Jonker, BT				Park, YD; Hanbicki, AT; Erwin, SC; Hellberg, CS; Sullivan, JM; Mattson, JE; Ambrose, TF; Wilson, A; Spanos, G; Jonker, BT			A group-IV ferromagnetic semiconductor: MnxGe1-x	SCIENCE			English	Article							MOLECULAR-BEAM EPITAXY; MAGNETIC SEMICONDUCTORS; (GA,MN)AS; MAGNETOTRANSPORT; TEMPERATURE; FIELD; GAAS	We report on the epitaxial growth of a group-IV ferromagnetic semiconductor, MnxGe1-x, in which the Curie temperature is found to increase linearly with manganese (Mn) concentration from 25 to 116 kelvin. The p-type semiconducting character and hole-mediated exchange permit control of ferromagnetic order through application of a +/-0.5-volt gate voltage, a value compatible with present microelectronic technology. Total-energy calculations within density-functional theory show that the magnetically ordered phase arises from a tong-range ferromagnetic interaction that dominates a short-range antiferromagnetic interaction. Calculated spin interactions and percolation theory predict transition temperatures larger than measured, consistent with the observed suppression of magnetically active Mn atoms and hole concentration.	USN, Res Lab, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Jonker, BT (corresponding author), USN, Res Lab, Washington, DC 20375 USA.	jonker@nrl.navy.mil	Park, Yun D/A-9559-2008; Hellberg, C. Stephen/E-5391-2010; Erwin, Steven C/B-1850-2009	Park, Yun D/0000-0001-7699-0432; 				Abe E, 2000, PHYSICA E, V7, P981, DOI 10.1016/S1386-9477(00)00100-4; DeBoeck J, 1996, APPL PHYS LETT, V68, P2744, DOI 10.1063/1.115584; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Dietl T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.195205; Fuchs M, 1999, COMPUT PHYS COMMUN, V119, P67, DOI 10.1016/S0010-4655(98)00201-X; Haas C., 1970, CRIT REV SOLID STATE, V1, P47, DOI [10.1080/10408437008243418, DOI 10.1080/10408437008243418]; Hayashi T, 2000, J APPL PHYS, V87, P4673, DOI 10.1063/1.373126; Iye Y, 1999, MAT SCI ENG B-SOLID, V63, P88, DOI 10.1016/S0921-5107(99)00057-4; Kortus J, 2001, PHYS REV LETT, V86, P3400, DOI 10.1103/PhysRevLett.86.3400; Litvinov VI, 2001, PHYS REV LETT, V86, P5593, DOI 10.1103/PhysRevLett.86.5593; Maeda T, 1999, J CRYST GROWTH, V201, P194, DOI 10.1016/S0022-0248(98)01319-0; Martin RL, 1997, PHYS REV LETT, V79, P1539, DOI 10.1103/PhysRevLett.79.1539; MASSALASKI TB, 1990, BINARY ALLOY PHASE D, V2, P1964; Matsukura F, 1998, PHYS REV B, V57, pR2037, DOI 10.1103/PhysRevB.57.R2037; Medvedkin GA, 2000, JPN J APPL PHYS 2, V39, pL949, DOI 10.1143/JJAP.39.L949; MUNEKATA H, 1989, PHYS REV LETT, V63, P1849, DOI 10.1103/PhysRevLett.63.1849; NAGAEV EL, 1988, PHYS STATUS SOLIDI B, V145, P11, DOI 10.1002/pssb.2221450102; Ohldag H, 2000, APPL PHYS LETT, V76, P2928, DOI 10.1063/1.126519; Ohno H, 1996, APPL PHYS LETT, V69, P363, DOI 10.1063/1.118061; Ohno H, 1998, SCIENCE, V281, P951, DOI 10.1126/science.281.5379.951; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; Omiya T, 2000, PHYSICA E, V7, P976, DOI 10.1016/S1386-9477(00)00099-0; Park YD, 2001, APPL PHYS LETT, V78, P2739, DOI 10.1063/1.1369151; Schulthess TC, 2001, J APPL PHYS, V89, P7021, DOI 10.1063/1.1359456; van Schilfgaarde M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.233205; VanEsch A, 1997, PHYS REV B, V56, P13103, DOI 10.1103/PhysRevB.56.13103	27	801	820	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					651	654		10.1126/science.1066348	http://dx.doi.org/10.1126/science.1066348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809964				2022-12-28	WOS:000173560900036
J	Dixon, J				Dixon, J			Commentary: Funding is not the only factor	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, Hlth Policy Programme, London W1G 0AN, England		Dixon, J (corresponding author), Kings Fund, Hlth Policy Programme, London W1G 0AN, England.								0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					142	142						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11822329				2022-12-28	WOS:000173470600014
J	Fayers, PM; Sprangers, MAG				Fayers, PM; Sprangers, MAG			Understanding self-rated health	LANCET			English	Editorial Material							QUALITY-OF-LIFE; ONCOLOGY		Univ Aberdeen, Sch Med, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland; Norwegian Univ Sci & Technol, Unit Appl Clin Res, Trondheim, Norway; Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands	University of Aberdeen; Norwegian University of Science & Technology (NTNU); University of Amsterdam; Academic Medical Center Amsterdam	Fayers, PM (corresponding author), Univ Aberdeen, Sch Med, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland.		Fayers, Peter M/A-5999-2010	Fayers, Peter/0000-0003-4778-1513				Bjorner J. B., 1996, 96 SWED COUNC PLANN, P9; Coates A, 1997, EUR J CANCER, V33, P1025, DOI 10.1016/S0959-8049(97)00049-X; Eriksson I, 2001, INT J EPIDEMIOL, V30, P326, DOI 10.1093/ije/30.2.326; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; KRAUSE NM, 1994, MED CARE, V32, P930, DOI 10.1097/00005650-199409000-00004; Osoba D, 1999, EUR J CANCER, V35, P1565, DOI 10.1016/S0959-8049(99)00192-6; Schwartz CE, 2000, ADAPTATION CHANGING	7	362	367	2	33	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					187	188		10.1016/S0140-6736(02)07466-4	http://dx.doi.org/10.1016/S0140-6736(02)07466-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812551				2022-12-28	WOS:000173350800007
J	Ybarra, J; Fuster, D; Martin, F; Lomena, F; Torregrossa, JV				Ybarra, J; Fuster, D; Martin, F; Lomena, F; Torregrossa, JV			Amiodarone-induced thyroiditis	LANCET			English	Article									Hosp Clin Barcelona, Renal Transplant Unit, E-08036 Barcelona, Spain; Hosp Clin Barcelona, Dept Nucl Med, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Ybarra, J (corresponding author), Hosp Clin Barcelona, Renal Transplant Unit, C Villarroel 170, E-08036 Barcelona, Spain.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					69	69		10.1016/S0140-6736(02)07328-2	http://dx.doi.org/10.1016/S0140-6736(02)07328-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809205				2022-12-28	WOS:000173143500034
J	Vassallo, R; Ryu, JH; Schroeder, DR; Decker, PA; Limper, AH				Vassallo, R; Ryu, JH; Schroeder, DR; Decker, PA; Limper, AH			Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE INDUSTRIAL-STATE; HIGH-RESOLUTION CT; EOSINOPHILIC GRANULOMA; MULTIPLE-MYELOMA; ACUTE-LEUKEMIA; LUNG; ASSOCIATION; MALIGNANCY; LYMPHOMAS; MICHIGAN	Background: Pulmonary Langerhans'-cell histiocytosis is an uncommon interstitial lung disease in adults. It has an unpredictable course and may be associated with an increased susceptibility to the development of malignant neoplasms. Methods: We reviewed the records of 102 adults with histopathologically confirmed pulmonary Langerhans'-cell histiocytosis to ascertain their vital status and whether cancer had been diagnosed. The health status of surviving patients was quantified with the use of the 36-Item Short-Form General Health Survey. Factors potentially associated with survival after the diagnosis of pulmonary Langerhans'-cell histiocytosis were analyzed with the Cox proportional-hazards model. Results: The median follow-up period was 4 years (range, 0 to 23). There were 33 deaths, 15 of which were attributable to respiratory failure. Six hematologic cancers were diagnosed. The overall median survival was 12.5 years, which was significantly shorter than that expected for persons of the same sex and calendar year of birth (P<0.001). In a univariate analysis, variables predictive of shorter survival included an older age (P=0.003), a lower forced expiratory volume in one second (FEV1 (P=0.004), a higher residual volume (P=0.007), a lower ratio of FEV1 to forced vital capacity (P=0.03), and a reduced carbon monoxide diffusing capacity (P=0.001). Conclusions: The survival of adults with pulmonary Langerhans'-cell histiocytosis is shorter than that in the general population, and respiratory failure accounts for a substantial proportion of deaths among such patients. (N Engl J Med 2002;346:484-90.) Copyright (C) 2002 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Vassallo, R (corresponding author), Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, Stable Bldg 8-54,200 1st St SW, Rochester, MN 55905 USA.		Vassallo, Robert/R-7752-2019	Vassallo, Robert/0000-0003-2328-0255; Ryu, Jay/0000-0002-9576-2272				American Thoracic Society, 1991, AM REV RESP DIS, V144, P1202; BASSET F, 1978, AM REV RESPIR DIS, V118, P811; BENEZRA JM, 1993, AM J CLIN PATHOL, V99, P464, DOI 10.1093/ajcp/99.4.464; Bernstrand C, 2000, ACTA PAEDIATR, V89, P1389, DOI 10.1080/080352500300002642; Bonelli FS, 1998, AM J ROENTGENOL, V170, P1507, DOI 10.2214/ajr.170.6.9609163; BRAUNER MW, 1989, RADIOLOGY, V172, P255, DOI 10.1148/radiology.172.1.2787036; Brauner MW, 1997, RADIOLOGY, V204, P497, DOI 10.1148/radiology.204.2.9240543; BURNS BF, 1983, AM J SURG PATHOL, V7, P529, DOI 10.1097/00000478-198309000-00003; Chang JA, 1999, CHEST, V116, P1175, DOI 10.1378/chest.116.5.1175; COLBY TV, 1983, HUM PATHOL, V14, P847, DOI 10.1016/S0046-8177(83)80160-9; Collins J, 2001, RADIOL CLIN N AM, V39, P1115, DOI 10.1016/S0033-8389(05)70334-1; de Andres CI, 1999, VIRCHOWS ARCH, V434, P259, DOI 10.1007/s004280050338; DECAMARGO B, 1993, MED PEDIATR ONCOL, V21, P451, DOI 10.1002/mpo.2950210612; Delobbe K, 1996, EUR RESPIR J, V9, P2002; EGELER RM, 1993, CANCER, V71, P865, DOI 10.1002/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0; Egeler RM, 1998, HEMATOL ONCOL CLIN N, V12, P369, DOI 10.1016/S0889-8588(05)70516-5; EGELER RM, 1994, MED PEDIATR ONCOL, V23, P81, DOI 10.1002/mpo.2950230204; EMILE JF, 1995, AM J SURG PATHOL, V19, P636, DOI 10.1097/00000478-199506000-00003; FRIEDMAN PJ, 1981, MEDICINE, V60, P385, DOI 10.1097/00005792-198111000-00001; HOUSINI I, 1994, ARCH PATHOL LAB MED, V118, P523; KRENACS L, 1993, J PATHOL, V171, P99, DOI 10.1002/path.1711710206; LOMBARD CM, 1987, ARCH PATHOL LAB MED, V111, P339; Malpas JS, 1996, MED PEDIATR ONCOL, V27, P540; Michetti G, 1996, Minerva Med, V87, P243; MILLER A, 1986, B EUR PHYSIOPATH RES, V22, P589; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Nagai S, 2000, Curr Opin Pulm Med, V6, P415, DOI 10.1097/00063198-200009000-00005; Ryu JH, 2001, EUR RESPIR J, V17, P122, DOI 10.1183/09031936.01.17101220; *SURV EP END RES, 2000, SEER PROGR PUBL US D; Therneau TMSJ, 1994, TECHNICAL REPORT SER, V52; TRAVIS WD, 1993, AM J SURG PATHOL, V17, P971, DOI 10.1097/00000478-199310000-00002; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607; Ware J.E, 1994, PHYS MENTAL HLTH SUM; YAMASHITA H, 1992, CLIN EXP DERMATOL, V17, P275, DOI 10.1111/j.1365-2230.1992.tb02167.x; Yousem SA, 2001, AM J SURG PATHOL, V25, P630, DOI 10.1097/00000478-200105000-00010	35	272	295	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					484	490		10.1056/NEJMoa012087	http://dx.doi.org/10.1056/NEJMoa012087			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844849				2022-12-28	WOS:000173815300004
J	Jacoby, DB				Jacoby, DB			Virus-induced asthma attacks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYNCYTIAL VIRUS; AIRWAY EPITHELIAL-CELLS; INDUCED CYTOKINE PRODUCTION; PULMONARY PARASYMPATHETIC NERVES; MUSCARINIC RECEPTOR FUNCTION; CHALLENGED GUINEA-PIGS; NITRIC-OXIDE SYNTHASE; MAJOR BASIC-PROTEIN; RHINOVIRUS INFECTION; INFLUENZA-VIRUS	Viral respiratory tract infections are a common cause of asthma attacks. Study of this phenomenon has revealed multiple mechanisms and contributed to understanding of the increase in airway inflammation and bronchoconstriction observed in this context. Changes in the neural control of the airways contribute to bronchoconstriction, which is reflected in an increased efficacy of anticholinergic medications during acute asthma attacks. The ability to prevent or treat viral respiratory tract infections is currently limited. However, as more effective antiviral treatments and vaccines become available, such therapies are likely to be effective in patients with asthma. Clinical management of this problem is illustrated in this article by the case of a 40-year-old woman with history of mild asthma who was admitted to an intensive care unit with severe bronchospasm and an upper respiratory tract infection.	Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jacoby, DB (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, 615 N Wolfe St,Room W7006, Baltimore, MD 21205 USA.	djacoby@jhmi.edu		Jacoby, David/0000-0003-2195-9512	NHLBI NIH HHS [HL-54659, HL61013] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061013, R01HL054659] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*2 EXP PAN MAN AST, 1997, GUID DIAGN MAN ASTHM; Adamko DJ, 1999, J EXP MED, V190, P1465, DOI 10.1084/jem.190.10.1465; ADAMKO DJ, 2001, AM J RESP CRIT CARE, V163, pA952; ADAMKO DJ, 2000, AM J RESP CRIT CARE, V161, pA842; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; AQUILINA AT, 1980, AM REV RESPIR DIS, V122, P3; Atmar RL, 1998, ARCH INTERN MED, V158, P2453, DOI 10.1001/archinte.158.22.2453; Becker S, 1997, AM J PHYSIOL-LUNG C, V272, pL512, DOI 10.1152/ajplung.1997.272.3.L512; Behera AK, 1998, BIOCHEM BIOPH RES CO, V251, P704, DOI 10.1006/bbrc.1998.9537; Brophy C, 1998, THORAX, V53, P363, DOI 10.1136/thx.53.5.363; BUCKNER CK, 1985, AM REV RESPIR DIS, V132, P305; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; CARR MJ, IN PRESS AM J RESP C; CASTELMAN WL, 1984, AM J PATHOL, V114, P322; CIRINO NM, 1993, J GEN VIROL, V74, P1527, DOI 10.1099/0022-1317-74-8-1527; COLASURDO GN, 1995, AM J PHYSIOL-LUNG C, V268, pL1006, DOI 10.1152/ajplung.1995.268.6.L1006; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; DUSSER DJ, 1989, J APPL PHYSIOL, V67, P1504, DOI 10.1152/jappl.1989.67.4.1504; ELIAS JA, 1994, J BIOL CHEM, V269, P22261; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; Evans CM, 2001, AM J RESP CRIT CARE, V163, P1484, DOI 10.1164/ajrccm.163.6.2007047; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; EVANS CM, 1998, AM J RESP CRIT CARE, V157, pA599; FOLKERTS G, 1995, J CLIN INVEST, V95, P26, DOI 10.1172/JCI117649; FRICK OL, 1979, J ALLERGY CLIN IMMUN, V63, P228, DOI 10.1016/0091-6749(79)90106-4; FRYER AD, 1992, J CLIN INVEST, V90, P2292, DOI 10.1172/JCI116116; FRYER AD, 1984, BRIT J PHARMACOL, V83, P973, DOI 10.1111/j.1476-5381.1984.tb16539.x; FRYER AD, 1991, BRIT J PHARMACOL, V102, P267, DOI 10.1111/j.1476-5381.1991.tb12164.x; Gao J, 1999, J VIROL, V73, P1411, DOI 10.1128/JVI.73.2.1411-1418.1999; Griego SD, 2000, J IMMUNOL, V165, P5211, DOI 10.4049/jimmunol.165.9.5211; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; HENRY PJ, 1991, BRIT J PHARMACOL, V104, P914, DOI 10.1111/j.1476-5381.1991.tb12526.x; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Imani F, 1999, J IMMUNOL, V162, P1597; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Jacoby DB, 1998, J CLIN INVEST, V102, P242, DOI 10.1172/JCI1114; JACOBY DB, 1988, J APPL PHYSIOL, V64, P2653, DOI 10.1152/jappl.1988.64.6.2653; Jacoby DB, 2001, AM J RESP CELL MOL, V24, P485, DOI 10.1165/ajrcmb.24.4.4379; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kaiser L, 2000, ANTIVIR RES, V47, P215, DOI 10.1016/S0166-3542(00)00106-6; Kao YJ, 2001, AM J RESP CRIT CARE, V163, P532, DOI 10.1164/ajrccm.163.2.9912068; Kawaguchi M, 2000, INT ARCH ALLERGY IMM, V122, P44, DOI 10.1159/000053632; Knobil K, 1998, AM J PHYSIOL-LUNG C, V274, pL134, DOI 10.1152/ajplung.1998.274.1.L134; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Lee CG, 2000, AM J RESP CELL MOL, V23, P662, DOI 10.1165/ajrcmb.23.5.4188; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; Martinez FD, 2000, AM J RESP CRIT CARE, V162, pS95, DOI 10.1164/ajrccm.162.supplement_2.ras-8; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; Matsuse H, 2000, J IMMUNOL, V164, P6583, DOI 10.4049/jimmunol.164.12.6583; MINETTE PA, 1988, J APPL PHYSIOL, V64, P2532, DOI 10.1152/jappl.1988.64.6.2532; NAKAZAWA H, 1994, AM J RESP CRIT CARE, V149, P1180, DOI 10.1164/ajrccm.149.5.8173757; NOAH TL, 1993, AM J PHYSIOL, V265, pL472, DOI 10.1152/ajplung.1993.265.5.L472; Olszewska-Pazdrak B, 1998, J VIROL, V72, P4756, DOI 10.1128/JVI.72.6.4756-4764.1998; Papi A, 1999, J BIOL CHEM, V274, P30041, DOI 10.1074/jbc.274.42.30041; PATTEMORE PK, 1992, CLIN EXP ALLERGY, V22, P325, DOI 10.1111/j.1365-2222.1992.tb03094.x; Piedimonte G, 1999, AM J PHYSIOL-LUNG C, V277, pL831, DOI 10.1152/ajplung.1999.277.4.L831; PIEDIMONTE G, 1990, J APPL PHYSIOL, V68, P754, DOI 10.1152/jappl.1990.68.2.754; Pirhonen J, 2001, EUR J IMMUNOL, V31, P726, DOI 10.1002/1521-4141(200103)31:3<726::AID-IMMU726>3.0.CO;2-5; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Qureshi F, 1998, NEW ENGL J MED, V339, P1030, DOI 10.1056/NEJM199810083391503; Rodrigo CJ, 2000, AM J RESP CRIT CARE, V161, P1862; ROONEY JC, 1971, J PEDIATR-US, V79, P744, DOI 10.1016/S0022-3476(71)80385-2; Rosenberg HF, 1999, IMMUNOL RES, V20, P261, DOI 10.1007/BF02790409; Samransamruajkit R, 2000, INT J MOL MED, V6, P101; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Sanders SP, 2001, J ALLERGY CLIN IMMUN, V107, P235, DOI 10.1067/mai.2001.112028; SAWATZKY DA, IN PRESS AM J PHYSL; SORKNESS R, 1991, J APPL PHYSIOL, V70, P375, DOI 10.1152/jappl.1991.70.1.375; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Terajima M, 1997, AM J PHYSIOL-LUNG C, V273, pL749, DOI 10.1152/ajplung.1997.273.4.L749; Turner RB, 1999, JAMA-J AM MED ASSOC, V281, P1797, DOI 10.1001/jama.281.19.1797; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339	74	51	53	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					755	761		10.1001/jama.287.6.755	http://dx.doi.org/10.1001/jama.287.6.755			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851543				2022-12-28	WOS:000173809500033
J	Miller, LJ				Miller, LJ			Postpartum depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MATERNITY BLUES; MOOD; PREGNANCY; WOMEN; FLUOXETINE; EXCRETION; ESTROGEN		Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Miller, LJ (corresponding author), Univ Illinois, Dept Psychiat, 912 S Wood St,M-C 913, Chicago, IL 60612 USA.	ljm@psych.uic.edu						Ahokas A, 2001, J CLIN PSYCHIAT, V62, P332, DOI 10.4088/JCP.v62n0504; Ahokas A, 2000, J CLIN PSYCHIAT, V61, P166, DOI 10.4088/JCP.v61n0303; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ATTIA E, 1999, CLIN PRAC, P99; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Coe C.L., 1990, P157; CONDON JT, 1986, AM J PSYCHIAT, V143, P987; Demand N. H., 1994, BIRTH DEATH MOTHERHO; DeMier R L, 1996, J Perinatol, V16, P276; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Georgiopoulos AM, 2001, J FAM PRACTICE, V50, P117; Gregoire AJP, 1996, LANCET, V347, P930, DOI 10.1016/S0140-6736(96)91414-2; Hagg S, 2000, BRIT J CLIN PHARMACO, V49, P286, DOI 10.1046/j.1365-2125.2000.00142-3.x; HAPGOOD CC, 1988, AUST NZ J PSYCHIAT, V22, P299, DOI 10.3109/00048678809161211; HARRIS B, 1994, BRIT MED J, V308, P949, DOI 10.1136/bmj.308.6934.949; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; Jacobsen T., 1999, CLIN PRAC, P119; Janssen HJEM, 1996, AM J PSYCHIAT, V153, P226; Jennings KD, 1999, J AFFECT DISORDERS, V54, P21; Josefsson A, 2001, ACTA OBSTET GYN SCAN, V80, P251; KENDELL RE, 1981, J AFFECT DISORDERS, V3, P317, DOI 10.1016/0165-0327(81)90001-X; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Kristensen JH, 1999, BRIT J CLIN PHARMACO, V48, P521, DOI 10.1046/j.1365-2125.1999.00040.x; LESTER BM, 1993, J AM ACAD CHILD PSY, V32, P1253, DOI 10.1097/00004583-199311000-00020; MCNEIL TF, 1988, ACTA PSYCHIAT SCAND, V78, P613, DOI 10.1111/j.1600-0447.1988.tb06393.x; MILLER LJ, 1994, HOSP COMMUNITY PSYCH, V45, P444; Miller LJ, 1998, CLIN PRAC, P3; Miller PS, 1998, TOP EARLY CHILD SPEC, V18, P49, DOI 10.1177/027112149801800108; Misri S, 2000, CAN J PSYCHIAT, V45, P554, DOI 10.1177/070674370004500607; Nappi RE, 2001, OBSTET GYNECOL, V97, P77, DOI 10.1016/S0029-7844(00)01112-1; Neugebauer R, 1997, JAMA-J AM MED ASSOC, V277, P383, DOI 10.1001/jama.277.5.383; NEVALA AE, 2001, CHICAGO TRIBUNE 0719, P1; O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039; OHARA MW, 1991, J ABNORM PSYCHOL, V100, P63, DOI 10.1037/0021-843X.100.1.63; Ohman R, 1999, J CLIN PSYCHIAT, V60, P519, DOI 10.4088/JCP.v60n0803; Onozawa K, 2001, J AFFECT DISORDERS, V63, P201, DOI 10.1016/S0165-0327(00)00198-1; Raty-Vohsen D, 1982, Acta Psychiatr Belg, V82, P596; Robling SA, 2000, PSYCHOL MED, V30, P1263, DOI 10.1017/S0033291799003025; Schmidt K, 2000, BIOL PSYCHIAT, V47, P164, DOI 10.1016/S0006-3223(99)00155-9; SPINELLI M, IN PRESS INFANTICIDE; SPINELLI MG, 1999, CLIN PRAC, P217; STEINER M, 1999, CLIN PRAC, P47; Thompson JF, 2000, MED J AUSTRALIA, V172, P532, DOI 10.5694/j.1326-5377.2000.tb124098.x; WILE J, 1999, CLIN PRAC, P83; Wisner KL, 2001, J CLIN PSYCHIAT, V62, P82, DOI 10.4088/JCP.v62n0202; 2002, NY TIMES        0106; [No title captured]	47	247	261	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					762	765		10.1001/jama.287.6.762	http://dx.doi.org/10.1001/jama.287.6.762			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520XR	11851544				2022-12-28	WOS:000173809500034
J	Argo, AM; Odzak, JF; Lai, FS; Gates, BC				Argo, AM; Odzak, JF; Lai, FS; Gates, BC			Observation of ligand effects during alkene hydrogenation catalysed by supported metal clusters	NATURE			English	Article							SUM-FREQUENCY GENERATION; ETHYLENE HYDROGENATION; MGO(001) SURFACE; PT(111); PLATINUM; PERFORMANCE; ADSORPTION; PROPYLENE; PROPENE; SIZE	Homogeneous organometallic catalysts and many enzymes activate reactants through coordination to metal atoms; that is, the reactants are turned into ligands and their reactivity controlled through other ligands in the metal's coordination sphere(1). In the case of supported metal clusters, catalytic performance is influenced by the support and by adsorbed reactants, intermediates or products. The adsorbates are usually treated as ligands, whereas the influence of the supports is usually ascribed to electronic interactions(2,3), even though metal clusters supported on oxides(4-6) and zeolites(7) form chemical bonds to support oxygen atoms. Here we report direct observations of the structure of supported metal clusters consisting of four iridium atoms, and the identification of hydrocarbon ligands bound to them during propene hydrogenation. We find that propene and molecular hydrogen form propylidyne and hydride ligands, respectively(8), whereas simultaneous exposure of the reactants to the supported iridium cluster yields ligands that are reactive intermediates during the catalytic propane-formation reaction. These intermediates weaken the bonding within the tetrahedral iridium cluster and the interactions between the cluster and the support, while replacement of the MgO support with gamma-Al2O3 boosts the catalytic activity tenfold, by affecting the bonding between the reactant-derived ligands and the cluster and therefore also the abundance of individual ligands. This interplay between the support and the reactant-derived ligands, whereby each influences the interaction of the metal cluster with the other, shows that the catalytic properties of supported metal catalysts can be tuned by careful choice of their supports.	Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Gates, BC (corresponding author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.	bcgates@ucdavis.edu	Argo, Antonina/AAY-2699-2021	Argo, Antonina/0000-0002-9964-0184				Argo AM, 2001, J AM CHEM SOC, V123, P2275, DOI 10.1021/ja002818q; ARGO AM, 2001, INFLUENCE SUPPORTS C; BENT BE, 1987, J PHYS CHEM-US, V91, P1493, DOI 10.1021/j100290a042; CHESTERS MA, 1990, J CHEM SOC FARADAY T, V86, P2757, DOI 10.1039/ft9908602757; Collman J.P., 1987, PRINCIPLES APPL ORGA; Cremer PS, 1996, J PHYS CHEM-US, V100, P16302, DOI 10.1021/jp9613394; Cremer PS, 1996, J AM CHEM SOC, V118, P2942, DOI 10.1021/ja952800t; Ferrari AM, 1999, J PHYS CHEM B, V103, P5311, DOI 10.1021/jp990369e; GATES BC, 1995, CHEM REV, V95, P511, DOI 10.1021/cr00035a003; Goellner JF, 2000, LANGMUIR, V16, P2736, DOI 10.1021/la9912388; HALLER GL, 1989, ADV CATAL, V36, P173, DOI 10.1016/S0360-0564(08)60018-8; Jentoft RE, 1998, J CATAL, V179, P565, DOI 10.1006/jcat.1998.2229; Matveev AV, 1999, CHEM PHYS LETT, V299, P603, DOI 10.1016/S0009-2614(98)01183-X; MCVICKER GB, 1993, J CATAL, V139, P48, DOI 10.1006/jcat.1993.1006; Neurock M, 2000, J PHYS CHEM B, V104, P11127, DOI 10.1021/jp994082t; Newell HE, 1998, J CHEM SOC FARADAY T, V94, P3695, DOI 10.1039/a806786d; Odzak JF, 2001, REV SCI INSTRUM, V72, P3943, DOI 10.1063/1.1403011; SHAHID G, 1990, SPECTROCHIM ACTA A, V46, P999, DOI 10.1016/0584-8539(90)80017-S; Stevenson SA, 1987, METAL SUPPORT INTERA; XU Z, 1994, NATURE, V372, P346, DOI 10.1038/372346a0; Yudanov IV, 1997, CHEM PHYS LETT, V275, P245, DOI 10.1016/S0009-2614(97)00772-0	21	172	177	10	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					623	626		10.1038/415623a	http://dx.doi.org/10.1038/415623a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832941				2022-12-28	WOS:000173709100041
J	Lowenstein, E; Wanzer, SH				Lowenstein, E; Wanzer, SH			Sounding board - The US Attorney General's intrusion into medical practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Lowenstein, E (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							*ACOG, 1999, ACOG PRACT B, V10; *ACOG, 1999, 228 ACOG; ASHCROFT J, 2001, COMMUNICATION   1106; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; *MED EC, 2002, PHYS DESK REF, P3202; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624	7	6	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					447	448		10.1056/NEJM200202073460613	http://dx.doi.org/10.1056/NEJM200202073460613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832536				2022-12-28	WOS:000173686400011
J	Schwetz, BA				Schwetz, BA			New contraceptive patch	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					578	578		10.1001/jama.287.5.578-a	http://dx.doi.org/10.1001/jama.287.5.578-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829678				2022-12-28	WOS:000173686700005
J	Schulz, KF; Chalmers, I; Altman, DG				Schulz, KF; Chalmers, I; Altman, DG			The landscape and lexicon of blinding in randomized trials	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PLACEBO CONTROLS; CLINICAL-TRIALS; QUALITY; BIAS; OBSTETRICS		Family Hlth Int, Res Triangle Pk, NC 27709 USA; United Kingdom Cochrane Ctr, Oxford OX2 7LG, England; Imperial Canc Res Fund, Med Stat Grp, Ctr Stat Med, Inst Hlth SCi, Oxford OX3 7LF, England	Cochrane Centre; University of Oxford	Schulz, KF (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.							Adetugbo K, 2000, ARCH DERMATOL, V136, P381, DOI 10.1001/archderm.136.3.381; Altman D.G., 1991, PRACTICAL STAT MED R; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ALTMAN DG, 1990, LANCET, V335, P149, DOI 10.1016/0140-6736(90)90014-V; [Anonymous], 1998, Fed Regist, V63, P49583; Chalmers I, 1997, BRIT MED J, V314, P74, DOI 10.1136/bmj.314.7073.74a; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; DAY S, 1999, DICT CLIN TRIALS; Day SJ, 2000, BRIT MED J, V321, P504, DOI 10.1136/bmj.321.7259.504; Dean ME, 2000, ALTERN THER HEALTH M, V6, P58; DERSIMONIAN R, 1982, NEW ENGL J MED, V306, P1332, DOI 10.1056/NEJM198206033062204; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Franklin B, 1785, RAPPORT COMMISSAIRES; FRIEDMAN LM, 1996, FUNDAMENTALS CLIN TR; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; LANG T, 2000, MEDGENMED, pE25; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lintula H, 2001, BRIT J SURG, V88, P510, DOI 10.1046/j.1365-2168.2001.01723.x; MEINERT CL, 1996, CLIN TRIALS DICT; Meinert CL., 1986, CLIN TRIALS DESIGN C; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; Pocock SJ., 2013, CLIN TRIALS PRACTICA; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V274, P1456; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 1996, BRIT MED J, V312, P742; WOLF S, 1950, J CLIN INVEST, V29, P100, DOI 10.1172/JCI102225	33	173	181	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					254	259		10.7326/0003-4819-136-3-200202050-00022	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00022			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827510				2022-12-28	WOS:000173637400016
J	Ley, TJ; Rosenberg, LE				Ley, TJ; Rosenberg, LE			Removing career obstacles for young physician-scientists - Loan-repayment programs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLINICAL RESEARCH; INVESTIGATOR		Washington Univ, Sch Med, St Louis, MO 63110 USA; Princeton Univ, Princeton, NJ 08544 USA	Washington University (WUSTL); Princeton University	Ley, TJ (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.							Ahrens E.H., 1992, CRISIS CLIN RES OVER; *AM MED ASS, 1999, 1989 1999 SOC MON SY; ARIAS IM, 1989, NEW ENGL J MED, V321, P972, DOI 10.1056/NEJM198910053211412; *ASS AM MED COLL, 1999, AAMC REP MED SCH FAC; Cech TR, 2001, SCIENCE, V293, P573, DOI 10.1126/science.293.5530.573; *COUNC TEACH HOSP, 2001, COTH SURV HOUS STIP; GILL GN, 1984, AM SCHOLAR, V53, P353; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; Heinig SJ, 1999, ACAD MED, V74, P726, DOI 10.1097/00001888-199906000-00024; *NAT RES COUNC, 2000, ADDR NAT CHANG NEDS; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; Rosenberg LE, 2000, ANN INTERN MED, V133, P831, DOI 10.7326/0003-4819-133-10-200011210-00017; Rosenberg LE, 1999, J CLIN INVEST, V103, P1621, DOI 10.1172/JCI7304; Schechter AN, 1998, JAMA-J AM MED ASSOC, V280, P1440, DOI 10.1001/jama.280.16.1440; Sutton J, 1996, ACAD MED, V71, P454, DOI 10.1097/00001888-199605000-00013; Thompson JN, 1997, JAMA-J AM MED ASSOC, V278, P241, DOI 10.1001/jama.278.3.241; Thompson JN, 1997, JAMA-J AM MED ASSOC, V278, P388; Williams GH, 1997, JAMA-J AM MED ASSOC, V278, P227, DOI 10.1001/jama.278.3.227; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221; [No title captured]; 2001, FED REG, V66, P46643; 2001, FED REG, V66, P46645	23	83	85	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					368	372		10.1056/NEJM200201313460515	http://dx.doi.org/10.1056/NEJM200201313460515			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821517				2022-12-28	WOS:000173545300014
J	Nathan, DG				Nathan, DG			Educational-debt relief for clinical investigators - Vote of confidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSTITUTES-OF-HEALTH; SCIENTIST		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Nathan, DG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							*ADV COMM NIH DIR, 1997, NIH DIR PAN CLIN RES; Ahrens E.H., 1992, CRISIS CLIN RES OVER; Blumenthal D, 1996, HEALTH AFFAIR, V15, P200, DOI 10.1377/hlthaff.15.2.200; CULLITON BJ, 1995, NAT MED, V1, P281, DOI 10.1038/nm0495-281; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; *H HUGH MED I, 1999, HHMI AAMC PHYS SCI T; Mark AL, 2001, J INVEST MED, V49, P486, DOI 10.2310/6650.2001.33624; Moy E, 1997, JAMA-J AM MED ASSOC, V278, P217, DOI 10.1001/jama.278.3.217; *NAT I GEN MED, 1998, NIH PUBL; Nathan DG, 2000, NAT MED, V6, P1201, DOI 10.1038/81282; Nathan DG, 1998, JAMA-J AM MED ASSOC, V280, P1427, DOI 10.1001/jama.280.16.1427; Schechter AN, 1998, JAMA-J AM MED ASSOC, V280, P1440, DOI 10.1001/jama.280.16.1440; Schrier RW, 1997, ACAD MED, V72, P589, DOI 10.1097/00001888-199707000-00010; Shine KI, 1998, JAMA-J AM MED ASSOC, V280, P1442, DOI 10.1001/jama.280.16.1442; Shine KI, 1997, JAMA-J AM MED ASSOC, V278, P245, DOI 10.1001/jama.278.3.245; Shulman LE, 1996, ACAD MED, V71, P362, DOI 10.1097/00001888-199604000-00013; SHULMAN LE, 1996, ACAD MED, V71, P398; Thompson JN, 1997, JAMA-J AM MED ASSOC, V278, P388; Williams GH, 1997, JAMA-J AM MED ASSOC, V278, P227, DOI 10.1001/jama.278.3.227; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221; [No title captured]; 2001, FED REG, V66, P46643	23	25	27	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					372	374		10.1056/NEJM200201313460516	http://dx.doi.org/10.1056/NEJM200201313460516			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821519				2022-12-28	WOS:000173545300015
J	Makeig, S; Westerfield, M; Jung, TP; Enghoff, S; Townsend, J; Courchesne, E; Sejnowski, TJ				Makeig, S; Westerfield, M; Jung, TP; Enghoff, S; Townsend, J; Courchesne, E; Sejnowski, TJ			Dynamic brain sources of visual evoked responses	SCIENCE			English	Article							ALPHA-BAND; SPATIAL ATTENTION; RHYTHMS; EEG; POTENTIALS	It has been long debated whether averaged electrical responses recorded from the scalp result from stimulus-evoked brain events or stimulus-induced changes in ongoing brain dynamics. In a human visual selective attention task, we show that nontarget event-related potentials were mainly generated by partial stimulus-Induced phase resetting of multiple electroencephalographic processes. Independent component analysis applied to the single-trial data identified at least eight classes of contributing components, including those producing central and lateral posterior alpha, left and right mu, and frontal midline theta rhythms. Scalp topographies of these components were consistent with their generation in compact cortical domains.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Inst Neural Computat, San Diego, CA 92093 USA; Univ Calif San Diego, Dept Biol, San Diego, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Makeig, S (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Sejnowski, Terrence/AAV-5558-2021		NIMH NIH HHS [2RO1-MH36840] Funding Source: Medline; NINDS NIH HHS [1RO1-NS34155] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034155] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrew C, 1997, NEUROSCI LETT, V222, P103, DOI 10.1016/S0304-3940(97)13358-4; Barry RJ, 2000, INT J PSYCHOPHYSIOL, V39, P39, DOI 10.1016/S0167-8760(00)00114-8; Basar E., 1980, EEG BRAIN DYNAMICS R; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BELL AJ, INPRESS HDB NEURAL N; Brandt ME, 1997, INT J PSYCHOPHYSIOL, V26, P285, DOI 10.1016/S0167-8760(97)00771-X; BRANDT ME, 1991, ELECTROEN CLIN NEURO, V80, P16, DOI 10.1016/0168-5597(91)90037-X; BRANDT ME, 1991, ELECTROENCEPHALOGR C, V80, P241; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; CHAPMAN R, 2001, 7 ANN M ORG HUM BRAI; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fellous JM, 2001, NEUROCOMPUTING, V38, P587, DOI 10.1016/S0925-2312(01)00422-2; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Klopp J, 2000, HUM BRAIN MAPP, V11, P286, DOI 10.1002/1097-0193(200012)11:4<286::AID-HBM80>3.3.CO;2-I; Kolev V, 2001, INT J PSYCHOPHYSIOL, V39, P159, DOI 10.1016/S0167-8760(00)00139-2; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lutzenberger W, 1997, INT J PSYCHOPHYSIOL, V26, P273, DOI 10.1016/S0167-8760(97)00770-8; Makeig S, 1999, PHILOS T ROY SOC B, V354, P1135, DOI 10.1098/rstb.1999.0469; Makeig S, 2000, IEEE T REHABIL ENG, V8, P208, DOI 10.1109/86.847818; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; MANGUN R, 1992, INDUCED RHYTHMS BRAI, P219; Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TOWNSEND J, 1994, J COGNITIVE NEUROSCI, V6, P220, DOI 10.1162/jocn.1994.6.3.220; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Worden MS, 2000, J NEUROSCI, V20	35	1178	1237	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					690	694		10.1126/science.1066168	http://dx.doi.org/10.1126/science.1066168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809976				2022-12-28	WOS:000173560900049
J	Pellikka, M; Tanentzapf, G; Pinto, M; Smith, C; McGlade, CJ; Ready, DF; Tepass, U				Pellikka, M; Tanentzapf, G; Pinto, M; Smith, C; McGlade, CJ; Ready, DF; Tepass, U			Crumbs, the Drosophila homologue of human CRB1/RP12, is essential for photoreceptor morphogenesis	NATURE			English	Article							ZONULA ADHERENS FORMATION; RETINITIS-PIGMENTOSA; CELL FATES; MEMBRANE; SPECTRIN; EPITHELIA; MUTATIONS; STARDUST; POLARITY; CRB1	The apical transmembrane protein Crumbs is a central regulator of epithelial apical-basal polarity in Drosophila. Loss-of-function mutations in the human homologue of Crumbs, CRB1 (RP12), cause recessive retinal dystrophies, including retinitis pigmentosa. Here we show that Crumbs and CRB1 localize to corresponding subdomains of the photoreceptor apical plasma membrane: the stalk of the Drosophila photoreceptor and the inner segment of mammalian photoreceptors. These subdomains support the morphogenesis and orientation of the photosensitive membrane organelles: rhabdomeres and outer segments, respectively. Drosophila Crumbs is required to maintain zonula adherens integrity during the rapid apical membrane expansion that builds the rhabdomere. Crumbs also regulates stalk development by stabilizing the membrane-associated spectrin cytoskeleton, a function mechanistically distinct from its role in epithelial apical-basal polarity. We propose that Crumbs is a central component of a molecular scaffold that controls zonula adherens assembly and defines the stalk as an apical membrane subdomain. Defects in such scaffolds may contribute to human CRB1-related retinal dystrophies.	Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada; Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47906 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tepass, U (corresponding author), Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada.	utepass@zoo.utoronto.ca	Pellikka, Milena/L-8930-2015; Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X				ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bessant DAR, 2001, CURR OPIN GENET DEV, V11, P307, DOI 10.1016/S0959-437X(00)00195-7; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; De Matteis MA, 2000, J CELL SCI, V113, P2331; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, HUM MOL GENET, V10, P2767, DOI 10.1093/hmg/10.24.2767; den Hollander AI, 2001, AM J HUM GENET, V69, P198; DUNN RF, 1973, ULTRASTRUCTURE SENSO, P153; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Grawe F, 1996, DEVELOPMENT, V122, P951; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Kumar JP, 1995, DEVELOPMENT, V121, P4359; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; MORROW JS, 1997, HDB PHYSIOL 14, P485; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nelson WJ, 2000, FR MOLEC B, V28, P106; Newsome TP, 2000, DEVELOPMENT, V127, P851; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Tabuchi K, 2000, J NEUROSCI RES, V59, P94, DOI 10.1002/(SICI)1097-4547(20000101)59:1<94::AID-JNR11>3.3.CO;2-H; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; THOMAS GH, 1994, DEVELOPMENT, V120, P2039; Thomas GH, 1998, DEVELOPMENT, V125, P2125; Thomas GH, 2001, BIOESSAYS, V23, P152, DOI 10.1002/1521-1878(200102)23:2<152::AID-BIES1022>3.0.CO;2-1; Van Soest S, 1999, SURV OPHTHALMOL, V43, P321, DOI 10.1016/S0039-6257(98)00046-0; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wolff Tanya, 1993, P1277	43	332	335	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					143	149		10.1038/nature721	http://dx.doi.org/10.1038/nature721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11850625				2022-12-28	WOS:000174348100028
J	Green, RJ; Metlay, JP; Propert, K; Catalano, PJ; Macdonald, JS; Mayer, RJ; Haller, DG				Green, RJ; Metlay, JP; Propert, K; Catalano, PJ; Macdonald, JS; Mayer, RJ; Haller, DG			Surveillance for second primary colorectal cancer after adjuvant chemotherapy: An analysis of intergroup 0089	ANNALS OF INTERNAL MEDICINE			English	Article							PREVENTION; POLYPECTOMY; GUIDELINES; COLON	Background: The incidence of second primary colorectal cancer in patients with a history of colon cancer, compared with patients with a history of adenomatous polyps, is unknown. It is unclear whether guidelines for colonoscopy screening in patients with polyps are appropriate for patients with previous colon cancer. Objective: To determine the incidence of second primary colorectal cancer after treatment for localized colon cancer and to compare this incidence with that of first primary colorectal cancer in both the general population and high-risk patients. Design: Historical cohort study. Setting: An international, multi-institutional trial of adjuvant 5-fluorouracil-based chemotherapy for localized colon cancer. Patients: 3278 patients with resected stage II and stage III colon cancer. Measurements: Occurrence of endoscopic or radiologic colon surveillance and incidence of second primary colorectal cancer. Results: Forty-two cases of second primary invasive colon cancer were found over 15 345 person-years of follow-up, yielding an incidence rate of 274 per 100 000 person-years (95% Cl, 196 to 369 per 100 000 person-years) and a cumulative incidence of 1.5% (CI, 1.1% to 2.0%) at 5 years. This rate was compared with rates of first colon cancer in two reference groups: the general population and patients who had undergone frequent colonoscopy and polypectomy because of a history of adenomatous polyps; standardized incidence ratios were 1.6 (Cl, 1.2 to 2.2) and 6.8 (Cl, 2.7 to 22.0), respectively. Conclusion: The incidence of second primary colorectal cancer remains high despite intensive surveillance strategies.	Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; St Vincents Comprehens Canc Ctr, New York, NY USA	University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Saint Vincents Hospital Manhattan	Haller, DG (corresponding author), 16 Penn Tower,3400 Spruce St, Philadelphia, PA 19104 USA.	haller.daniel@uphs.upenn.edu			NCI NIH HHS [T32 CA-09679, CA66636, CA31946, P30-CA-16520-25, CA32102, 5U10 CA-32291-19, CA15488, CA21115, CA23318] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA021115, T32CA009679, U10CA032102, U10CA031946, P30CA016520, U10CA032291, U10CA023318, U10CA066636, U10CA015488] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arenas RB, 1997, SURGERY, V122, P706, DOI 10.1016/S0039-6060(97)90077-5; Armstrong Ben G., 1995, Annals of Epidemiology, V5, P60, DOI 10.1016/1047-2797(94)00032-O; Barillari P, 1996, DIS COLON RECTUM, V39, P388, DOI 10.1007/BF02054052; Breslow NE., 1987, STAT METHODS CANC RE, P81; CALI RL, 1993, DIS COLON RECTUM, V36, P388, DOI 10.1007/BF02053945; Desch CE, 1999, J CLIN ONCOL, V17, P1312, DOI 10.1200/JCO.1999.17.4.1312; ENBLAD P, 1990, CANCER, V65, P2091, DOI 10.1002/1097-0142(19900501)65:9<2091::AID-CNCR2820650934>3.0.CO;2-M; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Haller DG, 1998, P AN M AM SOC CLIN, V17, p256a; Khoury DA, 1996, DIS COLON RECTUM, V39, P252, DOI 10.1007/BF02049461; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; OVASKA J, 1990, AM J SURG, V159, P593, DOI 10.1016/S0002-9610(06)80074-7; Ries LAG, 1996, SEER CANC STAT REV 1; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	17	123	126	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					261	269		10.7326/0003-4819-136-4-200202190-00005	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FQ	11848723				2022-12-28	WOS:000173943700001
J	Helfand, I; Forrow, L; Tiwari, J				Helfand, I; Forrow, L; Tiwari, J			Nuclear terrorism	BRITISH MEDICAL JOURNAL			English	Article									Cooley Dickinson Hosp, Emergency Med Sect, Northampton, MA 01061 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Phys Social Responsibil, Ctr Global Secur & Hlth, Washington, DC 20009 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Helfand, I (corresponding author), Cooley Dickinson Hosp, Emergency Med Sect, 30 Locust St, Northampton, MA 01061 USA.							Allison Graham, 1996, AVOIDING NUCL ANARCH; ALLISON GT, 2001, ECONOMIST       1101; FINLEY NC, 1989, SAND790369 SAND NAT; Forrow L, 1998, JAMA-J AM MED ASSOC, V280, P456, DOI 10.1001/jama.280.5.456; HELFAND L, 2002, CLINMED         0111; Kluger J, 2001, TIME            0716, P38; Muirhead CR, 2001, OCCUP ENVIRON MED, V58, P482, DOI 10.1136/oem.58.7.482; ORRICK DN, 1999, DIFFERING PROFESSION; Tanaka K, 1996, Eur J Emerg Med, V3, P263, DOI 10.1097/00063110-199612000-00009; TIWARI J, 2001, COOPERATIVE THREAT R; TIWARI J, 2001, VULNERABILITY US NUC; *US DEP EN, 2001, MAT PROT CONTR ACC P; *US DEP EN, 2001, TASK FORC REP REP CA; 2001, REUTERS         1106; 2001, GUARDIAN        1024	15	20	20	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					356	358		10.1136/bmj.324.7333.356	http://dx.doi.org/10.1136/bmj.324.7333.356			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834569	Green Published			2022-12-28	WOS:000173866300027
J	Hattar, S; Liao, HW; Takao, M; Berson, DM; Yau, KW				Hattar, S; Liao, HW; Takao, M; Berson, DM; Yau, KW			Melanopsin-containing retinal. ganglion cells: Architecture, projections, and intrinsic photosensitivity	SCIENCE			English	Article							RETINOHYPOTHALAMIC TRACT; SUPRACHIASMATIC NUCLEUS; INTERGENICULATE LEAFLET; BODY-TEMPERATURE; LIGHT REFLEX; RAT; OLIVARY; PACAP; EEG	The primary circadian pacemaker, in the suprachiasmatic nucleus (SCN) of the mammalian brain, is photoentrained by light signals from the eyes through the retinohypothalamic tract. Retinal rod and cone cells are not required for photoentrainment. Recent evidence suggests that the entraining photoreceptors are retinal ganglion cells (RGCs) that project to the SCN. The visual pigment for this photoreceptor may be melanopsin, an opsin-like protein whose coding messenger RNA is found in a subset of mammalian RGCs. By cloning rat melanopsin and generating specific antibodies, we show that melanopsin is present in cell bodies, dendrites, and proximal axonal segments of a subset of rat RGCs. In mice heterozygous for tau-lacZ targeted to the melanopsin gene locus, P-galactosidase-positive RGC axons projected to the SCN and other brain nuclei involved in circadian photoentrainment or the pupillary light reflex. Rat RGCs that exhibited intrinsic photosensitivity invariably expressed melanopsin. Hence, melanopsin is most likely the visual pigment of phototransducing RGCs that set the circadian clock and initiate other non-image-forming visual functions.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Brown University	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.	kwyau@mail.jhmi.edu	Hattar, Samer/W-6927-2019; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL EYE INSTITUTE [R37EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-15, R37 EY006837, R37 EY006837-14, R37 EY006837-15S1, R37 EY006837-13] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BADIA P, 1991, PHYSIOL BEHAV, V50, P583, DOI 10.1016/0031-9384(91)90549-4; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CAJOCHEN C, 1992, SLEEP, V15, P337; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; CRESPO D, 1985, DEV BRAIN RES, V19, P129, DOI 10.1016/0165-3806(85)90238-X; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DUNN FA, COMMUNICATION; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Green DG, 1999, VISUAL NEUROSCI, V16, P727, DOI 10.1017/S0952523899164125; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; KLEIND C, 1991, SUPRACHIASMATIC NUCL; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; PICKARD GE, 1985, NEUROSCI LETT, V55, P211, DOI 10.1016/0304-3940(85)90022-9; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4	29	1735	1789	7	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1065	1070		10.1126/science.1069609	http://dx.doi.org/10.1126/science.1069609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834834	Green Accepted			2022-12-28	WOS:000173793000064
J	Gao, YH; Bando, Y				Gao, YH; Bando, Y			Carbon nanothermometer containing gallium - Gallium's macroscopic properties are retained on a miniature scale in this nanodevice.	NATURE			English	Article							NANOTUBES		Natl Inst Mat Sci, Adv Mat Lab, Tsukuba, Ibaraki 3050044, Japan; Natl Inst Mat Sci, Nanomat Lab, Tsukuba, Ibaraki 3050044, Japan	National Institute for Materials Science; National Institute for Materials Science	Gao, YH (corresponding author), Natl Inst Mat Sci, Adv Mat Lab, Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.	bando.yoshio@nims.go.jp	ling, peng/D-1464-2012; gao, yi/HCI-8298-2022; BANDO, Yoshio/H-2875-2011	ling, peng/0000-0002-7902-4384; BANDO, Yoshio/0000-0002-6543-5529; Gao, Yihua/0000-0003-1905-9531				AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0; Chanal O, 1997, REV SCI INSTRUM, V68, P2442, DOI 10.1063/1.1148130; Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; GRAY DE, 1972, AM I PHYSICS HDB; Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; LIDE DR, 1990, CRC HDB CHEM PHYSICS; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Tang ZK, 2001, SCIENCE, V292, P2462, DOI 10.1126/science.1060470; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Wu YY, 2001, ADV MATER, V13, P520, DOI 10.1002/1521-4095(200104)13:7<520::AID-ADMA520>3.0.CO;2-W	13	452	461	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					599	599		10.1038/415599a	http://dx.doi.org/10.1038/415599a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832929				2022-12-28	WOS:000173709100029
J	Ridley, RG				Ridley, RG			Medical need, scientific opportunity and the drive for antimalarial drugs	NATURE			English	Review							IN-VITRO ACTIVITY; PLASMODIUM-FALCIPARUM; LUMEFANTRINE BENFLUMETOL; CHLOROQUINE RESISTANCE; HEME POLYMERIZATION; PFMDR1 GENE; MALARIA; ARTEMISININ; IDENTIFICATION; HEMATIN	Continued and sustainable improvements in antimalarial medicines through focused research and development are essential for the world's future ability to treat and control malaria. Unfortunately, malaria is a disease of poverty, and despite a wealth of scientific knowledge there is insufficient market incentive to generate the competitive, business-driven industrial antimalarial drug research and development that is normally needed to deliver new products. Mechanisms of partnering with industry have been established to overcome this obstacle and to open up and build on scientific opportunities for improved chemotherapy in the future.	Med Malaria Venture, CH-1215 Geneva 15, Switzerland		Ridley, RG (corresponding author), Med Malaria Venture, Box 1826, CH-1215 Geneva 15, Switzerland.	ridleyr@mmv.org						Alnwick D, 2000, B WORLD HEALTH ORGAN, V78, P1377; Alzeer J, 2000, J MED CHEM, V43, P560, DOI 10.1021/jm990002y; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Basco LK, 1998, ANTIMICROB AGENTS CH, V42, P2347, DOI 10.1128/AAC.42.9.2347; Blackman Michael J., 2000, Current Drug Targets, V1, P59, DOI 10.2174/1389450003349461; Bloland PB, 2000, B WORLD HEALTH ORGAN, V78, P1378; Bray PG, 1998, PHARMACOL THERAPEUT, V77, P1, DOI 10.1016/S0163-7258(97)00083-1; Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Buysse JM, 2001, CURR MED CHEM, V8, P1713, DOI 10.2174/0929867013371699; Calabrese L, 2000, AM J MED, V108, P487, DOI 10.1016/S0002-9343(99)00408-8; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; Clough B, 2001, INFEC DIS S, P265; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; COWMAN A, 1999, MALARIA PARASITE BIO, P317; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Dayan A D, 1998, Med Trop (Mars), V58, P32; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; Dong YX, 2001, EXPERT OPIN THER PAT, V11, P1753, DOI 10.1517/13543776.11.11.1753; Dorsey G, 2001, INFEC DIS S, P153; Dunn CR, 1996, NAT STRUCT BIOL, V3, P912, DOI 10.1038/nsb1196-912; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; Ginsburg H, 1999, DRUG RESIST UPDATE, V2, P180, DOI 10.1054/drup.1999.0085; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; Horrocks P, 2000, B WORLD HEALTH ORGAN, V78, P1424; HYDE J, IN PRESS MICROB INFE; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kappes B, 1999, PARASITOL TODAY, V15, P449, DOI 10.1016/S0169-4758(99)01527-6; Kinyanjui SM, 1999, AM J TROP MED HYG, V60, P943, DOI 10.4269/ajtmh.1999.60.943; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Kissinger E, 2000, AM J TROP MED HYG, V63, P48, DOI 10.4269/ajtmh.2000.63.48; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kurosawa Y, 2000, ANTIMICROB AGENTS CH, V44, P2638, DOI 10.1128/AAC.44.10.2638-2644.2000; Leonardi E, 2001, T ROY SOC TROP MED H, V95, P182, DOI 10.1016/S0035-9203(01)90157-9; Li Y, 1998, Med Trop (Mars), V58, P9; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Looareesuwan S, 1999, AM J TROP MED HYG, V60, P533, DOI 10.4269/ajtmh.1999.60.533; Macreadie I, 2000, PARASITOL TODAY, V16, P438, DOI 10.1016/S0169-4758(00)01758-0; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Meshnick Sr, 2001, INFEC DIS S, P191; Meshnick Sr, 2001, INFEC DIS S, P15; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; Mungthin M, 1998, ANTIMICROB AGENTS CH, V42, P2973, DOI 10.1128/AAC.42.11.2973; Noedl H, 2001, ANTIMICROB AGENTS CH, V45, P2106, DOI 10.1128/AAC.45.7.2106-2109.2001; Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707; O'Neill PM, 1998, PHARMACOL THERAPEUT, V77, P29, DOI 10.1016/S0163-7258(97)00084-3; Ohkanda J, 2001, BIOORG MED CHEM LETT, V11, P761, DOI 10.1016/S0960-894X(01)00055-5; Olliaro PL, 1999, PHARMACOL THERAPEUT, V81, P91, DOI 10.1016/S0163-7258(98)00036-9; Olliaro PL, 2001, TRENDS PARASITOL, V17, P122, DOI 10.1016/S1471-4922(00)01838-9; Padmanaban Govinarajan, 2001, Expert Opin Ther Targets, V5, P423, DOI 10.1517/14728222.5.4.423; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Petras JM, 2000, ANAT EMBRYOL, V201, P383, DOI 10.1007/s004290050326; Posner GH, 1998, EXPERT OPIN THER PAT, V8, P1487, DOI 10.1517/13543776.8.11.1487; Price RN, 2000, EXPERT OPIN INV DRUG, V9, P1815, DOI 10.1517/13543784.9.8.1815; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Ridley RG, 1997, EXP PARASITOL, V87, P293, DOI 10.1006/expr.1997.4230; Ridley RG, 1998, EXPERT OPIN THER PAT, V8, P121, DOI 10.1517/13543776.8.2.121; Ridley RG, 1997, ANN TROP MED PARASIT, V91, P559, DOI 10.1080/00034989760932; Rosenthal P.J., 2001, ANTIMALARIAL CHEMOTH; Sachs JD, 2001, NAT MED, V7, P521, DOI 10.1038/87830; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sherman Irwin W., 1998, P177; Sirawaraporn W, 1998, DRUG RESIST UPDATE, V1, P397, DOI 10.1016/S1368-7646(98)80015-0; Skelton-Stroud P, 1998, Med Trop (Mars), V58, P77; Sowunmi A, 1997, T ROY SOC TROP MED H, V91, P63, DOI 10.1016/S0035-9203(97)90399-0; Stocks PA, 2001, INFEC DIS S, P235; SUGIOKA Y, 1991, BIOCHIM BIOPHYS ACTA, V1074, P19, DOI 10.1016/0304-4165(91)90032-C; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Takechi M, 2001, TROP MED INT HEALTH, V6, P429, DOI 10.1046/j.1365-3156.2001.00735.x; Teichmann SA, 1999, CURR OPIN STRUC BIOL, V9, P390, DOI 10.1016/S0959-440X(99)80053-0; Tilley L, 2001, INFEC DIS S, P87; Vaidya AB, 2001, INFEC DIS S, P203; Venkatesh S, 2000, J PHARM SCI-US, V89, P145, DOI 10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6; Vial HJ, 1999, NOVART FDN SYMP, V226, P82; Vroman JA, 1999, CURR PHARM DESIGN, V5, P101; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Waters AP, 1997, METHODS, V13, P134, DOI 10.1006/meth.1997.0506; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; White NJ, 1998, BRIT MED BULL, V54, P703, DOI 10.1093/oxfordjournals.bmb.a011721; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; *WHO, 2001, WHOCDSRBM200135; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Winstanley PA, 2000, PARASITOL TODAY, V16, P146, DOI 10.1016/S0169-4758(99)01622-1; Wolfe EB, 2001, AM J TROP MED HYG, V64, P178, DOI 10.4269/ajtmh.2001.64.178; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; World Health Organization, 1998, WHOMAL981086; World Health Organization, 2001, WHOCDSRBM200133; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; 2001, EXP OPIN THER PATENT, V11, P1351	98	639	659	1	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					686	693		10.1038/415686a	http://dx.doi.org/10.1038/415686a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832957				2022-12-28	WOS:000173709100058
J	Jefferson, JA; Escudero, E; Hurtado, ME; Pando, J; Tapia, R; Swenson, ER; Prchal, J; Schreiner, GF; Schoene, RB; Hurtado, A; Johnson, RJ				Jefferson, JA; Escudero, E; Hurtado, ME; Pando, J; Tapia, R; Swenson, ER; Prchal, J; Schreiner, GF; Schoene, RB; Hurtado, A; Johnson, RJ			Excessive erythrocytosis, chronic mountain sickness, and serum cobalt levels	LANCET			English	Article								In a subset of high-altitude dwellers, the appropriate erythrocytotic response becomes excessive and can result in chronic mountain sickness. We studied men with (study group) and without excessive erythrocytosis (packed-cell volume >65%) living in Cerro de Pasco, Peru (altitude 4300 m), and compared them with controls living in Lima, Peru (at sea-level). Toxic serum cobalt concentrations were detected in 11 of 21 (52%) study participants with excessive erythrocytosis, but were undetectable in high altitude or sea-level controls. In the mining community of Cerro de Pasco, cobalt toxicity might be an important contributor to excessive erythrocytosis.	Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; Univ Washington, Med Ctr, Div Nephrol, Seattle, WA 98195 USA; Univ Peruana Cayetano Heredia, Div Nephrol, Hosp Loayza, Carlos Monge Cassinelli Nephrol Ctr, Lima, Peru; Scios, Sunnyvale, CA USA	Baylor College of Medicine; University of Washington; University of Washington Seattle; Universidad Peruana Cayetano Heredia; Scios	Johnson, RJ (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Smith 1273,6550 Fannin St, Houston, TX 77030 USA.		Jefferson, Jonathan/AAA-9679-2019	Hurtado, Abdias/0000-0001-8850-7903	BLRD VA [I01 BX002586] Funding Source: Medline	BLRD VA		ALIPPI RM, 1992, HAEMATOLOGICA, V77, P446; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; MONGE CARLOS, 1942, SCIENCE, V95, P79, DOI 10.1126/science.95.2456.79; NORDBERG G, 1994, SCI TOTAL ENVIRON, V150, P201, DOI 10.1016/0048-9697(94)90151-1; Winslow RM, 1987, HYPOXIA POLYCYTHEMIA	5	58	61	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					407	408		10.1016/S0140-6736(02)07594-3	http://dx.doi.org/10.1016/S0140-6736(02)07594-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844517				2022-12-28	WOS:000173686500017
J	Richardson, J; Coid, J; Petruckevitch, A; Chung, WS; Moorey, S; Feder, G				Richardson, J; Coid, J; Petruckevitch, A; Chung, WS; Moorey, S; Feder, G			Identifying domestic violence: cross sectional study in primary care	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; PREVALENCE; ABUSE; WOMEN; EXPERIENCES	Objectives To measure the prevalence of domestic Violence among women attending general practice; test the association between experience of domestic violence and demographic factors; evaluate the extent of recording of domestic violence in records held by general practices; and assess acceptability to women of screening for domestic violence by general practitioners or practice nurses. Design Self administered questionnaire survey. Review of medical records. Setting General practices in Hackney, London. Participants 1207 women (> 15 years) attending selected practices. Main outcome measures Prevalence of domestic violence against women. Association between demographic factors and domestic violence reported in questionnaire. Comparison of recording of domestic Violence in medical records with that reported in questionnaire. Attitudes of women towards being questioned about domestic violence by general practitioners or practice nurses. Results 425/1035 women (41%, 95% confidence interval 38% to 44%) had ever experienced physical violence from a partner or former partner and 160/949 (17%, 14% to 19%) had experienced it within the past year. Pregnancy in the past year was associated with an increased risk of current violence (adjusted odds ratio 2.11, 1.39 to 3.19). Physical violence was recorded in the medical records of 15/90 (17%) women who reported it on the questionnaire. At least 202/1010 (20%) women objected to screening for domestic violence. Conclusions With the high prevalence of domestic violence, health professionals should maintain a high level of awareness of the possibility of domestic violence, especially affecting pregnant women, but the case for screening is not yet convincing.	Queen Marys Sch Med & Dent, Barts & London, Dept Gen Practice & Primary Care, London E1 4NS, England; St Bartholomews Hosp, Queen Marys Sch Med & Dent, Barts & London, Dept Forens Psychiat, London EC1A 7BE, England; Maudsley Hosp & Inst Psychiat, Cognit Behav Therapy Unit, London SE5 8AZ, England	University of London; Queen Mary University London; University of London; Queen Mary University London; South London & Maudsley NHS Trust; University of London; King's College London	Richardson, J (corresponding author), Queen Marys Sch Med & Dent, Barts & London, Dept Gen Practice & Primary Care, London E1 4NS, England.			Feder, Gene/0000-0002-7890-3926				ALPERT EJ, 1995, ANN INTERN MED, V123, P774, DOI 10.7326/0003-4819-123-10-199511150-00006; *AM MED ASS, 1992, ARCH FAM MED, V1, P39; Bradley F, 2002, BRIT MED J, V324, P271, DOI 10.1136/bmj.324.7332.271; BROWN R, 1992, JAMA-J AM MED ASSOC, V267, P3184; Caralis PV, 1997, SOUTH MED J, V90, P1075, DOI 10.1097/00007611-199711000-00003; Cole TB, 2000, JAMA-J AM MED ASSOC, V284, P551, DOI 10.1001/jama.284.5.551; DAVIDSON L, 2000, POLICING REDUCING CR; *DEP HLTH, 2000, DOM VIOL RES MAN HLT; *DEP HLTH, 2001, CRIT APPR VIAB EFF A; Department of Health, 1998, WHY MOTHERS DIE REPO; Dobash R. E., 1996, RES EVALUATION PROGR; DROSSMAN DA, 1995, ANN INTERN MED, V123, P782, DOI 10.7326/0003-4819-123-10-199511150-00007; Freund KM, 1996, J GEN INTERN MED, V11, P44, DOI 10.1007/BF02603485; FRIEDMAN LS, 1992, ARCH INTERN MED, V152, P1186, DOI 10.1001/archinte.152.6.1186; Hamberger L K, 1992, Fam Med, V24, P283; Hegarty K, 1998, AUST NZ J PUBL HEAL, V22, P49, DOI 10.1111/j.1467-842X.1998.tb01144.x; JOHNSON H, 1995, CAN J CRIMINOL, V37, P281; Johnson M, 1997, J FAM PRACTICE, V44, P391; KELLEHER P, 1995, MAKING LINKS INTEGRA; Marais A, 1999, S AFR MED J, V89, P635; Mazza D, 1996, MED J AUSTRALIA, V164, P14, DOI 10.5694/j.1326-5377.1996.tb94101.x; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; MCGIBBON A, 1989, WHAT SUPPORT HAMMERS; McNutt L A, 1999, J Am Med Womens Assoc (1972), V54, P85; Mezey GC, 1997, BRIT MED J, V314, P1295, DOI 10.1136/bmj.314.7090.1295; Mirrlees-Black C., 1999, DOMESTIC VIOLENCE FI; Mooney J., 1993, HIDDEN FIGURE DOMEST; MULLENDER A, 2000, POLICING REDUCING CR; NEWBERGER EH, 1992, JAMA-J AM MED ASSOC, V267, P2370, DOI 10.1001/jama.267.17.2370; Rath G D, 1989, J Am Board Fam Pract, V2, P227; Richardson J, 1996, BRIT J GEN PRACT, V46, P239; Richardson J, 2001, BRIT J GEN PRACT, V51, P468; Rosenberg Mark L., 1991, VIOLENCE AM PUBLIC H; SASSETTI MR, 1993, PRIMARY CARE, V20, P289; STANKO E, 1987, COUNTING COSTS ESTIM; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	178	187	3	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					274	+		10.1136/bmj.324.7332.274	http://dx.doi.org/10.1136/bmj.324.7332.274			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823360	Bronze, Green Published			2022-12-28	WOS:000173728300019
J	Spiegelhalter, DJ				Spiegelhalter, DJ			Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data	BRITISH MEDICAL JOURNAL			English	Article							IN-HOSPITAL MORTALITY; TRANSPLANTATION CENTERS; LIVER-TRANSPLANTATION	Objectives To determine whether mortality between 1991 and 1995 in hospitals in England carrying out surgery for congenital heart disease in children was associated with the annual volume of cases and to estimate the extent to which an association could explain the apparent divergent mortality at Bristol Royal Infirmary. Design Retrospective analysis of data from two sources, a register of returns by surgeons to their professional society and an administrative database. Setting 12 hospitals in England carrying out surgery for congenital heart disease over the period April 1991 to March 1995. Main outcome measure 30 day mortality. Results For open heart operations in children under 1 year old, and in particular for arterial switches and repair of atrioventricular septal defect, there is strong and consistent evidence of an inverse association between mortality and volume of cases (not taking into account any data from Bristol). A hospital carrying out 120 open operations per year in 1991-5 on children aged under 1 year would be expected to have a mortality 25% lower than that in a hospital carrying out 40 operations. If the children in the hospitals had the same mix of operations, this reduction is 34%. Stratifying for types of operation or including the results from Bristol strengthens this association. It was also estimated that less than a fifth of the excess mortality at Bristol Royal Infirmary in open operations in children less than 1 year old was due to the hospital's lower volume of surgery. Conclusions Using appropriate methods, this study showed that mortality in paediatric cardiac surgery was inversely related to the Volume of surgery. Considerable caution is needed in interpreting these results, and it does not necessarily follow that concentrating resources in fewer centres would reduce mortality.	Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	MRC Biostatistics Unit; University of Cambridge	Spiegelhalter, DJ (corresponding author), Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England.							Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; *BRIST ROYAL INF I, 2001, INQ ISS LIST 1; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Hannan EL, 1998, PEDIATRICS, V101, P963, DOI 10.1542/peds.101.6.963; JENKINS KJ, 1995, PEDIATRICS, V95, P323; Kennedy I, 2001, INQUIRY MANAGEMENT C; Laks MP, 2000, NEW ENGL J MED, V342, P1527; Posnett J, 1999, BRIT MED J, V319, P1063, DOI 10.1136/bmj.319.7216.1063; Sollano JA, 1999, J THORAC CARDIOV SUR, V117, P419, DOI 10.1016/S0022-5223(99)70320-X	10	62	65	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					261	264		10.1136/bmj.324.7332.261	http://dx.doi.org/10.1136/bmj.324.7332.261			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823355	Green Published, Bronze			2022-12-28	WOS:000173728300013
J	Welfare, W; Sasi, P; English, ME				Welfare, W; Sasi, P; English, ME			Chalenges in managing profound hypokalaemia	BRITISH MEDICAL JOURNAL			English	Article									KEMRI, Wellcome Trust Res Labs, Ctr Geog Med Res Coast, Kilifi, Kenya; Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	English, ME (corresponding author), KEMRI, Wellcome Trust Res Labs, Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.			Welfare, William/0000-0002-8304-1048; English, Michael/0000-0002-7427-0826	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; HEYMAN SN, 1994, LANCET, V344, P1509, DOI 10.1016/S0140-6736(94)90328-X; World Health Organization, 2000, MAN CHILD SER INF SE	3	10	12	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					269	270		10.1136/bmj.324.7332.269	http://dx.doi.org/10.1136/bmj.324.7332.269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823358	Green Published, Bronze			2022-12-28	WOS:000173728300017
J	McDaniel, L; Houchin, LA; Williamson, SJ; Paul, JH				McDaniel, L; Houchin, LA; Williamson, SJ; Paul, JH			Plankton blooms - Lysogeny in marine Synechococcus	NATURE			English	Article							VIRUSES; ABUNDANCE; MORTALITY; SEAWATER		Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida	McDaniel, L (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.							Ackermann H., 1987, VIRUSES PROKARYOTES, V1; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; COTTRELL MT, 1995, LIMNOL OCEANOGR, V40, P730, DOI 10.4319/lo.1995.40.4.0730; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; SUTTLE CA, 1992, MAR ECOL PROG SER, V87, P105, DOI 10.3354/meps087105; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weinbauer MG, 1996, APPL ENVIRON MICROB, V62, P4374, DOI 10.1128/AEM.62.12.4374-4380.1996; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	10	97	105	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					496	496		10.1038/415496a	http://dx.doi.org/10.1038/415496a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823851	Bronze			2022-12-28	WOS:000173564300037
J	Kilmarx, PH				Kilmarx, PH			Commentary: Virus, host, or environment?	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE PROGRESSION; INFECTION; SURVIVAL		Minist Publ Hlth, Thailand MOPH US CDC Collaborat, Nonthaburi 11000, Thailand	Ministry of Public Health - Thailand	Kilmarx, PH (corresponding author), Minist Publ Hlth, Thailand MOPH US CDC Collaborat, Nonthaburi 11000, Thailand.			Kilmarx, Peter/0000-0001-6464-3345				Del Amo J, 1998, AIDS, V12, P1203, DOI 10.1097/00002030-199810000-00013; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; *JOINT UN PROGR HI, 2001, AIDS EP UPD DEC 2001; Kilmarx PH, 2000, J INFECT DIS, V181, P1598, DOI 10.1086/315469; Schupbach J, 2001, J MED VIROL, V65, P225, DOI 10.1002/jmv.2024	5	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					197	197						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11831202				2022-12-28	WOS:000173604800014
J	Cardinale, BJ; Palmer, MA; Collins, SL				Cardinale, BJ; Palmer, MA; Collins, SL			Species diversity enhances ecosystem functioning through interspecific facilitation	NATURE			English	Article							CHANGING BIODIVERSITY; PARTICLE CAPTURE; PLANT DIVERSITY; FLOW; CONSEQUENCES; PRODUCTIVITY; SEDIMENTS	Facilitation between species is thought to be a key mechanism by which biodiversity affects the rates of resource use that govern the efficiency and productivity of ecosystems(1-4); however, there is no direct empirical evidence to support this hypothesis. Here we show that increasing the species diversity of a functional group of aquatic organisms induces facilitative interactions, leading to non-additive changes in resource consumption. We increased the richness and evenness of suspension-feeding caddisfly larvae (Insecta, Trichoptera) in stream mesocosms and found that the increased topographical complexity of the benthic habitat alters patterns of near-bed flow such that the feeding success of individuals is enhanced. Species diversity reduces 'current shading' (that is, the deceleration of flow from upstream to downstream neighbours), allowing diverse assemblages to capture a greater fraction of suspended resources than is caught by any species monoculture. The fundamental nature of this form of hydrodynamic facilitation suggests that it is broadly applicable to freshwater and marine habitats; in addition, it has several analogues in terrestrial ecosystems where fluxes of energy and matter can be influenced by biophysical complexity(3,5,6). Thus, changes in species diversity may alter the probability of positive species interactions, resulting in disproportionately large changes in the functioning of ecosystems.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Cardinale, BJ (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.		Collins, Scott L/P-7742-2014; Palmer, Margaret A/F-9648-2013; Cardinale, Bradley J/I-7076-2013	Collins, Scott L/0000-0002-0193-2892; Palmer, Margaret A/0000-0003-1468-7993; 				[Anonymous], 1997, PHYSL ECOLOGY TROPIC; BUTMAN CA, 1994, LIMNOL OCEANOGR, V39, P1755, DOI 10.4319/lo.1994.39.7.1755; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; CARDINALE BJ, IN PRESS ECOLOGY; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; ECKMAN JE, 1981, J MAR RES, V39, P361; ENGLUND G, 1991, FRESHWATER BIOL, V26, P425, DOI 10.1111/j.1365-2427.1991.tb01409.x; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; HART DD, 1986, OIKOS, V46, P88, DOI 10.2307/3565384; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUETTEL M, 1992, MAR ECOL PROG SER, V89, P253, DOI 10.3354/meps089253; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; JOHNSON AS, 1990, LIMNOL OCEANOGR, V35, P1395, DOI 10.4319/lo.1990.35.6.1395; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; LOUDON C, 1990, AM NAT, V135, P360, DOI 10.1086/285051; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; OKAMURA B, 1992, ECOLOGY, V73, P1502, DOI 10.2307/1940693; Palmer M, 1997, AMBIO, V26, P571; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Vogel S, 1994, LIFE MOVING FLUIDS; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	30	570	626	7	511	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					426	429		10.1038/415426a	http://dx.doi.org/10.1038/415426a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807553				2022-12-28	WOS:000173433600049
J	Pomeroy, SL; Tamayo, P; Gaasenbeek, M; Sturla, LM; Angelo, M; McLaughlin, ME; Kim, JYH; Goumnerova, LC; Black, PM; Lau, C; Allen, JC; Zagzag, D; Olson, JM; Curran, T; Wetmore, C; Biegel, JA; Poggio, T; Mukherjee, S; Rifkin, R; Califano, A; Stolovitzky, G; Louis, DN; Mesirov, JP; Lander, ES; Golub, TR				Pomeroy, SL; Tamayo, P; Gaasenbeek, M; Sturla, LM; Angelo, M; McLaughlin, ME; Kim, JYH; Goumnerova, LC; Black, PM; Lau, C; Allen, JC; Zagzag, D; Olson, JM; Curran, T; Wetmore, C; Biegel, JA; Poggio, T; Mukherjee, S; Rifkin, R; Califano, A; Stolovitzky, G; Louis, DN; Mesirov, JP; Lander, ES; Golub, TR			Prediction of central nervous system embryonal tumour outcome based on gene expression	NATURE			English	Article							HUMAN HOMOLOG; CEREBELLAR MEDULLOBLASTOMA; SONIC HEDGEHOG; RECEPTOR TRKC; CELL LINEAGE; GERM-LINE; MUTATIONS; CANCER; PATTERNS	Embryonal tumours of the central nervous system (CNS) represent a heterogeneous group of tumours about which little is known biologically, and whose diagnosis, on the basis of morphologic appearance alone, is controversial. Medulloblastomas, for example, are the most common malignant brain tumour of childhood, but their pathogenesis is unknown, their relationship to other embryonal CNS tumours is debated(1,2), and patients' response to therapy is difficult to predict(3). We approached these problems by developing a classification system based on DNA microarray gene expression data derived from 99 patient samples. Here we demonstrate that medulloblastomas are molecularly distinct from other brain tumours including primitive neuroectodermal tumours (PNETs), atypical teratoid/rhabdoid tumours (AT/RTs) and malignant gliomas. Previously unrecognized evidence supporting the derivation of medulloblastomas from cerebellar granule cells through activation of the Sonic Hedgehog (SHH) pathway was also revealed. We show further that the clinical outcome of children with medulloblastomas is highly predictable on the basis of the gene expression profiles of their tumours at diagnosis.	Harvard Univ, Sch Med, Dept Neurol, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol & Neurosurg Serv, Boston, MA 02115 USA; MIT, Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02139 USA; MIT, McGovern Inst, Ctr Biol & Computat Learning, AI Lab, Cambridge, MA 02139 USA; Baylor Coll Med, Div Pediat Oncol, Houston, TX 77030 USA; Beth Israel Deaconess Med Ctr, New York, NY 10128 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Human Genet, Philadelphia, PA 19104 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; New York University; Fred Hutchinson Cancer Center; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Massachusetts Institute of Technology (MIT); International Business Machines (IBM)	Pomeroy, SL (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Div Neurosci, Boston, MA 02115 USA.	scott.pomeroy@tch.harvard.edu; golub@genome.wi.mit.edu	Curran, Thomas/AAE-7631-2019; Mesirov, Jill/AGF-7626-2022; Curran, Tom/F-5234-2018; Califano, Andrea/F-7239-2012; Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Allen, Jeffrey/0000-0001-9957-6664; Mukherjee, Sayan/0000-0002-6715-3920; Califano, Andrea/0000-0003-4742-3679				ARUGA J, 1994, J NEUROCHEM, V63, P1880; Biegel JA, 1999, CANCER RES, V59, P74; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; CALIFANO, 2000, P 8 INT C INT SYST M, P75; DASARATHY VB, 1991, NEAREST NEIGHBOOR NN; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GIANGASPERO F, 2000, WHO CLASSIFICATION T, P129; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KADIN ME, 1970, J NEUROPATH EXP NEUR, V29, P583, DOI 10.1097/00005072-197010000-00005; Kim JYH, 1999, CANCER RES, V59, P711; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; MUKHERJEE S, 1999, 182AI CBCL MIT; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Packer RJ, 1999, J CLIN ONCOL, V17, P2127, DOI 10.1200/JCO.1999.17.7.2127; Pietsch T, 1997, CANCER RES, V57, P2085; Raffel C, 1997, CANCER RES, V57, P842; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; RORKE LB, 1983, J NEUROPATH EXP NEUR, V42, P1, DOI 10.1097/00005072-198301000-00001; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; SLONIM DK, 2000, P 4 ANN INT C COMP M, P263; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2000, CANCER RES, V60, P2239; XIE J, 1997, CANCER RES, V57, P2397; Yokota N, 1996, CANCER RES, V56, P377	30	1711	1781	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					436	442		10.1038/415436a	http://dx.doi.org/10.1038/415436a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807556				2022-12-28	WOS:000173433600052
J	Boersma, E; Harrington, RA; Moliterno, DJ; White, H; Theroux, P; Van de Werf, F; de Torbal, A; Armstrong, PW; Wallentin, LC; Wilcox, RG; Simes, J; Califf, RM; Topol, EJ; Simoons, ML				Boersma, E; Harrington, RA; Moliterno, DJ; White, H; Theroux, P; Van de Werf, F; de Torbal, A; Armstrong, PW; Wallentin, LC; Wilcox, RG; Simes, J; Califf, RM; Topol, EJ; Simoons, ML			Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials	LANCET			English	Article							ST-SEGMENT ELEVATION; MANAGEMENT; ABCIXIMAB; EVENTS; RISK	Background Platelet glycoprotein IIb/IIIa inhibitors have been shown to reduce cardiac complications in patients undergoing percutaneous coronary intervention. The clinical efficacy of these drugs in acute coronary syndromes, however, is still unclear. We did a meta-analysis of all large randomised trials designed to study the clinical efficacy and safety of glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes who were not routinely scheduled to undergo early coronary revascularisation. Methods Inclusion criteria were: randomisation of patients with acute coronary syndromes but without persistent ST elevation;l comparison of a glycoprotein IIb/IIIa inhibitor with placebo or control therapy; non-recommendation of early coronary revascularisation during study-drug infusion; and enrollment of at least 1000 patients. Data on individual patients were obtained from all participants in these trials. Findings Six trials, enrolling 31402 patients, fulfilled the inclusion criteria. 30 days after randomisation, 3530 (11.2%) patients died or developed a myocardial infarction. At:30 days, a 9% reduction in the odds of death or myocardial infarction was seen with glycoprotein IIb/IIIa inhibitors compared with placebo or control (10.8% [1980/18297] vs 11.8% [1550/13105] events; odds ratio 0.91 [95% CI 0.84-0.98]; p=0.015). The relative treatment benefit was similar in subgroups of patients according to important clinical baseline characteristics; hence, the absolute treatment benefit was largest in high-risk patients. An unexpected and significant interaction was seen between sex and allocated treatment, with a treatment benefit in men (0.81 [0.75-0.89] but not in women (1.15 [1.01-1.30]). However, once patients were stratified according to troponin concentration, there was no evidence of a sex difference in treatment response, and a risk reduction was seen in men and women with raised troponin concentrations. Major bleeding complications were increased by glycoprotein IIb/IIIa inhibitors (2.4% [445/18297] vs 1.4% [180/13105]; p<0.0001), but intracranial bleeding was not (16 [0.09%] vs 8 [0.06%]; p=0.40). Interpretation Glycoprotein IIb/IIIa inhibitors reduce the occurrence of death or myocardial infarction in patients with acute coronary syndromes not routinely scheduled for early revascularisation. The event reduction is greatest in patients at high risk of thrombotic complications. Treatment with a glycoprotein IIb/IIIa inhibitor might therefore be considered especially in such patients early after admission, and continued until a decision about early coronary revascularisation has been made.	Univ Rotterdam Hosp, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands; Duke Clin Res Inst, Durham, NC USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Green Lane Hosp, Auckland 3, New Zealand; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; Univ Hosp Leuven, Louvain, Belgium; Univ Alberta, Edmonton, AB, Canada; Univ Hosp, Uppsala, Sweden; Queens Med Ctr, Nottingham NG7 2UH, England; Univ Sydney, Sydney, NSW 2006, Australia	Erasmus University Rotterdam; Erasmus MC; Duke University; Cleveland Clinic Foundation; Universite de Montreal; KU Leuven; University Hospital Leuven; University of Alberta; Uppsala University; Uppsala University Hospital; University of Nottingham; University of Sydney	Boersma, E (corresponding author), Univ Rotterdam Hosp, Dept Cardiol, Room H543,Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	boersma@thch.azr.nl	Simes, Robert John/P-1497-2014	Van de Werf, Frans/0000-0001-9479-7767; Armstrong, Paul/0000-0002-0460-3445; Topol, Eric/0000-0002-1478-4729				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; Bazzino O, 1998, NEW ENGL J MED, V338, P1498; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bertrand ME, 2000, EUR HEART J, V21, P1406, DOI 10.1053/euhj.2000.2301; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Cho L, 2000, J AM COLL CARDIOL, V36, P381, DOI 10.1016/S0735-1097(00)00746-4; *DIR THROMB INH TR, 2001, AM HEART J, V141, pE2; *DIR THROMB INH TR, IN PRESS LANCET; *EARL BREAST CANC, 1990, TREATM EARL BREAST C, V1, P12; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; *PARAGON B INV, IN PRESS CIRCULATION; Roe MT, 2000, CIRCULATION, V102, P1101, DOI 10.1161/01.CIR.102.10.1101; Ronner E, 1998, EUR HEART J, V19, P1608, DOI 10.1053/euhj.1998.1222; Simoons ML, 1997, LANCET, V349, P1429; Simoons ML, 2001, LANCET, V357, P1915; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Tardiff BE, 2001, CIRCULATION, V104, P399, DOI 10.1161/hc2901.093500; Tcheng JE, 1997, LANCET, V349, P1422; Tcheng JE, 2000, LANCET, V356, P2037; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol E, 1998, CIRCULATION, V97, P2386; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Yusuf S, 2001, NEW ENGL J MED, V345, P494	31	689	734	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2002	359	9302					189	198		10.1016/S0140-6736(02)07442-1	http://dx.doi.org/10.1016/S0140-6736(02)07442-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812552				2022-12-28	WOS:000173350800008
J	Welsh, S; Deahl, MP				Welsh, S; Deahl, MP			Modern psychiatric ethics	LANCET			English	Editorial Material							HEALTH		E London & City Mental Hlth NHS Trust, London, England		Deahl, MP (corresponding author), St Bartholomews Hosp, London EC1A 7BE, England.							Adshead G., 1999, ADV PSYCHIAT TREAT, V5, P321; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; *BRIT MED ASS, 1992, MED BETR; Crisp A, 2001, BRIT J PSYCHIAT, V178, P197, DOI 10.1192/bjp.178.3.197; DAVID M, 1991, PSYCHIAT ETHICS; DEAHL M, 1997, BRIT J PSYCHIAT, V171, P68; *DECL HELS, 1964, HUM RIGHTS PROF RESP, P12; EASTMAN N, 1994, BRIT MED J, V308, P43, DOI 10.1136/bmj.308.6920.43; Fulford KWM, 1994, PRINCIPLES HEALTHCAR; *GEN MED COUNC, 1995, GUID DOCT; HOGGETT B, 1984, MENTAL HLTH LAW, P7; Hotopf M, 2000, BRIT J PSYCHIAT, V176, P479, DOI 10.1192/bjp.176.5.479; Mason J.K., 1994, LAW MED ETHICS; Mill JS, 1969, UTILITARIANISM; Muller-Hill B., 1991, PSYCHIAT ETHICS; Pappworth M. H., 1967, HUMAN GUINEA PIGS EX; SCHMIDTKE J, 1992, J PHARM PHARMACOL, V44, P205; Szasz T.S., 1987, INSANITY IDEA ITS CO; The British Medical Association, 1993, MED ETH TOD ITS PRAC	19	19	19	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					253	255		10.1016/S0140-6736(02)07452-4	http://dx.doi.org/10.1016/S0140-6736(02)07452-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512YH	11812580				2022-12-28	WOS:000173350800035
J	Brown, V; Caron, P; Ford, N; Cabrol, JC; Tremblay, JP; Lepec, R				Brown, V; Caron, P; Ford, N; Cabrol, JC; Tremblay, JP; Lepec, R			Violence in southern sudan	LANCET			English	Editorial Material									Epictr, F-75011 Paris, France; Med Sans Frontieres, Paris, France	Doctors Without Borders	Brown, V (corresponding author), Epictr, 8 Rue St Sabin, F-75011 Paris, France.							Creusvaux H, 1999, LANCET, V354, P832, DOI 10.1016/S0140-6736(99)80016-6; Legros D, 2001, LANCET, V357, P1429, DOI 10.1016/S0140-6736(00)04569-4	2	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					161	161		10.1016/S0140-6736(02)07378-6	http://dx.doi.org/10.1016/S0140-6736(02)07378-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809279				2022-12-28	WOS:000173212400036
J	Chelala, C				Chelala, C			Sudan: a war against the people	LANCET			English	Editorial Material											Chelala, C (corresponding author), 390 W Broadway, New York, NY 10012 USA.							*AMN INT, 2000, WINN OIL LOS PEOPL; *SUD FED MIN HLTH, 2001, NAT SAF MOTH SURV	2	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					161	162		10.1016/S0140-6736(02)07377-4	http://dx.doi.org/10.1016/S0140-6736(02)07377-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809278				2022-12-28	WOS:000173212400035
J	Ray, WA; Stein, CM; Hall, K; Daugherty, JR; Griffin, MR				Ray, WA; Stein, CM; Hall, K; Daugherty, JR; Griffin, MR			Non-steroidal anti-inflamatory drugs and risk of serious coronary heart disease: an observational cohort study	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ELDERLY PERSONS; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; PEPTIC-ULCER; WOMEN; ROFECOXIB; MORTALITY; NAPROXEN; ACCURACY	Background Non-aspirin, non-steroidal anti-inflammatory drugs (NANSAIDs) have complex effects that could either prevent or promote coronary heart disease. Comparison of the NANSAID rofexocib with naproxen showed a substantial difference in acute myocardial infarction risk, which has been interpreted as a protective effect of naproxen. We did an observational study to measure the effects of NANSAIDs, including naproxen, on risk of serious coronary heart disease. Methods We used data from the Tennessee Medicaid programme obtained between Jan 1, 1987, and Dec 31, 1998, to identify a cohort of new NANSAID users (n = 181 441) and an equal number of non-users, matched for age, sex, and date NANSAID use began. Both groups were 50-84 years of age, were not resident in a nursing home, and did not have life-threatening illness. The study endpoint was hospital admission for acute myocardial infarction or death from coronary heart disease. Findings During 532 634 person-years of follow-up, 6362 cases of serious coronary heart disease occurred, or 11.9 per 1000 person-years. Multivariate-adjusted rate ratios for current and former use of NANSAIDs were 1.05 (95% Cl 0.97-1.14) and 1.02 (0.97-1.08), respectively. Rate ratios for naproxen, ibuprofen, and other NANSAIDs were 0.95 (0.82-1.09), 1.15 (1.02-1.28), and 1.03 (0.92-1.16), respectively. There was no protection among long-term NANSAID users with uninterrupted use; the rate ratio among current users with more than 60 days of continuous use was 1.05 (0.91-1.21). When naproxen was directly compared with ibuprofen, the current-use rate ratio was 0.83 (0.69-0.98). Interpretation Absence of a protective effect of naproxen or other NANSAIDs on risk of coronary heart disease suggests that these drugs should not be used for cardioprotection.	Vanderbilt Univ, Med Ctr, Med Ctr N, Sch Med,Dept Prevent Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Vanderbilt Univ, Med Ctr, Med Ctr N, Sch Med,Dept Prevent Med, A-1124, Nashville, TN 37232 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; AHRQ HHS [HS1-0384] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Boers M, 2001, LANCET, V357, P1222, DOI 10.1016/S0140-6736(00)04451-2; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; BRODY JE, 2001, NY TIMES        0612, P7; CHRISCHILLES EA, 1990, J AM GERIATR SOC, V38, P979, DOI 10.1111/j.1532-5415.1990.tb04419.x; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Griffin MR, 2000, AM J EPIDEMIOL, V151, P488; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; HELIOVAARA M, 1995, ANN RHEUM DIS, V54, P811, DOI 10.1136/ard.54.10.811; JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011; JOHNSTON RJ, 1999, GEOGRAPHICAL INFORMA, V1, P39; LEISTER KA, 1981, MED CARE, V19, P658, DOI 10.1097/00005650-198106000-00008; Masferrer JL, 2000, P NATL ACAD SCI USA, V97, P12400, DOI 10.1073/pnas.240459597; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Meade TW, 1998, LANCET, V351, P233; MIRVIS DM, 1995, JAMA-J AM MED ASSOC, V274, P1235, DOI 10.1001/jama.274.15.1235; MYLLYKANGASLUOSUJARVI R, 1995, J RHEUMATOL, V22, P1065; Page J, 2000, ARCH INTERN MED, V160, P777, DOI 10.1001/archinte.160.6.777; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2001, MED CARE, V39, P425, DOI 10.1097/00005650-200105000-00003; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P382, DOI 10.1097/00001648-200007000-00004; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; STROM BL, 1990, EPIDEMIOL REV, V12, P87, DOI 10.1093/oxfordjournals.epirev.a036064; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563	29	263	272	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					118	123		10.1016/S0140-6736(02)07370-1	http://dx.doi.org/10.1016/S0140-6736(02)07370-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809254				2022-12-28	WOS:000173212400011
J	Tunbridge, AJ; Dockrell, DH; Channer, KS; McKendrick, MW				Tunbridge, AJ; Dockrell, DH; Channer, KS; McKendrick, MW			A breathless triathlete	LANCET			English	Editorial Material							JARISCH-HERXHEIMER REACTION; LEPTOSPIROSIS		Royal Hallamshire Hosp, Dept Infect & Trop Med, Sheffield S10 ZJF, S Yorkshire, England		McKendrick, MW (corresponding author), Royal Hallamshire Hosp, Dept Infect & Trop Med, Sheffield S10 ZJF, S Yorkshire, England.			Dockrell, David/0000-0002-2718-4861				EVANS ME, 1994, J INFECT DIS, V169, P471; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; FRIEDLAND JS, 1991, REV INFECT DIS, V13, P207; NEGUSSIE Y, 1992, J EXP MED, V175, P1207, DOI 10.1084/jem.175.5.1207; SALZER WL, 1990, J CLIN INVEST, V85, P1135, DOI 10.1172/JCI114545	5	10	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					130	130		10.1016/S0140-6736(02)07372-5	http://dx.doi.org/10.1016/S0140-6736(02)07372-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809256				2022-12-28	WOS:000173212400013
J	Bartelink, AKM; Boon, ES; Budel, LM				Bartelink, AKM; Boon, ES; Budel, LM			Clinical picture: Asymmetrical fat embolism	LANCET			English	Editorial Material									Eemland Hosp, NL-3818 ES Amersfoort, Netherlands		Bartelink, AKM (corresponding author), Eemland Hosp, NL-3818 ES Amersfoort, Netherlands.								0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					795	795		10.1016/S0140-6736(01)05968-2	http://dx.doi.org/10.1016/S0140-6736(01)05968-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11837276				2022-12-28	WOS:000170989300011
J	Walker, S; Sheikh, A				Walker, S; Sheikh, A			10-minute consultation - Rhinitis	BRITISH MEDICAL JOURNAL			English	Article									Natl Resp Training Ctr, Warwick CV34 4AB, England; Imperial Coll Sch Med, Dept Gen Practice & Primary Hlth Care, London W6 8RP, England	Imperial College London	Walker, S (corresponding author), Natl Resp Training Ctr, 10 Church St, Warwick CV34 4AB, England.		Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056					0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					403	403		10.1136/bmj.324.7334.403	http://dx.doi.org/10.1136/bmj.324.7334.403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850373	Green Published, Bronze			2022-12-28	WOS:000174006300021
J	Drazen, JM				Drazen, JM			Perspective - Sleep apnea syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	9	9	2	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					390	390		10.1056/NEJM200202073460602	http://dx.doi.org/10.1056/NEJM200202073460602			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832526				2022-12-28	WOS:000173686400001
J	Seward, JF; Watson, BM; Peterson, CL; Mascola, L; Peloso, JW; Zhang, JX; Maupin, TJ; Goldman, GS; Tabony, LJ; Brodovicz, KG; Jumaan, AO; Wharton, M				Seward, JF; Watson, BM; Peterson, CL; Mascola, L; Peloso, JW; Zhang, JX; Maupin, TJ; Goldman, GS; Tabony, LJ; Brodovicz, KG; Jumaan, AO; Wharton, M			Varicella disease after introduction of varicella vaccine in the United States, 1995-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTLICENSURE; IMMUNIZATION; SAFETY; SURVEILLANCE; EPIDEMIOLOGY; CHICKENPOX; LICENSURE	Context Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11000 hospitalizations, and 100 deaths every year. Objective To examine population-based disease surveillance data in 3 communities to document the impact of the varicella vaccination program. Design, Setting, and Subjects Active surveillance for varicella conducted among the populations of Antelope Valley, Calif; Travis County, Tex; and West Philadelphia, Pa; from January 1, 1995, to December 31, 2000. Reporting sites included child care centers, schools, universities, physicians, public health clinics, hospitals, emergency departments, and households. Main Outcome Measures Trends in number and rate of varicella cases and hospitalizations; varicella vaccine coverage. Results From 1995 through 1998, in each surveillance area, the number of verified varicella cases varied from year to year with marked springtime seasonality. In 1999, the number and rates of varicella cases and hospitalizations declined markedly. From 1995 through 2000, in Antelope Valley, Travis County, and West Philadelphia, varicella cases declined 71%, 84%, and 79%, respectively. Cases declined to the greatest extent among children aged 1 to 4 years, but cases declined in all age groups, including infants and adults. In the combined 3 surveillance areas, hospitalizations due to varicella declined from a range of 2.7 to 4.2 per 100000 population in 1995 through 1998 to 0.6 and 1.5 per 100000 population in 1999 and 2000, respectively (P=.15). By 2000, vaccine coverage among children aged 19 to 35 months was 82.1%, 73.6%, and 83.8% in Los Angeles County, Texas, and Philadelphia County, respectively. Conclusions Varicella disease has declined dramatically in surveillance areas with moderate vaccine coverage. Continued implementation of existing vaccine policies should lead to further reductions of varicella disease in these communities and throughout the United States.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Philadelphia Dept Publ Hlth, Philadelphia, PA USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; Texas Dept Hlth, Austin, TX 78756 USA	Centers for Disease Control & Prevention - USA; Texas Department of State Health Services	Seward, JF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-62, Atlanta, GA 30333 USA.	jseward@cdc.gov	Goldman, Gary/D-1131-2016; Goldman, Gary/AAD-6289-2021	Goldman, Gary/0000-0002-6039-3921				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Black S, 1999, PEDIATR INFECT DIS J, V18, P1041, DOI 10.1097/00006454-199912000-00003; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; *CDCP, 1997, MMWR-MORBID MORTAL W, V47, P944; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P365; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P55; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P637; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P657; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P409; Chen RT, 1996, EPIDEMIOL REV, V18, P99, DOI 10.1093/oxfordjournals.epirev.a017931; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Clements DA, 2001, ARCH PEDIAT ADOL MED, V155, P455, DOI 10.1001/archpedi.155.4.455; Comm Infect Dis, 2000, PEDIATRICS, V105, P136; Deguen S, 1998, J EPIDEMIOL COMMUN H, V52, p46S; FREED GL, 1994, PEDIATRICS, V93, P747; GALIL K, 2000, JOINT M PED AC SOC A; Gershon A, 1998, ARCH DIS CHILD, V79, P470, DOI 10.1136/adc.79.6.470; GORDON JE, 1962, AM J MED SCI, V244, P362, DOI 10.1097/00000441-196209000-00013; GUESS HA, 1986, PEDIATRICS, V78, P723; HALL CB, 1995, PEDIATRICS, V95, P791; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; PETERSON CL, 1997, 37 INT C ANT AG CHEM, P233; Plotkin SA, 1996, PEDIATRICS, V97, P251; Schaffer SJ, 1999, ARCH PEDIAT ADOL MED, V153, P357; Shapiro ED, 1997, JAMA-J AM MED ASSOC, V278, P1529, DOI 10.1001/jama.278.18.1529; Sharrar RG, 2000, VACCINE, V19, P916, DOI 10.1016/S0264-410X(00)00297-8; SMITH PJ, 2001, AM J PREV MED, V20, P61; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5; Wise RP, 2000, JAMA-J AM MED ASSOC, V284, P1271, DOI 10.1001/jama.284.10.1271; 1968, N ENGL J MED, V278, P275	37	379	405	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					606	611		10.1001/jama.287.5.606	http://dx.doi.org/10.1001/jama.287.5.606			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829699	Bronze			2022-12-28	WOS:000173686700029
J	Levine, AM				Levine, AM			Evaluation and management of HIV-infected women	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; PELVIC-INFLAMMATORY-DISEASE; SQUAMOUS INTRAEPITHELIAL LESIONS; SEXUALLY-TRANSMITTED DISEASES; ACTIVE ANTIRETROVIRAL THERAPY; PLASMA VIRAL LOAD; RNA LEVELS; RISK-FACTORS; HETEROSEXUAL TRANSMISSION	The rate of newly diagnosed AIDS in the United States is increasing fastest in women, who are infected with HIV primarily through heterosexual transmission. Approximately 60% of these women are African American, and 18% are Latina. A gynecologic infection is the most common symptom that leads to initial medical evaluation. Specific studies at baseline should include CD4 lymphocyte count, HIV-1 RNA level, and gynecologic examination with Papanicolaou smear. Decisions about initiation of antiretroviral therapy depend on the patient's clinical diagnoses, her willingness to adhere to treatment, and CD4 lymphocyte and HIV-1 RNA levels. Levels of HIV-1 RNA may be somewhat lower in women than in men at the same CD4 count, whereas women have higher CD4 lymphocyte counts at the time of AIDS diagnosis. However, prospective trials have not yet indicated the need to change the threshold CD4 lymphocyte counts or HIV-RNA levels for initiation of therapy in women. The efficacy of antiretroviral therapy appears to be similar in men and women, although women are more likely to experience toxicities. Abnormal Papanicolaou smears occur in approximately 40% of women at baseline, and 58% are infected with human papillomavirus. The prevalence of both conditions increases with lower CD4 lymphocyte counts and higher HIV-1 RNA levels. Precursor lesions to cervical cancer may be effectively treated, but almost 50% recur within 1 year, mandating careful follow-up. Referral should be sought for specialized gynecologic care and for issues related to HIV itself, since survival is prolonged in patients treated by physicians who are experienced in treating HIV. When they are provided the same access to care, HIV-infected women have similar prognoses as HIV-infected men.	Univ So Calif, Keck Sch Med, Los Angeles, CA USA	University of Southern California	Levine, AM (corresponding author), Univ So Calif, Norris Canc Hosp, 1441 Eastlake Ave,Room 3468, Los Angeles, CA 90033 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035004, U01AI031834, U01AI034989, U01AI034993, U01AI034994, U01AI042590] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-34989, U01-AI-42590, U01-AI-35004, U01-AI-34994, U01-AI-34993, U01-AI-31834] Funding Source: Medline; NICHD NIH HHS [U01-HD-32632] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRIOLA K, 2000, 13 INT C AIDS SOC SC; Ait-Khaled M, 1998, J INFECT DIS, V177, P1097, DOI 10.1086/517403; Anastos K, 2000, J ACQ IMMUN DEF SYND, V24, P218; ANDIEH L, 1999, 6 C RETR OPP INF CHI; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1995, MMWR MORB MORTAL WKL, V44, P1; [Anonymous], 1999, HAZ MAT TRANSP REG E, P1; ARNSTEN J, 2000, 7 C RETR OPP INF CHI; *ATIS, 2001, CURR TREATM GUID; BAKER DA, 1994, AIDS RES HUM RETROV, V10, P935, DOI 10.1089/aid.1994.10.935; Barbosa C, 1997, OBSTET GYNECOL, V89, P65, DOI 10.1016/S0029-7844(96)00387-0; BARTLETT JG, 2000, 2000 2001 MED MANAGE, P155; BARTLETT JG, 2001, 2001 2002 MED MANAGE, P31; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; BULTERYS M, 1995, AIDS, V9, P93; Bush CE, 1996, J CLIN MICROBIOL, V34, P970, DOI 10.1128/JCM.34.4.970-972.1996; CAMERON DW, 1989, LANCET, V2, P403; Cannistra SA, 1996, NEW ENGL J MED, V334, P1030, DOI 10.1056/NEJM199604183341606; CARMONA A, 2000, 13 INT C AIDS SOC SC; CARPENTER CCJ, 1991, MEDICINE, V70, P307, DOI 10.1097/00005792-199109000-00003; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; CARPENTER CCJ, 1989, AM J MED, V86, P771, DOI 10.1016/0002-9343(89)90471-3; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; CHAISSON RE, 1995, NEW ENGL J MED, V333, P751, DOI 10.1056/NEJM199509213331202; CHEEVER LW, 1998, 38 INT C ANT AG CHEM; COURGNAUD V, 1991, AIDS RES HUM RETROV, V7, P337, DOI 10.1089/aid.1991.7.337; CREAGHKIRK T, 1988, JAMA-J AM MED ASSOC, V260, P3009, DOI 10.1001/jama.260.20.3009; CRUM CP, 1985, J VIROL, V54, P675, DOI 10.1128/JVI.54.3.675-681.1985; Cu-Uvin S, 1999, CLIN INFECT DIS, V29, P1145, DOI 10.1086/313434; CURRIER JS, 1997, 1 NAT C WOM HIV PAS; DELMAN MC, 1998, 12 WORLD AIDS C GEN; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; Duerr A, 1997, OBSTET GYNECOL, V90, P252, DOI 10.1016/S0029-7844(97)00253-6; DUERR A, 1998, 12 WORLD AIDS C GEN; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; ELSADR W, 2000, 13 INT C AIDS SOC SC, P79; Evans JS, 1997, J INFECT DIS, V175, P795, DOI 10.1086/513973; FARNSWORTH A, 1998, 12 WORLD AIDS C GEN; FARRELLY JG, 1999, WORKSH DET POT TOX F, P45; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; FLEXNER C, 2001, MANAGING DRUG DRUG I; Frankel RE, 1997, CLIN INFECT DIS, V25, P706, DOI 10.1086/513775; FREEDBERG KA, 1994, J ACQ IMMUN DEF SYND, V7, P1134; GARCIA PM, 2001, WOMEN HIV CONTINUING; GERSTEN M, 1997, 1 NAT C WOM HIV PAS; Gervasoni C, 1999, AIDS, V13, P465, DOI 10.1097/00002030-199903110-00004; Goletti D, 1996, J IMMUNOL, V157, P1271; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; GULICK RM, 2000, 7 C RETR OPP INF CHI; HANKINS C, 1998, 12 WORLD AIDS C GEN; HEARD I, 1998, 12 WORLD AIDS C GEN; HOEGSBERG B, 1990, AM J OBSTET GYNECOL, V163, P1135, DOI 10.1016/0002-9378(90)90671-S; HOGG R, 2000, 13 INT C AIDS SOC SC; HOWLEY PM, 1991, CANCER RES, V51, pS5019; IMAM N, 1990, AM J MED, V89, P142, DOI 10.1016/0002-9343(90)90291-K; JOHNSON JC, 1992, OBSTET GYNECOL, V79, P321, DOI 10.1097/00006250-199203000-00001; Junghans C, 1999, LANCET, V353, P589, DOI 10.1016/S0140-6736(05)75645-2; JUSTMAN J, 1999, 6 C RETR OPP INF CHI; Kemper CA, 1997, INT J STD AIDS, V8, P44, DOI 10.1258/0956462971918760; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; KORN AP, 1993, OBSTET GYNECOL, V82, P765; LAZZARIN A, 1991, ARCH INTERN MED, V151, P2411, DOI 10.1001/archinte.151.12.2411; LEMP GF, 1992, J INFECT DIS, V166, P74, DOI 10.1093/infdis/166.1.74; Levine AM, 2001, J ACQ IMMUN DEF SYND, V26, P28, DOI 10.1097/00126334-200101010-00004; LEVINE AM, 2001, HIV DIS WOMEN 2000; LoussertAjaka I, 1997, AIDS, V11, P1575, DOI 10.1097/00002030-199713000-00005; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MAIER JA, 1986, AM J OBSTET GYNECOL, V155, P756, DOI 10.1016/S0002-9378(86)80014-X; MAIMAN M, 1993, OBSTET GYNECOL, V82, P170; MAIMAN M, 1999, 6 C RETR OPP INF CHI; MANDELBLATT JS, 1992, AIDS, V6, P173, DOI 10.1097/00002030-199202000-00005; Massad LS, 1999, J ACQ IMMUN DEF SYND, V21, P33, DOI 10.1097/00126334-199905010-00005; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MELNICK SL, 1994, JAMA-J AM MED ASSOC, V272, P1915, DOI 10.1001/jama.272.24.1915; Minkoff HL, 1999, AM J OBSTET GYNECOL, V180, P824, DOI 10.1016/S0002-9378(99)70653-8; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; MOFENSON LM, 2000, ANTIRETROVIRAL THERA; MONTANER J, 2000, 13 INT C AIDS SOC SC; MONTESSORI V, 2000, 13 INT C AIDS SOC SC; Moore RD, 1999, LANCET, V353, P463, DOI 10.1016/S0140-6736(98)05379-3; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Moore RD, 1999, CLIN INFECT DIS, V29, P44, DOI 10.1086/520178; MORENO S, 1993, ANN INTERN MED, V119, P194, DOI 10.7326/0003-4819-119-3-199308010-00003; MORLAT P, 1992, AIDS, V6, P1187, DOI 10.1097/00002030-199210000-00020; MUNGER K, 1989, J VIROL, V63, P4417; MUURHAINEN N, 1999, 3 INT C NUTR HIV INF; NAKASHIMA AK, 2000, 13 INT C AIDS SOC SC; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; OBRIEN WA, 1995, BLOOD, V86, P1082; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson D., 1999, 6 C RETR OPP INF CHI; PECHERE M, 1993, NEW ENGL J MED, V328, P1785; *PER HIV GUID WORK, 2001, PUBL HLTH TASK FORC; PHAM P, 1997, HIV ADV RES THERAPY, V7, P10; Phillips AN, 1996, AIDS, V10, P859, DOI 10.1097/00002030-199607000-00009; Prevention and control of influenza, 1990, MMWR MORB MORTAL WKL, V39, P1; Prins M, 1999, AIDS, V13, P2361, DOI 10.1097/00002030-199912030-00007; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; REID R, 1984, CANCER-AM CANCER SOC, V53, P943, DOI 10.1002/1097-0142(19840215)53:4<943::AID-CNCR2820530421>3.0.CO;2-X; Rezza G, 2000, J ACQ IMMUN DEF SYND, V25, P56, DOI 10.1097/00126334-200009010-00008; RHOADS JL, 1987, JAMA-J AM MED ASSOC, V257, P3105, DOI 10.1001/jama.257.22.3105; Richardson J, 2001, SOC WORK HEALTH CARE, V32, P93, DOI 10.1300/J010v32n04_05; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; RUFF AJ, 1994, J ACQ IMMUN DEF SYND, V7, P68; SCHAFER A, 1991, AM J OBSTET GYNECOL, V164, P593, DOI 10.1016/S0002-9378(11)80029-3; SCHULTZ RM, 1998, 38 INT C ANT AG CHEM; SEIDLIN M, 1993, AIDS, V7, P1247, DOI 10.1097/00002030-199309000-00015; SHAH K, 1998, 12 WORLD AIDS C GEN; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Singh N, 1996, AIDS CARE, V8, P261, DOI 10.1080/09540129650125696; Six C, 1998, AIDS, V12, P1047, DOI 10.1097/00002030-199809000-00012; Smith SR, 1999, HEALTH SERV RES, V34, P123; Solomon L, 1998, J ACQ IMMUN DEF SYND, V17, P253, DOI 10.1097/00042560-199803010-00011; SQUIRES KS, 2000, 7 C RETR OPP INF CHI; Stanley SK, 1996, NEW ENGL J MED, V334, P1222, DOI 10.1056/NEJM199605093341903; Stein MD, 2000, J ACQ IMMUN DEF SYND, V25, P51, DOI 10.1097/00126334-200009010-00007; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; STIEHM ER, 1991, J PEDIATR-US, V118, P410, DOI 10.1016/S0022-3476(05)82157-2; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Sullivan PS, 1997, J ACQ IMMUN DEF SYND, V14, P374, DOI 10.1097/00042560-199704010-00011; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Thomas DL, 1996, J INFECT DIS, V174, P690, DOI 10.1093/infdis/174.4.690; THOMPSON M, 2000, 13 INT C AIDS SOC SC; TURNER BJ, 1992, J ACQ IMMUN DEF SYND, V5, P978; *US DEP HHS, 1997, EST INC AIDS DEATH P, V5, P1; Vanhove GF, 1996, JAMA-J AM MED ASSOC, V276, P1955, DOI 10.1001/jama.276.24.1955; VERMUND SH, 1991, AM J OBSTET GYNECOL, V165, P392, DOI 10.1016/0002-9378(91)90101-V; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; WENGER N, 1999, 6 C RETR OPP INF CHI; WILLIAMS AB, 1994, OBSTET GYNECOL, V83, P205; WILSON T, 2000, 13 INT C AIDS SOC SC; WOFSY CB, 1986, LANCET, V1, P527; Yarasheski KE, 1999, J ACQ IMMUN DEF SYND, V21, P209, DOI 10.1097/00126334-199907010-00005; 1999, MMWR MORB MORTAL WKL, V48, P61; 1988, MMWR MORB MORTAL WKL, V37, P600; 1995, MMWR MORB MORTAL WKL, V44, P81; 1990, MMWR MORB MORTAL WKL, V39, P845; 1999, MMWR MORB MORTAL WKL, V48, P1	148	17	19	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					228	242		10.7326/0003-4819-136-3-200202050-00011	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00011			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827499				2022-12-28	WOS:000173637400006
J	Brivanlou, AH; Darnell, JE				Brivanlou, AH; Darnell, JE			Transcription - Signal transduction and the control of gene expression	SCIENCE			English	Review							NF-KAPPA-B; EXPORT SIGNAL; BINDING PROTEIN; KINASE; ACTIVATION; CELLS; YEAST; PHOSPHORYLATION; REPRESSION; INDUCTION	More than 2000 transcription factors are encoded in the human genome. Such proteins have often been classified according to common structural elements. But because transcription factors evolved in the service of biologic function, we propose an alternative grouping of eukaryotic transcription factors on the basis of characteristics that describe their roles within cellular regulatory circuits.	Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Darnell, JE (corresponding author), Rockefeller Univ, Mol Cell Biol Lab, 1230 York Ave, New York, NY 10021 USA.	darnell@rockefeller.edu			NEI NIH HHS [1RO1EY12370-03] Funding Source: Medline; NIAID NIH HHS [AI32489, AI34420] Funding Source: Medline; NICHD NIH HHS [2RO1HD/GM32105-06A1] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032105] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034420, R01AI032489, R01AI034420] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Barish GD, 2000, CANC DRUG DISC DEV, V5, P53; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; CHODOSH LA, 1988, CELL, V53, P25, DOI 10.1016/0092-8674(88)90484-9; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Courey AJ, 2001, GENE DEV, V15, P2786; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Davis RJ, 2000, CANC DRUG DISC DEV, V5, P153; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Editorial Nature, 2001, NATURE, V409; Evans Richard, COMMUNICATION; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GROSSCHEDL R, 1995, CURR OPIN CELL BIOL, V7, P362, DOI 10.1016/0955-0674(95)80091-3; Haspel RL, 1999, P NATL ACAD SCI USA, V96, P10188, DOI 10.1073/pnas.96.18.10188; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Howell M, 1999, DEV BIOL, V214, P354, DOI 10.1006/dbio.1999.9430; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hunter T, 2000, HARVEY LECT, V94, P81; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Israel A, 1997, NATURE, V388, P519, DOI 10.1038/41433; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; JANKNECHT R, 1995, IMMUNOBIOLOGY, V193, P137, DOI 10.1016/S0171-2985(11)80536-X; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; Jones KA, 2000, GENE DEV, V14, P1992; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kolligs FT, 2000, GENE DEV, V14, P1319; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LEFKOWITZ RJ, 1983, ANNU REV BIOCHEM, V52, P159, DOI 10.1146/annurev.bi.52.070183.001111; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lufkin T, 1996, CURR OPIN GENET DEV, V6, P575, DOI 10.1016/S0959-437X(96)80086-4; Mackem S, 2001, J BIOL CHEM, V276, P45501, DOI 10.1074/jbc.C100269200; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Masuyama N, 1999, J BIOL CHEM, V274, P12163, DOI 10.1074/jbc.274.17.12163; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Naar AM, 1998, COLD SPRING HARB SYM, V63, P189, DOI 10.1101/sqb.1998.63.189; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Polakis P, 2000, GENE DEV, V14, P1837; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RINGOLD GM, 1977, P NATL ACAD SCI USA, V74, P2879, DOI 10.1073/pnas.74.7.2879; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Starr R, 1999, BIOESSAYS, V21, P47, DOI 10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N; STJOHNSTON D, 1992, CELL, V68, P201; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; XANTHOPOULOS KG, 1989, P NATL ACAD SCI USA, V86, P4117, DOI 10.1073/pnas.86.11.4117; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; 2001, SCIENCE, V291	92	465	503	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					813	818		10.1126/science.1066355	http://dx.doi.org/10.1126/science.1066355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823631				2022-12-28	WOS:000173733000033
J	Bruick, RK; McKnight, SL				Bruick, RK; McKnight, SL			Transcription - Oxygen sensing gets a second wind	SCIENCE			English	Editorial Material							INDUCIBLE FACTOR 1-ALPHA; HYPOXIA; STABILIZATION; HIF-1-ALPHA; PROTEIN; DOMAINS		Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd L3-124, Dallas, TX 75390 USA.		Junk, Wolfgang J/A-6172-2017					Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0	16	119	134	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					807	808		10.1126/science.1069825	http://dx.doi.org/10.1126/science.1069825			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823627				2022-12-28	WOS:000173733000029
J	van't Veer, LJ; Dai, HY; van de Vijver, MJ; He, YDD; Hart, AAM; Mao, M; Peterse, HL; van der Kooy, K; Marton, MJ; Witteveen, AT; Schreiber, GJ; Kerkhoven, RM; Roberts, C; Linsley, PS; Bernards, R; Friend, SH				van't Veer, LJ; Dai, HY; van de Vijver, MJ; He, YDD; Hart, AAM; Mao, M; Peterse, HL; van der Kooy, K; Marton, MJ; Witteveen, AT; Schreiber, GJ; Kerkhoven, RM; Roberts, C; Linsley, PS; Bernards, R; Friend, SH			Gene expression profiling predicts clinical outcome of breast cancer	NATURE			English	Article							SPORADIC BREAST; BRCA1; PATTERNS; TUMORS	Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for metastases (for example, lymph node status and histological grade) fail to classify accurately breast tumours according to their clinical behaviour(1-3). Chemotherapy or hormonal therapy reduces the risk of distant metastases by approximately one-third; however 70-80% of patients receiving this treatment would have survived without it(4,5). None of the signatures of breast cancer gene expression reported to date(6-12) allow for patient-tailored therapy strategies. Here we used DNA microarray analysis supervised classification to identify a gene expression signature strongly predictive of a short interval to distant metastases ('poor prognosis' signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative). In addition, we established a signature that identifies tumours of BRCA1 carriers. The poor prognosis signature consists of genes regulating cell cycle, invasion, metastasis and angiogenesis. This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.	Rosetta Inpharmat, Kirkland, WA 98034 USA; Netherlands Canc Inst, Div Diagnost Oncol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Merck & Company; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Friend, SH (corresponding author), Rosetta Inpharmat, 12040 115th Ave NE, Kirkland, WA 98034 USA.			Bernards, Rene/0000-0001-8677-3423; van de Vijver, Marc/0000-0002-0385-4787				Abe O, 1998, LANCET, V352, P930; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Brenton JD, 2001, BREAST CANCER RES, V3, P77, DOI 10.1186/bcr274; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Clarke M, 1998, LANCET, V351, P1451; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Gruvberger S, 2001, CANCER RES, V61, P5979; He YDD, 2001, NAT MED, V7, P658, DOI 10.1038/89022; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Janicke F, 2001, J NATL CANCER I, V93, P913, DOI 10.1093/jnci/93.12.913; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Martin K, 2000, CANCER RES, V60, P2232; MCGUIRE WL, 1991, J NATL CANCER I, V83, P154, DOI 10.1093/jnci/83.3.154; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 1998, BREAST CANCER RES TR, V52, P17, DOI 10.1023/A:1006102916060; vanDiest PJ, 1997, AM J PATHOL, V150, P705; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	26	6997	7395	17	799	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					530	536		10.1038/415530a	http://dx.doi.org/10.1038/415530a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823860	Green Published			2022-12-28	WOS:000173564300048
J	Berwick, D				Berwick, D			"We all have AIDS": case for reducing the cost of HIV drugs to zero	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY	An editorial last year in the Washington Post challenged directors of drug companies to reduce the cost of HIV drugs in poor countries to zero. Here the reproduced editorial is accompanied by a discussion about why it was written and the response to it. We invited comment from one of the named directors and from a man with AIDS who refuses to take antiretroviral drugs until they are available to the public sector in South Africa.	Inst Healthcare Improvement, Boston, MA 02215 USA	Institute for Healthcare Improvement	Berwick, D (corresponding author), Inst Healthcare Improvement, 375 Longwood Ave, Boston, MA 02215 USA.							Berwick Donald M., 2001, WASHINGTON POST 0626, pA17; Farmer P, 1998, BRIT MED J, V317, P671, DOI 10.1136/bmj.317.7159.671; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; *JOINT UN PROGR HI, 2000, AIDS EP UPD DEC 2000; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; WHO, 1997, GUID MAN DRUG RES TU	8	14	14	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					214	216		10.1136/bmj.324.7331.214	http://dx.doi.org/10.1136/bmj.324.7331.214			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809645	Green Published			2022-12-28	WOS:000173604800020
J	Grimes, DA; Schulz, KF				Grimes, DA; Schulz, KF			Cohort studies: marching towards outcomes	LANCET			English	Article							NESTED CASE-CONTROL; RISK-FACTORS; WOMEN; ILLNESS; CANCER	A cohort study tracks two or more groups forward from exposure to outcome. This type of study can be done by going ahead in time from the present (prospective cohort study) or, alternatively, by going back in time to comprise the cohorts and following them up to the present (retrospective cohort study). A cohort study is the best way to identify incidence and natural history of a disease, and can be used to examine multiple outcomes after a single exposure. However, this type of study is less useful for examination of rare events or those that take a long time to develop. A cohort study should provide specific definitions of exposures and outcomes: determination of both should be as objective as possible. The control group (unexposed) should be similar in all important respects to the exposed, with the exception of not having the exposure. Observational studies, however, rarely achieve such a degree of similarity, so investigators need to measure and control for confounding factors. Reduction of loss to follow-up over time is a challenge, since differential losses to follow-up introduce bias. Variations on the cohort theme include the before-after study and nested case-control study (within a cohort study). Strengths of a cohort study include the ability to calculate incidence rates, relative risks, and 95% CIs. This format is the preferred way of presenting study results, rather that with p values.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.		Hug, Balthasar L./G-1568-2010					[Anonymous], 1987, N ENGL J MED, V316, P650; ARMON C, 1991, REV INFECT DIS, V13, pS68; Atterbury MR, 1996, AM J IND MED, V30, P695, DOI 10.1002/(SICI)1097-0274(199612)30:6<695::AID-AJIM5>3.0.CO;2-Q; Benjamin S, 2000, ARTHRITIS RHEUM-US, V43, P561, DOI 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O; Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; BRACKEN MB, 1989, BRIT J OBSTET GYNAEC, V96, P383, DOI 10.1111/j.1471-0528.1989.tb02410.x; Colditz GA, 1996, J NATL CANCER I, V88, P365, DOI 10.1093/jnci/88.6.365; CROFT P, 1989, BRIT MED J, V298, P674, DOI 10.1136/bmj.298.6674.674; Doll R, 2000, BRIT MED J, V320, P1097, DOI 10.1136/bmj.320.7242.1097; Ewan PW, 2001, LANCET, V357, P111, DOI 10.1016/S0140-6736(00)03543-1; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Hannaford PC, 1998, BRIT J GEN PRACT, V48, P1657; HASKETT RF, 1983, PSYCHIAT RES, V9, P125, DOI 10.1016/0165-1781(83)90034-3; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hulley SB., 2001, DESIGNING CLIN RES; KAWAKAMI N, 1990, J OCCUP ENVIRON MED, V32, P722; Kelsey JL., 1996, METHODS OBSERVATIONA; LANG TA, 1997, HOW REPORT STAT MED; Last J., 1988, DICT EPIDEMIOLOGY; Levgur M, 2000, OBSTET GYNECOL SURV, V55, P41, DOI 10.1097/00006254-200001000-00022; Lilienfeld AM, 1980, FDN EPIDEMIOLOGY; Rohrmus B, 2000, LANCET, V356, P2160, DOI 10.1016/S0140-6736(00)03503-0; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rothman N, 1997, LANCET, V350, P240, DOI 10.1016/S0140-6736(97)02088-6; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; SCHLUEDERBERG A, 1992, ANN INTERN MED, V117, P325, DOI 10.7326/0003-4819-117-4-325; Seman LJ, 1999, CLIN CHEM, V45, P1039; WASSERTHEILSMOL.S, 1995, BIOSTATISTICS EPIDEM; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427; 2000, MMWR MORB MORTAL WKL, V49, pS35	34	241	252	4	41	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					341	345		10.1016/S0140-6736(02)07500-1	http://dx.doi.org/10.1016/S0140-6736(02)07500-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830217				2022-12-28	WOS:000173588100031
J	Terrin, G; Borrelli, O; Di Nardo, G; Pacchiarotti, C; Cucchiara, S				Terrin, G; Borrelli, O; Di Nardo, G; Pacchiarotti, C; Cucchiara, S			A child with aphthae and diarrhoea	LANCET			English	Editorial Material							BEHCETS-SYNDROME; DISEASE		Univ Roma La Sapienza, Pediat Gastroenterol Unit, I-00161 Rome, Italy	Sapienza University Rome	Cucchiara, S (corresponding author), Univ Roma La Sapienza, Pediat Gastroenterol Unit, Piazzale Aldo Moro 5, I-00161 Rome, Italy.		; Cucchiara, Salvatore/K-1628-2016	Terrin, Gianluca/0000-0003-3541-2876; /0000-0003-0241-0508; Cucchiara, Salvatore/0000-0002-2939-9698				KALLINOWSKI B, 1994, Z GASTROENTEROL, V32, P642; Kone-Paut I, 1998, J PEDIATR-US, V132, P721, DOI 10.1016/S0022-3476(98)70368-3; KONEPAUT I, 1993, ARCH FR PEDIATR, V50, P561; Shek LPC, 1999, PEDIATRICS, V103, P1295, DOI 10.1542/peds.103.6.1295; Yazici Hasan, 1999, Current Opinion in Rheumatology, V11, P53, DOI 10.1097/00002281-199901000-00009	5	5	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					316	316		10.1016/S0140-6736(02)07498-6	http://dx.doi.org/10.1016/S0140-6736(02)07498-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830199				2022-12-28	WOS:000173588100013
J	Bewtra, C				Bewtra, C			Learning experiences	LANCET			English	Editorial Material									Creighton Univ, Sch Med, Omaha, NE 68131 USA	Creighton University	Bewtra, C (corresponding author), Creighton Univ, Sch Med, Omaha, NE 68131 USA.								0	0	0	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					22	22		10.1016/S0140-6736(02)07274-4	http://dx.doi.org/10.1016/S0140-6736(02)07274-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809182				2022-12-28	WOS:000173143500011
J	Lee, KB; Park, SJ; Mirkin, CA; Smith, JC; Mrksich, M				Lee, KB; Park, SJ; Mirkin, CA; Smith, JC; Mrksich, M			Protein nanoarrays generated by dip-pen nanolithography	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; FABRICATION; ADSORPTION; PARALLEL; PATTERNS	Dip-pen nanolithography was used to construct arrays of proteins with 100- to 350-nanometer features. These nanoarrays exhibit almost no detectable nonspecific binding of proteins to their passivated portions even in complex mixtures of proteins, and therefore provide the opportunity to study a variety of surface-mediated biological recognition processes. For example, reactions involving the protein features and antigens in complex solutions can be screened easily by atomic force microscopy. As further proof-of-concept, these arrays were used to study cellular adhesion at the submicrometer scale.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Ctr Nanofabricat & Mol Self Assembly, Evanston, IL 60208 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	Northwestern University; Northwestern University; University of Chicago; University of Chicago	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	camirkin@chem.northwestern.edu; mmrksich@midway.uchicago.edu	Mrksich, Milan/G-2469-2011; Park, So-Jung/F-9471-2017; Lee, KiBum/F-3702-2012; Lee, Ki-Bum/G-7503-2015; Mirkin, Chad A/E-3911-2010	Mrksich, Milan/0000-0002-4964-796X; LEE, Ki-Bum/0000-0002-8164-0047; Mirkin, Chad/0000-0002-6634-7627				Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864; Bergman AA, 1998, LANGMUIR, V14, P6785, DOI 10.1021/la980642o; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4; BrowningKelley ME, 1997, LANGMUIR, V13, P343, DOI 10.1021/la960918x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Kenseth JR, 2001, LANGMUIR, V17, P4105, DOI 10.1021/la0100744; KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572; LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038; MacBeath G, 2000, SCIENCE, V289, P1760; Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775; Nicolau DV, 1998, LANGMUIR, V14, P1927, DOI 10.1021/la970802g; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140; Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n; Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9; Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198	23	1028	1081	3	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1702	1705		10.1126/science.1067172	http://dx.doi.org/10.1126/science.1067172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11834780				2022-12-28	WOS:000174212900043
J	Taylor, B; Miller, E; Lingam, R; Andrews, N; Simmons, A; Stowe, J				Taylor, B; Miller, E; Lingam, R; Andrews, N; Simmons, A; Stowe, J			Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study	BRITISH MEDICAL JOURNAL			English	Article							CAUSAL ASSOCIATION; MMR; DISORDERS	Objectives To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence of a "new variant" form of autism. Design Population study with case note review linked to independently recorded vaccine data. Setting Five health districts in north east London. Participants 278 children with core autism and 195 with atypical autism, mainly identified froth computerised disability registers and born between 1979 and 1998. Main outcome measures Recorded bowel problems lasting at least three months, age of reported regression of the child's development where it was a feature, and relation of these to MMR vaccination. Results The proportion of children with developmental regression (25% overall) or bowel symptoms (17%) did not change significantly (P value for trend 0.50 and 0.47, respectively) during the 20 years from 197 9, a period which included the introduction of MMR vaccination in October 1988. No significant difference was found in rates of bowel problems or regression in children who received the MMR vaccine before their parents became concerned about their development (where MMR might have caused or triggered the autism with regression or bowel problem), compared with those who received it only after such concern and those who had not received the MMR vaccine. A possible association between non-specific bowel problems and regression in children with autism was seen but this was unrelated to MMR vaccination. Conclusions These findings provide no support for an MMR associated "new variant" form of autism with developmental regression and bowel problems, and further evidence against involvement of MMR vaccine in the initiation of autism.	UCL, Royal Free & Univ Coll Med Sch, Ctr Community Child Hlth, London NW3 2PF, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England	University of London; University College London; Public Health England	Taylor, B (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Ctr Community Child Hlth, Royal Free Campus, London NW3 2PF, England.	b.taylor@rfc.ucl.ac.uk		Stowe, Julia/0000-0002-3999-6461				Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; DeWilde S, 2001, BRIT J GEN PRACT, V51, P226; Farrington CP, 2001, VACCINE, V19, P3632, DOI 10.1016/S0264-410X(01)00097-4; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Halsey NA, 2001, PEDIATRICS, V107, P1; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; KURITA H, 1992, J AUTISM DEV DISORD, V22, P175, DOI 10.1007/BF01058149; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285	12	210	213	0	77	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					393	396		10.1136/bmj.324.7334.393	http://dx.doi.org/10.1136/bmj.324.7334.393			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850369	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-28	WOS:000174006300016
J	Klier, EM; Wang, HY; Constantin, AG; Crawford, JD				Klier, EM; Wang, HY; Constantin, AG; Crawford, JD			Midbrain control of three-dimensional head orientation	SCIENCE			English	Article							OCULAR TILT REACTION; INTERSTITIAL NUCLEUS; 3-DIMENSIONAL EYE; GAZE SHIFTS; MOTOR CONTROL; MOVEMENTS; CAJAL; COORDINATION; STRATEGIES; SIGNALS	Little is known about the neural mechanisms controlling head posture and why they fait in clinical syndromes like torticollis. It is well established, however, that the brain controls eye position by integrating eye velocity commands. By electrically stimulating and reversibly inactivating midbrain sites in the head-free (nonimmobilized) monkey, we found that the interstitial nucleus of Cajal functions as a neural integrator for head posture. We suggest that a bilateral imbalance in this structure, through either direct damage or inappropriate input, could be one of the mechanisms underlying torticollis.	York Univ, CIHR Grp Act & Percept, York Ctr Vis Res, Toronto, ON M3J 1P3, Canada; York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Kinesiol, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada	Crawford, JD (corresponding author), York Univ, CIHR Grp Act & Percept, York Ctr Vis Res, Toronto, ON M3J 1P3, Canada.	jdc@yorku.ca		Crawford, Doug/0000-0003-2288-1286				BUTTNERENNEVER JA, 1988, NEUROANATOMY OCULOMO, P137; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Ceylan M, 2000, J NEUROSCI, V20, P2719; Crawford JD, 1999, J NEUROPHYSIOL, V81, P1760, DOI 10.1152/jn.1999.81.4.1760; CRAWFORD JD, 1991, SCIENCE, V252, P1551, DOI 10.1126/science.2047862; Dauer WT, 1998, BRAIN, V121, P547, DOI 10.1093/brain/121.4.547; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; FUKUSHIMA K, 1987, PROG NEUROBIOL, V29, P107, DOI 10.1016/0301-0082(87)90016-5; GUITTON D, 1992, TRENDS NEUROSCI, V15, P174, DOI 10.1016/0166-2236(92)90169-9; HALMAGYI GM, 1990, NEUROLOGY, V40, P1503, DOI 10.1212/WNL.40.10.1503; Helmchen C, 1998, EXP BRAIN RES, V119, P436, DOI 10.1007/s002210050359; KESHNER EA, 1988, PROG BRAIN RES, V76, P329; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Medendorp WP, 1999, J NEUROPHYSIOL, V82, P2833, DOI 10.1152/jn.1999.82.5.2833; Ohashi T, 1998, J NEURO-OPHTHALMOL, V18, P40; RADAU P, 1994, J NEUROPHYSIOL, V72, P2840, DOI 10.1152/jn.1994.72.6.2840; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; ROBINSON DA, 1971, CONTROL EYE MOVEMENT, P519; SCHOR RH, 1988, CONTROL HEAD MOVEMEN, P141; TWEED D, 1990, VISION RES, V30, P97, DOI 10.1016/0042-6989(90)90130-D	20	73	71	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1314	1316		10.1126/science.1067300	http://dx.doi.org/10.1126/science.1067300			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847347				2022-12-28	WOS:000173926000049
J	Theissen, G				Theissen, G			Secret life of genes	NATURE			English	Editorial Material									Univ Jena, Lehrstuhl Genet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Theissen, G (corresponding author), Univ Jena, Lehrstuhl Genet, Philosophenweg 12, D-07743 Jena, Germany.							Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631	4	61	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					741	741		10.1038/415741a	http://dx.doi.org/10.1038/415741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845189	Bronze			2022-12-28	WOS:000173833900028
J	Leaning, J				Leaning, J			Was the Afghan conflict a just war?	BRITISH MEDICAL JOURNAL			English	Article									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Leaning, J (corresponding author), Harvard Univ, Sch Publ Hlth, 651 Huntington Ave, Boston, MA 02115 USA.							DELUPIS I, 1987, LAW WAR, P19; GROTIUS H, 1996, EMORY INT LAW REV, V10, P31; *INT COMM RED CROS, 1989, GEN CONV AUG 12 1949; SCHAFF P, 2002, POST NICENE FATHERS; STEINER H, 2000, INT HUMAN RIGHTS CON, P113; *US SUP DOC, 1949, TRIALS WAR CRIM NUR, V1; Walzer M, 1977, JUST UNJUST WARS MOR	7	0	0	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					353	355		10.1136/bmj.324.7333.353	http://dx.doi.org/10.1136/bmj.324.7333.353			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834567	Green Published			2022-12-28	WOS:000173866300026
J	Krieger, UK; Huthwelker, T; Daniel, C; Weers, U; Peter, T; Lanford, WA				Krieger, UK; Huthwelker, T; Daniel, C; Weers, U; Peter, T; Lanford, WA			Rutherford backscattering to study the near-surface region of volatile liquids and solids	SCIENCE			English	Article							LASER RESONANT DESORPTION; SULFURIC-ACID; ICE PARTICLES; DIFFUSION; STRATOSPHERE; HCL; SPECTROSCOPY; SOLUBILITY; SYSTEM; VAPOR	Here we describe the use of Rutherford backscattering spectrometry (RBS) to measure quantitative in situ elemental profiles with high depth resolution, online and nondestructively, in volatile substances (liquid and frozen acids, ice). Samples for analysis are held in a chamber with controlled temperature and partial pressures designed to match conditions for aerosols in Earth's atmosphere. This technique is demonstrated in studies of water solubility in sulfuric acid, hydrochloric acid (HCl) on ice surfaces, the formation of a HCl-hexahydrate surface layer on evaporating HCl-doped ice, and the diffusion of water through this layer.	Swiss Fed Inst Technol, Honggerberg HPP, Inst Atmospher & Climate Sci, CH-8093 Zurich, Switzerland; SUNY Albany, Dept Phys, Albany, NY 12222 USA; Max Planck Inst Chem, D-55128 Mainz, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Max Planck Society	Krieger, UK (corresponding author), Swiss Fed Inst Technol, Honggerberg HPP, Inst Atmospher & Climate Sci, CH-8093 Zurich, Switzerland.	krieger@atmos.umnw.ethz.ch	Peter, Thomas/B-2529-2018; Krieger, Ulrich K/E-2916-2016	Peter, Thomas/0000-0002-7218-7156; Krieger, Ulrich K/0000-0003-4958-2657				ABBATT JPD, 1992, J GEOPHYS RES-ATMOS, V97, P15819, DOI 10.1029/92JD01220; CARSLAW KS, 1995, J PHYS CHEM-US, V99, P11557, DOI 10.1021/j100029a039; Chu W. K., 1978, BACKSCATTERING SPECT, DOI 10.1016/B978-0-12-173850-1.50008-9; DOMINE F, 1994, GEOPHYS RES LETT, V21, P601, DOI 10.1029/94GL00512; Domine F, 2001, ANAL CHEM, V73, P4348, DOI 10.1021/ac010255a; DOOLITTLE LR, 1985, NUCL INSTRUM METH B, V9, P344, DOI 10.1016/0168-583X(85)90762-1; Fairbrother DH, 1996, J PHYS CHEM-US, V100, P13696, DOI 10.1021/jp960246j; Livingston FE, 2001, J PHYS CHEM A, V105, P5155, DOI 10.1021/jp0043773; LUO BP, 1994, GEOPHYS RES LETT, V21, P49, DOI 10.1029/93GL02956; MOLINA MJ, 1987, SCIENCE, V238, P1253, DOI 10.1126/science.238.4831.1253; MULVANEY R, 1988, NATURE, V331, P247, DOI 10.1038/331247a0; NYE JF, 1992, PHYS CHEM ICE, P200; PETER T, 1994, GEOPHYS RES LETT, V21, P1331, DOI 10.1029/93GL03019; Raduge C, 1997, CHEM PHYS LETT, V274, P140, DOI 10.1016/S0009-2614(97)00631-3; SMITH VG, 1955, CAN J PHYS, V33, P723, DOI 10.1139/p55-089; TABAZADEH A, 1994, J GEOPHYS RES-ATMOS, V99, P12897, DOI 10.1029/94JD00820; Tassotto M, 1997, J CHEM PHYS, V107, P8899, DOI 10.1063/1.475181; Tesmer J. R., 1995, HDB MODERN ION BEAM; VUILLARD G, 1955, CR HEBD ACAD SCI, V241, P1308; WOFSY SC, 1990, GEOPHYS RES LETT, V17, P449, DOI 10.1029/GL017i004p00449; WOLFF EW, 1989, GEOPHYS RES LETT, V16, P487, DOI 10.1029/GL016i006p00487	21	23	23	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1048	1050		10.1126/science.1066654	http://dx.doi.org/10.1126/science.1066654			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834829				2022-12-28	WOS:000173793000059
J	Rezaie, T; Child, A; Hitchings, R; Brice, G; Miller, L; Coca-Prados, M; Heon, E; Krupin, T; Ritch, R; Kreutzer, D; Crick, RP; Sarfarazi, M				Rezaie, T; Child, A; Hitchings, R; Brice, G; Miller, L; Coca-Prados, M; Heon, E; Krupin, T; Ritch, R; Kreutzer, D; Crick, RP; Sarfarazi, M			Adult-onset primary open-angle glaucoma caused by mutations in optineurin	SCIENCE			English	Article							LOW-TENSION GLAUCOMA; PRIMARY CONGENITAL GLAUCOMA; NECROSIS-FACTOR-ALPHA; CYTOCHROME P4501B1; IDENTIFICATION; PREVALENCE; PROTEIN; REGION; LOCUS; 2P21	Primary open-angle glaucoma (POAG) affects 33 million individuals worldwide and is a leading cause of blindness. In a study of 54 families with autosomal dominantly inherited adult-onset POAG, we identified the causative gene on chromosome 10p14 and designated it OPTN (for "optineurin"). Sequence alterations in OPTN were found in 16.7% of families with hereditary POAG, including individuals with normal intraocular pressure. The OPTN gene codes for a conserved 66-kilodalton protein of unknown function that has been implicated in the tumor necrosis factor-alpha signaling pathway and that interacts with diverse proteins including Huntingtin, Ras-associated protein RABB, and transcription factor IIIA. Optineurin is expressed in trabecular meshwork, nonpigmented ciliary epithelium, retina, and brain, and we speculate that it plays a neuroprotective role.	Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Moorfields Eye Hosp, Glaucoma Res Unit, London EC1V 2PD, England; Univ Connecticut, Ctr Hlth, Dept Pathol, Farmington, CT 06030 USA; Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Vis Res Program UHN, Dept Ophthalmol, Toronto, ON M5T 2S8, Canada; Univ Eye Specialists, Chicago, IL 60611 USA; New York Eye & Ear Infirm, Valhalla, NY 10003 USA; New York Med Coll, Valhalla, NY 10003 USA; Int Glaucoma Assoc, London SE5 9HQ, England	University of Connecticut; St Georges University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Connecticut; Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; New York Eye & Ear Infirmary of Mount Sinai; New York Medical College	Sarfarazi, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA.		Quill, Barry/O-2614-2014	Quill, Barry/0000-0002-0578-5703	NATIONAL EYE INSTITUTE [R01EY009947] Funding Source: NIH RePORTER; NEI NIH HHS [EY-09947] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; GROSSKREUTZ C, 1994, INT OPHTHALMOL CLIN, V34, P173, DOI 10.1097/00004397-199403430-00016; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; HITCHINGS RA, 1992, BRIT J OPHTHALMOL, V76, P494, DOI 10.1136/bjo.76.8.494; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; REZAIE T, UNPUB; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tezel G, 2000, J NEUROSCI, V20, P8693; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; WERNER EB, 1996, GLAUCOMAS, V2, pCH36; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V	21	809	875	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1077	1079		10.1126/science.1066901	http://dx.doi.org/10.1126/science.1066901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834836				2022-12-28	WOS:000173793000067
J	Strain, AJ; Neuberger, JM				Strain, AJ; Neuberger, JM			A bioartificial liver - State of the art	SCIENCE			English	Editorial Material							FULMINANT HEPATIC-FAILURE; STEM-CELL LINES; ASSIST DEVICE; IN-VITRO; BONE-MARROW; HEPATOCYTES; CULTURE; TRIAL; VIVO		Univ Birmingham, Sch Biosci, Birmingham B15 2TH, W Midlands, England; Univ Birmingham, Sch Med, Birmingham B15 2TH, W Midlands, England; Univ Hosp Birmingham, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Strain, AJ (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TH, W Midlands, England.		Neuberger, James/ABG-3010-2020					Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Auth MKH, 2001, HEPATOLOGY, V33, P519, DOI 10.1053/jhep.2001.22703; Crosby HA, 2001, GASTROENTEROLOGY, V120, P534, DOI 10.1053/gast.2001.21175; De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o; Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625; Flendrig LM, 1997, J HEPATOL, V26, P1379, DOI 10.1016/S0168-8278(97)80475-8; Flendrig LM, 1999, INT J ARTIF ORGANS, V22, P701, DOI 10.1177/039139889902201008; GERLACH J, 1995, HEPATOLOGY, V22, P246; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Hay PD, 2000, ARTIF ORGANS, V24, P278, DOI 10.1046/j.1525-1594.2000.06499.x; Hazell AS, 1999, P SOC EXP BIOL MED, V222, P99, DOI 10.1046/j.1525-1373.1999.d01-120.x; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; JAUREGUI HO, 1995, HEPATOLOGY, V21, P460, DOI 10.1016/0270-9139(95)90108-6; Kawada M, 1998, IN VITRO CELL DEV-AN, V34, P109; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; MATSUMURA KN, 1987, SURGERY, V101, P99; NYBERG SL, 1993, AM J SURG, V166, P512, DOI 10.1016/S0002-9610(05)81146-8; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; ROZGA J, 1993, HEPATOLOGY, V17, P258, DOI 10.1016/0270-9139(93)90086-3; Sirica AE, 1997, HEPATOLOGY, V26, P537, DOI 10.1053/jhep.1997.v26.pm0009303480; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; Stevens AC, 2001, HEPATOLOGY, V34, p299A; STRAIN AJ, 1994, GUT, V35, P433, DOI 10.1136/gut.35.4.433; STRAIN AJ, 1998, LIVER GROWTH REPAIR, P3; SUSSMAN NL, 1994, J CLIN GASTROENTEROL, V18, P320, DOI 10.1097/00004836-199406000-00013; SUSSMAN NL, 1992, HEPATOLOGY, V16, P60, DOI 10.1002/hep.1840160112; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Watanabe FD, 1997, ANN SURG, V225, P484, DOI 10.1097/00000658-199705000-00005; Weiss RA, 2001, PHILOS T R SOC B, V356, P957, DOI 10.1098/rstb.2001.0838	34	229	272	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1005	+		10.1126/science.1068660	http://dx.doi.org/10.1126/science.1068660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834813				2022-12-28	WOS:000173793000041
J	Murphy, KC				Murphy, KC			Schizophrenia and velo-cardio-facial syndrome	LANCET			English	Review							SYNDROME CRITICAL REGION; 22Q11 DELETION SYNDROME; VELOCARDIOFACIAL-SYNDROME; POTENTIAL LINKAGE; BRAIN ANOMALIES; NO OVERLAP; GENE; PSYCHOSIS; ADULTS; MICRODELETIONS	Velo-cardio-facial syndrome (VCFS), the most frequent known interstitial deletion identified in man, is associated with chromosomal microdeletions in the q11 band of chromosome 22. The VCFS phenotype Is complex, with multiple congenital abnormalities affecting several tissues and organs, many of which are derived from neural crest cells. Although phenotypic variability occurs, individuals with VCFS have high rates of psychiatric disorder, especially schizophrenia. Additionally, an increased prevalence of chromosome 22q11 deletions has been reported in populations of people with schizophrenia. Furthermore, results of molecular genetic studies suggest that a schizophrenia susceptibility locus maps to chromosome 22q. These data indicate that aside from being the child of two parents with schizophrenia or the monozygotic co-twin of an affected individual, VCFS and deletion 22q:11 represents the highest known risk factor for the development of schizophrenia. Since the entire sequence of chromosome 22 has now been identified, the study of VCFS offers a timely and uniquely powerful opportunity to identify susceptibility genes for schizophrenia in the general population. Furthermore, the strength of the association between schizophrenia and VCFS has important implications for the clinical management of these disorders.	Kings Coll London, Inst Psychiat, Div Psychol Med, London SE5 8AF, England	University of London; King's College London	Murphy, KC (corresponding author), Kings Coll London, Inst Psychiat, Div Psychol Med, De Crespigny Pk, London SE5 8AF, England.	k.murphy@iop.kcl.ac.uk	Murphy, Kieran C/D-3577-2012	Murphy, Kieran/0000-0003-2930-4465				Bassett AS, 1998, AM J MED GENET, V81, P328, DOI 10.1002/(SICI)1096-8628(19980710)81:4<328::AID-AJMG10>3.3.CO;2-8; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; BRAFF DL, 1993, SCHIZOPHRENIA BULL, V19, P233, DOI 10.1093/schbul/19.2.233; Chow EWC, 1999, BIOL PSYCHIAT, V46, P1436, DOI 10.1016/S0006-3223(99)00150-X; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DUNHAM I, 1992, LANCET, V340, P1361, DOI 10.1016/0140-6736(92)92553-R; Eliez S, 2001, AM J PSYCHIAT, V158, P447, DOI 10.1176/appi.ajp.158.3.447; Ellenbroek B.A., 1990, Behav Pharmacol, V1, P469; FRASER W, 1994, MENTAL HLTH MENTAL R, P79; Gill M, 1996, AM J MED GENET, V67, P40, DOI 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; GOLDINGKUSHNER KJ, 1985, J CRAN GENET DEV BIO, V5, P259; Gothelf D, 1997, AM J MED GENET, V72, P455; Gottlieb S, 1997, AM J HUM GENET, V60, P1194; Hafner H, 1997, CAN J PSYCHIAT, V42, P139; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Karayiorgou M, 1997, MOL PSYCHIATR, V2, P211, DOI 10.1038/sj.mp.4000271; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; LASSETER VK, 1995, AM J MED GENET, V60, P172, DOI 10.1002/ajmg.1320600217; LEWIS SW, 1985, PSYCHOL MED, V15, P43, DOI 10.1017/S0033291700020912; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; LYNCH DR, 1995, J MED GENET, V32, P561, DOI 10.1136/jmg.32.7.561; MARTIN P, 1995, SCHIZOPHRENIA BULL, V21, P241, DOI 10.1093/schbul/21.2.241; MCGUE M, 1989, ARCH GEN PSYCHIAT, V46, P478; MCGUFFIN P, 1995, LANCET, V346, P678, DOI 10.1016/S0140-6736(95)92285-7; McGuffin P, 1996, COLD SPRING HARB SYM, V61, P815; MCGUFFIN P, 1994, SEMINARS PSYCHIAT GE; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; MITNICK RJ, 1994, AM J MED GENET, V54, P100, DOI 10.1002/ajmg.1320540204; Murphy KC, 2000, AM J MED GENET, V96, P476; Murphy KC, 1996, BRIT J PSYCHIAT, V168, P397, DOI 10.1192/S0007125000298760; Murphy KC, 1998, BRIT J PSYCHIAT, V172, P180, DOI 10.1192/bjp.172.2.180; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; ODonnell H, 1997, AM J HUM GENET, V60, P1544; Papolos DF, 1996, AM J PSYCHIAT, V153, P1541; Pizzuti A, 1997, HUM MOL GENET, V6, P259, DOI 10.1093/hmg/6.2.259; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Rauch A, 1999, AM J HUM GENET, V64, P659, DOI 10.1086/302235; Razi K, 1999, BRIT J PSYCHIAT, V174, P512, DOI 10.1192/bjp.174.6.512; SCAMBLER PJ, 1993, CURR OPIN GENET DEV, V3, P432, DOI 10.1016/0959-437X(93)90117-8; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; Swillen A, 1997, J MED GENET, V34, P453, DOI 10.1136/jmg.34.6.453; Usiskin SI, 1999, J AM ACAD CHILD PSY, V38, P1536, DOI 10.1097/00004583-199912000-00015; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; Vataja R, 1998, BRIT J PSYCHIAT, V172, P518, DOI 10.1192/bjp.172.6.518; Ward KE, 1996, SCHIZOPHR RES, V22, P197, DOI 10.1016/S0920-9964(96)00076-X; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; WROSLEY MM, 1999, AM J MED GENET, V88, P544	54	207	215	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					426	430		10.1016/S0140-6736(02)07604-3	http://dx.doi.org/10.1016/S0140-6736(02)07604-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518UP	11844533				2022-12-28	WOS:000173686500033
J	Breon, FM; Tanre, D; Generoso, S				Breon, FM; Tanre, D; Generoso, S			Aerosol effect on cloud droplet size monitored from satellite	SCIENCE			English	Article							POLARIZATION MEASUREMENTS; ANTHROPOGENIC AEROSOLS; OPTICAL-THICKNESS; SOLAR-RADIATION; POLLUTION; SPECTRA; OCEANS; RADIUS	Aerosol concentration and cloud droplet radii derived from space-borne measurements are used to explore the effect of aerosols on cloud microphysics. Cloud droplet size is found to be largest (14 micrometers) over remote tropical oceans and smallest (6 micrometers) over highly polluted continental areas. Small droplets are also present in clouds downwind of continents. By using estimates of droplet radii coupled with aerosol load, a statistical mean relationship is derived. The cloud droplet size appears to be better correlated with an aerosol index that is representative of the aerosol column number under some assumptions than with the aerosol optical thickness. This study reveals that the effect of aerosols on cloud microphysics is significant and occurs on a global scale.	CEA, Lab Sci Climat & Environm, Gif Sur Yvette, France; Univ Sci & Technol Lille, CNRS, Opt Atmospher Lab, Villeneuve Dascq, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Breon, FM (corresponding author), CEA, Lab Sci Climat & Environm, Gif Sur Yvette, France.		Breon, Francois-Marie A/M-4639-2016	Breon, Francois-Marie A/0000-0003-2128-739X; Generoso, Sylvia/0000-0002-2197-482X				Boucher O, 2000, GEOPHYS RES LETT, V27, P1103, DOI 10.1029/1999GL010963; Breon FM, 1998, GEOPHYS RES LETT, V25, P1879, DOI 10.1029/98GL01221; Breon FM, 2000, GEOPHYS RES LETT, V27, P4065, DOI 10.1029/2000GL011691; CHARLSON RJ, 1992, SCIENCE, V255, P423, DOI 10.1126/science.255.5043.423; COAKLEY JA, 1987, SCIENCE, V237, P1020, DOI 10.1126/science.237.4818.1020; DESCHAMPS PY, 1994, IEEE T GEOSCI REMOTE, V32, P598, DOI 10.1109/36.297978; Deuze JL, 2001, J GEOPHYS RES-ATMOS, V106, P4913, DOI 10.1029/2000JD900364; Feingold G, 2001, J GEOPHYS RES-ATMOS, V106, P22907, DOI 10.1029/2001JD000732; FRICK GM, 1993, B AM METEOROL SOC, V74, P2195, DOI 10.1175/1520-0477(1993)074<2195:AMOASD>2.0.CO;2; HAN QY, 1994, J CLIMATE, V7, P465, DOI 10.1175/1520-0442(1994)007<0465:NGSOED>2.0.CO;2; Haywood JM, 1999, SCIENCE, V283, P1299, DOI 10.1126/science.283.5406.1299; HERMAN GF, 1984, J CLIM APPL METEOROL, V23, P5, DOI 10.1175/1520-0450(1984)023<0005:OATSOS>2.0.CO;2; Herman M, 1997, J GEOPHYS RES-ATMOS, V102, P17039, DOI 10.1029/96JD02109; NAKAJIMA T, 1990, J ATMOS SCI, V47, P1878, DOI 10.1175/1520-0469(1990)047<1878:DOTOTA>2.0.CO;2; Nakajima T, 2001, GEOPHYS RES LETT, V28, P1171, DOI 10.1029/2000GL012186; PENNER JE, 1994, B AM METEOROL SOC, V75, P375, DOI 10.1175/1520-0477(1994)075<0375:QAMUOC>2.0.CO;2; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Snider JR, 2000, TELLUS B, V52, P828, DOI 10.1034/j.1600-0889.2000.00044.x; Tanre D, 2001, GEOPHYS RES LETT, V28, P4555, DOI 10.1029/2001GL013036; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; Twomey S., 1977, ATMOSPHERIC AEROSOLS; Vong RJ, 1998, J ATMOS SCI, V55, P2180, DOI 10.1175/1520-0469(1998)055<2180:SOOAAC>2.0.CO;2; Wetzel MA, 1999, J GEOPHYS RES-ATMOS, V104, P31287, DOI 10.1029/1999JD900922	23	319	347	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					834	838		10.1126/science.1066434	http://dx.doi.org/10.1126/science.1066434			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823636				2022-12-28	WOS:000173733000039
J	Smetacek, V				Smetacek, V			Balance: Mind-grasping gravity - Is the mind's balance, and hence its functioning, derived from that of the body?	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							Brandt T, 1999, ANN NY ACAD SCI, V871, P293, DOI 10.1111/j.1749-6632.1999.tb09193.x; HECK D, 2001, SPEKTRUM WISSENS OCT, P36; Lackner JR, 1999, EXP BRAIN RES, V126, P459, DOI 10.1007/s002210050753; Ramachandran V.S., 1999, PHANTOMS BRAIN PROBI	4	6	6	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					481	481		10.1038/415481a	http://dx.doi.org/10.1038/415481a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823838	Bronze			2022-12-28	WOS:000173564300026
J	McIntyre, J; Gray, G				McIntyre, J; Gray, G			What can we do to reduce mother to child transmission of HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VERTICAL TRANSMISSION; ORAL ZIDOVUDINE; COTE-DIVOIRE; PREVENTION; NEVIRAPINE; WOMEN; DURBAN; IMPACT	In rich countries antiretroviral treatment in pregnancy has been highly successful in reducing transmission of HIV from mother to child. James McIntyre and Glenda Gray examine whether the success of that treatment-and other strategies, such its changing infant feeding practices-call be repeated in poor countries, which lack both money and infrastructure.	Univ Witwatersrand, Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, ZA-2013 Johannesburg, South Africa	University of Witwatersrand	McIntyre, J (corresponding author), Univ Witwatersrand, Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, PO Bertsham, ZA-2013 Johannesburg, South Africa.	mcintyre@pixie.co.za						*CDCP, 2000, HIV AIDS SURV REP, V2, P25; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; *DEP HLTH SA, 1999, 2 DEP HLTH SA; DITRAME ANRS 049 Study Grp, 1999, LANCET, V354, P2050, DOI 10.1016/S0140-6736(99)04388-3; Eshleman SH, 2001, J INFECT DIS, V184, P914, DOI 10.1086/323153; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Fowler MG, 2000, PEDIATR CLIN N AM, V47, P21, DOI 10.1016/S0031-3955(05)70193-0; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; LANGE JMA, 2001, PETRA STUDY EARLY LA; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; MOUZIN E, 2001, UN SPONSORED PILOT P; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Nduati R, 2001, LANCET, V357, P1651, DOI 10.1016/S0140-6736(00)04820-0; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Simonds RJ, 1998, AIDS, V12, P301, DOI 10.1097/00002030-199803000-00008; Taha TET, 1996, AIDS, V10, P111, DOI 10.1097/00002030-199601000-00021; Thorne C, 2001, AIDS, V15, P761, DOI 10.1097/00002030-200104130-00012; *UNAIDS, 2000, REP GLOB HIV AIDS EP; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9	24	29	29	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2002	324	7331					218	221		10.1136/bmj.324.7331.218	http://dx.doi.org/10.1136/bmj.324.7331.218			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809646	Green Published			2022-12-28	WOS:000173604800023
J	Hsu, SY; Nakabayashi, K; Nishi, S; Kumagai, J; Kudo, M; Sherwood, OD; Hsueh, AJW				Hsu, SY; Nakabayashi, K; Nishi, S; Kumagai, J; Kudo, M; Sherwood, OD; Hsueh, AJW			Activation of orphan receptors by the hormone relaxin	SCIENCE			English	Article							THYROTROPIN RECEPTORS; BINDING; CELLS; IDENTIFICATION; CRYPTORCHIDISM; GONADOTROPIN; INSULIN; PEPTIDE; GROWTH; INSL3	Relaxin is a hormone important for the growth and remodeling of reproductive and other tissues during pregnancy. Although binding sites for relaxin are widely distributed, the nature of its receptor has been elusive. Here, we demonstrate that two orphan heterotrimeric guanine nucleotide binding protein (G protein)-coupled receptors, LGR7 and LGR8, are capable of mediating the action of relaxin through an adenosine 3',5'-monophosphate (cAMP)-dependent pathway distinct from that of the structurally related insulin and insulin-like growth factor family ligand. Treatment of antepartum mice with the soluble ligand-binding region of LGR7 caused parturition delay. The wide and divergent distribution of the two relaxin receptors implicates their roles in reproductive, brain, renal, cardiovascular, and other functions.	Stanford Univ, Dept Gynecol & Obstet, Sch Med, Div Reprod Biol, Stanford, CA 94305 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Hsueh, AJW (corresponding author), Stanford Univ, Dept Gynecol & Obstet, Sch Med, Div Reprod Biol, Stanford, CA 94305 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD023273, R01HD023273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK058534] Funding Source: NIH RePORTER; NICHD NIH HHS [HD23273] Funding Source: Medline; NIDDK NIH HHS [DK58534] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARTSCH O, 2001, MOL HUM REPROD, V7, P799; Bani D, 1997, GEN PHARMACOL-VASC S, V28, P13, DOI 10.1016/S0306-3623(96)00171-1; BATHGATE RA, 2001, J BIOL CHEM, V31, P31; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DAVOREN JB, 1985, BIOL REPROD, V33, P37, DOI 10.1095/biolreprod33.1.37; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; GEDDES BJ, 1995, J NEUROENDOCRINOL, V7, P411, DOI 10.1111/j.1365-2826.1995.tb00777.x; HSU CJ, 1985, ENDOCRINOLOGY, V116, P2029, DOI 10.1210/endo-116-5-2029; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; HWANG JJ, 1989, ENDOCRINOLOGY, V125, P260, DOI 10.1210/endo-125-1-260; Min G, 1996, BIOL REPROD, V55, P1243, DOI 10.1095/biolreprod55.6.1243; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; OSHEROFF PL, 1992, P NATL ACAD SCI USA, V89, P2384, DOI 10.1073/pnas.89.6.2384; OSHEROFF PL, 1991, P NATL ACAD SCI USA, V88, P6413, DOI 10.1073/pnas.88.15.6413; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; SHERWOOD CD, 1974, ARCH BIOCHEM BIOPHYS, V160, P185, DOI 10.1016/S0003-9861(74)80025-1; SHERWOOD OD, 1994, PHYSL REPRODUCTION, V1, P861; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	25	644	682	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					671	674		10.1126/science.1065654	http://dx.doi.org/10.1126/science.1065654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809971				2022-12-28	WOS:000173560900043
J	Berend, K				Berend, K			Trust and responsibility	LANCET			English	Editorial Material									Diatel Curacao, Curacao, Neth Antilles		Berend, K (corresponding author), Diatel Curacao, Jan Noorduynweg 81, Curacao, Neth Antilles.								0	0	0	2	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					203	203		10.1016/S0140-6736(02)07444-5	http://dx.doi.org/10.1016/S0140-6736(02)07444-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812554				2022-12-28	WOS:000173350800010
J	Carr-Hill, RA; Jamison, JQ; O'Reilly, D; Stevenson, MR; Reid, J; Merriman, B				Carr-Hill, RA; Jamison, JQ; O'Reilly, D; Stevenson, MR; Reid, J; Merriman, B			Risk adjustment for hospital use using social security data: cross sectional small area analysis	BRITISH MEDICAL JOURNAL			English	Article							ALLOCATING RESOURCES; HEALTH AUTHORITIES; INPATIENT SERVICES; CARE; COMPETITION; REFORMS	Objectives To identify demographic and socioeconomic determinants of need for acute hospital treatment at small area level. To establish whether there is a relation between poverty and use of inpatient services. To devise a risk adjustment formula for distributing public funds for hospital services using, as far as possible, variables that can be updated between censuses. Design Cross sectional analysis. Spatial interactive modelling was used to quantify the proximity of the population to health service facilities. Two stage weighted least squares regression was used to model use against supply of hospital and community services and a wide range of potential needs drivers including health, socioeconomic census variables, uptake of income support and family credit, and religious denomination. Setting Northern Ireland. Main outcome measure Intensity of use of inpatient services. Results After endogeneity of supply and use was taken into account, a statistical model was produced that predicted use based on five variables: income support, family credit, elderly people living alone, all ages standardised mortality ratio, and low birth weight. The main effect of the formula produced is to move resources from urban to rural areas. Conclusions This work has produced a population risk adjustment formula for acute hospital treatment in which four of the five variables can be updated annually rather than relying on census derived data. Inclusion of the social security data makes a substantial difference to the model and to the results produced by the formula.	Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; Queens Univ Belfast, Inst Clin Sci, Hlth & Social Care Res Unit, Belfast BT12 6BJ, Antrim, North Ireland; Queens Univ Belfast, No Ireland Canc Registry, Belfast, Antrim, North Ireland	University of York - UK; Queens University Belfast; Queens University Belfast	Jamison, JQ (corresponding author), Queens Univ Belfast, Ctr Social Res, Belfast BT7 1NN, Antrim, North Ireland.							Armitage P., 1971, STAT METHODS MED RES, V1; Batty M., 1976, URBAN MODELLING ALGO; BRENNAN M, 1996, NO NEED WEIGHT COMMU; CARRHILL RA, 1994, BRIT MED J, V309, P1046, DOI 10.1136/bmj.309.6961.1046; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; *DEP HLTH SOC SEC, 1976, SHAR RES HLTH ENG RE; Department of Health and Social Security, 1976, SHAR RES HLTH ENGL R; Elola J, 1996, INT J HEALTH SERV, V26, P239, DOI 10.2190/TC9K-VQBR-NR64-AGVQ; EYLES J, 1991, SOC SCI MED, V33, P489, DOI 10.1016/0277-9536(91)90331-6; GOLDSTEIN H, 1987, MLTILEVEL MODELS ED; JUDGE K, 1994, BRIT MED J, V309, P1031, DOI 10.1136/bmj.309.6961.1031; MADDALA G, 1987, ECONOMETRICS; Marquis MS, 1999, HEALTH AFFAIR, V18, P75, DOI 10.1377/hlthaff.18.6.75; MATSUOKA M, 1990, HEPATOLOGY, V11, P173, DOI 10.1002/hep.1840110204; MAYS N, 1989, COMMUNITY MED, V11, P173; *ORG EC COOP DEV, 1996, HLTH REF WILL CHANG; *ORG EC COOP DEV, 1990, SOC POL STUD, V7; *ORG EC COOP DEV, 1990, SOCIAL POLICY STUDIE, V7; *ORG EC COOP DEV, 1996, HLTH CAR REF WILL CH; Pampalon R, 1996, SOC SCI MED, V42, P909, DOI 10.1016/0277-9536(95)00189-1; Rice N, 1996, J Health Serv Res Policy, V1, P154; SMITH P, 1994, BRIT MED J, V309, P1050, DOI 10.1136/bmj.309.6961.1050; *STAND ADV COMM HU, 1990, REL POL DISCR EQ OPP; Taylor DH, 1998, SOC SCI MED, V47, P713, DOI 10.1016/S0277-9536(98)00109-9; VANDEVEN WPMM, 1994, HEALTH AFFAIR, V13, P120, DOI 10.1377/hlthaff.13.5.120; *WHO, 1978, INT CLASS DIS; *WHO, 1996, EUR HLTH REF AN CURR; Wysong JA, 1996, SOZ PRAVENTIV MED, V41, P212, DOI 10.1007/BF01299481	28	12	12	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					390	392		10.1136/bmj.324.7334.390	http://dx.doi.org/10.1136/bmj.324.7334.390			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850368	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000174006300015
J	Meek, S; Morris, F				Meek, S; Morris, F			ABC of clinical electrocardiography - Introduction. I - Leads, rate, rhythm, and cardiac axis	BRITISH MEDICAL JOURNAL			English	Article									Royal United Hosp, Bath BA1 3NG, Avon, England		Meek, S (corresponding author), Royal United Hosp, Bath BA1 3NG, Avon, England.								0	43	43	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					415	418		10.1136/bmj.324.7334.415	http://dx.doi.org/10.1136/bmj.324.7334.415			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850377	Green Published			2022-12-28	WOS:000174006300025
J	Arnqvist, G; Rowe, L				Arnqvist, G; Rowe, L			Antagonistic coevolution between the sexes in a group of insects	NATURE			English	Article							SEXUAL CONFLICT; WATER STRIDERS; ARMS RACES; MATE CHOICE; EVOLUTION; COSTS; ADAPTATION; SPECIATION; SELECTION; MODEL	In coevolutionary 'arms races' between the sexes, the outcome of antagonistic interactions may remain at an evolutionary standstill. The advantage gained by one sex, with any evolutionary exaggeration of arms, is expected to be matched by analogous counteradaptations in the other sex(1,2). This fundamental coevolutionary process may thus be hidden from the evolutionist's eye(3,4), and no natural examples are known. We have studied the effects of male and female armament (clasping and anti-clasping morphologies) on the outcome of antagonistic mating interactions in 15 species of water strider, using a combination of experimental and phylogenetic comparative methods. Here we present, by assessing the independent effects of both species-specific level of arms escalation and small imbalances in the amounts of arms between the sexes within species, the consequences of a sexual arms race. Evolutionary change in the balance of armament between males and females, but not in the species-specific level of escalation, has resulted in evolutionary change in the outcome of sexually antagonistic interactions such as mating rate.	Univ Uppsala, Evolutionary Biol Ctr, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Univ Toronto, Dept Zool, Toronto, ON M5S 1A1, Canada	Uppsala University; University of Toronto	Arnqvist, G (corresponding author), Univ Uppsala, Evolutionary Biol Ctr, Dept Anim Ecol, Norbyvagen 18D, SE-75236 Uppsala, Sweden.		Arnqvist, Göran/E-6782-2015	Arnqvist, Göran/0000-0002-3501-3376				ARNQVIST G, 1989, OIKOS, V56, P344, DOI 10.2307/3565619; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; ARNQVIST G, IN PRESS EVOLUTION; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Chapman T, 1996, NATURE, V381, P189, DOI 10.1038/381189a0; Civetta A, 2000, P NATL ACAD SCI USA, V97, P13162, DOI 10.1073/pnas.230305397; Damgaard J, 2001, SYST ENTOMOL, V26, P241, DOI 10.1046/j.1365-3113.2001.00141.x; FELSENSTEIN J, 2001, PHYLOGENY INFERENCE; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Hardling R, 1999, J THEOR BIOL, V196, P163, DOI 10.1006/jtbi.1998.0828; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Parker G.A., 1979, P123; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; PARKER GA, 1983, J THEOR BIOL, V101, P619, DOI 10.1016/0022-5193(83)90019-X; Partridge L, 1998, SCIENCE, V281, P2003, DOI 10.1126/science.281.5385.2003; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; ROWE L, IN PRESS EVOLUTION; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101	30	366	369	0	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					787	789		10.1038/415787a	http://dx.doi.org/10.1038/415787a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845208				2022-12-28	WOS:000173833900045
J	Arthur, W				Arthur, W			The emerging conceptual framework of evolutionary developmental biology	NATURE			English	Review							SEGMENT NUMBER; REGULATORY GENE; FUSHI-TARAZU; DROSOPHILA; PATTERN; ULTRABITHORAX; EXPRESSION; STABILITY; SEQUENCE; POLARITY	Over the last twenty years, there has been rapid growth of a new approach to understanding the evolution of organismic form. This evolutionary developmental biology, or 'evo-devo', is focused on the developmental genetic machinery that lies behind embryological phenotypes, which were all that could be studied in the past. Are there any general concepts emerging from this new approach, and if so, how do they impact on the conceptual structure of traditional evolutionary biology? In providing answers to these questions, this review assesses whether evo-devo is merely filling in some missing details, or whether it will cause a large-scale change in our thinking about the evolutionary process.	Univ Sunderland, Sch Sci, Ctr Ecol, Sunderland SR1 3SD, England	University of Sunderland	Arthur, W (corresponding author), Univ Sunderland, Sch Sci, Ctr Ecol, Sunderland SR1 3SD, England.	wallace.arthur@sunderland.ac.uk						Abouheif E, 1997, TRENDS GENET, V13, P432, DOI 10.1016/S0168-9525(97)01271-7; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; [Anonymous], 1861, ORIGIN SPECIES MEANS; [Anonymous], 1991, HETEROCHRONY EVOLUTI; Arthur, 1984, MECH MORPHOLOGICAL E; Arthur W, 1999, J THEOR BIOL, V200, P183, DOI 10.1006/jtbi.1999.0986; Arthur W, 2000, EVOL DEV, V2, P49, DOI 10.1046/j.1525-142x.2000.00028.x; Arthur W, 2001, EVOL DEV, V3, P271, DOI 10.1046/j.1525-142x.2001.003004271.x; Arthur Wallace, 1997, ORIGIN ANIMAL BODY P; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Baer v., 1828, ENTWICKLUNGSGESCHICH; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bechtel PW, 1986, INTEGRATING SCI DISC; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Chipman AD, 2001, EVOL DEV, V3, P299, DOI 10.1046/j.1525-142X.2001.01033.x; Clark R. B., 1964, DYNAMICS METAZOAN EV; Davidson E. H., 1986, GENE ACTIVITY EARLY; Davis GK, 2000, AM ZOOL, V40, P992; DAWES R, 1994, DEVELOPMENT, V120, P1561; de Beer G. R., 1940, EMBRYOS ANCESTORS; DeRobertis EM, 1997, NATURE, V387, P25, DOI 10.1038/387025a0; Dobzhansky T., 1937; Donoghue MJ, 2000, AM ZOOL, V40, P759, DOI 10.1668/0003-1569(2000)040[0759:HADCAM]2.0.CO;2; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DUBOULE D, 1994, DEVELOPMENT S; Fisher R.A., 1930, GENETICAL THEORY NAT; Ford EB, 1971, ECOLOGICAL GENETICS; GELIVA EA, 1987, HEREDITY, V59, P383; Geoffroy Saint-Hilaire E., 1822, MEMOIRES DU MUSEUM D, V9, P89; Gibson G, 1996, SCIENCE, V271, P200, DOI 10.1126/science.271.5246.200; Goodwin Brian C, 1994, LEOPARD CHANGED ITS; Gould S. J., 1977, ONTOGENY PHYLOGENY; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; HAECKEL E, 1903, PEDIGREE MAN OTHER E; Haeckel E., 1866, GEN MORPHOLOGIE ORG; Hall BK., 1999, EVOLUTIONARY DEV BIO, V2; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Hillis DM, 1994, HOMOLOGY HIERARCHICA; Holland LZ, 1997, DEVELOPMENT, V124, P1723; Holland PWH, 1999, SEMIN CELL DEV BIOL, V10, P541, DOI 10.1006/scdb.1999.0335; Hollemann T, 1998, DEVELOPMENT, V125, P2425; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Kettle C, 2000, P ROY SOC B-BIOL SCI, V267, P1393, DOI 10.1098/rspb.2000.1155; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lowe CJ, 1997, NATURE, V389, P718, DOI 10.1038/39580; Maglia AM, 2001, AM ZOOL, V41, P538, DOI 10.1668/0003-1569(2001)041[0538:CDOAUP]2.0.CO;2; MALLET J, 1986, HEREDITY, V56, P191, DOI 10.1038/hdy.1986.31; Mayr E, 1942, SYSTEMATICS ORIGIN S; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; Medawar P, 1977, LIFE SCI CURRENT IDE; Metscher BD, 1999, DEV BIOL, V210, P1, DOI 10.1006/dbio.1999.9230; Mindell DP, 2001, TRENDS ECOL EVOL, V16, P434, DOI 10.1016/S0169-5347(01)02206-6; Minelli A, 2000, EVOL DEV, V2, P157, DOI 10.1046/j.1525-142x.2000.00054.x; NELSON G, 1978, SYST ZOOL, V27, P324, DOI 10.2307/2412883; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Owen R., 1848, ARCHETYPE HOMOLOGIES, DOI [10.5962/bhl.title.118611, DOI 10.5962/BHL.TITLE.118611]; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; PATEL NH, 1994, SCIENCE, V266, P581, DOI 10.1126/science.7939712; PATEL NH, 1994, DEVELOPMENT S; Purugganan MD, 2000, GENETICS, V155, P855; Purugganan MD, 1998, P NATL ACAD SCI USA, V95, P8130, DOI 10.1073/pnas.95.14.8130; Raff R. A., 1996, SHAPE LIFE GENES DEV; Raff R.A., 1983, EMBRYOS GENES EVOLUT; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; Richardson MK, 1997, ANAT EMBRYOL, V196, P91, DOI 10.1007/s004290050082; Riedl R., 1978, ORDER LIVING ORGANIS; Robert JS, 2001, EVOL DEV, V3, P287, DOI 10.1046/j.1525-142x.2001.003004287.x; ROTH G, 1985, ACTA BIOTHEOR, V34, P175, DOI 10.1007/BF00046783; Roux W., 1894, BIOL LECT MARINE BIO, P149; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Salazar-Ciudad I, 2001, EVOL DEV, V3, P95, DOI 10.1046/j.1525-142x.2001.003002095.x; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Salser SJ, 1996, DEVELOPMENT, V122, P1651; Sander K., 1983, DEV EVOLUTION, P137; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Schroder R, 1999, MECH DEVELOP, V80, P191, DOI 10.1016/S0925-4773(98)00211-1; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; Shaw PJ, 2001, EVOL DEV, V3, P251, DOI 10.1046/j.1525-142x.2001.003004251.x; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Tabin CJ, 1999, AM ZOOL, V39, P650; Tang AH, 2001, DEVELOPMENT, V128, P801; Turner J. R. G., 1977, Evolutionary Biol, V10, P163; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Waddington C., 1957, STRATEGY GENES; Wagner GP, 2000, EVOL BIOL, V31, P155; Wells Carolyn L., 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P1, DOI 10.1078/1433-8319-00001; Whyte L.L., 1965, INTERNAL FACTORS EVO; WRAY GA, 1994, DEVELOPMENT S; Xu PX, 1999, DEVELOPMENT, V126, P383; Yampolsky LY, 2001, EVOL DEV, V3, P73, DOI 10.1046/j.1525-142x.2001.003002073.x; Zelditch ML, 1996, PALEOBIOLOGY, V22, P241, DOI 10.1017/S0094837300016195	99	225	247	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					757	764		10.1038/415757a	http://dx.doi.org/10.1038/415757a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845200				2022-12-28	WOS:000173833900037
J	Friml, J; Wisniewska, J; Benkova, E; Mendgen, K; Palme, K				Friml, J; Wisniewska, J; Benkova, E; Mendgen, K; Palme, K			Lateral relocation of auxin efflux regulator PIN3 mediates tropism in Arabidopsis	NATURE			English	Article							TRANSPORT; GRAVITROPISM; THALIANA; ROOTS; SEEDLINGS	Long-standing models propose that plant growth responses to light or gravity are mediated by asymmetric distribution of the phytohormone auxin(1-3). Physiological studies implicated a specific transport system that relocates auxin laterally, thereby effecting differential growth(4); however, neither the molecular components of this system nor the cellular mechanism of auxin redistribution on light or gravity perception have been identified. Here, we show that auxin accumulates asymmetrically during differential growth in an efflux-dependent manner. Mutations in the Arabidopsis gene PIN3, a regulator of auxin efflux, alter differential growth. PIN3 is expressed in gravity-sensing tissues, with PIN3 protein accumulating predominantly at the lateral cell surface. PIN3 localizes to the plasma membrane and to vesicles that cycle in an actin-dependent manner. In the root columella, PIN3 is positioned symmetrically at the plasma membrane but rapidly relocalizes laterally on gravity stimulation. Our data indicate that PIN3 is a component of the lateral auxin transport system regulating tropic growth. In addition, actin-dependent relocalization of PIN3 in response to gravity provides a mechanism for redirecting auxin flux to trigger asymmetric growth.	Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Univ Konstanz, Lehrstuhl Phytopathol, D-78457 Constance, Germany; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Nicolaus Copernicus University; University of Konstanz; University of Freiburg	Friml, J (corresponding author), Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany.	jiri.friml@zmbp.uni-tuebingen.de; palme@mpiz-koeln.mpg.de	Wisniewska, Justyna/D-4351-2009; Palme, Klaus/A-9524-2013; Friml, Jiri/D-9511-2012; Benkova, Eva/E-2910-2012	Palme, Klaus/0000-0002-2728-3835; Friml, Jiri/0000-0002-8302-7596; 				BJORKMAN T, 1988, PLANTA, V176, P513, DOI 10.1007/BF00397658; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Collings DA, 2001, PLANTA, V212, P392, DOI 10.1007/s004250000406; Darwin C., 1881, DARWINS GESAMMELTE W, V13; EPEL BL, 1992, J PLANT PHYSIOL, V140, P310, DOI 10.1016/S0176-1617(11)81084-9; FRIML J, IN PRESS CELL; FRIML J, IN PRESS PLANT MOL B; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hart JW., 1990, PLANT TROPISM OTHER; Hasenstein KH, 1999, ADV SPACE RES-SERIES, V24, P677, DOI 10.1016/S0273-1177(99)00399-3; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; LI Y, 1991, PLANT CELL, V3, P1167, DOI 10.1105/tpc.3.11.1167; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Monshausen GB, 1996, PLANT CELL ENVIRON, V19, P1408, DOI 10.1111/j.1365-3040.1996.tb00019.x; MORRIS DA, 1978, J EXP BOT, V29, P147, DOI 10.1093/jxb/29.1.147; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Palme K, 1999, CURR OPIN PLANT BIOL, V2, P375, DOI 10.1016/S1369-5266(99)00008-4; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; SIEVERS A, 1995, PLANTA, V197, P392, DOI 10.1007/BF00202662; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; [No title captured]	26	1009	1075	8	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					806	809		10.1038/415806a	http://dx.doi.org/10.1038/415806a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845211	Green Published			2022-12-28	WOS:000173833900050
J	Ryan, MP; Williams, DE; Chater, RJ; Hutton, BM; McPhail, DS				Ryan, MP; Williams, DE; Chater, RJ; Hutton, BM; McPhail, DS			Why stainless steel corrodes	NATURE			English	Article							PITTING CORROSION; SULFIDE INCLUSIONS; CREVICE CORROSION; MNS INCLUSIONS; INITIATION; METALS; DISSOLUTION; MICROSCOPY; BREAKDOWN; MECHANISM	Stainless steels are used in countless diverse applications for their corrosion resistance. Although they have extremely good general resistance, they are nevertheless susceptible to pitting corrosion. This localized dissolution of an oxide-covered metal in specific aggressive environments is one of the most common and catastrophic causes of failure of metallic structures. The pitting process has been described as random, sporadic and stochastic and the prediction of the time and location of events remains extremely difficult(1). Many contested models of pitting corrosion exist, but one undisputed aspect is that manganese sulphide inclusions play a critical role. Indeed, the vast majority of pitting events are found to occur at, or adjacent to, such second-phase particles(2,3). Chemical changes in and around sulphide inclusions have been postulated(4) as a mechanism for pit initiation but such variations have never been measured. Here we use nanometre-scale secondary ion mass spectroscopy to demonstrate a significant reduction in the Cr:Fe ratio of the steel matrix around MnS particles. These chromium-depleted zones are susceptible to high-rate dissolution that 'triggers' pitting. The implications of these results are that materials processing conditions control the likelihood of corrosion failures, and these data provide a basis for optimizing such conditions.	Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England; UCL, Dept Chem, London WC1H 0AJ, England	Imperial College London; University of London; University College London	Ryan, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.	m.p.ryan@ic.ac.uk	Williams, David E/B-3222-2012	Williams, David E/0000-0003-4123-5626; Ryan, Mary/0000-0001-8582-3003				BAKER MA, 1993, CORROS SCI, V34, P667, DOI 10.1016/0010-938X(93)90279-P; Brossia CS, 1998, CORROSION-US, V54, P145, DOI 10.5006/1.3284838; CHAO CY, 1981, J ELECTROCHEM SOC, V128, P1187, DOI 10.1149/1.2127591; EKLUND GS, 1974, J ELECTROCHEM SOC, V121, P467, DOI 10.1149/1.2401840; Frankel GS, 1998, J ELECTROCHEM SOC, V145, P2186, DOI 10.1149/1.1838615; GALVELE JR, 1976, J ELECTROCHEM SOC, V123, P464, DOI 10.1149/1.2132857; HOAR TP, 1981, CORROSION, V5, P279; LOTT SE, 1989, J ELECTROCHEM SOC, V136, P973, DOI 10.1149/1.2096896; MARCUS P, 1984, CORROS SCI, V24, P259, DOI 10.1016/0010-938X(84)90012-X; Monnartz P., 1911, METALLURGIE, V8, P161; RICHARDSON JA, 1970, CORROS SCI, V10, P313, DOI 10.1016/S0010-938X(70)80023-3; Ryan MP, 1998, J ELECTROCHEM SOC, V145, P1566, DOI 10.1149/1.1838519; SATO N, 1971, ELECTROCHIM ACTA, V16, P1683, DOI 10.1016/0013-4686(71)85079-X; STEWART J, 1992, CORROS SCI, V33, P457, DOI 10.1016/0010-938X(92)90074-D; Suter T, 2001, ELECTROCHIM ACTA, V47, P191, DOI 10.1016/S0013-4686(01)00551-5; UHLIG HH, 1950, J ELECTROCHEM SOC, V97, pC215, DOI 10.1149/1.2777892; Webb EG, 2001, J ELECTROCHEM SOC, V148, pB186, DOI 10.1149/1.1360205; WILLIAMS DE, 1991, NATURE, V350, P216, DOI 10.1038/350216a0; WILLIAMS DE, 1985, J ELECTROCHEM SOC, V132, P1796, DOI 10.1149/1.2114220; Williams DE, 1998, J ELECTROCHEM SOC, V145, P2664, DOI 10.1149/1.1838697; Williams DE, 2000, J ELECTROCHEM SOC, V147, P1763, DOI 10.1149/1.1393431; WRANGLEN G, 1974, CORROS SCI, V14, P331, DOI 10.1016/S0010-938X(74)80047-8	22	475	496	19	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					770	774		10.1038/415770a	http://dx.doi.org/10.1038/415770a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845203				2022-12-28	WOS:000173833900040
J	Murray, CJL; King, G; Lopez, AD; Tomijima, N; Krug, EG				Murray, CJL; King, G; Lopez, AD; Tomijima, N; Krug, EG			Armed conflict as a public health problem	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; WAR		WHO, CH-1211 Geneva 27, Switzerland; Harvard Univ, Ctr Basic Res Social Sci, Cambridge, MA 02138 USA	World Health Organization; Harvard University	Murray, CJL (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.		Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; 	NIA NIH HHS [P01 AG17625-02, P01 AG017625] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beck N, 2000, AM POLIT SCI REV, V94, P21, DOI 10.2307/2586378; BOND J, 1999, VRA READER; *CENTR E EUR LAW I, 2000, POL KILL KOS KOS; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; COUPLAND RM, 1991, BMJ-BRIT MED J, V303, P1509, DOI 10.1136/bmj.303.6816.1509; *EUR, 2001, EUR ID WARS SYST CON; GARFIELD RM, 1987, AM J PUBLIC HEALTH, V77, P615, DOI 10.2105/AJPH.77.5.615; HILL K, 1977, POP STUD-J DEMOG, V31, P75, DOI 10.1080/00324728.1977.10412748; *INT CAMP BAN LAND, 2001, LANDM MON REP 2001 M; King G, 2001, WORLD POLIT, V53, P623, DOI 10.1353/wp.2001.0018; KING G, 2001, AUTOMATED INFORMATIO; KING G, 2002, POLITICAL SCI Q; Levy Barry S, 1997, WAR PUBLIC HLTH; MARSHALL M, 2001, REACTION CONFLICT PR, P63; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Project Ploughshares, 2001, ARM CONFL REP 2001; RUSSETT B, IN PRESS ENCY SOCIAL; Seybolt Taylor B., 2001, SIPRI YB 2001 ARMAME, p[15, 16]; SINGER JD, 1972, WAGES WAR 1816 1965; SIVARD R., 1991, WORLD MILITARY SOCIA; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; *U CATH LOUV, 2001, EM DAT OFDA CRED INT; USTUN TB, 2001, WHO MULTICOUNTRY HOU; VALENTINO BA, 2001, DRAINING SEA MASS KI; Wallensteen P, 2001, J PEACE RES, V38, P629, DOI 10.1177/0022343301038005008; WHO, 2001, WORLD HLTH REPORT 20	28	197	200	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					346	349		10.1136/bmj.324.7333.346	http://dx.doi.org/10.1136/bmj.324.7333.346			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521XH	11834565	Green Submitted, Green Published			2022-12-28	WOS:000173866300024
J	Feldbaum, C				Feldbaum, C			Biotechnology - Some history should be repeated	SCIENCE			English	Editorial Material									Biotechnol Ind Org, Washington, DC 20006 USA		Feldbaum, C (corresponding author), Biotechnol Ind Org, Washington, DC 20006 USA.								0	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					975	975		10.1126/science.1069614	http://dx.doi.org/10.1126/science.1069614			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834802				2022-12-28	WOS:000173793000027
J	Hench, LL; Polak, JM				Hench, LL; Polak, JM			Third-generation biomedical materials	SCIENCE			English	Editorial Material							TISSUE; TRANSPLANTATION; BIOMATERIALS; MATRICES; CELLS		Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England; Univ London Imperial Coll Sci Technol & Med, Tissue Engn Ctr, London SW7 2BP, England	Imperial College London; Imperial College London	Polak, JM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.	julia.polak@ic.ac.uk						Bielby R., 2000, Tissue Engineering, V6, P693; BONFIELD W, 1990, CRC HDB BIOACTIVE CE, V2, pCH16; Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323; Hastings G., 1984, MACROMOLECULAR BIOMA; Hench LL, 1998, J AM CERAM SOC, V81, P1705; HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253; HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576; HENCH LL, 1996, CLIN PERFORMANCE SKE, pCH13; Hench LL, 1971, J BIOMED MATER RES S, V5, P117, DOI [10.1002/jbm.820050611, DOI 10.1002/JBM.820050611]; HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568; HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565; HUNTER DD, 1991, J NEUROSCI, V11, P3960; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; KLEIN CPA, 1993, INTRO BIOCERAMICS, P199; LENZA RFS, IN PRESS J MAT SCI M; Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934; Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8; Patel N, 1998, FASEB J, V12, P1447, DOI 10.1096/fasebj.12.14.1447; Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7; Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D; ROMANSKA H, COMMUNICATION; Schoen F J, 1992, Cardiovasc Pathol, V1, P29, DOI 10.1016/1054-8807(92)90006-A; WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208; Wroblewski BM, 1999, J BONE JOINT SURG BR, V81B, P427, DOI 10.1302/0301-620X.81B3.9521; Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4; YAMAMURO T, 1990, CRC HDB BIOACTIVE CE, P89; Yamamuro T., 1990, CRC HDB BIOACTIVE CE, V2	27	2031	2190	32	822	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1014	+		10.1126/science.1067404	http://dx.doi.org/10.1126/science.1067404			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834817				2022-12-28	WOS:000173793000045
J	McCarthy, PM; Smith, WA				McCarthy, PM; Smith, WA			Mechanical circulatory support - a long and winding road	SCIENCE			English	Editorial Material							TOTAL ARTIFICIAL-HEART		Cleveland Clin Fdn, George M & Linda H Kaufman Ctr Heart Failure, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	McCarthy, PM (corresponding author), Cleveland Clin Fdn, George M & Linda H Kaufman Ctr Heart Failure, Dept Thorac & Cardiovasc Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA.							ASKARI AT, IN PRESS SEMIN THORA; FRAZIER OH, IN PRESS CIRCULATION; KUNG RTV, 1995, ASAIO J, V41, pM245, DOI 10.1097/00002480-199507000-00004; Marshall E, 2002, SCIENCE, V295, P1000, DOI 10.1126/science.295.5557.1000; MCCARTHY PM, 1994, J THORAC CARDIOV SUR, V108, P420, DOI 10.1016/S0022-5223(94)70251-9; McCarthy PM, 1998, J THORAC CARDIOV SUR, V115, P904, DOI 10.1016/S0022-5223(98)70373-3; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Ochiai Y, 2001, ANN THORAC SURG, V72, P747, DOI 10.1016/S0003-4975(01)02892-2; Pantalos GM, 1998, ANN THORAC SURG, V66, P1852, DOI 10.1016/S0003-4975(98)01164-3; Saito S, 2001, EUR J CARDIO-THORAC, V19, P678, DOI 10.1016/S1010-7940(01)00640-6; Slater JP, 1996, ANN THORAC SURG, V62, P1321, DOI 10.1016/0003-4975(96)00750-3; Wieselthaler GM, 2001, ANN THORAC SURG, V71, pS139, DOI 10.1016/S0003-4975(00)02636-9; WILLMAN VL, 1999, EXPERT PANEL REV NHL; Yacoub MH, 2001, J CONGEST HEART FAIL, V2, P27	14	28	28	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					998	999		10.1126/science.1068555	http://dx.doi.org/10.1126/science.1068555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834809				2022-12-28	WOS:000173793000037
J	Zrenner, E				Zrenner, E			Will retinal implants restore vision?	SCIENCE			English	Editorial Material							SUBRETINAL MICROPHOTODIODE ARRAYS; LONG-TERM IMPLANTATION; ELECTRICAL-STIMULATION; VISUAL PROSTHESIS; YUCATAN MICROPIG; BLIND; FEASIBILITY		Univ Tubingen, Hosp Eye, Dept Pathophysiol Vis & Neuroophthalmol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Zrenner, E (corresponding author), Univ Tubingen, Hosp Eye, Dept Pathophysiol Vis & Neuroophthalmol, Schleichstr 12, D-72076 Tubingen, Germany.	ezrenner@uni-tuebingen.de						BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; Chow AY, 1997, NEUROSCI LETT, V225, P13, DOI 10.1016/S0304-3940(97)00185-7; CHOW AY, 1993, INVEST OPHTH VIS SCI, V34, P835; Chow AY, 2001, IEEE T NEUR SYS REH, V9, P86, DOI 10.1109/7333.918281; CHOW AY, 1998, INVEST OPHTH VIS SCI, V39, P5565; CHOW AY, COMMUNICATION; DOBELLE WH, 1974, J PHYSIOL-LONDON, V243, P553, DOI 10.1113/jphysiol.1974.sp010766; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; Eckhorn R, 2001, OPHTHALMOLOGE, V98, P369, DOI 10.1007/s003470170143; Eckmiller R, 1997, OPHTHALMIC RES, V29, P281, DOI 10.1159/000268026; Eckmiller R., 1998, IOVS, V39, pS990; EYSEL U, UNPUB; Gekeler F. E., 2001, IOVS, V42, pS815; Grumet AE, 2000, J NEUROSCI METH, V101, P31, DOI 10.1016/S0165-0270(00)00246-6; Guenther E, 1999, VISION RES, V39, P3988, DOI 10.1016/S0042-6989(99)00128-5; Humayun MS, 1999, VISION RES, V39, P2569, DOI 10.1016/S0042-6989(99)00052-8; Humayun MS, 1996, ARCH OPHTHALMOL-CHIC, V114, P40, DOI 10.1001/archopht.1996.01100130038006; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; HUMAYUN MS, 1999, IEEE INT SOLID STATE; Kobuch K., 1998, IOVS, V39, pS903; Kohler K, 2001, OPHTHALMOLOGE, V98, P364, DOI 10.1007/s003470170142; Krumpaszky H. G., 1996, Ophthalmologica, V210, P1; Normann RA, 2001, VISION RES, V41, P1261, DOI 10.1016/S0042-6989(00)00273-X; Normann RA, 1996, IEEE SPECTRUM, V33, P54, DOI 10.1109/6.490057; Pardue MT, 2001, EXP EYE RES, V73, P333, DOI 10.1006/exer.2001.1041; Peachey NS, 1999, J REHABIL RES DEV, V36, P371; Peyman G, 1998, OPHTHALMIC SURG LAS, V29, P234; Rauschecker JP, 2002, SCIENCE, V295, P1025, DOI 10.1126/science.1067796; Rizzo JF, 1997, NEUROSCIENTIST, V3, P251, DOI 10.1177/107385849700300413; Rizzo JF, 1999, INVEST OPHTH VIS SCI, V40, pS783; Rizzo JF, 2001, OPHTHALMOLOGY, V108, P13, DOI 10.1016/S0161-6420(00)00430-9; Rizzo JF, 1999, RETINAL DEGENERATIVE DISEASES AND EXPERIMENTAL THERAPY, P463, DOI 10.1007/978-0-585-33172-0_43; RIZZO JF, COMMUNICATION; Sachs HG, 1999, INVEST OPHTH VIS SCI, V40, pS734; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Schwahn HN, 2001, GRAEF ARCH CLIN EXP, V239, P961, DOI 10.1007/s004170100368; Stett A, 2000, INVEST OPHTH VIS SCI, V41, pS859; Stett A, 1999, INVEST OPHTH VIS SCI, V40, pS736; Stett A, 2000, VISION RES, V40, P1785, DOI 10.1016/S0042-6989(00)00005-5; Tassicker GE, 1956, Retinal stimulator. U. S. patent, Patent No. 2760483; Veraart C, 1998, BRAIN RES, V813, P181, DOI 10.1016/S0006-8993(98)00977-9; Walter P, 1999, RETINA-J RET VIT DIS, V19, P546, DOI 10.1097/00006982-199911000-00012; Zrenner E, 1999, VISION RES, V39, P2555, DOI 10.1016/S0042-6989(98)00312-5; Zrenner E, 1997, OPHTHALMIC RES, V29, P269, DOI 10.1159/000268025; Zrenner E, 2001, OPHTHALMOLOGE, V98, P357, DOI 10.1007/s003470170141	46	543	621	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1022	1025		10.1126/science.1067996	http://dx.doi.org/10.1126/science.1067996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834821				2022-12-28	WOS:000173793000049
J	Firschke, C; Zrenner, B				Firschke, C; Zrenner, B			Malposition of dual-chamber pacemaker lead	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Deutsch Herzzentrum Munchen, D-80636 Munich, Germany	German Heart Centre Munich; Technical University of Munich	Firschke, C (corresponding author), Deutsch Herzzentrum Munchen, D-80636 Munich, Germany.								0	6	6	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					E2	E2		10.1056/ENEJMicm010653	http://dx.doi.org/10.1056/ENEJMicm010653			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832525				2022-12-28	WOS:000173686400007
J	Kerwin, L				Kerwin, L			Franco Rasetti (1901-2001) - Obituary	NATURE			English	Biographical-Item									Univ Laval, St Foy, PQ G1K 7P4, Canada	Laval University	Kerwin, L (corresponding author), Univ Laval, St Foy, PQ G1K 7P4, Canada.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					597	597		10.1038/415597a	http://dx.doi.org/10.1038/415597a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832928				2022-12-28	WOS:000173709100028
J	Miller, LH; Baruch, DI; Marsh, K; Doumbo, OK				Miller, LH; Baruch, DI; Marsh, K; Doumbo, OK			The pathogenic basis of malaria	NATURE			English	Review							FALCIPARUM-INFECTED ERYTHROCYTES; INTERCELLULAR-ADHESION MOLECULE-1; RED-CELL SURFACE; PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; ENDOTHELIAL-CELLS; GLYCOSYLPHOSPHATIDYLINOSITOL TOXIN; RHOPTRY-PROTEIN; VARIANT ANTIGEN; VAR GENES	Malaria is today a disease of poverty and underdeveloped countries. In Africa, mortality remains high because there is limited access to treatment in the villages. We should follow in Pasteur's footsteps by using basic research to develop better tools for the control and cure of malaria. Insight into the complexity of malaria pathogenesis is vital for understanding the disease and will provide a major step towards controlling it. Those of us who work on pathogenesis must widen our approach and think in terms of new tools such as vaccines to reduce disease. The inability of many countries to fund expensive campaigns and antimalarial treatment requires these tools to be highly effective and affordable.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; Ctr Geog Med Res Coast, KEMRI Wellcome Trust Collaborat Programme, Kilifi, Kenya; Malaria Res & Training Ctr, Bamako, Mali	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miller, LH (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	kmarsh@kilifi.mim.com.net; okd@mrtcbko.malinet.ml						ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baruch DI, 1999, BEST PRACT RES CL HA, V12, P747, DOI 10.1053/beha.1999.0051; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; BRAUNBRETON C, 1992, P NATIONAL ACADEMY S, V89, P9647; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chen QJ, 2000, CLIN MICROBIOL REV, V13, P439, DOI 10.1128/CMR.13.3.439-450.2000; Chitnis CE, 2001, CURR OPIN HEMATOL, V8, P85, DOI 10.1097/00062752-200103000-00005; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Clark IA, 1999, PARASITOL TODAY, V15, P458, DOI 10.1016/S0169-4758(99)01535-5; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Crawley J, 1996, QJM-INT J MED, V89, P591; Dobbie M, 2000, AM J TROP MED HYG, V62, P284, DOI 10.4269/ajtmh.2000.62.284; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; English M, 1996, AM J TROP MED HYG, V55, P525, DOI 10.4269/ajtmh.1996.55.525; English M, 1997, QJM-INT J MED, V90, P263, DOI 10.1093/qjmed/90.4.263; English M, 1996, AM J TROP MED HYG, V55, P521, DOI 10.4269/ajtmh.1996.55.521; English MC, 1996, ARCH DIS CHILD, V74, P201, DOI 10.1136/adc.74.3.201; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gamain B, 2001, BLOOD, V97, P3268, DOI 10.1182/blood.V97.10.3268; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Hirunpetcharat C, 1998, P NATL ACAD SCI USA, V95, P1715, DOI 10.1073/pnas.95.4.1715; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Hodder AN, 1996, J BIOL CHEM, V271, P29446, DOI 10.1074/jbc.271.46.29446; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; KEEN JK, 1994, MOL BIOCHEM PARASIT, V65, P171, DOI 10.1016/0166-6851(94)90125-2; LANGRETH SG, 1985, INFECT IMMUN, V47, P760, DOI 10.1128/IAI.47.3.760-766.1985; Levesque MC, 1999, J INFECT DIS, V180, P1994, DOI 10.1086/315140; LUSE SA, 1971, AM J TROP MED HYG, V20, P655, DOI 10.4269/ajtmh.1971.20.655; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MILLER LH, 1971, J CLIN INVEST, V50, P1451, DOI 10.1172/JCI106629; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 1998, AM J TROP MED HYG, V59, P336, DOI 10.4269/ajtmh.1998.59.336; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Patel SS, 2001, BLOOD, V98, P3489, DOI 10.1182/blood.V98.12.3489; PRADA J, 1993, LANCET, V342, P1114, DOI 10.1016/0140-6736(93)92096-C; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rogerson SJ, 1997, EXP PARASITOL, V86, P8, DOI 10.1006/expr.1996.4142; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Smith JD, 2001, TRENDS PARASITOL, V17, P538, DOI 10.1016/S1471-4922(01)02079-7; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Snow RW, 1998, BRIT MED BULL, V54, P293, DOI 10.1093/oxfordjournals.bmb.a011689; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tachado SD, 1996, J IMMUNOL, V156, P1897; TAYLOR TE, 1993, Q J MED, V86, P99; ToureBalde A, 1996, INFECT IMMUN, V64, P744, DOI 10.1128/IAI.64.3.744-750.1996; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	82	1170	1201	4	480	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					673	679		10.1038/415673a	http://dx.doi.org/10.1038/415673a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832955				2022-12-28	WOS:000173709100056
J	Walsh, CR; Larson, MG; Evans, JC; Djousse, L; Ellison, RC; Vasan, RS; Levy, D				Walsh, CR; Larson, MG; Evans, JC; Djousse, L; Ellison, RC; Vasan, RS; Levy, D			Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; CIGARETTE-SMOKING; NATURAL-HISTORY; BLOOD-PRESSURE; MORTALITY; POPULATION; DISEASE; WOMEN; MEN; DYSFUNCTION	Background: Although excessive alcohol consumption can promote cardiomyopathy, little is known about the association between alcohol consumption and risk for congestive heart failure in the community. Objective: To determine the relation between alcohol consumption and risk for congestive heart failure in the community. Design: Community-based, prospective observational study. Setting: Framingham, Massachusetts. Participants: Participants in the Framingham Heart Study who were free of congestive heart failure and coronary heart disease. Measurements: Self-reported alcohol consumption; sex-specific rates of congestive heart failure per 1000 person-years of follow-up by level of alcohol consumption. Results: In men, 99 cases of congestive heart failure occurred during 26 035 person-years of follow-up. In women, 120 cases of congestive heart failure occurred during 35 563 person-years of follow-up. After adjustment for multiple confounders, risk for congestive heart failure was lower among men at all levels of alcohol consumption compared with men who consumed less than 1 drink/wk. The hazard ratio for congestive heart failure was lowest among men who consumed 8 to 14 drinks/wk (0.41 [95% CI, 0.21 to 0.81]) compared with those who consumed less than 1 drink/wk. In women, the age-adjusted hazard ratio for congestive heart failure was lowest among those who consumed 3 to 7 drinks/wk (0.49 [CI, 0.25 to 0.96]) compared with those who consumed less than 1 drink/wk. However, after adjustment for multiple predictors of congestive heart failure, this association was no longer statistically significant. Conclusions: In the community, alcohol consumption is not associated with increased risk for congestive heart failure, even among heavy drinkers (greater than or equal to15 drinks/wk in men and greater than or equal to8 drinks/wk in women). To the contrary, when consumed in moderation, alcohol appears to protect against congestive heart failure.	NHLBI, Framingham Heart Study, NIH, Framingham, MA 01702 USA; Boston Univ, Sch Med, Massachusetts Gen Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 02118 USA; Harvard Univ, Sch Med, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts General Hospital; Harvard University; Harvard Medical School	Levy, D (corresponding author), NHLBI, Framingham Heart Study, NIH, 5 Thurber St, Framingham, MA 01702 USA.		Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Djousse, Luc/F-5033-2017	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Djousse, Luc/0000-0002-9902-3047; Ellison, Robert Curtis/0000-0002-0582-7467; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, 1K24 HL04334] Funding Source: Medline; NIAMS NIH HHS [AR/AG 41398] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; ALEXANDE.CS, 1972, AM J MED, V53, P395, DOI 10.1016/0002-9343(72)90136-2; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; BERTOLET BD, 1991, DRUG ALCOHOL DEPEN, V28, P113, DOI 10.1016/0376-8716(91)90067-9; Black HR, 1997, ARCH INTERN MED, V157, P2413; BYRNEQUINN E, 1969, BMJ-BRIT MED J, V4, P25, DOI 10.1136/bmj.4.5674.25; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; Cooper HA, 2000, J AM COLL CARDIOL, V35, P1753, DOI 10.1016/S0735-1097(00)00625-2; COX DR, 1972, J R STAT SOC B, V34, P187; CRIQUI MH, 1987, AM J EPIDEMIOL, V126, P629, DOI 10.1093/oxfordjournals.aje.a114702; DANCY M, 1985, LANCET, V1, P1122; Dawber, 1959, J CHRON DIS, V10, P186, DOI 10.1016/0021-9681(59)90002-5; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; FernandezSola J, 1997, AM J CARDIOL, V80, P481, DOI 10.1016/S0002-9149(97)00399-8; FRIEDMAN LA, 1986, AM J EPIDEMIOL, V124, P481, DOI 10.1093/oxfordjournals.aje.a114418; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; HARRIS M, 1979, DIABETES, V28, P1039; HASKELL WL, 1984, NEW ENGL J MED, V310, P805, DOI 10.1056/NEJM198403293101301; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; KUPARI M, 1991, AM J CARDIOL, V67, P274, DOI 10.1016/0002-9149(91)90559-4; KUPARI M, 1993, AM J CARDIOL, V72, P1418, DOI 10.1016/0002-9149(93)90190-N; MANOLIO TA, 1991, J AM COLL CARDIOL, V17, P717, DOI 10.1016/S0735-1097(10)80189-5; MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McKenna CJ, 1998, AM HEART J, V135, P833, DOI 10.1016/S0002-8703(98)70042-0; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; National Institute on Alcohol Abuse and Alcoholism, 1995, PUBL NIH; PATEL VB, 1995, BIOCHEM SOC T, V23, pS461, DOI 10.1042/bst023461s; Prazak P, 1996, EUR HEART J, V17, P251; REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220; *SAS I INC, 1996, SAS STAT SOFTW CHANG, P807; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; SUH I, 1992, ANN INTERN MED, V116, P881, DOI 10.7326/0003-4819-116-11-881; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; *USDA, 1999, USDA NUTR DAT STAND; WU CF, 1976, AM HEART J, V91, P281, DOI 10.1016/S0002-8703(76)80209-8	47	151	156	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					181	191		10.7326/0003-4819-136-3-200202050-00005	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827493				2022-12-28	WOS:000173637400001
J	Elinav, E; Chajek-Shaul, TA; Stern, M				Elinav, E; Chajek-Shaul, TA; Stern, M			Improvement in cholesterol emboli syndrome after iloprost therapy	BRITISH MEDICAL JOURNAL			English	Article									Hadassah Univ Hosp, Dept Med, IL-91240 Jerusalem, Israel; Hadassah Univ Hosp, Med Day Care Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Chajek-Shaul, TA (corresponding author), Hadassah Univ Hosp, Dept Med, Mt Scopus, IL-91240 Jerusalem, Israel.		Elinav, Eran/C-8077-2011; Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110				GRANT SM, 1992, DRUGS, V43, P889, DOI 10.2165/00003495-199243060-00008; KARA HVK, 1993, J VASC SURG, V17, P328; OKEEFFE ST, 1992, ARCH INTERN MED, V152, P2197, DOI 10.1001/archinte.152.11.2197	3	46	50	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					268	269		10.1136/bmj.324.7332.268	http://dx.doi.org/10.1136/bmj.324.7332.268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823357	Bronze, Green Published			2022-12-28	WOS:000173728300016
J	McLellan, F				McLellan, F			Doing justice - justly	LANCET			English	Editorial Material									The Lancet, New York, NY 10011 USA		McLellan, F (corresponding author), The Lancet, New York, NY 10011 USA.			McLellan, Faith/0000-0003-0744-1450					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					372	372		10.1016/S0140-6736(02)07589-X	http://dx.doi.org/10.1016/S0140-6736(02)07589-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844505				2022-12-28	WOS:000173686500005
J	Hartmann, DL				Hartmann, DL			Climate change - Tropical surprises	SCIENCE			English	Editorial Material							NINO		Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hartmann, DL (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.							Cess RD, 2001, J CLIMATE, V14, P2129, DOI 10.1175/1520-0442(2001)014<2129:TIOTEN>2.0.CO;2; Chen JY, 2002, SCIENCE, V295, P838, DOI 10.1126/science.1065835; Hartmann DL, 2001, J CLIMATE, V14, P4495, DOI 10.1175/1520-0442(2001)014<4495:TCATEB>2.0.CO;2; HARTMANN DL, 1994, GLOBAL PHYSICAL CLIM; Held IM, 2000, ANNU REV ENERG ENV, V25, P441, DOI 10.1146/annurev.energy.25.1.441; Houghton J. T., 2001, CLIMATE CHANGE 2001; SHINE KP, 1991, NATURE, V354, P382, DOI 10.1038/354382a0; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	12	24	24	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					811	812		10.1126/science.1068447	http://dx.doi.org/10.1126/science.1068447			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823630				2022-12-28	WOS:000173733000032
J	Liemann, S; Chandran, K; Baker, TS; Nibert, ML; Harrison, SC				Liemann, S; Chandran, K; Baker, TS; Nibert, ML; Harrison, SC			Structure of the reovirus membrane-penetration protein, mu 1, in a complex with its protector protein, sigma 3	CELL			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN REOVIRUSES; CHROMIUM RELEASE; CAPSID PROTEIN; SUBVIRION PARTICLES; M2 GENE; BINDING; SEQUENCE; ENTRY; CRYSTALLOGRAPHY	Cell entry by nonenveloped animal viruses requires membrane penetration without membrane fusion. The reovirus penetration agent is the outer-capsid protein, mu1. The structure of mu1, complexed with its "protector" protein, sigma3, and the fit of this mu1(3)sigma3(3) heterohexameric complex into the cryoEM image of an intact virion, reveal molecular events essential for viral penetration. Autolytic cleavage divides mu1 into myristoylated mu1N and mu1C. A long hydrophobic pocket can receive the myristoyl group. Dissociation of mu1N, linked to a major conformational change of the entire mu1 trimer, must precede myristoyl-group insertion into the cellular membrane. A myristoyl switch, coupling exposure of the fatty acid chain, autolytic cleavage of mu1N, and long-range molecular rearrangement of mu1C, thus appears to be part of the penetration mechanism.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Chandran, Kartik/I-2232-2012	, Timothy/0000-0001-6543-8968	NCI NIH HHS [CA-13202, R37 CA013202, R01 CA013202] Funding Source: Medline; NIAID NIH HHS [R01 AI046440, P01 AI045976, AI-46440] Funding Source: Medline; NIGMS NIH HHS [R01 GM033050, GM-33050, R37 GM033050] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA013202, R37CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046440, P01AI045976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033050, R01GM033050] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandran K, 1998, J VIROL, V72, P467, DOI 10.1128/JVI.72.1.467-475.1998; Chandran K, 1999, J VIROL, V73, P3941, DOI 10.1128/JVI.73.5.3941-3950.1999; CHANDRAN K, 2001, THESIS U WISCONSIN M; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; CHEN WY, 1991, J BIOL CHEM, V266, P9355; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; FIELDS BN, 1971, VIROLOGY, V43, P569, DOI 10.1016/0042-6822(71)90282-0; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooper JW, 1996, J VIROL, V70, P672, DOI 10.1128/JVI.70.1.672-677.1996; Hooper JW, 1996, J VIROL, V70, P459, DOI 10.1128/JVI.70.1.459-467.1996; HUISMANS H, 1976, VIROLOGY, V70, P411, DOI 10.1016/0042-6822(76)90282-8; IMANI F, 1988, P NATL ACAD SCI USA, V85, P7887, DOI 10.1073/pnas.85.21.7887; JAYASURIYA AK, 1988, VIROLOGY, V163, P591, DOI 10.1016/0042-6822(88)90300-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; LUCIAJANDRIS P, 1993, J VIROL, V67, P5339, DOI 10.1128/JVI.67.9.5339-5345.1993; MOSCUFO N, 1993, J VIROL, V67, P5075, DOI 10.1128/JVI.67.8.5075-5078.1993; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; Nibert ML., 2001, FIELDS VIROLOGY, P1679; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olland AM, 2001, EMBO J, V20, P979, DOI 10.1093/emboj/20.5.979; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHIFF LA, 1988, MOL CELL BIOL, V8, P273, DOI 10.1128/MCB.8.1.273; SHARPE AH, 1982, VIROLOGY, V122, P381, DOI 10.1016/0042-6822(82)90237-9; SHATKIN AJ, 1972, J VIROL, V10, P698, DOI 10.1128/JVI.10.4.698-706.1972; Shing M, 1996, VIRUS RES, V46, P19, DOI 10.1016/S0168-1702(96)01372-X; SILVERSTEIN SC, 1970, P NATL ACAD SCI USA, V67, P275, DOI 10.1073/pnas.67.1.275; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; TOSTESON MT, 1993, P NATL ACAD SCI USA, V90, P10549, DOI 10.1073/pnas.90.22.10549; WIENER JR, 1988, VIROLOGY, V163, P603, DOI 10.1016/0042-6822(88)90301-7; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6; [No title captured]	59	179	202	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					283	295		10.1016/S0092-8674(02)00612-8	http://dx.doi.org/10.1016/S0092-8674(02)00612-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832217	Green Accepted, Bronze			2022-12-28	WOS:000173521300014
J	Schmittner, A; Yoshimori, M; Weaver, AJ				Schmittner, A; Yoshimori, M; Weaver, AJ			Instability of glacial climate in a model of the ocean-atmosphere-cryosphere system	SCIENCE			English	Article							LAURENTIDE ICE-SHEET; ATLANTIC THERMOHALINE CIRCULATION; NORTH-ATLANTIC; GREENLAND ICE; STABILITY; CYCLES; KYR; AGE	In contrast to the relatively stable climate of the past 10,000 years, during glacial times the North Atlantic region experienced large-amplitude transitions between cold (stadial) and warm (interstadial) states. In this modeling study, we demonstrate that hydrological interactions between the Atlantic thermohaline circulation (THC) and adjacent continental ice sheets can trigger abrupt warming events and also limit the lifetime of the interstadial circulation mode. These interactions have the potential to destabilize the THC, which is already more sensitive for glacial conditions than for the present-day climate, thus providing an explanation for the increased variability of glacial climate.	Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada	University of Victoria	Schmittner, A (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, POB 3055, Victoria, BC V8W 3P6, Canada.		Schmittner, Andreas/A-3101-2008; Weaver, Andrew J/E-7590-2011; Schmittner, Andreas/O-9647-2015	Weaver, Andrew J/0000-0001-8919-3598; Schmittner, Andreas/0000-0002-8376-0843; Yoshimori, Masakazu/0000-0003-0236-8442				BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; BRYAN F, 1986, NATURE, V323, P301, DOI 10.1038/323301a0; CAILLON N, 2001, EOS, V82; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; Dansgaard W., 1984, GEOPHYS MONOGR SER, P288, DOI DOI 10.1029/GM029P0288; Fanning AF, 1996, J GEOPHYS RES-ATMOS, V101, P15111, DOI 10.1029/96JD01017; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Holland MM, 2001, J CLIMATE, V14, P656, DOI 10.1175/1520-0442(2001)014<0656:TROIOI>2.0.CO;2; Johnsen SJ, 1997, J GEOPHYS RES-OCEANS, V102, P26397, DOI 10.1029/97JC00167; Licciardi JM, 1998, QUATERNARY SCI REV, V17, P427, DOI 10.1016/S0277-3791(97)00044-9; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Marotzke J., 1988, Tellus, Series A (Dynamic Meteorology and Oceanography), V40A, P162, DOI 10.1111/j.1600-0870.1988.tb00414.x; Marshall SJ, 1999, CLIM DYNAM, V15, P533, DOI 10.1007/s003820050298; Marshall SJ, 1999, QUATERNARY RES, V52, P300, DOI 10.1006/qres.1999.2079; Marshall SJ, 1997, J GEOPHYS RES-SOL EA, V102, P20599, DOI 10.1029/97JB01188; Marshall SJ, 2000, CAN J EARTH SCI, V37, P769, DOI [10.1139/cjes-37-5-769, 10.1139/e99-113]; MIKOLAJEWICZ U, 1994, J GEOPHYS RES-OCEANS, V99, P22633, DOI 10.1029/94JC01989; OESCHGER H, 1984, AM GEOPHYS UNION MON, V29, P299; PACANOWSKI R, 1995, TECHNICAL REPORT NAT; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Schiller A, 1997, CLIM DYNAM, V13, P325, DOI 10.1007/s003820050169; SCHMITTNER A, IN PRESS PALEOCEANOG; SCHMITZ WJ, 1995, REV GEOPHYS, V33, P151, DOI 10.1029/95RG00879; Stocker TF, 1999, INT J EARTH SCI, V88, P365, DOI 10.1007/s005310050271; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; van Kreveld S, 2000, PALEOCEANOGRAPHY, V15, P425, DOI 10.1029/1999PA000464; Weaver AJ, 2001, ATMOS OCEAN, V39, P361, DOI 10.1080/07055900.2001.9649686; Weaver AJ, 1998, NATURE, V394, P847, DOI 10.1038/29695; Yoshimori M, 2001, CLIM DYNAM, V17, P571, DOI 10.1007/s003820000134	38	102	106	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1489	1493		10.1126/science.1066174	http://dx.doi.org/10.1126/science.1066174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11823604				2022-12-28	WOS:000173981300043
J	Gille, ST				Gille, ST			Warming of the Southern Ocean since the 1950s	SCIENCE			English	Article							LAGRANGIAN CIRCULATION EXPLORER; CLIMATE-CHANGE; REANALYSIS; RECIRCULATION; TEMPERATURE	Autonomous Lagrangian Circulation Explorer floats recorded temperatures in depths between 700 and 1100 meters in the Southern Ocean throughout the 1990s. These temperature records are systematically warmer than earlier hydrographic temperature measurements from the region, suggesting that mid-depth Southern Ocean temperatures have risen 0.17degreesC between the 1950s and the 1980s. This warming is faster than that of the global ocean and is concentrated within the Antarctic Circumpolar Current, where temperature rates of change are comparable to Southern Ocean atmospheric temperature increases.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Gille, ST (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	sgille@ucsd.edu	Gille, Sarah T./B-3171-2012	Gille, Sarah/0000-0001-9144-4368	NERC [NE/N018095/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; BINDOFF NL, 1994, J PHYS OCEANOGR, V24, P1137, DOI 10.1175/1520-0485(1994)024<1137:DCCAOV>2.0.CO;2; BOYER TP, 1998, WORLD OCEAN DATABASE, V5; Conkright M. E., 1998, 14 NODC; Davis RE, 1996, J GEOPHYS RES-OCEANS, V101, P855, DOI 10.1029/95JC02538; Davis RE, 1998, J GEOPHYS RES-OCEANS, V103, P24619, DOI 10.1029/98JC01913; DAVIS RE, 1992, J ATMOS OCEAN TECH, V9, P264, DOI 10.1175/1520-0426(1992)009<0264:TALCE>2.0.CO;2; DAVIS RE, 2001, COMMUNICATION; GOURETSKI VV, 1998, 16298 WOCE MAXPL I; GOURETSKI VV, 1998, 3 WHP SAC WOCE; Hanawa K., 2001, OCEAN CIRCULATION CL, P373, DOI DOI 10.1016/S0074-6142(01)80129-7; Hines KM, 2000, J CLIMATE, V13, P3940, DOI 10.1175/1520-0442(2000)013<3940:ASPTIT>2.0.CO;2; Jacka TH, 1998, ANN GLACIOL, V27, P553; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Lavender KL, 2000, NATURE, V407, P66, DOI 10.1038/35024048; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; LEVITUS S, 1989, J GEOPHYS RES-OCEANS, V94, P6091, DOI 10.1029/JC094iC05p06091; Levitus S., 1998, WORLD OCEAN DATABASE, V1; MANTYLA W, 1970, THESIS U CALIFORNIA; McCartney M. S., 1979, VOYAGE DISCOVERY G D, P103; McCartney MS, 1982, J MAR RES, V40, P427; Olbers D., 1992, HYDROGRAPHIC ATLAS S; Rintoul S. R., 2001, OCEAN CIRCULATION CL, P271, DOI DOI 10.1016/S0074-6142(01)80124-8; ROEMMICH D, 1987, DEEP-SEA RES, V34, P299, DOI 10.1016/0198-0149(87)90088-4; SWIFT JH, 1995, INT WOCE NEWSLETTER, V18, P15; Wong APS, 2001, J CLIMATE, V14, P1613, DOI 10.1175/1520-0442(2001)014<1613:FAHCIT>2.0.CO;2	27	482	506	15	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1275	1277		10.1126/science.1065863	http://dx.doi.org/10.1126/science.1065863			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847337				2022-12-28	WOS:000173926000038
J	Johnson, G				Johnson, G			Signal transduction - Scaffolding proteins - More than meets the eye	SCIENCE			English	Editorial Material							TAK1 MAPKKK; KINASE; ACTIVATION		Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Johnson, G (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave, Denver, CO 80262 USA.							Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	8	13	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1249	1250		10.1126/science.1069828	http://dx.doi.org/10.1126/science.1069828			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847330				2022-12-28	WOS:000173926000030
J	Trainor, PA; Ariza-McNaughton, L; Krumlauf, R				Trainor, PA; Ariza-McNaughton, L; Krumlauf, R			Role of the isthmus and FGFs in resolving the paradox of neural crest plasticity and prepatterning	SCIENCE			English	Article							TIME-LAPSE ANALYSIS; HOMEOTIC TRANSFORMATION; GENE-EXPRESSION; CELL-MIGRATION; HINDBRAIN; EMBRYO; HOXA-2; DISRUPTION; RHOMBOMERE; MESENCHYME	Cranial neural crest cells generate the distinctive bone and connective tissues in the vertebrate head. Classical models of craniofacial development argue that the neural crest is prepatterned or preprogrammed to make specific head structures before its migration from the neural tube. In contrast, recent studies in several vertebrates have provided evidence for plasticity in patterning neural crest populations. Using tissue transposition and molecular analyses in avian embryos, we reconcile these findings by demonstrating that classical manipulation experiments, which form the basis of the prepatterning model, involved transplantation of a local signaling center, the isthmic organizer. FGF8 signaling from the isthmus alters Hoxa2 expression and consequently branchial. arch patterning, demonstrating that neural crest cells are patterned by environmental signals.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AX, England	Stowers Institute for Medical Research; MRC National Institute for Medical Research	Krumlauf, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.		Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927; Trainor, Paul/0000-0003-2774-3624				CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Couly G, 1996, DEVELOPMENT, V122, P3393; Couly G, 1998, DEVELOPMENT, V125, P3445; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Grammatopoulos GA, 2000, DEVELOPMENT, V127, P5355; GRAPINBOTTON A, 1995, DEVELOPMENT, V121, P2707; Hunt P, 1998, DEV BIOL, V198, P82, DOI 10.1006/dbio.1998.8886; Irving C, 2000, DEVELOPMENT, V127, P177; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kulesa P, 2000, DEVELOPMENT, V127, P2843; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N., 1999, DEV CELL BIOL SERIES, V2nd, DOI [10.1017/CBO9780511897948, DOI 10.1017/CBO9780511897948, 10.1017/cbo9780511897948]; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; NODEN DM, 1988, DEVELOPMENT, V103, P121; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Pasqualetti M, 2000, DEVELOPMENT, V127, P5367; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Saldivar JR, 1997, DEVELOPMENT, V124, P2729; Saldivar JR, 1996, DEVELOPMENT, V122, P895; Schilling TF, 2001, DEV BIOL, V231, P201, DOI 10.1006/dbio.2000.9997; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; SECHRIST J, 1993, DEVELOPMENT, V118, P691; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Trainor P, 2000, NAT CELL BIOL, V2, P96, DOI 10.1038/35000051; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056	30	132	137	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1288	1291		10.1126/science.1064540	http://dx.doi.org/10.1126/science.1064540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847340				2022-12-28	WOS:000173926000042
J	Houchmandzadeh, B; Wieschaus, E; Leibler, S				Houchmandzadeh, B; Wieschaus, E; Leibler, S			Establishment of developmental precision and proportions in the early Drosophila embryo	NATURE			English	Article							DEPENDENT MANNER; BICOID PROTEIN; GAP GENES; HUNCHBACK; GRADIENT; STAUFEN	During embryonic development, orderly patterns of gene expression eventually assign each cell in the embryo its particular fate. For the anteroposterior axis of the Drosophila embryo, the first step in this process depends on a spatial gradient of the maternal morphogen Bicoid (Bcd). Positional information of this gradient is transmitted to downstream gap genes, each occupying a well defined spatial domain(1-4). We determined the precision of the initial process by comparing expression domains in different embryos. Here we show that the Bcd gradient displays a high embryo-to-embryo variability, but that this noise in the positional information is strongly decreased ('filtered') at the level of hunchback (hb) gene expression. In contrast to the Bcd gradient, the hb expression pattern already includes the information about the scale of the embryo. We show that genes known to interact directly with Hb are not responsible for its spatial precision, but that the maternal gene staufen may be crucial.	Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Grenoble 1, Spectrometrie Phys Lab, CNRS, F-38402 St Martin Dheres, France; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Princeton University	Wieschaus, E (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.		Houchmandzadeh, Bahram/F-9199-2012	Houchmandzadeh, Bahram/0000-0001-8104-2576				DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; HULSKAMP M, 1994, GENETICS, V138, P125; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; KOSSMAN D, 1908, DEV GENES EVOL, V208, P290; Lacalli T.C., 1991, Seminars in Developmental Biology, V2, P107; MERRILL PT, 1988, DEVELOPMENT, V104, P495; PRESS WH, 1992, NUMERICAL RECIPES; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Segel I.H., 1975, ENZYME KINETICS; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	18	364	373	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					798	802		10.1038/415798a	http://dx.doi.org/10.1038/415798a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845210				2022-12-28	WOS:000173833900048
J	Evans, PG; Isaacs, ED; Aeppli, G; Cai, Z; Lai, B				Evans, PG; Isaacs, ED; Aeppli, G; Cai, Z; Lai, B			X-ray microdiffraction images of antiferromagnetic domain evolution in chromium	SCIENCE			English	Article							THIN-FILMS; DENSITY WAVES; CHARGE; MAGNETORESISTANCE; SCATTERING	Magnetic x-ray diffraction combined with x-ray focusing optics was used to image individual antiferromagnetic spin density wave domains in a chromium single crystal at the micron scale. The cross section for nonresonant magnetic x-ray scattering depends on the antiferromagnetic modulation vector and spin polarization direction and allows these quantities to be extracted independently. The technique was used to show that the broadening of the nominally first-order "spin-flip" transition at 123 kelvin, at which the spins rotate by 90degrees, originates at the walls between domains with orthogonal modulation vectors. During cooling, the transition begins at these walls and progresses inward. The modulation vector domains are themselves unchanged.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; NEC Res Inst, Princeton, NJ 08540 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Alcatel-Lucent; Lucent Technologies; AT&T; NEC Corporation; United States Department of Energy (DOE); Argonne National Laboratory	Evans, PG (corresponding author), Lucent Technol, Bell Labs, 600-700 Mt Ave, Murray Hill, NJ 07974 USA.		Evans, Paul G/A-9260-2009	Evans, Paul G/0000-0003-0421-6792				ANDO M, 1972, PHYS REV LETT, V29, P281, DOI 10.1103/PhysRevLett.29.281; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; BLUME M, 1988, PHYS REV B, V37, P1779, DOI 10.1103/PhysRevB.37.1779; Braun KF, 2000, PHYS REV LETT, V85, P3500, DOI 10.1103/PhysRevLett.85.3500; DAVIDSON JB, 1973, AIP C P, V18, P396; Di Fabrizio E, 1999, NATURE, V401, P895, DOI 10.1038/44791; FAWCETT E, 1988, REV MOD PHYS, V60, P209, DOI 10.1103/RevModPhys.60.209; HILL JP, 1995, PHYS REV B, V51, P10336, DOI 10.1103/PhysRevB.51.10336; IMRY Y, 1979, PHYS REV B, V19, P3580, DOI 10.1103/PhysRevB.19.3580; LAI B, 1992, APPL PHYS LETT, V61, P1877, DOI 10.1063/1.108400; LOMER WM, 1962, P PHYS SOC LOND, V80, P489, DOI 10.1088/0370-1328/80/2/316; MATTSON JE, 1992, J MAGN MAGN MATER, V109, P179, DOI 10.1016/0304-8853(92)91747-H; MORI M, 1993, J PHYS-CONDENS MAT, V5, pL77, DOI 10.1088/0953-8984/5/7/001; Nolting F, 2000, NATURE, V405, P767, DOI 10.1038/35015515; OVERHAUSER AW, 1962, PHYS REV, V128, P1437, DOI 10.1103/PhysRev.128.1437; Rice TM, 1970, PHYS REV B-SOLID ST, V2, P3619, DOI 10.1103/PhysRevB.2.3619; Scholl A, 2000, SCIENCE, V287, P1014, DOI 10.1126/science.287.5455.1014; Schuster E A, 1992, Holist Nurs Pract, V6, P1; SHULL CG, 1953, REV MOD PHYS, V25, P100, DOI 10.1103/RevModPhys.25.100; Soh YA, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.020402; WERNER SA, 1967, PHYS REV, V155, P528, DOI 10.1103/PhysRev.155.528; Zabel H, 1999, J PHYS-CONDENS MAT, V11, P9303, DOI 10.1088/0953-8984/11/48/301	22	84	84	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1042	1045		10.1126/science.1066870	http://dx.doi.org/10.1126/science.1066870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834828	Green Submitted			2022-12-28	WOS:000173793000057
J	Beja, O; Suzuki, MT; Heidelberg, JF; Nelson, WC; Preston, CM; Hamada, T; Eisen, JA; Fraser, CM; DeLong, EF				Beja, O; Suzuki, MT; Heidelberg, JF; Nelson, WC; Preston, CM; Hamada, T; Eisen, JA; Fraser, CM; DeLong, EF			Unsuspected diversity among marine aerobic anoxygenic phototrophs	NATURE			English	Article							PHOTOSYNTHESIS GENE-CLUSTER; RHODOBACTER-CAPSULATUS; BACTERIOCHLOROPHYLL ALPHA; BACTERIA; ORGANIZATION; SUBUNIT; REGION	Aerobic, anoxygenic, phototrophic bacteria containing bacteriochlorophyll a (Bchla) require oxygen for both growth and Bchla synthesis(1-6). Recent reports suggest that these bacteria are widely distributed in marine plankton, and that they may account for up to 5% of surface ocean photosynthetic electron transport 7 and 11% of the total microbial community(8). Known planktonic anoxygenic phototrophs belong to only a few restricted groups within the Proteobacteria a-subclass. Here we report genomic analyses of the photosynthetic gene content and operon organization in naturally occurring marine bacteria. These photosynthetic gene clusters included some that most closely resembled those of Proteobacteria from the beta-subclass, which have never before been observed in marine environments. Furthermore, these photosynthetic genes were broadly distributed in marine plankton, and actively expressed in neritic bacterioplankton assemblages, indicating that the newly identified phototrophs were photosynthetically competent. Our data demonstrate that planktonic bacterial assemblages are not simply composed of one uniform, widespread class of anoxygenic phototrophs, as previously proposed(8); rather, these assemblages contain multiple, distantly related, photosynthetically active bacterial groups, including some unrelated to known and cultivated types.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Inst Genom Res, Rockville, MD 20850 USA; Marine Biotechnol Inst, Kamaishi Labs, Kamaishi, Iwate 0260001, Japan	Monterey Bay Aquarium Research Institute; J. Craig Venter Institute	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Suzuki, Marcelino/D-3329-2009; chen, qi/C-8585-2011; Nelson, William C/E-9263-2016; Eisen, Jonathan A./H-2706-2019	Suzuki, Marcelino/0000-0003-3868-6362; Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Fraser, Claire/0000-0003-1462-2428; Heidelberg, John/0000-0003-0673-3224				Achenbach LA, 2001, APPL ENVIRON MICROB, V67, P2922, DOI 10.1128/AEM.67.7.2922-2926.2001; Alberti M, 1995, ANOXYGENIC PHOTOSYNT, P1083; BAUER CE, 1991, MOL GEN GENET, V228, P433, DOI 10.1007/BF00260637; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; BURKE DH, 1993, J BACTERIOL, V175, P2414, DOI 10.1128/JB.175.8.2414-2422.1993; Choudhary M, 2000, NUCLEIC ACIDS RES, V28, P862, DOI 10.1093/nar/28.4.862; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenchel T, 2001, SCIENCE, V292, P2444, DOI 10.1126/science.1062799; Hahn FM, 1996, J BACTERIOL, V178, P619, DOI 10.1128/jb.178.3.619-624.1996; Harashima K., 1989, AEROBIC PHOTOSYNTHET; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Naylor GW, 1999, PHOTOSYNTH RES, V62, P121, DOI 10.1023/A:1006350405674; Petersen BL, 1998, HEREDITAS, V129, P131, DOI 10.1111/j.1601-5223.1998.00131.x; SHIBA T, 1991, APPL ENVIRON MICROB, V57, P295, DOI 10.1128/AEM.57.1.295-300.1991; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Suzuki MT, 1997, APPL ENVIRON MICROB, V63, P983, DOI 10.1128/AEM.63.3.983-989.1997; Suzuki MT, 2001, AQUAT MICROB ECOL, V24, P117, DOI 10.3354/ame024117; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	25	317	339	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					630	633		10.1038/415630a	http://dx.doi.org/10.1038/415630a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832943	hybrid			2022-12-28	WOS:000173709100043
J	Chiu, CH; Wu, TL; Su, LH; Chu, CS; Chia, JH; Kuo, AJ; Chien, MS; Lin, TY				Chiu, CH; Wu, TL; Su, LH; Chu, CS; Chia, JH; Kuo, AJ; Chien, MS; Lin, TY			The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIELD GEL-ELECTROPHORESIS; VIRULENCE PLASMIDS; UNITED-STATES; QUINOLONE; CIPROFLOXACIN; BACTEREMIA; MUTATIONS; OUTBREAK; SEROVARS; HUMANS	Background Salmonella enterica: serotype choleraesuis is a cause of serious systemic infections. Because fluoroquinolones are the drug of choice for the treatment of severe salmonella infections, the emergence and dissemination of fluoroquinolone-resistant S. enterica serotype choleraesuis have clinical consequences. Methods: In Taiwan, a hospital-based surveillance system has been in place since 1987 to monitor the incidence of S. enterica serotype choleraesuis infections and the antimicrobial susceptibility of the isolates. We investigated the rapid emergence of fluoroquinolone resistance in this serotype in 2000 and 2001. Pigs in Taiwan were evaluated as a potential source of the resistant salmonella. Results: A total of 501 clinical isolates of S. enterica serotype choleraesuis were recovered in our hospital from 1987 through 2000. The proportion of total salmonella isolates made up by S. enterica serotype choleraesuis decreased from an average of 8.4 percent before 1995 to 2.7 percent in 1996 through 1998. During 1999 and 2000, this proportion increased significantly, to an average of 5.0 percent. Ciprofloxacin resistance in S. enterica serotype choleraesuis has been observed since 2000. In the third quarter of 2001, 60 percent of isolates were resistant to ciprofloxacin. Molecular typing indicated that the primary source of S. enterica serotype choleraesuis isolates was herds of swine. All the resistant isolates from humans and swine had mutations that led to the substitution of phenylalanine for serine at position 83 and asparagine for aspartic acid at position 87 in the gene for DNA gyrase A. Conclusions: This investigation in Taiwan indicates that fluoroquinolone-resistant S. enterica serotype choleraesuis can spread from swine to humans. The use of fluoroquinolones in food animals should be prohibited.	Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; Chang Gung Mem Hosp, Dept Clin Pathol, Tao Yuan, Taiwan; Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan; Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung 40227, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Chung Hsing University	Chiu, CH (corresponding author), Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, 5 Pu Hsin St,Kweishan 333, Tao Yuan, Taiwan.	chchiu@adm.cgmh.org.tw						Bender JB, 2001, NEW ENGL J MED, V344, P189, DOI 10.1056/NEJM200101183440305; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619, DOI 10.1128/JCM.34.10.2619-2622.1996; Chiu CH, 1999, MICROBIOL IMMUNOL, V43, P899, DOI 10.1111/j.1348-0421.1999.tb01225.x; Chiu CH, 1999, INT J CLIN PRACT, V53, P161; Chu C, 2001, ANTIMICROB AGENTS CH, V45, P2299, DOI 10.1128/AAC.45.8.2299-2303.2001; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Farmer J. J. Iii, 1995, P438; Frost JA, 1996, J ANTIMICROB CHEMOTH, V37, P85, DOI 10.1093/jac/37.1.85; Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131, DOI 10.1128/AAC.43.9.2131; Gorbach SL, 2001, NEW ENGL J MED, V345, P1202, DOI 10.1056/NEJM200110183451610; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Herikstad H, 1997, EMERG INFECT DIS, V3, P371, DOI 10.3201/eid0303.970316; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606; JACOBSON MA, 1989, ANN INTERN MED, V110, P1027, DOI 10.7326/0003-4819-110-12-1027; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; McDonald Lawrence Clifford, 2001, Journal of Microbiology Immunology and Infection, V34, P97; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Moller FM, 1998, APMIS, V106, P606, DOI 10.1111/j.1699-0463.1998.tb01391.x; National Archives, 2000, M7A5 NCCLS, P1; National Heart L.a.B.I, 2000, PRACTICAL GUIDE IDEN, P1; Olsen SJ, 2001, NEW ENGL J MED, V344, P1572, DOI 10.1056/NEJM200105243442102; PIDDOCK LJV, 1993, ANTIMICROB AGENTS CH, V37, P662, DOI 10.1128/AAC.37.4.662; Su LH, 2000, J HOSP INFECT, V46, P110, DOI 10.1053/jhin.2000.0815; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; White DG, 2001, NEW ENGL J MED, V345, P1147, DOI 10.1056/NEJMoa010315; Wiuff C, 2000, MICROB DRUG RESIST, V6, P11, DOI 10.1089/mdr.2000.6.11	31	201	211	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					413	419		10.1056/NEJMoa012261	http://dx.doi.org/10.1056/NEJMoa012261			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832529				2022-12-28	WOS:000173686400004
J	Merz, JF; Kriss, AG; Leonard, DGB; Cho, MK				Merz, JF; Kriss, AG; Leonard, DGB; Cho, MK			Diagnostic testing fails the test - The pitfalls of patents are illustrated by the case of haemochromatosis.	NATURE			English	Editorial Material							GENE; HEMOCHROMATOSIS		Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; George Mason Univ, Sch Law, Arlington, VA 22201 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA	University of Pennsylvania; Pennsylvania Medicine; George Mason University; University of Pennsylvania; Stanford University	Merz, JF (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.			Merz, Jon/0000-0002-0612-7104	NHGRI NIH HHS [R01 HG002034-01A1S2, R01 HG002034-03, R01 HG002034-01A1S1, R01 HG002034, R01 HG002034-01A1, R01 HG002034-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002034] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Cho M. K., 1998, PREPARING MILLENNIUM, P47; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gochee PA, 2001, CURR OPIN HEMATOL, V8, P98, DOI 10.1097/00062752-200103000-00007; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Merz JF, 1999, CLIN CHEM, V45, P324; Pointon JJ, 2000, GENET TEST, V4, P151, DOI 10.1089/10906570050114867; Schissel A, 1999, NATURE, V402, P118, DOI 10.1038/45907; Thomas SM, 1996, NATURE, V380, P387, DOI 10.1038/380387a0; Thomas SM, 1997, NATURE, V388, P709, DOI 10.1038/41853; Thorstensen K, 2000, GENET TEST, V4, P371, DOI 10.1089/109065700750065117; Wadman M, 2001, NATURE, V413, P443, DOI 10.1038/35097228	12	97	98	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					577	579		10.1038/415577a	http://dx.doi.org/10.1038/415577a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832913	Green Accepted			2022-12-28	WOS:000173709100016
J	Grewal, HP				Grewal, HP			Impact of surgical innovation on liver transplantation	LANCET			English	Editorial Material							DONOR LIVER; RIGHT LOBE; RECIPIENTS; CHILDREN; ADULT; EXPERIENCE; SELECTION		Univ Tennessee, Dept Surg, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Grewal, HP (corresponding author), Univ Tennessee, Dept Surg, Memphis, TN 38163 USA.							Alonso EM, 1996, HEPATOLOGY, V23, P40, DOI 10.1053/jhep.1996.v23.pm0008550046; Azoulay D, 2001, ANN SURG, V233, P565, DOI 10.1097/00000658-200104000-00013; Bak T, 2001, LIVER TRANSPLANT, V7, P680, DOI 10.1053/jlts.2001.26509; BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; DEGOYET JD, 1993, TRANSPLANTATION, V56, P1130, DOI 10.1097/00007890-199311000-00016; EMOND JC, 1989, HEPATOLOGY, V10, P867, DOI 10.1002/hep.1840100520; Emond JC, 1996, TRANSPLANT P, V28, P2375; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Grewal HP, 2001, ANN SURG, V233, P502, DOI 10.1097/00000658-200104000-00004; JURIM O, 1995, AM J SURG, V169, P529, DOI 10.1016/S0002-9610(99)80211-6; Kato T, 1997, TRANSPLANTATION, V64, P415, DOI 10.1097/00007890-199708150-00007; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; MALAGO M, 1994, TRANSPLANT P, V26, P3620; Marcos A, 2000, TRANSPLANTATION, V69, P2410, DOI 10.1097/00007890-200006150-00034; Marcos A, 2000, LIVER TRANSPLANT, V6, P296, DOI 10.1053/lv.2000.6354; Millis JM, 2000, ANN SURG, V232, P104, DOI 10.1097/00000658-200007000-00015; Otte JB, 1996, TRANSPLANT P, V28, P2378; PICHLMAYR R, 1988, LANGENBECK ARCH CHIR, V373, P127, DOI 10.1007/BF01262776; STERNECK MR, 1995, TRANSPLANTATION, V60, P667, DOI 10.1097/00007890-199510150-00009; Trotter JF, 2000, LIVER TRANSPLANT, V6, P290, DOI 10.1053/lv.2000.6351	20	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					368	370		10.1016/S0140-6736(02)07586-4	http://dx.doi.org/10.1016/S0140-6736(02)07586-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844502				2022-12-28	WOS:000173686500002
J	Morgan, D; Mahe, C; Mayanja, B; Whitworth, JAG				Morgan, D; Mahe, C; Mayanja, B; Whitworth, JAG			Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; RAPID PROGRESSION; SURVIVAL; ADULTS; KIGALI; RWANDA; WOMEN; PREDICTORS; MORTALITY	Objectives To estimate the rate of progression from seroconversion to symptomatic disease in adults infected with HIV-1, and to establish whether the background level of signs and symptoms commonly associated with HIV-1 in uninfected controls are likely to affect progression rates. Design Longitudinal, prospective cohort study of people infected with HIV-1 and randomly selected subjects negative for HIV-1 antibodies identified during population studies. Setting Study clinic with basic medical care in rural Uganda. Subjects 275 patients infected with HIV-1 (107 prevalent cases and 168 incident cases) and 246 controls negative for HIV-1 antibodies. Main outcome measures Signs and symptoms of HIV disease, as determined by stages 2 and 3 of the World Health Organization clinical staging system. Results The median time front seroconversion to WHO stage 2 was 25.4 months and to stage 3 was 45.5 months. 43% of the participants infected with HIV-1 had signs or symptoms by two years after seroconversion. The most common clinical conditions used to define progression of disease were weight loss, mucocutaneous manifestations, bacterial infections, chronic fever, and chronic diarrhoea. Although the rates of these conditions (apart from minor weight loss) were significantly higher in the participants infected with HIV-1, they were also relatively frequent. in the control group. Herpes zoster, oral candidiasis, and pulmonary tuberculosis were not common events in the control group and therefore were more indicative of infection with HIV-1. Conclusions Disease progression associated with infection with HIV-1 seems to be rapid in rural Uganda. This is most likely due to the high prevalence of conditions in the general population that could be taken as symptoms and signs of infection with HIV-1.	Uganda Virus Res Inst, Programme AIDS, MRC, Entebbe, Uganda	Uganda Virus Research Institute	Morgan, D (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.		Mayanja, Billy/AAL-5087-2021					ANZALA OA, 1995, J INFECT DIS, V171, P686, DOI 10.1093/infdis/171.3.686; Brettle RP, 1996, INT J STD AIDS, V7, P110, DOI 10.1258/0956462961917302; COLEBUNDERS R, 1991, J INFECT DIS, V164, P450, DOI 10.1093/infdis/164.3.450; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; French N, 1999, J ACQ IMMUN DEF SYND, V22, P509; HOLMBERG SD, 1995, AM J EPIDEMIOL, V141, P395, DOI 10.1093/oxfordjournals.aje.a117441; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; KERLIKOWSKE KM, 1994, AIDS, V8, P963, DOI 10.1097/00002030-199407000-00014; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415; LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320; MANN JM, 1986, LANCET, V2, P707; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MILLER WC, 1995, J ACQ IMMUN DEF SYND, V9, P408; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; NAGELKERKE NJD, 1990, AIDS, V4, P743, DOI 10.1097/00002030-199008000-00005; NGALY B, 1988, NEW ENGL J MED, V319, P1123, DOI 10.1056/NEJM198810273191704; WHITTLE H, 1992, AIDS, V6, P685, DOI 10.1097/00002030-199207000-00011; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221	20	83	84	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					193	196		10.1136/bmj.324.7331.193	http://dx.doi.org/10.1136/bmj.324.7331.193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809639	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000173604800013
J	Venkitaraman, AR				Venkitaraman, AR			Cancer susceptibility and the functions of BRCA1 and BRCA2	CELL			English	Review							DNA-DAMAGE RESPONSE; GROSS CHROMOSOMAL REARRANGEMENTS; TRANSCRIPTION-COUPLED REPAIR; DOUBLE-STRAND BREAKS; CENTROSOME AMPLIFICATION; GENETIC INSTABILITY; REPLICATION FORKS; MEIOTIC CELLS; COMPLEX; RECOMBINATION	Inherited mutations in BRCA1 or BRCA2 predispose to breast, ovarian, and other cancers. Their ubiquitously expressed protein products are implicated in processes fundamental to all cells, including DNA repair and recombination, checkpoint control of cell cycle, and transcription. Here, I examine what is known about the biological functions of the BRCA proteins and ask how their disruption can induce susceptibility to specific types of cancer.	Univ Cambridge, CRC, Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England	University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, CRC, Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.							Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Baer R, 2001, NAT STRUCT BIOL, V8, P822, DOI 10.1038/nsb1001-822; Bennett LM, 2000, CANCER RES, V60, P3461; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Fuks F, 1998, ONCOGENE, V17, P2531, DOI 10.1038/sj.onc.1202475; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Goggins M, 2000, AM J PATHOL, V156, P1767, DOI 10.1016/S0002-9440(10)65047-X; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Greenblatt MS, 2001, CANCER RES, V61, P4092; Gretarsdottir S, 1998, CANCER RES, V58, P859; Haber JE, 1999, NATURE, V398, P665, DOI 10.1038/19423; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Le Page F, 2000, CANCER RES, V60, P5548; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; TAKATA M, 2002, IN PRESS ONCOGENE; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Tirkkonen M, 1997, CANCER RES, V57, P1222; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Venkitaraman AR, 2000, PHILOS T R SOC B, V355, P191, DOI 10.1098/rstb.2000.0558; Wang Y, 2000, GENE DEV, V14, P927; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Wu-Baer F, 2001, Nature, V414, P36, DOI 10.1038/35102118; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	78	1264	1317	2	327	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					171	182		10.1016/S0092-8674(02)00615-3	http://dx.doi.org/10.1016/S0092-8674(02)00615-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832208	Bronze			2022-12-28	WOS:000173521300005
J	Berwick, DM				Berwick, DM			Commentary: Same price, better care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Healthcare Improvement, Boston, MA 02215 USA	Institute for Healthcare Improvement	Berwick, DM (corresponding author), Inst Healthcare Improvement, 375 Longwood Ave, Boston, MA 02215 USA.								0	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					142	143						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11822330				2022-12-28	WOS:000173470600015
J	Clark, C; Buchwald, D; MacIntyre, A; Sharpe, M; Wessely, S				Clark, C; Buchwald, D; MacIntyre, A; Sharpe, M; Wessely, S			Chronic fatigue syndrome: a step towards agreement	LANCET			English	Editorial Material									Act ME, London EC4V 5AA, England; Univ Washington, Harborview Med Ctr, Chron Fatigue Cooperat Res Ctr, Seattle, WA 98195 USA; Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland; Guys Kings & St Thomas Sch Med, Dept Psychol Med, London, England	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Edinburgh; University of London; King's College London	Clark, C (corresponding author), Act ME, 4 Deans Court,St Pauls Churchyard, London EC4V 5AA, England.		Wessely, Simon C/A-8713-2008	sharpe, michael/0000-0002-6474-9980				*ROY COLL PHYS PSY, 1996, CHRON FAT SYNDR; Straus SE, 1996, BRIT MED J, V313, P831; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360; 1996, LANCET, V348, P971	4	18	20	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					97	98		10.1016/S0140-6736(02)07336-1	http://dx.doi.org/10.1016/S0140-6736(02)07336-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809249				2022-12-28	WOS:000173212400006
J	Chan, FKL; To, KF; Wu, JCY; Yung, MY; Leung, WK; Kwok, T; Hui, Y; Chan, HLY; Chan, CSY; Hui, E; Woo, J; Sung, JJY				Chan, FKL; To, KF; Wu, JCY; Yung, MY; Leung, WK; Kwok, T; Hui, Y; Chan, HLY; Chan, CSY; Hui, E; Woo, J; Sung, JJY			Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SERIOUS GASTROINTESTINAL COMPLICATIONS; RHEUMATOID-ARTHRITIS; INFECTION; GASTRITIS; THERAPY; METAANALYSIS; ULCERATION; TOXICITY	Background Whether Helicobacter pylori increases the risk of ulcers in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) is controversial. We hypothesised that eradication of H pylori infection would reduce the risk of ulcers for patients starting long-term NSAID treatment. Methods Patients were enrolled if they were NSAID naive, had a positive urea breath test, had dyspepsia or an ulcer history, and required long-term NSAID treatment. They were randomly assigned omeprazole triple therapy (eradication group) or omeprazole with placebo antibiotics (placebo group) for 1 week. All patients were given diclofenac slow release 100 mg daily for 6 months from randomisation. Endoscopy was done at 6 months or if severe dyspepsia or gastrointestinal bleeding occurred. The primary endpoint was the probability of ulcers within 6 months. Analyses were by intention to treat. Findings Of 210 arthritis patients screened, 128 (61%) were positive for H pylori. 102 patients were enrolled, and 100 were included in the intention-to-treat analysis. H pylori was eradicated in 90% of the eradication group and 6% of the placebo group. Five of 51 eradication-group patients and 15 of 49 placebo-group patients had ulcers. The 6-month probability of ulcers was 12.1% (95% CI 3.1-21.1) in the eradication group and 34.4% (21.1-47.7) in the placebo group (p=0.0085). The corresponding 6-month probabilities of complicated ulcers were 4.2% (1.3-9.7) and 27.1% (14.7-39.5; p=0.0026). Interpretation Screening and treatment for H pylori infection significantly reduces the risk of ulcers for patients starting long-term NSAID treatment.	Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Community & Family Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong	Chan, FKL (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, 30-32 Mgan Shing St, Shatin, Hong Kong, Peoples R China.		Lee, Yeong Yeh/G-2470-2010; Leung, Wai Keung/B-8140-2011; Hui, Edwin/ABC-1818-2021; Chan, Henry Lik-Yuen/B-9636-2008; Sung, Joseph J. Y./R-3203-2018; Chan, Francis K. L./F-4851-2010; Wu, Justin/N-6916-2015; Woo, Jean/K-2625-2014	Lee, Yeong Yeh/0000-0002-6486-7717; Leung, Wai Keung/0000-0002-5993-1059; Chan, Henry Lik-Yuen/0000-0002-7790-1611; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Francis K. L./0000-0001-7388-2436; Woo, Jean/0000-0001-7593-3081				Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Goldstein JL, 2001, AM J GASTROENTEROL, V96, P1019; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1653, DOI 10.1016/0016-5085(91)90665-8; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Hawkey CJ, 1998, LANCET, V352, P1016, DOI 10.1016/S0140-6736(98)04206-8; Henry D, 1996, BRIT MED J, V312, P1563, DOI 10.1136/bmj.312.7046.1563; Kim Jong G., 1994, American Journal of Gastroenterology, V89, P203; Konturek JW, 1998, GASTROENTEROLOGY, V114, P245, DOI 10.1016/S0016-5085(98)70474-3; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; Lundell L, 1999, GASTROENTEROLOGY, V117, P319, DOI 10.1053/gast.1999.0029900319; Malfertheiner P, 1997, EUR J GASTROEN HEPAT, V9, P1; McCarthy DM, 1998, YALE J BIOL MED, V71, P101; Roberts AP, 2000, FAM PRACT, V17, pS12, DOI 10.1093/fampra/17.suppl_2.S12; Russell RI, 1999, ITAL J GASTROENTEROL, V31, P116; Scheiman JM, 2001, ALIMENT PHARM THER, V15, P63, DOI 10.1046/j.1365-2036.2001.00874.x; SHALLCROSS TM, 1990, ALIMENT PHARM THERAP, V4, P515; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; TAHA AS, 1995, GUT, V36, P334, DOI 10.1136/gut.36.3.334; TAHA AS, 1999, GASTROENTEROLOGY, V116, P1; UPADHYAY R, 1988, BRIT J RHEUMATOL, V27, P113; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	26	205	217	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					9	13		10.1016/S0140-6736(02)07272-0	http://dx.doi.org/10.1016/S0140-6736(02)07272-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809180				2022-12-28	WOS:000173143500009
J	Azevedo, C; Sadanandom, A; Kitagawa, K; Freialdenhoven, A; Shirasu, K; Schulze-Lefert, P				Azevedo, C; Sadanandom, A; Kitagawa, K; Freialdenhoven, A; Shirasu, K; Schulze-Lefert, P			The RAR1 interactor SGT1, an essential component of R gene-triggered disease resistance	SCIENCE			English	Article							COP9 SIGNALOSOME; PROTEIN; ARABIDOPSIS; EXPRESSION; BARLEY	Plant disease resistance (R) genes trigger innate immune responses upon pathogen attack. RAR1 is an early convergence: point in a signaling pathway engaged by multiple R genes. Here, vie show that RAR1 interacts with plant orthologs of the yeast protein SGT1, an essential regulator in the cell cycle. Silencing the barley gene Sgt1 reveals its role in R gene-triggered, Rar1-dependent disease resistance. SGT1 associates with SKP1 and CUL1, subunits of the SCF (Skp1-Cullin-F-box) ubiquitin ligase complex. Furthermore, the RAR1-SGT1 complex also interacts with two COP9 signalosome components. The interactions among RAR1, SGT1, SCF, and signalosome subunits indicate a link between disease resistance and ubiquitination.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; Max Planck Inst Zuchtungsforsch, Biochem Abt, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; St Jude Children's Research Hospital; Max Planck Society	Shirasu, K (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	ken.shirasu@bbrsc.ac.uk	Azevedo, Cristina/Y-4296-2019; Shirasu, Ken/A-4455-2010; Shirasu, Ken/ABF-5306-2020; Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008	Azevedo, Cristina/0000-0002-6997-1265; Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; 				Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Jorgensen JH, 1996, GENOME, V39, P492, DOI 10.1139/g96-063; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Schweizer P, 2000, PLANT J, V24, P895, DOI 10.1046/j.1365-313x.2000.00941.x; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	23	472	514	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2073	2076		10.1126/science.1067554	http://dx.doi.org/10.1126/science.1067554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11847307				2022-12-28	WOS:000174450500049
J	Mann, JJ				Mann, JJ			A current perspective of suicide and attempted suicide	ANNALS OF INTERNAL MEDICINE			English	Review							FLUID MONOAMINE METABOLITES; MAJOR DEPRESSION; MENTAL-DISORDERS; CEREBROSPINAL-FLUID; PERSONALITY-DISORDER; NICOTINE DEPENDENCE; IMPULSIVE VIOLENCE; ADOLESCENT SUICIDE; LOCUS-COERULEUS; LETHAL METHODS	Suicide and suicide attempts are a major cause of death and morbidity worldwide. Suicide is generally a complication of a psychiatric disorder, but it requires additional risk factors because most psychiatric patients never attempt suicide. This review includes a hypothesized stress-diathesis model, which has implications for detection of high-risk patients and treatment interventions, and discusses promising treatment approaches that have been recently identified.	Columbia Univ, New York, NY 10032 USA	Columbia University	Mann, JJ (corresponding author), New York State Psychiat Inst & Hosp, Dept Neurosci, 1051 Riverside Dr,Box 42, New York, NY 10032 USA.	jjm@columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH046745, R10MH056390, R01MH056390, P50MH046745, R01MH040210, R01MH048514] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46745, MH40210, MH56390, MH48514] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Arango V, 1996, BIOL PSYCHIAT, V39, P112, DOI 10.1016/0006-3223(95)00107-7; Baldessarini RJ, 1999, J CLIN PSYCHIAT, V60, P77; BARRACLOUGH B, 1974, BRIT J PSYCHIAT, V125, P355, DOI 10.1192/bjp.125.4.355; Beautrais AL, 1996, AUST NZ J PSYCHIAT, V30, P741, DOI 10.3109/00048679609065040; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; BECK AT, 1989, J AFFECT DISORDERS, V17, P203, DOI 10.1016/0165-0327(89)90001-3; BECK AT, 1975, AM J PSYCHIAT, V132, P285; BECK AT, 1976, ARCH GEN PSYCHIAT, V33, P835; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; BOYD JH, 1983, NEW ENGL J MED, V308, P872, DOI 10.1056/NEJM198304143081504; BRENT DA, 1986, J AM ACAD CHILD PSY, V25, P242, DOI 10.1016/S0002-7138(09)60232-6; BRENT DA, 1993, J AM ACAD CHILD PSY, V32, P69, DOI 10.1097/00004583-199301000-00010; BRENT DA, 1994, J AM ACAD CHILD PSY, V33, P1080, DOI 10.1097/00004583-199410000-00003; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; BRESLAU N, 1992, NEUROLOGY, V42, P392, DOI 10.1212/WNL.42.2.392; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P1069; BRESLAU N, 1991, PSYCHIAT RES, V37, P11, DOI 10.1016/0165-1781(91)90102-U; BRESLAU N, 1993, ARCH GEN PSYCHIAT, V50, P31; Brodsky BS, 1997, AM J PSYCHIAT, V154, P1715, DOI 10.1176/ajp.154.12.1715; BROWN RP, 1988, PSYCHIAT RES, V23, P167, DOI 10.1016/0165-1781(88)90007-8; BUCHHEIT KH, 1991, EUR J PHARMACOL, V200, P373, DOI 10.1016/0014-2999(91)90601-L; BUNNEY WE, 1969, ARCH GEN PSYCHIAT, V21, P138; BURVILL PW, 1982, PSYCHOL MED, V12, P295, DOI 10.1017/S0033291700046638; Cantor C, 2000, AUST NZ J PSYCHIAT, V34, P370, DOI 10.1080/j.1440-1614.2000.00756.x; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; COOPER SJ, 1992, LANCET, V340, P940, DOI 10.1016/0140-6736(92)92819-2; CORNELIUS JR, 1995, AM J PSYCHIAT, V152, P358; Cornelius JR, 1998, ADDICT BEHAV, V23, P119, DOI 10.1016/S0306-4603(97)00019-1; DORPAT TL, 1960, COMPR PSYCHIAT, V1, P349, DOI 10.1016/S0010-440X(60)80058-2; DULIT RA, 1990, AM J PSYCHIAT, V147, P1002; ELLIOTT FA, 1992, ARCH NEUROL-CHICAGO, V49, P595, DOI 10.1001/archneur.1992.00530300027006; FARRER LA, 1986, AM J MED GENET, V24, P305, DOI 10.1002/ajmg.1320240211; Fawcett J, 1997, ANN NY ACAD SCI, V836, P288, DOI 10.1111/j.1749-6632.1997.tb52366.x; Frances A, 1986, Ann N Y Acad Sci, V487, P281, DOI 10.1111/j.1749-6632.1986.tb27907.x; Frost E. A. M., 1994, Annals Academy of Medicine Singapore, V23, P497; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; GLASSMAN AH, 1993, AM J PSYCHIAT, V150, P546; GOLDSTEIN RB, 1991, ARCH GEN PSYCHIAT, V48, P418; Golomb BA, 1998, ANN INTERN MED, V128, P478, DOI 10.7326/0003-4819-128-6-199803150-00009; GORENSTEIN EE, 1980, PSYCHOL REV, V87, P301, DOI 10.1037/0033-295X.87.3.301; GOULD MS, 1990, JAMA-J AM MED ASSOC, V263, P2051, DOI 10.1001/jama.263.15.2051; GOULD MS, 1990, AM J EPIDEMIOL, V131, P71, DOI 10.1093/oxfordjournals.aje.a115487; GOULD MS, 1994, INT J EPIDEMIOL, V23, P1185, DOI 10.1093/ije/23.6.1185; Harkavy-Friedman JM, 1999, AM J PSYCHIAT, V156, P1276; HENDEE WR, 1989, PUBLIC HEALTH REP, V104, P111; Henriksson MM, 1995, J AFFECT DISORDERS, V36, P11, DOI 10.1016/0165-0327(95)00047-X; HENRIKSSON MM, 1993, AM J PSYCHIAT, V150, P935; Hirschfeld RMA, 1997, NEW ENGL J MED, V337, P910, DOI 10.1056/NEJM199709253371307; ISACSSON G, 1992, ACTA PSYCHIAT SCAND, V85, P444, DOI 10.1111/j.1600-0447.1992.tb03209.x; ISACSSON G, 1995, BRIT MED J, V310, P127, DOI 10.1136/bmj.310.6972.127a; ISOMETSA E, 1995, BRIT MED J, V310, P1366, DOI 10.1136/bmj.310.6991.1366; ISOMETSA E, 1994, BRIT MED J, V308, P915, DOI 10.1136/bmj.308.6933.915; ISOMETSA ET, 1995, AM J PSYCHIAT, V152, P919; Jamison K R, 1986, Ann N Y Acad Sci, V487, P301, DOI 10.1111/j.1749-6632.1986.tb27909.x; Johns C A, 1986, Ann N Y Acad Sci, V487, P294; KAPLAN JR, 1994, PSYCHOSOM MED, V56, P479, DOI 10.1097/00006842-199411000-00001; KAPUR S, 1992, JAMA-J AM MED ASSOC, V268, P3441, DOI 10.1001/jama.268.24.3441; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Lambert MT, 1998, PSYCHIAT QUART, V69, P127, DOI 10.1023/A:1024714619938; LEON AC, 1990, PSYCHIAT RES, V31, P99, DOI 10.1016/0165-1781(90)90112-I; LESTER D, 1989, ACTA PSYCHIAT SCAND, V80, P180, DOI 10.1111/j.1600-0447.1989.tb01324.x; Linehan M M, 1986, Ann N Y Acad Sci, V487, P16; LISHMAN WA, 1987, PSYCHOLOGICAL CONSEQ; Malone KM, 1996, BRIT J PSYCHIAT, V168, P324, DOI 10.1192/bjp.168.3.324; MALONE KM, 1995, J AFFECT DISORDERS, V34, P173, DOI 10.1016/0165-0327(95)00015-F; Mann JJ, 1996, NEUROPSYCHOPHARMACOL, V15, P576, DOI 10.1016/S0893-133X(96)00102-9; Mann JJ, 2000, ARCH GEN PSYCHIAT, V57, P729, DOI 10.1001/archpsyc.57.8.729; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; Mann JJ, 2001, NEUROPSYCHOPHARMACOL, V24, P467, DOI 10.1016/S0893-133X(00)00228-1; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; MANN JJ, 1999, HARVARD MED SCH QUID, P98; Maris RW, 2000, COMPREHENSIVE TEXTBOOK OF SUICIDOLOGY, P26; MARTTUNEN MJ, 1991, ARCH GEN PSYCHIAT, V48, P834; MARZUK PM, 1988, JAMA-J AM MED ASSOC, V259, P1333, DOI 10.1001/jama.259.9.1333; MARZUK PM, 1992, ARCH GEN PSYCHIAT, V49, P451; MARZUK PM, 1988, PSYCHIAT ANN, V18, P639; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MELTZER HY, 1995, AM J PSYCHIAT, V152, P183; MULDOON MF, 1990, BMJ-BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309; MULDOON MF, 1993, METABOLISM, V42, P45, DOI 10.1016/0026-0495(93)90259-Q; MURPHY GE, 1990, ARCH GEN PSYCHIAT, V47, P383; MURPHY GE, 1992, ARCH GEN PSYCHIAT, V49, P459; MURPHY GE, 1988, ARCH GEN PSYCHIAT, V45, P593; NEMEROFF CB, 1988, ARCH GEN PSYCHIAT, V45, P577; Nilsson A, 1999, J CLIN PSYCHIAT, V60, P85; NORDSTROM P, 1994, SUICIDE LIFE-THREAT, V24, P1; Oquendo MA, 1999, AM J PSYCHIAT, V156, P190; Ordway GA, 1997, ANN NY ACAD SCI, V836, P233, DOI 10.1111/j.1749-6632.1997.tb52363.x; POKORNY AD, 1983, ARCH GEN PSYCHIAT, V40, P249; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Reid WH, 1998, PSYCHIATR SERV, V49, P1029, DOI 10.1176/ps.49.8.1029; RICH CL, 1995, AM J PSYCHIAT, V152, P1239; RICH CL, 1988, ARCH GEN PSYCHIAT, V45, P589, DOI 10.1001/archpsyc.1988.01800300087012; ROBINS E, 1959, AM J PUBLIC HEALTH N, V49, P888, DOI 10.2105/AJPH.49.7.888; ROY A, 1995, AM J PSYCHIAT, V152, P1075; ROY A, 1991, ARCH GEN PSYCHIAT, V48, P29; ROY A, 1986, SUICIDE LIFE-THREAT, V16, P244; ROY A, 1990, AM J PSYCHIAT, V147, P761; ROY A, 1989, ARCH GEN PSYCHIAT, V46, P609; ROY A, 1983, ARCH GEN PSYCHIAT, V40, P971; ROY A, 1990, ACTA PSYCHIAT SCAND, V81, P58, DOI 10.1111/j.1600-0447.1990.tb06449.x; RUNESON B, 1989, ACTA PSYCHIAT SCAND, V79, P490, DOI 10.1111/j.1600-0447.1989.tb10292.x; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x; Rutz W, 1997, Int J Psychiatry Clin Pract, V1, P39, DOI 10.3109/13651509709069204; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; SCHMIDTKE A, 1988, PSYCHOL MED, V18, P665, DOI 10.1017/S0033291700008345; SCHOENFELD M, 1984, J NEUROL NEUROSUR PS, V47, P1283, DOI 10.1136/jnnp.47.12.1283; Schulsinger F., 1979, ORIGIN PREVENTION TR, P277; Shaffer D, 1996, ARCH GEN PSYCHIAT, V53, P339; SHEARER SL, 1988, AM J PSYCHIAT, V145, P1424; SMITH JC, 1988, AM J PUBLIC HEALTH, V78, P78, DOI 10.2105/AJPH.78.1.78; STENGEL E, 1974, SUICIDE ATTEMPTED SU; VAUHKONEN K, 1959, ACTA PSYCHIAT NEUR S, V137, P90; Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010	119	379	392	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					302	311		10.7326/0003-4819-136-4-200202190-00010	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523FQ	11848728				2022-12-28	WOS:000173943700007
J	Martin, A; Bardwell, PD; Woo, CJ; Fan, MX; Shulman, MJ; Scharff, MD				Martin, A; Bardwell, PD; Woo, CJ; Fan, MX; Shulman, MJ; Scharff, MD			Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas	NATURE			English	Article							B-CELL LINE; MSH2-DEFICIENT MICE; MISMATCH REPAIR; IMMUNE-RESPONSE; IN-VITRO; SEQUENCES; GENES; NUCLEOTIDE; INDUCTION; MUTATION	The production of high-affinity protective antibodies requires somatic hypermutation (SHM) of the antibody variable (V) region genes. SHM is characterized by a high frequency of point mutations that occur only during the centroblast stage of B-cell differentiation. Activation-induced cytidine deaminase (AID), which is expressed specifically in germinal-centre centroblasts(1), is required for this process, but its exact role is unknown(2). Here we show that AID is required for SHM in the centroblast-like Ramos cells, and that expression of AID is sufficient to induce SHM in hybridoma cells, which represent a later stage of B-cell differentiation that does not normally undergo SHM. In one hybridoma, mutations were exclusively in G.C base pairs that were mostly within RGYW or WRCY motifs, suggesting that AID has primary responsibility for mutations at these nucleotides. The activation of SHM in hybridomas indicates that AID does not require other centroblast-specific cofactors to induce SHM, suggesting either that it functions alone or that the factors it requires are expressed at other stages of B-cell differentiation.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Scharff, MD (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave Chanin 403, Bronx, NY 10461 USA.		Martin, Alberto/B-1421-2008; Bardwell, Philip/H-2219-2014; Bardwell, Philip D./K-8442-2013	Bardwell, Philip/0000-0002-3835-255X; Bardwell, Philip D./0000-0002-3835-255X; Martin, Alberto/0000-0002-0795-0418				Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; CONNOR A, 1994, J BIOL CHEM, V269, P25178; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; KOBRIN BJ, 1990, SOMATIC HYPERMUTATIO, V5, P11; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lin MMQ, 1997, P NATL ACAD SCI USA, V94, P5284, DOI 10.1073/pnas.94.10.5284; Luria SE, 1943, GENETICS, V28, P491; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 1997, EUR J IMMUNOL, V27, P3115, DOI 10.1002/eji.1830271206; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2001, EMBO J, V20, P4570, DOI 10.1093/emboj/20.16.4570; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sack SZ, 2001, MOL IMMUNOL, V38, P303, DOI 10.1016/S0161-5890(01)00058-X; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Spencer J, 1999, J IMMUNOL, V162, P6596; TAO W, 1990, J IMMUNOL, V145, P3216; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang W, 2001, INT IMMUNOL, V13, P1175, DOI 10.1093/intimm/13.9.1175	27	211	226	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					802	806		10.1038/nature714	http://dx.doi.org/10.1038/nature714			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11823785				2022-12-28	WOS:000173833900049
J	Xu, HE; Stanley, TB; Montana, VG; Lambert, MH; Shearer, BG; Cobb, JE; McKee, DD; Galardi, CM; Plunket, KD; Nolte, RT; Parks, DJ; Moore, JT; Kliewer, SA; Willson, TM; Stimmel, JB				Xu, HE; Stanley, TB; Montana, VG; Lambert, MH; Shearer, BG; Cobb, JE; McKee, DD; Galardi, CM; Plunket, KD; Nolte, RT; Parks, DJ; Moore, JT; Kliewer, SA; Willson, TM; Stimmel, JB			Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR alpha	NATURE			English	Article							ACTIVATED RECEPTOR-GAMMA; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; PROMYELOCYTIC LEUKEMIA; HORMONE RECEPTORS; BINDING; COACTIVATOR; RECOGNITION; SMRT; COREPRESSORS	Repression of gene transcription by nuclear receptors is mediated by interactions with co-repressor proteins such as SMRT and NCoR1,2, which in turn recruit histone deacetylases to the chromatin(3-5). Aberrant interactions between nuclear receptors and co-repressors contribute towards acute promyelocytic leukaemia and thyroid hormone resistance syndrome (6-8). The binding of co-repressors to nuclear receptors occurs in the unliganded state, and can be stabilized by antagonists(9). Here we report the crystal structure of a ternary complex containing the peroxisome proliferator-activated receptor-alpha ligand-binding domain bound to the antagonist GW6471 and a SMRT co-repressor motif. In this structure, the co-repressor motif adopts a three-turn alpha-helix that prevents the carboxy-terminal activation helix (AF-2) of the receptor from assuming the active conformation. Binding of the co-repressor motif is further reinforced by the antagonist, which blocks the AF-2 helix from adopting the active position. Biochemical analyses and structure-based mutagenesis indicate that this mode of co-repressor binding is highly conserved across nuclear receptors.	GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline	Xu, HE (corresponding author), GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA.	ex11957@gsk.com	feinstein, doug/M-9414-2019; ID, IMCACAT/D-5867-2014					Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NAVAZA J, 1992, MOL REPLACEMENT, P87; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; ONATE SA, 1995, SCIENCE, V270, P1354; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yoh SM, 1997, MOL ENDOCRINOL, V11, P470, DOI 10.1210/me.11.4.470; Zhou GC, 1998, MOL ENDOCRINOL, V12, P1594, DOI 10.1210/me.12.10.1594	30	499	523	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					813	817		10.1038/415813a	http://dx.doi.org/10.1038/415813a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845213				2022-12-28	WOS:000173833900052
J	Geller, G; Bernhardt, BA; Holtzman, NA				Geller, G; Bernhardt, BA; Holtzman, NA			The media and public reaction to genetic research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Geller, G (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.							Bernhardt BA, 2000, AM J HUM GENET, V67, P62; Beskow LM, 2001, JAMA-J AM MED ASSOC, V286, P2315, DOI 10.1001/jama.286.18.2315; Condit CM, 1998, AM J HUM GENET, V62, P979, DOI 10.1086/301784; CONRAD P, 1996, PERS SPC PT, V8, P3; Hopkins PD, 1998, HASTINGS CENT REP, V28, P6, DOI 10.2307/3527566; Nelkin D., 1995, DNA MYSTIQUE GENE CU; Petersen A, 2001, SOC SCI MED, V52, P1255, DOI 10.1016/S0277-9536(00)00229-X; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; TAMBOR ES, IN PRESS GENET MED; THOMPSON L, 1994, GENES HUMAN SELF KNO, P104	10	47	47	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					773	773		10.1001/jama.287.6.773	http://dx.doi.org/10.1001/jama.287.6.773			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851549	hybrid			2022-12-28	WOS:000173809500038
J	Turner, CF; Rogers, SM; Miller, HG; Miller, WC; Gribble, JN; Chromy, JR; Leone, PA; Quinn, TC; Zenilman, JM				Turner, CF; Rogers, SM; Miller, HG; Miller, WC; Gribble, JN; Chromy, JR; Leone, PA; Quinn, TC; Zenilman, JM			Untreated gonococcal and chlamydial infection in a probability sample of adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED DISEASES; LIGASE CHAIN-REACTION; TRACHOMATIS INFECTION; NEISSERIA-GONORRHOEAE; DIAGNOSIS; URINE; MEN; WOMEN; PREVALENCE; BEHAVIOR	Context The prevalence and distribution of gonococcal and chlamydial infections in the general population are poorly understood. Development of nucleic acid amplification tests, such as the ligase chain reaction assay, provides new opportunities to estimate the prevalence of untreated infections in the population. Objective To estimate the overall prevalence of untreated gonococcal and chlamydial infections and to describe patterns of infection within specific demographic subgroups of the young adult population in Baltimore, Md. Design and Setting Cross-sectional behavioral survey based on a probability sample of Baltimore households with collection of urine specimens between January 1997 and September 1998. Participants A total of 728 adults aged 18 to 35 years completed the interview portion of the study, and 579 of these respondents also provided a urine specimen adequate for testing. Main Outcome Measure Prevalence of untreated infection, as measured by the percentage of specimens testing positive for gonococcal and chlamydial infection by ligase chain reaction, weighted to reflect variations in probabilities of sample selection from the population. Alternate estimates of the prevalence of recent treated infection were derived from clinically diagnosed cases reported to the Baltimore City Health Department and by diagnoses reported by participants in the survey. Results An estimated 5.3% (SE, 1.4%) of the population aged 18 to 35 years has an untreated gonococcal infection, and 3.0% (SE, 0.8%) is estimated to have an untreated chlamydial infection. While 7.9% (SE, 1.6%) of the population is estimated to have either an untreated gonococcal or chlamydial infection, estimated prevalence is substantially higher among black women (15.0%; SE, 3.7%). Few participants with untreated infections reported dysuria or discharge during the 6 months preceding testing. The estimated number of untreated gonococcal infections in the population (9241; SE, 2441) substantially exceeds both the number of such infections diagnosed among Baltimore adults aged 18 to 35 years and reported to the Baltimore City Health Department during 1998 (4566), and the estimated number of diagnoses derived using participants' reports for the 12 months prior to the survey (4708 [SE, 1918] to 5231 [SE, 2092]). The estimated number of untreated chlamydial infections (5231; SE, 1395) is also greater than the number of cases reported to the health department in 1998 (3664) but is slightly less than the estimated number of diagnoses derived using participants' reports of chlamydial infections diagnosed during the 12 months prior to the survey (5580 [SE, 1918] to 6975 [SE, 2441]). Conclusion In 1997-1998, the estimated number of undiagnosed gonococcal and chlamydial infections prevalent in the population of Baltimore adults aged 18 to 35 years approached or exceeded the number of infections that were diagnosed and treated annually.	Res Triangle Inst, Program Hlth & Behav Measurement, Washington, DC 20036 USA; CUNY Queens Coll, Flushing, NY 11367 USA; CUNY, Grad Ctr, Flushing, NY USA; Res Triangle Inst, Div Stat Res, Res Triangle Pk, NC 27709 USA; Res Triangle Inst, Res Comp Div, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; NIAID, Bethesda, MD 20892 USA	Research Triangle Institute; City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; Research Triangle Institute; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Turner, CF (corresponding author), Res Triangle Inst, Program Hlth & Behav Measurement, 1615 M St NW, Washington, DC 20036 USA.		Quinn, Thomas/A-2494-2010; Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	NCRR NIH HHS [RR00046] Funding Source: Medline; NIAID NIH HHS [K24-AI01633, U19-AI38533] Funding Source: Medline; NICHD NIH HHS [R01-HD31067] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI038533, ZIAAI000358, Z01AI000358, K24AI001633] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brodine SK, 1998, J INFECT DIS, V178, P1202, DOI 10.1086/515685; CHERNESKY MA, 1994, J CLIN MICROBIOL, V32, P2682, DOI 10.1128/JCM.32.11.2682-2685.1994; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; *I MED, 1996, HIDD EP CONFR SEX TR; Ku L, 1997, SEX TRANSM DIS, V24, P299, DOI 10.1097/00007435-199705000-00012; KU L, IN PRESS AM J PUBLIC; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; LEE HH, 1995, LANCET, V345, P213, DOI 10.1016/S0140-6736(95)90221-X; MCNAGNY SE, 1992, J INFECT DIS, V165, P573, DOI 10.1093/infdis/165.3.573; Mehta SD, 2000, SEX TRANSM DIS, V27, P154, DOI 10.1097/00007435-200003000-00007; Pack RP, 2000, SEX TRANSM DIS, V27, P175, DOI 10.1097/00007435-200003000-00011; Parks KS, 1997, SEX TRANSM DIS, V24, P229, DOI 10.1097/00007435-199704000-00008; POTTERAT JJ, 1981, JAMA-J AM MED ASSOC, V245, P578, DOI 10.1001/jama.245.6.578; Quinn TC, 1996, J CLIN MICROBIOL, V34, P1401, DOI 10.1128/JCM.34.6.1401-1406.1996; QUINN TC, 1994, SEX TRANSM DIS, V21, P19; Rogers SM, 1999, POPULATION, V54, P231, DOI 10.2307/1534900; ROGERS SM, 2001, TRANSMISSIBILITY GC; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Shah BV, 1996, SUDAAN USERS MANUAL; SMITH KR, 1995, J CLIN MICROBIOL, V33, P455, DOI 10.1128/JCM.33.2.455-457.1995; Stary A, 1997, J CLIN MICROBIOL, V35, P239, DOI 10.1128/JCM.35.1.239-242.1997; *STAT CORP, 1999, STAT STAT SOFTW REL; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; TURNER CF, 1998, COMPUTER ASSISTED SU; TURNER CF, TECHNICAL PAPERS HLT; TURNER CF, 1999, 13 M INT SOC SEX TRA; *US BUR CENS, 2000, POP EST COUNT AG SEX; Whittington WLH, 2000, J INFECT DIS, V181, P1044, DOI 10.1086/315343; Zenilman JM, 1997, SEX TRANSM DIS, V24, P310, DOI 10.1097/00007435-199705000-00013	30	153	157	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					726	733		10.1001/jama.287.6.726	http://dx.doi.org/10.1001/jama.287.6.726			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851539	Bronze			2022-12-28	WOS:000173809500029
J	Wilson, RS; de Leon, CFM; Barnes, LL; Schneider, JA; Bienias, JL; Evans, DA; Bennett, DA				Wilson, RS; de Leon, CFM; Barnes, LL; Schneider, JA; Bienias, JL; Evans, DA; Bennett, DA			Participation in cognitively stimulating activities and risk of incident Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEFINED POPULATION; OLDER PERSONS; LIFE-STYLE; DEMENTIA; EDUCATION; IMPAIRMENT; DECLINE; INDIVIDUALS; ASSOCIATION; CONSORTIUM	Context Frequent participation in cognitively stimulating activities has been hypothesized to reduce risk of Alzheimer disease (AD), but prospective data regarding an association are lacking. Objective To test the hypothesis that frequent participation in cognitive activities is associated with a reduced risk of AD. Design Longitudinal cohort study with baseline evaluations performed between January 1994 and July 2001 and mean follow-up of 4.5 years. Participants and Setting A total of 801 older Catholic nuns, priests, and brothers without dementia at enrollment, recruited from 40 groups across the United States. At baseline, they rated frequency of participation in common cognitive activities (eg, reading a newspaper), from which a previously validated composite measure of cognitive activity frequency was derived. Main Outcome Measures Clinical diagnosis of AD by a board-certified neurologist using National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria and change in global and specific measures of cognitive function, compared by cognitive activity scare at baseline. Results Baseline scores on the composite measure of cognitive activity ranged from 1.57 to 4.71 (mean, 3.57; SD, 0.55), with higher scores indicating more frequent activity. During an average of 4.5 years of follow-up, 111 persons developed AD. In a proportional hazards model that controlled for age, sex, and education, a 1-point increase in cognitive activity score was associated with a 33% reduction in risk of AD (hazard ratio, 0.67; 95% confidence interval, 0.49-0.92). Results were comparable when persons with memory impairment at baseline were excluded and when terms for the apolipoprotein E epsilon4 allele and other medical conditions were added. in random-effects models that controlled for age, sex, education, and baseline level of cognitive function, a 1-point increase in cognitive activity was associated with reduced decline in global cognition (by 47%), working memory (by 60%), and perceptual speed (by 30%). Conclusion These results suggest that frequent participation in cognitively stimulating activities is associated with reduced risk of AD.	Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; Rush Inst Healthy Aging, Chicago, IL USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Psychol, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Med, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University; Rush University	Wilson, RS (corresponding author), Rush Alzheimers Dis Ctr, 1645 W Jackson Blvd,Suite 675, Chicago, IL 60612 USA.	rwilson@rush.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026	NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG015819, K08AG000849] Funding Source: NIH RePORTER; NIA NIH HHS [KO8 AG00849, P30 AG10161, R01 AG15819] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; [Anonymous], 1994, ASSESSMENT CLIN MANU; BICKEL H, 1994, PSYCHOL MED, V24, P179, DOI 10.1017/S0033291700026945; Bowen J, 1997, LANCET, V349, P763, DOI 10.1016/S0140-6736(96)08256-6; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; CHRISTENSEN H, 1993, AGE AGEING, V22, P175, DOI 10.1093/ageing/22.3.175; COBB JL, 1995, NEUROLOGY, V45, P1707, DOI 10.1212/WNL.45.9.1707; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; COX DR, 1972, J R STAT SOC B, V34, P187; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; FRIEDLAND RP, 1993, NEUROLOGY, V43, P246, DOI 10.1212/WNL.43.2.246; Hertzog C, 1999, PSYCHOL AGING, V14, P528, DOI 10.1037/0882-7974.14.3.528; HIXSON JE, 1990, J LIPID RES, V31, P545; Howieson DB, 1997, J AM GERIATR SOC, V45, P584, DOI 10.1111/j.1532-5415.1997.tb03091.x; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; HULTSCH DF, 1993, J GERONTOL, V48, pP1, DOI 10.1093/geronj/48.1.P1; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MCPHILLIPS JB, 1989, AM J PREV MED, V5, P65, DOI 10.1016/S0749-3797(18)31107-3; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mortimer JA, 1997, GERIATRICS, V52, pS50; Mufson EJ, 1999, EXP NEUROL, V158, P469, DOI 10.1006/exnr.1999.7086; Nelson HE., 1982, NATL ADULT READING T; Ott A, 1999, NEUROLOGY, V52, P663, DOI 10.1212/WNL.52.3.663; PAYKEL ES, 1994, ARCH GEN PSYCHIAT, V51, P325; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raven JC., 1992, MANUAL RAVENS PROGR; SAS, 1997, SAS STAT US GUID VER; Smith A., 1982, SYMBOL DIGIT MODALIT; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Weschler D, 1987, WECHSLER MEMORY SCAL; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Wilson RS, 2000, ARCH NEUROL-CHICAGO, V57, P1718, DOI 10.1001/archneur.57.12.1718; Wilson RS, 2000, PSYCHOL AGING, V15, P18, DOI 10.1037/0882-7974.15.1.18; Wilson RS, 1999, J GERONTOL B-PSYCHOL, V54, pP155, DOI 10.1093/geronb/54B.3.P155; WILSON RS, IN PRESS PSYCHOL AGI; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161	51	839	864	2	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					742	748		10.1001/jama.287.6.742	http://dx.doi.org/10.1001/jama.287.6.742			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520XR	11851541				2022-12-28	WOS:000173809500031
J	Cheour, M; Martynova, O; Naatanen, R; Erkkola, R; Sillanpaa, M; Kero, P; Raz, A; Kaipio, ML; Hiltunen, J; Aaltonen, O; Savela, J; Hamalainen, H				Cheour, M; Martynova, O; Naatanen, R; Erkkola, R; Sillanpaa, M; Kero, P; Raz, A; Kaipio, ML; Hiltunen, J; Aaltonen, O; Savela, J; Hamalainen, H			Psychobiology - Speech sounds learned by sleeping newborns	NATURE			English	Article							CHILDREN		Univ Turku, Ctr Cognit Neurosci, Language & Dev Brain Lab, Turku 20100, Finland; Univ Turku, Dept Psychol, Turku 20100, Finland; Univ Turku, Dept Phonet, Turku 20100, Finland; Univ Helsinki, Cent Hosp, BioMag Lab, Helsinki 00029, Finland; Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Helsinki Brain Res Ctr, FIN-00014 Helsinki, Finland; Turku Univ, Cent Hosp, Dept Obstet & Gynaecol, Turku 20100, Finland; Turku Univ, Cent Hosp, Dept Child Neurol, Turku 20100, Finland; Turku Univ, Cent Hosp, Dept Pediat, Turku 20100, Finland; Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst Dev Psychobiol, New York, NY 10021 USA	University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Turku; University of Turku; University of Turku; Cornell University	Cheour, M (corresponding author), Univ Turku, Ctr Cognit Neurosci, Language & Dev Brain Lab, Turku 20100, Finland.	marie.cheour@utu.fi	Sillanpaa, Matti L/G-4708-2015; Martynova, Olga V/K-3900-2012	Sillanpaa, Matti L/0000-0003-4190-3698; Martynova, Olga V/0000-0001-9047-2893; Sillanpaa, Matti/0000-0002-1521-3602				Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 1998, INT J PSYCHOPHYSIOL, V29, P217, DOI 10.1016/S0167-8760(98)00017-8; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; van Heteren CF, 2000, LANCET, V356, P1169, DOI 10.1016/S0140-6736(00)02766-5	8	132	140	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					599	600		10.1038/415599b	http://dx.doi.org/10.1038/415599b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832930				2022-12-28	WOS:000173709100030
J	Knowler, WC; Barrett-Connor, E; Fowler, SE; Hamman, RF; Lachin, JM; Walker, EA; Nathan, DM				Knowler, WC; Barrett-Connor, E; Fowler, SE; Hamman, RF; Lachin, JM; Walker, EA; Nathan, DM		Diabetes Prevention Program Res G	Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MELLITUS; AMERICAN; DISEASE; NIDDM	Background: Type 2 diabetes affects approximately 8 percent of adults in the United States. Some risk factors-elevated plasma glucose concentrations in the fasting state and after an oral glucose load, overweight, and a sedentary lifestyle-are potentially reversible. We hypothesized that modifying these factors with a lifestyle-intervention program or the administration of metformin would prevent or delay the development of diabetes. Methods: We randomly assigned 3234 nondiabetic persons with elevated fasting and post-load plasma glucose concentrations to placebo, metformin (850 mg twice daily), or a lifestyle-modification program with the goals of at least a 7 percent weight loss and at least 150 minutes of physical activity per week. The mean age of the participants was 51 years, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 34.0; 68 percent were women, and 45 percent were members of minority groups. Results: The average follow-up was 2.8 years. The incidence of diabetes was 11.0, 7.8, and 4.8 cases per 100 person-years in the placebo, metformin, and lifestyle groups, respectively. The lifestyle intervention reduced the incidence by 58 percent (95 percent confidence interval, 48 to 66 percent) and metformin by 31 percent (95 percent confidence interval, 17 to 43 percent), as compared with placebo; the lifestyle intervention was significantly more effective than metformin. To prevent one case of diabetes during a period of three years, 6.9 persons would have to participate in the lifestyle-intervention program, and 13.9 would have to receive metformin. Conclusions: Lifestyle changes and treatment with metformin both reduced the incidence of diabetes in persons at high risk. The lifestyle intervention was more effective than metformin.	George Washington Univ, Ctr Biostat, Diabet Prevent Progarm Coordinating Ctr, Rockville, MD 20852 USA	George Washington University	Knowler, WC (corresponding author), George Washington Univ, Ctr Biostat, Diabet Prevent Progarm Coordinating Ctr, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA.		Cerviño, Alejandro/L-5853-2014; Williams, Katherine/AGH-6828-2022	Cerviño, Alejandro/0000-0001-8014-3279; Kriska, Andrea/0000-0002-3522-0869; Ciobanu, Voicu/0000-0002-5750-2402	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069051, U01DK048489] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK048489] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2000, Diabetes Care, V23, P1619; [Anonymous], 1987, STEP STEP EAT LOW YO; Bray GA, 1999, DIABETES CARE, V22, P623; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; *DIAB PREV PROGR R, IN PRESS CONTROL CLI; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gillum RF, 2000, J CLIN EPIDEMIOL, V53, P511, DOI 10.1016/S0895-4356(99)00208-5; Harris MI, 2000, DIABETES-METAB RES, V16, P230, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR122>3.3.CO;2-N; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; KNOWLER WC, 1995, DIABETES, V44, P483, DOI 10.2337/diabetes.44.5.483; Kriska A.M., 1997, MED SCI SPORTS EXERC, V29, P5, DOI [DOI 10.1097/00005768-199706001-00003, https://doi.org/10.1097/00005768-199706001-00003]; Kuller LH, 2000, ARTERIOSCL THROM VAS, V20, P823, DOI 10.1161/01.ATV.20.3.823; Lachin J. M., 2000, WILEY SER PROB STAT; LAN KKG, 1990, BIOMETRICS, V46, P759, DOI 10.2307/2532094; Mayer-Davis EJ, 1999, ANN EPIDEMIOL, V9, P314, DOI 10.1016/S1047-2797(98)00070-2; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Tataranni PA, 2001, NEW ENGL J MED, V344, P1390, DOI 10.1056/NEJM200105033441809; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UK PROSP DIAB STU, 1998, LANCET, V352, P1557; *USDA, 1996, HOM GARD B, V252; 1907, MMWR MORB MORTAL WKL, V46, P1014	27	11749	12120	40	1518	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					393	403		10.1056/nejmoa012512	http://dx.doi.org/10.1056/nejmoa012512			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832527	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000173686400002
J	Sox, HC; Blank, L; Cohen, J; Kimball, H; Smelser, N; Copeland, R; Lavizzo-Mourey, R; McDonald, W; Brenning, G; Davidson, C; Jaeger, P; Malliani, A; Muller, H; Sereni, D; Sutorius, E; Cruess, R; Cruess, S; Merino, J				Sox, HC; Blank, L; Cohen, J; Kimball, H; Smelser, N; Copeland, R; Lavizzo-Mourey, R; McDonald, W; Brenning, G; Davidson, C; Jaeger, P; Malliani, A; Muller, H; Sereni, D; Sutorius, E; Cruess, R; Cruess, S; Merino, J		Project ABIM Fdn; ACP ASIM Fdn; European Federation Internal Med	Medical professionalism in the new millennium: A physician charter	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									ABIM Fdn, Philadelphia, PA 19106 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Assoc Amer Med Coll, Washington, DC USA; Amer Board Internal Med, Philadelphia, PA USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; So Cardiopulm Associates, La Grange, GA USA; Robert Wood Johnson Fdn, Princeton, NJ 08540 USA; Amer Coll Physicians, Amer Soc Internal Med, Philadelphia, PA USA; Univ Uppsala Hosp, Uppsala, Sweden; Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; CHU Vaudois, CH-1011 Lausanne, Switzerland; Univ Milan, Milan, Italy; Ziekenhuis Gooi Noord, Rijksstraatweg, Netherlands; Hop St Louis, Paris, France; Fac Rechts Geleerdheid, Amsterdam, Netherlands; McGill Univ, Montreal, PQ, Canada; Univ Miguel Hernandez, Alacant, Spain	American Board of Internal Medicine; Harvard University; Brigham & Women's Hospital; Association of American Medical Colleges; American Board of Internal Medicine; University of California System; University of California Berkeley; Robert Wood Johnson Foundation (RWJF); American College of Physicians; Uppsala University; Uppsala University Hospital; University of Brighton; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; McGill University; Universidad Miguel Hernandez de Elche	Blank, L (corresponding author), ABIM Fdn, 510 Walnut St,Suite 1700, Philadelphia, PA 19106 USA.	lblank@abim.org							0	1332	1368	2	80	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					243	246		10.7326/0003-4819-136-3-200202050-00012	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827500				2022-12-28	WOS:000173637400007
J	Eslick, GD; Hammond, SR				Eslick, GD; Hammond, SR			Cystic lesion of the posterior fossa	LANCET			English	Editorial Material									Univ Sydney, Nepean Hosp, Dept Med, Sydney, NSW 2006, Australia; Orange Base Hosp, Orange, NSW 2751, Australia	Nepean Hospital; University of Sydney	Eslick, GD (corresponding author), Univ Sydney, Nepean Hosp, Dept Med, Sydney, NSW 2006, Australia.								0	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					396	396		10.1016/S0140-6736(02)07599-2	http://dx.doi.org/10.1016/S0140-6736(02)07599-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844510				2022-12-28	WOS:000173686500010
J	Greaves, M				Greaves, M			Science, medicine, and the future - Childhood leukaemia	BRITISH MEDICAL JOURNAL			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; ETIOLOGY; CANCER		Inst Canc Res, Chester Beatty Labs, Leukaemia Res Fund Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Greaves, M (corresponding author), Inst Canc Res, Chester Beatty Labs, Leukaemia Res Fund Ctr, London SW3 6JB, England.							Alexander FE, 2001, CANCER RES, V61, P2542; Auvinen A, 2000, BRIT J CANCER, V83, P956, DOI 10.1054/bjoc.2000.1382; Boulton A, 2000, BRIT J CANCER, V82, P1073; Cheng KK, 2000, BRIT J CANCER, V83, P1573, DOI 10.1054/bjoc.2000.1550; DOCKERTY JD, IN PRESS INT J EPIDE; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fenaux P, 2001, BEST PRACT RES CL HA, V14, P153, DOI 10.1053/beha.2000.0121; FORD AM, 1993, NATURE, V363, P358, DOI 10.1038/363358a0; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greaves M, 1999, EUR J CANCER, V35, P173, DOI 10.1016/S0959-8049(98)00433-X; GREAVES M, 2000, CANC EVOLUTIONARY LE; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; Guidez F, 2001, CURR TOP MICROBIOL, V254, P165; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kersey JH, 1997, BLOOD, V90, P4243, DOI 10.1182/blood.V90.11.4243.4243_4243_4251; KINLEN LJ, 1995, BRIT J CANCER, V71, P1, DOI 10.1038/bjc.1995.1; Redner RL, 1999, BLOOD, V94, P417, DOI 10.1182/blood.V94.2.417.414k49_417_428; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Taylor GM, 1998, BRIT J CANCER, V78, P561, DOI 10.1038/bjc.1998.540; Thompson JR, 2001, LANCET, V358, P1935, DOI 10.1016/S0140-6736(01)06959-8; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Wiemels JL, 1999, BLOOD, V94, P1057, DOI 10.1182/blood.V94.3.1057.415k10_1057_1062; Wiemels JL, 1999, CANCER RES, V59, P4095; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579	28	194	202	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					283	287		10.1136/bmj.324.7332.283	http://dx.doi.org/10.1136/bmj.324.7332.283			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823363	Green Published			2022-12-28	WOS:000173728300022
J	Kuznedelov, K; Minakhin, L; Niedziela-Majka, A; Dove, SL; Rogulja, D; Nickels, BE; Hochschild, A; Heyduk, T; Severinov, K				Kuznedelov, K; Minakhin, L; Niedziela-Majka, A; Dove, SL; Rogulja, D; Nickels, BE; Hochschild, A; Heyduk, T; Severinov, K			A role for interaction of the RNA polymerase flap domain with the sigma subunit in promoter recognition	SCIENCE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTION; ACTIVATION; BINDING; PROTEIN; SITE	In bacteria, promoter recognition depends on the RNA polymerase sigma subunit, which combines with the catalytically proficient RNA polymerase core to form the holoenzyme. The major class of bacterial promoters is defined by two conserved elements (the -10 and -35 elements, which are 10 and 35 nucleotides upstream of the initiation point, respectively) that are contacted by sigma the holoenzyme. We show that recognition of promoters of this class depends on the "flexible flap" domain of the RNA polymerase beta subunit. The flap interacts with conserved region 4 of sigmaand triggers:a conformational change that moves region 4 into the correct position for interaction with the -35 element. Because the flexible flap is evolutionarily conserved, this domain may facilitate promoter recognition by specificity factors in eukaryotes as well.	Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08854 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Rutgers State University New Brunswick; Saint Louis University; Harvard University; Harvard Medical School	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, POB 759, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Nickels, Bryce/AAF-2549-2020; Severinov, Konstantin/C-8545-2016	Nickels, Bryce/0000-0001-7449-8831	NIGMS NIH HHS [GM44025, GM50514] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Colland F, 2001, MOL MICROBIOL, V41, P477, DOI 10.1046/j.1365-2958.2001.02537.x; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dove SL, 2000, P NATL ACAD SCI USA, V97, P13215, DOI 10.1073/pnas.97.24.13215; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Gerber JS, 1996, J BACTERIOL, V178, P6133, DOI 10.1128/jb.178.21.6133-6139.1996; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	16	148	152	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					855	857		10.1126/science.1066303	http://dx.doi.org/10.1126/science.1066303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823642				2022-12-28	WOS:000173733000045
J	Day, JJ; Norman, DB; Upchurch, P; Powell, HP				Day, JJ; Norman, DB; Upchurch, P; Powell, HP			Biomechanics - Dinosaur locomotion from a new trackway	NATURE			English	Article									Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Oxford, Museum Nat Hist, Oxford OXD1 3PW, England	University of Cambridge; University of Oxford	Day, JJ (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.		Upchurch, Paul/C-1654-2008	Day, Julia/0000-0002-6765-7782				ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALEXANDER RM, 1986, ZOOL J LINN SOC-LOND, V83, P1; Cope J.C.W., 1980, SPECIAL PUBLICATIONS, V15, P109; PADIAN K, 1984, COPEIA, P662, DOI 10.2307/1445147; THULBORN RA, 1981, NATURE, V292, P273, DOI 10.1038/292273c0; Thulborn RA., 1990, DINOSAUR TRACKS	6	51	55	8	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					494	495		10.1038/415494a	http://dx.doi.org/10.1038/415494a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823849	Green Published			2022-12-28	WOS:000173564300035
J	Schiffl, H; Lang, SM; Fischer, R				Schiffl, H; Lang, SM; Fischer, R			Daily hemodialysis and the outcome of acute renal failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIALYSIS; MORTALITY	Background: Intermittent hemodialysis is widely used as renal-replacement therapy in patients with acute renal failure, but an adequate dose has not been defined. We performed a prospective study to determine the effect of daily intermittent hemodialysis, as compared with conventional (alternate-day) intermittent hemodialysis, on survival among patients with acute renal failure. Methods: A total of 160 patients with acute renal failure were assigned to receive daily or conventional intermittent hemodialysis. Survival was the primary end point of the study. The duration of acute renal failure and the frequency of therapy-related complications were secondary end points. Results: The two study groups were similar with respect to age, sex, cause and severity of acute renal failure, medical or surgical intensive care setting, and the score on the Acute Physiology, Age, and Chronic Health Evaluation. Daily hemodialysis resulted in better control of uremia, fewer hypotensive episodes during hemodialysis, and more rapid resolution of acute renal failure (mean [+/-SD], 9+/-2 vs. 16+/-6 days; P=0.001) than did conventional hemodialysis. The mortality rate, according to the intention-to-treat analysis, was 28 percent for daily dialysis and 46 percent for alternate-day dialysis (P=0.01). In a multiple regression analysis, less frequent hemodialysis (on alternate days, as opposed to daily) was an independent risk factor for death. Conclusions: The high mortality rate among critically ill patients with acute renal failure who require renal-replacement therapy is related to both coexisting conditions and uremic damage to other organ systems. Intensive hemodialysis reduces mortality without increasing hemodynamically induced morbidity. (N Engl J Med 2002;346:305-10.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Munich, Med Klin Innenstadt, Dept Nephrol, D-80336 Munich, Germany; Univ Munich, Med Poliklin Innenstadt, D-80336 Munich, Germany	University of Munich; University of Munich	Schiffl, H (corresponding author), Univ Munich, Med Klin Innenstadt, Dept Nephrol, Ziemssenstr 1, D-80336 Munich, Germany.							Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Clark W R, 1997, Adv Ren Replace Ther, V4, P64; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; DAUGIRDAS JT, 1995, ASAIO, V41, P719; DEPNER TA, 1994, SEMIN DIALYSIS, V7, P315, DOI 10.1111/j.1525-139X.1994.tb00843.x; Evanson JA, 1999, KIDNEY INT, V55, P1501, DOI 10.1046/j.1523-1755.1999.00355.x; Evanson JA, 1998, AM J KIDNEY DIS, V32, P731, DOI 10.1016/S0272-6386(98)70127-1; GILLUM DM, 1986, CLIN NEPHROL, V25, P249; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; McCarthy JT, 1996, MAYO CLIN PROC, V71, P117, DOI 10.4065/71.2.117; Paganini EP, 1996, AM J KIDNEY DIS, V28, pS81, DOI 10.1016/S0272-6386(96)90084-0; Paganini EP, 2001, BLOOD PURIFICAT, V19, P238, DOI 10.1159/000046948; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; WOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230, DOI 10.1093/oxfordjournals.ndt.a092111	15	524	572	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					305	310		10.1056/NEJMoa010877	http://dx.doi.org/10.1056/NEJMoa010877			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821506				2022-12-28	WOS:000173545300002
J	Griffiths, CEM				Griffiths, CEM			Immunotherapy for psoriasis: from serendipity to selectivity	LANCET			English	Editorial Material							PLAQUE-TYPE PSORIASIS; QUALITY-OF-LIFE; T-CELLS; ANTIBODY		Univ Manchester, Hope Hosp, Sch Med, Dermatol Ctr, Manchester M6 8HD, Lancs, England	University of Manchester	Griffiths, CEM (corresponding author), Univ Manchester, Hope Hosp, Sch Med, Dermatol Ctr, Manchester M6 8HD, Lancs, England.	christopher.griffiths@man.ac.uk	Griffiths, Christopher E.M./P-5448-2014	Griffiths, Christopher E.M./0000-0001-5371-4427				Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; Fortune DG, 1997, BRIT J DERMATOL, V137, P755; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger JG, 2000, J AM ACAD DERMATOL, V43, P448, DOI 10.1067/mjd.2000.106515; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; MUELLER W, 1979, NEW ENGL J MED, V301, P555; Oh CJ, 2000, J AM ACAD DERMATOL, V42, P829, DOI 10.1067/mjd.2000.105948; Papp K, 2001, J AM ACAD DERMATOL, V45, P665, DOI 10.1067/mjd.2001.117850; Richards HL, 1999, J AM ACAD DERMATOL, V41, P581, DOI 10.1016/S0190-9622(99)70301-4; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x	16	21	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					279	280		10.1016/S0140-6736(02)07536-0	http://dx.doi.org/10.1016/S0140-6736(02)07536-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830192				2022-12-28	WOS:000173588100006
J	Aurelio, O; Hall, DH; Hobert, O				Aurelio, O; Hall, DH; Hobert, O			Immunoglobulin-domain proteins required for maintenance of ventral nerve cord organization	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; NEURONS; SYSTEM; UNC-6	During development, neurons extend axons along defined routes to specific target cells. We show that additional mechanisms ensure that axons maintain their correct positioning in defined axonal tracts. After termination of axonal outgrowth and target recognition, axons in the ventral nerve cord (VNC) of Caenorhabditis elegans require the presence of a specific VNC neuron, PVT, to maintain their correct positioning in the left and right fascicles of the VNC. PVT may exert its stabilizing function by the temporally tightly controlled secretion of 2-immunoglobulin (Ig)-domain proteins encoded by the zig genes. Dedicated axon maintenance mechanisms may be widely used to ensure the preservation of functional neuronal circuitries.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Ctr C Elegans Anat, Bronx, NY 10461 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 722 W 168th St, New York, NY 10032 USA.			Hobert, Oliver/0000-0002-7634-2854	NCRR NIH HHS [RR12596, R24 RR012596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline; NINDS NIH HHS [5F32NS11107-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011107] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; DURBIN RM, 1987, THESIS U CAMBRIDGE; HALL DH, 1991, J NEUROSCI, V11, P1; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; LEWIS JA, 1980, GENETICS, V95, P905; MILLER DM, 1995, DEVELOPMENT, V121, P2877; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; SONDEREGGER P, 1998, IG SUPERFAMILY MOL N; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zallen JA, 1999, DEVELOPMENT, V126, P3679	13	88	105	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					686	690		10.1126/science.1066642	http://dx.doi.org/10.1126/science.1066642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809975				2022-12-28	WOS:000173560900048
J	Kim, JJ; Choi, Y; Suresh, S; Argon, AS				Kim, JJ; Choi, Y; Suresh, S; Argon, AS			Nanocrystallization during nanoindentation of a bulk amorphous metal alloy at room temperature	SCIENCE			English	Article							MECHANICAL-PROPERTIES; PLASTIC-FLOW; GLASSES; CRYSTALLIZATION; DEFORMATION; ALUMINUM	It is known that nanocrystallites can form in shear bands produced during severe bending or high-energy ball milling of thin ribbons of a metallic glass. We present direct experimental evidence that highly confined and controlled local contact at the ultrafine scale in the form of quasi-static nanoindentation of a bulk glassy metal alloy at room temperature can also cause nanocrystallization. Atomic force microscopy and transmission electron microscopy show that nanocrystallites nucleate in and around shear bands produced near indents and that they are the same as crystatlites formed during annealing without deformation at 783 kelvin. Analogous to results from recent experiments with glassy polymers, our results are reasoned to be a consequence of flow dilatation inside the bands and of the attendant, radically enhanced, atomic diffusional mobility inside actively deforming shear bands.	MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Suresh, S (corresponding author), MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.		Suresh, Subra/B-8289-2008	Suresh, Subra/0000-0002-6223-6831				ARGON AS, 1979, ACTA METALL MATER, V27, P47, DOI 10.1016/0001-6160(79)90055-5; CANTOR B, 1986, AMORPHOUS METALS SEM, P108; CHEN H, 1994, NATURE, V367, P541, DOI 10.1038/367541a0; DONOVAN PE, 1989, ACTA METALL MATER, V37, P445, DOI 10.1016/0001-6160(89)90228-9; ESHELBY JD, 1956, ACTA METALL MATER, V4, P560, DOI 10.1016/0001-6160(56)90056-6; Flores KM, 1999, J MATER RES, V14, P638, DOI 10.1557/JMR.1999.0642; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; HE Y, 1995, ACTA METALL MATER, V43, P83, DOI 10.1016/0956-7151(94)00219-8; HE Y, 1988, SCIENCE, V241, P1640, DOI 10.1126/science.241.4873.1640; INOUE A, 1990, MATER T JIM, V31, P177, DOI 10.2320/matertrans1989.31.177; LEAMY HJ, 1972, METALL TRANS, V3, P699, DOI 10.1007/BF02642754; Liu CT, 1998, METALL MATER TRANS A, V29, P1811, DOI 10.1007/s11661-998-0004-6; Lu K, 1996, MAT SCI ENG R, V16, P161, DOI 10.1016/0927-796X(95)00187-5; MAKINO A, 1995, MATER T JIM, V36, P924, DOI 10.2320/matertrans1989.36.924; MASUMOTO T, 1975, MATER SCI ENG, V19, P1, DOI 10.1016/0025-5416(75)90002-6; Matko I, 1997, MAT SCI ENG A-STRUCT, V225, P145, DOI 10.1016/S0921-5093(96)10567-0; Megusar J., 1982, Rapidly Solidified Amorphous and Crystalline Alloys. Proceedings of the Materials Research Society Annual Meeting, P283; NEUHAUSER H, 1978, SCRIPTA METALL MATER, V12, P471, DOI 10.1016/0036-9748(78)90260-0; PEKER A, 1993, APPL PHYS LETT, V63, P2342, DOI 10.1063/1.110520; SPAEPEN F, 1977, ACTA METALL MATER, V25, P407, DOI 10.1016/0001-6160(77)90232-2; SURESH S, 2000, ACTA MATER, V48, P279; Vaidyanathan R, 2001, ACTA MATER, V49, P3781, DOI 10.1016/S1359-6454(01)00263-4; Wang JG, 2000, J MATER RES, V15, P798, DOI 10.1557/JMR.2000.0114; Wang WH, 1999, APPL PHYS LETT, V75, P2770, DOI 10.1063/1.125144; Wright WJ, 2001, MATER TRANS, V42, P642, DOI 10.2320/matertrans.42.642; Zhou QY, 2001, POLYMER, V42, P613, DOI 10.1016/S0032-3861(00)00376-1; [No title captured]	27	531	553	10	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					654	657						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809965				2022-12-28	WOS:000173560900037
J	Quinlivan, EP; McPartlin, J; McNulty, H; Ward, M; Strain, JJ; Weir, DG; Scott, JM				Quinlivan, EP; McPartlin, J; McNulty, H; Ward, M; Strain, JJ; Weir, DG; Scott, JM			Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease	LANCET			English	Article							PLASMA	Fortification of food with folic acid to prevent neural-tube defects in babies also lowers plasma total homocysteine, which is a risk factor for vascular disease. We investigated the effect of folate and vitamin B12 on homocysteine concentrations. 30 men and 23 women received sequential supplementation with increasing doses of folic acid. After supplementation, the usual dependency of homocysteine on folate diminished, and vitamin B12 became the main determinant of plasma homocysteine concentration. This finding suggests that a fortification policy based on folic acid and vitamin B12, rather than folic acid alone, is likely to be much more effective at lowering of homocysteine concentrations, with potential benefits for reduction of risk of vascular disease.	St James Hosp, Trinity Ctr, Dept Clin Med, Dublin 8, Ireland; Trinity Coll Dublin, Dept Biochem, Dublin, Ireland; Univ Ulster, Sch Biomed Sci, No Ireland Ctr Diet & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland	Trinity College Dublin; Trinity College Dublin; Ulster University	McPartlin, J (corresponding author), St James Hosp, Trinity Ctr, Dept Clin Med, Dublin 8, Ireland.		Quinlivan, Eoin P/B-8454-2008; Quinlivan, Eoin/AAJ-1979-2021	Quinlivan, Eoin P/0000-0002-0908-1762; Quinlivan, Eoin/0000-0002-0908-1762; McNulty, Helene/0000-0002-4366-6457				BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; *DEP HLTH, 2000, FOL AC PREV DIS REP, P50; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; KIRKE PN, 1993, Q J MED, V86, P703	5	162	169	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					227	228		10.1016/S0140-6736(02)07439-1	http://dx.doi.org/10.1016/S0140-6736(02)07439-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812560				2022-12-28	WOS:000173350800016
J	Koide, S; Shibata, K; Kudoh, T; Meier, DL				Koide, S; Shibata, K; Kudoh, T; Meier, DL			Extraction of black hole rotational energy by a magnetic field and the formation of relativistic jets	SCIENCE			English	Article							ANGULAR-MOMENTUM TRANSPORT; ACCRETION DISKS; FLOWS; SIMULATIONS; DRIVEN; MODEL	Using numerical simulations, we modeled the general relativistic magnetohydrodynamic behavior of a plasma flowing into a rapidly rotating black hole in a large-scale magnetic field. The results show that a torsional Atfven wave is generated by the rotational dragging of space near the black hole. The wave transports energy along the magnetic field tines outward, causing the total energy of the plasma near the hole to decrease to negative values. When this negative energy plasma enters the horizon, the rotational energy of the black hole decreases. Through this process, the energy of the spinning black hole is extracted magnetically.	Toyama Univ, Fac Engn, Toyama 9308555, Japan; Kyoto Univ, Kwasan & Hida Observ, Kyoto 6078471, Japan; Natl Astron Observ, Tokyo 1818588, Japan; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Toyama; Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Koide, S (corresponding author), Toyama Univ, Fac Engn, Toyama 9308555, Japan.			Kudoh, Takahiro/0000-0003-1292-940X				Biretta JA, 1999, ASTROPHYS J, V520, P621, DOI 10.1086/307499; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; HIROTANI K, 1992, ASTROPHYS J, V386, P455, DOI 10.1086/171031; Koide S, 1999, ASTROPHYS J, V522, P727, DOI 10.1086/307667; Koide S, 2000, ASTROPHYS J, V536, P668, DOI 10.1086/308986; Koide S, 1998, ASTROPHYS J, V495, pL63, DOI 10.1086/311204; Kudoh T, 1999, ASTROPHYS J, V514, P493, DOI 10.1086/306930; Kudoh T, 1998, ASTROPHYS J, V508, P186, DOI 10.1086/306377; Kulkarni SR, 1999, NATURE, V398, P389, DOI 10.1038/18821; MacFadyen AI, 2001, ASTROPHYS J, V550, P410, DOI 10.1086/319698; Meier DL, 2001, SCIENCE, V291, P84, DOI 10.1126/science.291.5501.84; Meier DL, 2001, ASTROPHYS J, V548, pL9, DOI 10.1086/318921; Meier DL, 1999, ASTROPHYS J, V522, P753, DOI 10.1086/307671; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; Ouyed R, 1997, NATURE, V385, P409, DOI 10.1038/385409a0; PEARSON TJ, 1981, NATURE, V290, P365, DOI 10.1038/290365a0; Penrose R., 1969, Rivista del Nuovo Cimento, V1, P252, DOI 10.1023/A:1016578408204; Popham R, 1999, ASTROPHYS J, V518, P356, DOI 10.1086/307259; PUNSLY B, 1990, ASTROPHYS J, V354, P583, DOI 10.1086/168717; SHIBATA K, 1986, PUBL ASTRON SOC JPN, V38, P631; TAKAHASHI M, 1990, ASTROPHYS J, V363, P206, DOI 10.1086/169331; UCHIDA Y, 1985, PUBL ASTRON SOC JPN, V37, P515; WALD RM, 1974, PHYS REV D, V10, P1680, DOI 10.1103/PhysRevD.10.1680; Wilms J, 2001, MON NOT R ASTRON SOC, V328, pL27, DOI 10.1046/j.1365-8711.2001.05066.x; YOKOSAWA M, 1993, PUBL ASTRON SOC JPN, V45, P207	26	179	180	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1688	1691		10.1126/science.1068240	http://dx.doi.org/10.1126/science.1068240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11809939				2022-12-28	WOS:000174212900039
J	Hamada, K; Doi, T; Sakurai, M; Matsumoto, K; Yanagisawa, K; Suzuki, T; Kikuchi, N; Okuda, J; Miyazaki, H; Okoshi, H; Zeniya, M; Asukata, I				Hamada, K; Doi, T; Sakurai, M; Matsumoto, K; Yanagisawa, K; Suzuki, T; Kikuchi, N; Okuda, J; Miyazaki, H; Okoshi, H; Zeniya, M; Asukata, I			Effects of hydration on fluid balance and lower-extremity blood viscosity during long airplane flights	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							THROMBOEMBOLISM; TRAVEL		Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan; Japan Airlines Med Serv, Tokyo, Japan	Otsuka Pharmaceutical	Hamada, K (corresponding author), Otsuka Pharmaceut Co Ltd, Saga Nutraceut Res Inst, Saga, Japan.							DILL DB, 1974, J APPL PHYSIOL, V37, P247, DOI 10.1152/jappl.1974.37.2.247; Eklof B, 1996, DERMATOL SURG, V22, P637, DOI 10.1111/j.1524-4725.1996.tb00610.x; Greenleaf JE, 1998, AVIAT SPACE ENVIR MD, V69, P936; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; SLADEN GE, 1969, CLIN SCI, V36, P119; SYMINGTON IS, 1977, BRIT J DIS CHEST, V71, P138, DOI 10.1016/0007-0971(77)90097-3	6	14	14	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					844	845		10.1001/jama.287.7.844-a	http://dx.doi.org/10.1001/jama.287.7.844-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851575				2022-12-28	WOS:000173922500022
J	Schneider, RK; Levenson, JL				Schneider, RK; Levenson, JL			Update in psychiatry	ANNALS OF INTERNAL MEDICINE			English	Review							SOCIAL PHOBIA; WEIGHT-GAIN; ANXIETY DISORDER		Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA	Virginia Commonwealth University	Schneider, RK (corresponding author), Virginia Commonwealth Univ, Dept Psychiat, Med Coll Virginia Campus,POB 980268, Richmond, VA 23298 USA.	rkschnei@mail2.vcu.edu						Ganguli R, 1999, J CLIN PSYCHIAT, V60, P20; George MS, 1999, ARCH GEN PSYCHIAT, V56, P300, DOI 10.1001/archpsyc.56.4.300; Goisman RM, 1999, AM J PSYCHIAT, V156, P1819; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Jeste DV, 2000, AM J PSYCHIAT, V157, P1150, DOI 10.1176/appi.ajp.157.7.1150; Melkersson KI, 2000, J CLIN PSYCHIAT, V61, P742, DOI 10.4088/JCP.v61n1006; Pelonero AL, 1998, PSYCHIATR SERV, V49, P1163, DOI 10.1176/ps.49.9.1163; Schneider RK, 1999, ANN INTERN MED, V131, P514, DOI 10.7326/0003-4819-131-7-199910050-00007; Schneider RK, 2001, ANN INTERN MED, V134, P387, DOI 10.7326/0003-4819-134-5-200103060-00011; SOLOMON SD, 1992, JAMA-J AM MED ASSOC, V268, P633, DOI 10.1001/jama.268.5.633; Stein MB, 2000, AM J PSYCHIAT, V157, P1606, DOI 10.1176/appi.ajp.157.10.1606; Stein MB, 1999, AM J PSYCHIAT, V156, P756; Wirshing DA, 1999, J CLIN PSYCHIAT, V60, P358, DOI 10.4088/JCP.v60n0602; 1993, AM J PSYCHIAT S, V150, P1	14	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					293	301		10.7326/0003-4819-136-4-200202190-00009	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FQ	11848727				2022-12-28	WOS:000173943700006
J	Li, JM; Nam, KH				Li, JM; Nam, KH			Regulation of brassinosteroid signaling by a GSK3/SHAGGY-like kinase	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ARABIDOPSIS; FAMILY; GENE; EXPRESSION; GROWTH	GSK3/SHAGGY is a highly conserved serine/threonine kinase implicated in many signaling pathways in eukaryotes. Although many GSK3/SHAGGY-like kinases have been identified in plants, little is known about their functions in plant growth and development. Here we show that the Arabidopsis BRASSINOSTEROID-INSENSITIVE 2 (BIN2) gene encodes a GSK3/SHAGGY-like kinase. Gain-of-function mutations within its coding sequence or its overexpression inhibit brassinosteroid (BR) signaling, resulting in plants that resemble BR-deficient and BR-response mutants. In contrast, reduced BIN2 expression via cosuppression partially rescues a weak BR-signaling mutation. Thus, BIN2 acts as a negative regulator to control steroid signaling in plants.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Li, JM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.		Li, Jianming/O-1772-2014	Li, Jianming/0000-0003-3231-0778	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060519] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060519, R01 GM060519-02, GM60519] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Dornelas MC, 1998, GENE, V212, P249, DOI 10.1016/S0378-1119(98)00147-4; Dornelas MC, 1999, PLANT MOL BIOL, V39, P137, DOI 10.1023/A:1006102812280; Dornelas MC, 2000, PLANT J, V21, P419, DOI 10.1046/j.1365-313x.2000.00691.x; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Jonak C, 2000, PLANT CELL, V12, P1467, DOI 10.1105/tpc.12.8.1467; Li J. P. H., UNPUB; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Piao HL, 1999, PLANT PHYSIOL, V119, P1527, DOI 10.1104/pp.119.4.1527; PIERCE SB, 1995, DEVELOPMENT, V121, P755; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	22	445	481	14	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1299	1301						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847343				2022-12-28	WOS:000173926000045
J	Willis, KJ; Whittaker, RJ				Willis, KJ; Whittaker, RJ			Ecology - Species diversity - Scale matters	SCIENCE			English	Editorial Material									Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England	University of Oxford	Willis, KJ (corresponding author), Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England.		Whittaker, Robert J/H-1548-2015	Whittaker, Robert J/0000-0001-7775-3383; Willis, Katherine/0000-0002-6763-2489				Briggs JC., 1995, GLOBAL BIOGEOGRAPHY; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Gould SJ, 1998, PHILOS T R SOC B, V353, P307, DOI 10.1098/rstb.1998.0211; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x	10	392	452	4	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1245	+		10.1126/science.1067335	http://dx.doi.org/10.1126/science.1067335			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847328				2022-12-28	WOS:000173926000028
J	Scholz, BC				Scholz, BC			Innateness	NATURE			English	Editorial Material									San Jose State Univ, Dept Philosophy, San Jose, CA 95192 USA	California State University System; San Jose State University	Scholz, BC (corresponding author), San Jose State Univ, Dept Philosophy, San Jose, CA 95192 USA.							Oyama S., 2000, EVOLUTIONS EYE SYSTE; OYAMA S, 2001, CONTINGENCY DEV SYST	2	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					739	739		10.1038/415739a	http://dx.doi.org/10.1038/415739a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845188				2022-12-28	WOS:000173833900027
J	Arruda-Olson, AM; Mahoney, DW; Nehra, A; Leckel, M; Pellikka, PA				Arruda-Olson, AM; Mahoney, DW; Nehra, A; Leckel, M; Pellikka, PA			Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease - A Randomized crossover trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ERECTILE DYSFUNCTION; STRESS-ECHOCARDIOGRAPHY; MYOCARDIAL-INFARCTION; ORAL SILDENAFIL; SEXUAL-ACTIVITY; STABLE ANGINA; PATIENT; HEART; PERFORMANCE; DIAGNOSIS	Context The relationship between sildenafil citrate use and reported adverse cardiovascular events in men with coronary artery disease (CAD) is unclear. Objective To evaluate the cardiovascular effects of sildenafil during exercise in men with CAD. Design, Setting, and Subjects Randomized, double-blind, placebo-controlled crossover trial conducted March to October 2000 at a US ambulatory-care referral center among 105 men with a mean (SD) age of 66 (9) years who had erectile dysfunction and known or highly suspected CAD. Interventions All patients underwent 2 symptom-limited supine bicycle echocardiograms separated by an interval of 1 to 3 days after receiving a single dose of sildenafil (50 or 100 mg) or placebo 1 hour before each exercise test. Main Outcome Measures Hemodynamic effects of sildenafil during exercise (onset, extent, and severity of ischemia) assessed by exercise echocardiography. Results Mean (SD) resting ejection fraction was 56% (7%) (range, 39%-68%). After sildenafil use, resting systolic blood pressure was reduced from 135 (19) mm Hg to 128 (17) mm Hg, for a mean change of -7 mm Hg (95% confidence interval [CI], -9 to -4 mm Hg; P<.001). After placebo use, the mean (SD) change was from 135 (20) mm Hg to 133 (19) mm Hg, a difference of -2 mm Hg (95% Cl, -6 to 0.3 mm Hg; P=.08). The difference between mean change after sildenafil and placebo use was 4.3 (95% CI, 0.9-7.7; P=.01). Resting heart rate, diastolic blood pressure, and wall motion score index (a measure of the extent and severity of wall motion abnormalities) did not change significantly in either group. Exercise capacity was similar with sildenafil use (mean [SD], 4.5 [1.0] metabolic equivalents) and placebo use (mean [SD], 4.6 [1.0] metabolic equivalents; mean difference, 0.07; 95% CI, -0.06 to 0.19; P=.29). Exercise blood pressure and heart rate increments were similar. Dyspnea or angina developed in 69 patients who took sildenafil and 70 patients who took placebo (P=.89); exercise electrocardiography was positive in 12 patients (11%) who took sildenafil and 17 patients (16%) who took placebo (P=.09). Exercise-induced wall motion abnormalities developed in similar numbers of patients after sildenafil and placebo use (84 and 86 patients, respectively; P=.53). Wall motion score index at peak exercise was similar after sildenafil and placebo use (mean [SD], 1.4 [0.4] vs 1.4 [0.4]; mean difference, 0.01; 95% CI, -0.01 to 0.03; P=.40). Conclusion In men with stable CAD, sildenafil had no effect on symptoms, exercise duration, or presence or extent of exercise-induced ischemia, as assessed by exercise echocardiography.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biostat, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Pellikka, PA (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.		Pellikka, Patricia A/N-5387-2014	Pellikka, Patricia A/0000-0001-6800-3521				Armstrong WF, 1998, J AM SOC ECHOCARDIOG, V11, P97, DOI 10.1016/S0894-7317(98)70132-4; Badruddin SM, 1999, J AM COLL CARDIOL, V33, P1485, DOI 10.1016/S0735-1097(99)00043-1; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; FALK E, 1992, CIRCULATION, V86, P30; Feenstra J, 1998, LANCET, V352, P957, DOI 10.1016/S0140-6736(98)00015-4; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fleischmann KE, 1998, JAMA-J AM MED ASSOC, V280, P913, DOI 10.1001/jama.280.10.913; FROELICHER VF, 2000, EXERCISE HEART, P93; GART JJ, 1969, BIOMETRIKA, V56, P75, DOI 10.2307/2334692; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Harrold LR, 2000, ARCH INTERN MED, V160, P3401, DOI 10.1001/archinte.160.22.3401; Hayashi K, 1999, JPN HEART J, V40, P827, DOI 10.1536/jhj.40.827; HELLERSTEIN HK, 1970, ARCH INTERN MED, V125, P987, DOI 10.1001/archinte.125.6.987; Herrmann HC, 2000, NEW ENGL J MED, V342, P1622, DOI 10.1056/NEJM200006013422201; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x; Ishikura F, 2000, CIRCULATION, V102, P2516, DOI 10.1161/01.CIR.102.20.2516; Jackson G, 1999, AM J CARDIOL, V83, p13C; Jackson G, 2000, AM J CARDIOL, V86, p35F; Katz SD, 2000, J AM COLL CARDIOL, V36, P845, DOI 10.1016/S0735-1097(00)00790-7; MASTER AM, 1952, JAMA-J AM MED ASSOC, V148, P794, DOI 10.1001/jama.1952.02930100012003; Morales A, 1998, INT J IMPOT RES, V10, P69, DOI 10.1038/sj.ijir.3900354; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; Padma-Nathan H, 1998, INT J CLIN PRACT, V52, P375; Pellikka PA, 1997, PROG CARDIOVASC DIS, V39, P523, DOI 10.1016/S0033-0620(97)80011-4; Porter A, 1999, CLIN CARDIOL, V22, P762, DOI 10.1002/clc.4960221122; PRESCOTT RJ, 1979, APPL STAT, V30, P9; ROGER VL, 1995, MAYO CLIN PROC, V70, P5; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SCHILLER NB, 1979, CIRCULATION, V60, P547, DOI 10.1161/01.CIR.60.3.547; Shah PK, 1998, NEW ENGL J MED, V339, P699; Webb DJ, 2000, J AM COLL CARDIOL, V36, P25, DOI 10.1016/S0735-1097(00)00705-1; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	36	139	145	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					719	725		10.1001/jama.287.6.719	http://dx.doi.org/10.1001/jama.287.6.719			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851538	Bronze			2022-12-28	WOS:000173809500028
J	Gudiksen, MS; Lauhon, LJ; Wang, J; Smith, DC; Lieber, CM				Gudiksen, MS; Lauhon, LJ; Wang, J; Smith, DC; Lieber, CM			Growth of nanowire superlattice structures for nanoscale photonics and electronics	NATURE			English	Article							SEMICONDUCTOR NANOWIRES; CARBON NANOTUBES; SILICON NANOWIRES; TRANSPORT	The assembly of semiconductor nanowires and carbon nanotubes into nanoscale devices and circuits could enable diverse applications in nanoelectronics and photonics(1). Individual semiconducting nanowires have already been configured as field-effect transistors(2), photodetectors(3) and bio/chemical sensors(4). More sophisticated light-emitting diodes(5) (LEDs) and complementary and diode logic(6-8) devices have been realized using both n- and p-type semiconducting nanowires or nanotubes. The n- and p-type materials have been incorporated in these latter devices either by crossing p- and n-type nanowires(2,5,6,9) or by lithographically defining distinct p- and n-type regions in nanotubes 8,10, although both strategies limit device complexity. In the planar semiconductor industry, intricate n- and p-type and more generally compositionally modulated (that is, superlattice) structures are used to enable versatile electronic and photonic functions. Here we demonstrate the synthesis of semiconductor nanowire superlattices from group III-V and group IV materials. (The superlattices are created within the nanowires by repeated modulation of the vapour-phase semiconductor reactants during growth of the wires.) Compositionally modulated superlattices consisting of 2 to 21 layers of GaAs and GaP have been prepared. Furthermore, n-Si/p-Si and n-InP/p-InP modulation doped nanowires have been synthesized. Single-nanowire photoluminescence, electrical transport and electroluminescence measurements show the unique photonic and electronic properties of these nanowire superlattices, and suggest potential applications ranging from nano-barcodes to polarized nanoscale LEDs.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.		Lauhon, Lincoln/H-2976-2015; Wang, Jianfang/O-1810-2013; huihui, zhang/M-9283-2014; Chu, Yung-Ming/C-6318-2009; Smith, David C/B-1485-2010; Lauhon, Lincoln J/B-7526-2009; Lauhon, Lincoln/AAF-8269-2020	Lauhon, Lincoln/0000-0001-6046-3304; Wang, Jianfang/0000-0002-2467-8751; Smith, David C/0000-0003-0931-3874; Lauhon, Lincoln/0000-0001-6046-3304	Engineering and Physical Sciences Research Council [GR/A11595/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; Chow E, 2000, NATURE, V407, P983, DOI 10.1038/35039583; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Cui Y, 2001, APPL PHYS LETT, V78, P2214, DOI 10.1063/1.1363692; Cui Y, 2000, J PHYS CHEM B, V104, P5213, DOI 10.1021/jp0009305; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; Gudiksen MS, 2001, J PHYS CHEM B, V105, P4062, DOI 10.1021/jp010540y; Gudiksen MS, 2000, J AM CHEM SOC, V122, P8801, DOI 10.1021/ja002008e; Hu JT, 1999, NATURE, V399, P48, DOI 10.1038/19941; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Lieber CM, 2001, SCI AM, V285, P58, DOI 10.1038/scientificamerican0901-58; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Nicewarner-Pena SR, 2001, SCIENCE, V294, P137, DOI 10.1126/science.294.5540.137; WAGNER RS, 1970, WHISKER TECHNOLOGY, P47; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Zhou CW, 2000, SCIENCE, V290, P1552, DOI 10.1126/science.290.5496.1552	23	2409	2533	27	1830	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					617	620		10.1038/415617a	http://dx.doi.org/10.1038/415617a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832939				2022-12-28	WOS:000173709100039
J	Gelber, AC; Wigley, FM				Gelber, AC; Wigley, FM			Disease severity as a predictor of outcome in scleroderma	LANCET			English	Editorial Material							SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; TRIAL		Johns Hopkins Univ, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University	Wigley, FM (corresponding author), Johns Hopkins Univ, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA.							Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Binks M, 2001, ANN RHEUM DIS, V60, P577, DOI 10.1136/ard.60.6.577; Bryan C, 1999, ARTHRITIS RHEUM-US, V42, P2660, DOI 10.1002/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N; Clements PJ, 1999, ARTHRITIS RHEUM-US, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7; Geirsson AJ, 2001, ANN RHEUM DIS, V60, P1117, DOI 10.1136/ard.60.12.1117; LOPEZOVEJERO JA, 1979, NEW ENGL J MED, V300, P1417, DOI 10.1056/NEJM197906213002505; Medsger TA, 2000, CURR OPIN RHEUMATOL, V12, P545, DOI 10.1097/00002281-200011000-00012; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; WIGLEY FM, 1994, ANN INTERN MED, V120, P199, DOI 10.7326/0003-4819-120-3-199402010-00004	11	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					277	279		10.1016/S0140-6736(02)07535-9	http://dx.doi.org/10.1016/S0140-6736(02)07535-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830191				2022-12-28	WOS:000173588100005
J	Westwood, ME; Kelly, S; Berry, E; Bamford, JM; Gough, MJ; Airey, CM; Meaney, JFM; Davies, LM; Cullingworth, J; Smith, MA				Westwood, ME; Kelly, S; Berry, E; Bamford, JM; Gough, MJ; Airey, CM; Meaney, JFM; Davies, LM; Cullingworth, J; Smith, MA			Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review	BRITISH MEDICAL JOURNAL			English	Article							FLIGHT MR-ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; ARTERY STENOSIS; CONVENTIONAL ANGIOGRAPHY; DECISION-MAKING; DIAGNOSTIC-TEST; NECK COIL; BIFURCATION; ENDARTERECTOMY; ARTERIOGRAPHY	Objective To determine if sufficient evidence exists to support the use of magnetic resonance angiography as a means of selecting patients with recently symptomatic high grade carotid stenosis for surgery. Design Systematic review of published research on the diagnostic performance of magnetic resonance angiography, 1990-9. Main outcome measures Performance characteristics of diagnostic test. Results 126 potentially relevant articles were identified, but many articles failed to examine die performance of magnetic resonance angiography as a diagnostic test at the surgical decision thresholds used in major clinical trials on endarterectomy. 26 articles were included in a meta-analysis that showed a maximal joint sensitivity and specificity of 99% (95% confidence interval 98% to 100%) for identifying 70-99% stenosis and 90% (81% to 99%) for identifying 50-99% stenosis. Only four articles evaluated contrast enhanced magnetic resonance angiography. Conclusions Magnetic resonance angiography is accurate for selecting patients for carotid endarterectomy at the surgical decision thresholds established in the major endarterectomy trials, but the evidence is not very robust because of the heterogeneity of the studies included. Research is to determine the diagnostic performance of the most recent developments in magnetic resonance angiography, including contrast enhanced techniques, as well as to assess the impact of magnetic resonance angiography on surgical decision making and outcomes.	Univ Leeds, Gen Infirm, Acad Unit Med Phys, Leeds LS1 3EX, W Yorkshire, England; Univ Leeds, Gen Infirm, Ctr Med Imaging Res, Leeds LS1 3EX, W Yorkshire, England; Leeds Gen Infirm, Leeds Teaching Hosp NHS Trust, Dept Radiol, Leeds, W Yorkshire, England; St James Hosp, Leeds Teaching Hosp NHS Trust, Dept Neurol, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, Nuffield Inst Hlth, Div Publ Hlth, Leeds LS2 9PL, W Yorkshire, England; Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England	Leeds General Infirmary; University of Leeds; Leeds General Infirmary; University of Leeds; Leeds General Infirmary; University of Leeds; Saint James's University Hospital; University of Leeds; University of Leeds; University of York - UK	Berry, E (corresponding author), Univ Leeds, Gen Infirm, Acad Unit Med Phys, Leeds LS1 3EX, W Yorkshire, England.		Bamford, John/ABE-6218-2021	Davies, Linda/0000-0001-8801-3559; Meaney, James FM/0000-0003-1596-4972				Altman D.G., 1991, PRACTICAL STAT MED R; Bamford J, 2001, BRAIN, V124, P455, DOI 10.1093/brain/124.3.455; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Berry E, 2000, INT J TECHNOL ASSESS, V16, P668, DOI 10.1017/S0266462300101229; BIANCHI MC, 1995, NUOVA RIV NEUROLOGIA, V5, P229; CINA CS, 2001, COCHRANE DATABASE SY; Dadachanji M C, 1995, J Assoc Physicians India, V43, P92; DAVIES KN, 1993, J NEUROL NEUROSUR PS, V56, P967, DOI 10.1136/jnnp.56.9.967; Drevet D, 1997, J RADIOL, V78, P1271; EDELMAN RR, 1993, AM J ROENTGENOL, V161, P1, DOI 10.2214/ajr.161.1.8517285; Erdoes LS, 1996, J VASC SURG, V23, P950, DOI 10.1016/S0741-5214(96)70262-8; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Fellner C, 1997, NEURORADIOLOGY, V39, P763, DOI 10.1007/s002340050502; HUSTON J, 1993, RADIOLOGY, V186, P339, DOI 10.1148/radiology.186.2.8421731; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; KIDO DK, 1991, ARCH NEUROL-CHICAGO, V48, P484, DOI 10.1001/archneur.1991.00530170044019; LASTER RE, 1993, AM J NEURORADIOL, V14, P681; Link J, 1996, ROFO-FORTSCHR RONTG, V165, P544, DOI 10.1055/s-2007-1015809; LITT AW, 1991, AM J NEURORADIOL, V12, P149; Magarelli N, 1998, NEURORADIOLOGY, V40, P367, DOI 10.1007/s002340050601; Martinat P, 1998, J RADIOL, V79, P673; MATTLE HP, 1991, J VASC SURG, V13, P838; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; NICHOLAS GG, 1995, J VASC SURG, V22, P9, DOI 10.1016/S0741-5214(95)70082-X; Ozaki CK, 1999, AM J SURG, V178, P182, DOI 10.1016/S0002-9610(99)00141-5; Pavone P, 1993, Radiol Med, V86, P579; POLAK JF, 1992, RADIOLOGY, V182, P35, DOI 10.1148/radiology.182.1.1727306; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Remonda L, 1998, RADIOLOGY, V209, P95, DOI 10.1148/radiology.209.1.9769818; RILES TS, 1992, STROKE, V23, P341, DOI 10.1161/01.STR.23.3.341; Sardanelli F, 1999, J COMPUT ASSIST TOMO, V23, P208, DOI 10.1097/00004728-199903000-00008; Scarabino T, 1998, EUR J RADIOL, V28, P117, DOI 10.1016/S0720-048X(97)00121-6; Scarabino T, 1999, J NEURORADIOLOGY, V26, P87; SITZER M, 1993, STROKE, V24, P1513, DOI 10.1161/01.STR.24.10.1513; TURNIPSEED WD, 1993, SURGERY, V114, P643; UEHARA T, 1995, CEREBROVASC DIS, V5, P199, DOI 10.1159/000107852; Vamvakas EC, 1998, ARCH PATHOL LAB MED, V122, P675; WILKERSON DK, 1991, J VASC SURG, V14, P803, DOI 10.1067/mva.1991.33241; YOUNG GR, 1994, J NEUROL NEUROSUR PS, V57, P1466, DOI 10.1136/jnnp.57.12.1466; [No title captured]	40	41	43	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					198	201		10.1136/bmj.324.7331.198	http://dx.doi.org/10.1136/bmj.324.7331.198			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809640	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000173604800015
J	Thomas, DN; Dieckmann, GS				Thomas, DN; Dieckmann, GS			Ocean science - Antarctic Sea ice - a habitat for extremophites	SCIENCE			English	Review							ALGAE; TEMPERATURES; SALINITY; BACTERIA; DIATOMS; NITRATE; EUROPA; BRINE; EARTH	The pack ice of Earth's polar oceans appears to be frozen white desert, devoid of life. However, beneath the snow ties a unique habitat for a group of bacteria and microscopic plants and animals that are encased in an ice matrix at tow temperatures and light levels. with the only liquid being pockets of concentrated brines. Survival in these conditions requires a complex suite of physiological and metabolic adaptations, but sea-ice organisms thrive in the ice, and their prolific growth ensures they play a fundamental role in polar ecosystems. Apart from their ecological importance, the bacterial and algae species found in sea ice have become the focus for novel biotechnology, as well as being considered proxies for possible life forms on ice-covered extraterrestrial bodies.	Univ Wales, Sch Ocean Sci, Menai Bridge LL59 5EY, Anglesey, Wales; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Thomas, DN (corresponding author), Univ Wales, Sch Ocean Sci, Menai Bridge LL59 5EY, Anglesey, Wales.		Dieckmann, Gerhard S/B-4307-2010; Thomas, David N./B-1448-2010	Thomas, David N./0000-0001-8832-5907				Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1171, DOI 10.1099/00207713-48-4-1171; Chyba CF, 2001, SCIENCE, V292, P2026, DOI 10.1126/science.1060081; COX GFN, 1986, J GLACIOL, V32, P371, DOI 10.3189/S0022143000012065; Devos N, 1998, J PHYCOL, V34, P655, DOI 10.1046/j.1529-8817.1998.340655.x; Eicken H, 2000, COLD REG SCI TECHNOL, V31, P207, DOI 10.1016/S0165-232X(00)00016-1; EICKEN H, 1992, POLAR BIOL, V12, P3; Gaidos EJ, 1999, SCIENCE, V284, P1631, DOI 10.1126/science.284.5420.1631; GLEITZ M, 1995, MAR CHEM, V51, P81, DOI 10.1016/0304-4203(95)00053-T; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOOVER RB, 1986, EARTH MOON PLANETS, V35, P19, DOI 10.1007/BF00054132; KIRST GO, 1995, J PHYCOL, V31, P181, DOI 10.1111/j.0022-3646.1995.00181.x; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Krembs C, 2000, J EXP MAR BIOL ECOL, V243, P55, DOI 10.1016/S0022-0981(99)00111-2; KREMBS C, 2001, ASLO 2001 AQ SCI M A; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Lizotte MP, 1998, ANTARCT RES SER, V73, P93; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; McCord TB, 2001, SCIENCE, V292, P1523, DOI 10.1126/science.1059916; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; MOCK T, COMMUNICATION; Nichols D, 1999, CURR OPIN BIOTECH, V10, P240, DOI 10.1016/S0958-1669(99)80042-1; Nichols David S., 1995, Science Progress, V78, P311; Nichols DS, 2000, APPL ENVIRON MICROB, V66, P2422, DOI 10.1128/AEM.66.6.2422-2429.2000; Palmisano A.C., 1993, P167; Parkinson CL, 1993, ATLAS SATELLITE OBSE; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; Prezelin BB, 1998, ANTARCT RES SER, V73, P45; Priscu JC, 1998, ANTARCT RES SER, V73, P147; Raven JA, 2000, J MAR BIOL ASSOC UK, V80, P1, DOI 10.1017/S0025315499001526; RAVEN JA, 1992, NEW PHYTOL, V121, P19, DOI 10.1111/j.1469-8137.1992.tb01088.x; Raven JA, 1991, PALAEOGEOGR PALAEOCL, V97, P19, DOI 10.1016/0031-0182(91)90179-U; Raymond JA, 2000, POLAR BIOL, V23, P721, DOI 10.1007/s003000000147; Reay DS, 1999, APPL ENVIRON MICROB, V65, P2577; Russell NJ, 1997, COMP BIOCHEM PHYS A, V118, P489, DOI 10.1016/S0300-9629(97)87354-9; SCHRIEK R, 2000, REPORTS POLAR RES, V349, P1; Stoecker DK, 1998, J PHYCOL, V34, P60, DOI 10.1046/j.1529-8817.1998.340060.x; Thomas DN, 2001, ANN GLACIOL, V33, P297, DOI 10.3189/172756401781818338; Thomashow MF, 2001, PLANT PHYSIOL, V125, P89, DOI 10.1104/pp.125.1.89; Vincent Warwick F., 1993, Environmental Reviews, V1, P1; Zaslavskaia LA, 2001, SCIENCE, V292, P2073, DOI 10.1126/science.160015	41	438	495	7	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					641	644		10.1126/science.1063391	http://dx.doi.org/10.1126/science.1063391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809961	Green Submitted			2022-12-28	WOS:000173560900033
J	Buist, MD; Moore, GE; Bernard, SA; Waxman, BP; Anderson, JN; Nguyen, TV				Buist, MD; Moore, GE; Bernard, SA; Waxman, BP; Anderson, JN; Nguyen, TV			Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: preliminary study	BRITISH MEDICAL JOURNAL			English	Article							AUSTRALIAN HEALTH-CARE; ADVERSE EVENTS; INTENSIVE-CARE; SURVIVAL; QUALITY	Objectives To determine whether earlier clinical intervention by a medical emergency team prompted by clinical instability in a patient could reduce the incidence of and mortality from unexpected cardiac arrest in hospital. Design A non-randomised, population based study before (1996) and after (1999) introduction of the medical emergency team. Setting 300 bed tertiary referral teaching hospital. Participants All patients admitted to the hospital in 1996 (n=19 317) and 1999 (n=22 847). Interventions Medical emergency team (two doctors and one senior intensive care nurse) attended clinically unstable patients immediately with resuscitation drugs, fluid, and equipment. Response activated by the bedside nurse or doctor according to predefined criteria. Main outcome measures Incidence and outcome of unexpected cardiac arrest. Results The incidence of unexpected cardiac arrest was 3.77 per 1000 hospital admissions (73 cases) in 1996 (before intervention) and 2.05 per 1000 admissions (47 cases) in 1999 (after intervention), with mortality being 77% (56 patients) mid 55% (26 patients), respectively. After adjustment for case mix the intervention was associated with a 50% reduction in the incidence of unexpected cardiac arrest (odds ratio 0.50, 95% confidence interval 0.35 to 0.73). Conclusions In clinically unstable inpatients early intervention by a medical emergency team significantly reduces the incidence of mid mortality from unexpected cardiac arrest in hospital.	Dandenong Hosp, Dept Intens Care, Intens Care Unit, Dandenong, Vic 3175, Australia; Dandenong Hosp, Dept Surg, Dandenong, Vic 3175, Australia; Dandenong Hosp, Surg Programme, Dandenong, Vic 3175, Australia; Monash Univ, Inst Publ Hlth, Clayton, Vic 3168, Australia; Univ New S Wales, Dept Anaesthet, Kensington, NSW 2033, Australia; Univ New S Wales, Dept Emergency Med, Kensington, NSW 2033, Australia; Univ New S Wales, Dept Crit Care, Kensington, NSW 2033, Australia	Monash University; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Buist, MD (corresponding author), Dandenong Hosp, Dept Intens Care, Intens Care Unit, Dandenong, Vic 3175, Australia.		Nguyen, Tuan V./AAD-9503-2020	Nguyen, Tuan V./0000-0002-3246-6281; Moore, Gaye/0000-0002-2699-7510				AKBAR MH, 2002, CPR TEAM WORK POSITI; BEDELL SE, 1983, NEW ENGL J MED, V309, P569, DOI 10.1056/NEJM198309083091001; BLACKIE K, 2002, SURVIVAL CPR INCREAS; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Bristow PJ, 2000, MED J AUSTRALIA, V173, P236, DOI 10.5694/j.1326-5377.2000.tb125627.x; BROWN AEP, 2002, HEART DEATHS TERMINA; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; CROOT J, 2002, COVER PICTURE IS FAK; FRANKLIN C, 1994, CRIT CARE MED, V22, P244, DOI 10.1097/00003246-199402000-00014; FRAZER RS, 2002, TOO MANY PREVENTABLE; Hourihan F., 1995, CLIN INTENSIVE CARE, V6, P269, DOI [10.3109/tcic.6.6.269.272, DOI 10.3109/TCIC.6.6.269.272]; HOWSE ML, 2002, YES WHAT DID THEY DO; HYOLLMAEN A, 2002, COVER PICTURE IS FAK; Kerridge RH, 2000, MED J AUSTRALIA, V173, P228, DOI 10.5694/j.1326-5377.2000.tb125623.x; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LEE A, 1995, ANAESTH INTENS CARE, V23, P183, DOI 10.1177/0310057X9502300210; LEMAN P, 2002, COMMENTS PAPER; LEWIS AH, 2002, IMPLEMENTING CHANGE; PEATFIELD RC, 1977, LANCET, V1, P1223; *SAS I INC, 1990, SAS STAT US GUID REL, P549; SCHEIN RMH, 1990, CHEST, V98, P1388, DOI 10.1378/chest.98.6.1388; TEMPEST ME, 2002, COVER PHOTOGRAPH; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	25	514	526	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					387	390		10.1136/bmj.324.7334.387	http://dx.doi.org/10.1136/bmj.324.7334.387			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850367	Green Published, Bronze			2022-12-28	WOS:000174006300014
J	Morrow, M; Gradishar, W				Morrow, M; Gradishar, W			Recent developments - Breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BILATERAL PROPHYLACTIC MASTECTOMY; SURGICAL ADJUVANT BREAST; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; MEGESTROL-ACETATE; SENTINEL NODE; DOUBLE-BLIND; PHASE-III; AROMATASE INHIBITORS; AXILLARY DISSECTION		Northwestern Univ, Dept Surg, Chicago, IL 60611 USA; Northwestern Univ, Dept Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Morrow, M (corresponding author), NW Mem Hosp, Dept Surg, 251 E Huron St,Galter 13-174, Chicago, IL 60611 USA.	mmorrow@nmh.org			NCI NIH HHS [P50-CA89018, P50 CA089018] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089018] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Brodie AMH, 1998, J STEROID BIOCHEM, V66, P1, DOI 10.1016/S0960-0760(98)00022-3; Buzdar A, 2001, J CLIN ONCOL, V19, P3357, DOI 10.1200/JCO.2001.19.14.3357; Buzdar A, 2001, CLIN CANCER RES, V7, P2620; Buzdar AU, 1997, CANCER, V79, P730, DOI 10.1002/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.3.CO;2-Z; DIRIX I, 2001, P AN M AM SOC CLIN, V20, pA29; Dixon JM, 2000, CLIN CANCER RES, V6, P2229; Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO;2-H; Ellis M. J., 2000, Breast Cancer Research and Treatment, V64, P29; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; Gemignani ML, 2001, WORLD J SURG, V25, P809, DOI 10.1007/s00268-001-0010-y; Giuliano AE, 2000, J CLIN ONCOL, V18, P2553, DOI 10.1200/JCO.2000.18.13.2553; Giuliano AE, 1997, J CLIN ONCOL, V15, P2345, DOI 10.1200/JCO.1997.15.6.2345; Grann VR, 2000, CANCER J SCI AM, V6, P13; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HARTMANN LC, IN PRESS J NATL CANC; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; HOWELL UR, 2000, BREAST CANC RES TREA, V64, P27; JORDAN VC, 2001, JNCI-J NATL CANCER I, V8, P745; Kaufmann M, 2000, J CLIN ONCOL, V18, P1399, DOI 10.1200/JCO.2000.18.7.1399; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Lonning PE, 2001, BRIT MED J, V323, P880, DOI 10.1136/bmj.323.7318.880; McMasters KM, 2001, ANN SURG, V234, P292, DOI 10.1097/00000658-200109000-00003; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Nabholtz JM, 2000, J CLIN ONCOL, V18, P3758, DOI 10.1200/JCO.2000.18.22.3758; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; Osborne C. K., 2000, Breast Cancer Research and Treatment, V64, P27; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022; Simmons RM, 2001, J AM COLL SURGEONS, V193, P206, DOI 10.1016/S1072-7515(01)00998-X; Smith R., 2000, Breast Cancer Research and Treatment, V64, P27; Stefanek M, 2001, JNCI-J NATL CANCER I, V93, P1297, DOI 10.1093/jnci/93.17.1297; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Tafra L, 2001, ANN SURG, V233, P51, DOI 10.1097/00000658-200101000-00009	37	13	15	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2002	324	7334					410	414		10.1136/bmj.324.7334.410	http://dx.doi.org/10.1136/bmj.324.7334.410			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850376	Green Published			2022-12-28	WOS:000174006300024
J	Dekker, J; Rippe, K; Dekker, M; Kleckner, N				Dekker, J; Rippe, K; Dekker, M; Kleckner, N			Capturing chromosome conformation	SCIENCE			English	Article							HIGHER-ORDER STRUCTURE; SACCHAROMYCES-CEREVISIAE; CHROMATIN FIBER; IN-VIVO; YEAST; MEIOSIS; ORGANIZATION; RECOMBINATION	We describe an approach to detect the frequency of interaction between any two genomic loci. Generation of a matrix of interaction frequencies between sites on the same or different chromosomes reveals their relative spatial disposition and provides information about the physical properties of the chromatin fiber. This methodology can be applied to the spatial organization of entire genomes in organisms from bacteria to human. Using the yeast Saccharomyces cerevisiae, we could confirm known qualitative features of chromosome organization within the nucleus and dynamic changes in that organization during meiosis. We also analyzed yeast chromosome III at the G(1) stage of the cell cycle. We found that chromatin is highly flexible throughout. Furthermore, functionally distinct AT- and GC-rich domains were found to exhibit different conformations, and a population-average 3D model of chromosome III could be determined. Chromosome III emerges as a contorted ring.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Heidelberg, Kirchhoff Inst Phys, Phys Mol Biol Prozesse, D-69120 Heidelberg, Germany	Harvard University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Dekker, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Rippe, Karsten/A-3562-2012	Rippe, Karsten/0000-0001-9951-9395	NIGMS NIH HHS [GM25326, R01 GM025326, GM44794] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326, R37GM025326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Burgess SM, 1999, GENE DEV, V13, P1627, DOI 10.1101/gad.13.12.1627; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; HAHNFELDT P, 1993, P NATL ACAD SCI USA, V90, P7857; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jin QW, 2000, J CELL SCI, V113, P1903; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; LATORAYA S, 2000, J CELL BIOL, V151, P1047; MOENS PB, 1988, BIOESSAYS, V9, P151, DOI 10.1002/bies.950090503; OSTASHEVSKY JY, 1994, J BIOMOL STRUCT DYN, V11, P813, DOI 10.1080/07391102.1994.10508034; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; van Holde KE., 1989, SPRINGER SERIES MOL; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Wolffe A., 1998, CHROMATIN STRUCTURE; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	36	2361	2519	19	316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1306	1311		10.1126/science.1067799	http://dx.doi.org/10.1126/science.1067799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847345				2022-12-28	WOS:000173926000047
J	Casadevall, N; Nataf, J; Viron, B; Kolta, A; Kiladjian, J; Martin-Dupont, P; Michaud, P; Papo, T; Ugo, V; Teyssandier, I; Varet, B; Mayeux, P				Casadevall, N; Nataf, J; Viron, B; Kolta, A; Kiladjian, J; Martin-Dupont, P; Michaud, P; Papo, T; Ugo, V; Teyssandier, I; Varet, B; Mayeux, P			Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR; ANEMIA; CDNA	Background: Within a period of three years, we identified 13 patients in whom pure red-cell aplasia developed during treatment with recombinant human erythropoietin (epoetin). We investigated whether there was an immunologic basis for the anemia in these patients. Methods: Serum samples from the 13 patients with pure red-cell aplasia were tested for neutralizing antibodies that could inhibit erythroid-colony formation by normal bone marrow cells in vitro. The presence of antierythropoietin antibodies was identified by means of binding assays with the use of radiolabeled intact, deglycosylated, or denatured epoetin. Results: Serum from all 13 patients blocked the formation of erythroid colonies by normal bone marrow cells. The inhibition was reversed by epoetin. Antibodies from 12 of the 13 patients bound only conformational epitopes in the protein moiety of epoetin; serum from the remaining patient bound to both conformational and linear epitopes in erythropoietin. In all the patients, the antibody titer slowly decreased after the discontinuation of treatment with epoetin. Conclusions: Neutralizing antierythropoietin antibodies and pure red-cell aplasia can develop in patients with the anemia of chronic renal failure during treatment with epoetin. (N Engl J Med 2002;346:469-75.) Copyright (C) 2002 Massachusetts Medical Society.	Hop Hotel Dieu, Dept Hematol, F-75181 Paris 04, France; Hop Hotel Dieu, Dept Nucl Med, Paris, France; INSERM, U362, Paris, France; Hop Bichat, Dept Nephrol, F-75877 Paris, France; Hop Bichat, Dept Internal Med, F-75877 Paris, France; Assoc Utilisat Rein Artificiel Reg Parisienne, St Ouen, France; Hop Beaujon, Dept Hematol, Clichy, France; Ctr Treitement Malad Renales St Augustin, Bordeaux, France; Polyclin Lagny, Lagny Sur Marne, France; Univ Paris 05, Ctr Hosp Univ Necker Enfants Malad, Dept Hematol, Paris, France; Inst Cochin Genet Mol, INSERM, U363, F-75014 Paris, France; Inst Cochin Genet Mol, Dept Hematol, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Casadevall, N (corresponding author), Hop Hotel Dieu, Dept Hematol, F-75181 Paris 04, France.		Kiladjian, Jean-Jacques/K-5345-2019	Kiladjian, Jean-Jacques/0000-0002-8121-438X; Ugo, Valerie/0000-0002-4678-2138				Casadevall N, 1996, NEW ENGL J MED, V334, P630, DOI 10.1056/NEJM199603073341004; DESSYPRIS EN, 1991, SEMIN HEMATOL, V28, P275; ESCHBACH JW, 1985, KIDNEY INT, V28, P1, DOI 10.1038/ki.1985.109; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; MAYEUX P, 1987, J BIOL CHEM, V262, P13985; MAYEUX P, 1990, FEBS LETT, V269, P167, DOI 10.1016/0014-5793(90)81145-E; MAYEUX P, 1991, J BIOL CHEM, V266, P23380; Peces R, 1996, NEW ENGL J MED, V335, P523, DOI 10.1056/NEJM199608153350717; Prabhakar SS, 1997, CLIN NEPHROL, V47, P331; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Storring PL, 1998, BRIT J HAEMATOL, V100, P79; Stridsberg M., 1993, ERYTHROPOIETIN MOL P, P266; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1	15	864	924	1	23	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					469	475		10.1056/NEJMoa011931	http://dx.doi.org/10.1056/NEJMoa011931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844847				2022-12-28	WOS:000173815300002
J	Gergely, G; Bekkering, H; Kiraly, I				Gergely, G; Bekkering, H; Kiraly, I			Rational imitation in preverbal infants	NATURE			English	Article							MEMORY		Hungarian Acad Sci, Inst Psychol, H-1132 Budapest, Hungary; Max Planck Inst Psychol Res, D-80799 Munich, Germany	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Max Planck Society	Gergely, G (corresponding author), Hungarian Acad Sci, Inst Psychol, H-1132 Budapest, Hungary.		Király, Ildikó/AGD-5122-2022; Bekkering, Harold/A-6357-2009	Király, Ildikó/0000-0002-4857-1764; Gergely, Gyorgy/0000-0002-2094-4258				Bekkering H, 2000, Q J EXP PSYCHOL-A, V53, P153, DOI 10.1080/027249800390718; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Csibra G, 1998, DEVELOPMENTAL SCI, V1, P255, DOI 10.1111/1467-7687.00039; Gergely G, 1997, COGNITION, V63, P227, DOI 10.1016/S0010-0277(97)00004-8; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; MELTZOFF AN, 1995, J EXP CHILD PSYCHOL, V59, P497, DOI 10.1006/jecp.1995.1023; MELTZOFF AN, 1988, DEV PSYCHOL, V24, P470, DOI 10.1037/0012-1649.24.4.470; Tomasello Michael, 1999, CULTURAL ORIGINS HUM	8	716	727	1	483	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					755	755		10.1038/415755a	http://dx.doi.org/10.1038/415755a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	521HE	11845198	Bronze			2022-12-28	WOS:000173833900035
J	Di Croce, L; Raker, VA; Corsaro, M; Fazi, F; Fanelli, M; Faretta, M; Fuks, F; Lo Coco, F; Kouzarides, T; Nervi, C; Minucci, S; Pelicci, PG				Di Croce, L; Raker, VA; Corsaro, M; Fazi, F; Fanelli, M; Faretta, M; Fuks, F; Lo Coco, F; Kouzarides, T; Nervi, C; Minucci, S; Pelicci, PG			Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor	SCIENCE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; HISTONE DEACETYLASE; RAR-ALPHA; FUSION PROTEINS; DIFFERENTIATION; METHYLATION; CANCER; GENE; EPIGENETICS; REPRESSION	DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.	European Inst Oncol, Dept Expt Oncol, Milan, Italy; Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy; Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; Univ Cambridge, Wellcome CRC Inst, Cambridge, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Camerino, Dept Morphol Sci, I-62032 Camerino, Italy; Italian Fdn Canc Res, Inst Mol Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); Sapienza University Rome; Sapienza University Rome; University of Cambridge; University of Cambridge; University of Camerino; IFOM - FIRC Institute of Molecular Oncology	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.		Pelicci, Pier Giuseppe/AAL-6572-2020; Fazi, Francesco/K-5304-2018; Di Croce, Luciano/E-7759-2015; Minucci, Saverio/J-9669-2012; Fanelli, Mirco/F-2665-2011; Faretta, Mario/H-8946-2012	Fazi, Francesco/0000-0003-2910-7912; Di Croce, Luciano/0000-0003-3488-6228; Fanelli, Mirco/0000-0002-9649-8661; Faretta, Mario/0000-0003-1678-5781; Kouzarides, Tony/0000-0002-8918-4162; NERVI, Clara/0000-0001-9341-0188				Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Benedetti L, 1996, BLOOD, V87, P1939; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Casini T, 1999, ONCOGENE, V18, P3235, DOI 10.1038/sj.onc.1202630; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DICROCE L, UNPUB; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PELICCI PG, UNPUB; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Ruthardt M, 1997, MOL CELL BIOL, V17, P4859, DOI 10.1128/MCB.17.8.4859; Widschwendter M, 2000, J NATL CANCER I, V92, P826, DOI 10.1093/jnci/92.10.826	25	619	638	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1079	1082		10.1126/science.1065173	http://dx.doi.org/10.1126/science.1065173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834837				2022-12-28	WOS:000173793000068
J	Schwab, ME				Schwab, ME			Repairing the injured spinal cord	SCIENCE			English	Editorial Material							NEURITE GROWTH-INHIBITORS; CENTRAL-NERVOUS-SYSTEM; ADULT-RAT; AXONAL REGENERATION; PARAPLEGIC RATS; MYELIN; ANTIBODY; RECOVERY; IN-1		Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Swiss Fed Inst Technol, Dept Biol, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schwab, ME (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Schwab, Martin E/B-6818-2016					Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6; Brosamle C, 2000, J NEUROSCI, V20, P8061; Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Dyer JK, 1998, EXP NEUROL, V154, P12, DOI 10.1006/exnr.1998.6905; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Lacroix S, 2000, NEUROREHAB NEURAL RE, V14, P265, DOI 10.1177/154596830001400403; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 2001, P NATL ACAD SCI USA, V98, P6929, DOI 10.1073/pnas.111165498; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Sasaki M, 2001, GLIA, V35, P26, DOI 10.1002/glia.1067; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720	26	322	388	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1029	1031		10.1126/science.1067840	http://dx.doi.org/10.1126/science.1067840			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834824				2022-12-28	WOS:000173793000052
J	Silver, PG; Holt, WE				Silver, PG; Holt, WE			The mantle flow field beneath western North America	SCIENCE			English	Article							SEISMIC ANISOTROPY; SHEAR STRUCTURE; PLATE BOUNDARY; RANGE PROVINCE; UNITED-STATES; 1992 LANDERS; DEFORMATION; KINEMATICS; DYNAMICS; MOTION	Although motions at the surface of tectonic plates are well determined, the accompanying horizontal mantle flow is not. We have combined observations of surface deformation and upper mantle seismic anisotropy to estimate this flow field for western North America. We find that the mantle velocity is 5.5 +/- 1.5 centimeters per year due east in a hot spot reference frame, nearly opposite to the direction of North American plate motion (west-southwest). The flow is only weakly coupled to the motion of the surface plate, producing a small drag force. This flow field is probably due to heterogeneity in mantle density associated with the former Farallon oceanic plate beneath North America.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA	Carnegie Institution for Science; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Silver, PG (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	silver@dtm.ciw.edu		Holt, William/0000-0002-0267-5306				Adams KD, 1999, GEOL SOC AM BULL, V111, P1739, DOI 10.1130/0016-7606(1999)111<1739:IRAFAP>2.3.CO;2; Antonelis K, 1999, GEOLOGY, V27, P299, DOI 10.1130/0091-7613(1999)027<0299:GDOCPN>2.3.CO;2; Atwater T, 1998, INT GEOL REV, V40, P375, DOI 10.1080/00206819809465216; Bennett RA, 1999, GEOLOGY, V27, P371, DOI 10.1130/0091-7613(1999)027<0371:PDPOCD>2.3.CO;2; Bevington P. R, 1969, DATA REDUCTION ERROR; BILLS BG, 1994, J GEOPHYS RES-SOL EA, V99, P22059, DOI 10.1029/94JB01192; BOKELMANN G, 2002, GEOPHYS J INT, V148, P1; CHASE CG, 1979, GEOPHYS J ROY ASTR S, V56, P1, DOI 10.1111/j.1365-246X.1979.tb04764.x; Deng JS, 1998, SCIENCE, V282, P1689, DOI 10.1126/science.282.5394.1689; Dixon TH, 2000, TECTONICS, V19, P1, DOI 10.1029/1998TC001088; Flesch LM, 2000, SCIENCE, V287, P834, DOI 10.1126/science.287.5454.834; Freed AM, 2001, NATURE, V411, P180, DOI 10.1038/35075548; Freymueller JT, 1999, J GEOPHYS RES-SOL EA, V104, P7419, DOI 10.1029/1998JB900118; GRAND SP, 1984, GEOPHYS J ROY ASTR S, V76, P399, DOI 10.1111/j.1365-246X.1984.tb05053.x; GRAND SP, 1994, J GEOPHYS RES-SOL EA, V99, P11591, DOI 10.1029/94JB00042; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1109, DOI 10.1029/GL017i008p01109; HAGER BH, 1981, J GEOPHYS RES, V86, P4843, DOI 10.1029/JB086iB06p04843; HAINES AJ, 1993, J GEOPHYS RES-SOL EA, V98, P12057, DOI 10.1029/93JB00892; HOLT WE, 1995, J GEOPHYS RES-SOL EA, V100, P17991, DOI 10.1029/95JB01059; HUMPHREYS ED, 1990, J GEOPHYS RES-SOLID, V95, P19747, DOI 10.1029/JB095iB12p19747; HUMPHREYS ED, 2000, EOS, V81, P13; Lithgow-Bertelloni C, 1998, REV GEOPHYS, V36, P27, DOI 10.1029/97RG02282; LITHGOWBERTELLO.C, COMMUNICATION; MA C, 1998, NASA SPACE GEODESY P; McCaffrey R, 2000, GEOPHYS RES LETT, V27, P3117, DOI 10.1029/2000GL011768; OConnell R.J., 2000, GEOPHYSICAL MONOGRAP, P377; Oskin M, 2001, GEOLOGY, V29, P459, DOI 10.1130/0091-7613(2001)029<0459:RLOPNA>2.0.CO;2; Peyton V, 2001, GEOPHYS RES LETT, V28, P379, DOI 10.1029/2000GL012200; Polet J, 2000, J GEOPHYS RES-SOL EA, V105, P6287, DOI 10.1029/1999JB900326; POLET J, IN PRESS GEOPHYS J I; Pollitz FF, 2000, J GEOPHYS RES-SOL EA, V105, P8035, DOI 10.1029/1999JB900380; RICARD Y, 1993, J GEOPHYS RES-SOL EA, V98, P21895, DOI 10.1029/93JB02216; RICHARDSON RM, 1992, J GEOPHYS RES-SOL EA, V97, P11739, DOI 10.1029/91JB00475; RICHARDSON RM, 1991, J GEOPHYS RES-SOLID, V96, P12201, DOI 10.1029/91JB00958; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Schutt DL, 2001, GEOLOGY, V29, P291, DOI 10.1130/0091-7613(2001)029<0291:EFADAB>2.0.CO;2; SCHUTT DL, COMMUNICATION; Shen-Tu BM, 1999, J GEOPHYS RES-SOL EA, V104, P28927, DOI 10.1029/1999JB900293; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; Thatcher W, 1999, SCIENCE, V283, P1714, DOI 10.1126/science.283.5408.1714; vanderLee S, 1997, NATURE, V386, P266, DOI 10.1038/386266a0; vanderLee S, 1997, J GEOPHYS RES-SOL EA, V102, P22815, DOI 10.1029/97JB01168; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0; ZOBACK ML, 2000, EOS, V81, P12	45	138	146	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1054	1057		10.1126/science.1066878	http://dx.doi.org/10.1126/science.1066878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834831				2022-12-28	WOS:000173793000061
J	Hu, K; Carroll, J; Fedorovich, S; Rickman, C; Sukhodub, A; Davletov, B				Hu, K; Carroll, J; Fedorovich, S; Rickman, C; Sukhodub, A; Davletov, B			Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion	NATURE			English	Article							PHOSPHOLIPID-BINDING; SPEED LIMIT; SYNAPTOTAGMIN; PROTEIN; COMPLEX; SYNAPTOPHYSIN; EXOCYTOSIS; VESICLES; TETANUS; RELEASE	Release of neurotransmitter occurs when synaptic vesicles fuse with the plasma membrane. This neuronal exocytosis is triggered by calcium and requires three SNARE (soluble-N-ethylmaleimide-sensitive factor attachment protein receptors) proteins: synaptobrevin (also known as VAMP) on the synaptic vesicle, and syntaxin and SNAP-25 on the plasma membrane(1-4). Neuronal SNARE proteins form a parallel four-helix bundle that is thought to drive the fusion of opposing membranes(5,6). As formation of this SNARE complex in solution does not require calcium, it is not clear what function calcium has in triggering SNARE-mediated membrane fusion. We now demonstrate that whereas syntaxin and SNAP-25 in target membranes are freely available for SNARE complex formation, availability of synaptobrevin on synaptic vesicles is very limited. Calcium at micromolar concentrations triggers SNARE complex formation and fusion between synaptic vesicles and reconstituted target membranes. Although calcium does promote interaction of SNARE proteins between opposing membranes, it does not act by releasing synaptobrevin from synaptic vesicle restriction. Rather, our data suggest a mechanism in which calcium-triggered membrane apposition enables syntaxin and SNAP-25 to engage synaptobrevin, leading to membrane fusion.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Davletov, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	baz@mrc-lmb.cam.ac.uk	Davletov, Bazbek/ABA-8569-2021; Fedorovich, Sergei/N-4315-2013	Rickman, Colin/0000-0001-8938-524X				Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Capogna M, 1997, J NEUROSCI, V17, P7190; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Elferink LA, 1995, PROG BRAIN RES, V105, P79; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; KELLY RB, 1999, FR MOLEC B, V23, P1; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; McCammon JA, 1996, P NATL ACAD SCI USA, V93, P11426, DOI 10.1073/pnas.93.21.11426; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meyuhas D, 1996, BIOPHYS J, V71, P2602, DOI 10.1016/S0006-3495(96)79452-3; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; PERIN MS, 1991, J BIOL CHEM, V266, P615; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; Quetglas S, 2000, P NATL ACAD SCI USA, V97, P9695, DOI 10.1073/pnas.97.17.9695; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schikorski T, 1997, J NEUROSCI, V17, P5858; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tolar LA, 1998, J NEUROSCI, V18, P10250; VIGUERA AR, 1993, BIOCHEMISTRY-US, V32, P3708, DOI 10.1021/bi00065a024; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wittung-Stafshede P, 1999, P NATL ACAD SCI USA, V96, P6587, DOI 10.1073/pnas.96.12.6587; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	30	149	152	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					646	650		10.1038/415646a	http://dx.doi.org/10.1038/415646a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832947				2022-12-28	WOS:000173709100048
J	Bazari, H; Mauiyyedi, S; O'Malley, M; McDougal, WS; Colvin, RB; Niles, JL				Bazari, H; Mauiyyedi, S; O'Malley, M; McDougal, WS; Colvin, RB; Niles, JL			A 75-year-old man with acute renal failure five months after cystoprostatectomy and urethrectomy for carcinoma - Glomerulonephritis mediated by anti glomerular-basement-membrane antibodies.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; GOODPASTURES-SYNDROME; CIPROFLOXACIN; VASCULITIS; DISEASE; INSUFFICIENCY; SECONDARY; KIDNEYS; LUNG		Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Bazari, H (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							ABBOUD HE, 1981, NEPHRON, V27, P101, DOI 10.1159/000182033; ANDRASSY K, 1991, NEPHRON, V59, P206, DOI 10.1159/000186552; BRADY HR, 1995, LANCET, V346, P1533, DOI 10.1016/S0140-6736(95)92057-9; COLLINS AB, 1997, MANUAL CLIN LABORATO, P1008; COLVIN RB, 1994, RENAL PATHOLOGY CLIN, P723; CONNOR JP, 1994, J UROLOGY, V151, P975, DOI 10.1016/S0022-5347(17)35139-X; COSIO FG, 1981, CLIN NEPHROL, V15, P206; COUSER WG, 1982, AM J NEPHROL, V2, P57, DOI 10.1159/000166586; CREAVEN PJ, 1972, J UROLOGY, V108, P223, DOI 10.1016/S0022-5347(17)60694-3; Daly C, 1996, RENAL FAILURE, V18, P105, DOI 10.3109/08860229609052780; DAVIES DJ, 1982, BMJ-BRIT MED J, V285, P606, DOI 10.1136/bmj.285.6342.606; DOBRIN RS, 1975, AM J MED, V59, P325, DOI 10.1016/0002-9343(75)90390-3; EISINGER AJ, 1973, AM J MED, V55, P565, DOI 10.1016/0002-9343(73)90215-5; Espiritu J, 1995, W V Med J, V91, P16; Goodpasture EW, 1919, AM J MED SCI, V158, P863, DOI 10.1097/00000441-191911000-00012; HRICIK DE, 1983, ARCH INTERN MED, V143, P2013, DOI 10.1001/archinte.1983.00350100197041; HUDSON BG, 1993, KIDNEY INT, V43, P135, DOI 10.1038/ki.1993.22; JENNETTE JC, 1989, AM J PATHOL, V135, P921; JOHNSON JP, 1985, MEDICINE, V64, P219, DOI 10.1097/00005792-198507000-00003; KANFER A, 1976, CANCER, V38, P2588, DOI 10.1002/1097-0142(197612)38:6<2588::AID-CNCR2820380653>3.0.CO;2-W; KAUFMAN J, 1991, AM J KIDNEY DIS, V17, P191, DOI 10.1016/S0272-6386(12)81128-0; KYLE RA, 1994, ANNU REV MED, V45, P71; LEATHERMAN JW, 1984, MEDICINE, V63, P343, DOI 10.1097/00005792-198411000-00002; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; LOCKWOOD CM, 1976, LANCET, V1, P711; LOMBARD CM, 1989, HUM PATHOL, V20, P445, DOI 10.1016/0046-8177(89)90009-9; LUCENA MI, 1995, ARCH INTERN MED, V155, P114; NARYSHKIN S, 1991, J UROLOGY, V146, P1610, DOI 10.1016/S0022-5347(17)38183-1; NILES JL, 1991, J AM SOC NEPHROL, V2, P27; Niles JL, 1996, ANNU REV MED, V47, P303; NOLAN CR, 1986, NEW ENGL J MED, V315, P1516, DOI 10.1056/NEJM198612113152404; PALLER MS, 1990, MED CLIN N AM, V74, P909, DOI 10.1016/S0025-7125(16)30525-9; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; SHIH DJ, 1995, AM J KIDNEY DIS, V26, P516, DOI 10.1016/0272-6386(95)90500-6; SOMERVILLE CA, 1992, MED J AUSTRALIA, V156, P721, DOI 10.5694/j.1326-5377.1992.tb121515.x; STANTON M. C., 1958, AUSTRALASEAN ANN MED, V7, P132; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; THADHANI RI, 1995, MEDICINE, V74, P350, DOI 10.1097/00005792-199511000-00005; WILSON DM, 1976, BMJ-BRIT MED J, V2, P459, DOI 10.1136/bmj.2.6033.459	39	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					353	360		10.1056/NEJMcpc020004	http://dx.doi.org/10.1056/NEJMcpc020004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821513				2022-12-28	WOS:000173545300009
J	Fraser, PJ; Shelmerdine, RL				Fraser, PJ; Shelmerdine, RL			Fish physiology - Dogfish hair cells sense hydrostatic pressure	NATURE			English	Article									Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland	University of Aberdeen	Fraser, PJ (corresponding author), Univ Aberdeen, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.			Shelmerdine, Richard L./0000-0003-2135-3326				BLAXTER JHS, 1980, ENV PHYSL FISHES, P369; Conradi P, 1999, ORL J OTO-RHINO-LARY, V61, P57, DOI 10.1159/000027642; DIGBY PS, 1961, NATURE, V191, P366, DOI 10.1038/191366a0; DOWSE HB, 1994, BIOL RHYTHM RES, V25, P1; FRASER PJ, 1994, NATURE, V371, P383, DOI 10.1038/371383b0; HARDY AC, 1951, NATURE, V168, P327; LOWENSTEIN O, 1978, PROC R SOC SER B-BIO, V202, P313, DOI 10.1098/rspb.1978.0070; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; Pavlov DS, 2000, J FISH BIOL, V57, P69, DOI 10.1006/jfbi.2000.1287	9	31	31	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					495	496		10.1038/415495a	http://dx.doi.org/10.1038/415495a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823850				2022-12-28	WOS:000173564300036
J	Ma, RCW; Cockram, CS				Ma, RCW; Cockram, CS			Metastatic calcification	LANCET			English	Editorial Material									Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Ma, RCW (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.		Ma, Ronald/C-2788-2009	Ma, Ronald/0000-0002-1227-803X					0	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					293	293		10.1016/S0140-6736(02)07552-9	http://dx.doi.org/10.1016/S0140-6736(02)07552-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830195	Bronze			2022-12-28	WOS:000173588100009
J	Al-Olayan, EM; Beetsma, AL; Butcher, GA; Sinden, RE; Hurd, H				Al-Olayan, EM; Beetsma, AL; Butcher, GA; Sinden, RE; Hurd, H			Complete development of mosquito phases of the malaria parasite in vitro	SCIENCE			English	Article							PLASMODIUM-BERGHEI; SPOROGONIC DEVELOPMENT; ANOPHELES-STEPHENSI; IN-VITRO; TRANSMISSION; GALLINACEUM; INVITRO; EXPRESSION; HEMOLYMPH; PROTEINS	Methods for reproducible in vitro development of the mosquito stages of malaria parasites to produce infective sporozoites have been elusive for over 40 years. We have cultured gametocytes of Plasmodium berghei through to infectious sporozoites with efficiencies similar to those recorded in vivo and without the need for salivary gland invasion. Oocysts developed extracellularly in a system whose essential elements include co-cultured Drosophila S2 cells, basement membrane matrix, and insect tissue culture medium. Sporozoite production required the presence of para-aminobenzoic acid. The entire life cycle of P. berghei, a useful model malaria parasite, can now be achieved in vitro.	Univ Keele, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, London SW7 2AZ, England	Keele University; Imperial College London	Hurd, H (corresponding author), Univ Keele, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England.							Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; ALOLAYAN EM, UNPUB J CELL BIOL; Arrighi RBG, 2002, INT J PARASITOL, V32, P91, DOI 10.1016/S0020-7519(01)00298-3; BALL GH, 1964, J PARASITOL, V50, P3, DOI 10.2307/3276018; Billingsley PF, 1997, PARASITOL TODAY, V13, P297, DOI 10.1016/S0169-4758(97)01094-6; Billker O, 2000, PARASITOLOGY, V120, P547, DOI 10.1017/S0031182099005946; BOULANGER N, 1995, PARASITOL RES, V81, P58, DOI 10.1007/BF00932418; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; MACK SR, 1978, J PARASITOL, V64, P918, DOI 10.2307/3279531; PETERS W, 1980, ANN TROP MED PARASIT, V74, P275, DOI 10.1080/00034983.1980.11687345; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shahabuddin M, 1998, P NATL ACAD SCI USA, V95, P3385, DOI 10.1073/pnas.95.7.3385; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Sinden R. E., 1997, The molecular biology of insect disease vectors: a methods manual., P67; Sinden RE, 2001, TRENDS PARASITOL, V17, P209, DOI 10.1016/S1471-4922(01)01928-6; SINDEN RE, 1987, PROC R SOC SER B-BIO, V230, P443, DOI 10.1098/rspb.1987.0028; SYAFRUDDIN RA, 1992, J PROTOZOOL, V39, P333; UCHIDA K, 1990, J MED ENTOMOL, V27, P302, DOI 10.1093/jmedent/27.3.302; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; VANDERBERG JP, 1977, B WORLD HEALTH ORGAN, V55, P377; VARMA MGR, 1969, J MED ENTOMOL, V6, P432, DOI 10.1093/jmedent/6.4.432; VAUGHAN JA, 1994, J PARASITOL, V80, P674, DOI 10.2307/3283245; Vlachou D, 2001, MOL BIOCHEM PARASIT, V112, P229, DOI 10.1016/S0166-6851(00)00371-6; WARBURG A, 1993, EXP PARASITOL, V76, P121, DOI 10.1006/expr.1993.1014; WARBURG A, 1992, SCIENCE, V255, P448, DOI 10.1126/science.1734521; WINGER LA, 1992, PARASITOL RES, V78, P427, DOI 10.1007/BF00931700; YEON SH, 2000, EMBO J, V19, P6030; Yuda M, 1999, J EXP MED, V189, P1947, DOI 10.1084/jem.189.12.1947; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	31	80	86	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					677	679		10.1126/science.1067159	http://dx.doi.org/10.1126/science.1067159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809973				2022-12-28	WOS:000173560900045
J	Lloyd, TE; Atkinson, R; Wu, MN; Zhou, Y; Pennetta, G; Bellen, HJ				Lloyd, TE; Atkinson, R; Wu, MN; Zhou, Y; Pennetta, G; Bellen, HJ			Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila	CELL			English	Article							EMBRYONIC VENTRAL ECTODERM; GROWTH-FACTOR RECEPTOR; ZINC-FINGER DOMAIN; EGF RECEPTOR; NEUROTRANSMITTER RELEASE; MULTIVESICULAR BODY; PROTEIN; ENDOCYTOSIS; MELANOGASTER; INTERACTS	Signaling through tyrosine kinase receptors (TKRs) is thought to be modulated by receptor-mediated endocytosis and degradation of the receptor in the lysosome. However, factors that regulate endosomal sorting of TKRs are largely unknown. Here, we demonstrate that Hrs ((H) under bar epatocyte growth factor-(r) under bar egulated tyrosine kinase (s) under bar ubstrate) is one such factor. Electron microscopy studies of hrs mutant larvae reveal an impairment in endosome membrane invagination and formation of multivesicular bodies (MVBs). hrs mutant animals fail to degrade active epidermal growth factor (EGF) and Torso TKRs, leading to enhanced signaling and altered embryonic patterning. These data suggest that Hrs and MVB formation function to downregulate TKR signaling.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.			Bellen, Hugo/0000-0001-5992-5989; Lloyd, Thomas/0000-0003-4756-3700				Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; CHOU TB, 1993, DEVELOPMENT, V119, P1359; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DOYLE HJ, 1993, GENE DEV, V7, P633, DOI 10.1101/gad.7.4.633; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gabay L, 1996, DEVELOPMENT, V122, P3355; Gabay L, 1997, DEVELOPMENT, V124, P3535; Ghiglione C, 1999, DEV BIOL, V205, P181, DOI 10.1006/dbio.1998.9102; Golembo M, 1996, DEVELOPMENT, V122, P3363; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; KOENIG JH, 1990, CELL TISSUE RES, V262, P233, DOI 10.1007/BF00309878; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 2001, BIOCHEM BIOPH RES CO, V281, P1065, DOI 10.1006/bbrc.2001.4441; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Kwong J, 2000, J CELL SCI, V113, P2273; LEPTIN M, 1992, DEVELOPMENT, P23; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; LITTLETON JT, 1994, GENETICS, V138, P111; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; NARITA K, 1989, J CELL PHYSIOL, V141, P383, DOI 10.1002/jcp.1041410220; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PERRIMON N, 1993, CELL, V74, P219, DOI 10.1016/0092-8674(93)90412-J; PERRIMON N, 1986, GENETICS, V113, P695; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; RAZ E, 1993, GENE DEV, V7, P1937, DOI 10.1101/gad.7.10.1937; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Seaman MNJ, 1996, CURR OPIN CELL BIOL, V8, P549, DOI 10.1016/S0955-0674(96)80034-2; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SPRENGER F, 1992, CELL, V71, P987, DOI 10.1016/0092-8674(92)90394-R; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STURTEVANT MA, 1994, DEVELOPMENT, V120, P2593; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; WIDES RJ, 1990, EUR J BIOCHEM, V189, P637, DOI 10.1111/j.1432-1033.1990.tb15532.x; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129	53	359	363	2	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					261	269		10.1016/S0092-8674(02)00611-6	http://dx.doi.org/10.1016/S0092-8674(02)00611-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832215	Bronze			2022-12-28	WOS:000173521300012
J	Pluk, H; Dorey, K; Superti-Furga, G				Pluk, H; Dorey, K; Superti-Furga, G			Autoinhibition of c-Abl	CELL			English	Article							TYROSINE KINASE-ACTIVITY; BCR-ABL; SH3 DOMAINS; SRC-FAMILY; POSITIVE CELLS; HUMAN LEUKEMIA; PROTEIN; GROWTH; TRANSFORMATION; INHIBITOR	Despite years of investigation, the molecular mechanism responsible for regulation of the c-Abl tyrosine kinase has remained elusive. We now report inhibition of the catalytic activity of purified c-Abl in vitro, demonstrating that regulation is an intrinsic property of the molecule. We show that the interaction of the N-terminal 80 residues with the rest of the protein mediates autoregulation. This N-terminal "cap" is required to achieve and maintain inhibition, and its loss turns c-Abl into an oncogenic protein and contributes to deregulation of BCR-Abl.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH	Superti-Furga, G (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Dorey, Karel/0000-0003-0846-5286				Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Dorey K, 1999, BIOL CHEM, V380, P223; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hardin JD, 1996, ONCOGENE, V12, P2669; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Koegl M, 1995, ONCOGENE, V11, P2317; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; McCormick F, 2001, NATURE, V412, P281, DOI 10.1038/35085665; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; RENSHAW MW, 1992, EMBO J, V11, P3941, DOI 10.1002/j.1460-2075.1992.tb05488.x; SAWYERS CL, 1992, CANCER SURV, V15, P37; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Smith KM, 2001, J BIOL CHEM, V276, P24372, DOI 10.1074/jbc.M100786200; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Thiesing JT, 2000, BLOOD, V96, P3195, DOI 10.1182/blood.V96.9.3195.h8003195_3195_3199; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Walkenhorst J, 1996, ONCOGENE, V12, P1513; WANG JYJ, 1988, ONCOGENE RES, V3, P293; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200	48	184	200	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					247	259		10.1016/S0092-8674(02)00623-2	http://dx.doi.org/10.1016/S0092-8674(02)00623-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832214	Bronze			2022-12-28	WOS:000173521300011
J	Conley, LJ; Ellerbrock, TV; Bush, TJ; Chiasson, MA; Sawo, D; Wright, TC				Conley, LJ; Ellerbrock, TV; Bush, TJ; Chiasson, MA; Sawo, D; Wright, TC			HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; UNITED-STATES; WOMEN; PREVALENCE; DISEASE; TRENDS; DISORDERS; CARCINOMA; CANCERS	Background Information about vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia in women infected with HIV-1 is needed to develop guidelines for clinical care. Our aim was to investigate the incidence of these lesions in HIV-1-positive and HIV-1-negative women and to examine risk factors for disease. Methods In a prospective cohort study, 925 women had a gynaecological examination twice yearly-including colposcopy and tests for human papillomavirus DNA in cervicovaginal lavage-for a median follow-up of 3.2 years (IQR 0.98-4.87). Findings Vulvovaginal and perianal condylomata acuminata or intraepithelial neoplasia were present in 30 (6%) of 481 HIV-1-positive and four (1%) of 437 HIV-1-negative women (p < 0.0001) at enrolment. Women without lesions at enrolment were included in an incidence analysis. 33 (9%) of 385 HIV-1-positive and two (1%) of 341 HIV-1-negative women developed vulvovaginal or perianal lesions, resulting in an incidence of 2.6 and 0.16 cases per 100 person-years, respectively (relative risk 16, 95% Cl 12.9-20.5; p < 0.0001). Risk factors for incident lesions included HIV-1 infection (p = 0.013), human papillomavirus infection (p = 0.0013), lower CD4 T lymphocyte count (p = 0.0395), and history of frequent injection of drugs (P = 0.0199). Interpretation Our results suggest that HIV-1-positive women are at increased risk of development of invasive vulvar carcinoma. Thus, we recommend that, as part of every gynaecological examination, HIV-1-positive women should have a thorough inspection of the vulva and perianal region, and women with abnormalities-except for typical, exophytic condylomata acuminata-should undergo colposcopy and biopsy.	Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Publ Hlth Serv,US Dept Hlth & Human Serv, Atlanta, GA USA; New York City Dept Hlth, Bur Dis Intervent Res, New York, NY 10013 USA	Columbia University; Centers for Disease Control & Prevention - USA; United States Public Health Service; New York City Department of Health & Mental Hygiene	Wright, TC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Room 16-402,630 W 168th St, New York, NY 10032 USA.				ODCDC CDC HHS [U64/CCU206822] Funding Source: Medline	ODCDC CDC HHS		Bersoff-Matcha SJ, 1998, J INFECT DIS, V178, P1174, DOI 10.1086/515678; BLOHME I, 1985, TRANSPLANTATION, V39, P23; BYRNE MA, 1989, AIDS, V3, P379, DOI 10.1097/00002030-198906000-00007; *CDCP, 1993, MMWR-MORBID MORTAL W, V41, P1; CHIASSON M, 1998, P 2 AIDS MAL C APR B; Chiasson MA, 1997, OBSTET GYNECOL, V89, P690, DOI 10.1016/S0029-7844(97)00069-0; Chin KM, 1998, OBSTET GYNECOL, V92, P83, DOI 10.1016/S0029-7844(98)00140-9; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; FENNEMA JSA, 1995, AIDS, V9, P1071, DOI 10.1097/00002030-199509000-00014; Frankel RE, 1997, CLIN INFECT DIS, V25, P706, DOI 10.1086/513775; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; GHYS PD, 1995, J INFECT DIS, V172, P1371, DOI 10.1093/infdis/172.5.1371; JONES RW, 1995, BRIT J OBSTET GYNAEC, V102, P764, DOI 10.1111/j.1471-0528.1995.tb10839.x; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; JONES RW, 1994, OBSTET GYNECOL, V84, P741; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; KAUFMAN RH, 1995, GYNECOL ONCOL, V56, P8, DOI 10.1006/gyno.1995.1003; KOULOS JP, 1993, GYNECOL ONCOL, V48, P364, DOI 10.1006/gyno.1993.1064; KURMAN RJ, 1994, BLAUSTEINS PATHOLOGY, P229; LAGA M, 1992, INT J CANCER, V50, P45, DOI 10.1002/ijc.2910500110; MAIMAN M, 1990, GYNECOL ONCOL, V38, P377, DOI 10.1016/0090-8258(90)90077-X; Minkoff HL, 1999, AM J OBSTET GYNECOL, V180, P824, DOI 10.1016/S0002-9378(99)70653-8; PENN I, 1986, CANCER-AM CANCER SOC, V58, P611, DOI 10.1002/1097-0142(19860801)58:3<611::AID-CNCR2820580303>3.0.CO;2-M; STURGEON SR, 1992, AM J OBSTET GYNECOL, V166, P1482, DOI 10.1016/0002-9378(92)91623-I; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SUN XW, 1995, OBSTET GYNECOL, V85, P681; Wortley PM, 1997, JAMA-J AM MED ASSOC, V278, P911, DOI 10.1001/jama.278.11.911; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591	28	119	127	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					108	113		10.1016/S0140-6736(02)07368-3	http://dx.doi.org/10.1016/S0140-6736(02)07368-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809252				2022-12-28	WOS:000173212400009
J	Wengelnik, K; Vidal, V; Ancelin, ML; Cathiard, AM; Morgat, JL; Kocken, CH; Calas, M; Herrera, S; Thomas, AW; Vial, HJ				Wengelnik, K; Vidal, V; Ancelin, ML; Cathiard, AM; Morgat, JL; Kocken, CH; Calas, M; Herrera, S; Thomas, AW; Vial, HJ			A class of potent antimalarials and their specific accumulation in infected erythrocytes	SCIENCE			English	Article							FALCIPARUM PHOSPHOLIPID-METABOLISM; PLASMODIUM-FALCIPARUM; MALARIA; CHLORIDE	During asexual development within erythrocytes, malaria parasites synthesize considerable amounts of membrane. This activity provides an attractive target for chemotherapy because it is absent from mature erythrocytes. We found that compounds that inhibit phosphatidylcholine biosynthesis de novo from choline were potent antimalarial drugs. The lead compound, G25, potently inhibited in vitro growth of the human malaria parasites Plasmodium falciparum and P. vivax and was 1000-fold less toxic to mammalian cell lines. A radioactive derivative specifically accumulated in infected erythrocytes to levels several hundredfold higher than in the surrounding medium, and very low dose G25 therapy completely cured monkeys infected with P. falciparum and A cynomolgi.	Univ Montpellier 2, CNRS, UMR 5539, F-34095 Montpellier 5, France; Univ Montpellier 2, CNRS, UMR 5810, F-34095 Montpellier, France; Univ Montpellier 1, Fac Pharm, CRBA, CNRS UMR 5473, F-34060 Montpellier, France; Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands; Univ Valle, Fdn Ctr Primates, Cali, Colombia	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universidad del Valle	Vial, HJ (corresponding author), Univ Montpellier 2, CNRS, UMR 5539, CP 107,Pl E Bataillon, F-34095 Montpellier 5, France.		Ancelin, Marie-Laure/L-1198-2019; Ancelin, Marie-Laure/F-3079-2013	Ancelin, Marie-Laure/0000-0002-1149-4320; Ancelin, Marie-Laure/0000-0002-1149-4320; Kocken, Clemens/0000-0002-4784-1734; Wengelnik, Kai/0000-0002-4547-4205				AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Ancelin ML, 1998, BLOOD, V91, P1426, DOI 10.1182/blood.V91.4.1426; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; BEAUMELLE BD, 1987, J PARASITOL, V73, P743, DOI 10.2307/3282405; Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Calas M, 2000, J MED CHEM, V43, P505, DOI 10.1021/jm9911027; Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886; CAMPBELL CC, 1979, LANCET, V2, P1151; COATNEY GR, 1971, PRIMATE MALARIAS; Gumila C, 1996, ANTIMICROB AGENTS CH, V40, P602, DOI 10.1128/AAC.40.3.602; HERRERA S, 1990, P NATL ACAD SCI USA, V87, P4017, DOI 10.1073/pnas.87.10.4017; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; KIRK K, 1994, J BIOL CHEM, V269, P3339; KOCKEN C, UNPUB; Kocken CHM, 1996, EXP PARASITOL, V84, P439, DOI 10.1006/expr.1996.0132; KUTNER S, 1985, J CELL PHYSIOL, V125, P521, DOI 10.1002/jcp.1041250323; Peters W, 1970, CHEMOTHERAPY DRUG RE; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Stead AMW, 2001, MOL PHARMACOL, V59, P1298, DOI 10.1124/mol.59.5.1298; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDEENEN LLM, 1975, RED BLOOD CELL, P147; Vial H., 1998, MALARIA PARASITE BIO, P159; Vial H J, 1999, Novartis Found Symp, V226, P74; VIAL HJ, UNPUB; Winstanley PA, 2000, PARASITOL TODAY, V16, P146, DOI 10.1016/S0169-4758(99)01622-1	26	144	150	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1311	1314		10.1126/science.1067236	http://dx.doi.org/10.1126/science.1067236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847346				2022-12-28	WOS:000173926000048
J	Adini, Y; Sagi, D; Tsodyks, M				Adini, Y; Sagi, D; Tsodyks, M			Context-enabled learning in the human visual system	NATURE			English	Article							SYNAPTIC PLASTICITY; CORTEX; DISCRIMINATION; EXPERIENCE; NEURONS; VISION	Training was found to improve the performance of humans on a variety of visual perceptual tasks(1,2). However, the ability to detect small changes in the contrast of simple visual stimuli could not be improved by repetition(3). Here we show that the performance of this basic task could be modified after the discrimination of the stimulus contrast was practised in the presence of similar laterally placed stimuli, suggesting a change in the local neuronal circuit involved in the task. On the basis of a combination of hebbian and anti-hebbian synaptic learning rules compatible with our results, we propose a mechanism of plasticity in the visual cortex that is enabled by a change in the context.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Sagi, D (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	dov.sagi@weizmann.ac.il	Sagi, Dov/A-5454-2008; tsodyks, misha/J-4430-2013	Sagi, Dov/0000-0002-8446-9230; Tsodyks, Misha/0000-0002-5661-4349				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Adini Y, 1997, P NATL ACAD SCI USA, V94, P10426, DOI 10.1073/pnas.94.19.10426; Adini Y, 2001, J OPT SOC AM A, V18, P2228, DOI 10.1364/JOSAA.18.002228; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dorais A, 1997, VISION RES, V37, P1725, DOI 10.1016/S0042-6989(96)00329-X; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; LEGGE GE, 1981, VISION RES, V21, P457, DOI 10.1016/0042-6989(81)90092-4; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; POLLEN DA, 1983, IEEE T SYST MAN CYB, V13, P907, DOI 10.1109/TSMC.1983.6313086; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Zenger B, 2002, PERCEPTUAL LEARNING, P177; Zenger-Landolt B, 2001, VISION RES, V41, P3663, DOI 10.1016/S0042-6989(01)00175-4	31	128	130	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					790	793		10.1038/415790a	http://dx.doi.org/10.1038/415790a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845209				2022-12-28	WOS:000173833900046
J	Evison, D; Hinsley, D; Rice, P				Evison, D; Hinsley, D; Rice, P			Chemical weapons	BRITISH MEDICAL JOURNAL			English	Review							SULFUR MUSTARD; BURNS		Def Sci & Technol Labs, Salisbury SP4 0JQ, Wilts, England	Defence Science & Technology Laboratory	Rice, P (corresponding author), Def Sci & Technol Labs, Porton Down, Salisbury SP4 0JQ, Wilts, England.							Borak J, 2001, J OCCUP ENVIRON MED, V43, P110, DOI 10.1097/00043764-200102000-00008; *CHEM WEAP CONV, 1993, CONV PROH DEV PROD S; Diller W F, 1985, Toxicol Ind Health, V1, P93; Diller W F, 1985, Toxicol Ind Health, V1, P7; Ecobichon D.J., 1996, CASARETT DOULLS TOXI, P643; Eldad A, 1998, BURNS, V24, P166, DOI 10.1016/S0305-4179(97)00086-7; GROB D, 1953, AM J MED, V14, P52, DOI 10.1016/0002-9343(53)90358-1; HALDANE JB, 1925, DEFENCE CHEM WARFARE; Maynard R.L., 1999, GEN APPL TOXICOLOGY, P2079; MELLOR SG, 1991, BRIT J PLAST SURG, V44, P434; *N ATL TREAT ORG, 1996, HDB MED ASP NBC DEF; NEWMANTAYLOR AJ, 1991, LANCET, V337, P242, DOI 10.1016/0140-6736(91)92210-S; PAPIRMEISTER B, 1991, MED DEFENSE MUSTARD, P13; Regan R A, 1985, Toxicol Ind Health, V1, P69; Rice P, 2000, BURNS, V26, P34, DOI 10.1016/S0305-4179(99)00096-0; SINCLAIR DC, 1949, BRIT J DERMATOL SYPH, V61, P113, DOI 10.1111/j.1365-2133.1949.tb11067.x; SOMANI SM, 1989, INT J CLIN PHARM TH, V27, P419; Tu AT, 2000, ACS SYM SER, V745, P304; *UN SEC COUNC, 1987, S18852 UN SEC COUNC; Wells B A, 1985, Toxicol Ind Health, V1, P81; Wessely S, 2001, BRIT MED J, V323, P878, DOI 10.1136/bmj.323.7318.878; Willems J.L., 1989, ANN MED MILITARIS BE, V3, P1	22	139	145	0	26	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					332	335		10.1136/bmj.324.7333.332	http://dx.doi.org/10.1136/bmj.324.7333.332			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834561	Green Published			2022-12-28	WOS:000173866300019
J	Gadek, TR; Burdick, DJ; McDowell, RS; Stanley, MS; Marsters, JC; Paris, KJ; Oare, DA; Reynolds, ME; Ladner, C; Zioncheck, KA; Lee, WP; Gribling, P; Dennis, MS; Skelton, NJ; Tumas, DB; Clark, KR; Keating, SM; Beresini, MH; Tilley, JW; Presta, LG; Bodary, SC				Gadek, TR; Burdick, DJ; McDowell, RS; Stanley, MS; Marsters, JC; Paris, KJ; Oare, DA; Reynolds, ME; Ladner, C; Zioncheck, KA; Lee, WP; Gribling, P; Dennis, MS; Skelton, NJ; Tumas, DB; Clark, KR; Keating, SM; Beresini, MH; Tilley, JW; Presta, LG; Bodary, SC			Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule	SCIENCE			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASES; ADHESION MOLECULES; BINDING; DOMAINS; POTENT; RHINOVIRUS; INHIBITION; NONPEPTIDE	The protein-protein interaction between leukocyte functional antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) is critical to lymphocyte and immune system function. Here, we report on the transfer of the contiguous, nonlinear epitope of ICAM-1, responsible for its association with LFA-1, to a small-molecule framework. These LFA-1 antagonists bound LFA-1, blocked binding of ICAM-1, and inhibited a mixed lymphocyte reaction (MLR) with potency significantly greater than that of cyclosporine A. Furthermore, in comparison to an antibody to LFA-1, they exhibited significant anti-inflammatory effects in vivo. These results demonstrate the utility of small-molecule mimics of nonlinear protein epitopes and the protein epitopes themselves as leads in the identification of novel pharmaceutical agents.	Genentech Inc, Dept Bioorgan Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Small Mol Pharmacol, San Francisco, CA 94080 USA; Genentech Inc, Dept Antibody Technol, San Francisco, CA 94080 USA; Hoffmann La Roche Inc, Roche Res Ctr, Nutley, NJ 07110 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding	Gadek, TR (corresponding author), Genentech Inc, Dept Bioorgan Chem, 1 DNA Way, San Francisco, CA 94080 USA.							ADLER M, 1993, BIOCHEMISTRY-US, V32, P282, DOI 10.1021/bi00052a036; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BODARY SC, UNPUB; BURDICK DJ, 1999, Patent No. 9949856; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; CONNOLLY MK, 1994, CLIN IMMUNOL IMMUNOP, V72, P198, DOI 10.1006/clin.1994.1130; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; Fisher KL, 1997, MOL BIOL CELL, V8, P501, DOI 10.1091/mbc.8.3.501; Gottlieb A, 2000, J AM ACAD DERMATOL, V42, P428, DOI 10.1016/S0190-9622(00)90214-7; GRANLUND H, 2000, CURR OPIN ANTIINFLAM, V2, P332; KAKIMOTO K, 1992, CELL IMMUNOL, V142, P326, DOI 10.1016/0008-8749(92)90294-Y; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kelly TA, 1999, J IMMUNOL, V163, P5173; Liu G, 2001, EXPERT OPIN THER PAT, V11, P1383, DOI 10.1517/13543776.11.9.1383; Liu G, 2001, J MED CHEM, V44, P1202, DOI 10.1021/jm000503f; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5077, DOI 10.1021/ja00091a008; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5069, DOI 10.1021/ja00091a007; MCDOWELL RS, 1992, J AM CHEM SOC, V114, P9245, DOI 10.1021/ja00050a001; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; NAKAKURA EK, 1993, TRANSPLANTATION, V55, P412; OppenheimerMarks N, 1996, CLIN IMMUNOL IMMUNOP, V79, P203, DOI 10.1006/clin.1996.0069; SPRAGG JH, 1996, MOL MED SCI, P131; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Werther WA, 1996, J IMMUNOL, V157, P4986	25	143	159	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1086	1089		10.1126/science.295.5557.1086	http://dx.doi.org/10.1126/science.295.5557.1086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834839				2022-12-28	WOS:000173793000070
J	Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Sun, YB; Narayanan, T; Boesecke, P; Lombardi, V; Irving, M				Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Sun, YB; Narayanan, T; Boesecke, P; Lombardi, V; Irving, M			Mechanism of force generation by myosin heads in skeletal muscle	NATURE			English	Article							STRIATED-MUSCLE; ISOMETRIC CONTRACTION; FINE-STRUCTURE; POWER STROKE; LIGHT-CHAIN; FIBERS; FROG; ACTIN; MOTOR; CONFORMATION	Muscles generate force and shortening in a cyclical interaction between the myosin head domains projecting from the myosin filaments and the adjacent actin filaments. Although many features of the dynamic performance of muscle are determined by the rates of attachment and detachment of myosin and actin 1, the primary event in force generation is thought to be a conformational change or 'working stroke' in the actin-bound myosin head(2-8). According to this hypothesis, the working stroke is much faster than attachment or detachment, but can be observed directly in the rapid force transients that follow step displacement of the filaments(3). Although many studies of the mechanism of muscle contraction(9-13) have been based on this hypothesis, the alternative view-that the fast force transients are caused by fast components of attachment and detachment(14-17) has not been excluded definitively. Here we show that measurements of the axial motions of the myosin heads at angstrom resolution by a new X-ray interference technique(18) rule out the rapid attachment/detachment hypothesis, and provide compelling support for the working stroke model of force generation.	Kings Coll London, Sch Biomed Sci, Randall Ctr, London SE1 1UL, England; Univ Florence, I-50134 Florence, Italy; European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of London; King's College London; University of Florence; European Synchrotron Radiation Facility (ESRF)	Irving, M (corresponding author), Kings Coll London, Sch Biomed Sci, Randall Ctr, London SE1 1UL, England.	malcolm.irving@kcl.ac.uk	Sun, Yin-Biao/F-9988-2018	Sun, Yin-Biao/0000-0002-4992-8198; LINARI, MARCO/0000-0001-6512-4897; RECONDITI, MASSIMO/0000-0001-5065-924X; Narayanan, Theyencheri/0000-0003-1957-1041	Telethon [625] Funding Source: Medline	Telethon(Fondazione Telethon)		BOESECKE P, 1995, REV SCI INSTRUM, V66, P1636; BRENNER B, 1991, P NATL ACAD SCI USA, V88, P10490, DOI 10.1073/pnas.88.23.10490; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; CRAIG R, 1977, J MOL BIOL, V109, P69, DOI 10.1016/S0022-2836(77)80046-6; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; HASELGROVE JC, 1975, J MOL BIOL, V92, P113, DOI 10.1016/0022-2836(75)90094-7; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1981, J PHYSIOL-LONDON, V317, pP12; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0; Piazzesi G, 1999, J PHYSIOL-LONDON, V514, P305, DOI 10.1111/j.1469-7793.1999.305ae.x; PODOLSKY RJ, 1973, COLD SPRING HARB SYM, V37, P661, DOI 10.1101/SQB.1973.037.01.080; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SJOSTROM M, 1977, J MOL BIOL, V109, P49, DOI 10.1016/S0022-2836(77)80045-4; THORSON J, 1969, BIOPHYS J, V9, P360, DOI 10.1016/S0006-3495(69)86392-7	30	116	119	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					659	662		10.1038/415659a	http://dx.doi.org/10.1038/415659a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832949	Green Published			2022-12-28	WOS:000173709100051
J	Thomson, CC; Tager, AM; Weller, PF				Thomson, CC; Tager, AM; Weller, PF			More than your average wheeze	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHURG-STRAUSS-SYNDROME; HYPEREOSINOPHILIC SYNDROME; SYSTEMIC VASCULITIS		Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pulm & Crit Care Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Allergy & Inflammat, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Infect Dis, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Thomson, CC (corresponding author), Massachusetts Gen Hosp, Pulm & Crit Care Unit, Bulfinch 148,55 Fruit St, Boston, MA 02114 USA.	cthomson@partners.org	Thomson, Carey/AAF-3905-2019					ALLEN JN, 1994, AM J RESP CRIT CARE, V150, P1423, DOI 10.1164/ajrccm.150.5.7952571; CHEN K-R, 1992, Journal of Dermatology (Tokyo), V19, P40; CHURG J, 1951, AM J PATHOL, V27, P277; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; LANHAM JG, 1984, MEDICINE, V63, P65, DOI 10.1097/00005792-198403000-00001; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; SCHWARTZ RA, 1992, BRIT J DERMATOL, V127, P199, DOI 10.1111/j.1365-2133.1992.tb00114.x; Tatsis E, 1998, ANN INTERN MED, V129, P370, DOI 10.7326/0003-4819-129-5-199809010-00004; Watts RA, 2000, ARTHRITIS RHEUM, V43, P414, DOI 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0; Weller Peter F., 2001, Journal of Allergy and Clinical Immunology, V108, P175, DOI 10.1067/mai.2001.117176; WELLER PF, 1994, BLOOD, V83, P2759, DOI 10.1182/blood.V83.10.2759.2759	11	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					438	442		10.1056/NEJMcps012402	http://dx.doi.org/10.1056/NEJMcps012402			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832533				2022-12-28	WOS:000173686400009
J	Yamamoto, K; Higuchi, M; Shiki, S; Tsuruta, M; Chiba, H				Yamamoto, K; Higuchi, M; Shiki, S; Tsuruta, M; Chiba, H			Stepwise radial complexation of imine groups in phenylazomethine dendrimers	NATURE			English	Article							DENDRITIC MACROMOLECULES; SELECTIVE SYNTHESIS; NANOCLUSTERS; MOLECULES; GRADIENT	Dendrimers(1-6) are highly branched organic macromolecules with successive layers or 'generations' of branch units surrounding a central core. Organic-inorganic hybrid versions have also been produced, by trapping metal ions or metal clusters within the voids of the dendrimers(7-13). The unusual, tree-like topology endows these nanometre-sized macromolecules with a gradient in branch density from the interior to the exterior, which can give rise to an energy gradient that directs the transfer of charge and energy from the dendrimer periphery to its core(4-6). Here we show that tin ions, Sn2+, complex to the imine groups of a spherical polyphenylazomethine dendrimer in a stepwise fashion. This behaviour reflects a gradient in the electron density associated with the imine groups, with complexation in a more peripheral generation proceeding only after complexation in generations closer to the core has been completed. By attaching an electron-withdrawing group to the dendrimer core, we are able to change the complexation pattern, so that the core imines are complexed last. By further extending this strategy, it should be possible to control the number and location of metal ions incorporated into dendrimer structures, which might find uses as tailored catalysts or building blocks for advanced materials.	Kanagawa Acad Sci & Technol, Yokohama, Kanagawa 2238522, Japan; Keio Univ, Fac Sci & Technol, Dept Chem, Yokohama, Kanagawa 2238522, Japan	Kanagawa Academy Science & Technology; Keio University	Yamamoto, K (corresponding author), Kanagawa Acad Sci & Technol, Yokohama, Kanagawa 2238522, Japan.		Higuchi, Masayoshi/H-2796-2011	Higuchi, Masayoshi/0000-0001-9877-1134				Balogh L, 1998, J AM CHEM SOC, V120, P7355, DOI 10.1021/ja980861w; Crooks RM, 2001, ACCOUNTS CHEM RES, V34, P181, DOI 10.1021/ar000110a; Devadoss C, 1996, J AM CHEM SOC, V118, P9635, DOI 10.1021/ja961418t; Diaz DJ, 1999, LANGMUIR, V15, P7351, DOI 10.1021/la990513n; Hecht S, 1999, J AM CHEM SOC, V121, P4084, DOI 10.1021/ja9842215; Higuchi M, 2000, ORG LETT, V2, P3079, DOI 10.1021/ol006241t; Higuchi M, 2000, J ORG CHEM, V65, P5680, DOI 10.1021/jo000509c; Higuchi M, 2001, J AM CHEM SOC, V123, P4414, DOI 10.1021/ja004239r; Higuchi M, 1999, ORG LETT, V1, P1881, DOI 10.1021/ol990975s; Jiang DL, 1997, NATURE, V388, P454, DOI 10.1038/41290; Kawa M, 1998, CHEM MATER, V10, P286, DOI 10.1021/cm970441q; NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052; Petrucci-Samija M, 1999, J AM CHEM SOC, V121, P1968, DOI 10.1021/ja983132p; Schmidt E, 1996, J AM CHEM SOC, V118, P2954, DOI 10.1021/ja950744q; Selby TD, 1998, J AM CHEM SOC, V120, P12155, DOI 10.1021/ja9821091; Tomalia D.A., 1984, 1 SPSJ INT POL C SOC, P65; TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117; Tominaga M, 2000, CHEM COMMUN, P719, DOI 10.1039/b000318m; Zhao MQ, 1998, J AM CHEM SOC, V120, P4877, DOI 10.1021/ja980438n	19	296	298	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					509	511		10.1038/415509a	http://dx.doi.org/10.1038/415509a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823855				2022-12-28	WOS:000173564300041
J	Nair, S; Eustace, J; Thuluvath, PJ				Nair, S; Eustace, J; Thuluvath, PJ			Effect of race on outcome of orthotopic liver transplantation: a cohort study	LANCET			English	Article							HEPATITIS-B VIRUS; DONOR AGE; HEPATOCELLULAR-CARCINOMA; ALLOGRAFT-REJECTION; ORGAN DONATION; RISK-FACTORS; RECIPIENTS; IMMUNOGLOBULIN; MORTALITY; SURVIVAL	Background There is significant evidence to suggest that long-term survival after renal transplantation is significantly lower in African Americans than In other races. We aimed to establish whether there was a difference in survival in African Americans compared with other races after orthotopic liver transplantation (OLT) and whether race was an independent predictor of survival. Methods We collected data from the United Network of Organ Sharing transplant registry for all liver transplants done between 1988 and 1996 in the USA, We also recorded information on age, sex, race, blood group, and cause of death for the donors and recipients. Findings 2-year graft survival was significantly lower for African Americans (601 of 884, 680) and Asians (266 of 416, 64%) compared with white Americans (8703 of 11762, 74%) and Hispanics (878 of 1220, 72%). 2-year and 5-year patient survival were significantly lower for African Americans (654 of 884 [74%], 270 of 565 [48%]) and Asians (287 of 416 [69%], 92 of 252 [37%]) compared with white Americans (9786 of 11762 [83%], 4357 of 7514 [58%]) and Hispanics (964 of 1220 [79%], 341 of 657 [52%]). Compared with white Americans, African American (hazard ratio 1.36, 95% CI 1.16-1.60, p<0.0001) and Asian (1.25, 1.01-1.56, p=0.03) race were independent predictors of poor survival at 2 years. Interpretation African Americans and Asians have a worse outcome after OLT compared with white Americans and Hispanics. The higher rate of chronic rejection in African Americans and a relatively worse outcome in other minority races merits further examination.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Ochsner Med Fdn, Div Gastroenterol & Hepatol, New Orleans, LA USA	Johns Hopkins University; Ochsner Health System	Thuluvath, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Room 429,1830 Bldg,1830 E Monument St, Baltimore, MD 21205 USA.							BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BELLE SH, 1993, TRANSPLANT P, V25, P1137; BISMUTH H, 1995, ANN SURG, V222, P109, DOI 10.1097/00000658-199508000-00002; Braunfeld MY, 1996, J CLIN ANESTH, V8, P585, DOI 10.1016/S0952-8180(96)00142-0; Burbach GJ, 1997, TRANSPLANTATION, V63, P478, DOI 10.1097/00007890-199702150-00027; CAREGARO L, 1994, ARCH INTERN MED, V154, P201, DOI 10.1001/archinte.154.2.201; Charlton M, 1998, HEPATOLOGY, V28, P823, DOI 10.1002/hep.510280333; Chen PJ, 1999, SEMIN LIVER DIS, V19, P253, DOI 10.1055/s-2007-1007115; Dawson S, 1996, ARTIF ORGANS, V20, P1063; Detre K M, 1995, Liver Transpl Surg, V1, P311, DOI 10.1002/lt.500010507; DEVLIN J, 1995, HEPATOLOGY, V21, P1018; Eckhoff DE, 1998, LIVER TRANSPLANT SUR, V4, P499, DOI 10.1002/lt.500040606; Flechner SM, 1996, TRANSPLANTATION, V62, P1235, DOI 10.1097/00007890-199611150-00009; Fraley DS, 1998, KIDNEY INT, V54, P518, DOI 10.1046/j.1523-1755.1998.00004.x; Gallichio M H, 1998, Clin Transpl, P169; Gjertson D W, 1996, Clin Transpl, P343; GONWA TA, 1991, ARCH SURG-CHICAGO, V126, P1141; Grande L, 1999, TRANSPLANT P, V31, P2482, DOI 10.1016/S0041-1345(99)00427-3; Graziadei IW, 1999, HEPATOLOGY, V30, P1121, DOI 10.1002/hep.510300501; HARIHARAN S, 1993, CLIN TRANSPLANT, V7, P235; Ho BM, 1997, HEPATOLOGY, V25, P223, DOI 10.1002/hep.510250140; Hoofnagle JH, 1996, HEPATOLOGY, V24, P89, DOI 10.1002/hep.510240116; Isaacs RB, 1999, AM J KIDNEY DIS, V34, P706, DOI 10.1016/S0272-6386(99)70397-5; KASISKE BL, 1991, NEW ENGL J MED, V324, P302, DOI 10.1056/NEJM199101313240505; KEEFFE EB, 1994, TRANSPLANTATION, V57, P309; Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1016/0270-9139(95)90202-3; OJO AO, 1995, KIDNEY INT, V48, P1592, DOI 10.1038/ki.1995.452; PILLAY P, 1990, DIGEST DIS SCI, V35, P1391, DOI 10.1007/BF01536746; Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505; PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024; Ratziu V, 1999, J HEPATOL, V30, P131, DOI 10.1016/S0168-8278(99)80017-8; Reddy KR, 1999, HEPATOLOGY, V30, P787, DOI 10.1002/hep.510300319; Sawyer RG, 1999, CLIN TRANSPLANT, V13, P126, DOI 10.1034/j.1399-0012.1999.130111.x; Shields PL, 1999, TRANSPLANTATION, V68, P530, DOI 10.1097/00007890-199908270-00015; TEPERMAN L, 1989, TRANSPLANT P, V21, P3963; Terrault NA, 1996, HEPATOLOGY, V24, P1327, DOI 10.1053/jhep.1996.v24.pm0008938155; Tisone G, 1997, TRANSPLANT P, V29, P2825, DOI 10.1016/S0041-1345(97)00693-3; Valente JF, 1997, CLIN TRANSPLANT, V11, P231; Wiesner RH, 1998, HEPATOLOGY, V28, P638, DOI 10.1002/hep.510280306	39	127	128	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					287	293		10.1016/S0140-6736(02)07494-9	http://dx.doi.org/10.1016/S0140-6736(02)07494-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830194				2022-12-28	WOS:000173588100008
J	Salomoni, P; Pandolfi, PP				Salomoni, P; Pandolfi, PP			The role of PML in tumor suppression	CELL			English	Review							ACUTE PROMYELOCYTIC LEUKEMIA; PREMATURE SENESCENCE; ONCOGENIC RAS; NUCLEAR-BODY; APOPTOSIS; ACETYLATION; PROTEIN; PATHWAY; GROWTH; ALPHA	The PML gene, involved in the t(15;17) chromosomal translocation of acute promyelocytic leukemia (APL), encodes a protein which localizes to the PML-nuclear body, a subnuclear macromolecular structure. PML controls apoptosis, cell proliferation, and senescence. Here, we review the current understanding of its role in tumor suppression.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org						Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Le XF, 1998, ONCOGENE, V16, P1839, DOI 10.1038/sj.onc.1201705; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Pandolfi PP, 2001, ONCOGENE, V20, P5726, DOI 10.1038/sj.onc.1204600; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Pollock JL, 1999, P NATL ACAD SCI USA, V96, P15103, DOI 10.1073/pnas.96.26.15103; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	29	438	460	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					165	170		10.1016/S0092-8674(02)00626-8	http://dx.doi.org/10.1016/S0092-8674(02)00626-8			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832207	Bronze			2022-12-28	WOS:000173521300004
J	Cleland, JGF				Cleland, JGF			No reduction in cardiovascular risk with NSAIDs - including aspirin?	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; ROFECOXIB; NAPROXEN		Univ Hull, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England	University of Hull	Cleland, JGF (corresponding author), Univ Hull, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England.		Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016				Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; Cleland JGF, 2001, CURR OPIN NEPHROL HY, V10, P625, DOI 10.1097/00041552-200109000-00012; Fored CM, 2001, NEW ENGL J MED, V345, P1801, DOI 10.1056/NEJMoa010323; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; O'Brien J, 2000, LANCET, V355, P1295; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27	12	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					92	93		10.1016/S0140-6736(02)07332-4	http://dx.doi.org/10.1016/S0140-6736(02)07332-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809245				2022-12-28	WOS:000173212400002
J	Grant, AJ; Lalor, PF; Salmi, M; Jalkanen, S; Adams, DH				Grant, AJ; Lalor, PF; Salmi, M; Jalkanen, S; Adams, DH			Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease	LANCET			English	Review							VASCULAR ADHESION PROTEIN-1; PRIMARY SCLEROSING CHOLANGITIS; THYMUS-EXPRESSED CHEMOKINE; T-CELLS; PERIPHERAL ARTHROPATHIES; HEPATOCELLULAR-CARCINOMA; REGIONAL SPECIALIZATION; CLINICAL-FEATURES; LYMPHOID-TISSUE; NATURAL-HISTORY	Primary sclerosing cholangitis Is strongly linked to Inflammatory bowel disease, but any model to explain the development of primary sclerosing cholangitis must take Into account the fact that It usually runs a course Independent from Inflammation In the bowel, Illustrated by the fact that this disease can develop many years after proctocolectomy. Thus, liver disease can develop In the absence of a diseased colon and cannot be explained solely by release of toxic factors from the Inflamed gut. We propose the existence of an enterohepatic circulation of lymphocytes, whereby some mucosal lymphocytes generated In the gut during active Inflammatory disease subsequently persist as longlived memory cells capable of recirculation through the liver. Under the right conditions, these dual-homing lymphocytes might become activated In the liver resulting In hepatic Inflammation that Is Independent from Inflammation In the gut. Recent reports that some lymphocyte homing-receptors are shared by the liver and gut provide a molecular basis for this hypothesis and explain the distribution of extraintestinal disease In Inflammatory bowel disease.	Univ Birmingham, Queen Elizabeth Hosp, Inst Clin Sci, MRC,Ctr Immune Regulat,Liver Res Labs, Birmingham B15 2TT, W Midlands, England; Univ Turku, Med Res Labs, Turku, Finland; Natl Publ Hlth Inst, Turku, Finland	University of Birmingham; University of Turku; Finland National Institute for Health & Welfare	Adams, DH (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Inst Clin Sci, MRC,Ctr Immune Regulat,Liver Res Labs, Birmingham B15 2TT, W Midlands, England.		Lalor, Patricia/AAB-9621-2019; Adams, David H/C-9092-2009	Lalor, Patricia/0000-0001-8733-5273; Adams, David H/0000-0001-6776-0336				Ahmad T, 2001, ALIMENT PHARM THER, V15, P731, DOI 10.1046/j.1365-2036.2001.00981.x; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Akbar AN, 2000, IMMUNOL TODAY, V21, P337, DOI 10.1016/S0167-5699(00)01652-2; Anderson G, 1999, IMMUNOL TODAY, V20, P463, DOI 10.1016/S0167-5699(99)01524-8; Befeler AS, 1998, TRANSPLANTATION, V65, P393, DOI 10.1097/00007890-199802150-00017; Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116; BILLSON FA, 1967, GUT, V8, P102, DOI 10.1136/gut.8.2.102; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Briskin M, 1997, AM J PATHOL, V151, P97; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; CHANDLER JW, 1983, OPHTHALMOLOGY, V90, P585; CHAPMAN RW, 1991, GUT, V32, P1433, DOI 10.1136/gut.32.12.1433; CHAPMAN RWG, 1980, GUT, V21, P870, DOI 10.1136/gut.21.10.870; Crispe IN, 1996, IMMUNOL TODAY, V17, P522, DOI 10.1016/S0167-5699(96)80906-6; Cuoco L, 1997, AM J GASTROENTEROL, V92, P2134; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Faint JM, 2001, J IMMUNOL, V167, P212, DOI 10.4049/jimmunol.167.1.212; FAUSA O, 1991, SEMIN LIVER DIS, V11, P31, DOI 10.1055/s-2008-1040420; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GRANFORS K, 1989, NEW ENGL J MED, V320, P216, DOI 10.1056/NEJM198901263200404; Grant AJ, 2001, HEPATOLOGY, V33, P1065, DOI 10.1053/jhep.2001.24231; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; HAMANN A, 1994, J IMMUNOL, V152, P3282; Haynes RJ, 1999, EXP EYE RES, V69, P397, DOI 10.1006/exer.1999.0712; Hesterberg PE, 1996, GASTROENTEROLOGY, V111, P1373, DOI 10.1053/gast.1996.v111.pm8898653; Hillan KJ, 1999, LIVER, V19, P509, DOI 10.1111/j.1478-3231.1999.tb00084.x; Jaeschke H, 1997, AM J PHYSIOL-GASTR L, V273, pG1169; Kadioglu A, 1996, BRIT J RHEUMATOL, V35, P218; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Kurkijarvi R, 2000, GASTROENTEROLOGY, V119, P1096, DOI 10.1053/gast.2000.18163; Kurkijarvi R, 1998, J IMMUNOL, V161, P1549; Lalor PF, 1999, J CLIN PATHOL-MOL PA, V52, P214, DOI 10.1136/mp.52.4.214; MACKAY CR, 1993, CURR OPIN IMMUNOL, V5, P423, DOI 10.1016/0952-7915(93)90063-X; Marotta PJ, 1997, BAILLIERE CLIN GASTR, V11, P781, DOI 10.1016/S0950-3528(97)90021-X; McNab G, 1996, GASTROENTEROLOGY, V110, P522, DOI 10.1053/gast.1996.v110.pm8566600; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Muhaya M, 1999, CLIN EXP IMMUNOL, V116, P410; MUNCH H, 1986, HEPATO-GASTROENTEROL, V33, P123; Murai M, 1999, J CLIN INVEST, V104, P49, DOI 10.1172/JCI6642; Nagashima S, 2000, INT J IMMUNOTHER, V16, P1; NORTON KI, 1993, AM J GASTROENTEROL, V88, P948; Orchard TR, 1998, GUT, V42, P387, DOI 10.1136/gut.42.3.387; Orchard TR, 2000, GASTROENTEROLOGY, V118, P274, DOI 10.1016/S0016-5085(00)70209-5; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; PICKER LJ, 1991, NATURE, V349, P796, DOI 10.1038/349796a0; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; Raj V, 1999, GASTROENTEROL CLIN N, V28, P491, DOI 10.1016/S0889-8553(05)70067-4; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SALMI M, 1995, J EXP MED, V181, P137, DOI 10.1084/jem.181.1.137; Salmi M, 1997, ADV IMMUNOL, V64, P139, DOI 10.1016/S0065-2776(08)60889-5; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Salmi M, 2001, J IMMUNOL, V166, P4650, DOI 10.4049/jimmunol.166.7.4650; Salmi M, 1998, AM J PHYSIOL-GASTR L, V274, pG1, DOI 10.1152/ajpgi.1998.274.1.G1; SALMI M, 1994, GASTROENTEROLOGY, V106, P596, DOI 10.1016/0016-5085(94)90691-2; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; SALMI M, 1993, J EXP MED, V178, P2255, DOI 10.1084/jem.178.6.2255; Shields PL, 1999, J IMMUNOL, V163, P6236; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STEINHOFF G, 1993, AM J PATHOL, V142, P481; Tamaru M, 2000, CYTOKINE, V12, P299, DOI 10.1006/cyto.1999.0560; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; Yoong KF, 1998, J IMMUNOL, V160, P3978; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147	70	172	179	1	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					150	157		10.1016/S0140-6736(02)07374-9	http://dx.doi.org/10.1016/S0140-6736(02)07374-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809275				2022-12-28	WOS:000173212400032
J	Shanahan, F				Shanahan, F			Crohn's disease	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; T-CELLS; MATRIX METALLOPROTEINASES; EXPERIMENTAL COLITIS; ESCHERICHIA-COLI; ANIMAL-MODELS; FECAL STREAM; HUMAN GUT; FLORA	Crohn's disease is a disorder mediated by T lymphocytes which arises In genetically susceptible Individuals as a result of a breakdown in the regulatory constraints on mucosal immune responses to enteric bacteria, Regulation of Immune reactivity to enteric antigens has improved understanding of the pathophysiological mechanisms of Crohn's disease, and has expanded therapeutic options for patients with this disorder. Disease heterogeneity Is probable, with various underlying defects associated with a similar pathophysiological outcome. Although most conventional drug treatments are directed at modification of host response, therapeutic manipulation of the enteric flora Is becoming a realistic option.	Cork Univ Hosp, Dept Med, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Cork, Ireland	University College Cork; University College Cork	Shanahan, F (corresponding author), Cork Univ Hosp, Dept Med, Clin Sci Bldg, Cork, Ireland.	F.shanahan@ucc.ie	Shanahan, Fergus/ABF-2390-2020	Shanahan, Fergus/0000-0003-0467-0936				Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; BOCCI V, 1992, PERSPECT BIOL MED, V35, P251; Boirivant M, 1999, GASTROENTEROLOGY, V116, P557, DOI 10.1016/S0016-5085(99)70177-0; Campieri M, 1999, GASTROENTEROLOGY, V116, P1246, DOI 10.1016/S0016-5085(99)70029-6; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Elliott DE, 2000, FASEB J, V14, P1848, DOI 10.1096/fj.99-0885hyp; Elson CO, 2000, GASTROENTEROLOGY, V119, P254, DOI 10.1053/gast.2000.9159; Farrell RJ, 2000, GASTROENTEROLOGY, V118, P279, DOI 10.1016/S0016-5085(00)70210-1; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; FERGUSON A, 1994, BRIT MED J, V309, P355, DOI 10.1136/bmj.309.6951.355; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Gordon JI, 1997, AM J PHYSIOL-GASTR L, V273, pG565, DOI 10.1152/ajpgi.1997.273.3.G565; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; HARPER PH, 1985, GUT, V26, P279, DOI 10.1136/gut.26.3.279; Heuschkel RB, 2000, GUT, V47, P57, DOI 10.1136/gut.47.1.57; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ina K, 1999, J IMMUNOL, V163, P1081; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kosiewicz MM, 2001, J CLIN INVEST, V107, P695, DOI 10.1172/JCI10956; MacDonald TT, 2001, TRENDS IMMUNOL, V22, P244, DOI 10.1016/S1471-4906(01)01892-0; Mahida YR, 2001, CLIN EXP IMMUNOL, V123, P347, DOI 10.1046/j.1365-2249.2001.01470.x; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orchard TR, 2000, SCAND J IMMUNOL, V51, P10; Pender SLF, 1998, GASTROENTEROLOGY, V115, P573, DOI 10.1016/S0016-5085(98)70136-2; Pender SLF, 1997, J IMMUNOL, V158, P1582; Powell JJ, 1996, GUT, V38, P390, DOI 10.1136/gut.38.3.390; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Qiu BS, 1999, NAT MED, V5, P1178, DOI 10.1038/13503; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Robertson DJ, 2001, INFLAMM BOWEL DIS, V7, P51, DOI 10.1097/00054725-200102000-00008; Rook GAW, 1998, IMMUNOL TODAY, V19, P113, DOI 10.1016/S0167-5699(97)01204-8; Sands BE, 2000, GASTROENTEROLOGY, V118, pS68, DOI 10.1016/S0016-5085(00)70007-2; Sartor RB, 1998, GASTROENTEROLOGY, V114, P398, DOI 10.1016/S0016-5085(98)70492-5; Sartor RB, 1997, INFLAMM BOWEL DIS, V3, P230, DOI 10.1002/ibd.3780030309; Schreiber S, 2000, GUT, V47, P746, DOI 10.1136/gut.47.6.746; Schuppan D, 2000, GUT, V47, P12, DOI 10.1136/gut.47.1.12; Shanahan F, 2000, INFLAMM BOWEL DIS, V6, P107, DOI 10.1097/00054725-200005000-00007; Shanahan F, 1993, Gastroenterology, V104, P327; Shanahan F, 2000, AM J PHYSIOL-GASTR L, V278, pG191, DOI 10.1152/ajpgi.2000.278.2.G191; Shanahan F, 1999, Semin Gastrointest Dis, V10, P8; Shanahan F, 2000, GUT, V46, P6, DOI 10.1136/gut.46.1.6; Shanahan F, 2001, GASTROENTEROLOGY, V120, P622, DOI 10.1053/gast.2001.22122; Shanahan F, 2000, SCIENCE, V289, P1311, DOI 10.1126/science.289.5483.1311; Shields PL, 1996, BRIT MED J, V313, P265, DOI 10.1136/bmj.313.7052.265; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Taylor KD, 2001, GASTROENTEROLOGY, V120, P1347, DOI 10.1053/gast.2001.23966; TAYLOR KD, IN PRESS INFLAMMATOR; van Heel DA, 2001, LANCET, V357, P1902, DOI 10.1016/S0140-6736(00)05091-1; VANDEMERWE JP, 1983, A VAN LEEUW J MICROB, V49, P119, DOI 10.1007/BF00393669; Walmsley RS, 1998, J CLIN PATHOL, V51, P657, DOI 10.1136/jcp.51.9.657; Wirtz S, 2000, INT J COLORECTAL DIS, V15, P144, DOI 10.1007/s003840000227; Yang HY, 2000, HEPATO-GASTROENTEROL, V47, P5	67	419	444	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2002	359	9300					62	69		10.1016/S0140-6736(02)07284-7	http://dx.doi.org/10.1016/S0140-6736(02)07284-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809204				2022-12-28	WOS:000173143500033
J	Paddock, S				Paddock, S			Optical sectioning - Slices of life	SCIENCE			English	Editorial Material							MICROSCOPY		Univ Wisconsin, Mol Biol Lab, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Paddock, S (corresponding author), Univ Wisconsin, Mol Biol Lab, Howard Hughes Med Inst, Madison, WI 53706 USA.	paddock@facstaff.wisc.edu						BRELJE TC, 1993, METHOD CELL BIOL, V38, P97; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Dickinson ME, 2001, BIOTECHNIQUES, V31, P1272, DOI 10.2144/01316bt01; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; HAUGHLAND RP, 2001, HDB FLUORESCENT PROB; Klarreich E, 2001, NATURE, V413, P450, DOI 10.1038/35097256; MADDOX P, 2001, MICROSC MICROANAL, V7, P8; Mohler WA, 1999, MOL BIOL CELL, V10, P3061, DOI 10.1091/mbc.10.10.3061; Paddock S, 2001, BIOTECHNIQUES, V30, P756, DOI 10.2144/01304bt01; Paddock SW, 1999, CONFOCAL MICROSCOPY, V122; Piston DW, 1999, TRENDS CELL BIOL, V9, P66, DOI 10.1016/S0962-8924(98)01432-9; Smallcombe A, 2001, BIOTECHNIQUES, V30, P1240, DOI 10.2144/01306bt01; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; van Roessel P, 2002, NAT CELL BIOL, V4, pE15, DOI 10.1038/ncb0102-e15; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Waterman-Storer C, 2000, J CELL BIOL, V150, P361, DOI 10.1083/jcb.150.2.361; WHITE JG, 1987, NATURE, V328, P183, DOI 10.1038/328183a0	19	3	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1319	1321		10.1126/science.295.5558.1319	http://dx.doi.org/10.1126/science.295.5558.1319			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847348				2022-12-28	WOS:000173926000050
J	Sherwood, S				Sherwood, S			A microphysical connection among biomass burning, cumulus clouds, and stratospheric moisture	SCIENCE			English	Article							WATER-VAPOR	A likely causal chain is established here that connects humidity in the stratosphere, relative humidity near the tropical tropopause, ice crystal size in towering cumulus clouds, and aerosols associated with tropical biomass burning, The connections are revealed in satellite-observed fluctuations of each quantity on monthly to yearly time scales. More aerosols lead to smaller ice crystals and more water vapor entering the stratosphere. The connections are consistent with physical reasoning, probably hold on longer time scales, and may help to explain why stratospheric water vapor appears to have been increasing for the past five decades.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Yale University	Sherwood, S (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA.		Sherwood, Steven/B-5673-2008	Sherwood, Steven/0000-0001-7420-8216				Bartlett MS, 1935, J R STAT SOC, V98, P536, DOI 10.2307/2342284; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Forster PMD, 1999, GEOPHYS RES LETT, V26, P3309, DOI 10.1029/1999GL010487; FREDERICK JE, 1983, MON WEATHER REV, V111, P1397, DOI 10.1175/1520-0493(1983)111<1397:ATNTTT>2.0.CO;2; Harries JE, 1996, J GEOPHYS RES-ATMOS, V101, P10205, DOI 10.1029/95JD02933; Highwood EJ, 1998, Q J ROY METEOR SOC, V124, P1579, DOI 10.1002/qj.49712454911; HOUGHTON RA, 1991, GLOBAL BIOMASS BURNING, P321; Ji WS, 1999, J ATMOS SCI, V56, P829, DOI 10.1175/1520-0469(1999)056<0829:VCFFIC>2.0.CO;2; JOHNSTON HS, 1979, J GEOPHYS RES-OC ATM, V84, P3155, DOI 10.1029/JC084iC06p03155; Kirk-Davidoff DB, 1999, NATURE, V402, P399, DOI 10.1038/46521; Massie ST, 1996, J GEOPHYS RES-ATMOS, V101, P9757, DOI 10.1029/95JD03225; Mote PW, 1996, J GEOPHYS RES-ATMOS, V101, P3989, DOI 10.1029/95JD03422; Moulin C, 1997, NATURE, V387, P691, DOI 10.1038/42679; ORCUTT GH, 1948, BIOMETRIKA, V35, P397, DOI 10.2307/2332358; PHILLIPS VTJ, IN PRESS Q J R METEO; Plumb RA, 1996, J GEOPHYS RES-ATMOS, V101, P3957, DOI 10.1029/95JD03002; Pruppacher HR, 1997, MICROPHYSICS CLOUDS; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rosenlof KH, 2001, GEOPHYS RES LETT, V28, P1195, DOI 10.1029/2000GL012502; Seidel DJ, 2001, J GEOPHYS RES-ATMOS, V106, P7857, DOI 10.1029/2000JD900837; Sherwood SC, 2000, GEOPHYS RES LETT, V27, P2513, DOI 10.1029/2000GL011438; Sherwood SC, 2001, J ATMOS SCI, V58, P765, DOI 10.1175/1520-0469(2001)058<0765:AMFTAT>2.0.CO;2; Sherwood SC, 2000, J GEOPHYS RES-ATMOS, V105, P29489, DOI 10.1029/2000JD900586; SHERWOOD SC, IN PRESS J CLIM; WEINSTOCK EM, 1995, GEOPHYS RES LETT, V22, P3231, DOI 10.1029/95GL03058; Zhou XL, 2001, J GEOPHYS RES-ATMOS, V106, P1511, DOI 10.1029/2000JD900472	26	79	82	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1272	1275		10.1126/science.1065080	http://dx.doi.org/10.1126/science.1065080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847336				2022-12-28	WOS:000173926000037
J	Oberholzer, S; Sukhorukov, EV; Schoenenberger, C				Oberholzer, S; Sukhorukov, EV; Schoenenberger, C			Crossover between classical and quantum shot noise in chaotic cavities	NATURE			English	Article							POINT CONTACTS; CONDUCTANCE	The discreteness of charge in units of e led Schottky in 1918 to predict that the electrical current in a vacuum tube fluctuates even if all spurious noise sources are eliminated carefully(1). This phenomenon is now widely known as shot noise. In recent years, shot noise in mesoscopic conductors, where charge motion is quantum-coherent over distances comparable to the system size, has been studied extensively(2-5). In those experiments, charge does not propagate as an isolated entity through free space, as for vacuum tubes, but is part of a degenerate and quantum-coherent Fermi sea of charges. It has been predicted that shot noise in mesoscopic conductors can disappear altogether when the system is tuned to a regime where electron motion becomes classically chaotic(6). Here we experimentally verify this prediction by using chaotic cavities where the time that electrons dwell inside can be tuned(7). Shot noise is present for large dwell times, where the electron motion through the cavity is 'smeared' by quantum scattering, and it disappears for short dwell times, when the motion becomes classically deterministic.	Univ Basel, Inst Phys, CH-4056 Basel, Switzerland	University of Basel	Schoenenberger, C (corresponding author), Univ Basel, Inst Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.		Schoenenberger, Christian/N-3187-2017	Schoenenberger, Christian/0000-0002-5652-460X				Agam O, 2000, PHYS REV LETT, V85, P3153, DOI 10.1103/PhysRevLett.85.3153; BEENAKKER CWJ, 1991, PHYS REV B, V43, P12066, DOI 10.1103/PhysRevB.43.12066; Blanter YM, 2000, PHYS REV LETT, V84, P1280, DOI 10.1103/PhysRevLett.84.1280; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; BUTTIKER M, 1992, PHYS REV B, V46, P12485, DOI 10.1103/PhysRevB.46.12485; Hartmann CA, 1921, ANN PHYS-BERLIN, V65, P51; Hull AW, 1925, PHYS REV, V25, P147, DOI 10.1103/PhysRev.25.147; JALABERT RA, 1994, EUROPHYS LETT, V27, P255, DOI 10.1209/0295-5075/27/4/001; Kumar A, 1996, PHYS REV LETT, V76, P2778, DOI 10.1103/PhysRevLett.76.2778; LESOVIK GB, 1989, JETP LETT+, V49, P592; Oberholzer S, 2001, PHYS REV LETT, V86, P2114, DOI 10.1103/PhysRevLett.86.2114; REZNIKOV M, 1995, PHYS REV LETT, V75, P3340, DOI 10.1103/PhysRevLett.75.3340; Schottky W, 1918, ANN PHYS-BERLIN, V57, P541; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; [No title captured]	15	90	91	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					765	767		10.1038/415765a	http://dx.doi.org/10.1038/415765a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845201				2022-12-28	WOS:000173833900038
J	Gabriel, R; Neal, LA				Gabriel, R; Neal, LA			Post-traumatic stress disorder following military combat or peace keeping	BRITISH MEDICAL JOURNAL			English	Review							WAR		St Thomas Hosp, Gulf Vet Med Assessment Programme, London SE1 7EH, England; Duchess Kent Mil Hosp Catterick, Def PTSD Serv, Catterick Camp DL9 4DF, N Yorkshire, England	Guy's & St Thomas' NHS Foundation Trust	Gabriel, R (corresponding author), St Thomas Hosp, Gulf Vet Med Assessment Programme, London SE1 7EH, England.							American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bonwick RJ, 1996, INT J GERIATR PSYCH, V11, P1071, DOI 10.1002/(SICI)1099-1166(199612)11:12<1071::AID-GPS511>3.0.CO;2-B; Engel CC, 2000, PSYCHOSOM MED, V62, P739, DOI 10.1097/00006842-200011000-00001; HERMAN N, 1994, CANADIAN J PSYCHIATR, V39, P439; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Lee H A, 2001, J R Army Med Corps, V147, P153; Lee HA, 2001, LANCET ONCOL, V2, P197, DOI 10.1016/S1470-2045(00)00287-4; Neal LA, 2001, MED SCI LAW, V41, P26, DOI 10.1177/002580240104100105; PILOWSKY I, 1985, BRIT J PSYCHIAT, V147, P310, DOI 10.1192/bjp.147.3.310; SOLOMON Z, 1995, MIL MED, V160, P425, DOI 10.1093/milmed/160.9.425; Turner J, 2001, BRIT MED J, V322, P745, DOI 10.1136/bmj.322.7289.745; Upshall D G, 2000, J R Army Med Corps, V146, P13; Vuksic-Mihaljevic Z, 1998, EUR J PSYCHIAT, V12, P225	14	16	20	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					340	341		10.1136/bmj.324.7333.340	http://dx.doi.org/10.1136/bmj.324.7333.340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521XH	11834563	Green Published			2022-12-28	WOS:000173866300021
J	Hobson, KA				Hobson, KA			Incredible journeys	SCIENCE			English	Editorial Material									Canadian Wildlife Serv, Saskatoon, SK S7N 0X4, Canada	Environment & Climate Change Canada; Canadian Wildlife Service	Hobson, KA (corresponding author), Canadian Wildlife Serv, Saskatoon, SK S7N 0X4, Canada.		Hobson, Keith/Q-9306-2019					CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P365, DOI 10.1016/0016-7037(94)90470-7; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Meehan TD, 2001, CONDOR, V103, P11, DOI 10.1650/0010-5422(2001)103[0011:UHIGTE]2.0.CO;2; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1	7	15	16	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					981	+		10.1126/science.1069824	http://dx.doi.org/10.1126/science.1069824			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834804				2022-12-28	WOS:000173793000031
J	Eagle, KA; Goodman, SG; Avezum, A; Budaj, A; Sullivan, CM; Lopez-Sendon, J				Eagle, KA; Goodman, SG; Avezum, A; Budaj, A; Sullivan, CM; Lopez-Sendon, J		GRACE Investigators	Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)	LANCET			English	Article							THROMBOLYTIC THERAPY; COMBINATION THERAPY; NATIONAL REGISTRY; ELDERLY-PATIENTS; ANGIOPLASTY; INHIBITION; ELIGIBILITY; MANAGEMENT; BENEFIT	Background The benefits of reperfusion therapy for patients with acute coronary syndromes have been established, but there is much variation in the type of reperfusion given and decisions about which patients are eligible. This study assessed current practices in relation to reperfusion therapy of ST-segment-elevation myocardial infarction from data collected in the multinational, prospective Global Registry of Acute Coronary Events. Methods 94 hospitals in 14 countries are recruiting patients for the registry, Hospitals are organised into population-based clusters that reflect the population characteristics of the region. Information about patients' demographic characteristics, presenting symptoms, medical history, time between symptom onset and presentation, and clinical and electrocardiographic features is recorded in a standard case record. Findings Of the 9251 patients enrolled, 1763 presented within 12 h of symptom onset with ST-segment-elevation myocardial infarction. Of these, 30% did not receive reperfusion therapy. Elderly patients (75 years and older), those presenting without chest pain, and those with a history of diabetes, congestive heart failure, myocardial infarction, or coronary bypass surgery were less likely to receive reperfusion therapy. The rate of primary percutaneous coronary intervention was highest in the USA and lowest in Australia, New Zealand, and Canada. The rate at sites with a catheterisation laboratory was 19% compared with zero at sites without this facility. Interpretation A substantial proportion of patients who are eligible for reperfusion therapy still do not receive this treatment. These typically high-risk patients can be identified in advance, and reasons for the underuse of these beneficial treatments need to be clarified.	Univ Michigan Hosp, Div Cardiol, Ann Arbor, MI 48109 USA; Univ Toronto, St Michaels Hosp, Div Cardiol, Canadian Heart Res Ctr, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada; CTIA Hosp Albert Einstein, Sao Paulo, Brazil; Grochowski Hosp, Dept Cardiol, Warsaw, Poland; Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA USA; Hosp Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain	University of Michigan System; University of Michigan; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Hospital Israelita Albert Einstein; Centre of Postgraduate Medical Education - Poland; University of Massachusetts System; University of Massachusetts Worcester; General University Gregorio Maranon Hospital	Eagle, KA (corresponding author), Univ Michigan Hosp, Div Cardiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	keagle@umich.edu	Avezum, Alvaro AA/K-6137-2016; Avezum, Alvaro/AAP-7687-2020	Avezum, Alvaro AA/0000-0002-3073-6890; Budaj, Andrzej/0000-0002-6395-2098				Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Akkerhuis KM, 2000, EUR HEART J, V21, P371, DOI 10.1053/euhj.1999.1743; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Berger AK, 1999, JAMA-J AM MED ASSOC, V282, P341, DOI 10.1001/jama.282.4.341; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Califf RM, 2000, AM HEART J, V139, pS33, DOI 10.1067/mhj.2000.104090; Cannon CP, 2000, J THROMB THROMBOLYS, V9, P235, DOI 10.1023/A:1018714627681; Cariou A, 1997, EUR HEART J, V18, P1583; French WJ, 2000, AM J CARDIOL, V85, p5B; Gibson CM, 1999, ANN INTERN MED, V130, P841, DOI 10.7326/0003-4819-130-10-199905180-00019; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; HIMBERT D, 1994, EUR HEART J, V15, P483, DOI 10.1093/oxfordjournals.eurheartj.a060531; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Holmes DR, 1997, LANCET, V349, P75, DOI 10.1016/S0140-6736(96)03031-0; Julian DG, 1996, EUR HEART J, V17, P43; Juliard JM, 1997, J AM COLL CARDIOL, V30, P157, DOI 10.1016/S0735-1097(97)00119-8; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; Tresch DD, 1996, ARCH INTERN MED, V156, P1089, DOI 10.1001/archinte.156.10.1089; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; White HD, 2000, LANCET, V356, P2028, DOI 10.1016/S0140-6736(00)03397-3; White HD, 1998, AM J CARDIOL, V82, p57P, DOI 10.1016/S0002-9149(98)00663-8; Zijlstra F, 2000, EUR HEART J, V21, P1487, DOI 10.1053/euhj.2000.2192	28	414	447	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					373	377		10.1016/S0140-6736(02)07595-5	http://dx.doi.org/10.1016/S0140-6736(02)07595-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844506				2022-12-28	WOS:000173686500006
J	Dixon, S; McDonald, S; Roberts, J				Dixon, S; McDonald, S; Roberts, J			The impact of HIV and AIDS on Africa's economic development	BRITISH MEDICAL JOURNAL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEXUALLY-TRANSMITTED DISEASES; RURAL RAKAI DISTRICT; RISK-FACTORS; COMMUNITY TRIAL; INFECTION; TANZANIA; UGANDA; WOMEN; TRANSMISSION	The macroeconomic effects of HIV/AIDS in Africa are substantial, and policies fill. dealing with them may be controversial-one is whether expensive antiretroviral drugs Should be targeted at economically productive groups of people. The authors review the evidence and consider how economic theory can contribute to our response to the pandemic.	Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Univ Sheffield, Dept Econ, Sheffield S1 4DA, S Yorkshire, England	University of Sheffield; University of Sheffield	Dixon, S (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.			Dixon, Simon/0000-0001-7394-7009; Roberts, Jennifer/0000-0003-2883-7251				ALTENROXEL L, 2000, STAR            0904; Arndt C., 2001, Journal of International Development, V13, P427, DOI 10.1002/jid.796; Arndt Channing, 2000, INT AIDS EC NETW IAE; Auvert B, 2001, AIDS, V15, P885, DOI 10.1097/00002030-200105040-00009; BARONGO LR, 1994, TROP GEOGR MED, V46, P157; BARONGO LR, 1992, AIDS, V6, P1521, DOI 10.1097/00002030-199212000-00016; BASSETT MT, 1992, J ACQ IMMUN DEF SYND, V5, P556; Bloom DE, 1997, J ECONOMETRICS, V77, P105, DOI 10.1016/S0304-4076(96)01808-8; Bollinger L, 1999, EC IMPACT AIDS; Bonnel R, 2000, S AFR J ECON, V68, P820; *BOTSW I DEV POL A, 2000, MACR IMP HIV AIDS EP; BULTERYS M, 1994, AIDS, V8, P1585, DOI 10.1097/00002030-199411000-00010; CUDDINGTON JT, 1993, WORLD BANK ECON REV, V7, P173, DOI 10.1093/wber/7.2.173; CUDDINGTON JT, 1993, WORLD BANK ECON REV, V7, P403, DOI 10.1093/wber/7.3.403; CUDDINGTON JT, 1994, J DEV ECON, V43, P363, DOI 10.1016/0304-3878(94)90013-2; DATTA P, 1994, J INFECT DIS, V170, P1134, DOI 10.1093/infdis/170.5.1134; DECOCK KM, 1994, BMJ-BRIT MED J, V308, P441, DOI 10.1136/bmj.308.6926.441; Dixon S., 2001, Journal of International Development, V13, P411, DOI 10.1002/jid.795; Fontanet AL, 1998, AIDS, V12, P315, DOI 10.1097/00002030-199803000-00010; GROSSKURTH H, 1995, AIDS, V9, P927, DOI 10.1097/00002030-199508000-00015; HIRA SK, 1990, J PEDIATR-US, V117, P421, DOI 10.1016/S0022-3476(05)81084-4; Kambou G., 1992, J AFR ECON, V1, P109, DOI [10.1093/oxfordjournals.jae.a036738, DOI 10.1093/OXFORDJOURNALS.JAE.A036738, DOI 10.1093/oxfordjournals.jae.a036738]; KAPIGA SH, 1994, J ACQ IMMUN DEF SYND, V7, P301; KILLEWO J, 1990, AIDS, V4, P1081, DOI 10.1097/00002030-199011000-00005; KondeLule JK, 1997, AIDS, V11, P791, DOI 10.1097/00002030-199706000-00012; KONDELULE JK, 1989, AIDS, V3, P513, DOI 10.1097/00002030-198908000-00005; LEPAGE P, 1986, LANCET, V2, P1103; LEROY V, 1994, AIDS, V8, P683; MANN JM, 1986, LANCET, V2, P654; MANN JM, 1986, JAMA-J AM MED ASSOC, V256, P3099, DOI 10.1001/jama.256.22.3099; NAGELKERKE N, 2001, CMHWG54; NGALY B, 1988, NEW ENGL J MED, V319, P1123, DOI 10.1056/NEJM198810273191704; Olayinka BA, 1999, E AFR MED J, V76, P566; Over M., 1992, MACROECONOMIC IMPACT; POULSEN AG, 1993, J ACQ IMMUN DEF SYND, V6, P941; PRAZUCK T, 1993, AIDS, V7, P103, DOI 10.1097/00002030-199301000-00016; QOLOHLE DC, 1995, GENITOURIN MED, V71, P65; Quattek K., 2000, EC IMPACT AIDS S AFR; Quigley MA, 2000, J ACQ IMMUN DEF SYND, V23, P418, DOI 10.1097/00042560-200004150-00009; SERWADDA D, 1992, AIDS, V6, P983, DOI 10.1097/00002030-199209000-00012; SODERLUND N, 1993, B WORLD HEALTH ORGAN, V71, P595; Taha TE, 1998, AIDS, V12, P197, DOI 10.1097/00002030-199802000-00010; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Tengia-Kessy A, 1998, E AFR MED J, V75, P528; *UNAIDS, 2002, AIDS EP UPD DEC 2001; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; *WORLD BANK MACR T, 2001, 22044SW WORLD BANK M; *WORLD BANK MACR T, 2001, 22046NAM WORLD BANK; *WORLD BANK MACR T, 2000, 21103LSO WORLD BANK; Zaba BW, 2000, AIDS, V14, P2741, DOI 10.1097/00002030-200012010-00014; Ziegler JL, 1996, INT J CANCER, V65, P200, DOI 10.1002/(SICI)1097-0215(19960117)65:2&lt;200::AID-IJC12&gt;3.0.CO;2-H	51	99	106	0	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					232	234B		10.1136/bmj.324.7331.232	http://dx.doi.org/10.1136/bmj.324.7331.232			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	517HJ	11809650	Green Published, Green Accepted			2022-12-28	WOS:000173604800028
J	Mugerwa, RD; Kaleebu, P; Mugyenyi, P; Katongole-Mbidde, E; Hom, DL; Byaruhanga, R; Salata, RA; Ellner, JJ				Mugerwa, RD; Kaleebu, P; Mugyenyi, P; Katongole-Mbidde, E; Hom, DL; Byaruhanga, R; Salata, RA; Ellner, JJ		HIV-1 Vaccine Trial Grp	First trial of the HIV-1 vaccine in Africa: Ugandan experience	BRITISH MEDICAL JOURNAL			English	Article							DEVELOPING-COUNTRIES; SAFETY; RISK	Problems in setting up die first trial of an HIV-1 vaccine in Uganda are described here by Mugerwa and colleagues. The authors explain how they solved these problems and give suggestions to help researchers who are starting future trials of HIV vaccines.	Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; Uganda Virus Res Inst, MRC, Entebbe, Uganda; Joint Clin Res Ctr, Kampala, Uganda; Uganda Canc Inst, Kampala, Uganda; Univ Med & Dent New Jersey, New Jersey Med Sch, Clin Res Grp, Newark, NJ 07107 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA	Makerere University; Uganda Virus Research Institute; Joint Clinic Research Center - United Arab Emirates; Rutgers State University New Brunswick; Rutgers State University Medical Center; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mugerwa, RD (corresponding author), Makerere Univ, Sch Med, Dept Med, Kampala, Uganda.			Ellner, Jerrold/0000-0001-6150-0082	FOGARTY INTERNATIONAL CENTER [D43TW000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI035173, P30AI036219] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000011, TW-00011] Funding Source: Medline; NIAID NIH HHS [N01 AI035173, P30 AI036219, AI-35173, AI-36219] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berkley S, 1998, AIDS RES HUM RETROV, V14, pS191; Esparza J, 2000, LANCET, V355, P2061, DOI 10.1016/S0140-6736(00)02360-6; Excler JL, 2000, J HUMAN VIROL, V3, P193; Hom DL, 1997, J ACQ IMMUN DEF SYND, V15, P375, DOI 10.1097/00042560-199708150-00008; *JOINT UN PROGR HI, 2000, ETH CONS HIV PREV VA; KEBBA A, 2000, 13 INT C AIDS DURB S; LURIE P, 1994, JAMA-J AM MED ASSOC, V271, P295, DOI 10.1001/jama.271.4.295; Mbidde E, 1998, SCIENCE, V279, P155; McGrath JW, 2001, J ACQ IMMUN DEF SYND, V26, P176, DOI 10.1097/00126334-200102010-00012; MUGYENYI P, 1996, 11 INT C AIDS VANC C; PLOTKIN SA, 1995, DEV BIOL STAND, V84, P165; Salmon-Ceron D, 1999, AIDS RES HUM RETROV, V15, P633, DOI 10.1089/088922299310935; TEMOSHOK LR, 1994, AIDS RES HUM RETROV, V10, pS277	13	34	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					226	229		10.1136/bmj.324.7331.226	http://dx.doi.org/10.1136/bmj.324.7331.226			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809648	Green Published			2022-12-28	WOS:000173604800026
J	Nash, DT				Nash, DT			Invasive and medical therapy for coronary artery disease	LANCET			English	Letter									State Univ Med, Syracuse, NY USA		Nash, DT (corresponding author), State Univ Med, Syracuse, NY USA.							Pfisterer M, 2001, LANCET, V358, P951; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711	3	0	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					354	354		10.1016/S0140-6736(02)07513-X	http://dx.doi.org/10.1016/S0140-6736(02)07513-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830230	Bronze			2022-12-28	WOS:000173588100044
J	Vrijheid, M; Dolk, H; Armstrong, B; Abramsky, L; Bianchi, F; Fazarinc, I; Garne, E; Ide, R; Nelen, V; Robert, E; Scott, JES; Stone, D; Tenconi, R				Vrijheid, M; Dolk, H; Armstrong, B; Abramsky, L; Bianchi, F; Fazarinc, I; Garne, E; Ide, R; Nelen, V; Robert, E; Scott, JES; Stone, D; Tenconi, R			Chromosomal congenital anomalies and residence near hazardous waste landfill sites	LANCET			English	Article							RISK	Previous findings of the EUROHAZCON study showed a 33% Increase In risk of non-chromosomal anomalies near hazardous waste landfill sites. Here, we studied 245 cases of chromosomal anomalies and 2412 controls who lived near 23 such sites In Europe, After adjustment for confounding by maternal age and socioeconomic status, we noted a higher risk of chromosomal anomalies In people who lived close to sites (0-3 km) than In those who lived further away (3-7 km; odds ratio 1.41, 95% CI 1.00-1.99). Our results suggest an increase in risk of chromosomal anomalies similar to that found for non-chromosomal anomalies.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Environm Epidemiol Unit, EUROCAT Cent Registry, London WC1E 7HT, England; Univ Ulster, Fac Life & Hlth Sci, EUROCAT Registry, Belfast, Antrim, North Ireland; Northwick Pk Hosp & Clin Res Ctr, N Thames Perinatal Publ Hlth Unit, N Thames W Congenital Malformat Register, London, England; CNR, Inst Clin Physiol, Epidemiol Unit, Tuscany EUROCAT Register, I-56100 Pisa, Italy; Inst Publ Hlth, Ljubljana, Slovenia; Univ So Denmark, Inst Publ Hlth, Funen Cty Eurocat Register, Odense, Denmark; St Bartholomews & London Sch Med & Dent, Wolfson Inst Prevent Med, Natl Down Syndrome Cytogenet Register, London, England; Prov Inst Hyg, Antwerp Eurocat Register, Antwerp, Belgium; Inst Europeen Genomutat, France Cent E Register Congenital Malformat, Lyon, France; Univ Newcastle Upon Tyne, Matern Survey Off, No Congenital Abnormal Survey, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Glasgow, Dept Child Hlth, Paediat Epidemiol & Community Hlth Unit, Glasgow EUROCAT Register, Glasgow, Lanark, Scotland; Univ Padua, NE Italy Registry Congenital Malformat, Padua, Italy	University of London; London School of Hygiene & Tropical Medicine; Ulster University; Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Southern Denmark; University of London; Queen Mary University London; Newcastle University - UK; University of Glasgow; University of Padua	Vrijheid, M (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Environm Epidemiol Unit, EUROCAT Cent Registry, Keppel St, London WC1E 7HT, England.		Bianchi, Fabrizio/F-7900-2015; Vrijheid, Martine/H-2702-2014	Bianchi, Fabrizio/0000-0002-3459-9301; Vrijheid, Martine/0000-0002-7090-1758; armstrong, benedict/0000-0003-4407-0409				Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; DOLK H, 1999, DIS MAPPING RISK ASS; GESCHWIND SA, 1992, AM J EPIDEMIOL, V135, P1197, DOI 10.1093/oxfordjournals.aje.a116226; VJIJHEID M, 2000, THESIS U LONDON LOND; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349	5	54	56	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					320	322		10.1016/S0140-6736(02)07531-1	http://dx.doi.org/10.1016/S0140-6736(02)07531-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830202				2022-12-28	WOS:000173588100016
J	Huang, JK; Rozelle, S; Pray, C; Wang, QF				Huang, JK; Rozelle, S; Pray, C; Wang, QF			Plant biotechnology in China	SCIENCE			English	Article								A survey of China's plant biotechnologists shows that China is developing the largest plant biotechnology capacity outside of North America. The list of genetically modified plant technologies in trials, including rice, wheat, potatoes, and peanuts, is impressive and differs from those being worked on in other countries. Poor farmers in China are cultivating more area of genetically modified plants than are small farmers in any other developing country. A survey of agricultural producers in China demonstrates that Bacillus thuringiensis cotton adoption increases production efficiency and improves farmer health.	Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08901 USA; Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China	University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Rutgers State University New Brunswick; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Rozelle, S (corresponding author), Univ Calif Davis, Dept Agr & Resource Econ, 1 Shields Ave, Davis, CA 95616 USA.							BYLERLEE D, 2000, 4 INT C EC AGR BIOT; COURTMANCHE A, 2001, IMPROTANCE INTELLECT; HUANG J, 2000, CHINAS AGR RES INVES, P105; HUANG J, 2001, SMALL HOLDERS TRANSG; HUANG J, 2001, BIOTECHNOLOGY ALTERN; HUANG JK, 2001, AGR BIOTECHNOLOGY DE; JAMES C, 2000, ISAAA BRIEFS, V17, P65; PAARLBERG RL, 2001, 16 20 20 VIS PEAC EN; Pray C, 2001, WORLD DEV, V29, P813, DOI 10.1016/S0305-750X(01)00010-9; PRAY CE, 2001, 2001 AM AGR EC ASS A; PRAY CE, 2001, PRIVATE SECTOR INVES; QAIM M, 2001, SITUATION AGR BIOTEC; *WORLD BANK, 2000, ENT 21 CENT WORLD DE, P821; XU Z, 2000, BIOL ENG PROGR, V20, P20	14	273	329	9	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					674	677		10.1126/science.1067226	http://dx.doi.org/10.1126/science.1067226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809972				2022-12-28	WOS:000173560900044
J	Enninga, J; Levy, DE; Blobel, G; Fontoura, BMA				Enninga, J; Levy, DE; Blobel, G; Fontoura, BMA			Role of nucleoporin induction in releasing an mRNA nuclear export block	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; PORE COMPLEX; MATRIX PROTEIN; NUP98; BIOGENESIS; EXPRESSION; TRANSPORT; DOMAIN; SITE; RAN	Signal-mediated nuclear import and export proceed through the nuclear pore complex (NPC). Some NPC components, such as the nucleoporins (Nups) Nup98 and Nup96, are also associated with the nuclear interior. Nup98 is a target of the vesicular stomatitis virus (VSV) matrix (M) protein-mediated inhibition of messenger RNA (mRNA) nuclear export. Here, Nup98 and Nup96 were found to be up-regulated by interferon (IFN). M protein-mediated inhibition of mRNA nuclear export was reversed when cells were treated with IFN-gamma or transfected with a complementary DNA (cDNA) encoding Nup98 and Nup96. Thus, increased Nup98 and Nup96 expression constitutes an IFN-mediated mechanism that reverses M protein-mediated inhibition of gene expression.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Miami, Sch Med, Sylvester Canc Ctr, Miami, FL 33136 USA	Howard Hughes Medical Institute; Rockefeller University; New York University; New York University; University of Miami; University of Miami	Blobel, G (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA.		Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; 	NIAID NIH HHS [AI28900, AI46503, AI48204] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900, P01AI048204, R01AI046503] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahuja HG, 2001, GENE CHROMOSOME CANC, V30, P410, DOI 10.1002/1098-2264(2001)9999:9999<::AID-GCC1108>3.0.CO;2-9; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; CHILAKAMARTI V, 2001, P NATL ACAD SCI USA, V98, P6674; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIELDS BN, 1996, FUNDAMENTAL VIROLOGY, P561; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; YANG SD, 1995, MOL IMMUNOL, V32, P733, DOI 10.1016/0161-5890(95)00035-D	27	131	141	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1523	1525		10.1126/science.1067861	http://dx.doi.org/10.1126/science.1067861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11809937				2022-12-28	WOS:000173981300053
J	Salisbury, C; Chalder, M; Scott, TM; Pope, C; Moore, L				Salisbury, C; Chalder, M; Scott, TM; Pope, C; Moore, L		Natl Walk-In Ctr Evaluation Team	What is the role of walk-in centres in the NHS?	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; PRIMARY-CARE		Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Cardiff Univ, Sch Social Sci, Cardiff CF10 3WT, S Glam, Wales	University of Bristol; University of Bristol; Cardiff University	Salisbury, C (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.		Salisbury, Chris/C-6724-2008	Salisbury, Chris/0000-0002-4378-3960; Chalder, Melanie/0000-0003-1964-2815; Pope, Catherine/0000-0002-8935-6702; Moore, Laurence/0000-0003-2182-823X				Hutchison B, 2000, BRIT MED J, V321, P909, DOI 10.1136/bmj.321.7266.909; Kinnersley P, 2000, BRIT MED J, V320, P1043, DOI 10.1136/bmj.320.7241.1043; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; MCCORMICK KA, 1995, MORBIDITY STAT GEN P; *NHS EX, 1999, NHS PRIM CAR WALK CT; *ROYAL COLL GEN PR, 1999, DISC PAP IMPL GEN PR; Venning P, 2000, BMJ-BRIT MED J, V320, P1048, DOI 10.1136/bmj.320.7241.1048	7	42	42	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					399	402		10.1136/bmj.324.7334.399	http://dx.doi.org/10.1136/bmj.324.7334.399			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850372	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000174006300020
J	Ge, BX; Gram, H; Di Padova, F; Huang, B; New, L; Ulevitch, RJ; Luo, Y; Han, JH				Ge, BX; Gram, H; Di Padova, F; Huang, B; New, L; Ulevitch, RJ; Luo, Y; Han, JH			MAPKK-independent activation of p38 alpha mediated by TAB1-dependent autophosphorylation of p38 alpha	SCIENCE			English	Article							PROTEIN-KINASE; SIGNAL-TRANSDUCTION; P38; TAK1; APOPTOSIS; PATHWAYS; TYROSINE; INVITRO; CELLS	Phosphorylation of mitogen-activated protein kinases (MAPKs) on specific tyrosine and threonine sites by MAP kinase kinases (MAPKKs) is thought to be the sole activation mechanism. Here, we report an unexpected activation mechanism for p38alpha MAPK that does not involve the prototypic kinase cascade. Rather it depends on interaction of p38alpha with TAB1 [transforming growth factor-beta-activated protein kinase 1 (TAK1)-binding protein 1] leading to autophosphorylation and activation of p38alpha. We detected formation of a TRAF6-TAB1-p38alpha complex and showed stimulus-specific TAB1-dependent and TAB1-independent p38alpha activation. These findings suggest that alternative activation pathways contribute to the biological responses of p38alpha to various stimuli.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Novartis Pharma AG, CH-4002 Basel, Switzerland; Rigel Inc, San Francisco, CA 94080 USA; Shanghai Genom Inc, Shanghai, Peoples R China	Scripps Research Institute; Novartis	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Ulevitch, Richard J/Q-3393-2017; Han, J/G-4671-2010		NHLBI NIH HHS [HL07195] Funding Source: Medline; NIAID NIH HHS [AI41637] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P263; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HER JH, 1993, BIOCHEM J, V296, P25, DOI 10.1042/bj2960025; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; MORGUCHI T, 1996, J BIOL CHEM, V271, P26981; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROSSOMANDO AJ, 1992, P NATL ACAD SCI USA, V89, P5779, DOI 10.1073/pnas.89.13.5779; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	21	410	445	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1291	1294		10.1126/science.1067289	http://dx.doi.org/10.1126/science.1067289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847341				2022-12-28	WOS:000173926000043
J	Seshadri, S; Beiser, A; Selhub, J; Jacques, PF; Rosenberg, IH; D'Agostino, RB; Wilson, PWF; Wolf, PA				Seshadri, S; Beiser, A; Selhub, J; Jacques, PF; Rosenberg, IH; D'Agostino, RB; Wilson, PWF; Wolf, PA			Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; COGNITIVE PERFORMANCE; COBALAMIN DEFICIENCY; UNITED-STATES; POPULATION; SERUM; FOLATE; VITAMIN-B12; ROTTERDAM	Background: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. Methods: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B(sub 12) and B(sub 6). Results: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. Conclusions: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease. (N Engl J Med 2002;346:476-83.) Copyright (C) 2002 Massachusetts Medical Society.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Boston, MA 02111 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Tufts University; United States Department of Agriculture (USDA); Boston University	Wolf, PA (corresponding author), Boston Univ, Sch Med, Dept Neurol Neurol Epidemiol & Genet, 715 Albany St,B-608, Boston, MA 02118 USA.		Wilson, Peter W.F./J-2455-2016; Friedland, Robert/A-2834-2010	Friedland, Robert/0000-0001-5721-1843; Wolf, Philip/0000-0002-3628-301X; Beiser, Alexa/0000-0001-8551-7778; Seshadri, Sudha/0000-0001-6135-2622	NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline; NIA NIH HHS [5R01-AG16495-02, 5R01-AG08122-11] Funding Source: Medline; NINDS NIH HHS [5R01-NS17950-19, R01 NS017950] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122, R01AG016495] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P143; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BELL IR, 1992, ACTA PSYCHIAT SCAND, V86, P386, DOI 10.1111/j.1600-0447.1992.tb03285.x; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Bots ML, 1997, J INTERN MED, V242, P339, DOI 10.1046/j.1365-2796.1997.00239.x; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Chao CL, 2000, CIRCULATION, V101, P485, DOI 10.1161/01.CIR.101.5.485; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; COLE MG, 1984, AGE AGEING, V13, P101, DOI 10.1093/ageing/13.2.101; Cox D. R., 1984, ANAL SURVIVAL DATA; Diaz-Arrastia R, 1998, ARCH NEUROL-CHICAGO, V55, P1407, DOI 10.1001/archneur.55.11.1407; Elias PK, 1999, AM J EPIDEMIOL, V150, P580; Fassbender K, 1999, LANCET, V353, P1586; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; HORNE DW, 1988, CLIN CHEM, V34, P2357; IKEDA T, 1990, ACTA PSYCHIAT SCAND, V82, P327, DOI 10.1111/j.1600-0447.1990.tb01395.x; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kalmijn S, 1999, AM J EPIDEMIOL, V150, P283, DOI 10.1093/oxfordjournals.aje.a010000; KARNAZE DS, 1987, ARCH INTERN MED, V147, P429, DOI 10.1001/archinte.147.3.429; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lehmann M, 1999, DEMENT GERIATR COGN, V10, P12, DOI 10.1159/000017092; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; LEVITT AJ, 1992, ACTA PSYCHIAT SCAND, V86, P301, DOI 10.1111/j.1600-0447.1992.tb03270.x; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; McCann SM, 1997, EXP GERONTOL, V32, P431, DOI 10.1016/S0531-5565(96)00154-4; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris MS, 2001, AM J CLIN NUTR, V73, P927; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nilsson K, 1996, EUR J CLIN INVEST, V26, P853, DOI 10.1111/j.1365-2362.1996.tb02129.x; ORDOVAS JM, 1987, J LIPID RES, V28, P371; Perry DJ, 1999, BEST PRACT RES CL HA, V12, P451, DOI 10.1053/beha.1999.0036; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Rasmussen K, 1996, CLIN CHEM, V42, P630; Riggs KM, 1996, AM J CLIN NUTR, V63, P306, DOI 10.1093/ajcn/63.3.306; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; SHIN YS, 1983, CLIN CHIM ACTA, V127, P77, DOI 10.1016/0009-8981(83)90077-3; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; Wald DS, 2001, ARCH INTERN MED, V161, P695, DOI 10.1001/archinte.161.5.695; Wang HX, 2001, NEUROLOGY, V56, P1188, DOI 10.1212/WNL.56.9.1188; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Welty FK, 1998, ARTERIOSCL THROM VAS, V18, P1745, DOI 10.1161/01.ATV.18.11.1745; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x	56	2553	2678	2	280	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					476	483		10.1056/NEJMoa011613	http://dx.doi.org/10.1056/NEJMoa011613			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844848				2022-12-28	WOS:000173815300003
J	Watanabe, N; Mitchison, TJ				Watanabe, N; Mitchison, TJ			Single-molecule speckle analysis of Aactin filament turnover in lamellipodia	SCIENCE			English	Article							ACTIN POLYMERIZATION; ARP2/3 COMPLEX; LEADING-EDGE; BARBED ENDS; CELLS; DYNAMICS; FIBROBLASTS; JASPLAKINOLIDE; MICROTUBULES; ADF/COFILIN	Lamellipodia are thin, veil-like extensions at the edge of cells that contain a dynamic array of actin filaments. We describe an approach for analyzing spatial regulation of actin polymerization and depolymerization in vivo in which we tracked single molecules of actin fused to the green fluorescent protein. Polymerization and the lifetime of actin filaments in lamellipodia were measured with high spatial precision. Basal polymerization and depolymerization occurred throughout lamellipodia with largely constant kinetics, and polymerization was promoted within one micron of the lamellipodium tip. Most of the actin filaments in the lamellipodium were generated by polymerization away from the tip.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Watanabe, N (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.				NIGMS NIH HHS [GM48027] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Hahne P, 2001, FEBS LETT, V492, P215, DOI 10.1016/S0014-5793(01)02239-6; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HITCHCOCKDEGREG.SE, 1988, BIOCHEMISTRY-US, V27, P9183; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakagawa H, 2001, J CELL SCI, V114, P1555; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Tardy Y, 1995, BIOPHYS J, V69, P1674, DOI 10.1016/S0006-3495(95)80085-8; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417	31	350	354	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1083	1086		10.1126/science.1067470	http://dx.doi.org/10.1126/science.1067470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834838				2022-12-28	WOS:000173793000069
J	McPhaden, MJ; Zhang, DX				McPhaden, MJ; Zhang, DX			Slowdown of the meridional overturning circulation in the upper Pacific Ocean	NATURE			English	Article							TROPICAL PACIFIC; EQUATORIAL PACIFIC; NORTH PACIFIC; CLIMATE VARIABILITY; EL-NINO; ENSO; MODEL; TEMPERATURES; THROUGHFLOW; VENTILATION	Decadal temperature fluctuations in the Pacific Ocean have a significant effect on marine ecosystems and the climate of North America. The physical mechanisms responsible for these fluctuations are poorly understood. Some theories ascribe a central role to the wind-driven meridional overturning circulation between the tropical and subtropical oceans. Here we show, from observations over the past 50 years, that this overturning circulation has been slowing down since the 1970s, causing a decrease in upwelling of about 25% in an equatorial strip between 9 degreesN and 9 degreesS. This reduction in equatorial upwelling of relatively cool water, from 47 x 10(6) to 35 x 10(6) m(3) s(-1), is associated with a rise in equatorial sea surface temperatures of about 0.8 degreesC. Another effect of the slowing circulation is a reduction in the outgassing of CO2 from the equatorial Pacific Ocean-at present the largest oceanic source of carbon dioxide to the atmosphere.	NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	McPhaden, MJ (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way NE, Seattle, WA 98115 USA.	mcphaden@pmel.noaa.gov	Zhang, Dongxiao/A-8381-2009; McPhaden, Michael J/D-9799-2016	Zhang, Dongxiao/0000-0002-0962-7948; McPhaden, Michael J/0000-0002-8423-5805				Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chang P, 2001, GEOPHYS RES LETT, V28, P3461, DOI 10.1029/2001GL013018; Chavez FP, 1995, DAHL WS ENV, V18, P313; CONKRIGHT ME, 1999, 14 NAT OC ATM ADM; DASILVA AM, 1994, 6 NOAA ATL NESDIS US; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; FEELY RA, IN PRESS DEEP SEA RE; Fine RA, 2001, J GEOPHYS RES-OCEANS, V106, P22159, DOI 10.1029/1999JC000184; Garreaud RD, 1999, J CLIMATE, V12, P2113, DOI 10.1175/1520-0442(1999)012<2113:IEAIEL>2.0.CO;2; GODFREY JS, 1989, GEOPHYS ASTRO FLUID, V45, P89, DOI 10.1080/03091928908208894; GOLDENBERG SB, 1981, MON WEATHER REV, V109, P1190, DOI 10.1175/1520-0493(1981)109<1190:TASVOT>2.0.CO;2; Gordon AL, 1999, GEOPHYS RES LETT, V26, P3325, DOI 10.1029/1999GL002340; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Guilderson TP, 1998, SCIENCE, V281, P240, DOI 10.1126/science.281.5374.240; Hackert EC, 2001, J GEOPHYS RES-OCEANS, V106, P2345, DOI 10.1029/1999JC000055; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Huang BY, 1999, J GEOPHYS RES-OCEANS, V104, P11065, DOI 10.1029/1999JC900024; Johnson GC, 2001, J PHYS OCEANOGR, V31, P839, DOI 10.1175/1520-0485(2001)031<0839:EPOHVD>2.0.CO;2; Johnson GC, 1999, J PHYS OCEANOGR, V29, P3073, DOI 10.1175/1520-0485(1999)029<3073:IPFFTS>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KIRTMAN BP, 1998, J CLIMATOL, V11, P2843; Kleeman R, 1999, GEOPHYS RES LETT, V26, P1743, DOI 10.1029/1999GL900352; Knutson TR, 1998, J CLIMATE, V11, P2273, DOI 10.1175/1520-0442(1998)011<2273:MAODVA>2.0.CO;2; Latif M, 1996, J CLIMATE, V9, P2407, DOI 10.1175/1520-0442(1996)009<2407:DCVOTN>2.0.CO;2; LINDSEY BK, 2001, SCIENCE, V290, P1145; Liu ZY, 1999, GEOPHYS RES LETT, V26, P357, DOI 10.1029/1998GL900315; Liu ZY, 2000, GEOPHYS RES LETT, V27, P1935, DOI 10.1029/1999GL006093; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; MCCREARY JP, 1994, J PHYS OCEANOGR, V24, P466; MCPHADEN MJ, 1988, J PHYS OCEANOGR, V18, P1454, DOI 10.1175/1520-0485(1988)018<1454:ADIOTT>2.0.CO;2; Meehl GA, 1996, NATURE, V382, P56, DOI 10.1038/382056a0; Meinen CS, 2001, J PHYS OCEANOGR, V31, P3230, DOI 10.1175/1520-0485(2001)031<3230:VVATIT>2.0.CO;2; Miller AJ, 2000, PROG OCEANOGR, V47, P355, DOI 10.1016/S0079-6611(00)00044-6; Minobe S, 2000, PROG OCEANOGR, V47, P381, DOI 10.1016/S0079-6611(00)00042-2; Nonaka M, 2000, J OCEANOGR, V56, P173, DOI [10.1023/A:1011135113079, DOI 10.1023/A:1011135113079]; PHILANDER SGH, 1979, DYNAM ATMOS OCEANS, V3, P191, DOI 10.1016/0377-0265(79)90007-1; QUAY PD, 1983, J MAR RES, V41, P769, DOI 10.1357/002224083788520423; Ralph EA, 1999, J PHYS OCEANOGR, V29, P2121, DOI 10.1175/1520-0485(1999)029<2121:WDCITT>2.0.CO;2; Schneider N, 1998, J CLIMATE, V11, P676, DOI 10.1175/1520-0442(1998)011<0676:TITATG>2.0.CO;2; Schneider N, 1999, J PHYS OCEANOGR, V29, P1056, DOI 10.1175/1520-0485(1999)029<1056:SODNPT>2.0.CO;2; Schneider N, 1999, GEOPHYS RES LETT, V26, P1329, DOI 10.1029/1999GL900222; SMITH TM, 1994, J CLIMATE, V7, P949, DOI 10.1175/1520-0442(1994)007<0949:OAOSSS>2.0.CO;2; SVERDRUP HU, 1947, P NATL ACAD SCI USA, V33, P318, DOI 10.1073/pnas.33.11.318; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Wallace JM, 1998, J GEOPHYS RES-OCEANS, V103, P14241, DOI 10.1029/97JC02905; WYRTKI K, 1981, J PHYS OCEANOGR, V11, P1205, DOI 10.1175/1520-0485(1981)011<1205:AEOEUI>2.0.CO;2; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	49	414	480	5	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					603	608		10.1038/415603a	http://dx.doi.org/10.1038/415603a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832936				2022-12-28	WOS:000173709100036
J	Sachs, J; Malaney, P				Sachs, J; Malaney, P			The economic and social burden of malaria	NATURE			English	Review							NEUROLOGICAL SEQUELAE; CEREBRAL MALARIA; MORTALITY; CHILDREN; ANEMIA; IMPACT; MORBIDITY; FERTILITY; PRODUCTIVITY; BEDNETS	Where malaria prospers most, human societies have prospered least. The global distribution of per-capita gross domestic product shows a striking correlation between malaria and poverty, and malaria-endemic countries also have lower rates of economic growth. There are multiple channels by which malaria impedes development, including effects on fertility, population growth, saving and investment, worker productivity, absenteeism, premature mortality and medical costs.	Harvard Univ, John F Kennedy Sch Govt, Ctr Int Dev, Cambridge, MA 02138 USA; WHO, Commiss Macroecon & Hlth, CH-1211 Geneva 27, Switzerland	Harvard University; World Health Organization	Sachs, J (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Ctr Int Dev, 79 John F Kennedy St, Cambridge, MA 02138 USA.	pia_malaney@harvard.edu						Al Serouri AW, 2000, PARASITOLOGY, V121, P337, DOI 10.1017/S0031182099006502; ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; ANDERSON R M, 1991; BASTA SS, 1979, AM J CLIN NUTR, V32, P916, DOI 10.1093/ajcn/32.4.916; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Bloom DE, 2000, POPUL DEV REV, V26, P257; Breman JG, 2001, AM J TROP MED HYG, V64, P1; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Brooker S, 2000, PARASITOL TODAY, V16, P183, DOI 10.1016/S0169-4758(00)01663-X; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; FILMER D, 2000, FEVER ITS TREATMENT; Galloway P. R., 1998, DEATH BIRTH MORTALIT, P182; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Gilles HM, 1993, BRUCE CHWATTS ESSENT; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; GRANTHAMMCGREGOR SM, 1991, LANCET, V338, P1, DOI 10.1016/0140-6736(91)90001-6; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Handa S, 2000, WORLD DEV, V28, P173, DOI 10.1016/S0305-750X(99)00114-X; HEDBERG K, 1993, AM J TROP MED HYG, V48, P365, DOI 10.4269/ajtmh.1993.48.365; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; Holding PA, 2001, AM J TROP MED HYG, V64, P68, DOI 10.4269/ajtmh.2001.64.68; Kere N. K., 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P659; KITRON U, 1989, REV INFECT DIS, V11, P391; LEIGHTON C, 1993, 6 HFS ABT ASS; LOZOFF B, 1989, AM PSYCHOL, V44, P231, DOI 10.1037/0003-066X.44.2.231; LURIA SE, 1975, LECT BIOL, P439; LUZZATTO L, 1979, BLOOD, V54, P961; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; MCKAY H, 1978, SCIENCE, V200, P270, DOI 10.1126/science.635585; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; NUR EM, 1993, SOC SCI MED, V37, P1115, DOI 10.1016/0277-9536(93)90250-8; REHER D, 1995, POP STUD-J DEMOG, V49, P519, DOI 10.1080/0032472031000148806; ROSENZWEIG MR, 1983, AM ECON REV, V73, P38; ROWLAND MGM, 1977, BRIT J NUTR, V37, P441, DOI 10.1079/BJN19770047; SAWYER D, 1993, SOC SCI MED, V37, P1131, DOI 10.1016/0277-9536(93)90252-Y; Scholz BD, 1997, BRIT J NUTR, V77, P47, DOI 10.1017/S0007114500002877; Shiff C, 1996, T ROY SOC TROP MED H, V90, P262, DOI 10.1016/S0035-9203(96)90240-0; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; SPIELMAN A, 1993, J MED ENTOMOL, V30, P6, DOI 10.1093/jmedent/30.1.6; Spielman A., 2001, MOSQUITO; TAYLOR HG, 1984, EARLY BRAIN DAMAGE R, P325; *WHO, 1998, 94 WHO; YAMADA T, 1985, SOUTHERN ECON J, V52, P364, DOI 10.2307/1059622; 2001, WALL ST J       0726	47	1259	1308	3	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					680	685		10.1038/415680a	http://dx.doi.org/10.1038/415680a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	519DC	11832956				2022-12-28	WOS:000173709100057
J	Cibelli, JB; Grant, KA; Chapman, KB; Cunniff, K; Worst, T; Green, HL; Walker, SJ; Gutin, PH; Vilner, L; Tabar, V; Dominko, T; Kane, J; Wettstein, PJ; Lanza, RP; Studer, L; Vrana, KE; West, MD				Cibelli, JB; Grant, KA; Chapman, KB; Cunniff, K; Worst, T; Green, HL; Walker, SJ; Gutin, PH; Vilner, L; Tabar, V; Dominko, T; Kane, J; Wettstein, PJ; Lanza, RP; Studer, L; Vrana, KE; West, MD			Development - Parthenogenetic stem cells in nonhuman primates	SCIENCE			English	Article							EMBRYOS		Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Adv Cell Technol, Worcester, MA 01605 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Wake Forest University; Wake Forest Baptist Medical Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic	Grant, KA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; West, Michael/0000-0002-4842-5468; Vrana, Kent/0000-0003-4902-7733; Lanza, Robert/0000-0002-3047-3074; Cibelli, Jose/0000-0002-2176-3854	NIAAA NIH HHS [T32-AA07565, P50-AA11997] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011997, T32AA007565] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Boediono A, 1999, MOL REPROD DEV, V53, P159, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;159::AID-MRD5&gt;3.0.CO;2-X; Carroll J, 2001, SEMIN CELL DEV BIOL, V12, P37, DOI 10.1006/scdb.2000.0215; FUKUI Y, 1992, MOL REPROD DEV, V33, P357, DOI 10.1002/mrd.1080330318; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253	8	240	270	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					819	819		10.1126/science.1065637	http://dx.doi.org/10.1126/science.1065637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823632				2022-12-28	WOS:000173733000034
J	Hua, W; Chung, J; Gelles, J				Hua, W; Chung, J; Gelles, J			Distinguishing inchworm and hand-over-hand processive kinesin movement by neck rotation measurements	SCIENCE			English	Article							STIMULATED ATP HYDROLYSIS; DIMERIC KINESIN; MICROTUBULE MOVEMENT; HEADED KINESIN; MOTOR; DERIVATIVES; MOLECULES; MECHANISM; BINDING; KIF1A	The motor enzyme kinesin makes hundreds of unidirectional 8-nanometer steps without detaching from or freely sliding along the microtubule on which it moves. We investigated the kinesin stepping mechanism by immobilizing a Drosophila kinesin derivative through the carboxyl-terminal end of the neck coiled-coil domain and measuring orientations of microtubules moved by single enzyme molecules at submicromolar adenosine triphosphate concentrations. The kinesin-mediated microtubule-surface linkage was sufficiently torsionally stiff (greater than or equal to2.0+/-0.9 x 10(-20) Newton meters per radian(2)) that stepping by the hypothesized symmetric hand-over-hand mechanism would produce 180degrees rotations of the microtubule relative to the immobilized kinesin neck. In fact, there were no rotations, a finding that is inconsistent with symmetric hand-over-hand movement, An alternative "inch-worm" mechanism is consistent with our experimental results.	Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA.							BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BLOCK SM, 1995, BIOPHYS J, V68, P23055; Chung J.-H., UNPUB; CROSS RA, 1995, J MUSCLE RES CELL M, V16, P91, DOI 10.1007/BF00122526; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hua W, UNPUB; HUNT AJ, 1993, P NATL ACAD SCI USA, V90, P11653, DOI 10.1073/pnas.90.24.11653; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; Young EC, 1998, BIOCHEMISTRY-US, V37, P3467, DOI 10.1021/bi972172n; YOUNG EC, 1995, J BIOL CHEM, V270, P3926, DOI 10.1074/jbc.270.8.3926	31	165	170	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					844	848		10.1126/science.1063089	http://dx.doi.org/10.1126/science.1063089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823639				2022-12-28	WOS:000173733000042
J	Seemann, J; Pypaert, M; Taguchi, T; Malsam, J; Warren, G				Seemann, J; Pypaert, M; Taguchi, T; Malsam, J; Warren, G			Partitioning of the matrix fraction of the Golgi apparatus during mitosis in animal cells	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; HELA-CELLS; IN-VIVO; TRANSPORT; PROTEIN; COMPLEX; GM130; DYNAMICS; PATHWAY; REVEALS	The Golgi apparatus is partitioned during mitosis in animal cells by a process of fragmentation, dispersal, and reassembly in each daughter cell. We fractionated the Golgi apparatus in vivo using the drug brefeldin A or a dominant-negative mutant of the Sar1p protein. After these treatments, Golgi enzymes moved back to the endoplasmic reticulum, leaving behind a matrix of Golgi structural proteins. Under these conditions, cells still entered and exited mitosis normally, and their Golgi matrix partitioned in a manner very similar to that of the complete organelle. Thus, the matrix may be the partitioning unit of the Golgi apparatus and may carry the Golgi enzyme-containing membranes into the daughter cells.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; Yale University	Warren, G (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Taguchi, Tomohiko/I-5014-2019	Taguchi, Tomohiko/0000-0003-0464-6370				BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Jesch SA, 2001, TRAFFIC, V2, P873, DOI 10.1034/j.1600-0854.2001.21203.x; Jokitalo E, 2001, J CELL BIOL, V154, P317, DOI 10.1083/jcb.200104073; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Miles S, 2001, J CELL BIOL, V155, P543, DOI 10.1083/jcb.200103104; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; Prescott AR, 2001, TRAFFIC, V2, P321, DOI 10.1034/j.1600-0854.2001.002005321.x; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; ROWE T, 1995, METHOD ENZYMOL, V257, P49; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Yoshimura S, 2001, J CELL SCI, V114, P4105; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	27	103	108	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					848	851		10.1126/science.1068064	http://dx.doi.org/10.1126/science.1068064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823640				2022-12-28	WOS:000173733000043
J	Wielicki, BA; Wong, TM; Allan, RP; Slingo, A; Kiehl, JT; Soden, BJ; Gordon, CT; Miller, AJ; Yang, SK; Randall, DA; Robertson, F; Susskind, J; Jacobowitz, H				Wielicki, BA; Wong, TM; Allan, RP; Slingo, A; Kiehl, JT; Soden, BJ; Gordon, CT; Miller, AJ; Yang, SK; Randall, DA; Robertson, F; Susskind, J; Jacobowitz, H			Evidence for large decadal variability in the tropical mean radiative energy budget	SCIENCE			English	Article							CLIMATE-MODEL; SYSTEM CERES; CLOUDS; EARTH	It is widely assumed that variations in Earth's radiative energy budget at large time and space scales are small. We present new evidence from a compilation of over two decades of accurate satellite data that the top-of-atmosphere (TOA) tropical radiative energy budget is much more dynamic and variable than previously thought. Results indicate that the radiation budget changes are caused by changes in tropical mean cloudiness. The results of several current climate model simulations fail to predict this large observed variation in tropical energy budget. The missing variability in the models highlights the critical need to improve cloud modeling in the tropics so that prediction of tropical climate on interannual and decadal time scales can be improved.	NASA, Langley Res Ctr, Hampton, VA 23681 USA; Hadley Ctr, Met Off, Bracknell RG12 2SY, Berks, England; Natl Ctr Atmospher Res, Boulder, CO 80303 USA; Princeton Univ, NOAA, GFDL, Princeton, NJ 08542 USA; NCEP, NOAA, Climate Predict Ctr, Camp Springs, MD 20746 USA; Colorado State Univ, Ft Collins, CO 80523 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; NOAA, NESDIS, Camp Springs, MD 20746 USA	National Aeronautics & Space Administration (NASA); NASA Langley Research Center; Met Office - UK; Hadley Centre; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Colorado State University; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Oceanic Atmospheric Admin (NOAA) - USA	Wielicki, BA (corresponding author), NASA, Langley Res Ctr, Hampton, VA 23681 USA.		Soden, Brian/ABC-3659-2021; Allan, Richard/B-5782-2008; Randall, David A/E-6113-2011; Wong, Takmeng/AHD-3691-2022; Wielicki, Bruce/AAX-3676-2020; Wong, Takmeng/AHD-3210-2022; Keyes, Dennis/AAZ-9285-2021	Allan, Richard/0000-0003-0264-9447; Randall, David A/0000-0001-6935-4112; Soden, Brian/0000-0001-9693-8236				BARKSTROM B, 1989, B AM METEOROL SOC, V70, P1254, DOI 10.1175/1520-0477(1989)070<1254:ERBEAA>2.0.CO;2; Chen JY, 2002, SCIENCE, V295, P838, DOI 10.1126/science.1065835; Gaffen DJ, 2000, SCIENCE, V287, P1242, DOI 10.1126/science.287.5456.1242; Gordon CT, 2000, J CLIMATE, V13, P2239, DOI 10.1175/1520-0442(2000)013<2239:TSOACM>2.0.CO;2; HOUGHTON JT, 2001, SCI BASIS, P87; Kiehl JT, 1998, J CLIMATE, V11, P1131, DOI 10.1175/1520-0442(1998)011<1131:TNCFAR>2.0.CO;2; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Lau NC, 2001, J CLIMATE, V14, P2846, DOI 10.1175/1520-0442(2001)014<2846:IOEOSV>2.0.CO;2; MINNIS P, 1993, SCIENCE, V259, P1411, DOI 10.1126/science.259.5100.1411; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Sexton DMH, 2001, CLIM DYNAM, V17, P669, DOI 10.1007/s003820000141; Smith TM, 1996, J CLIMATE, V9, P1403, DOI 10.1175/1520-0442(1996)009<1403:ROHSST>2.0.CO;2; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; WIELICKI BA, 1995, B AM METEOROL SOC, V76, P2125, DOI 10.1175/1520-0477(1995)076<2125:MTPERO>2.0.CO;2; WONG T, 2001, AMS 12 S GLOB CHANG; Wong TM, 2000, J CLIMATE, V13, P4256, DOI 10.1175/1520-0442(2000)013<4256:VOTCTE>2.0.CO;2; Young DF, 1998, J APPL METEOROL, V37, P572, DOI 10.1175/1520-0450(1998)037<0572:TIMFTC>2.0.CO;2	17	294	305	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					841	844		10.1126/science.1065837	http://dx.doi.org/10.1126/science.1065837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823638				2022-12-28	WOS:000173733000041
J	Kanamaru, S; Leiman, PG; Kostyuchenko, VA; Chipman, PR; Mesyanzhinov, VV; Arisaka, F; Rossmann, MG				Kanamaru, S; Leiman, PG; Kostyuchenko, VA; Chipman, PR; Mesyanzhinov, VV; Arisaka, F; Rossmann, MG			Structure of the cell-puncturing device of bacteriophage T4	NATURE			English	Article							TAIL LYSOZYME; BASEPLATE; PROGRAM; PROTEIN	Bacteriophage T4 has a very efficient mechanism for infecting cells(1). The key component of this process is the baseplate, located at the end of the phage tail, which regulates the interaction of the tail fibres and the DNA ejection machine(2). A complex of gene product (gp) 5 (63K) and gp27 (44K), the central part of the baseplate, is required to penetrate the outer cell membrane of Escherichia coli and to disrupt the intermembrane peptidoglycan layer, promoting subsequent entry of phage DNA into the host. We present here a crystal structure of the (gp5-gp27)(3) 321K complex, determined to 2.9 Angstrom resolution and fitted into a cryoelectron microscopy map at 17 Angstrom resolution of the baseplate-tail tube assembly. The carboxy-terminal domain of gp5 is a triple-stranded beta-helix that forms an equilateral triangular prism, which acts as a membrane-puncturing needle. The middle lysozyme domain of gp5, situated on the periphery of the prism, serves to digest the peptidoglycan layer. The amino-terminal, antiparallel beta-barrel domain of gp5 is inserted into a cylinder formed by three gp27 monomers, which may serve as a channel for DNA ejection.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow, Russia; Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Tokyo Institute of Technology	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	mgr@indiana.bio.purdue.edu	Kanamaru, Shuji/R-4049-2017; Leiman, Petr G/E-5120-2010	Kanamaru, Shuji/0000-0002-2765-531X; Leiman, Petr G/0000-0002-9091-0918; Chipman, Paul/0000-0003-3652-4087; Kostyuchenko, Victor/0000-0001-9751-307X				BOVA R, 1990, NUCLEIC ACIDS RES, V18, P3046, DOI 10.1093/nar/18.10.3046; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coombs D, 1994, MOL BIOL BACTERIOPHA, P259; EISERLING FA, 1994, MOL BIOL BACTERIOP T, V4, P209; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goldberg Edward, 1994, P347; Kanamaru S, 1999, J BACTERIOL, V181, P2739, DOI 10.1128/JB.181.9.2739-2744.1999; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; MATTHEWS BW, 1974, P NATL ACAD SCI USA, V71, P4178, DOI 10.1073/pnas.71.10.4178; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOSIG G, 1989, New Biologist, V1, P171; MURZIN AG, 1992, CURR OPIN STRUC BIOL, V2, P895; NAKAGAWA H, 1985, J VIROL, V54, P460, DOI 10.1128/JVI.54.2.460-466.1985; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Seckler R, 1998, J STRUCT BIOL, V122, P216, DOI 10.1006/jsbi.1998.3974; SHELDRICK GM, 2001, INT TABLES CRYSTALLO, VF, P734; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Takeda S, 1998, BBA-PROTEIN STRUCT M, V1384, P243, DOI 10.1016/S0167-4838(98)00016-8; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; VANDERSLICE RW, 1974, VIROLOGY, V60, P265, DOI 10.1016/0042-6822(74)90384-5	23	299	307	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					553	557		10.1038/415553a	http://dx.doi.org/10.1038/415553a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823865				2022-12-28	WOS:000173564300053
J	Bahn, S; Mimmack, M; Ryan, M; Caldwell, MA; Jaunlaux, E; Starkey, M; Svendsen, CN; Emson, P				Bahn, S; Mimmack, M; Ryan, M; Caldwell, MA; Jaunlaux, E; Starkey, M; Svendsen, CN; Emson, P			Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study	LANCET			English	Article							GROWTH-ASSOCIATED PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR CELLS; SYNAPSIN I; SCG10; MICE; L1; REPRESSOR; SYSTEM; GAP-43	Background Identification of genes and characterisation of their function is an essential step towards understanding complex pathophysiological abnormalities in Down's syndrome. We did a study to investigate abnormalities in gene expression in human neuronal stem cells and progenitor cells from Down's syndrome and control post-mortem human fetal tissue. Methods Indexing-based differential display PCR was done on neuronal precursor cells derived from the cortex of a fetus with Down's syndrome, and findings were compared with those of two control samples. Findings were validated against neurosphere preparations from three independent Down's syndrome fetuses and five independent controls by real-time quantitative PCR. Findings Results of differential display PCR analysis showed that SCG10-a neuron-specific growth-associated protein regulated by the neuron-restrictive silencer factor REST-was almost undetectable in the Down's syndrome sample. This finding was validated by real-time PCR. We also found that other genes regulated by the REST transcription factor were selectively repressed, whereas non-REST-regulated genes with similar functions were unaffected. Changes in expression of several key developmental genes in the Down's syndrome stem-cell and progenitor-cell pool correlated with striking changes in neuron morphology after differentiation. Interpretation Our findings suggest a link between dysregulation of the REST transcription factor and some of the neurological deficits seen in Down's syndrome. Experimental REST downregulation has been shown to trigger apoptosis, which could account for the striking and selective loss of neurons in the differentiated Down's syndrome cell preparations.	Babraham Inst, Dept Neurobiol, Cambridge CB2 4AT, England; UK Human Genome Mapping Project Resource Ctr, Cambridge, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 1TN, England; Univ Cambridge, MRC, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England; UCL, Dept Obstet & Gynaecol, London WC1E 6BT, England; Univ Wisconsin, Waisman Ctr Stem Cell Res Program, Dept Anat, Madison, WI USA; Univ Wisconsin, Waisman Ctr Stem Cell Res Program, Dept Neurol, Madison, WI USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bahn, S (corresponding author), Babraham Inst, Dept Neurobiol, Cambridge CB2 4AT, England.	sabine.bahn@bbsrc.ac.uk	Caldwell, Maeve/HHN-1986-2022	Caldwell, Maeve/0000-0001-7442-711X				CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; CROME L, 1972, PATHOLOGY MENTAL RET, P200; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Haydar TF, 2000, J NEUROSCI, V20, P4156; HAYES A, 1993, PEDIATR CLIN N AM, V40, P523; Higo N, 2000, J NEUROSCI, V20, P6030, DOI 10.1523/JNEUROSCI.20-16-06030.2000; HOOK EG, 1982, DOWN SYNDROME ADV BI; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Mahadeva H, 1998, J MOL BIOL, V284, P1391, DOI 10.1006/jmbi.1998.2292; OKAZAKI T, 1995, NEUROBIOL AGING, V16, P883, DOI 10.1016/0197-4580(95)02001-2; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palm K, 1998, J NEUROSCI, V18, P1280; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Saito Y, 2000, ACTA NEUROPATHOL, V100, P654, DOI 10.1007/s004010000230; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Sugiura Y, 1995, DEV BRAIN RES, V90, P73, DOI 10.1016/0165-3806(96)83488-2; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957	24	167	174	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					310	315		10.1016/S0140-6736(02)07497-4	http://dx.doi.org/10.1016/S0140-6736(02)07497-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830198				2022-12-28	WOS:000173588100012
J	Bulterys, M; Fowler, MG; Shaffer, N; Tih, PM; Greenberg, AE; Karita, E; Coovadia, H; De Cock, KM				Bulterys, M; Fowler, MG; Shaffer, N; Tih, PM; Greenberg, AE; Karita, E; Coovadia, H; De Cock, KM			Role of traditional birth attendants in preventing perinatal transmission of HIV	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TO-CHILD TRANSMISSION; COMBINATION; ZIDOVUDINE; COUNTRIES; MORTALITY; CARE	Every year a million women infected with HIV deliver babies without professional help. Marc Bulterys and colleagues suggest here that traditional birth attendants could be involved in preventing perinatal transmission of HIV by offering set-vices such as HIV testing and counselling and short courses of antiretroviral drugs. A research doctor in the Gambia comments on this suggestion.	CDCP, Epidemiol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD TB Prevent, Atlanta, GA 30333 USA; CDCP, Mother Child Transmiss & Pediat & Adolescent Stud, Natl Ctr HIV STD TB Prevent, Atlanta, GA 30333 USA; CDCP, Global Aids Program, Natl Ctr HIV STD TB Prevent, Atlanta, GA 30333 USA; Cameroon Baptist Convent Hlth Board, Nso, Northwest Provi, Cameroon; Rwanda Minist Hlth, Treatment & Res AIDS Ctr, Kigali, Rwanda; Univ KwaZulu Natal, Nelson R Mandela Med Sch, Dept Pediat & Child Hlth, ZA-4013 Durban, South Africa; Kenya Govt Med Res Ctr, CDC Kenya, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Kwazulu Natal; Kenya Medical Research Institute	Bulterys, M (corresponding author), CDCP, Epidemiol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD TB Prevent, Atlanta, GA 30333 USA.	mbulterys@cdc.gov						[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Baggaley R, 2000, B WORLD HEALTH ORGAN, V78, P1036; Bakari JP, 2000, ANN NY ACAD SCI, V918, P64; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Cartoux M, 1998, AIDS, V12, P2337, DOI 10.1097/00002030-199817000-00016; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Graham WJ, 1999, LANCET, V353, P836, DOI 10.1016/S0140-6736(98)12374-7; GREEN EC, 1988, SOC SCI MED, V27, P1125, DOI 10.1016/0277-9536(88)90341-3; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; HABIMANA P, 1994, AIDS, V8, P701, DOI 10.1097/00002030-199405000-00020; ISENALUMBE A E, 1990, World Health Forum, V11, P192; *MACRO INT US DEP, 1996, DEM HLTH SURV 1996; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Nahlen BL, 2000, NEW ENGL J MED, V343, P651, DOI 10.1056/NEJM200008313430909; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Piper CJ, 1997, ANN TROP MED PARASIT, V91, P237, DOI 10.1080/00034989761094; Shaffer N, 2001, JAMA-J AM MED ASSOC, V285, P2129, DOI 10.1001/jama.285.16.2129; Sinkala M, 2001, LANCET, V358, P1611, DOI 10.1016/S0140-6736(01)06662-4; Walraven G, 1999, TROP MED INT HEALTH, V4, P527, DOI 10.1046/j.1365-3156.1999.00441.x; 2001, LANCET, V358, P1	24	35	35	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2002	324	7331					222	224		10.1136/bmj.324.7331.222	http://dx.doi.org/10.1136/bmj.324.7331.222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809647	Green Published, Green Accepted			2022-12-28	WOS:000173604800024
J	Kiley, R				Kiley, R			Does the internet harm health? Some evidence exists that the internet does harm health	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Wellcome Trust Res Labs, Wellcome Lib Hist & Understanding Med, London NW1 2BE, England		Kiley, R (corresponding author), Wellcome Trust Res Labs, Wellcome Lib Hist & Understanding Med, London NW1 2BE, England.	r.kiley@wellcome.ac.uk		Kiley, Robert/0000-0003-4733-2558				[Anonymous], 2001, BMJ-BRIT MED J, V323, P651; Hainer MI, 2000, ANN INTERN MED, V133, P877, DOI 10.7326/0003-4819-133-11-200012050-00011	2	46	46	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2002	324	7331					238	239						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809659				2022-12-28	WOS:000173604800039
J	Duivenvoorden, JF; Svenning, JC; Wright, SJ				Duivenvoorden, JF; Svenning, JC; Wright, SJ			Ecology - Beta diversity in tropical forests	SCIENCE			English	Editorial Material							TREE		Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GT Amsterdam, Netherlands; Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University of Amsterdam; Smithsonian Institution; Smithsonian Tropical Research Institute	Duivenvoorden, JF (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, POB 94766, NL-1090 GT Amsterdam, Netherlands.	duivenvoorden@science.uva.nl; svenning@biology.au.dk; wrightj@tivoli.si.edu	Svenning, Jens-Christian/C-8977-2012; Wright, Stuart Joseph/M-3311-2013	Svenning, Jens-Christian/0000-0002-3415-0862; Wright, Stuart Joseph/0000-0003-4260-5676				Brako L., 1993, CATALOG FLOWERING PL; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; D'arcy W. G., 1987, FLORA PANAMA 1; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Hubbell Stephen P., 2001, V32, pi; JORGENSON PM, 1999, CATALOGUE VASCULAR P; Lobo JM, 2001, BIOL J LINN SOC, V73, P233, DOI 10.1111/j.1095-8312.2001.tb01360.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Prance GT, 2000, ANN MO BOT GARD, V87, P67, DOI 10.2307/2666209; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; Ter Steege H, 2000, J TROP ECOL, V16, P801, DOI 10.1017/S0266467400001735; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900; World Conservation Monitoring Centre, 1992, GLOB DIV STAT EARTHS	15	127	140	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					636	637		10.1126/science.295.5555.636	http://dx.doi.org/10.1126/science.295.5555.636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809957				2022-12-28	WOS:000173560900029
J	Niwa, R; Nagata-Ohashi, K; Takeichi, M; Mizuno, K; Uemura, T				Niwa, R; Nagata-Ohashi, K; Takeichi, M; Mizuno, K; Uemura, T			Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin	CELL			English	Article							LIM-KINASE 1; COFILIN PHOSPHORYLATION; DEPOLYMERIZING FACTOR; DROSOPHILA BRISTLES; FILAMENT DYNAMICS; BINDING PROTEIN; CELL POLARITY; GENE; EXPRESSION; BUNDLES	The ADF (actin-depolymerizing factor)/cofilin family is a stimulus-responsive mediator of actin dynamics. In contrast to the mechanisms of inactivation of ADF/cofilin by kinases such as LIM-kinase 1 (LIMK1), much less is known about its reactivation through dephosphorylation. Here we report Slingshot (SSH), a family of phosphatases that have the property of F actin binding. In Drosophila, loss of ssh function dramatically increased levels of both F actin and phospho-cofilin (P cofilin) and disorganized epidermal cell morphogenesis. In mammalian cells, human SSH homologs (hSSHs) suppressed LIMK1-induced actin reorganization. Furthermore, SSH and the hSSHs dephosphorylated P cofilin in cultured cells and in cell-free assays. Our results strongly suggest that the SSH family plays a pivotal role in actin dynamics by reactivating ADF/cofilin in vivo.	Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Japan Sci & Technol Corp, CREST, Tsukuba, Ibaraki, Japan	Kyoto University; Kyoto University; Kyoto University; Tohoku University; Japan Science & Technology Agency (JST)	Uemura, T (corresponding author), Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan.	tuemura@virus.kyoto-u.ac.jp	Mizuno, Kensaku/G-8631-2015; Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; UEMURA, Tadashi/0000-0001-7204-3606				ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; COHEN P, 1990, ADV SEC MESS PHOSPH, V24, P230; Cong JL, 2001, DEVELOPMENT, V128, P2793; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; DeRosier DJ, 2000, J CELL BIOL, V148, P1; EDWARDS KA, 1994, P NATL ACAD SCI USA, V91, P4589, DOI 10.1073/pnas.91.10.4589; Geng W, 2000, GENETICS, V156, P1817; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; HAY BA, 1994, DEVELOPMENT, V120, P2121; He B, 2001, MECH DEVELOP, V104, P69, DOI 10.1016/S0925-4773(01)00368-9; Hopmann R, 1996, J CELL BIOL, V133, P1293, DOI 10.1083/jcb.133.6.1293; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MITCHELL HK, 1990, DEV GENET, V11, P133, DOI 10.1002/dvg.1020110203; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; OVERTON J, 1967, J MORPHOL, V122, P367, DOI 10.1002/jmor.1051220406; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; ROBERTSON HM, 1988, GENETICS, V118, P461; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Sumida J, 1998, VICTORIAN STUD, V42, P147, DOI 10.2979/VIC.1998.42.1.147; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Tilney LG, 2000, J CELL SCI, V113, P1255; Tilney LG, 1996, J CELL BIOL, V135, P1291, DOI 10.1083/jcb.135.5.1291; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Toshima JY, 2001, J BIOL CHEM, V276, P43471, DOI 10.1074/jbc.M104620200; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yahara I, 1996, CELL STRUCT FUNCT, V21, P421, DOI 10.1247/csf.21.421; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	71	526	553	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					233	246		10.1016/S0092-8674(01)00638-9	http://dx.doi.org/10.1016/S0092-8674(01)00638-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832213	Bronze			2022-12-28	WOS:000173521300010
J	Pollack, MM; Patel, KM				Pollack, MM; Patel, KM			Need for shift in focus in research into quality of intensive care	LANCET			English	Editorial Material							OUTCOMES; UNITS		George Washington Univ, Sch Med, Washington, DC 20052 USA; Childrens Natl Med Ctr, Washington, DC 20010 USA	George Washington University; Children's National Health System	Pollack, MM (corresponding author), George Washington Univ, Sch Med, Washington, DC 20052 USA.	mpollack@cnmc.org						Hannan EL, 1998, PEDIATRICS, V101, P963, DOI 10.1542/peds.101.6.963; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Mitchell PH, 1997, MED CARE, V35, pNS19, DOI 10.1097/00005650-199711001-00003; POLLACK MM, 1994, JAMA-J AM MED ASSOC, V272, P941, DOI 10.1001/jama.272.12.941; Pollack Murray M., 2001, Pediatric Research, V49, p316A; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Ruttimann U E, 2000, Pediatr Crit Care Med, V1, P133, DOI 10.1097/00130478-200010000-00008; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8	9	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2002	359	9301					95	96		10.1016/S0140-6736(02)07334-8	http://dx.doi.org/10.1016/S0140-6736(02)07334-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809247				2022-12-28	WOS:000173212400004
J	Spanier, BWM; Heuff, G; Cuesta, MA				Spanier, BWM; Heuff, G; Cuesta, MA			Diaphragm rupture	LANCET			English	Editorial Material									Spaarne Ziekenhuis Heemstede, Dept Internal Med & Gastroenterol, NL-2012 CE Heemstede, Netherlands	Spaarne Hospital	Spanier, BWM (corresponding author), Spaarne Ziekenhuis Heemstede, Dept Internal Med & Gastroenterol, NL-2012 CE Heemstede, Netherlands.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					107	107		10.1016/S0140-6736(02)07367-1	http://dx.doi.org/10.1016/S0140-6736(02)07367-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809251	Bronze			2022-12-28	WOS:000173212400008
J	Horton, R				Horton, R			Clinical research - minus the volleyball	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		Horton, R (corresponding author), Lancet, London WC1X 8RR, England.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					8	8		10.1016/S0140-6736(02)07330-0	http://dx.doi.org/10.1016/S0140-6736(02)07330-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809178				2022-12-28	WOS:000173143500008
J	Richards, AM; Lainchbury, JG; Nicholls, MG; Cameron, AV; Yandle, TG				Richards, AM; Lainchbury, JG; Nicholls, MG; Cameron, AV; Yandle, TG			Dendroaspis natriuretic peptide: endogenous or dubious?	LANCET			English	Editorial Material							SEQUENCE-ANALYSIS; BRAIN; PRECURSOR; CLONING; MEMBER; FAMILY		Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand	University of Otago	Richards, AM (corresponding author), Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, POB 4345, Christchurch, New Zealand.			Cameron, Vicky/0000-0003-3147-683X				Collins E, 2000, J CARDIOVASC PHARM, V35, P614, DOI 10.1097/00005344-200004000-00015; Fabrega E, 2001, AM J GASTROENTEROL, V96, P2724; Lisy O, 2001, HYPERTENSION, V37, P1089, DOI 10.1161/01.HYP.37.4.1089; Lisy O, 1999, KIDNEY INT, V56, P502, DOI 10.1046/j.1523-1755.1999.00573.x; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; OIKAWA S, 1984, NATURE, V309, P724, DOI 10.1038/309724a0; Schirger JA, 1999, MAYO CLIN PROC, V74, P126, DOI 10.4065/74.2.126; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1989, BIOCHEM BIOPH RES CO, V159, P1427, DOI 10.1016/0006-291X(89)92269-9; SUDOH T, 1988, NATURE, V332, P76	11	30	34	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					5	6		10.1016/S0140-6736(02)07270-7	http://dx.doi.org/10.1016/S0140-6736(02)07270-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809176				2022-12-28	WOS:000173143500005
J	El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS				El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS			The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (vol 404, pg 398, 2000)	NATURE			English	Correction							HELICOBACTER-PYLORI INFECTION; NECROSIS-FACTOR-ALPHA; DUODENAL-ULCER DISEASE; ACID-SECRETION; STOMACH-CANCER; RECEPTOR; GENE; CELLS; RISK; ASSOCIATION	Helicobacter pylori infection is associated with a variety of clinical outcomes including gastric cancer and duodenal ulcer disease(1). The reasons for this variation are not clear, but the gastric physiological response is influenced by the severity and anatomical distribution of gastritis induced by H. pylori. Thus, individuals with gastritis predominantly localized to the antrum retain normal (or even high) acid secretion(2), whereas individuals with extensive corpus gastritis develop hypochlorhydria and gastric atrophy(3), which are presumptive precursors of gastric cancer(4). Here we report that interleukin-1 gene cluster polymorphisms suspected of enhancing production of interleukin-1-beta are associated with an increased risk of both hypochlorhydria induced by H. pylori and gastric cancer. Two of these polymorphism are in near-complete linkage disequilibrium and one is a TATA-box polymorphism that markedly affects DNA-protein interactions in vitro. The association with disease may be explained by the biological properties of interleukin-1-beta, which is an important pro-inflammatory cytokine(5) and a powerful inhibitor of gastric acid secretion(6,7). Host genetic factors that affect interleukin-1-beta may determine why some individuals infected with H. pylori develop gastric cancer while others do not.					Lissowska, Jolanta/AAH-3252-2020; El-Omar, Emad/AAT-7780-2021; Young, Howard/A-6350-2008	Lissowska, Jolanta/0000-0003-2695-5799; El-Omar, Emad/0000-0002-0011-3924; Young, Howard/0000-0002-3118-5111; Bream, Jay/0000-0002-9149-7643				Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; BIDWELL JL, CYTOKINE GENE POLYM; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt;871::AID-IJC6&gt;3.0.CO;2-#; CORREA P, 1992, CANCER RES, V52, P6735; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Hamajima N, 2001, JPN J CANCER RES, V92, P383, DOI 10.1111/j.1349-7006.2001.tb01106.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; RUIZ B, 1994, AM J GASTROENTEROL, V89, P533; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; SIPPONEN P, 1994, SCAND J GASTROENTERO, V29, P24, DOI 10.3109/00365529409105356; STOCKBRUEGGER RW, 1984, SCAND J GASTROENTERO, V19, P355, DOI 10.1080/00365521.1984.12005735; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; Wolfe M M, 1992, Gastroenterology, V102, P2177; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yu CR, 1996, J IMMUNOL, V157, P126; [No title captured]	32	227	231	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					99	+		10.1038/35083631	http://dx.doi.org/10.1038/35083631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11808612	Bronze			2022-12-28	WOS:000169644900053
J	Watson, ID; Lawton, K				Watson, ID; Lawton, K			Wrong biochemistry results - Companies and Medical Devices Agency must act to prevent wrong results	BRITISH MEDICAL JOURNAL			English	Letter									Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England		Watson, ID (corresponding author), Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England.			Watson, Ian D/0000-0003-2294-3715				Ismail AAA, 2001, BMJ-BRIT MED J, V323, P705, DOI 10.1136/bmj.323.7315.705	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					422	423						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850380				2022-12-28	WOS:000174006300031
J	Hurwitz, CA; Lev, MH; Mochida, GH; Faquin, WC; Grabowski, EF				Hurwitz, CA; Lev, MH; Mochida, GH; Faquin, WC; Grabowski, EF			A 15-year-old boy with a retro-orbital mass and impaired vision. Langerhans'-cell histiocytosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TOLOSA-HUNT SYNDROME; INTERGROUP RHABDOMYOSARCOMA; WEGENERS GRANULOMATOSIS; EOSINOPHILIC GRANULOMA; INVOLVEMENT; SINUS; SARCOIDOSIS; LYMPHOMA		Barbara Bush Childrens Hosp, Div Pediat Hematol Oncol, Portland, ME USA; Maine Childrens Canc Program, Scarborough, ME USA; Univ Vermont, Sch Med, Burlington, VT 05405 USA	University of Vermont	Hurwitz, CA (corresponding author), Barbara Bush Childrens Hosp, Div Pediat Hematol Oncol, Portland, ME USA.							Barber PA, 1999, ACTA NEUROL SCAND, V99, P202, DOI 10.1111/j.1600-0404.1999.tb07346.x; Barnes PD, 1996, NEUROIMAG CLIN N AM, V6, P179; Blodi F C, 1967, Trans Am Acad Ophthalmol Otolaryngol, V71, P303; Brodeur Garrett M., 1997, P761; DEVITA VT, 1997, CANC PRINCIPLES PRAC, V2, P2148; DUANE TD, 1989, CLIN OPHTHALMOLOGY, V2; ERLY WK, 1995, AM J NEURORADIOL, V16, P1258; FAVARA BE, 1991, SEMIN ONCOL, V18, P3; GLOVER AT, 1987, OPHTHALMOLOGY, V94, P1008; GODMAN GC, 1954, AMA ARCH PATHOL, V58, P533; GROSS FJ, 1989, OPHTHALMOLOGY, V96, P462; Harman LE, 1998, SURV OPHTHALMOL, V42, P458, DOI 10.1016/S0039-6257(97)00133-1; HAYNES BF, 1977, AM J MED, V63, P131, DOI 10.1016/0002-9343(77)90125-5; HOOVER DL, 1986, SURV OPHTHALMOL, V30, P215, DOI 10.1016/0039-6257(86)90118-9; HUNT WE, 1961, NEUROLOGY, V11, P56, DOI 10.1212/WNL.11.1.56; HUNT WE, 1976, J NEUROSURG, V44, P544, DOI 10.3171/jns.1976.44.5.0544; IDE F, 1984, CANCER, V53, P917, DOI 10.1002/1097-0142(19840215)53:4<917::AID-CNCR2820530417>3.0.CO;2-7; KLINE LB, 1982, SURV OPHTHALMOL, V27, P79, DOI 10.1016/0039-6257(82)90190-4; Kramer TR, 1997, AM J OPHTHALMOL, V124, P814, DOI 10.1016/S0002-9394(14)71699-X; Ladisch S, 1998, Curr Opin Hematol, V5, P54, DOI 10.1097/00062752-199801000-00010; LEINO M, 1982, ACTA OPHTHALMOL, V60, P809; Levin LA, 1996, SURV OPHTHALMOL, V41, P142, DOI 10.1016/S0039-6257(96)80004-X; LICHTENSTEIN L, 1953, AMA ARCH PATHOL, V56, P84; LOMBARDI T, 1993, J ORAL PATHOL MED, V22, P193, DOI 10.1111/j.1600-0714.1993.tb01056.x; LUDWIG I, 1983, J CLIN NEURO-OPHTHAL, V3, P41; MACCUMBER MW, 1990, OPHTHALMOLOGY, V97, P22; MALDJIAN JA, 1994, AM J NEURORADIOL, V15, P784; MURPHY GF, 1981, NEW ENGL J MED, V304, P791; MUZAFFAR M, 1994, J LARYNGOL OTOL, V108, P357, DOI 10.1017/S0022215100126775; Nezelof C, 1998, HEMATOL ONCOL CLIN N, V12, P385, DOI 10.1016/S0889-8588(05)70518-9; Nezelof C, 1985, Pediatr Pathol, V3, P1; Peterson KL, 1997, LARYNGOSCOPE, V107, P855, DOI 10.1097/00005537-199707000-00004; PINA CS, 1993, PEDIATR NEUROL, V9, P157, DOI 10.1016/0887-8994(93)90056-I; Roman-Goldstein SM, 1998, NEUROSURGERY, V43, P613, DOI 10.1097/00006123-199809000-00119; SMITH JL, 1966, AM J OPHTHALMOL, V61, P1466; TEFFT M, 1978, CANCER, V42, P253, DOI 10.1002/1097-0142(197807)42:1<253::AID-CNCR2820420139>3.0.CO;2-J; TOLOSA E, 1954, J NEUROL NEUROSUR PS, V17, P300, DOI 10.1136/jnnp.17.4.300; Vidal RW, 1999, ANN OTO RHINOL LARYN, V108, P411, DOI 10.1177/000348949910800417; WHARAM M, 1987, OPHTHALMOLOGY, V94, P251; Wirtschafter J D, 1987, J Pediatr Ophthalmol Strabismus, V24, P194	40	2	2	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					513	520		10.1056/NEJMcpc020005	http://dx.doi.org/10.1056/NEJMcpc020005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844854				2022-12-28	WOS:000173815300009
J	Griffith, LG; Naughton, G				Griffith, LG; Naughton, G			Tissue engineering - Current challenges and expanding opportunities	SCIENCE			English	Editorial Material							IN-VIVO INFECTION; STEM-CELLS; HUMAN HEPATOCYTES; OXYGEN-TENSION; HEPATITIS-B; MOUSE-LIVER; DIFFERENTIATION; TRANSPLANTATION; MATRICES; CULTURE		MIT, Dept Chem Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA; MIT, Ctr Biotechnol Proc Engn, Cambridge, MA 02139 USA; Adv Tissue Sci, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Griffith, LG (corresponding author), MIT, Dept Chem Engn, Div Bioengn & Environm Hlth, 66-466, Cambridge, MA 02139 USA.	griff@mit.edu	Sano, Michael/E-1715-2011					Bernhofer LP, 1999, TOXICOL IN VITRO, V13, P219, DOI 10.1016/S0887-2333(98)00087-3; Black AF, 1998, FASEB J, V12, P1331, DOI 10.1096/fasebj.12.13.1331; Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473; Brittberg M, 2001, CLIN ORTHOP RELAT R, pS337; *COMM BIOL BIOM AP, 2001, STEM CELLS FUT REG M; Crabb C, 2001, SCIENCE, V294, P506, DOI 10.1126/science.294.5542.506; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; DeBusschere BD, 2001, BIOSENS BIOELECTRON, V16, P543, DOI 10.1016/S0956-5663(01)00168-3; Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F; Fausto N, 2001, NAT MED, V7, P890, DOI 10.1038/90917; Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5; Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2; Griffith LG, 1997, ANN NY ACAD SCI, V831, P382; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Grompe M, 2001, HEPATOLOGY, V33, P1005, DOI 10.1053/jhep.2001.23784; Hall H, 2001, MICROVASC RES, V62, P315, DOI 10.1006/mvre.2001.2348; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Hevehan DL, 2000, EXP HEMATOL, V28, P267, DOI 10.1016/S0301-472X(99)00150-2; Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b; Ivanovic Z, 2000, BRIT J HAEMATOL, V108, P424; Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192; Kern A, 2001, J INVEST DERMATOL, V117, P112, DOI 10.1046/j.0022-202x.2001.01386.x; Krishnan M, 2001, CURR OPIN BIOTECH, V12, P92, DOI 10.1016/S0958-1669(00)00166-X; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110; Maheshwari G, 2000, J CELL SCI, V113, P1677; Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934; MANN BK, 2001, BIOMATERIALS, V2, P84; Mansbridge J, 1998, TISSUE ENG, V4, P403, DOI 10.1089/ten.1998.4.403; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Morrison SJ, 2000, J NEUROSCI, V20, P7370; NAUGHTON GK, 2002, METHODS TISSUE ENG, P1157; Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Ohashi K, 2000, NAT MED, V6, P327; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pollak RA, 1997, WOUNDS, V9, P175; POWERS M, IN PRESS TISSUE ENG; POWERS MJ, IN PRESS BIOTECHNOL; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; SACHS E, 1992, J ENG IND-T ASME, V114, P481; Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Strain AJ, 2002, SCIENCE, V295, P1005, DOI 10.1126/science.1068660; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; VACANTI CA, 1992, TISSUE INDUCING BIOM, V252, P323; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8	59	1709	1889	18	659	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1009	+		10.1126/science.1069210	http://dx.doi.org/10.1126/science.1069210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834815				2022-12-28	WOS:000173793000043
J	Heilbron, JL				Heilbron, JL			Coming to terms - Caloric, cathode, curium and quark - coinage from the mint of science.	NATURE			English	Article									Univ Oxford Worcester Coll, Oxford OX1 2HB, England	University of Oxford	Heilbron, JL (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.								0	8	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					585	585		10.1038/415585a	http://dx.doi.org/10.1038/415585a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832919				2022-12-28	WOS:000173709100021
J	Hoegh-Guldberg, O; Jones, RJ; Ward, S; Loh, WK				Hoegh-Guldberg, O; Jones, RJ; Ward, S; Loh, WK			Ecology - Is coral bleaching really adaptive?	NATURE			English	Article							HYPOTHESIS		Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia	University of Queensland	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia.		Hoegh-Guldberg, Ove/ABA-5420-2020; Jones, Ross/N-4651-2013; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Jones, Ross/0000-0003-1661-4149; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Baker, Andrew/0000-0002-7866-2587				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4	7	84	89	6	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					601	602		10.1038/415601a	http://dx.doi.org/10.1038/415601a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832932				2022-12-28	WOS:000173709100032
J	Hoffman, SL; Subramanian, GM; Collins, FH; Venter, JC				Hoffman, SL; Subramanian, GM; Collins, FH; Venter, JC			Plasmodium, human and Anopheles genomics and malaria	NATURE			English	Review							CD8+ T-CELLS; INFECTIOUS-DISEASE; DROSOPHILA-MELANOGASTER; FALCIPARUM MALARIA; RODENT MALARIA; BLOOD STAGES; GENE; PARASITE; SEQUENCE; MOSQUITO	The Plasmodium spp. parasites that cause malaria are transmitted to humans by Anopheles spp. mosquitoes. Scientists have now amassed a great body of knowledge about the parasite, its mosquito vector and human host. Yet this year there will be 300-500 million new malaria infections and 1-3 million deaths caused by the disease. We believe that integrated analyses of genome sequence, DNA polymorphisms, and messenger RNA and protein expression profiles will lead to greater understanding of the molecular basis of vector-human and host-parasite interactions and provide strategies to build upon these insights to develop interventions to mitigate human morbidity and mortality from malaria.	Celera Gen, Rockville, MD 20850 USA; Univ Notre Dame, Notre Dame, IN 46556 USA	University of Notre Dame	Hoffman, SL (corresponding author), Celera Gen, 45 W Gude Dr, Rockville, MD 20850 USA.	stephen.hoffman@celera.com						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Benedict MQ, 1996, MED VET ENTOMOL, V10, P93, DOI 10.1111/j.1365-2915.1996.tb00087.x; Black CG, 2001, MOL BIOCHEM PARASIT, V114, P217, DOI 10.1016/S0166-6851(01)00265-1; Bolshakov VN, 2002, GENOME RES, V12, P57, DOI 10.1101/gr.196101; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Brown Graham V., 1996, P145; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Carlton JMR, 2001, MOL BIOCHEM PARASIT, V118, P201, DOI 10.1016/S0166-6851(01)00371-1; CARUCCI DJ, 2000, NATURE, V6; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Collins FH, 2000, B WORLD HEALTH ORGAN, V78, P1412; Collins M, 1999, BUS HIST, V41, P163, DOI 10.1080/00076799900000387; Curtis CF, 2000, SCIENCE, V290, P1508, DOI 10.1126/science.290.5496.1508; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Dervan PB, 1999, CURR OPIN CHEM BIOL, V3, P688, DOI 10.1016/S1367-5931(99)00027-7; Dimopoulos G, 2000, P NATL ACAD SCI USA, V97, P6619, DOI 10.1073/pnas.97.12.6619; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Duffy Patrick E., 2001, Trends in Parasitology, V17, P354, DOI 10.1016/S1471-4922(01)02022-0; Enserink M, 2001, SCIENCE, V293, P2370; FEAGIN JE, 1991, J PROTOZOOL, V38, P243, DOI 10.1111/j.1550-7408.1991.tb04436.x; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Gardner MJ, 1999, CURR OPIN GENET DEV, V9, P704, DOI 10.1016/S0959-437X(99)00032-5; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; Hayward RE, 2000, MOL BIOCHEM PARASIT, V107, P227, DOI 10.1016/S0166-6851(00)00191-2; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Ho CK, 2001, P NATL ACAD SCI USA, V98, P3050, DOI 10.1073/pnas.061636198; Hoffman SL, 1997, NATURE, V387, P647, DOI 10.1038/42571; Hoffman SL, 2000, SCIENCE, V290, P1509, DOI 10.1126/science.290.5496.1509; Hoffman SL, 1998, NAT MED, V4, P1351, DOI 10.1038/3934; HOFFMAN SL, IN PRESS J INFECT DI; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kissinger JC, 2001, NUCLEIC ACIDS RES, V29, P66; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Kwiatkowski D, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P233; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; Lai ZW, 1999, NAT GENET, V23, P309, DOI 10.1038/15484; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marshall E, 2001, SCIENCE, V292, P822, DOI 10.1126/science.292.5518.822; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Mills CD, 1999, B WORLD HEALTH ORGAN, V77, P553; Mota MM, 2001, MOL BIOCHEM PARASIT, V113, P271, DOI 10.1016/S0166-6851(01)00228-6; Mukabayire O, 1996, CHROMOSOMA, V104, P585, DOI 10.1007/BF00352298; NARUM DL, IN PRESS MOL BIOCH P; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; Singh A, 2001, ANTIMICROB AGENTS CH, V45, P949, DOI 10.1128/AAC.45.3.949-951.2001; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Subramanian G, 2001, JAMA-J AM MED ASSOC, V286, P2296, DOI 10.1001/jama.286.18.2296; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Trexler M, 2000, EUR J BIOCHEM, V267, P5751, DOI 10.1046/j.1432-1327.2000.01641.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	85	98	101	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					702	709		10.1038/415702a	http://dx.doi.org/10.1038/415702a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832959	Bronze			2022-12-28	WOS:000173709100060
J	Richie, TL; Saul, A				Richie, TL; Saul, A			Progress and challenges for malaria vaccines	NATURE			English	Review							PLASMODIUM-FALCIPARUM MALARIA; MEROZOITE SURFACE PROTEIN-1; HUMORAL IMMUNE-RESPONSES; CD8(+) T CELL; DNA VACCINE; PROTECTIVE IMMUNITY; IMMUNODEFICIENCY-VIRUS; IRRADIATED SPOROZOITES; ACQUIRED-IMMUNITY; INTERFERON-GAMMA	Malaria causes much physical and economic hardship in tropical regions, particularly in communities where medical care is rudimentary. Should a vaccine be developed, it is the residents of these areas that stand to benefit the most. But the vaccine, which has been promised to be 'just round the corner' for many years, remains elusive. It is important to ask why this is so, when effective vaccines exist for many other infectious diseases. What are the reasons for the slow rate of progress, and what has been learned from the first clinical trials of candidate malaria vaccines? What are the remaining challenges, and what strategies can be pursued to address them?	Naval Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA; NIAID, Malaria Vaccine Dev Unit, NIH, Rockville, MD USA	Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Richie, TL (corresponding author), Naval Med Res Ctr, Malaria Program, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	richiet@nmrc.navy.mil; asaul@niaid.nih.gov	Saul, Allan/ABH-2091-2020; Saul, Allan J/I-6968-2013; Richie, Thomas L/A-8028-2011	Saul, Allan/0000-0003-0665-4091; Saul, Allan J/0000-0003-0665-4091; Richie, Thomas/0000-0002-2946-5456	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000727] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aguiar JC, 2001, VACCINE, V20, P275, DOI 10.1016/S0264-410X(01)00273-0; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bolad A, 2000, SCAND J IMMUNOL, V52, P233; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Carter R, 2001, VACCINE, V19, P2309, DOI 10.1016/S0264-410X(00)00521-1; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Collins WE, 2000, AM J TROP MED HYG, V62, P466, DOI 10.4269/ajtmh.2000.62.466; COLLINS WE, 1972, NATURE-NEW BIOL, V236, P176, DOI 10.1038/newbio236176a0; Daubersies P, 2000, NAT MED, V6, P1258, DOI 10.1038/81366; Davis NL, 2000, J VIROL, V74, P371, DOI 10.1128/JVI.74.1.371-378.2000; Degano P, 1999, VACCINE, V18, P623, DOI 10.1016/S0264-410X(99)00278-9; Dong WQ, 2001, INT J PARASITOL, V31, P57, DOI 10.1016/S0020-7519(00)00110-7; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 1998, CURR TOP MICROBIOL, V226, P37; Doolan DL, 2001, INT J PARASITOL, V31, P753, DOI 10.1016/S0020-7519(01)00184-9; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; EDOZIEN JC, 1962, LANCET, V2, P951; EGAN JE, 1993, AM J TROP MED HYG, V49, P166, DOI 10.4269/ajtmh.1993.49.166; Engers HD, 1998, PARASITOL TODAY, V14, P56, DOI 10.1016/S0169-4758(97)01184-8; Ferry G, 2000, CURR BIOL, V10, pR810, DOI 10.1016/S0960-9822(00)00810-1; Fox BA, 1997, EXP PARASITOL, V85, P121, DOI 10.1006/expr.1996.4118; Gamain B, 2001, P NATL ACAD SCI USA, V98, P2664, DOI 10.1073/pnas.041602598; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; GENTON B, IN PRESS J INFECT DI; Gramzinski RA, 1997, VACCINE, V15, P913, DOI 10.1016/S0264-410X(96)00270-8; GRAVES P, 2001, VACCINES PREVENTING; Hagan P, 1999, PARASITOL TODAY, V15, P47, DOI 10.1016/S0169-4758(98)01373-8; Heppner DG, 2001, TRENDS PARASITOL, V17, P419, DOI 10.1016/S1471-4922(01)02012-8; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOFFMAN SL, 1989, SCIENCE, V244, P1078, DOI 10.1126/science.2524877; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; HOFFMAN SL, IN PRESS J INFECT DI; Hoffman Stephen L., 1996, P35; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Jones TR, 1999, VACCINE, V17, P3065, DOI 10.1016/S0264-410X(99)00145-0; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; KUMAR S, IN PRESS TRENDS PARA; Le TP, 2000, VACCINE, V18, P1893, DOI 10.1016/S0264-410X(99)00407-7; LYON JA, 1989, MOL BIOCHEM PARASIT, V36, P77, DOI 10.1016/0166-6851(89)90203-X; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Miller EK, 1999, IEEE ANTENNAS PROPAG, V41, P82; Nardin EH, 2001, J IMMUNOL, V166, P481, DOI 10.4049/jimmunol.166.1.481; Narum DL, 2001, INFECT IMMUN, V69, P7250, DOI 10.1128/IAI.69.12.7250-7253.2001; Nossal GJV, 2000, NAT IMMUNOL, V1, P5, DOI 10.1038/76852; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; O'Hagan D, 2001, J VIROL, V75, P9037, DOI 10.1128/JVI.75.19.9037-9043.2001; Ockenhouse CF, 1998, J INFECT DIS, V177, P1664, DOI 10.1086/515331; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; OEUVRAY C, 1994, BLOOD, V84, P1594; PATARROYO ME, 1988, NATURE, V332, P158, DOI 10.1038/332158a0; Perlaza BL, 1998, INFECT IMMUN, V66, P3423, DOI 10.1128/IAI.66.7.3423-3428.1998; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rieckmann K H, 1979, Bull World Health Organ, V57 Suppl 1, P261; Rodrigues EG, 2000, PARASITE IMMUNOL, V22, P157, DOI 10.1046/j.1365-3024.2000.00289.x; Rogers WO, 2001, INFECT IMMUN, V69, P5565, DOI 10.1128/IAI.69.9.5565-5572.2001; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sakai Tohru, 1999, Parasitology International, V48, P27, DOI 10.1016/S1383-5769(98)00036-1; Saul A, 1999, PARASITOL TODAY, V15, P455, DOI 10.1016/S0169-4758(99)01534-3; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; Saul A, 2001, J EXP MED, V193, pF51, DOI 10.1084/jem.193.12.F51; Scherf A, 2001, CELL MICROBIOL, V3, P125, DOI 10.1046/j.1462-5822.2001.00109.x; Schneider J, 2001, VACCINE, V19, P4595, DOI 10.1016/S0264-410X(01)00260-2; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Sedegah M, 2000, J IMMUNOL, V164, P5905, DOI 10.4049/jimmunol.164.11.5905; Shi YP, 1999, P NATL ACAD SCI USA, V96, P1615, DOI 10.1073/pnas.96.4.1615; Singh S, 2001, J BIOL CHEM, V276, P17111, DOI 10.1074/jbc.M101531200; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Stowers AW, 2001, TRENDS PARASITOL, V17, P415, DOI 10.1016/S1471-4922(01)02011-6; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Wang L, 2001, INFECT IMMUN, V69, P4390, DOI 10.1128/IAI.69.7.4390-4397.2001; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Weiss WR, 1998, J IMMUNOL, V161, P2325; Wu SG, 2000, J BIOTECHNOL, V83, P125, DOI 10.1016/S0168-1656(00)00306-0; You ZY, 2001, CANCER RES, V61, P3704; Zhong H, 2000, Yi Chuan Xue Bao, V27, P966	87	248	270	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					694	701		10.1038/415694a	http://dx.doi.org/10.1038/415694a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832958	Bronze			2022-12-28	WOS:000173709100059
J	Nohria, A; Lewis, E; Stevenson, LW				Nohria, A; Lewis, E; Stevenson, LW			Medical management of advanced heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING-ENZYME-INHIBITION; LEFT-VENTRICULAR FUNCTION; IDIOPATHIC DILATED CARDIOMYOPATHY; LOW-DOSE AMIODARONE; QUALITY-OF-LIFE; ATRIAL-FIBRILLATION; EXERCISE CAPACITY; FILLING PRESSURES; CARDIAC TRANSPLANTATION; ISOSORBIDE DINITRATE	Context Advanced heart failure, defined as persistence of limiting symptoms despite therapy with agents of proven efficacy, accounts for the majority of morbidity and mortality in heart failure. Objective To review current medical therapy for advanced heart failure. Data Sources We searched MEDLINE for all articles containing the term advanced heart failure that were published between 1980 and 2001; EMBASE was searched from 1987-1999, Best Evidence from 1991-1998, and Evidence-Based Medicine from 1995-1999. The Cochrane Library also was searched for critical reviews and meta-analyses of congestive heart failure. Study Selection Randomized controlled trials of therapy for 150 patients or more were included if advanced heart failure was represented. Other common clinical situations were addressed from smaller trials as available, trials of milder heart failure, consensus guidelines, and both published and personal clinical experience. Data Extraction Data quality was determined by publication in peer-reviewed literature or inclusion in professional society guidelines. Data Synthesis A primary focus for care of advanced heart failure is ongoing identification and treatment of the elevated filling pressures that cause disabling symptoms. While angiotensin-converting enzyme inhibitors and beta-adrenergic agents can slow disease progression and prolong survival, titration and tolerability often present challenges. Most patients are not eligible for surgical intervention but do benefit from a medical regimen tailored to individual clinical and hemodynamic profiles and from heart failure management programs that reduce rehospitalization. Survival ranges from 80% at 2 years for patients rendered free of congestion to less than 50% at 6 months for patients with refractory symptoms, in whom end-of-life options may include hospice care and inactivation of implantable defibrillators. Conclusions Current management of advanced heart failure is based more on consensus than on randomized trials. Systematic investigation should address not only new therapies but also strategies for selecting and optimizing therapies already available.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Stevenson, LW (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St,Tower 3-A, Boston, MA 02115 USA.		Nohria, Anju/AAD-4925-2022					Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; Adams KF, 1998, AM HEART J, V135, pS204, DOI 10.1016/S0002-8703(98)70251-0; ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785; *AM HEART ASS, 2001, AM HEART ASS HEART S; Anker SD, 1997, CIRCULATION, V96, P526; Azevedo ER, 2000, CIRCULATION, V101, P2053, DOI 10.1161/01.CIR.101.17.2053; Badgett RG, 1997, JAMA-J AM MED ASSOC, V277, P1712, DOI 10.1001/jama.277.21.1712; Beyersdorf F, 2001, Semin Thorac Cardiovasc Surg, V13, P42; BINKLEY PF, 1991, AM J CARDIOL, V68, P1103, DOI 10.1016/0002-9149(91)90507-H; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; Bolling SF, 1998, J THORAC CARDIOV SUR, V115, P381, DOI 10.1016/S0022-5223(98)70282-X; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; BUTMAN SM, 1993, J AM COLL CARDIOL, V22, P968, DOI 10.1016/0735-1097(93)90405-P; CARR JG, 1989, AM J CARDIOL, V63, P709, DOI 10.1016/0002-9149(89)90256-7; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; Chomsky DB, 1997, J HEART LUNG TRANSPL, V16, P846; CODY RJ, 1993, J AM COLL CARDIOL  S, V22, pA65; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COHN JN, 1974, ANN INTERN MED, V81, P777, DOI 10.7326/0003-4819-81-6-777; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; DOVAL HC, 1994, LANCET, V344, P493, DOI 10.1016/S0140-6736(94)91895-3; Drazner MH, 1999, J HEART LUNG TRANSPL, V18, P1126, DOI 10.1016/S1053-2498(99)00070-4; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; Dries DL, 2001, J AM COLL CARDIOL, V38, P421, DOI 10.1016/S0735-1097(01)01408-5; Elefteriades John A., 1995, Cardiology Clinics, V13, P35; Elkayam U, 1999, CIRCULATION, V99, P2652, DOI 10.1161/01.CIR.99.20.2652; Felker GM, 2001, AM HEART J, V142, P393, DOI 10.1067/mhj.2001.117606; Felker GM, 2001, CIRCULATION, V104, P571; FONAROW GC, 1992, J AM COLL CARDIOL, V19, P842, DOI 10.1016/0735-1097(92)90529-V; FRANCIS G, 1998, MANAGEMENT END STAGE, P38; Goldstein S, 2001, J AM COLL CARDIOL, V37, p183A; Grady KL, 2000, CIRCULATION, V102, P2443, DOI 10.1161/01.CIR.102.19.2443; Hambrecht R, 2000, JAMA-J AM MED ASSOC, V283, P3095, DOI 10.1001/jama.283.23.3095; Hanumanthu S, 1997, CIRCULATION, V96, P2842, DOI 10.1161/01.CIR.96.9.2842; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Johnson W, 1998, CIRCULATION, V98, P780; KONSTAM M, 1994, AHCPR PUBLICATION; Krumholz HM, 1998, CIRCULATION, V98, P648, DOI 10.1161/01.CIR.98.7.648; Krumholz HM, 2000, AM J CARDIOL, V85, P1110, DOI 10.1016/S0002-9149(00)00705-0; Kubo SH, 1997, CARDIOLOGY, V88, P21, DOI 10.1159/000177481; LEE TH, 1993, AM J CARDIOL, V72, P672, DOI 10.1016/0002-9149(93)90883-E; LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257; Lewis EF, 2001, J HEART LUNG TRANSPL, V20, P1016, DOI 10.1016/S1053-2498(01)00298-4; LOUIE HW, 1991, CIRCULATION, V84, P290; Lucas C, 2000, AM HEART J, V140, P840, DOI 10.1067/mhj.2000.110933; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; MASSIE BM, 1993, CIRCULATION, V88, P492, DOI 10.1161/01.CIR.88.2.492; MASSIE BM, 2001, J CARD FAIL, V7, P60; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McCarthy PM, 2000, J HEART LUNG TRANSPL, V19, pS64, DOI 10.1016/S1053-2498(99)00102-3; McGee SR, 1998, AM HEART J, V136, P10, DOI 10.1016/S0002-8703(98)70175-9; METRA M, 1994, J AM COLL CARDIOL, V24, P1678, DOI 10.1016/0735-1097(94)90174-0; MIDDLEKAUFF HR, 1993, AM J CARDIOL, V72, pF75, DOI 10.1016/0002-9149(93)90967-H; MILLER LW, 1991, J HEART LUNG TRANSPL, V10, P482; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Murray MD, 1999, CIRCULATION, V100, P300; NOHRIA A, 2000, J CARD FAIL, V6, P64; Oliva F, 1999, AM HEART J, V138, P247, DOI 10.1016/S0002-8703(99)70108-0; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Packer M, 1999, AM J CARDIOL, V83, p1A; Pardaens K, 1997, HEART, V78, P564, DOI 10.1136/hrt.78.6.564; Perry G, 1997, NEW ENGL J MED, V336, P525; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; PIERPONT GL, 1978, CHEST, V73, P8, DOI 10.1378/chest.73.1.8; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poole-Wilson P, 1998, EUR HEART J, V19, P481; RECTOR TS, 1993, CIRCULATION, V87, P71; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Roglieri JL, 1997, AM J MANAG CARE, V3, P1831; Rosario LB, 1998, J AM COLL CARDIOL, V32, P1819, DOI 10.1016/S0735-1097(98)00461-6; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Schleman KA, 2001, J CARD FAIL, V7, P4, DOI 10.1054/jcaf.2001.22491; Silverberg DS, 2001, J AM COLL CARDIOL, V37, P1775, DOI 10.1016/S0735-1097(01)01248-7; Sindone AP, 1997, AM HEART J, V134, P889, DOI 10.1016/S0002-8703(97)80012-9; Skotzko CE, 2000, J CARD FAIL, V6, P300, DOI 10.1054/jcaf.2000.19222; Slatton ML, 1997, J AM COLL CARDIOL, V29, P1206, DOI 10.1016/S0735-1097(97)00057-0; Steimle AE, 1997, CIRCULATION, V96, P1165, DOI 10.1161/01.CIR.96.4.1165; Stevenson LW, 1998, AM HEART J, V135, pS293, DOI 10.1016/S0002-8703(98)70257-1; Stevenson LW, 1998, CIRCULATION, V98, P619, DOI 10.1161/01.CIR.98.7.619; STEVENSON LW, 1995, CIRCULATION, V92, P174, DOI 10.1161/01.CIR.92.9.174; STEVENSON LW, 1986, CIRCULATION, V74, P1303, DOI 10.1161/01.CIR.74.6.1303; STEVENSON LW, 1990, AM J CARDIOL, V66, P1348, DOI 10.1016/0002-9149(90)91166-4; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; STEVENSON WG, 1995, J AM COLL CARDIOL, V26, P1417, DOI 10.1016/0735-1097(95)00341-X; Tkacova R, 1998, CIRCULATION, V98, P2269, DOI 10.1161/01.CIR.98.21.2269; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Twidale N, 1998, PACE, V21, P641, DOI 10.1111/j.1540-8159.1998.tb00119.x; Uretsky BF, 1997, J AM COLL CARDIOL, V30, P1589, DOI 10.1016/S0735-1097(97)00361-6; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Weinfeld MS, 1999, AM HEART J, V138, P285, DOI 10.1016/S0002-8703(99)70113-4; Witte KKA, 2001, J AM COLL CARDIOL, V37, P1765, DOI 10.1016/S0735-1097(01)01227-X; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; ZEMA MJ, 1980, BRIT HEART J, V44, P560	99	258	280	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					628	640		10.1001/jama.287.5.628	http://dx.doi.org/10.1001/jama.287.5.628			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829703	Bronze			2022-12-28	WOS:000173686700033
J	Gaudet, J; Mango, SE				Gaudet, J; Mango, SE			Regulation of organogenesis by the Caenorhabditis elegans, FoxA protein PHA-41	SCIENCE			English	Article							HEAVY-CHAIN ISOFORMS; C-ELEGANS; FORK HEAD; DROSOPHILA EMBRYO; GENE-EXPRESSION; CELL LINEAGE; IDENTIFICATION; LOCALIZATION; HNF-3-BETA; HOMOLOG	The pha-4 locus encodes a forkhead box A (FoxA/HNF3) transcription factor homolog that specifies organ identity for Caenorhabditis elegans pharyngeal cells. We used microarrays to identify pharyngeal genes and analyzed those genes to determine which were direct PHA-4 targets. Our data suggest that PHA-4 directly activates most or all pharyngeal genes. Furthermore, the relative affinity of PHA-4 for different TRTTKRY (R=A/G, K=T/G, Y=T/C) elements modulates the onset of gene expression, providing a mechanism to activate pharyngeal genes at different developmental stages. We suggest that direct transcriptional regulation of entire gene networks may be a common feature of organ identity genes.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NIGMS NIH HHS [R01 GM056264] Funding Source: Medline; ODCDC CDC HHS [CCSG 2P30CA42014] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ODCDC CDC HHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; AVERY L, 1993, GENETICS, V133, P897; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; IP YT, 1992, J CELL SCI, P33; JURGENS G, 1988, ROUX ARCH DEV BIOL, V197, P345, DOI 10.1007/BF00375954; Kalb JM, 1998, DEVELOPMENT, V125, P2171; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Labouesse M, 1999, TRENDS GENET, V15, P307, DOI 10.1016/S0168-9525(99)01750-3; Lehmann M, 1996, EMBO J, V15, P4825, DOI 10.1002/j.1460-2075.1996.tb00863.x; MANGO SE, 1994, DEVELOPMENT, V120, P3019; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; Portereiko MF, 2001, DEV BIOL, V233, P482, DOI 10.1006/dbio.2001.0235; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; Schnabel R., 1997, C ELEGANS, P361; Shibata Y, 2000, GENETICS, V154, P635; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	31	299	302	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					821	825		10.1126/science.1065175	http://dx.doi.org/10.1126/science.1065175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823633				2022-12-28	WOS:000173733000035
J	Seidemann, E; Arieli, A; Grinvald, A; Slovin, H				Seidemann, E; Arieli, A; Grinvald, A; Slovin, H			Dynamics of depolarization and hyperpolarization in the frontal cortex and saccade goat	SCIENCE			English	Article							VOLTAGE-SENSITIVE DYES; EYE FIELDS; ELECTRICAL-STIMULATION; SUPERIOR COLLICULUS; VISUAL-CORTEX; MOVEMENTS; MICROSTIMULATION; REVEAL; MONKEY; SIGNAL	The frontal eye field and neighboring area 8Ar of the primate cortex are involved in programming and execution of saccades. Electrical microstimulation in these regions elicits short-latency contralateral saccades. To determine how spatiotemporal dynamics of microstimulation-evoked activity are converted into saccade plans, we used a combination of real-time optical imaging and microstimulation in behaving monkeys. Short stimulation trains evoked a rapid and widespread wave of depolarization followed by unexpected large and prolonged hyperpolarization. During this hyperpolarization saccades are almost exclusively ipsilateral, suggesting an important role for hyperpolarization in determining saccade goal.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Grodetsky Ctr Studies Higher Brain Funct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Seidemann, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	eyal.seidemann@weizmann.ac.il		Seidemann, Eyal/0000-0003-2841-5948; Slovin, Hamutal/0000-0001-6350-8141				ALBOWITZ B, 1993, EUR J NEUROSCI, V5, P1349, DOI 10.1111/j.1460-9568.1993.tb00921.x; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1990, NEUROSCI IN, P261; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; DOBELLE WH, 1979, NEUROSURGERY, V5, P521, DOI 10.1227/00006123-197910000-00022; Ferrier D., 1875, PHIL T LONDON CROONI, V65, P433, DOI DOI 10.1098/RSTL.1875.0016; GOLDBERG ME, 1986, EXP BRAIN RES, V61, P579; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; PETERSEN CCH, 2001, SOC NEUR ABSTR, V27; PREUSS TM, 1991, J COMP NEUROL, V310, P475, DOI 10.1002/cne.903100403; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; SCHALL JD, 1995, REV NEUROSCIENCE, V6, P63; Schall JD, 1997, CEREBR CORT, V12, P527; SCHILLER PH, 1983, EXP BRAIN RES, V49, P381; SCHLAG J, 1990, TRENDS NEUROSCI, V13, P410, DOI 10.1016/0166-2236(90)90122-Q; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; SEIDEMANN DE, 1999, SOC NEUR ABSTR, V25, P784; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Slovin H, 2000, EUR J NEUROSCI, V12, P126; Slovin H., 1999, Society for Neuroscience Abstracts, V25, P784; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X	28	105	105	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					862	865		10.1126/science.1066641	http://dx.doi.org/10.1126/science.1066641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823644	Green Submitted			2022-12-28	WOS:000173733000047
J	Sonna, LA				Sonna, LA			Pulmonary oedema at moderately high altitudes	LANCET			English	Editorial Material							ACUTE MOUNTAIN-SICKNESS; EDEMA; HIMALAYAS; ALPS		USA, Environm Med Res Inst, Thermal & Mt Med Div, Natick, MA 01760 USA		Sonna, LA (corresponding author), USA, Environm Med Res Inst, Thermal & Mt Med Div, Natick, MA 01760 USA.							Basnyat B, 1999, AVIAT SPACE ENVIR MD, V70, P867; Basnyat B, 2000, WILD ENVIRON MED, V11, P89, DOI 10.1580/1080-6032(2000)011[0089:DAAPAE]2.3.CO;2; BERT P, 1878, BAROMERIC PRESSURE R; HACKETT PH, 1982, RESPIRATION, V43, P321, DOI 10.1159/000194501; HACKETT PH, 1979, AM J MED, V67, P214, DOI 10.1016/0002-9343(79)90393-0; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; HOUSTON CS, 1976, JAMA-J AM MED ASSOC, V236, P2193, DOI 10.1001/jama.236.19.2193; HULTGREN HN, 1978, CHEST, V74, P372, DOI 10.1016/S0012-3692(15)37380-3; HULTGREN HN, 1961, MEDICINE, V40, P289, DOI 10.1097/00005792-196109000-00002; Lobenhoffer H., 1982, HIGH ALTITUDE PHYSL, P219; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; MONTGOMERY AB, 1989, JAMA-J AM MED ASSOC, V261, P732, DOI 10.1001/jama.261.5.732; Murdoch DR, 1998, NEW ZEAL MED J, V111, P168; PEACOCK AJ, 1995, EUR RESPIR J, V8, P1819, DOI 10.1183/09031936.95.08111819; Roach RC, 1998, AVIAT SPACE ENVIR MD, V69, P1182; Sonna LA, 2000, MIL MED, V165, P860, DOI 10.1093/milmed/165.11.860	18	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					276	277		10.1016/S0140-6736(02)07534-7	http://dx.doi.org/10.1016/S0140-6736(02)07534-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830190				2022-12-28	WOS:000173588100004
J	Aussel, L; Barre, FX; Aroyo, M; Stasiak, A; Stasiak, AZ; Sherratt, D				Aussel, L; Barre, FX; Aroyo, M; Stasiak, A; Stasiak, AZ; Sherratt, D			FtsK is a DNA motor protein that activates chromosome dimer resolution by switching the catalytic state of the XerC and XerD recombinases	CELL			English	Article							SITE-SPECIFIC RECOMBINATION; CELL-DIVISION PROTEIN; ESCHERICHIA-COLI; TOPOLOGICAL SELECTIVITY; DIF; TERMINUS; LOCALIZATION; SEGREGATION; TRANSPORT; SEPTUM	FtsK acts at the bacterial division septum to couple chromosome segregation with cell division. We demonstrate that a truncated FtsK derivative, FtsK(50C), uses ATP hydrolysis to translocate along duplex DNA as a multimer in vitro, consistent with FtsK having an in vivo role in pumping DNA through the closing division septum. FtsK(50C) also promotes a complete Xer recombination reaction between dif sites by switching the state of activity of the XerCD recombinases so that XerD makes the first pair of strand exchanges to form Holliday junctions that are then resolved by XerC. The reaction between directly repeated dif sites in circular DNA leads to the formation of uncatenated circles and is equivalent to the formation of chromosome monomers from dimers.	Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England; Univ Lausanne, Lab Anal Ultrastruct, CH-1015 Lausanne, Switzerland	University of Oxford; University of Lausanne	Sherratt, D (corresponding author), Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England.	sherratt@bioch.ox.ac.uk	Stasiak, Andrzej/E-5551-2010; Barre, François-Xavier/F-6767-2019	Stasiak, Andrzej/0000-0002-0398-1989; Aussel, Laurent/0000-0001-5239-4556				ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; ARCISZEWSKA LK, 1995, EMBO J, V14, P2112, DOI 10.1002/j.1460-2075.1995.tb07203.x; Barre F.-X., 2002, MOBILE DNA, P149; Barre FX, 2000, GENE DEV, V14, P2976, DOI 10.1101/gad.188700; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; BLAKELY G, 1991, NEW BIOL, V3, P789; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Colloms SD, 1997, CELL, V88, P855, DOI 10.1016/S0092-8674(00)81931-5; COLLOMS SD, 1990, J BACTERIOL, V172, P6973, DOI 10.1128/jb.172.12.6973-6980.1990; Colloms SD, 1996, EMBO J, V15, P1172, DOI 10.1002/j.1460-2075.1996.tb00456.x; Cornet F, 1996, GENE DEV, V10, P1152, DOI 10.1101/gad.10.9.1152; Diez AA, 1997, J BACTERIOL, V179, P5878, DOI 10.1128/jb.179.18.5878-5883.1997; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Hallet B, 1999, MOL CELL, V4, P949, DOI 10.1016/S1097-2765(00)80224-5; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; Huang J, 2001, P NATL ACAD SCI USA, V98, P968, DOI 10.1073/pnas.98.3.968; Kilbride E, 1999, J MOL BIOL, V289, P1219, DOI 10.1006/jmbi.1999.2864; KUEMPEL PL, 1991, NEW BIOL, V3, P799; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; Maurizi Michael R., 2001, EMBO Reports, V2, P980, DOI 10.1093/embo-reports/kve229; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Neilson L, 1999, MOL MICROBIOL, V31, P915, DOI 10.1046/j.1365-2958.1999.01231.x; Niki H, 2000, GENE DEV, V14, P212; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Perals K, 2000, MOL MICROBIOL, V36, P33, DOI 10.1046/j.1365-2958.2000.01847.x; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Recchia GD, 1999, MOL MICROBIOL, V34, P1146, DOI 10.1046/j.1365-2958.1999.01668.x; Sherratt DJ, 2001, CURR OPIN MICROBIOL, V4, P653, DOI 10.1016/S1369-5274(01)00265-X; SOGO JM, 1987, ELECTRON MICROS, P61; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Steiner WW, 1998, MOL MICROBIOL, V27, P257, DOI 10.1046/j.1365-2958.1998.00651.x; Steiner WW, 1998, J BACTERIOL, V180, P6269; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Yu XC, 1998, J BACTERIOL, V180, P6424; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998	41	255	261	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					195	205		10.1016/S0092-8674(02)00624-4	http://dx.doi.org/10.1016/S0092-8674(02)00624-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832210	Bronze			2022-12-28	WOS:000173521300007
J	Stegmeier, F; Visintin, R; Amon, A				Stegmeier, F; Visintin, R; Amon, A			Separase, polo kinase, the kinetochore protein Slk19 and Spo12 function in a network that controls Cdc14 localization during early anaphase	CELL			English	Article							SINGLE-DIVISION MEIOSIS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC EXIT; PHOSPHATASE CDC14; CYCLIN DESTRUCTION; SISTER CHROMATIDS; PROMOTING COMPLEX; MITOSIS; PHOSPHORYLATION	In budding yeast, the phosphatase Cdc14, a key regulator of exit from mitosis, is released from its inhibitor Cfi1/Net1 in the nucleolus during anaphase. A signaling cascade, known as the mitotic exit network (MEN), controls this release. We have identified a regulatory network, the FEAR (Cdc fourteen early anaphase release) network that promotes Cdc14 release from the nucleolus during early anaphase. The FEAR network is comprised of the polo kinase CdG5, the separase Esp1, the kinetochore-associated protein Slk19, and Spo12. We also show that the FEAR network initiates Cdc14 release from Cfi1/Net1 during early anaphase, and MEN maintains Cdc14 in the released state during late anaphase. We propose that one function of Cdc14 released by the FEAR network is to stimulate MEN activity.	MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, Howard Hughes Med Inst, E17-233,40 Ames St, Cambridge, MA 02139 USA.		Visintin, Rosella/J-9690-2012	Amon, Angelika/0000-0001-9837-0314; Visintin, Rosella/0000-0001-6758-9946	NIGMS NIH HHS [GM 56800] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cueille N, 2001, J CELL SCI, V114, P2649; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Kamieniecki RJ, 2000, CURR BIOL, V10, P1182, DOI 10.1016/S0960-9822(00)00723-5; KLAPHOLZ S, 1980, GENETICS, V96, P589; Lee SE, 2001, J CELL SCI, V114, P2345; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; PARKES V, 1992, NUCLEIC ACIDS RES, V20, P5617, DOI 10.1093/nar/20.21.5617; Severin F, 2001, J CELL BIOL, V155, P711, DOI 10.1083/jcb.200104096; SHARON G, 1990, GENETICS, V125, P487; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, YEAST, V10, P451, DOI 10.1002/yea.320100404; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2001, CURR OPIN CELL BIOL, V13, P754, DOI 10.1016/S0955-0674(00)00279-9; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Xu SC, 2000, CURR BIOL, V10, P329, DOI 10.1016/S0960-9822(00)00382-1; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	45	368	379	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					207	220		10.1016/S0092-8674(02)00618-9	http://dx.doi.org/10.1016/S0092-8674(02)00618-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832211	Bronze			2022-12-28	WOS:000173521300008
J	Helenius, J; Ng, DTW; Marolda, CL; Walter, P; Valvano, MA; Aebi, M				Helenius, J; Ng, DTW; Marolda, CL; Walter, P; Valvano, MA; Aebi, M			Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; GLYCOSYLATION REACTIONS; TRANSMEMBRANE MOVEMENT; BIOSYNTHESIS; TRANSPORT; CLONING; GLYCOPROTEINS; TOPOGRAPHY	N-linked glycosylation of proteins in eukaryotic cells follows a highly conserved pathway. The tetradecasaccharide substrate (Glc(3)Man(9)GlcNAc(2)) is first assembled at the membrane of the endoplasmic reticulum (ER) as a dolichylpyrophosphate (DolPP)-linked intermediate, and then transferred to nascent polypeptide chains in the lumen of the ER1. The assembly of the oligosaccharide starts on the cytoplasmic side of the ER membrane with the synthesis of a Man(5)GlcNAc(2)-PP-Dol intermediate. This lipid-linked intermediate is then translocated across the membrane so that the oligosaccharides face the lumen of the ER, where the biosynthesis of Glc(3)Man(9)GlcNAc(2)-PP-Dol continues to completion. The fully assembled oligosaccharide is transferred to selected asparagine residues of target proteins. The transmembrane movement of lipid-linked Man(5)GlcNAc(2) oligosaccharide is of fundamental importance in this biosynthetic pathway, and similar processes involving phospholipids and glycolipids are essential in all types of cells(2-4). The process is predicted to be catalysed by proteins, termed flippases, which to date have remained elusive(2-4). Here we provide evidence that yeast RFT1 encodes an evolutionarily conserved protein required for the translocation of Man(5)GlcNAc(2)-PP-Dol from the cytoplasmic to the lumenal leaflet of the ER membrane.	Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Western University (University of Western Ontario); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Aebi, M (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641				ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; BUGG TDH, 1994, FEMS MICROBIOL LETT, V119, P255; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; Davidson EA, 2001, BIOCHIMIE, V83, P601, DOI 10.1016/S0300-9084(01)01316-5; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; HANOVER JA, 1979, J BIOL CHEM, V254, P9237; HASILIK A, 1978, EUR J BIOCHEM, V91, P567, DOI 10.1111/j.1432-1033.1978.tb12710.x; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; MCCLOSKEY MA, 1980, BIOCHEMISTRY-US, V19, P2056, DOI 10.1021/bi00551a008; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; ORLEAN P, 1991, METHOD ENZYMOL, V194, P682; PEREZ M, 1986, J BIOL CHEM, V261, P6822; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SNIDER MD, 1984, CELL, V36, P753, DOI 10.1016/0092-8674(84)90355-6; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Wach A, 1998, METHOD MICROBIOL, V26, P67; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	28	200	205	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					447	450		10.1038/415447a	http://dx.doi.org/10.1038/415447a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807558				2022-12-28	WOS:000173433600054
J	Enthoven, AC				Enthoven, AC			Commentary: Competition made them do it	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University	Enthoven, AC (corresponding author), Stanford Univ, Grad Sch Business, Knight 214, Stanford, CA 94305 USA.							ENTHOVEN A, 1999, PURSUIT IMPROVING NA; ENTHOVEN C, 1985, 5 NUFF PROV HOSP TRU; *SECR STAT HLTH WA, 1989, WORK PAT; 2001, HLTH SERV J     1025	4	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					143	143						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11822331				2022-12-28	WOS:000173470600016
J	Green, J; Forster, A; Bogle, S; Young, J				Green, J; Forster, A; Bogle, S; Young, J			Physiotherapy for patients with mobility, problems more than 1 year after stroke: a randomised controlled trial	LANCET			English	Article							REHABILITATION	Background Community physiotherapy is often prescribed for stroke patients with long-term mobility problems. We aimed to assess the effectiveness of this treatment in patients who had mobility problems 1 year after stroke. Methods We screened 359 patients older than 50 years for a single-masked, randomised controlled trial to assess the effects of community physiotherapy. Assessments were made at baseline, 3, 6, and 9 months in 170 eligible patients assigned treatment or no intervention. The primary outcome measure was mobility measured by the Rivermead mobility index. Secondary outcome measures were gait speed, number of falls, daily activity (Barthel index scores), social activity (Frenchay activities index), hospital anxiety and depression scale, and emotional stress of carers (general health questionnaire 28). Analyses were by intention to treat. Findings Follow-up was available for 146 patients (86%). Changes in scores on the Rivermead mobility index (score range 0-15) differed significantly between treatment and control groups at 3 months (p=0.018), but only by a median of 1 point (95% CI 0.1), with an interpolated value of 0.55 (0.08-1.04). Gait speed was 2.6 m/min (0.30-4.95) higher in the treatment group at 3 months. Neither treatment effect persisted at 6-months' and 9-months' follow-up. Treatment had no effect on patients' daily activity, social activity, anxiety, depression, and number of falls, or on emotional stress of carers. Interpretation Community physiotherapy treatment for patients with mobility problems 1 year after stroke leads to significant, but clinically small, improvements in mobility and gait speed that are not sustained after treatment ends.	St Lukes Hosp, Dept Hlth Care Elderly, Bradford BD5 0NA, W Yorkshire, England; Bradford Community NHS Trust, Rehabil Serv, Bradford, W Yorkshire, England; Aysgarth Stat, Beaconsfield, England		Green, J (corresponding author), St Lukes Hosp, Dept Hlth Care Elderly, Bradford BD5 0NA, W Yorkshire, England.			Forster, Anne/0000-0001-7466-4414; young, john/0000-0003-4085-9306				Collen F M, 1991, Int Disabil Stud, V13, P50; Collen F M, 1991, Int Disabil Stud, V13, P12; Collen F M, 1990, Int Disabil Stud, V12, P6; Collin C, 1988, Int Disabil Stud, V10, P61; Corr S, 1995, CLIN REHABIL, V9, P291; DAM M, 1993, STROKE, V24, P1186, DOI 10.1161/01.STR.24.8.1186; DOWSWELL G, IN PRESS B J THER RE; Enderby P M, 1987, Int Rehabil Med, V8, P166; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; GLADMAN JRF, 1995, CLIN REHABIL, V9, P245; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GREEN J, 1999, BR J THER REHABIL, V6, P216; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; LEHMANN JF, 1975, ARCH PHYS MED REHAB, V56, P375; Rodriquez AA, 1996, ARCH PHYS MED REHAB, V77, P801, DOI 10.1016/S0003-9993(96)90260-9; TANGEMAN PT, 1990, ARCH PHYS MED REHAB, V71, P876; WADE D, 2000, NATL CLIN GUIDELINES, P64; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; WALKER MF, 1996, CLIN REHABIL, V10, P23, DOI DOI 10.1177/026921559601000105; Werner RA, 1996, AM J PHYS MED REHAB, V75, P114, DOI 10.1097/00002060-199603000-00006; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	24	139	145	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					199	203		10.1016/S0140-6736(02)07443-3	http://dx.doi.org/10.1016/S0140-6736(02)07443-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812553				2022-12-28	WOS:000173350800009
J	Tucker, J; Mccabe, C; McCabe, C; Nicolson, P; Tarnow-Mordi, W; Marlow, N; Baumer, H; Boen, M; Hamilton, K; Meran, JA; Milligan, D; Nicoll, J; Redshaw, M; Rowan, K; Scott, J; Smith, J				Tucker, J; Mccabe, C; McCabe, C; Nicolson, P; Tarnow-Mordi, W; Marlow, N; Baumer, H; Boen, M; Hamilton, K; Meran, JA; Milligan, D; Nicoll, J; Redshaw, M; Rowan, K; Scott, J; Smith, J		UK Neonatgal Staffing Study Grp	Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation	LANCET			English	Article							BIRTH; MORTALITY	Background UK recommendations suggest that large neonatal intensive-care units (NICUs) have better outcomes than small units, although this suggestion remains unproven. We assessed whether patient volume, staffing levels, and workload are associated with risk-adjusted outcomes, and with costs or staff wellbeing. Methods 186 UK NICUs were stratified according to volume of patients, nursing provision, and neonatal consultant provision. Primary outcomes were hospital mortality, mortality or cerebral damage, and nosocomial bacteraemia. We studied 13 515 infants of all birthweights consecutively admitted to 54 randomly selected NICUs. Multiple logistic regression analyses were done with every primary outcome as the dependent variable. Staff wellbeing and stress were assessed by anonymous mental health index (MHI)-5 questionnaires. Findings Data were available for 13 334 (99%) infants. High-volume NICUs treated the sickest infants and had highest crude mortality. Risk-adjusted mortality and mortality or cerebral damage were unrelated to patient volume or staffing provision; however, nosocomial bacteraemia was less frequent in NICUs with low neonatal consultant provision (odds ratio 0.65, 95% Cl 0.43-0.98). Mortality was raised with increasing workload in all types of NICUs. Infants admitted at full capacity versus half capacity were about 50% more likely to die, but there was wide uncertainty around this estimate. Most staff had MHI-5 scores that suggested good mental health. Interpretation The implications of this report for staffing policy, medicolegal risk management, and ethical practice remain to be tested. Centralisation of only the sickest infants could improve efficiency, provided that this does not create excessive workload for staff. Assessment of increased staffing levels that are closer to those in adult intensive care might be appropriate.	Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland; Univ Sheffield, ScHARR, Med Care Res Unit, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, ScHARR, Sheffield Hlth Econ Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Sydney, Westmead & New Childrens Hosp, Sydney, NSW 2006, Australia	University of Aberdeen; University of Sheffield; University of Sheffield; University of Sydney	Tucker, J (corresponding author), Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland.	j.s.tucker@abdn.ac.uk	Parry, Gareth/CAF-6975-2022; Marlow, Neil/D-2918-2009; McCabe, Christopher/E-2051-2016	Marlow, Neil/0000-0001-5890-2953; 				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; *BRIT ASS PER MED, 1996, STAND HOSP PROV NEON; Brodie SB, 2000, PEDIATR INFECT DIS J, V19, P56, DOI 10.1097/00006454-200001000-00012; COCKBURN F, 1993, LANCET, V342, P193; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; FIELD D, 1991, ARCH DIS CHILD-FETAL, V66, P408, DOI 10.1136/adc.66.4_Spec_No.408; Field D, 1999, ARCH DIS CHILD-FETAL, V80, pF111, DOI 10.1136/fn.80.2.F111; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; GOLDFRAD C, 2000, J EPIDEMIOL COMMUN H, pA9; Jones J, 1995, INT J TECHNOL ASSESS, V11, P762, DOI 10.1017/S0266462300009193; McCabe CJ, 1996, BRIT J PSYCHIAT, V169, P517, DOI 10.1192/bjp.169.4.516; MCFARLANE A, 2000, BIRTH COUNTS STAT PR, P544; Mugford M, 1998, ARCH DIS CHILD-FETAL, V78, pF179; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; *NHS CTR REV DISS, 1996, EFFECTIVE HLTH CARE, V2, P1; O'Neill C, 2000, J PUBLIC HEALTH MED, V22, P108, DOI 10.1093/pubmed/22.1.108; Parmanum J, 2000, BMJ-BRIT MED J, V321, P727, DOI 10.1136/bmj.321.7263.727; Parry GJ, 1998, BRIT MED J, V316, P1931, DOI 10.1136/bmj.316.7149.1931; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; PICKERING J, 1993, ARCH DIS CHILD-FETAL, V68, P539; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; POLLACK MM, 1994, JAMA-J AM MED ASSOC, V272, P941, DOI 10.1001/jama.272.12.941; Redshaw M., 1996, DELIVERING NEONATAL; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; SEPKOWITZ S, 1993, LANCET, V342, P938, DOI 10.1016/0140-6736(93)91992-U; *SOC SERV COMM, 1980, PER NEON MORT 2 REP; Tarnow-Mordi W, 2000, ARCH DIS CHILD-FETAL, V82, pF118; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; TarnowMordi W, 1997, LANCET, V350, P66, DOI 10.1016/S0140-6736(05)66269-1; TARNOWMORDI W, 2002, RISK ADJUSTED OUTCOM; TARNOWMORDI WO, 1997, SEMIN NEONATOL, V2, P171; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289; Tucker J, 1999, ARCH DIS CHILD-FETAL, V80, pF233, DOI 10.1136/fn.80.3.F233; UKOUMUNNE OC, 1999, HEALTH TECHNOL ASSES, V3, P33; WHEELER RHB, 1995, ARCH DIS CHILD, V73, pF32; *WORK GROUP NEON I, 1995, NEON INT CAR ACC AV; 1986, LANCET, V1, P777	39	194	196	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2002	359	9301					99	107						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809250				2022-12-28	WOS:000173212400007
J	Vaira, D; Vakil, N; Menegatti, M; van't Hoff, B; Ricci, C; Gatta, L; Gasbarrini, G; Quina, M; Garcia, JMP; van der Ende, A; van der Hulst, R; Anti, M; Duarte, C; Gisbert, JP; Miglioli, M; Tytgat, G				Vaira, D; Vakil, N; Menegatti, M; van't Hoff, B; Ricci, C; Gatta, L; Gasbarrini, G; Quina, M; Garcia, JMP; van der Ende, A; van der Hulst, R; Anti, M; Duarte, C; Gisbert, JP; Miglioli, M; Tytgat, G			The stool antigen test for detection of Helicobacter pylori after eradication therapy	ANNALS OF INTERNAL MEDICINE			English	Article							ENZYME-IMMUNOASSAY; DYSPEPTIC PATIENTS; NONINVASIVE TESTS; INFECTION; MULTICENTER; MANAGEMENT; SPECIMENS; DIAGNOSIS; ACCURACY; TRIAL	Background: current noninvasive tests to confirm the eradication of Helicobacter pylori must be performed 4 weeks or more after eradication therapy is completed. Objective: To determine whether the stool antigen test, a relatively new noninvasive test for H. pylori, administered at various times after eradication therapy correctly identifies persons with persistent H. pylori infection. Design: Prospective blinded study. Setting: Six clinical centers in the United States and Europe. Patients: 84 H. pylori-infected patients undergoing endoscopy for upper abdominal symptoms. Measurements: At baseline and on day 35 after the completion of triple eradication therapy, all patients underwent endoscopy with histologic examination, rapid urease test and culture, urea breath test, and a stool antigen test. The stool antigen test was also performed on days 3, 7, 15, 21, 28, and 35 after completion of therapy. Results: Compared with the gold-standard endoscopic tests on day 35 after antimicrobial therapy, the urea breath test had a sensitivity of 94% (95% Cl, 71% to 100%) and a specificity of 100% (Cl, 94% to 100%). The stool antigen test had a sensitivity of 94% (Cl, 71% to 100%) and a specificity of 97% (Cl, 89% to 100%). On day 7 after treatment, the stool antigen test was predictive of eradication (positive predictive value, 100% [Cl, 69% to 100%]; negative predictive value, 91% [Cl, 82% to 97%]). Conclusion: A positive result on the stool antigen test 7 days after completion of therapy identifies patients in whom eradication of H. pylori was unsuccessful.	Univ Bologna, I-40138 Bologna, Italy; Policlin Gemelli, Rome, Italy; Univ Wisconsin, Sch Med, Milwaukee, WI 53201 USA; Univ Amsterdam, Amsterdam, Netherlands; Hospo Pulido Valente, Lisbon, Portugal; Hosp Princesa, Madrid, Spain	University of Bologna; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Wisconsin System; University of Wisconsin Milwaukee; University of Amsterdam; Hospital de La Princesa	Vaira, D (corresponding author), St Orsola Marcello Malpighi Hosp, Dept Internal Med & Gastroenterol, Via Massarenti 9, I-40138 Bologna, Italy.	vairadin@med.unibo.it	Gisbert, Javier P/ABB-7531-2021; van der Ende, Arie/A-4346-2012; Gisbert, Javier P/GRY-2719-2022; Gatta, Luigi/S-6795-2016	Gisbert, Javier P/0000-0003-2090-3445; van der Ende, Arie/0000-0003-1298-3086; Gatta, Luigi/0000-0001-5789-3813				[Anonymous], 1998, Gastroenterology, V114, P579; Dawson-Saunders B., 1994, BASIC CLIN BIOSTATIS; Fennerty MB, 1999, ARCH INTERN MED, V159, P1562, DOI 10.1001/archinte.159.14.1562; Forne M, 2000, AM J GASTROENTEROL, V95, P2200, DOI 10.1111/j.1572-0241.2000.02303.x; HEIKKINEN M, 1995, SCAND J GASTROENTERO, V30, P519, DOI 10.3109/00365529509089783; Howden CW, 1998, AM J GASTROENTEROL, V93, P2330, DOI 10.1111/j.1572-0241.1998.00684.x; KAGEVI I, 1989, SCAND J GASTROENTERO, V24, P145, DOI 10.3109/00365528909093029; KOSUNEN TU, 1992, LANCET, V339, P893, DOI 10.1016/0140-6736(92)90929-W; Laine L, 2000, AM J GASTROENTEROL, V95, P3393, DOI 10.1111/j.1572-0241.2000.03349.x; Lassen AT, 2000, LANCET, V356, P455, DOI 10.1016/S0140-6736(00)02553-8; Lind T, 1999, GASTROENTEROLOGY, V116, P248, DOI 10.1016/S0016-5085(99)70119-8; Malfertheiner P, 1997, GUT, V41, P8; Oderda G, 2000, BRIT MED J, V320, P347, DOI 10.1136/bmj.320.7231.347; ROKKAS T, 1995, GASTROINTEST ENDOSC, V41, P1, DOI 10.1016/S0016-5107(95)70266-0; Rollan A, 1997, AM J GASTROENTEROL, V92, P1268; Talley NJ, 1999, GUT, V45, P37; *US FDA, 2001, GUID IND EV CLIN STU; Vaira D, 1999, LANCET, V354, P30, DOI 10.1016/S0140-6736(98)08103-3; Vaira D, 2001, GUT, V48, P287, DOI 10.1136/gut.48.3.287; Vaira D, 2000, ALIMENT PHARM THER, V14, P13, DOI 10.1046/j.1365-2036.2000.00096.x; Vaira D, 2000, AM J GASTROENTEROL, V95, P925, DOI 10.1111/j.1572-0241.2000.01931.x; Vakil N, 1998, AM J GASTROENTEROL, V93, P1432, DOI 10.1111/j.1572-0241.1998.455_t.x; Vakil N, 2001, ALIMENT PHARM THERAP, V15, P10, DOI 10.1046/j.1365-2036.2001.00106.x; Vakil N, 2000, AM J GASTROENTEROL, V95, P1691; Vakil N, 2000, AM J GASTROENTEROL, V95, P1699; 1997, GUT S2, V41, pS10	26	82	87	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					280	286		10.7326/0003-4819-136-4-200202190-00007	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FQ	11848725				2022-12-28	WOS:000173943700003
J	Sayer, M; Bowman, D; Evans, D; Wessier, A; Wood, D				Sayer, M; Bowman, D; Evans, D; Wessier, A; Wood, D			Use of patients in professional medical examinations: current UK practice and the ethicolegal implications for medical education	BRITISH MEDICAL JOURNAL			English	Article									St Bartholomews Hosp, Robin Brook Ctr, Med Educ Res & Innovat Unit, London EC1A 7BE, England; St George Hosp, Sch Med, Dept Gen Practice & Primary Care, London SW17 0RE, England; St George Hosp, Sch Med, Dept Med & Healthcare Educ, London SW17 0RE, England	University of London; Queen Mary University London; St Georges University London; St Georges University London	Sayer, M (corresponding author), St Bartholomews Hosp, Robin Brook Ctr, Med Educ Res & Innovat Unit, London EC1A 7BE, England.							CAMPBELL A, 1997, RES ETHICS MED ETHIC, P173; COLETTA EM, 1993, ACAD MED, V68, P901, DOI 10.1097/00001888-199312000-00008; Collins JP, 1998, MED TEACH, V20, P508; FEATHER A, 2001, 9 INT OTT C CAP TOWN; *GEN MED COUNC, 1998, GOOD MED PRACT, P3; *GEN MED COUNC, 1993, TOM DOCT REC UND MED; KENNEDY I, 2000, MED LAW, P658; NEWBLE DI, 1991, MED EDUC, V25, P369, DOI 10.1111/j.1365-2923.1991.tb00083.x; SHARMA T, 1994, MED TEACH, V16, P61, DOI 10.3109/01421599409108259; Stacy R, 1999, MED EDUC, V33, P688, DOI 10.1046/j.1365-2923.1999.00454.x; STOKES J, 1974, CLIN EXAMINATION ASS; WALTON M, 1998, TROUBLE MED, P18; Welfare MR, 1999, MED EDUC, V33, P165; Wykurz G, 1999, MED EDUC, V33, P634, DOI 10.1046/j.1365-2923.1999.00525.x	14	17	19	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					404	407		10.1136/bmj.324.7334.404	http://dx.doi.org/10.1136/bmj.324.7334.404			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850374	Bronze, Green Published			2022-12-28	WOS:000174006300022
J	Wookey, J; Kendall, JM; Barruol, G				Wookey, J; Kendall, JM; Barruol, G			Mid-mantle deformation inferred from seismic anisotropy	NATURE			English	Article							TRANSITION-ZONE; SUBDUCTION ZONES; EARTHS MANTLE; PHASE-CHANGES; WAVE; BENEATH; LITHOSPHERE; DISCONTINUITY; PEROVSKITE; AUSTRALIA	With time, convective processes in the Earth's mantle will tend to align crystals, grains and inclusions. This mantle fabric is detectable seismologically, as it produces an anisotropy in material properties-in particular, a directional dependence in seismic-wave velocity. This alignment is enhanced at the boundaries of the mantle where there are rapid changes in the direction and magnitude of mantle flow(1), and therefore most observations of anisotropy are confined to the uppermost mantle or lithosphere(2,3) and the lowermost-mantle analogue of the lithosphere, the D" region(4). Here we present evidence from shear-wave splitting measurements for mid-mantle anisotropy in the vicinity of the 660-km discontinuity, the boundary between the upper and lower mantle. Deep-focus earthquakes in the Tonga-Kermadec and New Hebrides subduction zones recorded at Australian seismograph stations record some of the largest values of shear-wave splitting hitherto reported. The results suggest that, at least locally, there may exist a mid-mantle boundary layer, which could indicate the impediment of flow between the upper and lower mantle in this region.	Univ Leeds, Sch Earth Sci, Leeds LS2 9JT, W Yorkshire, England; Univ Montpellier, CNRS, F-34095 Montpellier 05, France	University of Leeds; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Kendall, JM (corresponding author), Univ Leeds, Sch Earth Sci, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.		Barruol, guilhem/M-8677-2019; BARRUOL, Guilhem/A-7116-2008; Kendall, Michael/D-5973-2011; Wookey, James/G-6113-2011; BARRUOL, Guilhem/AAN-4611-2021	Barruol, guilhem/0000-0002-4049-2375; BARRUOL, Guilhem/0000-0002-4049-2375; Kendall, Michael/0000-0002-1486-3945; Wookey, James/0000-0002-7403-4380				ANDERSON DL, 1987, J GEOPHYS RES-SOLID, V92, P13968, DOI 10.1029/JB092iB13p13968; Barruol G, 1999, J GEOPHYS RES-SOL EA, V104, P10757, DOI 10.1029/1999JB900033; CLITHEROE G, 1998, GEODYNAMICS, V26, P73; Fischer KM, 1996, EARTH PLANET SC LETT, V142, P253, DOI 10.1016/0012-821X(96)00084-2; Fouch MJ, 1996, J GEOPHYS RES-SOL EA, V101, P15987, DOI 10.1029/96JB00881; GAHERTY JB, 1995, SCIENCE, V268, P1468, DOI 10.1126/science.268.5216.1468; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; Karato S, 1998, NATURE, V395, P266, DOI 10.1038/26206; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Kendall JM, 1998, GEODYNAMICS, V28, P97; KENDALL JM, 1993, GEOPHYS J INT, V112, P39, DOI 10.1111/j.1365-246X.1993.tb01435.x; KIRBY SH, 1991, SCIENCE, V252, P216, DOI 10.1126/science.252.5003.216; Kusznir N., 2000, EOS T AGU, V81, P1081; Mainprice D., 2000, EARTHS DEEP INTERIOR, P237, DOI [10.1029/GM117p0237, DOI 10.1029/GM117P0237]; MEADE C, 1995, GEOPHYS RES LETT, V22, P1293, DOI 10.1029/95GL01091; Mitrovica JX, 1997, J GEOPHYS RES-SOL EA, V102, P2751, DOI 10.1029/96JB03175; Montagner JP, 1996, GEOPHYS J INT, V125, P229, DOI 10.1111/j.1365-246X.1996.tb06548.x; Montagner JP, 1998, PURE APPL GEOPHYS, V151, P223, DOI 10.1007/s000240050113; Oganov AR, 2001, NATURE, V411, P934, DOI 10.1038/35082048; Ozalaybey S, 1999, PHYS EARTH PLANET IN, V114, P197, DOI 10.1016/S0031-9201(99)00058-8; RINGWOOD AE, 1994, PHYS EARTH PLANET IN, V86, P5, DOI 10.1016/0031-9201(94)05058-9; Savage MK, 1999, REV GEOPHYS, V37, P65, DOI 10.1029/98RG02075; SILVER PG, 1988, NATURE, V335, P34, DOI 10.1038/335034a0; Silver PG, 1996, ANNU REV EARTH PL SC, V24, P385, DOI 10.1146/annurev.earth.24.1.385; Stixrude L, 1998, GEODYNAMICS, V28, P83; TONG C, 1994, J GEOPHYS RES-SOL EA, V99, P15783, DOI 10.1029/94JB00460; VANDERHILST R, 1995, NATURE, V374, P154, DOI 10.1038/374154a0; Vinnik L, 1998, GEOPHYS RES LETT, V25, P1995, DOI 10.1029/98GL01418; Vinnik L, 1996, GEOPHYS RES LETT, V23, P2449, DOI 10.1029/96GL02263; Widiyantoro S, 1999, EARTH PLANET SC LETT, V173, P91, DOI 10.1016/S0012-821X(99)00216-2; Wolfe CJ, 1998, J GEOPHYS RES-SOL EA, V103, P749, DOI 10.1029/97JB02023; YEGANEHHAERI A, 1994, PHYS EARTH PLANET IN, V87, P111, DOI 10.1016/0031-9201(94)90025-6	32	117	119	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					777	780		10.1038/415777a	http://dx.doi.org/10.1038/415777a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845205	Green Accepted, Green Submitted			2022-12-28	WOS:000173833900042
J	Dubrova, YE; Bersimbaev, RI; Djansugurova, LB; Tankimanova, MK; Mamyrbaeva, ZZ; Mustonen, R; Lindholm, C; Hulten, M; Salomaa, S				Dubrova, YE; Bersimbaev, RI; Djansugurova, LB; Tankimanova, MK; Mamyrbaeva, ZZ; Mustonen, R; Lindholm, C; Hulten, M; Salomaa, S			Nuclear weapons tests and human germline mutation rate	SCIENCE			English	Article									Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Kazakh State Natl Univ, Almaty 480121, Kazakhstan; Inst Gen Genet & Cytol, Almaty 480060, Kazakhstan; STUK Radiat & Nucl Safety Author, Helsinki 00881, Finland; Univ Warwick, Dept Biol Sci, Coventry CV4 7A1, W Midlands, England	University of Leicester; Al-Farabi Kazakh National University; Institute of Genetics & Physiology of the Ministry of Science & Higher Education; Radiation & Nuclear Safety Authority (STUK); University of Warwick	Dubrova, YE (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Leyla, Djansugurova/AAZ-1063-2020; Dubrova, Yuri/ABA-7148-2020	Leyla, Djansugurova/0000-0002-6745-9903; Dubrova, Yuri/0000-0001-5281-7539				Dubrova YE, 1997, MUTAT RES-FUND MOL M, V381, P267; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Gusev BI, 1997, RADIAT ENVIRON BIOPH, V36, P201, DOI 10.1007/s004110050072; MATSUSCHENKO M, 1998, NUCL TESTS LONG TERM, P89	4	108	123	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1037	1037		10.1126/science.1068102	http://dx.doi.org/10.1126/science.1068102			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834827				2022-12-28	WOS:000173793000055
J	Jula, A; Marniemi, J; Huupponen, R; Virtanen, A; Rastas, M; Ronnemaa, T				Jula, A; Marniemi, J; Huupponen, R; Virtanen, A; Rastas, M; Ronnemaa, T			Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 DIABETIC-PATIENTS; ALPHA-TOCOPHEROL; PLASMA; ACID; LIPOPROTEIN; FAT; SENSITIVITY; CHOLESTEROL; UBIQUINONE; PREVENTION	Context Limited information exists on the interaction between diet and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) and the interaction's effect on serum lipid and lipoprotein levels, insulin sensitivity, and circulating antioxidant vitamin and provitamin levels. Objective To evaluate the separate and combined effects of diet and simvastatin therapy on serum levels of lipids, lipoproteins, antioxidants, and insulin. Design, Setting, and Participants Randomized, controlled crossover trial conducted from August 1997 to June 1998 in 120 previously untreated hypercholesterolemic men aged 35 to 64 years who were recruited from the community in Turku, southwestern Finland. Interventions After a 4- to 6-week placebo run-in period, participants were randomly allocated to a habitual diet (n=60) or dietary treatment group (n=60), and each of these groups was further randomized in a double-blind crossover fashion to receive simivastatin (20 mg/d) or placebo, each for 12 weeks (n=30 in each group). The main goals of the dietary treatment were to reduce energy intake from saturated plus transunsaturated fats to no more than 10% by replacing them partly with monounsaturated and polyunsaturated fats rich in omega-3 fatty acids and to increase intake of fruits, vegetables, and dietary fiber. Main Outcome Measures Changes in levels of total, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) cholesterol; triglycerides; apolipoprotein B; insulin; glucose; and antioxidants at week 12 of each treatment period, compared among the 4 groups. Results Dietary treatment decreased levels of total cholesterol by 7.6% (P<.001), LDL cholesterol by 10.8% (P<.001), HDL cholesterol by 4.9% (P=.01), apolipoprotein B by 5.7% (P=.003), serum insulin by 14.0% (P=.02), and alpha-tocopherol by 3.5% (P=.04). Simvastatin decreased levels of total cholesterol by 20.8%, LDL cholesterol by 29.7%, triglycerides by 13.6%, apolipoprotein B by 22.4%, alpha-tocopherol by 16.2%, beta-carotene by 19.5%, and ubiquinol-10 by 22.0% (P<.001 for all) and increased levels of HDL cholesterol by 7.0% (P<.001) and serum insulin by 13.2% (P=.005). Glucose levels remained unchanged in all groups. The effects of dietary treatment and simvastatin were independent and additive. Conclusions A modified Mediterranean-type diet rich in omega-3 fatty acids efficiently potentiated the cholesterol-lowering effect of simvastatin, counteracted the fasting insulin-elevating effect of simvastatin, and, unlike simvastatin, did not decrease serum levels of beta-carotene and ubiquinol-10.	Social Insurance Inst, Ctr Res & Dev, FIN-20720 Turku, Finland; Univ Turku, Dept Pharmacol & Clin Pharmacol, SF-20500 Turku, Finland; Univ Turku, Dept Med, SF-20500 Turku, Finland	University of Turku; University of Turku	Jula, A (corresponding author), Social Insurance Inst, Ctr Res & Dev, Peltolantie 3, FIN-20720 Turku, Finland.	antti.jula@kela.memonet.fi						Ahotupa M, 1996, CLIN BIOCHEM, V29, P139, DOI 10.1016/0009-9120(95)02043-8; BEHRENS WA, 1982, AM J CLIN NUTR, V35, P691, DOI 10.1093/ajcn/35.4.691; BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Brown L, 1999, AM J CLIN NUTR, V69, P30; BURR ML, 1989, LANCET, V2, P757; DAY BR, 1979, CLIN BIOCHEM, V12, P22, DOI 10.1016/S0009-9120(79)90040-7; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; GARDNER CD, 1995, ARTERIOSCL THROM VAS, V15, P1917, DOI 10.1161/01.ATV.15.11.1917; GINSBERG BH, 1981, DIABETES, V30, P773, DOI 10.2337/diab.30.9.773; Girona J, 1999, AM J CARDIOL, V83, P846, DOI 10.1016/S0002-9149(98)01071-6; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hakala P, 1996, FOOD CHEM, V57, P71, DOI 10.1016/0308-8146(96)00077-5; Howell WH, 1997, AM J CLIN NUTR, V65, P1747, DOI 10.1093/ajcn/65.6.1747; Human JA, 1997, CLIN CHIM ACTA, V263, P67, DOI 10.1016/S0009-8981(97)06557-1; HUNNINGHAKE DB, 1993, NEW ENGL J MED, V328, P1213, DOI 10.1056/NEJM199304293281701; Hwu CM, 1999, DIABETIC MED, V16, P749, DOI 10.1046/j.1464-5491.1999.00113.x; KLEINVELD HA, 1993, EUR J CLIN INVEST, V23, P289, DOI 10.1111/j.1365-2362.1993.tb00776.x; Laaksonen R, 1996, AM J CARDIOL, V77, P851, DOI 10.1016/S0002-9149(97)89180-1; MILNE DB, 1986, CLIN CHEM, V32, P874; OHRVALL M, 1995, METABOLISM, V44, P212, DOI 10.1016/0026-0495(95)90267-8; Paolisso G, 2000, ATHEROSCLEROSIS, V150, P121, DOI 10.1016/S0021-9150(99)00352-4; PEDERSEN TR, 1994, LANCET, V344, P1383; PELIKANOVA T, 1989, METABOLISM, V38, P188, DOI 10.1016/0026-0495(89)90261-8; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SINGH RB, 1992, BRIT MED J, V304, P1015, DOI 10.1136/bmj.304.6833.1015; STEWART MW, 1995, DIABETIC MED, V12, P250, DOI 10.1111/j.1464-5491.1995.tb00467.x; STRALFORS P, 1988, NATURE, V335, P554, DOI 10.1038/335554a0; TAKADA M, 1984, METHOD ENZYMOL, V105, P147; UUSITUPA M, 1994, AM J CLIN NUTR, V59, P1310, DOI 10.1093/ajcn/59.6.1310; WATTS GF, 1993, J CLIN PATHOL, V46, P1055, DOI 10.1136/jcp.46.11.1055; WIELAND H, 1983, J LIPID RES, V24, P904	32	155	165	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					598	605		10.1001/jama.287.5.598	http://dx.doi.org/10.1001/jama.287.5.598			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829698				2022-12-28	WOS:000173686700028
J	Auluck, PK; Chan, HYE; Trojanowski, JQ; Lee, VMY; Bonini, NM				Auluck, PK; Chan, HYE; Trojanowski, JQ; Lee, VMY; Bonini, NM			Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease	SCIENCE			English	Article							LEWY BODIES; HSP70; EXPRESSION; NEURODEGENERATION; DEGENERATION; INCLUSIONS; DEMENTIA; MUTATION; NEURONS; HSP104	Parkinson's disease is a movement disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta. Dopaminergic neuronal loss also occurs in Drosophila melanogaster upon directed expression of alpha-synuclein, a protein implicated in the pathogenesis of Parkinson's disease and a major component of proteinaceous Lewy bodies. We report that directed expression of the molecular chaperone, Hsp70 prevented dopaminergic neuronal loss associated with alpha-synuclein in Drosophila and that interference with endogenous chaperone activity accelerated alpha-synuclein toxicity. Furthermore, Lewy bodies in human postmortem tissue immunostained for molecular chaperones, also suggesting that chaperones may play a role in Parkinson's disease progression.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.		Auluck, Pavan K/A-1160-2010; Chan, Edwin/A-9478-2011	Chan, Edwin/0000-0003-4307-474X				Baba M, 1998, AM J PATHOL, V152, P879; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3	21	996	1059	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					865	868		10.1126/science.1067389	http://dx.doi.org/10.1126/science.1067389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823645				2022-12-28	WOS:000173733000048
J	Dawson, CR; Schachter, J				Dawson, CR; Schachter, J			Should trachoma be treated with antibiotics?	LANCET			English	Editorial Material									Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, Chlamydia Res Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dawson, CR (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA.							Dawson C., 1990, CHLAMYDIAL INFECT, P271; DAWSON CR, 1981, GUIDE TRACHOMA CONTR, P1; Fraser-Hurt N, 2001, B WORLD HEALTH ORGAN, V79, P632; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; TIELSCH JM, 1988, AM J TROP MED HYG, V38, P393, DOI 10.4269/ajtmh.1988.38.393; TIELSCH JM, 1987, BRIT J OPHTHALMOL, V71, P371, DOI 10.1136/bjo.71.5.371	7	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					184	185		10.1016/S0140-6736(02)07463-9	http://dx.doi.org/10.1016/S0140-6736(02)07463-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812548				2022-12-28	WOS:000173350800004
J	Hack, M; Shah, D				Hack, M; Shah, D			Periventricular haemorrhage and tocolytic therapies	LANCET			English	Editorial Material							OUTCOMES; NETWORK		Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Hack, M (corresponding author), Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Pediat, Cleveland, OH 44106 USA.							Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HORBAR JD, 1995, SEMIN PERINATOL, V19, P124, DOI 10.1016/S0146-0005(05)80032-1; Hoyert DL, 2001, PEDIATRICS, V108, P1241, DOI 10.1542/peds.108.6.1241; KEIRSE MJN, 1989, EFFECTIVE CARE PREGN, V1; Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070; PHILIP AGS, 1995, J PEDIATR-US, V126, P427, DOI 10.1016/S0022-3476(95)70463-9; Stevenson DK, 1998, AM J OBSTET GYNECOL, V179, P1632, DOI 10.1016/S0002-9378(98)70037-7; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Weintraub Z, 2001, ARCH DIS CHILD-FETAL, V85, pF13, DOI 10.1136/fn.85.1.F13	10	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					185	186		10.1016/S0140-6736(02)07464-0	http://dx.doi.org/10.1016/S0140-6736(02)07464-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812549				2022-12-28	WOS:000173350800005
J	Gillespie, SH				Gillespie, SH			Microbes sans frontieres	LANCET			English	Editorial Material							GROUP-A; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCI; RESISTANCE; MITIS		UCL, Dept Med Microbiol, London NW3 2PF, England	University of London; University College London	Gillespie, SH (corresponding author), UCL, Dept Med Microbiol, Royal Free Campus, London NW3 2PF, England.	stepheng@rfc.ucl.ac.uk						Arpin C, 1999, J ANTIMICROB CHEMOTH, V44, P133, DOI 10.1093/jac/44.1.133; CLEARY PP, 1991, INFECT IMMUN, V59, P2305, DOI 10.1128/IAI.59.7.2305-2310.1991; Dowson Christopher G., 1994, Trends in Microbiology, V2, P361, DOI 10.1016/0966-842X(94)90612-2; Hardie J. M., 1997, V26, p1S; Hirst RA, 2000, INFECT IMMUN, V68, P1557, DOI 10.1128/IAI.68.3.1557-1562.2000; Kawamura Y, 1999, MICROBIOL-UK, V145, P2605, DOI 10.1099/00221287-145-9-2605; Kugi M, 1998, J INFECTION, V37, P308, DOI 10.1016/S0163-4453(98)92510-5; SKOGBERG K, 1988, SCAND J INFECT DIS, V20, P119, DOI 10.3109/00365548809032427; Sriprakash KS, 1997, ADV EXP MED BIOL, V418, P749; Vandamme P, 1996, INT J SYST BACTERIOL, V46, P774, DOI 10.1099/00207713-46-3-774; Wagner JG, 1996, CLIN INFECT DIS, V23, P1159, DOI 10.1093/clinids/23.5.1159; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; WHILEY RA, 1992, J CLIN MICROBIOL, V30, P243, DOI 10.1128/JCM.30.1.243-244.1992; Widdowson CA, 2000, ANTIMICROB AGENTS CH, V44, P393, DOI 10.1128/AAC.44.2.393-395.2000; Woo PCY, 2001, J CLIN MICROBIOL, V39, P3147, DOI 10.1128/JCM.39.9.3147-3155.2001	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2002	359	9301					93	95		10.1016/S0140-6736(02)07333-6	http://dx.doi.org/10.1016/S0140-6736(02)07333-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809246				2022-12-28	WOS:000173212400003
J	Fellay, J; Marzolini, C; Meaden, ER; Back, DJ; Buclin, T; Chave, JP; Decosterd, LA; Furrer, H; Opravil, M; Pantaleo, G; Retelska, D; Ruiz, L; Schinkel, AH; Vernazza, P; Eap, CB; Telenti, A				Fellay, J; Marzolini, C; Meaden, ER; Back, DJ; Buclin, T; Chave, JP; Decosterd, LA; Furrer, H; Opravil, M; Pantaleo, G; Retelska, D; Ruiz, L; Schinkel, AH; Vernazza, P; Eap, CB; Telenti, A		Swiss HIV Cohort Study	Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study	LANCET			English	Article							HIV PROTEASE INHIBITORS; PERFORMANCE LIQUID-CHROMATOGRAPHY; P-GLYCOPROTEIN; EXPRESSION; MICE; GENES; MDR1; NELFINAVIR; METABOLISM; THYMOCYTES	Background HIV-1-infected patients vary considerably by their response to antiretroviral treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several genes. Methods In 123 patients, we did PCR analyses of the gene for the multidrug-resistance transporter (MDR1), which codes for P-glycoprotein, of genes coding for isoenzymes of cytochrome P450, CYP3A4, CYP3A5, CYP2D6, and CYP2C19, and of the gene for the chemokine receptor CCR5. We measured concentrations in plasma of the antiretroviral agents efavirenz and nelfinavir by high-performance liquid-chromatography, and measured levels of P-glycoprotein expression, CD4-cell count, and HIV-1 viraemia. Findings Median drug concentrations in patients with the MDR1 3435 TT, CT, and CC genotypes were at the 30th, 50th, and 75th percentiles, respectively (p=0.0001). In patients with CYP2D6 extensive-metaboliser or poor-metaboliser alleles, median drug concentrations were at percentiles 45 and 62.5, respectively (p=0.04). Patients with the MDR1 TT genotype 6 months after starting treatment had a greater rise in CD4-cell count (257 cells/muL) than patients with the CT (165 cells/muL) and CC (121 cells/muL) genotype (p=0.0048), and the best recovery of naive CD4-cells. Interpretation The polymorphism MDR1 3435 C/T predicts immune recovery after initiation of antiretroviral treatment. This finding suggests that P-glycoprotein has an important role in admittance of antiretroviral drugs to restricted compartments in vivo.	Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland; Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland; Univ Lausanne Hosp, Div Immunol, Lausanne, Switzerland; Univ Lausanne Hosp, Unit Biochem & Clin Psychopharmacol, Lausanne, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Hosp La Source, Lausanne, Switzerland; Hosp St Gallen, St Gallen, Switzerland; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; Univ Hosp Germans Trias & Pujol, Retrovirol Lab, Barcelona, Spain; Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Liverpool; Netherlands Cancer Institute	Telenti, A (corresponding author), CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland.		Telenti, Amalio/AAY-1674-2021; VALLET, Yannick/F-9979-2011; Fellay, Jacques/A-6681-2009; Pantaleo, Giuseppe/K-6163-2016; Decosterd, Laurent/E-8494-2019; Buclin, Thierry/P-1640-2014; Furrer, Hansjakob/G-6768-2013; Marzolini, Catia/C-8253-2019	Fellay, Jacques/0000-0002-8240-939X; Decosterd, Laurent/0000-0002-9840-1325; Buclin, Thierry/0000-0003-0639-5536; Furrer, Hansjakob/0000-0002-1375-3146; Eap, Chin/0000-0002-5439-0230				Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005; Bardsley-Elliot A, 2000, DRUGS, V59, P581, DOI 10.2165/00003495-200059030-00014; Carrillo JA, 1998, THER DRUG MONIT, V20, P319, DOI 10.1097/00007691-199806000-00013; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Gutmann H, 1999, MOL PHARMACOL, V56, P383, DOI 10.1124/mol.56.2.383; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Huang LY, 2001, DRUG METAB DISPOS, V29, P754; Huisman MT, 2000, AIDS, V14, P237, DOI 10.1097/00002030-200002180-00005; Johansson I, 1996, PHARMACOGENETICS, V6, P351, DOI 10.1097/00008571-199608000-00008; Jones K, 2001, AIDS, V15, P675, DOI 10.1097/00002030-200104130-00002; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lavie Y, 2000, GLYCOCONJUGATE J, V17, P253, DOI 10.1023/A:1026553626537; Lee CGL, 2000, FASEB J, V14, P516, DOI 10.1096/fasebj.14.3.516; Li XL, 1999, ADV DRUG DELIVER REV, V39, P81, DOI 10.1016/S0169-409X(99)00021-6; MACDONALD HR, 1995, EUR J IMMUNOL, V25, P1457, DOI 10.1002/eji.1830250549; Marzolini C, 2000, J CHROMATOGR B, V740, P43, DOI 10.1016/S0378-4347(99)00573-3; PILARSKI LM, 1995, AM J HEMATOL, V49, P323, DOI 10.1002/ajh.2830490411; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schuetz EG, 2000, MOL PHARMACOL, V57, P188; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; Smit JW, 1998, BRIT J PHARMACOL, V124, P416, DOI 10.1038/sj.bjp.0701845; Srinivas RV, 1998, ANTIMICROB AGENTS CH, V42, P3157, DOI 10.1128/AAC.42.12.3157; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009	34	533	561	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					30	36		10.1016/S0140-6736(02)07276-8	http://dx.doi.org/10.1016/S0140-6736(02)07276-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809184				2022-12-28	WOS:000173143500013
J	Horsey, P				Horsey, P			Albumin and hypovolaemia: is the Cochrane evidence to be trusted?	LANCET			English	Editorial Material							PRESSURE; TRAUMA; TRIAL				Horsey, P (corresponding author), Old Manor, Stockbridge SO20 6RH, Berks, England.							Bell Ewan, 1999, Adverse Drug Reactions and Toxicological Reviews, V18, P149; CASH JD, 1981, HAEMOSTASIS THROMBOS, P475; Chalmers I, 1998, BRIT MED J, V317, P885; Drummond G, 1999, LANCET, V354, P1038, DOI 10.1016/S0140-6736(05)76653-8; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; GRUNDMANN R, 1982, INTENS CARE MED, V8, P179, DOI 10.1007/BF01725735; Horsey PJ, 1997, ANAESTHESIA, V52, P1027, DOI 10.1111/j.1365-2044.1997.266-az0392.x; LEDGERWOOD AM, 1974, ARCH SURG-CHICAGO, V108, P531; LOWE RJ, 1977, SURGERY, V81, P676; LUCAS CE, 1978, J TRAUMA, V18, P564, DOI 10.1097/00005373-197808000-00002; McClelland B, 1998, BRIT MED J, V317, P829, DOI 10.1136/bmj.317.7162.829; Offringa M, 1998, BMJ-BRIT MED J, V317, P223, DOI 10.1136/bmj.317.7153.223; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; So KW, 1997, ARCH DIS CHILD-FETAL, V76, pF43, DOI 10.1136/fn.76.1.F43; WOITTIEZ AJ, 1998, COCHRANE LIB; WOODS MS, 1993, AM SURGEON, V59, P758; ZETTERSTROM H, 1981, ACTA ANAESTH SCAND, V25, P133, DOI 10.1111/j.1399-6576.1981.tb01623.x	17	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					70	72		10.1016/S0140-6736(02)07285-9	http://dx.doi.org/10.1016/S0140-6736(02)07285-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809206				2022-12-28	WOS:000173143500035
J	Weinberg, PD; Hounshell, J; Sherman, LA; Godwin, J; Ali, S; Tomori, C; Bennett, CL				Weinberg, PD; Hounshell, J; Sherman, LA; Godwin, J; Ali, S; Tomori, C; Bennett, CL			Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s	ANNALS OF INTERNAL MEDICINE			English	Article							SAFETY; IMPACT	Ensuring the safety of the blood supply connects politics and science. The business and service sectors share responsibility for the collection and processing of blood donations, and government agencies perform regulatory and surveillance roles. The onset of the AIDS epidemic has challenged the interface among these systems, leading to widespread fears about compromised safety of the blood supply. Because of public concern about blood-supply decisions made in the 1980s, developed countries in the 1990s established reimbursement programs for persons with transfusion-acquired viral infections from blood or blood products, adopted diagnostic tests and procedures that improved the safety of the blood supply, and held criminal judicial investigations of government officials and industry leaders accused of delaying implementation of potential blood-safety measures. In contrast, developing countries continue to struggle with blood-supply safety issues. This paper summarizes the current status of these safety concerns in developed countries, where viral transmission from contaminated blood or blood products is extremely rare, and in developing countries, where up to 10% of HIV infections result from transfusion of blood or blood products.	Vet Affairs Chicago Healthcare Syst, Lakeside Div, Chicago, IL USA; Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; Northwestern Univ, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Mid W Ctr Hlth Serv & Policy Res, Maywood, IL 60153 USA; Loyola Univ, Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Loyola University Chicago; Loyola University Chicago	Bennett, CL (corresponding author), Vet Affairs Med Sci Bldg,400 E Ontario St,Suite 2, Chicago, IL 60611 USA.	cbenne@nwu.edu	Tomori, Cecilia/C-5147-2018; Bennett, Charles L/C-2050-2008	Tomori, Cecilia/0000-0003-4235-1821; 				ABBOTT A, 1995, NATURE, V376, P628; ABBOTT A, 1993, NATURE, V366, P98; ABBOTT A, 1993, NATURE, V365, P594, DOI 10.1038/365594b0; ALTER HJ, 1972, ANN INTERN MED, V77, P691, DOI 10.7326/0003-4819-77-5-691; AuBuchon JP, 1997, ANN INTERN MED, V127, P904, DOI 10.7326/0003-4819-127-10-199711150-00009; Barker S, 1996, NATURE, V379, P663, DOI 10.1038/379663a0; Bayer R, 1999, BLOOD FEUDS, P1; BERNTORP E, 1994, THROMB HAEMOSTASIS, V71, P678; BLAKESLEE S, 2000, NY TIMES        0725, P1; BRUNO S, 1998, LANCET, V352, P1916; BUTLER D, 1993, NATURE, V364, P269; BUTLER D, 1995, NATURE, V375, P526, DOI 10.1038/375526a0; BUTLER D, 1994, NATURE, V371, P548; BUTLER D, 1994, NATURE, V370, P404, DOI 10.1038/370404b0; BUTLER D, 1994, NATURE, V370, P319, DOI 10.1038/370319a0; BUTLER D, 1992, NATURE, V359, P764, DOI 10.1038/359764a0; BUTLER D, 1994, NATURE, V367, P304; *CDCP, 1981, MORB MORT WEEKL 0605, P5; *CDCP, 1982, MORB MORT WEEKL 0716; DUNN K, 1993, CAN MED ASSOC J, V148, P609; EFRON S, 2000, LOS ANGELES TIM 0225, pA1; ESMONDE TFG, 1993, LANCET, V341, P205, DOI 10.1016/0140-6736(93)90068-R; HUTCHCRAFT C, 1996, CHICAGO TRIBUNE 0531, P1; JAYARAMAN KS, 1995, NATURE, V376, P285, DOI 10.1038/376285b0; Kapoor D, 2000, Indian J Gastroenterol, V19, P64; KING M, 2000, GAZETTE MONTREA 0312, pA5; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Kondro W, 1997, LANCET, V350, P1688, DOI 10.1016/S0140-6736(05)64294-8; Kondro W, 1996, LANCET, V348, P52, DOI 10.1016/S0140-6736(05)64368-1; KREVER H, 1995, COMMISSION INQUIRY B; LACKRITZ EM, 1993, AIDS, V7, P995, DOI 10.1097/00002030-199307000-00014; Leveton Lauren B., 1995, HIV BLOOD SUPPLY ANA, P49; McGregor A, 1998, LANCET, V352, P1916, DOI 10.1016/S0140-6736(05)60413-8; Murray T, 1998, NAT MED, V4, P10, DOI 10.1038/nm0198-010a; *NAT BLOOD DON RES, 1999, REP BLOOD DON TRANSF; Pomfret J., 2001, WASHINGTON POST 0109, pA1; *REUT HLTH INF SER, 1996, HIV AIDS NEWSL  1028; *REUT HLTH INF SER, 1996, HIV AIDS NEWSLI 0924; ROSENDAAL FR, 1991, ANN HEMATOL, V62, P5, DOI 10.1007/BF01714977; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Sherman LA, 2000, TRANSFUSION, V40, P1268, DOI 10.1046/j.1537-2995.2000.40101268.x; Simons M, 1994, NY TIMES, pA1; STARR DP, 1998, EPIC HIST MED COMMER, P304; STARR DP, 1998, EPIC HIST MED COMMER, P303; STARR DP, 1998, BLOOD EPIC HIST MED, P283; STARR DP, 1998, BLOOD EPIC HIST MED, P320; STARR DP, 1998, EPIC HIST MED COMMER, P327; Swinbanks D, 1996, NATURE, V383, P291, DOI 10.1038/383291a0; TASTEMAIN C, 1995, NATURE, V375, P349, DOI 10.1038/375349a0; Tomlinson R, 1997, BRIT MED J, V314, P93; Trebilcock M, 1996, VA LAW REV, V82, P1407, DOI 10.2307/1073680; Warden J, 1998, BRIT MED J, V317, P1548, DOI 10.1136/bmj.317.7172.1548b; WHITNEY CR, 1998, NY TIMES        0718, pA4; WHITNEY CR, 1999, NY TIMES        0611, pA1; *WHO, 2000, SAF BLOOD STARTS ME; *WORLD BANK GROUP, 2001, IND NAT AIDS CONTR P; Zuck TF, 1996, TRANSFUSION, V36, P928, DOI 10.1046/j.1537-2995.1996.361097017181.x; 1997, WASHINGTON TIME 0729, pA12; 2001, SUMMARY RATIONALE DR; 1997, MACLEANS        1020, P110; R RAY HEMOPHILIA REL; 1996, NATURE, V383, P9; 1997, NATURE, V387, P840; 2001, GUILTY VERDIC UPHELD; 1997, IPS WIRE        098; 1997, REUTERS         1017; 1997, UNITED PRESS IN 0730	67	51	56	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					312	319		10.7326/0003-4819-136-4-200202190-00011	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523FQ	11848729				2022-12-28	WOS:000173943700008
J	Newhall, CG; Power, JA; Punongbayan, RS				Newhall, CG; Power, JA; Punongbayan, RS			Pinatubo eruption - "To make grow"	SCIENCE			English	Editorial Material							MOUNT-PINATUBO		Univ Washington, US Geol Survey, Seattle, WA 98195 USA; USGS, Alaska Volcano Observ, Anchorage, AK 99508 USA; Philippine Inst Volcanol & Seismol, Quezon City 1101, Philippines	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey	Newhall, CG (corresponding author), Univ Washington, US Geol Survey, Seattle, WA 98195 USA.		Newhall, Christopher/AAD-1028-2020					*AM GEOPH UN FALL, 2001, AM GEOPH UN FALL M S; Bak P., 1996, NATURE WORKS; Bautista BC, 1996, FIRE AND MUD, P351; BLUTH GJS, 1992, GEOPHYS RES LETT, V19, P151, DOI 10.1029/91GL02792; Buchanan M, 2000, UBIQUITY; Gerlach TM, 1996, FIRE AND MUD, P415; Harlow DH, 1996, FIRE AND MUD, P285; HAYES SK, IN PRESS GEOMORPHOLO; Hoblitt RP, 1996, FIRE AND MUD, P457; Janda RJ, 1996, FIRE AND MUD, P107; LUHR JF, 1984, J VOLCANOL GEOTH RES, V23, P69, DOI 10.1016/0377-0273(84)90057-X; Montgomery DR, 1999, GEOLOGY, V27, P271, DOI 10.1130/0091-7613(1999)027<0271:CBMRTE>2.3.CO;2; Newhall CG, 1996, FIRE MUD ERUPTIONS L; Pallister JS, 1996, FIRE AND MUD, P687; Polacci M, 2001, B VOLCANOL, V63, P83, DOI 10.1007/s004450000123; PUNONGBAYAN RS, 1996, MUD FIRE ERUPTIONS L, P21; Rosi M, 2001, B VOLCANOL, V62, P549; Rutherford MJ, 1996, FIRE AND MUD, P751; Scott WE, 1996, FIRE AND MUD, P545; Simkin T., 1994, VOLCANOES WORLD; TORRES RFC, 2001, THESIS U HAWAII; Umbal J.V., 1997, J GEOLOGICAL SOC PHI, V52, P1; Wallace PJ, 2001, J VOLCANOL GEOTH RES, V108, P85, DOI 10.1016/S0377-0273(00)00279-1; White RA, 1996, FIRE AND MUD, P307	24	7	7	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1241	1242		10.1126/science.1069838	http://dx.doi.org/10.1126/science.1069838			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847325				2022-12-28	WOS:000173926000025
J	Barry, L; Craig, GC; Thuburn, J				Barry, L; Craig, GC; Thuburn, J			Poleward heat transport by the atmospheric heat engine	NATURE			English	Article							BAROCLINIC INSTABILITY; GENERAL-CIRCULATION; EDDY FLUXES; BETA-PLANE; MODEL; TURBULENCE; SCALE	The atmospheric heat transport on Earth from the Equator to the poles is largely carried out by the mid-latitude storms. However, there is no satisfactory theory to describe this fundamental feature of the Earth's climate(1,2). Previous studies have characterized the poleward heat transport as a diffusion by eddies of specified horizontal length and velocity scales, but there is little agreement as to what those scales should be(3-7). Here we propose instead to regard the baroclinic zone-the zone of strong temperature gradients and active eddies-as a heat engine which generates eddy kinetic energy by transporting heat from a warmer to a colder region. This view leads to a new velocity scale, which we have tested along with previously proposed length and velocity scales, using numerical climate simulations in which the eddy properties have been varied by changing forcing and boundary conditions. The experiments show that the eddy velocity varies in accordance with the new scale, while the size of the eddies varies with the well-known Rhines beta-scale. Our results not only give new insight into atmospheric eddy heat transport, but also allow simple estimates of the intensities of mid-latitude storms, which have hitherto only been possible with expensive general circulation models.	Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England	University of Reading	Craig, GC (corresponding author), Univ Reading, Dept Meteorol, Earley Gate, Reading RG6 6BB, Berks, England.		Thuburn, John/ABC-8834-2021; Craig, George C/D-2577-2015	Craig, George C/0000-0002-7431-8164				BARRY L, UNPUB Q J R METEOROL; BARRY L, 2000, PREDICTING EDDY HEAT; Boer GJ, 1997, CLIM DYNAM, V13, P359, DOI 10.1007/s003820050171; BRANSCOME LE, 1983, J ATMOS SCI, V40, P2508, DOI 10.1175/1520-0469(1983)040<2508:APOTEH>2.0.CO;2; CHARNEY JG, 1971, J ATMOS SCI, V28, P1087, DOI 10.1175/1520-0469(1971)028<1087:GT>2.0.CO;2; CHARNEY JG, 1947, J METEOROL, V4, P135; EADY ET, 1949, TELLUS, V1, P33; Forster PM, 2000, CLIM DYNAM, V16, P833, DOI 10.1007/s003820000083; GOLITSYN GS, 1970, ICARUS, V13, P1, DOI 10.1016/0019-1035(70)90112-0; GREEN JSA, 1970, Q J ROY METEOR SOC, V96, P157, DOI 10.1002/qj.49709640802; Haine TWN, 1998, J PHYS OCEANOGR, V28, P634, DOI 10.1175/1520-0485(1998)028<0634:GSABIO>2.0.CO;2; Held IM, 1999, TELLUS A, V51, P59, DOI 10.1034/j.1600-0870.1999.t01-1-00006.x; Held IM, 1996, J ATMOS SCI, V53, P946, DOI 10.1175/1520-0469(1996)053<0946:ASTFHH>2.0.CO;2; HELD IM, 1978, J ATMOS SCI, V35, P572, DOI 10.1175/1520-0469(1978)035<0572:TVSOAU>2.0.CO;2; JAMES IN, 1994, INTRO CIRCULATING AT; JAMES IN, 1997, Q J R METEOROL SOC, V123, P1; LARICHEV VD, 1995, J PHYS OCEANOGR, V25, P2285, DOI 10.1175/1520-0485(1995)025<2285:EAAFIA>2.0.CO;2; PANETTA RL, 1993, J ATMOS SCI, V50, P2073, DOI 10.1175/1520-0469(1993)050<2073:ZJIWBU>2.0.CO;2; Pavan V, 1996, J ATMOS SCI, V53, P1262, DOI 10.1175/1520-0469(1996)053<1262:TDAFEF>2.0.CO;2; PIERREHUMBERT RT, 1995, ANNU REV FLUID MECH, V27, P419, DOI 10.1146/annurev.fl.27.010195.002223; RHINES PB, 1975, J FLUID MECH, V69, P417, DOI 10.1017/S0022112075001504; SALMON R, 1998, LECT GEOPHYSICAL FLU; STONE PH, 1992, J ATMOS SCI, V49, P355, DOI 10.1175/1520-0469(1992)049<0355:DFNIER>2.0.CO;2; STONE PH, 1980, J ATMOS SCI, V37, P1708, DOI 10.1175/1520-0469(1980)037<1708:ERBSCI>2.0.CO;2; STONE PH, 1972, J ATMOS SCI, V29, P405, DOI 10.1175/1520-0469(1972)029<0405:ASRDMF>2.0.CO;2; STONE PH, 1990, J CLIMATE, V3, P726, DOI 10.1175/1520-0442(1990)003<0726:DOATDZ>2.0.CO;2; VALLIS GK, 1988, Q J ROY METEOR SOC, V114, P183, DOI 10.1002/qj.49711447910; Visbeck M, 1997, J PHYS OCEANOGR, V27, P381, DOI 10.1175/1520-0485(1997)027<0381:SOETCI>2.0.CO;2	28	46	47	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					774	777		10.1038/415774a	http://dx.doi.org/10.1038/415774a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845204				2022-12-28	WOS:000173833900041
J	He, GS; Markowicz, PP; Lin, TC; Prasad, PN				He, GS; Markowicz, PP; Lin, TC; Prasad, PN			Observation of stimulated emission by direct three-photon excitation	NATURE			English	Article							OPTICAL-DATA STORAGE; 2-PHOTON ABSORPTION; 2-PHOTON-ABSORBING CHROMOPHORES; FLUORESCENCE; DESIGN; PHOTON; DYES	Multiphoton processes, predicted(1) theoretically in 1931, were for a long time considered to be mainly of academic interest. This view changed when it was shown(2,3) that a two-photon absorption process could, because of a quadratic dependence of excitation on intensity, produce a spatially confined excitation useful for three-dimensional data storage and imaging. Two-photon absorption has received considerable attention recently because of the development of highly efficient two-photon-sensitive materials, leading to numerous technological applications(4-28). These successes have created interest in exploring applications based on three-photon excitations(29). For a three-photon process, a longer excitation wavelength such as those common in optical communications can be used. Also, the cubic dependence of the three-photon process on the input light intensity provides a stronger spatial confinement, so that a higher contrast in imaging can be obtained. Here we report the observation of a highly directional and up-converted stimulated emission as an amplified spontaneous emission, produced in an organic chromophore solution by a strong simultaneous three-photon absorption at 1.3 mum. This achievement suggests opportunities for a three-photon process in frequency-upconversion lasing, short-pulse optical communications, and the emerging field of biophotonics.	SUNY Buffalo, Inst Laser Photon & Biophoton, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Prasad, PN (corresponding author), SUNY Buffalo, Inst Laser Photon & Biophoton, Buffalo, NY 14260 USA.	pnprasad@acsu.buffalo.edu	Prasad, Paras N/U-2269-2019					Adronov A, 2000, CHEM MATER, V12, P2838, DOI 10.1021/cm000586o; Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; Belfield KD, 2000, J ORG CHEM, V65, P4475, DOI 10.1021/jo991950+; Bhawalkar J D, 1997, J Clin Laser Med Surg, V15, P201; Bhawalkar JD, 1997, POLYMER, V38, P4551, DOI 10.1016/S0032-3861(97)00125-0; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dvornikov AS, 1997, OPT COMMUN, V136, P1, DOI 10.1016/S0030-4018(96)00645-1; Ehrlich JE, 1997, OPT LETT, V22, P1843, DOI 10.1364/OL.22.001843; GOPPERTMEYER M, 1931, ANN PHYS, V9, P275; Gura T, 1997, SCIENCE, V276, P1988, DOI 10.1126/science.276.5321.1988; HE GS, 1995, OPT LETT, V20, P1524, DOI 10.1364/OL.20.001524; He GS, 1997, J APPL PHYS, V81, P2529, DOI 10.1063/1.364303; He GS, 1998, IEEE J QUANTUM ELECT, V34, P7, DOI 10.1109/3.655001; He GS, 1998, IEEE J QUANTUM ELECT, V34, P2279, DOI 10.1109/3.736090; He GS, 1997, J OPT SOC AM B, V14, P1079, DOI 10.1364/JOSAB.14.001079; HE GS, 1995, OPT LETT, V20, P435, DOI 10.1364/OL.20.000435; HE GS, 1995, OPT LETT, V20, P2393, DOI 10.1364/OL.20.002393; Joshi MP, 1999, APPL PHYS LETT, V74, P170, DOI 10.1063/1.123283; Kannan R, 2001, CHEM MATER, V13, P1896, DOI 10.1021/cm000747o; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Kim OK, 2000, CHEM MATER, V12, P284, DOI 10.1021/cm990662r; PARTHENOPOULOS DA, 1990, J APPL PHYS, V68, P5814, DOI 10.1063/1.346953; PARTHENOPOULOS DA, 1989, SCIENCE, V245, P843, DOI 10.1126/science.245.4920.843; Pudavar HE, 1999, APPL PHYS LETT, V74, P1338, DOI 10.1063/1.123543; Reinhardt BA, 1998, CHEM MATER, V10, P1863, DOI 10.1021/cm980036e; STRICKLER JH, 1991, OPT LETT, V16, P1780, DOI 10.1364/OL.16.001780; Wang XP, 1999, P NATL ACAD SCI USA, V96, P11081, DOI 10.1073/pnas.96.20.11081; ZHAO CF, 1995, CHEM MATER, V7, P1979, DOI 10.1021/cm00058a032	29	365	377	7	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					767	770		10.1038/415767a	http://dx.doi.org/10.1038/415767a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845202				2022-12-28	WOS:000173833900039
J	Loscalzo, J				Loscalzo, J			Perspective: Homocysteine and dementias.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Med Ctr, Boston, MA 02118 USA	Boston University	Loscalzo, J (corresponding author), Boston Univ, Med Ctr, Boston, MA 02118 USA.		Loscalzo, Joseph/ABD-8980-2021						0	46	49	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					466	468		10.1056/NEJM200202143460702	http://dx.doi.org/10.1056/NEJM200202143460702			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844846				2022-12-28	WOS:000173815300001
J	Craelius, W				Craelius, W			The bionic man: Restoring mobility	SCIENCE			English	Editorial Material							COMPUTER; SYSTEM		Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Craelius, W (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	craelius@rci.rutgers.edu						Abboudi R L, 1999, IEEE Trans Rehabil Eng, V7, P121, DOI 10.1109/86.769401; Benabid AL, 2000, ARCH MED RES, V31, P282, DOI 10.1016/S0188-4409(00)00077-1; Branemark R, 2001, J REHABIL RES DEV, V38, P175; Curcie DJ, 2001, IEEE T NEUR SYS REH, V9, P69, DOI 10.1109/7333.918278; Goto K, 2001, IEEE T BIO-MED ENG, V48, P830, DOI 10.1109/10.930908; HUDGINS B, 1993, IEEE T BIO-MED ENG, V40, P82, DOI 10.1109/10.204774; Jarvik R, 1999, ARTIF ORGANS, V23, P487; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; KUIKEN TA, 1995, BRAIN RES, V676, P113, DOI 10.1016/0006-8993(95)00102-V; Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X; LOVCHIC C, 2001, Patent No. 6244644; MALONEY LD, 2000, DESIGN NEWS, V90; MICHAEL J, 1999, CLIN ORTHOP RELAT R, V361, P43; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; PHILLIPS SL, 2000, 6 WORLD BIOM C HAW 1; PHILLIPS SL, IN PRESS ROBOTICA; Rabischong P, 1999, B ACAD NAT MED PARIS, V183, P531; RAMACHANDRAN VS, 1993, P NATL ACAD SCI USA, V90, P10413, DOI 10.1073/pnas.90.22.10413; Rosengren J, 1998, IEEE SPECTRUM, V35, P62, DOI 10.1109/6.645982; Smith B, 1998, IEEE T BIO-MED ENG, V45, P463, DOI 10.1109/10.664202; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807	22	87	92	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1018	+		10.1126/science.295.5557.1018	http://dx.doi.org/10.1126/science.295.5557.1018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834819				2022-12-28	WOS:000173793000047
J	Piran, T				Piran, T			Demotion looms for gamma-ray bursts	SCIENCE			English	Editorial Material							GRB 990510; ENERGY; AFTERGLOW; PARAMETERS		Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Piran, T (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	tsvi@phys.huji.ac.il						Ayal S, 2001, ASTROPHYS J, V555, P23, DOI 10.1086/321431; Bloom JS, 2001, ASTRON J, V121, P2879, DOI 10.1086/321093; CONNAUGHTON V, IN PRESS ASTROPHYS J; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Harrison FA, 1999, ASTROPHYS J, V523, pL121, DOI 10.1086/312282; Heise J, 2001, ESO ASTROPHY SYMP, P16, DOI 10.1007/10853853_4; Kumar P, 2000, ASTROPHYS J, V538, pL125, DOI 10.1086/312821; Meszaros P, 2001, SCIENCE, V291, P79, DOI 10.1126/science.291.5501.79; Panaitescu A, 2001, ASTROPHYS J, V560, pL49, DOI 10.1086/324061; Piran T, 2001, ASTROPHYS J, V560, pL167, DOI 10.1086/324409; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; PIRAN T, IN PRESS P VAN PAR M; RICKER G, 2001, GAMM RAY BURST AFT A; Stanek KZ, 1999, ASTROPHYS J, V522, pL39, DOI 10.1086/312219; VANDENBERK DE, UNPUB	16	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					986	987		10.1126/science.1068157	http://dx.doi.org/10.1126/science.1068157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834807				2022-12-28	WOS:000173793000035
J	Bond, AB; Kamil, AC				Bond, AB; Kamil, AC			Visual predators select for crypticity and polymorphism in virtual prey	NATURE			English	Article							SEARCH IMAGE; BLUE JAYS; REFLEXIVE SELECTION; APOSTATIC SELECTION; CYANOCITTA-CRISTATA; NATURAL-SELECTION; HYPOTHESIS; ATTENTION; PATTERNS; STIMULI	Cryptically coloured animals commonly occur in several distinct pattern variants. Such phenotypic diversity may be promoted by frequency-dependent predation, in which more abundant variants are attacked disproportionately often, but the hypothesis has never been explicitly tested. Here we report the first controlled experiment on the effects of visual predators on prey crypticity and phenotypic variance, in which blue jays (Cyanocitta cristata) searched for digital moths on computer monitors. Moth phenotypes evolved via a genetic algorithm in which individuals detected by the jays were much less likely to reproduce. Jays often failed to detect atypical cryptic moths, confirming frequency-dependent selection and suggesting the use of searching images, which enhance the detection of common prey. Over successive generations, the moths evolved to become significantly harder to detect, and they showed significantly greater phenotypic variance than non-selected or frequency-independent selected controls.	Univ Nebraska, Sch Biol Sci, Nebraska Behav Biol Grp, Lincoln, NE 68588 USA; Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Bond, AB (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Behav Biol Grp, Lincoln, NE 68588 USA.							ALLEN JA, 1988, PHILOS T R SOC B, V319, P485, DOI 10.1098/rstb.1988.0061; ALLEN JA, 1988, OIKOS, V51, P251, DOI 10.2307/3565651; Back T., 1996, EVOLUTIONARY ALGORIT; Barnes W., 1918, Mem Amer mus NH New York, V3; Bond AB, 1998, NATURE, V395, P594, DOI 10.1038/26961; BOND AB, 1983, J EXP PSYCHOL ANIM B, V9, P292, DOI 10.1037/0097-7403.9.3.292; BOND AB, 1991, ETHOLOGY, V87, P203; Bond AB, 1999, ANIM LEARN BEHAV, V27, P461, DOI 10.3758/BF03209981; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Clark B, 1962, TAXONOMY GEOGRAPHY, P47; COMMON IFB, 1954, AUST J ZOOL, V2, P223, DOI 10.1071/ZO9540223; Cott H. B, 1957, ADAPTIVE COLORATION; DARLINGTON CD, 1950, ELEMENTS GENETICS; Dearn J.M., 1990, P517; Edmunds M., 1990, P3; Endler J.A., 1991, P169; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; Fleishman LJ, 1998, ANIM BEHAV, V56, P1035, DOI 10.1006/anbe.1998.0894; FORD EB, 1961, INSECT POLYMORPHISM, V1, P11; GUILDORD T, 1987, ANIM BEHAV, V35, P1838, DOI 10.1016/S0003-3472(87)80076-3; HALKKA O, 1990, EVOL BIOL, V24, P149; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kono H, 1998, ANIM BEHAV, V56, P963, DOI 10.1006/anbe.1998.0847; Langley CM, 1996, J EXP PSYCHOL ANIM B, V22, P152, DOI 10.1037/0097-7403.22.2.152; MOMENT GB, 1962, SCIENCE, V136, P262, DOI 10.1126/science.136.3512.262; Nabours RK, 1933, GENETICS, V18, P0159; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; OWEN DF, 1986, OIKOS, V47, P117, DOI 10.2307/3565927; PIETREWICZ AT, 1977, SCIENCE, V195, P580, DOI 10.1126/science.195.4278.580; PIETREWICZ AT, 1979, SCIENCE, V204, P1332, DOI 10.1126/science.204.4399.1332; PLAISTED KC, 1995, ANIM BEHAV, V50, P1219, DOI 10.1016/0003-3472(95)80039-5; Poulton E.B., 1890, COLOUR ANIMALS; PRUESS KP, 1967, ANN ENTOMOL SOC AM, V60, P910, DOI 10.1093/aesa/60.5.910; Rand AS, 1967, ATAS S SOBRE BIOTA A, V5, P73; REID PJ, 1992, J EXP PSYCHOL ANIM B, V18, P273, DOI 10.1037/0097-7403.18.3.273; RICKLEFS RE, 1975, EVOLUTION, V29, P313, DOI 10.1111/j.1558-5646.1975.tb00211.x; Robinson M. H., 1969, EVOL BIOL, VIII, P225; ROBINSON R, 1971, LEPIDOPTERAN GENETIC; SARGENT T.D., 1976, LEGION NIGHT UNDERWI; SARGENT TD, 1978, EVOLUTION, V32, P424, DOI 10.1111/j.1558-5646.1978.tb00657.x; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; WALLACE AR, 1891, DARWINISM EXPOSITION; Whiteley DAA, 1997, BIOL J LINN SOC, V62, P475, DOI 10.1006/bijl.1997.0168	47	212	221	7	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					609	613		10.1038/415609a	http://dx.doi.org/10.1038/415609a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	519DC	11832937	Green Published			2022-12-28	WOS:000173709100037
J	Clutton-Brock, TH; Coulson, TN; Milner-Gulland, EJ; Thomson, D; Armstrong, HM				Clutton-Brock, TH; Coulson, TN; Milner-Gulland, EJ; Thomson, D; Armstrong, HM			Sex differences in emigration and mortality affect optimal management of deer populations	NATURE			English	Article							DENSITY-RELATED CHANGES; FEMALE RED DEER; CERVUS-ELAPHUS; HABITAT SEGREGATION; RATIO; HIGHLANDS; SHEEP	Populations of red deer that are limited by food, like those of many other ungulates(1-3), commonly include more females than males(4-7). We assessed the contribution of variation in sex- and age-specific rates of mortality and emigration to density-dependent changes in the adult sex ratio, using long-term observations and demographic experiments involving the red deer population on Rum, Scotland(4,5). We incorporated these effects in a stochastic model of local populations under different management regimes to show here that, when female numbers are allowed to increase to more than 60% of the ecological carrying capacity, the sustainable annual harvest of males from local deer populations will fall. Because males are typically culled by fee-paying hunters and generate more income than females(5,8,9), income will decrease as the male harvest falls. Because numbers of female deer throughout much of the Highlands probably exceed the threshold at which male density starts to be affected(5), many managers might be able to raise income from local deer populations by reducing female numbers, with potential benefits to the vegetation of Scottish Highland environments(10).	Univ Cambridge, Dept Zool, Large Anim Res Grp, Cambridge CB2 3EJ, England; Univ London Imperial Coll Sci Technol & Med, Royal Sch Mines, TH Huxley Sch Environm Earth Sci & Engn, London SW7 2BP, England; Scottish Nat Heritage, Edinburgh EH6 5NP, Midlothian, Scotland	University of Cambridge; Imperial College London	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Large Anim Res Grp, Downing St, Cambridge CB2 3EJ, England.		Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003				Buckland ST, 1996, J APPL ECOL, V33, P118, DOI 10.2307/2405021; CHARLES WN, 1977, J APPL ECOL, V14, P55, DOI 10.2307/2401826; CLUTTONBROCK TH, 1987, J ZOOL, V211, P275, DOI 10.1111/j.1469-7998.1987.tb01534.x; CLUTTONBROCK TH, 1985, J ANIM ECOL, V54, P831, DOI 10.2307/4381; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; CLUTTONBROCK TH, 1994, J APPL ECOL, V31, P521, DOI 10.2307/2404447; CLUTTONBROCK TH, 1991, J ANIM ECOL, V60, P593, DOI 10.2307/5300; CLUTTONBROCK TH, 1992, NATURE, V358, P11; CluttonBrock TH, 1997, P ROY SOC B-BIOL SCI, V264, P1509, DOI 10.1098/rspb.1997.0209; Conradt L, 2000, ANIM BEHAV, V59, P1049, DOI 10.1006/anbe.2000.1409; Conradt L, 1999, OECOLOGIA, V119, P367, DOI 10.1007/s004420050797; KLEIN DR, 1968, J WILDLIFE MANAGE, V32, P350, DOI 10.2307/3798981; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Langvatn R, 1999, WILDLIFE BIOL, V5, P213; LOWE VPW, 1969, J ANIM ECOL, V38, P425, DOI 10.2307/2782; Lubow BC, 1996, J WILDLIFE MANAGE, V60, P787, DOI 10.2307/3802378; McCullough D. R., 1990, WILDLIFE MONOGR, V112, P1; McCullough DR, 2001, WILDLIFE BIOL, V7, P161, DOI 10.2981/wlb.2001.020; OSBORNE BC, 1984, J APPL ECOL, V21, P497, DOI 10.2307/2403424; [No title captured]; [No title captured]; [No title captured]; [No title captured]	23	121	133	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					633	637		10.1038/415633a	http://dx.doi.org/10.1038/415633a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832944				2022-12-28	WOS:000173709100044
J	Barsky, AJ; Saintfort, R; Rogers, MP; Borus, JF				Barsky, AJ; Saintfort, R; Rogers, MP; Borus, JF			Nonspecific medication side effects and the nocebo phenomenon	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG-REACTIONS; PLACEBO-RESPONSES; ANTICIPATORY NAUSEA; AIRWAY REACTIVITY; CHEMOTHERAPY; SPECIFICITY; PREVALENCE; SUGGESTION; PENICILLIN; INDUCTION	Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.	Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Barsky, AJ (corresponding author), Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA.							ADER R, 2001, CONDITIONING IMMUNIT; ANDRYKOWSKI MA, 1988, CANCER, V62, P2607, DOI 10.1002/1097-0142(19881215)62:12<2607::AID-CNCR2820621226>3.0.CO;2-S; ANDRYKOWSKI MA, 1987, J CONSULT CLIN PSYCH, V55, P36, DOI 10.1037/0022-006X.55.1.36; [Anonymous], 1991, Arch Intern Med, V151, P1413; BAKER DB, 1988, ARCH ENVIRON HEALTH, V43, P325; Balant LP, 2000, INT J CLIN PHARM TH, V38, P47; Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; BARSKY AJ, 1983, ARCH INTERN MED, V143, P1544, DOI 10.1001/archinte.143.8.1544; Barsky AJ, 1999, PSYCHOSOMATICS, V40, P396, DOI 10.1016/S0033-3182(99)71204-1; Benedetti F, 1997, PAIN, V71, P135, DOI 10.1016/S0304-3959(97)03346-0; Berthelot JM, 2001, JOINT BONE SPINE, V68, P65, DOI 10.1016/S1297-319X(00)00225-6; BLACKWELL B, 1972, LANCET, V1, P1279; BUCKALEW LW, 1982, J CLIN PSYCHOPHARM, V2, P245; Casper RC, 2001, BIOL PSYCHIAT, V49, P158, DOI 10.1016/S0006-3223(00)00966-5; CLARK PI, 1994, ANNU REV PUBL HEALTH, V15, P19; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; CUTLER NR, 1991, DICP ANN PHARMAC, V25, P471, DOI 10.1177/106002809102500506; DAVIS C, 1995, J CLIN PSYCHOPHARM, V15, P347, DOI 10.1097/00004714-199510000-00007; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; DEKKER E, 1956, J PSYCHOSOM RES, V1, P58, DOI 10.1016/0022-3999(56)90035-6; DHUME VG, 1975, CLINICIAN, V39, P289; Dormann H, 2000, DRUG SAFETY, V22, P161, DOI 10.2165/00002018-200022020-00007; DRICI MD, 1995, BRIT J CLIN PHARMACO, V39, P204, DOI 10.1111/j.1365-2125.1995.tb04434.x; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P282; Eland IA, 1999, BRIT J CLIN PHARMACO, V48, P623; FERGUSON JM, 1993, PSYCHIAT ANN, P20; Flaten MA, 1997, HUM PSYCHOPHARM CLIN, V12, P369, DOI 10.1002/(SICI)1099-1077(199707/08)12:4<369::AID-HUP881>3.3.CO;2-4; Flaten MA, 1999, PSYCHOSOM MED, V61, P250, DOI 10.1097/00006842-199903000-00018; GRAFFLONNEVIG V, 1988, ARCH DIS CHILD, V63, P1342, DOI 10.1136/adc.63.11.1342; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Harrington Anne, 1997, PLACEBO EFFECT INTER; HERNANSANZ MD, 1994, ATEN PRIM, V14, P783; Herzhaft G, 1969, Encephale, V58, P486; JEWETT DL, 1990, NEW ENGL J MED, V323, P429, DOI 10.1056/NEJM199008163230701; JOHNSON JA, 1995, ARCH INTERN MED, V155, P1949, DOI 10.1001/archinte.155.18.1949; JOYCE CRB, 1959, BRIT J PHARM CHEMOTH, V14, P512, DOI 10.1111/j.1476-5381.1959.tb00958.x; KAST EC, 1961, ILLINOIS MED J, V119, P390; KATON W, 1992, MED CARE, V30, P67, DOI 10.1097/00005650-199201000-00007; KENNEDY W P, 1961, Med World, V95, P203; Khosla P. P, 1992, Indian Journal of Physiology and Pharmacology, V36, P259; KIRK CR, 1988, BRIT MED J, V296, P1236, DOI 10.1136/bmj.296.6631.1236; KISSEL P, 1974, PLACEBOS EFFECT PLAC; LEESHALEY PR, 1992, PERCEPT MOTOR SKILL, V75, P531, DOI 10.2466/PMS.75.5.531-544; LONG DM, 1989, STEREOT FUNCT NEUROS, V53, P149, DOI 10.1159/000099531; LUPARELLO T, 1968, PSYCHOSOM MED, V30, P819, DOI 10.1097/00006842-196811000-00002; LUPARELLO TJ, 1970, PSYCHOSOM MED, V32, P509, DOI 10.1097/00006842-197009000-00009; MCFADDEN ER, 1969, PSYCHOSOM MED, V31, P134, DOI 10.1097/00006842-196903000-00007; MCNAIR DM, 1970, ARCH GEN PSYCHIAT, V22, P128; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; MORROW GR, 1988, CLIN PSYCHOL REV, V8, P517, DOI 10.1016/0272-7358(88)90077-3; MORSELLI PL, 1970, NATURE, V227, P611, DOI 10.1038/227611a0; MYERS MG, 1987, CLIN PHARMACOL THER, V42, P250, DOI 10.1038/clpt.1987.142; OSWALD NTA, 1983, BRIT MED J, V287, P265, DOI 10.1136/bmj.287.6387.265; PENNEBAKER JW, 1982, PSYCHOL PHYSICAL SYM; POGGE R C, 1963, Med Times, V91, P773; Preston RA, 2000, ARCH INTERN MED, V160, P1449, DOI 10.1001/archinte.160.10.1449; REIDENBERG MM, 1968, NEW ENGL J MED, V279, P678, DOI 10.1056/NEJM196809262791304; ROBERTS AH, 1987, S AFR MED J, V72, P131; ROHT LH, 1985, AM J EPIDEMIOL, V122, P418, DOI 10.1093/oxfordjournals.aje.a114123; ROSENZWEIG P, 1993, CLIN PHARMACOL THER, V54, P578, DOI 10.1038/clpt.1993.190; SCHWEIGER A, 1981, PAVLOVIAN J BIOL SCI, V16, P140; SHEPHERD M, 1993, PSYCHOL MED, V23, P569, DOI 10.1017/S0033291700025356; SIEGEL S, 1976, SCIENCE, V193, P323, DOI 10.1126/science.935870; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; Sorensen H T, 1986, Scand J Prim Health Care, V4, P252; SORTLAND O, 1992, ACTA RADIOL, V33, P368; SPRIET A, 1977, EUR J CLIN PHARMACOL, V11, P181, DOI 10.1007/BF00606408; Straus JL, 1996, PSYCHOSOMATICS, V37, P315, DOI 10.1016/S0033-3182(96)71544-X; Strohle A, 2000, J PSYCHIAT RES, V34, P439, DOI 10.1016/S0022-3956(00)00039-X; SURTEES SJ, 1991, BRIT MED J, V302, P1051, DOI 10.1136/bmj.302.6784.1051; Tangrea Joseph A., 1994, Annals of Epidemiology, V4, P327; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; Uhlenhuth EH, 1998, J AFFECT DISORDERS, V47, P183, DOI 10.1016/S0165-0327(97)00125-0; UKENS C, 1999, DRUG TOP, V143, P22; WILSON L, 1994, PAIN, V57, P55, DOI 10.1016/0304-3959(94)90107-4; WOLF S, 1954, JAMA-J AM MED ASSOC, V155, P339, DOI 10.1001/jama.1954.03690220013004	76	524	529	1	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					622	627		10.1001/jama.287.5.622	http://dx.doi.org/10.1001/jama.287.5.622			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518UR	11829702				2022-12-28	WOS:000173686700032
J	Chow, CC; Mo, KL; Wong, KS				Chow, CC; Mo, KL; Wong, KS			A woman with swollen legs	LANCET			English	Editorial Material							DIABETIC MUSCLE INFARCTION		Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	Pamela Youde Nethersole Eastern Hospital	Chow, CC (corresponding author), Pamela Youde Nethersole Eastern Hosp, Dept Med, 3 Lok Man Rd Chai Wan, Hong Kong, Hong Kong, Peoples R China.		Wong, Ka Sing Lawrence/N-3434-2015	Wong, Ka Sing Lawrence/0000-0002-2031-9866				BJORNSKOV EK, 1995, NEUROMUSCULAR DISORD, V5, P39, DOI 10.1016/0960-8966(94)E0027-6; Grigoriadis E, 2000, J RHEUMATOL, V27, P1063; HINTON A, 1993, ORTHOPEDICS, V16, P623; Madhan KK, 2000, AM J KIDNEY DIS, V35, P1212, DOI 10.1016/S0272-6386(00)70060-6; Umpierrez GE, 1996, AM J MED, V101, P245, DOI 10.1016/S0002-9343(96)00156-8	5	2	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					402	402		10.1016/S0140-6736(02)07602-X	http://dx.doi.org/10.1016/S0140-6736(02)07602-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844513				2022-12-28	WOS:000173686500013
J	Nutton, V				Nutton, V			Portraits of science - Logic, learning, and experimental medicine	SCIENCE			English	Article									UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of London; University College London	Nutton, V (corresponding author), UCL, Wellcome Trust Ctr Hist Med, Euston House,24 Eversholt St, London NW1 1AD, England.	v.nutton@ucl.ac.uk						Debru A., 1997, GALEN PHARM PHILOS H; Galen, 1991, On the Therapeutic Method; Galen P.N., 1997, SELECTED WORKS; Harris C.R.S., 1973, HEART VASCULAR SYSTE; KNOBLOCH K, 1821, C GALENI OPERA OMNIA; KUDLIEN F, 1991, GALENS METHOD HEALIN; Lloyd Geoffrey E. R., 1991, METHODS PROBLEMS GRE, P398; ROCCA J, 2002, GALEN BRAIN; Smith W.D., 1979, HIPPOCRATIC TRADITIO; Temkin Owsei, 1973, GALENISM RISE DECLIN	10	16	17	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					800	801		10.1126/science.1066244	http://dx.doi.org/10.1126/science.1066244			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823624				2022-12-28	WOS:000173733000024
J	Ye, KQ; Aghdasi, B; Luo, HBR; Moriarity, JL; Wu, FY; Hong, JJ; Hurt, KJ; Bae, SS; Suh, PG; Snyder, SH				Ye, KQ; Aghdasi, B; Luo, HBR; Moriarity, JL; Wu, FY; Hong, JJ; Hurt, KJ; Bae, SS; Suh, PG; Snyder, SH			Phospholipase C gamma 1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE	NATURE			English	Article							NERVE GROWTH-FACTOR; SH3 DOMAINS; CELL-DIFFERENTIATION; STRUCTURAL BASIS; FRIEND-CELLS; PROTEIN 4.1N; PC12 CELLS; C-GAMMA; RAS; ACTIVATION	Phospholipase Cgamma1 (PLC-gamma1) hydrolyses phosphatidylinositol-4,5-bisphosphate to the second messengers inositol-1,4,5-trisphosphate and diacylglycerol. PLC-gamma1 also has mitogenic activity upon growth-factor-dependent tyrosine phophorylation(1,2); however, this activity is not dependent on the phospholipase activity of PLC-gamma1, but requires an SH3 domain(3,4). Here, we demonstrate that PLC-gamma1 acts as a guanine nucleotide exchange factor (GEF) for PIKE (phosphatidylinositol-3-OH kinase (PI(3)K) enhancer). PIKE is a nuclear GTPase that activates nuclear PI(3)K activity, and mediates the physiological activation by nerve growth factor (NGF) of nuclear PI(3)K activity(5). This enzymatic activity accounts for the mitogenic properties of PLC-gamma1.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Pohang Univ Sci & Technol, Dept Life Sci, Div Mol Life Sci, Pohang 790784, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pohang University of Science & Technology (POSTECH)	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Suh, Pann-Ghill/F-3610-2010; Hurt, K. Joseph/J-8266-2019	Hurt, K. Joseph/0000-0001-6906-350X				Bae SS, 1998, J NEUROCHEM, V71, P178; Bertagnolo V, 1998, FEBS LETT, V441, P480, DOI 10.1016/S0014-5793(98)01593-2; BERTAGNOLO V, 1995, CELL SIGNAL, V7, P669, DOI 10.1016/0898-6568(95)00036-O; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HUANG KJ, 1995, CHINESE J CHEM ENG, V3, P1; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Kim MJ, 2000, BIOCHEMISTRY-US, V39, P8674, DOI 10.1021/bi992558t; LAI SHY, 1993, COMPUT IND ENG, V25, P13, DOI 10.1016/0360-8352(93)90209-G; MARMIROLI S, 1994, J BIOL CHEM, V269, P13; MARTELLI AM, 1994, CANCER RES, V54, P2536; MUNDER T, 1992, MOL CELL BIOL, V12, P2091, DOI 10.1128/MCB.12.5.2091; Neri LM, 1998, J BIOL CHEM, V273, P29738, DOI 10.1074/jbc.273.45.29738; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Pei ZD, 1997, ARCH BIOCHEM BIOPHYS, V345, P103, DOI 10.1006/abbi.1997.0245; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Scholler JK, 2000, EUR J IMMUNOL, V30, P2378, DOI 10.1002/1521-4141(2000)30:8<2378::AID-IMMU2378>3.0.CO;2-E; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; Smith MR, 1998, CARCINOGENESIS, V19, P177, DOI 10.1093/carcin/19.1.177; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Smith MR, 1996, BIOCHEM BIOPH RES CO, V222, P186, DOI 10.1006/bbrc.1996.0719; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZINI N, 1995, EUR J CELL BIOL, V68, P25	28	137	143	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					541	544		10.1038/415541a	http://dx.doi.org/10.1038/415541a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823862				2022-12-28	WOS:000173564300050
J	Jewkes, R; Levin, J; Mbananga, N; Bradshaw, D				Jewkes, R; Levin, J; Mbananga, N; Bradshaw, D			Rape of girls in South Africa	LANCET			English	Article								Child rape violates human rights and causes immediate and long-term health problems for the child. In the 1998 South Africa Demographic and Health Survey, we assessed frequency of rape in a nationally representative study of 11 735 women aged 15-49 years. 153 (1.6%, 95% CI 1.2-1.9%) of these women had been raped (forced or persuaded to have sex against their will) before the age of 15 years. Our results show that younger women were significantly more likely to report rape than older women (p<0.0001). The largest group of perpetrators (33%) were school teachers. Our findings suggest that child rape is becoming more common, and lend support to qualitative research of sexual harassment of female students in schools in Africa.	MRC, Gender & Hlth Grp, ZA-0001 Pretoria, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Grp, Private Bag X385, ZA-0001 Pretoria, South Africa.			Jewkes, Rachel/0000-0002-4330-6267				Garcia-Moreno C, 2000, AIDS, V14, pS253; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; OMAAR R, 1994, AFRICAN RIGHTS   JUL; Tjaden P., 2000, FULL REPORT PREVALEN	5	131	133	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					319	320		10.1016/S0140-6736(02)07530-X	http://dx.doi.org/10.1016/S0140-6736(02)07530-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	517AC	11830201				2022-12-28	WOS:000173588100015
J	Walraven, G				Walraven, G			Commentary: Involving traditional birth attendants in prevention of HIV transmission needs careful consideration	BRITISH MEDICAL JOURNAL			English	Editorial Material									MRC Labs, Farafenni Field Stn, Banjul, Gambia	MRC Laboratory Molecular Biology	Walraven, G (corresponding author), MRC Labs, Farafenni Field Stn, POB 273, Banjul, Gambia.							DEVAATE B, IN PRESS MIDWIFERY; HABIMANA P, 1994, AIDS, V8, P701, DOI 10.1097/00002030-199405000-00020; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; Walraven G, 1999, TROP MED INT HEALTH, V4, P527, DOI 10.1046/j.1365-3156.1999.00441.x; Walraven G, 2001, LANCET, V357, P1161, DOI 10.1016/S0140-6736(00)04333-6	5	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					224	225						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11831205				2022-12-28	WOS:000173604800025
J	Yusuf, S; Granger, C; Eikelboom, J; Mehta, S; Pogue, J; Tait, P; Behar, S; Benderly, M; Hod, H; Kaplinsky, E; Barrett, N; Bilke, R; Luz, M; Marhoefer, M; Roi, L; Trenery, D; Bittl, JA; Boersma, H; Flather, M; Baigent, C; Simoons, ML; Califf, R; Granger, C; Pieper, K; Topol, EJ; Weitz, J; Serruys, PW; White, HD; Neuhaus, KL; Zeymer, U; Simes, J; Close, P; Edwards, S; Gallo, P; Henis, M; Yusuf, S; Anand, S; Pogue, J; Kimball, W; Meanwell, C; Villiger, J; Antman, EM; Braunwald, E; Gibson, M; Murphy, S; Grip, L; Held, P				Yusuf, S; Granger, C; Eikelboom, J; Mehta, S; Pogue, J; Tait, P; Behar, S; Benderly, M; Hod, H; Kaplinsky, E; Barrett, N; Bilke, R; Luz, M; Marhoefer, M; Roi, L; Trenery, D; Bittl, JA; Boersma, H; Flather, M; Baigent, C; Simoons, ML; Califf, R; Granger, C; Pieper, K; Topol, EJ; Weitz, J; Serruys, PW; White, HD; Neuhaus, KL; Zeymer, U; Simes, J; Close, P; Edwards, S; Gallo, P; Henis, M; Yusuf, S; Anand, S; Pogue, J; Kimball, W; Meanwell, C; Villiger, J; Antman, EM; Braunwald, E; Gibson, M; Murphy, S; Grip, L; Held, P		Direct Thrombin Inhibitor Trialist	Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; HIRUDIN; HEPARIN; THROMBOLYSIS; HIRULOG; THERAPY; SAFETY; AGENTS; TERM	Background To obtain more reliable and precise estimates of the effect of direct thrombin inhibitors in the management of acute coronary syndromes, including patients undergoing percutaneous coronary intervention, we undertook a meta-analysis based on individual patients' data from randomised trials comparing a direct thrombin inhibitor (hirudin, bivalirudin, argatroban, efegatran, or inogatran) with heparin. Methods We included trials that involved at least 200 patients. The primary efficacy outcome was death or myocardial infarction, and the primary safety outcome was major bleeding. Data from individual trials were combined by use of a modified Mantel-Haenszel method. Findings In 11 randomised trials, 35 970 patients were assigned up to 7 days' treatment with a direct thrombin inhibitor or heparin and followed up for at least 30 days. Compared with heparin, direct thrombin inhibitors were associated with a lower risk of death or myocardial infarction at the end of treatment (4.3% vs 5.1%; odds ratio 0.85 [95% CI 0.77-0.94]; p=0.001) and at 30 days (7.4% vs 8.2%; 0.91 [0.84-0.99]; p=0.02). This was due primarily to a reduction in myocardial infarctions (2.8% vs 3.5%; 0.80 [0.71-0.90]; p<0.001) with no apparent effect on deaths (1.9% vs 2.0%; 0.97 [0.83-1.13]; p=0.69). Subgroup analyses suggested a benefit of direct thrombin inhibitors on death or myocardial infarction in trials of both acute coronary syndromes and percutaneous coronary interventions. A reduction in death or myocardial infarction was seen with hirudin and bivalirudin but not with univalent agents. Compared with heparin, there was an increased risk of major bleeding with hirudin, but a reduction with. bivalirudin. There was no excess in intracranial haemorrhage with direct thrombin inhibitors. Interpretation Direct thrombin inhibitors are superior to heparin for the prevention of death or myocardial infarction in patients with acute coronary syndromes. This information should prompt further clinical development of direct thrombin inhibitors for the management of arterial thrombosis.	Hamilton Gen Hosp, McMaster Clin, Hamilton, ON L8L 2X2, Canada	McMaster University	Yusuf, S (corresponding author), Hamilton Gen Hosp, McMaster Clin, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusuf@ccc.mcmaster.ca	Eikelboom, John/AAG-6117-2019; Simes, Robert John/P-1497-2014; Weitz, Jeffrey/AAD-1929-2019	Eikelboom, John/0000-0003-4126-1285; Weitz, Jeffrey/0000-0002-1092-7550				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; [Anonymous], 1994, Circulation, V90, P1631; ANTMAN EM, 1994, CIRCULATION, V90, P1624, DOI 10.1161/01.CIR.90.4.1624; Antman EM, 1996, CIRCULATION, V94, P911, DOI 10.1161/01.CIR.94.5.911; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Bata I, 1997, CIRCULATION, V96, P769; Bates SM, 1998, AM J CARDIOL, V82, p12P, DOI 10.1016/S0002-9149(98)00660-2; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Behar S, 1998, J AM COLL CARDIOL, V31, p74A, DOI 10.1016/S0735-1097(97)84029-6; BITTL JA, 1995, NEW ENGL J MED, V333, P764, DOI 10.1056/NEJM199509213331204; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Cairns JA, 1998, CHEST, V114, p611S, DOI 10.1378/chest.114.5_Supplement.611S; *DIR THROMB INH TR, 2001, AM HEART J, V141, pE2; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Greinacher A, 2001, CIRCULATION, V103, P1479, DOI 10.1161/01.CIR.103.10.1479; Grip L, 1997, EUR HEART J, V18, P1416; Klootwijk P, 1999, EUR HEART J, V20, P1101, DOI 10.1053/euhj.1999.1477; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mehta SR, 2000, EUR HEART J SUPPL, V2, pE6; Montalescot G, 2000, J AM COLL CARDIOL, V36, P110, DOI 10.1016/S0735-1097(00)00695-1; NEUHAUS KL, 1994, CIRCULATION, V90, P1638, DOI 10.1161/01.CIR.90.4.1638; Neuhaus KL, 1999, J AM COLL CARDIOL, V34, P966, DOI 10.1016/S0735-1097(99)00319-8; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; SERRUYS PW, 1995, NEW ENGL J MED, V333, P757, DOI 10.1056/NEJM199509213331203; SoRelle R, 2001, Circulation, V103, pE9030; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Topol EJ, 2001, LANCET, V357, P1905; Topol EJ, 1998, AM J CARDIOL, V82, p63P, DOI 10.1016/S0002-9149(98)00664-X; Toschi V, 1996, CORONARY ARTERY DIS, V7, P420, DOI 10.1097/00019501-199606000-00004; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Weitz JI, 1996, CORONARY ARTERY DIS, V7, P409; White HD, 1997, CIRCULATION, V96, P2155; White HD, 2001, LANCET, V358, P1855; White HD, 1998, AM J CARDIOL, V82, p57P, DOI 10.1016/S0002-9149(98)00663-8; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 1999, LANCET, V353, P429	46	179	183	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					294	302						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830196				2022-12-28	WOS:000173588100010
J	Ben-Asouli, Y; Banai, Y; Pel-Or, Y; Shir, A; Kaempfer, R				Ben-Asouli, Y; Banai, Y; Pel-Or, Y; Shir, A; Kaempfer, R			Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR	CELL			English	Article							DOUBLE-STRANDED-RNA; DSRNA-BINDING DOMAIN; SECONDARY STRUCTURE; CELLS; PHOSPHORYLATION; RECOGNITION; REGION	PKR, an interferon (IFN)-inducible protein kinase activated by double-stranded RNA, inhibits translation by phosphorylating the initiation factor eIF2alpha chain. We show that human IFN-gamma mRNA uses local activation of PKR in the cell to control its own translation yield. IFN-gamma mRNA activates PKR through a pseudoknot in its 5' untranslated region. Mutations that impair pseudoknot stability reduce the ability to activate PKR and strongly increase the translation efficiency of IFN-gamma mRNA. Nonphosphorylatable mutant eIF2alpha, knockout of PKR and PKR inhibitors 2-aminopurine, transdominant-negative PKR, or vaccinia E3L correspondingly enhances translation of IFN-gamma mRNA. The potential to form the pseudoknot is phylogenetically conserved. We propose that the RNA pseudoknot acts to adjust translation of IFN-gamma mRNA to the PKR level expressed in the cell.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Virol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kaempfer, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Virol, IL-91120 Jerusalem, Israel.	kaempfer@cc.huji.ac.il		Kaempfer, Raymond/0000-0002-5865-4619				Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Ben-Asouli Y, 2000, NUCLEIC ACIDS RES, V28, P1011, DOI 10.1093/nar/28.4.1011; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Circle DA, 1997, RNA, V3, P438; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; DIRKS W, 1994, GENE, V149, P389, DOI 10.1016/0378-1119(94)90187-2; Donahue TF, 2000, COLD SPRING HARBOR M, V39, P487; EDERY I, 1989, CELL, V56, P303, DOI 10.1016/0092-8674(89)90904-5; EFRAT S, 1982, NATURE, V297, P236, DOI 10.1038/297236a0; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; HARROD R, 1994, GENE, V140, P79, DOI 10.1016/0378-1119(94)90734-X; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jarrous N, 1996, MOL CELL BIOL, V16, P2814; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KOROMILAS AE, 1995, J BIOL CHEM, V270, P25426, DOI 10.1074/jbc.270.43.25426; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; ROSEN H, 1982, J BIOL CHEM, V257, P946; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; SCHMEDT C, 1995, J MOL BIOL, V249, P29, DOI 10.1006/jmbi.1995.0278; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	39	165	170	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					221	232		10.1016/S0092-8674(02)00616-5	http://dx.doi.org/10.1016/S0092-8674(02)00616-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832212	Bronze			2022-12-28	WOS:000173521300009
J	Beutler, E; Felitti, VJ; Koziol, JA; Ho, NJ; Gelbart, T				Beutler, E; Felitti, VJ; Koziol, JA; Ho, NJ; Gelbart, T			Penetrance of 845G -> A (C282Y) HFE hereditary haemochromatosis mutation in the USA	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Hematology	DEC 01-05, 2000	SAN FRANCISCO, CALIFORNIA	Amer Soc Hematol			HEMOCHROMATOSIS GENE; HOMOZYGOTES; DISEASE; POPULATION; ALLELE; COST; H63D	Background There has been much interest in screening populations for disease-associated mutations. A favoured candidate has been the HFE gene, mutations of which are the most common cause of haemochromatosis in the European population. About five people in 1000 are homozygotes for the 845G-->A mutation, but little is known of how many have mutation-caused clinical manifestations. Methods We screened 41038 individuals attending a health appraisal clinic in the USA for the 845G-->A and 187C-->G HFE mutations, and analysed laboratory data and data on signs and symptoms of haemochromatosis as elicited by questionnaire. Findings The most common symptoms of haemochromatosis, including poor general health, diabetes, arthropathies, arrhythmias, impotence, and skin pigmentation were no more prevalent among the 152 identified homozygotes than among the controls. The age distribution of homozygotes and compound heterozygotes did not differ significantly from that of controls: there was no measurable loss of such individuals from the population during ageing. However, there was a significantly increased prevalence of a history of hepatitis or "liver trouble" among homozygotes and in the proportion of homozygotes with increased concentrations of serum aspartate aminotransferase and collagen IV; these changes were not related to iron burden or to age. Only one of the 152 homozygotes had signs and symptoms that would suggest a diagnosis of haemochromatosis. Interpretation The normal age distribution of people with the haemochromatosis genotype, and the lack of symptoms in patients of all ages, indicate that the penetrance of hereditary haemochromatosis is much lower than generally thought. The clinical penetrance of a disorder is an essential consideration in screening for genetic disease; disorders with low penetrance are more expensive candidates for screening than disorders with high penetrance. Our best estimate is that less than 1% of homozygotes develop frank clinical haemochromatosis.	Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Hematol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Biomath, La Jolla, CA 92037 USA; Kaiser Permanente, Dept Prevent Med, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Kaiser Permanente	Beutler, E (corresponding author), Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Hematol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Gelbart, Terri/0000-0002-7863-1262	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK53505-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Adams PC, 1995, HEPATOLOGY, V22, P1720, DOI 10.1016/0270-9139(95)90197-3; Adams PC, 2000, MOL GENET METAB, V71, P81, DOI 10.1006/mgme.2000.3037; Bach G, 2001, AM J MED GENET, V99, P70, DOI 10.1002/1096-8628(20010215)99:1<70::AID-AJMG1120>3.0.CO;2-0; Barton JC, 1996, NAT MED, V2, P394, DOI 10.1038/nm0496-394; Beutler E, 1997, AM J HUM GENET, V61, P762; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; Beutler E, 2001, BLOOD, V98, P2597, DOI 10.1182/blood.V98.9.2597; Beutler E, 2000, ANN INTERN MED, V133, P329, DOI 10.7326/0003-4819-133-5-200009050-00008; Beutler E, 2000, GENET TEST, V4, P131, DOI 10.1089/10906570050114830; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Bradley L A, 1996, J Med Screen, V3, P178; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Edwards CQ, 1998, SEMIN HEMATOL, V35, P72; Fairbanks VF, 1998, GUT, V43, P441, DOI 10.1136/gut.43.3.441; Fasouliotis S J, 2000, Obstet Gynecol Surv, V55, P373, DOI 10.1097/00006254-200006000-00023; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; George DK, 1999, J HEPATOL, V31, P47, DOI 10.1016/S0168-8278(99)80162-7; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; LINDMARK B, 1985, ACTA MED SCAND, V218, P299; Lubin IM, 1999, ARCH PATHOL LAB MED, V123, P1177; McDonnell SM, 1999, AM J MED, V106, P619, DOI 10.1016/S0002-9343(99)00120-5; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Sheldon J. H., 1935, HAEMOCHROMATOSIS; STEINBERG MH, 1989, BRIT J HAEMATOL, V71, P297, DOI 10.1111/j.1365-2141.1989.tb04274.x; WILK MB, 1968, BIOMETRIKA, V55, P1; Willis G, 2000, GUT, V46, P401, DOI 10.1136/gut.46.3.401; Willis G, 1999, LANCET, V354, P221, DOI 10.1016/S0140-6736(99)02195-9; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; Yang QH, 1998, ANN INTERN MED, V129, P946, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00005; Yapp TR, 2001, INTERN MED J, V31, P48, DOI 10.1046/j.1445-5994.2001.00005.x	33	630	643	1	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					211	218		10.1016/S0140-6736(02)07447-0	http://dx.doi.org/10.1016/S0140-6736(02)07447-0			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812557				2022-12-28	WOS:000173350800013
J	Falck-Ytter, Y; Kale, H; Mullen, KD; Sarbah, SA; Sorescu, L; McCullough, AJ				Falck-Ytter, Y; Kale, H; Mullen, KD; Sarbah, SA; Sorescu, L; McCullough, AJ			Surprisingly small effect of antiviral treatment in patients with hepatitis C	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; LIVER FIBROSIS; INTERFERON-ALPHA-2B; RIBAVIRIN; PROGRESSION	Background: The effect and applicability of interferon-based antiviral therapies in the general population of persons with hepatitis C virus (HCV) infection are unknown. Objective: To determine the applicability and usefulness of antiviral therapy in a metropolitan clinic population. Design: Retrospective case series of consecutively referred patients. Setting: A teaching county hospital in Cleveland, Ohio. Patients: 327 patients referred to a liver clinic after a positive result for antibody against HCV on enzyme-linked immunosorbent assay (ELISA). Measurements: Treatment rates; reasons for nontreatment. Results: 34 patients had no detectable HCV RNA. Of the remaining 293 patients, 72% were not treated for the following reasons: 37% did not adhere to evaluation procedures, 34% had medical or psychiatric contraindications, 13% had ongoing substance or alcohol abuse, 11% preferred no treatment, and 5% had normal liver enzyme levels. Only 83 patients (28%) were treated; 13% had a sustained viral response. Conclusion: Most patients with HCV infection are not candidates for interferon-based therapies; alternative interventions should be sought for these patients.	Metrohlth Med Ctr, Div Gastroenterol, Cleveland, OH 44109 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	MetroHealth System; Case Western Reserve University	McCullough, AJ (corresponding author), Metrohlth Med Ctr, Div Gastroenterol, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	ajm3@po.cwru.edu	Falck-Ytter, Yngve/GZH-0993-2022; Yngve Falck-Ytter, AGAF/AAC-5362-2019	Yngve Falck-Ytter, AGAF/0000-0002-4688-3211				Aalto M, 2000, ALCOHOL CLIN EXP RES, V24, P1680, DOI 10.1097/00000374-200011000-00010; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Brienza RS, 2000, J SUBST ABUSE TREAT, V18, P331, DOI 10.1016/S0740-5472(99)00084-7; Davis GL, 1999, SEMIN LIVER DIS, V19, P103; Hourigan LF, 1999, HEPATOLOGY, V29, P1215, DOI 10.1002/hep.510290401; Kinzie JL, 1999, HEPATOLOGY, V30, p266A; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison John, 1999, American Journal of Medicine, V107, p56S; *NIH CONS DEV C PA, 1997, HEPATOLOGY S1, V26, P25; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Reindollar Robert W., 1999, American Journal of Medicine, V107, p100S; Schiff Eugene R., 1999, American Journal of Medicine, V107, p95S; Shad Javaid, 2000, Hepatology, V32, p283A; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; VIAL T, 1994, DRUG SAFETY, V10, P115, DOI 10.2165/00002018-199410020-00003; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; 1998, MMWR MORB MORTAL WKL, V471, P39	20	265	274	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					288	292		10.7326/0003-4819-136-4-200202190-00008	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FQ	11848726				2022-12-28	WOS:000173943700005
J	Lee, TH; Brennan, TA				Lee, TH; Brennan, TA			Direct-to-consumer marketing of high-technology screening tests.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BEAM COMPUTED-TOMOGRAPHY; LUNG-CANCER; PROJECT; DISEASE; EVENTS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lee, TH (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Detrano RC, 2000, CIRCULATION, V101, P1355; Detrano RC, 2000, CIRCULATION, V101, P697; Detrano RC, 1999, CIRCULATION, V99, P2633, DOI 10.1161/01.CIR.99.20.2633; HAAS N, 2001, NY TIMES        0826; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Marcus PM, 2000, J NATL CANCER I, V92, P1308, DOI 10.1093/jnci/92.16.1308; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; Patz EF, 2000, NEW ENGL J MED, V343, P1627, DOI 10.1056/NEJM200011303432208; Patz EF, 2000, CHEST, V117, P1568, DOI 10.1378/chest.117.6.1568; Sullivan WM, 1999, HASTINGS CENT REP, V29, P7, DOI 10.2307/3528344; Vastag B, 2001, JAMA-J AM MED ASSOC, V286, P3065, DOI 10.1001/jama.286.24.3065; 2001, MED LETT DRUGS THER, V43, P61	13	73	73	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					529	531		10.1056/NEJM200202143460715	http://dx.doi.org/10.1056/NEJM200202143460715			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844859				2022-12-28	WOS:000173815300014
J	Van Damme, R; Wilson, RS; Vanhooydonck, B; Aerts, P				Van Damme, R; Wilson, RS; Vanhooydonck, B; Aerts, P			Evolutionary biology - Performance constraints in decathletes	NATURE			English	Article							ENDURANCE		Univ Instelling Antwerp, Dept Biol, B-2610 Wilrijk, Belgium	University of Antwerp	Van Damme, R (corresponding author), Univ Instelling Antwerp, Dept Biol, Univ Pl 1, B-2610 Wilrijk, Belgium.		Wilson, Robbie S/F-1463-2011	Aerts, Peter/0000-0002-6867-5421; Wilson, Robbie/0000-0002-0116-5427; Van Damme, Raoul/0000-0002-4585-6940				Dohm MR, 1996, EVOLUTION, V50, P1688, DOI 10.1111/j.1558-5646.1996.tb03940.x; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Garland Theodore Jr., 1994, P251; Gilchrist GW, 1996, EVOLUTION, V50, P1560, DOI [10.2307/2410892, 10.1111/j.1558-5646.1996.tb03928.x]; LEVINS RICHARD, 1968; MCPEEK MA, 1996, AM NAT             S, V148, P124; RIVERO JLL, 1993, J APPL PHYSIOL, V75, P1758, DOI 10.1152/jappl.1993.75.4.1758; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; [No title captured]	10	127	127	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					755	756		10.1038/415755b	http://dx.doi.org/10.1038/415755b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845199				2022-12-28	WOS:000173833900036
J	Butler, D				Butler, D			Developing world gets patent aid	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					563	563		10.1038/415563b	http://dx.doi.org/10.1038/415563b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832894	Bronze			2022-12-28	WOS:000173709100004
J	Chambers, J; Blauth, C; Bucknall, C; Eykyn, S				Chambers, J; Blauth, C; Bucknall, C; Eykyn, S			Aspergilloma as a complication of pacemaker implantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Guys Hosp, London SE1 7EH, England; St Thomas Hosp, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Chambers, J (corresponding author), Guys Hosp, London SE1 7EH, England.			bucknall, clifford/0000-0003-0662-5856					0	8	8	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					428	428		10.1056/NEJMicm010051	http://dx.doi.org/10.1056/NEJMicm010051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832531				2022-12-28	WOS:000173686400006
J	van Dam, RM; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB				van Dam, RM; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB			Dietary patterns and risk for type 2 diabetes mellitus in US men	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; GLYCEMIC LOAD; PIMA-INDIANS; WOMEN; HEALTH; FIBER; FAT; REPRODUCIBILITY; QUESTIONNAIRE; CARBOHYDRATE	Background: The role of diet in the development of type 2 diabetes mellitus remains unsettled. Objective: To examine the association between major dietary patterns and risk for type 2 diabetes mellitus. Design: Prospective cohort study. Setting: United States. Participants: 42 504 male health professionals, 40 to 75 years of age, without diagnosed diabetes, cardiovascular disease, or cancer at baseline. Measurements: Using factor analysis based on data from food-frequency questionnaires, we identified and validated two major dietary patterns that we labeled "prudent" (characterized by higher consumption of vegetables, fruit, fish, poultry and whole grains) and "western" (characterized by higher consumption of red meat, processed meat, French fries, high-fat dairy products, refined grains, and sweets and desserts). Relative risks and 95% CIs were adjusted for potential confounders, including body mass index (BMI), physical activity, and cigarette smoking. Results: During 12 years of follow-up (466508 person-years), we documented 1321 cases of type 2 diabetes. The prudent dietary pattern score was associated with a modestly lower risk for type 2 diabetes (relative risk for extreme quintiles, 0.84 [CI, 0.70 to 1.00]). In contrast, the western dietary pattern score was associated with an increased risk for type 2 diabetes (relative risk, 1.59 [CI, 1.32 to 1.93]; P < 0.001 for trend). A high score for the western dietary pattern combined with low physical activity (relative risk comparing extreme quintiles of dietary pattern score and physical activity, 1.96 [CI, 1.35 to 2.84]) or obesity (relative risk for BMI greater than or equal to 30 kg/m(2) vs. <25 kg/m(2), 11.2 [CI, 8.07 to 15.6]) was associated with a particularly high risk for type 2 diabetes. Conclusion: Our findings suggest that a western dietary pattern is associated with a substantially increased risk for type 2 diabetes in men.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Netherlands National Institute for Public Health & the Environment	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	van Dam, Rob M/F-9674-2010; Robles-Sardin, Alma E/M-7714-2015; Hu, Frank/C-1919-2013	van Dam, Rob M/0000-0002-7354-8734; Robles-Sardin, Alma E/0000-0003-2044-7793; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NCI NIH HHS [CA 55075] Funding Source: Medline; NHLBI NIH HHS [HL 35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gittelsohn J, 1998, J NUTR, V128, P541, DOI 10.1093/jn/128.3.541; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Himsworth HP, 1935, CLIN SCI, V2, P117; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Kawate R, 1979, Diabetes Care, V2, P161, DOI 10.2337/diacare.2.2.161; Kim J, 1978, FACTOR ANAL STAT MET; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Pratley RE, 1998, P NUTR SOC, V57, P175, DOI 10.1079/PNS19980029; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; *SAS I, 1989, SAS STAT US GUID VER; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; SWINBURN BA, 1991, J CLIN ENDOCR METAB, V73, P156, DOI 10.1210/jcem-73-1-156; *WHO STUD GROUP DI, 1995, DIAB MELL REP WHO ST; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337	33	584	591	0	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					201	209		10.7326/0003-4819-136-3-200202050-00008	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827496				2022-12-28	WOS:000173637400003
J	Cherqui, D; Soubrane, O; Husson, E; Barshasz, E; Vignaux, O; Ghimouz, M; Branchereau, S; Chardot, C; Gauthier, F; Fagniez, PL; Houssin, D				Cherqui, D; Soubrane, O; Husson, E; Barshasz, E; Vignaux, O; Ghimouz, M; Branchereau, S; Chardot, C; Gauthier, F; Fagniez, PL; Houssin, D			Laparoscopic living donor hepatectomy for liver transplantation in children	LANCET			English	Article							SURGICAL TECHNIQUES; NEPHRECTOMY; COMPLICATIONS; MANAGEMENT; DONATION; TUMORS	Background Because cadaveric organ donors are in short supply, living donors are increasingly being used in transplantations. We have developed a safe and reproducible method for laparoscopic liver resection. Methods Left hepatic lobectomy (resection of segments 2 and 3) was done by laparoscopy in one woman aged 27 years and one man aged 31 years. The grafts were prepared under laparoscopy, without any vascular clamping, and were externalised through a suprapubic Pfannenstiel incision. Both grafts were transplanted conventionally to the patients' respective sons, who were both aged 1 year and had biliary atresia. Findings Donor operations lasted 7 h for the woman and 6 h for the man, and warm ischaemia times were 4 and 10 min, respectively. Blood loss was 150 and 450 mL, respectively, and no transfusions were required. Neither patient had complications during or after sugary; and hospital stay was 7 and 5 days, respectively. Both recipients are alive and have excellent graft function. Interpretation We have shown the feasibility of laparoscopic living donor hepatectomy from parent to child. If the safety and feasbility of this procedure can be shown in larger series, laparoscopic donor left lobectomy could become a new option for paediatric living donor liver transplantation.	Hop Henri Mondor, Dept Gen & Digest Surg, F-94010 Creteil, France; Hop Cochin, Dept Gen & Digest Surg, F-75674 Paris, France; Hop Cochin, Dept Anesthesiol, F-75674 Paris, France; Hop Cochin, Dept Radiol, F-75674 Paris, France; Hop Bicetre, Dept Pediat Surg, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Cherqui, D (corresponding author), Hop Henri Mondor, Dept Gen & Digest Surg, F-94010 Creteil, France.		Soubrane, Olivier/H-7799-2016; Soubrane, Olivier/ABB-4434-2021					Belghiti J, 2000, BRIT J SURG, V87, P1441, DOI 10.1046/j.1365-2168.2000.01603.x; BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; Cherqui D, 1995, HEPATOLOGY, V22, P1674, DOI 10.1016/0270-9139(95)90190-6; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Descottes B, 2000, ANN SURG, V232, P641, DOI 10.1097/00000658-200011000-00004; EMOND JC, 1993, TRANSPLANTATION, V55, P835, DOI 10.1097/00007890-199304000-00029; Flowers JL, 1997, ANN SURG, V226, P483, DOI 10.1097/00000658-199710000-00009; Fujita S, 2000, TRANSPLANT INT, V13, P333, DOI 10.1111/j.1432-2277.2000.tb01006.x; Ghobrial R M, 2000, Clin Liver Dis, V4, P553, DOI 10.1016/S1089-3261(05)70126-4; Grewal HP, 1998, ANN SURG, V228, P214, DOI 10.1097/00000658-199808000-00011; Huscher C G, 1998, Semin Laparosc Surg, V5, P204; Katkhouda N, 1999, ANN SURG, V229, P460, DOI 10.1097/00000658-199904000-00003; MAKUUCHI M, 1993, SURGERY, V113, P395; Merlin TL, 2000, TRANSPLANTATION, V70, P1659, DOI 10.1097/00007890-200012270-00001; RATNER LE, 1995, TRANSPLANTATION, V60, P1047; Ratner LE, 1997, TRANSPLANTATION, V63, P229, DOI 10.1097/00007890-199701270-00009; Renz JF, 2000, LIVER TRANSPLANT, V6, pS73, DOI 10.1053/jlts.2000.18686; Revillon Y, 1999, J PEDIATR SURG, V34, P851, DOI 10.1016/S0022-3468(99)90386-X; ROGIERS X, 1994, BRIT J SURG, V81, P1251, DOI 10.1002/bjs.1800810903; Samama G, 1998, SURG ENDOSC-ULTRAS, V12, P76, DOI 10.1007/s004649900599; Sasaki TM, 2000, ARCH SURG-CHICAGO, V135, P943, DOI 10.1001/archsurg.135.8.943; Schweitzer EJ, 2000, ANN SURG, V232, P392, DOI 10.1097/00000658-200009000-00011; Strong RW, 1999, LIVER TRANSPLANT SUR, V5, P536, DOI 10.1002/lt.500050613; TANAKA K, 1993, ANN SURG, V217, P82, DOI 10.1097/00000658-199301000-00014; Trotter JF, 2001, LIVER TRANSPLANT, V7, P485, DOI 10.1053/jlts.2001.24646; YAMAOKA Y, 1995, TRANSPLANTATION, V59, P224	26	269	319	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					392	396		10.1016/S0140-6736(02)07598-0	http://dx.doi.org/10.1016/S0140-6736(02)07598-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844509				2022-12-28	WOS:000173686500009
J	Chen, JY; Carlson, BE; Del Genio, AD				Chen, JY; Carlson, BE; Del Genio, AD			Evidence for strengthening of the tropical general circulation in the 1990s	SCIENCE			English	Article							CLOUDS	Satellite observations suggest that the thermal radiation emitted by Earth to space increased by more than 5 watts per square meter, while reflected sunlight decreased by less than 2 watts per square meter, in the tropics over the period 1985-2000, with most of the increase occurring after 1990. By analyzing temporal changes in the frequency of occurrence of emitted thermal and reflected solar fluxes, the effects of El Nino-Southern Oscillation are minimized, and an independent longer-time-scale variation of the radiation budget is identified. Similar analyses of upper tropospheric humidity, cloud amount, surface air temperature, and vertical velocity confirm that these flux changes are associated with a decadal-time-scale strengthening of the tropical Hadley and Walker circulations. Equatorial convective regions have intensified in upward motion and moistened, while both the equatorial and subtropical subsidence regions have become drier and less cloudy.	Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA	Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Chen, JY (corresponding author), Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA.		Chen, Junye/G-4301-2011; Carlson, Barbara E/D-8319-2012; Del Genio, Anthony/D-4663-2012; Keyes, Dennis/AAZ-9285-2021	Del Genio, Anthony/0000-0001-7450-1359; Carlson, Barbara/0000-0002-5635-9552				BARKSTROM BR, 1986, REV GEOPHYS, V24, P379, DOI 10.1029/RG024i002p00379; Bates JJ, 2001, GEOPHYS RES LETT, V28, P1695, DOI 10.1029/2000GL012544; CHELLIAH M, 1992, J CLIMATE, V5, P371, DOI 10.1175/1520-0442(1992)005<0371:LSIVOM>2.0.CO;2; Gaffen DJ, 2000, SCIENCE, V287, P1242, DOI 10.1126/science.287.5456.1242; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; LATIF M, 1997, J CLIMATOL, V10, P2222; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Parker DE, 2000, SCIENCE, V287, P1216, DOI 10.1126/science.287.5456.1216; Peixoto J. P., 1992, PHYS CLIMATE, DOI DOI 10.1063/1.2809772; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; Weatherhead EC, 1998, J GEOPHYS RES-ATMOS, V103, P17149, DOI 10.1029/98JD00995; Wielicki BA, 1996, B AM METEOROL SOC, V77, P853, DOI 10.1175/1520-0477(1996)077<0853:CATERE>2.0.CO;2; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837	15	203	215	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					838	841		10.1126/science.1065835	http://dx.doi.org/10.1126/science.1065835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823637				2022-12-28	WOS:000173733000040
J	Chen, X; Schauder, S; Potier, N; Van Dorsselaer, A; Pelczer, I; Bassler, BL; Hughson, FM				Chen, X; Schauder, S; Potier, N; Van Dorsselaer, A; Pelczer, I; Bassler, BL; Hughson, FM			Structural identification of a bacterial quorum-sensing signal containing boron	NATURE			English	Article							ESCHERICHIA-COLI; VIBRIO-HARVEYI; EXPRESSION; BIOSYNTHESIS; SEQUENCE; SYSTEMS; FAMILY	Cell-cell communication in bacteria is accomplished through the exchange of extracellular signalling molecules called autoinducers. This process, termed quorum sensing, allows bacterial populations to coordinate gene expression. Community cooperation probably enhances the effectiveness of processes such as bioluminescence, virulence factor expression, antibiotic production and biofilm development(1-4). Unlike other autoinducers, which are specific to a particular species of bacteria, a recently discovered autoinducer (AI-2)(5) is produced by a large number of bacterial species. AI-2 has been proposed to serve as a 'universal' signal for inter-species communication(1,2,6,7). The chemical identity of AI-2 has, however, proved elusive. Here we present the crystal structure of an AI-2 sensor protein, LuxP, in a complex with autoinducer. The bound ligand is a furanosyl borate diester that bears no resemblance to previously characterized autoinducers. Our findings suggest that addition of naturally occurring borate to an AI-2 precursor generates active AI-2. Furthermore, they indicate a potential biological role for boron, an element required by a number of organisms but for unknown reasons.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Ecol Chim Polymeres & Mat, Lab Spectrometrie Masse Bioorgan, F-67087 Strasbourg, France	Princeton University; Princeton University	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Noelle, POTIER/AAX-7633-2021	Bassler, Bonnie/0000-0002-0043-746X; POTIER, Noelle/0000-0002-6381-4365				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; BOESEKEN J, 1949, ADV CARBOHYD CHEM, V4, P189; Bowen H.J.M., 1966, TRACE ELEMENTS BIOCH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DUERRE JA, 1977, BIOCH ADENOSYLMETHIO, P43; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lewis HA, 2001, STRUCTURE, V9, P527, DOI 10.1016/S0969-2126(01)00613-X; LOOMIS WD, 1992, BIOFACTORS, V3, P229; MAZUREK M, 1963, CAN J CHEM, V41, P2403, DOI 10.1139/v63-354; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MILLER CH, 1968, J BIOL CHEM, V243, P92; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAGIONE ED, 1985, BIOCHEM J, V232, P335, DOI 10.1042/bj2320335; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Schummer D, 1996, LIEBIGS ANN, P965; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDENBERG R, 1994, CARBOHYD RES, V253, P1, DOI 10.1016/0008-6215(94)80050-2	31	1103	1204	13	361	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					545	549		10.1038/415545a	http://dx.doi.org/10.1038/415545a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823863				2022-12-28	WOS:000173564300051
J	Ioffe, LB; Feigel'man, MV; Ioselevich, A; Ivanov, D; Troyer, M; Blatter, G				Ioffe, LB; Feigel'man, MV; Ioselevich, A; Ivanov, D; Troyer, M; Blatter, G			Topologically protected quantum bits using Josephson junction arrays	NATURE			English	Article							VALENCE-BOND STATE; PHASE; LATTICE; SUPERCONDUCTIVITY; SUPERPOSITION; COMPUTATION	All physical implementations of quantum bits (or qubits, the logical elements in a putative quantum computer) must overcome conflicting requirements: the qubits should be manipulable through external signals, while remaining isolated from their environment. Proposals based on quantum optics emphasize optimal isolation(1-3), while those following the solid-state route exploit the variability and scalability of nanoscale fabrication techniques(4-8). Recently, various designs using superconducting structures have been successfully tested for quantum coherent operation(9-11), however, the ultimate goal of reaching coherent evolution over thousands of elementary operations remains a formidable task. Protecting qubits from decoherence by exploiting topological stability is a qualitatively new proposal(12) that holds promise for long decoherence times, but its physical implementation has remained unclear. Here we show how strongly correlated systems developing an isolated twofold degenerate quantum dimer liquid ground state can be used in the construction of topologically stable qubits; we discuss their implementation using Josephson junction arrays. Although the complexity of their architecture challenges the technology base available today, such topological qubits greatly benefit from their built-in fault-tolerance.	ETH Honggerberg, CH-8093 Zurich, Switzerland; Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; LD Landau Theoret Phys Inst, Moscow 117940, Russia	Swiss Federal Institutes of Technology Domain; ETH Zurich; Rutgers State University New Brunswick; Russian Academy of Sciences; Landau Institute for Theoretical Physics	Blatter, G (corresponding author), ETH Honggerberg, CH-8093 Zurich, Switzerland.	blatterj@itp.phys.ethz.ch	Feigelman, Mikhail/M-4113-2013; Troyer, Matthias/B-7826-2008; Ivanov, Dmitri A/B-1410-2012	Troyer, Matthias/0000-0002-1469-9444; Ivanov, Dmitri A/0000-0001-6903-0679; Blatter, Gianni/0000-0003-0521-8028				ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Averin DV, 1998, SOLID STATE COMMUN, V105, P659, DOI 10.1016/S0038-1098(97)10001-1; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Fradkin E., 1991, FIELD THEORIES CONDE; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; GRABERT H, 1992, SINGLE CHARGE TUNNEL; IOFFE LB, 1989, PHYS REV B, V40, P6941, DOI 10.1103/PhysRevB.40.6941; Ioffe LB, 1999, NATURE, V398, P679, DOI 10.1038/19464; KITAEV AY, 1997, QUANTPH9707021; KIVELSON SA, 1987, PHYS REV B, V35, P8865, DOI 10.1103/PhysRevB.35.8865; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Misguich G, 1999, PHYS REV B, V60, P1064, DOI 10.1103/PhysRevB.60.1064; Moessner R, 2001, PHYS REV LETT, V86, P1881, DOI 10.1103/PhysRevLett.86.1881; MOESSNER R, 2001, CONDMAT0103396; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; ROKHSAR DS, 1988, PHYS REV LETT, V61, P2376, DOI 10.1103/PhysRevLett.61.2376; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Shnirman A, 1997, PHYS REV LETT, V79, P2371, DOI 10.1103/PhysRevLett.79.2371; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; van der Wal CH, 2000, SCIENCE, V290, P773, DOI 10.1126/science.290.5492.773; WEN XG, 1991, PHYS REV B, V44, P2664, DOI 10.1103/PhysRevB.44.2664	25	173	173	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					503	506		10.1038/415503a	http://dx.doi.org/10.1038/415503a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823853	Green Submitted			2022-12-28	WOS:000173564300039
J	Murthy, S; Looney, J; Jaklitsch, MT				Murthy, S; Looney, J; Jaklitsch, MT			Brief report - Gastropericardial fistula after laparoscopic surgery for reflux disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NISSEN FUNDOPLICATION; UNUSUAL COMPLICATION; GASTRIC-ULCERATION; ANTIREFLUX SURGERY; HEART		Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; Cleveland Clin Fdn, Dept Cardiothorac Surg, Cleveland, OH 44195 USA; Milton Hosp, Milton, MA USA	Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation	Jaklitsch, MT (corresponding author), Brigham & Womens Hosp, Div Thorac Surg, 75 Francis St, Boston, MA 02115 USA.							AGREZ MV, 1990, AUST NZ J SURG, V60, P823, DOI 10.1111/j.1445-2197.1990.tb07482.x; Avis SP, 1996, AM J FOREN MED PATH, V17, P83, DOI 10.1097/00000433-199603000-00016; Bianchi A, 1991, Eur J Surg, V157, P61; BUSHKIN FL, 1976, AM SURGEON, V42, P821; CADIERE GB, 1994, BRIT J SURG, V81, P400, DOI 10.1002/bjs.1800810327; CAMPBELL R, 1983, BRIT J SURG, V70, P406, DOI 10.1002/bjs.1800700705; Cozart JC, 1999, GASTROINTEST ENDOSC, V49, P387, DOI 10.1016/S0016-5107(99)70020-9; Deschamps C, 1998, J THORAC CARDIOV SUR, V115, P281, DOI 10.1016/S0022-5223(98)70270-3; GAENSLER EHL, 1988, GASTROINTEST RADIOL, V13, P6, DOI 10.1007/BF01889013; HAUTERS P, 1990, J CLIN GASTROENTEROL, V12, P313, DOI 10.1097/00004836-199006000-00017; HERRINGTON JL, 1982, ANN SURG, V195, P574, DOI 10.1097/00000658-198205000-00006; Jobe BA, 1997, SURG ENDOSC-ULTRAS, V11, P1080, DOI 10.1007/s004649900534; LETOQUART JP, 1990, J CHIR-PARIS, V127, P6; Richardson WS, 1999, AM J SURG, V177, P155, DOI 10.1016/S0002-9610(98)00324-9; SCOBIE BA, 1979, MED J AUSTRALIA, V1, P409, DOI 10.5694/j.1326-5377.1979.tb127003.x; Soper NJ, 1999, ANN SURG, V229, P669, DOI 10.1097/00000658-199905000-00009; STOKES W, 1854, DIS HEART AORTA, P6; Watson DI, 1998, BRIT J SURG, V85, P1173; WEST AB, 1988, GASTROENTEROLOGY, V94, P1478, DOI 10.1016/0016-5085(88)90689-0; WINDSOR CWO, 1967, THORAX, V22, P73, DOI 10.1136/thx.22.1.73	20	31	31	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					328	332		10.1056/NEJMoa010259	http://dx.doi.org/10.1056/NEJMoa010259			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821509				2022-12-28	WOS:000173545300005
J	Campbell, C; Mzaidume, Y				Campbell, C; Mzaidume, Y			How can HIV be prevented in South Africa? A social perspective	BRITISH MEDICAL JOURNAL			English	Article							CONTEXT; AIDS	South Africa's lack of government leadership in the fight against HIV and AIDS has resulted in disunity in local HIV/AIDS circles. Catherine Campbell and Yodwa Mzaidume suggest that peer education-with local people taking control of HIV prevention efforts-can be successful but depends on collaboration between many stakeholder groups at local, national, and international level.	London Sch Econ, London WC2A 2AE, England; Carletonville Hosp, Mothusimpilo Project, ZA-2500 Carletonville, South Africa	University of London; London School Economics & Political Science	Campbell, C (corresponding author), London Sch Econ, London WC2A 2AE, England.							Campbell C, 1999, SOC SCI MED, V48, P1625, DOI 10.1016/S0277-9536(98)00449-3; Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7; Campbell C, 2000, SOC SCI MED, V50, P479, DOI 10.1016/S0277-9536(99)00317-2; Campbell C, 2001, AM J PUBLIC HEALTH, V91, P1978, DOI 10.2105/AJPH.91.12.1978; CAMPBELL C, IN PRESS SOC SCI MED; Campbell C., 1999, AUSTR J PRIMARY HLTH, V15, P9; CAMPBELL CM, 2001, PEER ED COMMUNITY MO; Gillespie MA, 1999, CRIT REV, V13, P1, DOI 10.1080/08913819908443520; *HOR PROJ, 1999, PEER ED HIV AIDS PAS; ISRAEL BA, 1994, HEALTH EDUC QUART, V21, P149, DOI 10.1177/109019819402100203; MacPhail C, 1999, S AFR J PSYCHOL, V29, P149, DOI 10.1177/008124639902900401; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Putnam R.D., 2000, BOWLING COLLAPSE REV; STOCKDALE J, 1995, REPRESENTATIONS HLTH; SWEAT M, 1998, HDB EC EVALUATION; TAWIL O, 1995, AIDS, V9, P1299, DOI 10.1097/00002030-199512000-00001; UNAIDS, 2001, HIV PREV NEEDS SUCC; *UNAIDS, 2000, REP GLOB HIV AIDS EP; Waldo CR, 2000, AIDS, V14, pS18; WILLIAMS R, 1999, STAKEHOLDER EVALUATI	20	40	40	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					229	232		10.1136/bmj.324.7331.229	http://dx.doi.org/10.1136/bmj.324.7331.229			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	517HJ	11809649	Green Published			2022-12-28	WOS:000173604800027
J	Pitcher, GJ; Bowley, DMG				Pitcher, GJ; Bowley, DMG			Infant rape in South Africa	LANCET			English	Editorial Material							HIV		Univ Witwatersrand, Sch Med, ZA-2193 Johannesburg, South Africa; Johannesburg Hosp, Div Paediat Surg, ZA-2193 Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	Pitcher, GJ (corresponding author), Johannesburg Hosp, Div Paediat Surg, ZA-2193 Johannesburg, South Africa.			Pitcher, Graeme/0000-0003-1908-6900				Babl FE, 2000, AM J EMERG MED, V18, P282, DOI 10.1016/S0735-6757(00)90123-2; Baleta A, 2001, LANCET, V358, P1707, DOI 10.1016/S0140-6736(01)06779-4; Bateman C, 2001, S AFR MED J, V91, P452; Bogert C, 2001, LANCET, V357, P304, DOI 10.1016/S0140-6736(00)03627-8; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P109; Drieschner K, 1999, CLIN PSYCHOL REV, V19, P57, DOI 10.1016/S0272-7358(98)00016-6; Eke N, 2000, LANCET, V356, pS57, DOI 10.1016/S0140-6736(00)92043-9; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Jewkes R, 2001, S AFR MED J, V91, P421; MCGREAL C, 2001, GUARDIAN        1103; Muleta M, 1999, LANCET, V354, P2051, DOI 10.1016/S0140-6736(99)05161-2; O'Farrell N, 2000, LANCET, V356, P773, DOI 10.1016/S0140-6736(05)73678-3; OFARRELL N, 1991, J ACQ IMMUN DEF SYND, V4, P1258; PHILLIPS B, 2002, BABY RAPES SHOCK S A; *S AFR LAW COMM, 2002, 4 S AFR LAW COMM; *S AFR LAW COMM, 102 S AFR LAW COMM; Shanks L, 2001, LANCET, V357, P304, DOI 10.1016/S0140-6736(00)03626-6; van As AB, 2001, SAMJ S AFR MED J, V91, P1035	18	27	27	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					274	275		10.1016/S0140-6736(02)07532-3	http://dx.doi.org/10.1016/S0140-6736(02)07532-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830188				2022-12-28	WOS:000173588100002
J	Turner, J; Reid, S				Turner, J; Reid, S			Munchausen's syndrome	LANCET			English	Editorial Material									St Marys Hosp, Paterson Ctr Mental Hlth, Dept Liaison Psychiat, London W2 1PD, England; Springfield Univ Hosp, London, England	Imperial College London	Reid, S (corresponding author), St Marys Hosp, Paterson Ctr Mental Hlth, Dept Liaison Psychiat, London W2 1PD, England.	steve.reid@kcl.ac.uk	Cervilla, Jorge A/O-2106-2016	Cervilla, Jorge A/0000-0001-6891-1992				ASHER R, 1951, LANCET, V260, P339; ASHER RAJ, 1947, BRIT MED J, V2, P967, DOI 10.1136/bmj.2.4536.967; Asher Richard, 1972, R ASHER TALKING SENS; FINK P, 1989, PSYCHOTHER PSYCHOSOM, V52, P164, DOI 10.1159/000288319; MEADOW R, 1977, LANCET, V2, P343; MENNINGER KA, 1934, PSYCHOL Q, V3, P883; POWELL R, 1993, BRIT J PSYCHIAT, V162, P253, DOI 10.1192/bjp.162.2.253; Raspe R. E., 1948, SINGULAR TRAVELS CAM; REICH P, 1983, ANN INTERN MED, V99, P240, DOI 10.7326/0003-4819-99-2-240	9	28	30	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					346	349		10.1016/S0140-6736(02)07502-5	http://dx.doi.org/10.1016/S0140-6736(02)07502-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	517AC	11830219				2022-12-28	WOS:000173588100033
J	Balmain, A				Balmain, A			Cancer as a complex genetic trait: Tumor susceptibility in humans and mouse models	CELL			English	Review							QUANTITATIVE TRAIT; LINKAGE DISEQUILIBRIUM; INTESTINAL NEOPLASIA; HAPLO-INSUFFICIENT; MAJOR MODIFIER; LUNG-CANCER; CELL TUMORS; CYCLIN D1; LOCI; MICE	Cancer directly affects at least one-third of the human population, but the inherited genetic determinants of cancer risk remain largely unknown. Mouse models of human cancer are helping us to understand this disease as a complex genetic trait and thus to identify the multiple genetic variant alleles involved in pathways that affect individual cancer susceptibility.	Univ Calif San Francisco, Dept Biochem & Biophys, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Balmain, A (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Ctr Comprehens Canc, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu			NATIONAL CANCER INSTITUTE [U01CA084244, P50CA089520] Funding Source: NIH RePORTER; NCI NIH HHS [CA 84244, CA 89520] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bala S, 2001, CANCER RES, V61, P6042; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Cormier RT, 2000, ONCOGENE, V19, P3182, DOI 10.1038/sj.onc.1203646; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Dunning AM, 1999, CANCER EPIDEM BIOMAR, V8, P843; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Fijneman RJA, 1998, CANCER RES, V58, P4794; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Kong SM, 2000, CANCER RES, V60, P249; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Legare ME, 2000, GENOME RES, V10, P42; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Linardopoulos S, 2000, INT J CANCER, V88, P920, DOI 10.1002/1097-0215(20001215)88:6<920::AID-IJC13>3.0.CO;2-#; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Manenti G, 1999, GENOME RES, V9, P639; Matin A, 1999, NAT GENET, V23, P237, DOI 10.1038/13874; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Nadeau JH, 2000, NAT GENET, V25, P381, DOI 10.1038/78051; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Nagase H, 2001, CANCER RES, V61, P1305; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Phelan CM, 1996, NAT GENET, V12, P309, DOI 10.1038/ng0396-309; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Radany EH, 1997, P NATL ACAD SCI USA, V94, P8664, DOI 10.1073/pnas.94.16.8664; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; Stam LF, 1996, GENETICS, V144, P1559; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Szymanska H, 1999, INT J CANCER, V83, P674, DOI 10.1002/(SICI)1097-0215(19991126)83:5<674::AID-IJC18>3.0.CO;2-M; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; van Wezel T, 1999, CANCER RES, V59, P4216; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Wright FA, 2001, GENOME BIOL, V2; WRIGHT S, 1980, EVOLUTION, V34, P825, DOI 10.1111/j.1558-5646.1980.tb04022.x; Zhang SL, 2001, MOL CELL BIOL, V21, P310, DOI 10.1128/MCB.21.1.310-318.2001	57	105	105	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					145	152		10.1016/S0092-8674(02)00622-0	http://dx.doi.org/10.1016/S0092-8674(02)00622-0			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832205	Bronze			2022-12-28	WOS:000173521300002
J	Barral, JM; Hutagalung, AH; Brinker, A; Hartl, FU; Epstein, HF				Barral, JM; Hutagalung, AH; Brinker, A; Hartl, FU; Epstein, HF			Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; TETRATRICOPEPTIDE REPEAT; HEAVY-CHAIN; DOMAIN; GENE; RECONSTITUTION; EXPRESSION; COMPLEXES; MACHINES; RECEPTOR	The organization of myosin into motile cellular structures requires precise temporal and spatial regulation. Proteins containing a UCS (UNC-45/CRO1/She4p) domain are necessary for the incorporation of myosin into the contractite ring during cytokinesis and into thick filaments during muscle development. We report that the carboxyl-terminal regions of UNC-45 bound and exerted chaperone activity on the myosin head. The amino-terminal tetratricopeptide repeat domain of UNC-45 bound the molecular chaperone Hsp90. Thus, UNC-45 functions both as a molecular chaperone and as an Hsp90 co-chaperone for myosin, which can explain previous findings of altered assembly and decreased accumulation of myosin in UNC-45 mutants of Caenorhabditis elegans.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society	Epstein, HF (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	hepstein@bcm.tmc.edu	Hartl, F. Ulrich/Y-8206-2019; Hutagalung, Alex/AAH-5795-2021					Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 1999, BIOESSAYS, V21, P813, DOI 10.1002/(SICI)1521-1878(199910)21:10<813::AID-BIES3>3.0.CO;2-0; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; DELOZANNE A, 1987, J CELL BIOL, V105, P2999, DOI 10.1083/jcb.105.6.2999; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; MCNALLY EM, 1988, P NATL ACAD SCI USA, V85, P7270, DOI 10.1073/pnas.85.19.7270; PRICE MG, UNPUB; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; WOLFFLONG VL, 1993, J BIOL CHEM, V268, P23162; Wong KCY, 2000, J CELL SCI, V113, P2421	26	196	198	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					669	671		10.1126/science.1066648	http://dx.doi.org/10.1126/science.1066648			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809970				2022-12-28	WOS:000173560900042
J	Vagero, D; Modin, B				Vagero, D; Modin, B			Prenatal growth, subsequent marital status, and mortality: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							FETAL		Stockholm Univ, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden; Stockholm Univ, Karolinska Inst CHESS, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Vagero, D (corresponding author), Stockholm Univ, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden.			Modin, Bitte/0000-0001-6606-2157				Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; OLSEN J, 1995, SCAND J SOC MED, V23, P156, DOI 10.1177/140349489502300304; Phillips DIW, 2001, BRIT MED J, V322, P771, DOI 10.1136/bmj.322.7289.771; PHILLIPS DIW, 2001, 1 WORLD C FET OR AD; Vagero D, 1999, ACTA PAEDIATR, V88, P445, DOI 10.1080/08035259950169855	5	22	22	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					398	398		10.1136/bmj.324.7334.398	http://dx.doi.org/10.1136/bmj.324.7334.398			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850371	Bronze, Green Published			2022-12-28	WOS:000174006300019
J	Sleutels, F; Zwart, R; Barlow, DP				Sleutels, F; Zwart, R; Barlow, DP			The non-coding Air RNA is required for silencing autosomal imprinted genes	NATURE			English	Article							X-INACTIVATION; ANTISENSE RNA; CPG ISLAND; TRANSCRIPT; LOCUS; METHYLATION; EXPRESSION; CHROMOSOME; OVERLAPS; IGF2	In genomic imprinting, one of the two parental alleles of an autosomal gene is silenced epigenetically by a cis-acting mechanism(1,2). A bidirectional silencer for a 400-kilobase region that contains three imprinted, maternally expressed protein-coding genes (Igf2r/Slc22a2/Slc22a3) has been shown by targeted deletion to be located in a sequence of 3.7 kilobases(3-5), which also contains the promoter for the imprinted, paternally expressed non-coding Air RNA(6). Expression of Air is correlated with repression of all three genes on the paternal allele(5); however, Air RNA overlaps just one of these genes in an antisense orientation(6). Here we show, by inserting a polyadenylation signal that truncates 96% of the RNA transcript, that Air RNA is required for silencing. The truncated Air allele maintains imprinted expression and methylation of the Air promoter, but shows complete loss of silencing of the Igf2r/Slc22a2/Slc22a3 gene cluster on the paternal chromosome. Our results indicate that non-coding RNAs have an active role in genomic imprinting.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; Netherlands Canc Inst, Dept Mol Genet, NL-1066 CX Amsterdam, Netherlands	Austrian Academy of Sciences; Netherlands Cancer Institute	Barlow, DP (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.							Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BEECHEY CV, 2000, MRC MAMMALIAN GENETI; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hogan B, 1994, MANIPULATING MOUSE E; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Lyon Mary F., 1999, Results and Problems in Cell Differentiation, V25, P73; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Sleutels F, 2001, MOL CELL BIOL, V21, P5008, DOI 10.1128/MCB.21.15.5008-5017.2001; SLEUTELS F, IN PRESS HOMOLOGY EF; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2001, DEVELOPMENT, V128, P1881; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	27	827	876	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					810	813		10.1038/415810a	http://dx.doi.org/10.1038/415810a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845212				2022-12-28	WOS:000173833900051
J	Jones, E; Hodgins-Vermaas, R; McCartney, H; Everitt, B; Beech, C; Poynter, D; Palmer, I; Hyams, K; Wessely, S				Jones, E; Hodgins-Vermaas, R; McCartney, H; Everitt, B; Beech, C; Poynter, D; Palmer, I; Hyams, K; Wessely, S			Post-combat syndromes from the Boer war to the Gulf war: A cluster analysis of their nature and attribution	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To discover whether post-combat syndromes have existed after modern wars mid what relation they bear to each other. Design Review of medical and military records of servicemen and cluster analysis of symptoms. Data sources Records for 1856 veterans randomly selected from war pension files awarded from 1872 and from the Medical Assessment Programme for Gulf war veterans. Main outcome measures Characteristic patterns of symptom clusters and their relation to dependent variables including war, diagnosis, predisposing physical illness, and exposure to combat; and servicemen's changing attributions for post-combat disorders. Results Three varieties of post-combat disorder were identified-a debility syndrome (associated with the 19th and early 20th centuries), somatic syndrome (related primarily to the first world war), and a neuropsychiatric syndrome (associated with the second world war and the Gulf conflict). The era in which the war occurred was overwhelmingly the best predictor of Cluster membership. Conclusions All modern wars have been associated with a syndrome characterised by unexplained medical symptoms. The form that these assume, the terms used to describe them, and die explanations offered by servicemen and doctors seem to be influenced by advances in medical science, changes in the nature of warfare, and underlying cultural forces.	Guys Kings & St Thomas Sch Med, Dept Med Psychol, London SE5 8AZ, England; Kings Coll London, Joint Serv Command & Staff Coll, Watchfield, England; Inst Psychiat, London, England; Royal Def Med Coll, Gosport, Hants, England; Dept Vet Affairs, Off Publ Hlth & Environm Hazards, Washington, DC USA	University of London; King's College London; University of London; King's College London; University of London; King's College London	Jones, E (corresponding author), Guys Kings & St Thomas Sch Med, Dept Med Psychol, London SE5 8AZ, England.	E.Jones@hogarth7.demon.co.uk	Wessely, Simon C/A-8713-2008	Jones, Edgar/0000-0002-4610-9584; Everitt, Barry/0000-0003-4431-6536; Wessely, Simon Charles/0000-0002-6743-9929; McCartney, Helen/0000-0002-1888-5236				Bergman B P, 2000, J R Army Med Corps, V146, P204; Doebbeling BN, 2000, AM J MED, V108, P695, DOI 10.1016/S0002-9343(00)00405-8; Everitt B. S., 2001, CLUSTER ANAL; FEUDTNER C, 1993, HIST SCI, V31, P377, DOI 10.1177/007327539303100402; Grant RT, 1925, HEART-J STUD CIRC, V12, P121; GREEN FHK, 1953, MED HIST 2 WORLD WAR; GRINKER RR, 1945, MEN STRESS, P108; Haley RW, 1997, JAMA-J AM MED ASSOC, V277, P215, DOI 10.1001/jama.277.3.215; HALEY RW, 1997, JAMA-J AM MED ASSOC, V277, P278; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Ismail K, 1999, LANCET, V353, P179, DOI 10.1016/S0140-6736(98)11339-9; Jones E, 2001, War Soc, V19, P91; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; LANGMAN MJS, 1979, EPIDEMIOLOGY CHRONIC; MITCHELL TJ, 1931, HIST GREAT WAR BASED, P103; RHIND TD, 1919, WAR PENSIONS GAZETTE, V25, P307; Riley ID, 1942, LANCET, V2, P485; SHEPHARD B, 2000, WAR NERVES SOLDIERS, P1; SHORTER E, 1986, J SOC HIST, V19, P549, DOI 10.1353/jsh/19.4.549; Shorter E., 1992, PARALYSIS FATIGUE HI; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TIDY HL, 1941, P ROY SOC MED, V34, P21; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Young Allan., 1995, HARMONY ILLUSIONS IN	24	103	107	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2002	324	7333					321	324		10.1136/bmj.324.7333.321	http://dx.doi.org/10.1136/bmj.324.7333.321			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834557	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000173866300015
J	Berson, DM; Dunn, FA; Takao, M				Berson, DM; Dunn, FA; Takao, M			Phototransduction by retinal ganglion cells that set the circadian clock	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; LIGHT; PHOTORECEPTORS; ENTRAINMENT; OPSIN; RAT; EYE; INTEGRATION; SENSITIVITY; PATHWAY	Light synchronizes mammalian circadian rhythms with environmental time by modulating retinal input to the circadian pacemaker-the suprachiasmatic nucleus (SCN) of the hypothalamus. Such photic entrainment requires neither rods nor cones, the only known retinal photoreceptors. Here, we show that retinal ganglion cells innervating the SCN are intrinsically photosensitive. Unlike other ganglion cells, they depolarized in response to tight even when all synaptic input from rods and cones was blocked. The sensitivity, spectral tuning, and slow kinetics of this tight response matched those of the photic entrainment mechanism, suggesting that these ganglion cells may be the primary photoreceptors for this system.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NEI NIH HHS [EY12793] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012793] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BARR L, 1963, J GEN PHYSIOL, V46, P1249, DOI 10.1085/jgp.46.6.1249; DANIOLOS A, 1990, PIGM CELL RES, V3, P38, DOI 10.1111/j.1600-0749.1990.tb00260.x; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; DODT E, 1961, J NEUROPHYSIOL, V24, P427, DOI 10.1152/jn.1961.24.4.427; DUNN FA, UNPUB; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Green DG, 1999, VISUAL NEUROSCI, V16, P727, DOI 10.1017/S0952523899164125; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Kojima D, 2000, J NEUROSCI, V20, P2845; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Meijer JH, 1998, J NEUROSCI, V18, P9078; MOORE MAS, 1995, CLIN CANCER RES, V1, P3; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Nelson DE, 1999, AM J PHYSIOL-REG I, V277, pR1351, DOI 10.1152/ajpregu.1999.277.5.R1351; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Pu M, 2000, J BIOL RHYTHM, V15, P31, DOI 10.1177/074873040001500104; PU M, 1992, J NEUROSCI METH, V41, P45, DOI 10.1016/0165-0270(92)90122-T; Pu ML, 1999, J COMP NEUROL, V414, P267; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; von Schantz M, 2000, INVEST OPHTH VIS SCI, V41, P1605	29	2201	2295	28	464	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1070	1073		10.1126/science.1067262	http://dx.doi.org/10.1126/science.1067262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834835				2022-12-28	WOS:000173793000065
J	Milly, PCD; Wetherald, RT; Dunne, KA; Delworth, TL				Milly, PCD; Wetherald, RT; Dunne, KA; Delworth, TL			Increasing risk of great floods in a changing climate	NATURE			English	Article							TRENDS	Radiative effects of anthropogenic changes in atmospheric composition are expected to cause climate changes, in particular an intensification of the global water cycle(1) with a consequent increase in flood risk(2). But the detection of anthropogenically forced changes in flooding is difficult because of the substantial natural variability(3); the dependence of streamflow trends on flow regime(4,5) further complicates the issue. Here we investigate the changes in risk of great floods-that is, floods with discharges exceeding 100-year levels from basins larger than 200,000 km(2)-using both streamflow measurements and numerical simulations of the anthropogenic climate change associated with greenhouse gases and direct radiative effects of sulphate aerosols(6). We find that the frequency of great floods increased substantially during the twentieth century. The recent emergence of a statistically significant positive trend in risk of great floods is consistent with results from the climate model, and the model suggests that the trend will continue.	US Geol Survey, GFDL, NOAA, Princeton, NJ 08542 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Milly, PCD (corresponding author), US Geol Survey, GFDL, NOAA, POB 308, Princeton, NJ 08542 USA.		Dunne, Krista/N-4230-2019; Costa, Henrique Caldeira/B-6574-2009; Milly, Paul C. D./H-1169-2019; Delworth, Thomas L/C-5191-2014	Dunne, Krista/0000-0002-1220-6140; Costa, Henrique Caldeira/0000-0003-1663-2371; Milly, Paul C. D./0000-0003-4389-3139; Delworth, Thomas L/0000-0003-4865-5391				Chase TN, 2000, CLIM DYNAM, V16, P93, DOI 10.1007/s003820050007; Cubash U, 2001, CLIMATE CHANGE 2001; DELWORTH TL, UNPUB CLIM DYN; Groisman PY, 2001, B AM METEOROL SOC, V82, P219, DOI 10.1175/1520-0477(2001)082&lt;0219:HPAHSI&gt;2.3.CO;2; Knutson TR, 1999, J GEOPHYS RES-ATMOS, V104, P30981, DOI 10.1029/1999JD900965; Lins HF, 1999, GEOPHYS RES LETT, V26, P227, DOI 10.1029/1998GL900291; McCabe GJ, 1997, CLIMATE RES, V8, P129, DOI 10.3354/cr008129; Milly PCD, 1997, GEOPHYS RES LETT, V24, P269, DOI 10.1029/96GL03968; Milly PCD, 2001, GEOPHYS RES LETT, V28, P1219, DOI 10.1029/2000GL012321; MILLY PCD, UNPUB WAT RESOUR RES; PEARSON K, 1930, TABLES STAT BIOMETRI; Sellers PJ, 1996, SCIENCE, V271, P1402, DOI 10.1126/science.271.5254.1402; White KS, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P19	13	1056	1108	25	525	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					514	517		10.1038/415514a	http://dx.doi.org/10.1038/415514a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823857				2022-12-28	WOS:000173564300043
J	Nagai, H; Kagan, JC; Zhu, XJ; Kahn, RA; Roy, CR				Nagai, H; Kagan, JC; Zhu, XJ; Kahn, RA; Roy, CR			A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes	SCIENCE			English	Article							INTRACELLULAR GROWTH; LEGIONNAIRES-DISEASE; HOST-CELLS; HELICOBACTER-PYLORI; HUMAN-MONOCYTES; PNEUMOPHILA; IDENTIFICATION; ESTABLISHMENT; ORGANELLE; GTPASES	The intracellular pathogen Legionella pneumophila subverts vesicle traffic in eukaryotic host cells to create a vacuole that supports replication. The dot/icm genes encode a protein secretion apparatus that L. pneumophila require for biogenesis of this vacuole. Here we show that L. pneumophila produce a protein called RalF that functions as an exchange factor for the ADP ribosylation factor (ARF) family of guanosine triphosphatases (GTPases). The RalF protein is required for the localization of ARF on phagosomes containing L. pneumophila. Translocation of RalF protein through the phagosomal membrane is a dot/km-dependent process. Thus, RalF is a substrate of the Dot/Icm secretion apparatus.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Yale University; Emory University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.		Nagai, Hiroki/G-4113-2015; Kahn, Richard/ABD-2666-2020; Nagai, Hiroki/GXZ-7815-2022	Nagai, Hiroki/0000-0003-1659-2197; Kahn, Richard/0000-0002-0259-0601; Roy, Craig/0000-0003-4490-440X	NIAID NIH HHS [R29 AI41699, R01 AI44371] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044371, R29AI041699] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Breiman R F, 1998, Semin Respir Infect, V13, P84; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jones S, 1999, GENETICS, V152, P1543; KAGAN J, UNPUB; Matthews M, 2000, INFECT IMMUN, V68, P3971, DOI 10.1128/IAI.68.7.3971-3982.2000; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	32	440	455	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					679	682		10.1126/science.1067025	http://dx.doi.org/10.1126/science.1067025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809974				2022-12-28	WOS:000173560900046
J	Harbison, J; Newton, JL; Seifer, C; Kenny, RA				Harbison, J; Newton, JL; Seifer, C; Kenny, RA			Stokes Adams attacks and cardiovascular syncope	LANCET			English	Editorial Material								A 71-year-old woman was admitted for investigation of collapses of unknown cause. She had a history of occasional faints since childhood, but in the previous 6 months the collapses had become more sinister. Collapses occurred without warning, at least once per week, and were associated with transient loss of consciousness. A witness account stated that the woman became very pale during the collapses but the witness did not recall the woman flushing on recovery. The patient was assigned a provisional diagnosis of Stokes Adams attacks and referred for further cardiovascular investigations. The woman's previous history was unremarkable apart from a diagnosis of mild hypertension treated with bendroflumethiazide. She was normotensive and results of cardiovascular examination were otherwise normal. Her electrocardiogram showed normal sinus rhythm and no abnormalities. Cardiovascular investigations showed a transient, symptomless 15 mm Hg postural drop in systolic blood pressure resulting from 3 min of standing unaided. Carotid sinus massage resulted in a sinus pause of 4.1 s, with reproduction of the patient's syncopal symptoms. A diagnosis of cardioinhibitory carotid sinus syndrome was made, the patient was referred for Insertion of a permanent pacemaker, and has had no further collapses since this procedure.	Royal Victoria Infirm, Care Elderly Off, Dept Geriatr Med, Cardiovasc Invest Unit, Newcastle Upon Tyne NE2 4LP, Tyne & Wear, England	Newcastle University - UK	Harbison, J (corresponding author), Royal Victoria Infirm, Care Elderly Off, Dept Geriatr Med, Cardiovasc Invest Unit, Newcastle Upon Tyne NE2 4LP, Tyne & Wear, England.			Kenny, Rose Anne/0000-0002-9336-8124; Newton, Julia/0000-0002-1249-5253; Harbison, Joseph/0000-0003-3680-5751				Adams R, 1827, DUBLIN HOSP REP, V4, P353; Coakley D, 1992, IRISH MASTERS MED; Getchell WS, 1999, J GEN INTERN MED, V14, P677, DOI 10.1046/j.1525-1497.1999.03199.x; Kenny RA, 2000, HEART, V83, P564, DOI 10.1136/heart.83.5.564; SIGURD B, 1990, CARDIOLOGY, V77, P195, DOI 10.1159/000174601; Stokes W, 1846, DUBLIN Q J MED SCI, V11, P73	6	6	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					158	160		10.1016/S0140-6736(02)07376-2	http://dx.doi.org/10.1016/S0140-6736(02)07376-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809277				2022-12-28	WOS:000173212400034
J	van Weel, C				van Weel, C			Commentary: More self reliance in patients and fewer antibiotics: still room for improvement	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Med Ctr St Radboud, Dept Gen Practice, Nijmegen, Netherlands	Radboud University Nijmegen	van Weel, C (corresponding author), Univ Med Ctr St Radboud, Dept Gen Practice, Nijmegen, Netherlands.		van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					94	94						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11808533				2022-12-28	WOS:000173325400020
J	Wagner, AM; Santalo, M				Wagner, AM; Santalo, M			Uses of error - A correct decision?	LANCET			English	Editorial Material									Hosp Sant Pau, Dept Emergency Med, Barcelona 08025, Spain	Hospital of Santa Creu i Sant Pau	Wagner, AM (corresponding author), Hosp Sant Pau, Dept Emergency Med, Barcelona 08025, Spain.		Wägner, Ana M/AAS-9601-2021	Wägner, Ana M/0000-0002-7663-9308					0	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					157	157		10.1016/S0140-6736(02)07375-0	http://dx.doi.org/10.1016/S0140-6736(02)07375-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809276				2022-12-28	WOS:000173212400033
J	Barrett-Connor, E; Grady, D; Sashegyi, A; Anderson, PW; Cox, DA; Hoszowski, K; Rautaharju, P; Harper, KD				Barrett-Connor, E; Grady, D; Sashegyi, A; Anderson, PW; Cox, DA; Hoszowski, K; Rautaharju, P; Harper, KD		MORE Investigators	Raloxifene and cardiovascular events in osteoporotic postmenopausal women - Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; CLINICAL-TRIALS; HEART-DISEASE; BREAST-CANCER; PREVENTION; RISK; CLASSIFICATION; INFLAMMATION; CHOLESTEROL; PROGRESSION	Context Raloxifene, a selective estrogen receptor modulator, improves cardiovascular risk factors, but its effect on cardiovascular events is unknown. Objective To determine the effect of raloxifene on cardiovascular events in osteoporotic postmenopausal women. Design Secondary analysis of data from the Multiple Outcomes of Raloxifene Evaluation trial, a randomized, double-blind, placebo-controlled trial conducted between November 1994 and September 1999. Setting Outpatient and community settings at 180 sites in 25 countries. Participants A total of 7705 osteoporotic postmenopausal women (mean age, 67 years). Intervention Patients were randomly assigned to receive raloxifene, 60 mg/d (n=2557), or 120 mg/d (n=2572), or placebo (n=2576) for 4 years. Main Outcome Measures Cardiovascular events, including coronary events (myocardial infarction, unstable angina, or coronary ischemia) and cerebrovascular events (stroke or transient ischemic attack), collected as safety end points and subsequently adjudicated by a cardiologist blinded to therapy. Cardiovascular risk at study entry was determined by the presence of multiple cardiovascular risk factors or prior coronary events or revascularization procedure. Results In the overall cohort, there were no significant differences between treatment groups in the number of combined coronary and cerebrovascular events: 96 (3.7%) with placebo, 82 (3.2%) with 60 mg/d of raloxifene, and 94 (3.7%) with 120 mg/d of raloxifene. Relative risks (RRs) were 0.86 (95% confidence interval [CI], 0.64-1.15) and 0.98 (95% CI, 0.74-1.30) for 60 mg/d and 120 mg/d of raloxifene, respectively. Similar results were obtained when coronary and cerebrovascular events were analyzed separately. Among the subset of 1035 women with increased cardiovascular risk at baseline, those assigned to raloxifene had a significantly lower risk of cardiovascular events compared with placebo (RR, 0.60; 95% CI, 0.38-0.95 for both raloxifene groups). The number of cardiovascular events during the first year was not significantly different across groups in the overall cohort (P=.94), or among women at increased cardiovascular risk (P=.86) or with evidence of established coronary heart disease (P=.60). Conclusions Raloxifene therapy for 4 years did not significantly affect the risk of cardiovascular events in the overall cohort but did significantly reduce the risk of cardiovascular events in the subset of women with increased cardiovascular risk. There was no evidence that raloxifene caused an early increase in risk of cardiovascular events. Before raloxifene is used for prevention of cardiovascular events, these findings require confirmation in trials with evaluation of cardiovascular outcomes as the primary objective.	Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Lilly Res Labs, Indianapolis, IN USA; Railway Hosp, Ctr Med, Warsaw, Poland; Wake Forest Univ, Dept Publ Hlth Serv, Winston Salem, NC 27109 USA	University of California System; University of California San Diego; University of California System; University of California San Francisco; Eli Lilly; Wake Forest University	Barrett-Connor, E (corresponding author), Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, Div Epidemiol, 9500 Gilman Dr,No 0607, La Jolla, CA 92093 USA.							Alexander KP, 2001, J AM COLL CARDIOL, V38, P1, DOI 10.1016/S0735-1097(01)01329-8; *AM HEART ASS, 2001, BIOST FACT SHEET WOM; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; Cushman M, 2001, ARTERIOSCL THROM VAS, V21, P255, DOI 10.1161/01.ATV.21.2.255; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Heckbert SR, 2001, ARCH INTERN MED, V161, P1709, DOI 10.1001/archinte.161.14.1709; Hemminki E, 1997, BRIT MED J, V315, P149, DOI 10.1136/bmj.315.7101.149; Hemminki E, 2000, LANCET, V355, P566, DOI 10.1016/S0140-6736(99)03432-7; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 1999, ANN INTERN MED, V131, P463, DOI 10.7326/0003-4819-131-6-199909210-00012; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; LENFANT C, 2002, WHI HRT UPDATE; Mosca L, 2001, AM J CARDIOL, V88, P392, DOI 10.1016/S0002-9149(01)01685-X; Mosca L, 1997, CIRCULATION, V96, P2468; RAUTAHARJU PM, 1992, J ELECTROCARDIOL, V24, P179; Rautaharju PM, 1998, J ELECTROCARDIOL, V31, P157, DOI 10.1016/S0022-0736(98)90132-7; Reis SE, 2001, J NATL CANCER I, V93, P16, DOI 10.1093/jnci/93.1.16; Rossouw JE, 2001, CURR OPIN LIPIDOL, V12, P371, DOI 10.1097/00041433-200108000-00001; Saitta A, 2001, ARTERIOSCL THROM VAS, V21, P1512, DOI 10.1161/hq0901.095565; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; Walsh BW, 2000, J CLIN ENDOCR METAB, V85, P214, DOI 10.1210/jc.85.1.214; Zanger D, 2000, J AM COLL CARDIOL, V36, P1797, DOI 10.1016/S0735-1097(00)00952-9	33	439	461	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2002	287	7					847	857		10.1001/jama.287.7.847	http://dx.doi.org/10.1001/jama.287.7.847			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522XP	11851576	Bronze			2022-12-28	WOS:000173922500023
J	Laflamme, L; Engstrom, K				Laflamme, L; Engstrom, K			Socioeconomic differences in Swedish children and adolescents injured in road traffic incidents: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, SE-17176 Stockholm, Sweden	Karolinska Institutet	Laflamme, L (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, SE-17176 Stockholm, Sweden.		Laflamme, Lucie/T-2953-2019	Laflamme, Lucie/0000-0002-6443-1307				Hasselberg M, 2001, J EPIDEMIOL COMMUN H, V55, P858, DOI 10.1136/jech.55.12.858; LAFLAMME I, 1998, SOCIAL INEQUALITY IN, P33; Laflamme L, 2000, Inj Prev, V6, P293, DOI 10.1136/ip.6.4.293; West P, 1997, SOC SCI MED, V44, P833, DOI 10.1016/S0277-9536(96)00188-8; *WHO, 1999, INJ LEAD CAUS GLOB B	5	46	48	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					396	397		10.1136/bmj.324.7334.396	http://dx.doi.org/10.1136/bmj.324.7334.396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850370	Bronze, Green Published			2022-12-28	WOS:000174006300017
J	Raxworthy, CJ; Forstner, MRJ; Nussbaum, RA				Raxworthy, CJ; Forstner, MRJ; Nussbaum, RA			Chameleon radiation by oceanic dispersal	NATURE			English	Article							HISTORICAL BIOGEOGRAPHY; INDIAN-OCEAN; MADAGASCAR; PHYLOGENY; VOLCANISM; REPTILIA; BREAKUP; SKULL	Historical biogeography is dominated by vicariance methods that search for a congruent pattern of fragmentation of ancestral distributions produced by shared Earth history(1-3). A focus of vicariant studies has been austral area relationships and the break-up of the supercontinent Gondwana(3-5). Chameleons are one of the few extant terrestrial vertebrates thought to have biogeographic patterns that are congruent with the Gondwanan break-up of Madagascar and Africa(6,7). Here we show, using molecular and morphological evidence for 52 chameleon taxa, support for a phylogeny and area cladogram that does not fit a simple vicariant history. Oceanic dispersal-not Gondwanan breakup-facilitated species radiation, and the most parsimonious biogeographic hypothesis supports a Madagascan origin for chameleons, with multiple 'out-of-Madagascar' dispersal events to Africa, the Seychelles, the Comoros archipelago, and possibly Reunion Island. Although dispersal is evident in other Indian Ocean terrestrial animal groups(8-16), our study finds substantial out-of-Madagascar species radiation, and further highlights the importance of oceanic dispersal as a potential precursor for speciation.	Amer Museum Nat Hist, New York, NY 10024 USA; SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	American Museum of Natural History (AMNH); Texas State University System; Texas State University San Marcos; University of Michigan System; University of Michigan	Raxworthy, CJ (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	rax@amnh.edu						ARNOLD EN, 1979, PHILOS T ROY SOC B, V286, P127, DOI 10.1098/rstb.1979.0022; BLANC C P, 1972, P501; Brown J. H., 1998, BIOGEOGRAPHY; Caccone A, 1999, MOL PHYLOGENET EVOL, V12, P1, DOI 10.1006/mpev.1998.0594; CRISCI JV, 1991, SYST ZOOL, V40, P152, DOI 10.2307/2992254; EMERICK CM, 1982, EARTH PLANET SC LETT, V60, P415, DOI 10.1016/0012-821X(82)90077-2; Fisher BL, 1996, COLLOQ SEMI, P457; FROST DR, 1989, MISC PUBL U KANSAS M, V81, P1; Griswold Charles E., 2000, P345; Hay WW, 1999, GEOL S AM S, P1; HILLENIUS D, 1978, Beaufortia, V28, P9; HOFMAN A, 1991, Amphibia-Reptilia, V12, P245, DOI 10.1163/156853891X00428; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Klaver CJJ, 1986, BONN ZOOL MONOGR, V22, P1; Kluge A. G., 1995, MISC PUBL MUS ZOOL, V183, P1; Mausfeld P, 2000, MOL PHYLOGENET EVOL, V17, P11, DOI 10.1006/mpev.2000.0809; MOODY S, 1980, Vestnik Ustredniho Ustavu Geologickeho, V55, P85; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Nelson G., 1981, SYSTEMATICS BIOGEORA; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; RIEPPEL O, 1992, J HERPETOL, V26, P77, DOI 10.2307/1565027; RIEPPEL O, 1987, ZOOL J LINN SOC-LOND, V89, P41, DOI 10.1111/j.1096-3642.1987.tb01343.x; Rieppel O, 1997, J ZOOL, V243, P351, DOI 10.1111/j.1469-7998.1997.tb02788.x; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Trueman JWH, 1998, SYST BIOL, V47, P733, DOI 10.1080/106351598260725; Yoder AD, 1996, COLLOQ SEMI, P245	30	247	258	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					784	787		10.1038/415784a	http://dx.doi.org/10.1038/415784a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845207	Green Published			2022-12-28	WOS:000173833900044
J	Chen, CL; Weiss, NS; Newcomb, P; Barlow, WN; White, E				Chen, CL; Weiss, NS; Newcomb, P; Barlow, WN; White, E			Hormone replacement therapy in relation to breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENOPAUSAL ESTROGENS; RISK; CARCINOMA; PROLIFERATION; PROGESTERONE; WOMEN; STAGE	Context Studies of long-term hormone replacement therapy (HRT) suggest an associated increased risk of breast cancer, but whether this association differs according to histologic type of cancer has not been extensively studied. Objective To determine whether the association between HRT and risk of breast cancer varies by HRT formulation and differs across histologic cancer types. Design, Setting, and Participants Nested case-control study among 705 postmenopausal women enrolled in the Group Health Cooperative of Puget Sound (GHC) who were aged 50 to 74 years and had primary invasive breast cancer diagnosed between July 1, 1990, and December 31, 1995 (cases), and 692 randomly selected aged-matched female members of GHC (controls). Main Outcome Measure Incidence and type of breast cancer by duration of HRT use in the 5-year period ending 1 year before diagnosis, which was ascertained from computerized pharmacy records. Results The incidence of breast cancer, all histologic types combined, was increased by 60% to 85% in recent long-term users of HRT, whether estrogen alone or estrogen plus progestin. Longer use of HRT (odds ratio [OR], 3.07 for 57 months or more; 95% confidence interval [CI], 1.55-6.06) and current use of combination therapy (OR, 3.91; 95% CI, 2.05-7.44) were associated with increased risk of lobular breast cancer. Long-term HRT use was associated with a 50% increase in nonlobular cancer (OR, 1.52 for 57 months or more; 95% CI, 1.01-2.29). Conclusion Our data add to the growing body of evidence that recent long-term use of HRT is associated with an increased risk of breast cancer and that such use may be related particularly to lobular tumors.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Ctr Hlth Studies, Grp Hlth Cooperat, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	White, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,MP702, Seattle, WA 98109 USA.	ewhite@fhcrc.org			NATIONAL CANCER INSTITUTE [U01CA063731] Funding Source: NIH RePORTER; NCI NIH HHS [UO1CA63731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON TJ, 1989, HUM PATHOL, V20, P1139, DOI 10.1016/S0046-8177(89)80003-6; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BERGKVIST L, 1989, NEW ENGL J MED, V321, P293, DOI 10.1056/NEJM198908033210505; BRINTON LA, 1986, BRIT J CANCER, V54, P825, DOI 10.1038/bjc.1986.246; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; DIXON JM, 1982, HISTOPATHOLOGY, V6, P149, DOI 10.1111/j.1365-2559.1982.tb02712.x; EWERTZ M, 1988, INT J CANCER, V42, P832, DOI 10.1002/ijc.2910420606; GAMBRELL RD, 1983, OBSTET GYNECOL, V62, P435; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; HARRIS RE, 1992, J NATL CANCER I, V84, P1575, DOI 10.1093/jnci/84.20.1575; HIATT RA, 1984, CANCER, V54, P139, DOI 10.1002/1097-0142(19840701)54:1<139::AID-CNCR2820540128>3.0.CO;2-X; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; HULKA BS, 1982, AM J OBSTET GYNECOL, V143, P638, DOI 10.1016/0002-9378(82)90108-9; JICK H, 1980, AM J EPIDEMIOL, V112, P586, DOI 10.1093/oxfordjournals.aje.a113031; KAUFMAN DW, 1991, AM J EPIDEMIOL, V134, P1375, DOI 10.1093/oxfordjournals.aje.a116041; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; LAVECCHIA C, 1992, INT J CANCER, V50, P161, DOI 10.1002/ijc.2910500131; LAVECCHIA C, 1995, BRIT J CANCER, V72, P244, DOI 10.1038/bjc.1995.310; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.3.CO;2-O; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; LIPWORTH L, 1995, INT J CANCER, V62, P548, DOI 10.1002/ijc.2910620510; LOBO RA, 1991, J CLIN ENDOCR METAB, V73, P925, DOI 10.1210/jcem-73-5-925; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; MILLS PK, 1989, CANCER, V64, P591, DOI 10.1002/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; NEWCOMB PA, 1995, AM J EPIDEMIOL, V142, P788, DOI 10.1093/oxfordjournals.aje.a117717; Newcomer LM, 1999, AM J EPIDEMIOL, V149, pS79; NEWSTEAD GM, 1992, RADIOLOGY, V184, P623, DOI 10.1148/radiology.184.3.1324506; NOMURA AMY, 1986, INT J CANCER, V37, P49, DOI 10.1002/ijc.2910370109; PALMER JR, 1991, AM J EPIDEMIOL, V134, P1386, DOI 10.1093/oxfordjournals.aje.a116042; Persson I, 1997, INT J CANCER, V72, P758, DOI 10.1002/(SICI)1097-0215(19970904)72:5<758::AID-IJC9>3.3.CO;2-2; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; RISCH HA, 1994, AM J EPIDEMIOL, V139, P670, DOI 10.1093/oxfordjournals.aje.a117057; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SCHUURMAN AG, 1995, CANCER CAUSE CONTROL, V6, P416, DOI 10.1007/BF00052181; STANFORD JL, 1995, JAMA-J AM MED ASSOC, V274, P137, DOI 10.1001/jama.274.2.137; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; TALAMINI R, 1985, INT J EPIDEMIOL, V14, P70, DOI 10.1093/ije/14.1.70; Taplin SH, 1997, CANCER EPIDEM BIOMAR, V6, P625; THOMPSON RS, 1988, HMO PRACT, V2, P178; WEINSTEIN AL, 1993, INT J EPIDEMIOL, V22, P781, DOI 10.1093/ije/22.5.781; WINGO PA, 1987, JAMA-J AM MED ASSOC, V257, P209, DOI 10.1001/jama.257.2.209; YANG CP, 1992, CANCER CAUSE CONTROL, V3, P475, DOI 10.1007/BF00051360	47	247	255	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					734	741		10.1001/jama.287.6.734	http://dx.doi.org/10.1001/jama.287.6.734			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851540	Bronze			2022-12-28	WOS:000173809500030
J	Schroeder, K; Fahey, T				Schroeder, K; Fahey, T			Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults	BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTION; COMMON COLD; ANTITUSSIVE EFFICACY; DEXTROMETHORPHAN; TOLERABILITY; CODEINE	Objectives To determine whether over the counter cough medicines are effective for acute cough in adults. Design Systematic review of randomised controlled trials. Data sources Search of die Cochrane Acute Respiratory Infections Group specialised register, Cochrane Controlled Trials Register, Medline, Embase, and the UK Department of Health National Research Register in all languages. Included studies All randomised controlled trials that compared oral over the counter cough preparations with placebo in adults with acute cough due to upper respiratory tract infection in ambulatory settings and that had cough symptoms as an outcome. Results 15 trials involving 2166 participants met all the inclusion criteria. Antihistamines seemed to be no better than placebo. There was conflicting evidence on the effectiveness of antitussives, expectorants, anthihistamine-decongestant combinations, and other drug combinations compared with placebo. Conclusion Over the Counter cough medicines for acute cough cannot be recommended because there is no good evidence for their effectiveness. Even when trials had significant results, the effect sizes were small and of doubtful clinical relevance. Because of the small number of trials in each category, the results have to be interpreted cautiously.	Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England	University of Bristol	Schroeder, K (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.		Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783				ADAMS R, 1993, ADV THER, V10, P263; BANDERALI G, 1995, J INT MED RES, V23, P175, DOI 10.1177/030006059502300304; BANKS I, 2001, NHS DIRECT HEALTHCAR; BERKOWITZ RB, 1991, ANN ALLERGY, V67, P593; BERKOWITZ RB, 1989, ANN ALLERGY, V63, P336; CASS LJ, 1953, NEW ENGL J MED, V249, P132, DOI 10.1056/NEJM195307232490402; CHERNISH SM, 1963, ANN ALLERGY, V21, P677; CURLEY FJ, 1988, AM REV RESPIR DIS, V138, P305, DOI 10.1164/ajrccm/138.2.305; ECCLES R, 1992, J CLIN PHARM THER, V17, P175, DOI 10.1111/j.1365-2710.1992.tb01289.x; Freestone C, 1997, J PHARM PHARMACOL, V49, P1045, DOI 10.1111/j.2042-7158.1997.tb06039.x; GAFFEY MJ, 1988, PEDIATR INFECT DIS J, V7, P223, DOI 10.1097/00006454-198803000-00032; GASTPAR H, 1984, CURR MED RES OPIN, V9, P21, DOI 10.1185/03007998409109554; IRWIN RS, 1993, DRUGS, V46, P80, DOI 10.2165/00003495-199346010-00006; KUHN JJ, 1982, CHEST, V82, P713, DOI 10.1378/chest.82.6.713; KURTH W, 1978, MED WELT, V29, P1906; Lee PCL, 2000, J PHARM PHARMACOL, V52, P1137, DOI 10.1211/0022357001774903; Morice A, 1998, PRESCRIBER, V9, P74; MOSS C, 2001, OTC DIRECTORY 2001 2; NESSWETHA W, 1967, ARZNEI-FORSCHUNG, V17, P1324; Parvez L, 1996, PULM PHARMACOL THER, V9, P299, DOI 10.1006/pulp.1996.0039; REYNOLDS JEF, 1993, MARTINDALE EXTRA PHA, P741; ROBINSON RE, 1977, CURR THER RES CLIN E, V22, P284; *ROYAL COLL GEN PR, 1992, MORB STAT GEN PRACT; SCHROEDER K, 2001, COCHRANE DATABASE SY; SCHROEDER K, 2001, COCHRANE DATABASE SY, V3; SMITH MBH, 1993, JAMA-J AM MED ASSOC, V269, P2258, DOI 10.1001/jama.269.17.2258; THACKRAY P, 1978, J INT MED RES, V6, P161, DOI 10.1177/030006057800600218; The Proprietary Association of Great Britain, 2000, ANN REV REP; TUKIAINEN H, 1986, EUR J RESPIR DIS, V69, P95; ZIMENT I, 1976, JAMA-J AM MED ASSOC, V236, P193, DOI 10.1001/jama.236.2.193; 1999, DRUG THER B, V37, P19	31	92	97	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					329	+		10.1136/bmj.324.7333.329	http://dx.doi.org/10.1136/bmj.324.7333.329			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834560	Bronze, Green Published			2022-12-28	WOS:000173866300018
J	Mintzes, B; Barer, ML; Kravitz, RL; Kazanjian, A; Bassett, K; Lexchin, J; Evans, RG; Pan, R; Marion, SA				Mintzes, B; Barer, ML; Kravitz, RL; Kazanjian, A; Bassett, K; Lexchin, J; Evans, RG; Pan, R; Marion, SA			Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V5Z 1M9, Canada; Univ Calif Davis, Ctr Hlth Serv Res Primary Care, Sacramento, CA 95817 USA; York Univ, Sch Hlth Policy & Management, N York, ON M3J 1P3, Canada; Univ Calif Davis, Med Ctr, Ctr Hlth Serv Res Primary Care, PC AWARE, Davis, CA 95616 USA	University of British Columbia; University of British Columbia; University of California System; University of California Davis; York University - Canada; University of California System; University of California Davis	Mintzes, B (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V6T 1Z3, Canada.		Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X				Findlay S, 2000, PRESCRIPTION DRUGS M; IMS Health, 2001, US LEAD PROD DTC SPE; Silversides A, 2001, CAN MED ASSOC J, V165, P462; *THER PROD PROGR, 1999, DIR CONS ADV PRESCR; WATSON R, 2001, BMJ-BRIT MED J, V323, P184	5	158	162	0	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					278	279		10.1136/bmj.324.7332.278	http://dx.doi.org/10.1136/bmj.324.7332.278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823361	Green Published, Bronze			2022-12-28	WOS:000173728300020
J	Zulicke, U				Zulicke, U			Applied physics - Ultrasmall wires get excited	SCIENCE			English	Editorial Material							JUNCTIONS		Univ Karlsruhe, Inst Theoret Festkorperphys, D-76128 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Zulicke, U (corresponding author), Univ Karlsruhe, Inst Theoret Festkorperphys, Kaiserstr 12, D-76128 Karlsruhe, Germany.		Zuelicke, Ulrich/B-1287-2009	Zuelicke, Ulrich/0000-0001-5055-3330				Auslaender OM, 2000, PHYS REV LETT, V84, P1764, DOI 10.1103/PhysRevLett.84.1764; Auslaender OM, 2002, SCIENCE, V295, P825, DOI 10.1126/science.1066266; EISENSTEIN JP, 1991, PHYS REV B, V44, P6511, DOI 10.1103/PhysRevB.44.6511; Fuhrer MS, 2000, SCIENCE, V288, P494, DOI 10.1126/science.288.5465.494; Huber M. Q., COMMUNICATION; Vdovin EE, 2000, SCIENCE, V290, P122, DOI 10.1126/science.290.5489.122; Voit J, 1994, REP PROG PHYS, V57, P977; WOLF EL, 1985, INT SERIES MONOGRAPH, V71; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241	9	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					810	811		10.1126/science.1069031	http://dx.doi.org/10.1126/science.1069031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823629				2022-12-28	WOS:000173733000031
J	Bartlett, JG				Bartlett, JG			Antibiotic-associated diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIFFICILE-ASSOCIATED DIARRHEA; CLOSTRIDIUM-DIFFICILE; ENZYME IMMUNOASSAYS; HOSPITALIZED-PATIENTS; TOXIN-A; COLITIS; DIAGNOSIS; METRONIDAZOLE; EPIDEMIOLOGY; CLINDAMYCIN		Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA	Johns Hopkins University	Bartlett, JG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 1830 E Monument St,Rm 439, Baltimore, MD 21287 USA.	jb@jhmi.edu						ALTEMEIER WA, 1963, ANN SURG, V157, P847, DOI 10.1097/00000658-196306000-00003; BARBUT F, 1993, J CLIN MICROBIOL, V31, P963, DOI 10.1128/JCM.31.4.963-967.1993; BARTLETT JG, 1985, GASTROENTEROLOGY, V89, P1192, DOI 10.1016/0016-5085(85)90227-6; BARTLETT JG, 1981, JOHNS HOPKINS MED J, V149, P6; BARTLETT JG, 1992, CLIN INFECT DIS, V15, P573, DOI 10.1093/clind/15.4.573; Bauer TH, 2001, JAMA-J AM MED ASSOC, V285, P313, DOI 10.1001/jama.285.3.313; Bulusu M, 2000, AM J GASTROENTEROL, V95, P3137, DOI 10.1111/j.1572-0241.2000.03284.x; Chassany O, 2000, DRUG SAFETY, V22, P53, DOI 10.2165/00002018-200022010-00005; Climo MW, 1998, ANN INTERN MED, V128, P989, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00005; FEKETY R, 1993, JAMA-J AM MED ASSOC, V269, P71, DOI 10.1001/jama.269.1.71; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; FORES D, 2001, ARCH DIS CHILD, V84, P328; GERDING DN, 1989, ANN INTERN MED, V110, P255, DOI 10.7326/0003-4819-110-4-255; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; GILBERT DN, 1995, INFECT DIS CLIN PRAC, V4, pS103; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; GORBACH SL, 1987, LANCET, V2, P1519; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Gustafsson A, 1999, SCAND J GASTROENTERO, V34, P580, DOI 10.1080/003655299750026038; Hogenauer C, 1998, CLIN INFECT DIS, V27, P702, DOI 10.1086/514958; HOVIUS SER, 1982, NETH J SURG, V34, P81; Johnson S, 1999, NEW ENGL J MED, V341, P1645, DOI 10.1056/NEJM199911253412203; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Karlstrom O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; LAUGHON BE, 1984, J INFECT DIS, V149, P781, DOI 10.1093/infdis/149.5.781; Lozniewski A, 2001, J CLIN MICROBIOL, V39, P1996, DOI 10.1128/JCM.39.5.1996-1998.2001; MANABE YC, 1995, ANN INTERN MED, V123, P835, DOI 10.7326/0003-4819-123-11-199512010-00004; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V272, P518; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MERZ CS, 1994, J CLIN MICROBIOL, V32, P1142, DOI 10.1128/JCM.32.5.1142-1147.1994; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525; Olsen SJ, 2001, NEW ENGL J MED, V344, P1572, DOI 10.1056/NEJM200105243442102; Peterson LR, 1996, EUR J CLIN MICROBIOL, V15, P330, DOI 10.1007/BF01695667; Salcedo J, 1997, GUT, V41, P366, DOI 10.1136/gut.41.3.366; SCHWAN A, 1984, SCAND J INFECT DIS, V16, P211, DOI 10.3109/00365548409087145; Sparks SG, 2001, J CLIN MICROBIOL, V39, P883, DOI 10.1128/JCM.39.3.883-888.2001; SUN M, 1984, SCIENCE, V226, P30, DOI 10.1126/science.6566452; TEASLEY DG, 1983, LANCET, V2, P1043; VISCIDI R, 1981, GASTROENTEROLOGY, V81, P5; Wenisch, 1996, CLIN INFECT DIS, V23, P423; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Wistrom J, 2001, J ANTIMICROB CHEMOTH, V47, P43, DOI 10.1093/jac/47.1.43	46	776	906	0	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					334	339		10.1056/NEJMcp011603	http://dx.doi.org/10.1056/NEJMcp011603			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821511				2022-12-28	WOS:000173545300007
J	Kennedy, MJ; Pevear, DR; Hill, RJ				Kennedy, MJ; Pevear, DR; Hill, RJ			Mineral surface control of organic carbon in black shale	SCIENCE			English	Article							ELECTRON-MICROSCOPY; MATTER PRESERVATION; MARINE-SEDIMENTS; MONTMORILLONITE; COMPLEXES; SORPTION; SOILS; AREA	We show that 85% of variation in total organic carbon can be explained by mineral surface area in a black shale deposit from two locations in the late Cretaceous Western Interior Seaway, United States. This relation suggests that, as in modern marine sediments, adsorption of carbon compounds onto clay mineral surfaces played a fundamental role in the burial and preservation of organic carbon. Our data also provide evidence for organic matter within the smectite interlayer. This association implies that organic carbon sequestration in a representative oil-prone black shale facies may be more closely related to patterns of continental weathering and clay mineralogy than to ocean water chemistry or marine productivity.	Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; US Geol Survey, Denver Fed Ctr, Lakewood, CO 80225 USA	University of California System; University of California Riverside; United States Department of the Interior; United States Geological Survey	Kennedy, MJ (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.			Kennedy, Martin/0000-0002-1330-6864				ARTHUR MA, 1994, ANNU REV EARTH PL SC, V22, P499, DOI 10.1146/annurev.ea.22.050194.002435; BARRIUSO E, 1994, SOIL SCI SOC AM J, V58, P1632, DOI 10.2136/sssaj1994.03615995005800060008x; BISHOP AN, 1992, ORG GEOCHEM, V18, P431, DOI 10.1016/0146-6380(92)90106-8; Bosetto M, 1997, CLAY MINER, V32, P341, DOI 10.1180/claymin.1997.032.3.02; CIHACEK LJ, 1979, SOIL SCI SOC AM J, V43, P821, DOI 10.2136/sssaj1979.03615995004300040045x; Dean W.E., 1998, CONCEPTS SEDIMENTOLO, V6, P227, DOI DOI 10.2110/CSP; Di Leo P, 2000, CLAY CLAY MINER, V48, P495, DOI 10.1346/CCMN.2000.0480501; Furukawa Y, 2000, ORG GEOCHEM, V31, P735, DOI 10.1016/S0146-6380(00)00043-7; GAUTIER DL, 1984, HYDROCARBON SOURCE R, P369; GREGG SJ, 1982, ADSORPTION SURFACE; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Johnston CT, 1996, CMS WORK LECT, V8, P1; KEIL RG, 1993, CHEM GEOL, V107, P385, DOI 10.1016/0009-2541(93)90215-5; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; Ohashi H, 1996, CLAY MINER, V31, P347, DOI 10.1180/claymin.1996.031.3.05; PARRISH JT, 1993, EVOLUTION W INTERIOR, V39, P319; PEVEAR D., 1988, SHORT COURS 22 SEPM, V22; Quirk JP, 1999, SOIL SCI SOC AM J, V63, P839, DOI 10.2136/sssaj1999.634839x; Ransom B, 1998, GEOCHIM COSMOCHIM AC, V62, P1329, DOI 10.1016/S0016-7037(98)00050-7; Ransom B, 1997, MAR GEOL, V138, P1, DOI 10.1016/S0025-3227(97)00012-1; Salmon V, 2000, ORG GEOCHEM, V31, P463, DOI 10.1016/S0146-6380(00)00013-9; SCHULTZ L., 1980, 1064B US GEOL SURV; Sheng GY, 2001, J AGR FOOD CHEM, V49, P2899, DOI 10.1021/jf001485d; TANCK GS, 1997, THESIS U ARIZONA; THENG BKG, 1986, SOIL SCI, V142, P262, DOI 10.1097/00010694-198611000-00003; Violante A, 1995, CLAY MINER, V30, P325, DOI 10.1180/claymin.1995.030.4.06; Wignall P.B., 1994, J PALEONTOL	28	389	447	12	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					657	660		10.1126/science.1066611	http://dx.doi.org/10.1126/science.1066611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809966				2022-12-28	WOS:000173560900038
J	Tijsterman, M; Ketting, RF; Okihara, KL; Sijen, T; Plasterk, RHA				Tijsterman, M; Ketting, RF; Okihara, KL; Sijen, T; Plasterk, RHA			RNA helicase MUT-14-dependent gene silencing triggered in C-elegans by short antisense RNAs	SCIENCE			English	Article							GERM-LINE DEVELOPMENT; MESSENGER-RNA; UNWINDING RNA; INTERFERENCE; REQUIREMENTS; POLYMERASE; TRANSGENE	Posttranscriptional gene silencing in Caenorhabditis elegans results from exposure to double-stranded RNA (dsRNA), a phenomenon designated as RNA interference (RNAi), or from co-suppression, in which transgenic DNA leads to silencing of both the transgene and the endogenous gene. Here we show that single-stranded RNA oligomers of antisense polarity can also be potent inducers of gene silencing. As is the case for co-suppression, antisense RNAs act independently of the RNAi genes rde-1 and rde-4 but require the mutator/RNAi gene mut-7 and a putative DEAD box RNA helicase, mut-14. Our data favor the hypothesis that gene silencing is accomplished by RNA primer extension using the mRNA as template, leading to dsRNA that is subsequently degraded.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Tijsterman, Marcel/H-5663-2018	Tijsterman, Marcel/0000-0001-8465-9002; Ketting, Rene/0000-0001-6161-5621				Baulcombe DC, 2000, SCIENCE, V290, P1108, DOI 10.1126/science.290.5494.1108; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ELBASHIR SM, IN PRESS EMBO J; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	26	119	213	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					694	697		10.1126/science.1067534	http://dx.doi.org/10.1126/science.1067534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809977				2022-12-28	WOS:000173560900050
J	Tan, HL; Kupershmidt, S; Zhang, R; Stepanovic, S; Roden, DM; Wilde, AAM; Anderson, ME; Balser, JR				Tan, HL; Kupershmidt, S; Zhang, R; Stepanovic, S; Roden, DM; Wilde, AAM; Anderson, ME; Balser, JR			A calcium sensor in the sodium channel modulates cardiac excitability	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; ST-SEGMENT ELEVATION; BRUGADA-SYNDROME; SLOW INACTIVATION; PROTEIN-KINASE; NA+ CHANNEL; CALMODULIN; ARRHYTHMIAS; DEATH; MECHANISM	Sodium channels are principal molecular determinants responsible for myocardial conduction and maintenance of the cardiac rhythm. Calcium ions (Ca2+) have a fundamental role in the coupling of cardiac myocyte excitation and contraction, yet mechanisms whereby intracellular Ca2+ may directly modulate Na channel function have yet to be identified. Here we show that calmodulin (CaM), a ubiquitous Ca2+-sensing protein, binds to the carboxy-terminal 'IQ' domain(1) of the human cardiac Na channel (hH1) in a Ca2+-dependent manner. This binding interaction significantly enhances slow inactivation-a channel-gating process linked to life-threatening idiopathic ventricular arrhythmias(2,3). Mutations targeted to the IQ domain disrupted CaM binding and eliminated Ca2+/CaM-dependent slow inactivation, whereas the gating effects of Ca2+/CaM were restored by intracellular application of a peptide modelled after the IQ domain. A naturally occurring mutation (A1924T) in the IQ domain altered hH1 function in a manner characteristic of the Brugada arrhythmia syndrome(4,5), but at the same time inhibited slow inactivation induced by Ca2+/CaM, yielding a clinically benign (arrhythmia free) phenotype.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Amsterdam; Academic Medical Center Amsterdam	Balser, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37232 USA.		Kupershmidt, Sabina/AAO-5464-2021; Roden, Dan/ABD-5412-2021	Kupershmidt, Sabina/0000-0002-8119-2723; 				Aimond F, 1999, CARDIOVASC RES, V42, P402, DOI 10.1016/S0008-6363(99)00070-X; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Balser JR, 1999, CIRC RES, V85, P872, DOI 10.1161/01.RES.85.9.872; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; CLUSIN WT, 1983, LANCET, V1, P272, DOI 10.1016/S0140-6736(83)91688-4; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DIDIEGO JM, 1994, CIRCULATION, V89, P1839, DOI 10.1161/01.CIR.89.4.1839; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; James P, 1996, GENETICS, V144, P1425; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richmond JE, 1998, BIOPHYS J, V74, P2945, DOI 10.1016/S0006-3495(98)78001-4; Rook MB, 1999, CARDIOVASC RES, V44, P507, DOI 10.1016/S0008-6363(99)00350-8; RUDY B, 1978, J PHYSL, V238, P1; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; Wilde A, 1999, CIRCULATION, V99, P722; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	30	175	186	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					442	447		10.1038/415442a	http://dx.doi.org/10.1038/415442a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807557				2022-12-28	WOS:000173433600053
J	Humar, D; Datta, V; Bast, DJ; Beall, B; De Azavedo, JCS; Nizet, V				Humar, D; Datta, V; Bast, DJ; Beall, B; De Azavedo, JCS; Nizet, V			Streptolysin S and necrotising infections produced by group G streptococcus	LANCET			English	Article							GROUP-A STREPTOCOCCI; TOXIC-SHOCK-SYNDROME; M-PROTEIN; GROUP-C; NECROTIZING FASCIITIS; CYSTEINE PROTEASE; VIRULENCE FACTOR; MURINE MODEL; EXPRESSION; IDENTIFICATION	Background We encountered three patients with severe necrotising soft tissue infections due to beta-haemolytic group G streptococcus. Due to strong clinical similarities with invasive infections produced by group A streptococcus, we investigated a potential link of shared beta-haemolytic phenotype to disease pathogenesis. Methods Hybridisation, DNA sequencing, targeted mutagenesis, and complementation studies were used to establish the genetic basis for group G streptococcus beta-haemolytic activity. The requirement of group G streptococcus beta-haemolysin in producing necrotising infection was examined in mice. Findings Each patient had an underlying medical condition. beta-haemolytic group G streptococcus was the sole microbial isolate from debrided necrotic tissue. The group G streptococcus chromosome contained a homologue of the nine-gene group A streptococcus sag operon encoding the beta-haemolysin streptolysin S (SLS). Targeted mutagenesis of the putative SLS structural gene sagA in group G streptococcus eliminated beta-haemolytic activity. Mice injected subcutaneously with wild-type group A streptococcus or group G streptococcus developed an inflammatory lesion with high bacterial counts, marked neutrophil infiltration, and histopathological evidence of diffuse tissue necrosis. These changes were not found in mice injected with the isogenic group A streptococcus or group G streptococcus SLS-negative mutants. Interpretation In patients with underlying medical conditions, beta-haemolytic group G streptococcus can produce necrotising soft tissue infections resembling those produced by group A streptococcus. The beta-haemolytic phenotype of group G streptococcus is produced by the exotoxin SLS, encoded by a functional homologue of the nine-gene group A streptococcus sag operon. SLS expression contributes to the pathogenesis of streptococcal necrotising soft tissue infection.	Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA; Univ Calif San Diego, Dept Pediat, Div Infect Dis, San Diego, CA 92103 USA; Mt Sinai Hosp, Toronto Med Labs, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON, Canada; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Resp Dis Branch, Atlanta, GA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Centers for Disease Control & Prevention - USA	Nizet, V (corresponding author), Univ Calif San Diego, Div Infect Dis, 9500 Gilman Dr,Mail Code 0672, La Jolla, CA 92093 USA.		Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	NIAID NIH HHS [AI01451] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001451] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; AUCKENTHALER R, 1983, REV INFECT DIS, V5, P196; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BERNHEIM.AW, 1967, J BACTERIOL, V93, P2024, DOI 10.1128/JB.93.6.2024-2025.1967; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bisno AL, 1997, INFECT IMMUN, V65, P4926, DOI 10.1128/IAI.65.12.4926-4930.1997; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; Chhatwal GS, 2000, GRAM-POSITIVE PATHOGENS, P177; DOURMASHKIN RR, 1966, AM J MED, V41, P699, DOI 10.1016/0002-9343(66)90031-3; ELIAS N, 1966, ISRAEL J MED SCI, V2, P302; GAUNT N, 1984, LANCET, V1, P516; Gaviria JM, 2000, STREPTOCOCCAL INFECT, P180; Geyer A, 2000, MOL GEN GENET, V262, P965, DOI 10.1007/PL00008665; GINSBURG I, 1972, J INFECT DIS, V126, P294, DOI 10.1093/infdis/126.3.294; Ginsburg I, 1999, APMIS, V107, P1051, DOI 10.1111/j.1699-0463.1999.tb01509.x; Honore PM, 1996, ACTA CLIN BELG, V51, P57, DOI 10.1080/17843286.1996.11718485; HRYNIEWICZ W, 1977, INFECT IMMUN, V16, P730, DOI 10.1128/IAI.16.3.730-733.1977; JOHNSON DR, 1993, J MED MICROBIOL, V38, P311, DOI 10.1099/00222615-38-5-311; KEHOE M, 1984, INFECT IMMUN, V43, P804, DOI 10.1128/IAI.43.3.804-810.1984; KOYAMA J, 1963, J BIOCHEM-TOKYO, V54, P146; LAM K, 1983, AM J MED, V75, P561, DOI 10.1016/0002-9343(83)90434-5; Liu C E, 1995, Zhonghua Yi Xue Za Zhi (Taipei), V56, P173; Lukomski S, 1999, INFECT IMMUN, V67, P1779; Malke H, 2000, GRAM-POSITIVE PATHOGENS, P163; NAKATA MM, 1983, ARCH INTERN MED, V143, P1328, DOI 10.1001/archinte.143.7.1328; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; Stepak P, 1999, JAMA-J AM MED ASSOC, V282, P934; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Stevens DL, 2000, ANNU REV MED, V51, P271, DOI 10.1146/annurev.med.51.1.271; TAKETO Y, 1966, J BIOCHEM, V60, P357, DOI 10.1093/oxfordjournals.jbchem.a128446; Taylor FB, 1999, CLIN INFECT DIS, V29, P167, DOI 10.1086/520147; Vandamme P, 1996, INT J SYST BACTERIOL, V46, P774, DOI 10.1099/00207713-46-3-774; Wagner JG, 1996, CLIN INFECT DIS, V23, P1159, DOI 10.1093/clinids/23.5.1159; WATSKY KL, 1985, ARCH INTERN MED, V145, P58, DOI 10.1001/archinte.145.1.58; Wessels MR, 1999, TRENDS MICROBIOL, V7, P428, DOI 10.1016/S0966-842X(99)01604-2; WIDDOWSON JP, 1971, J GEN MICROBIOL, V65, P69, DOI 10.1099/00221287-65-1-69	40	96	97	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					124	129		10.1016/S0140-6736(02)07371-3	http://dx.doi.org/10.1016/S0140-6736(02)07371-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809255				2022-12-28	WOS:000173212400012
J	Robock, A				Robock, A			Pinatubo eruption - The climatic aftermath	SCIENCE			English	Editorial Material							VOLCANIC-ERUPTIONS; OZONE; OSCILLATION; SIMULATION; AEROSOL; SIGNAL; IMPACT		Rutgers State Univ, Cook Coll, Dept Environm Sci, Ctr Environm Predict, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Robock, A (corresponding author), Rutgers State Univ, Cook Coll, Dept Environm Sci, Ctr Environm Predict, New Brunswick, NJ 08901 USA.	robcock@envsci.rutgers.edu	Robock, Alan/B-6385-2016	Robock, Alan/0000-0002-6319-5656				*AM GEOPH UN FALL, 2001, AM GEOPH UN FALL M S; Angell JK, 1997, GEOPHYS RES LETT, V24, P647, DOI 10.1029/97GL00544; BLUTH GJS, 1992, GEOPHYS RES LETT, V19, P151, DOI 10.1029/91GL02792; Coffey MT, 1996, J GEOPHYS RES-ATMOS, V101, P6767, DOI 10.1029/95JD03763; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; D'Arrigo R, 1999, CLIMATIC CHANGE, V42, P663, DOI 10.1023/A:1005471918574; Free M, 1999, J GEOPHYS RES-ATMOS, V104, P19057, DOI 10.1029/1999JD900233; GENIN A, 1995, NATURE, V377, P507, DOI 10.1038/377507a0; Houghton J. T., 2001, CLIMATE CHANGE 2001; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kirchner I, 1999, J GEOPHYS RES-ATMOS, V104, P19039, DOI 10.1029/1999JD900213; Randel WJ, 1999, J CLIMATE, V12, P1467, DOI 10.1175/1520-0442(1999)012<1467:COTAAA>2.0.CO;2; ROBOCK A, 1992, GEOPHYS RES LETT, V19, P2405, DOI 10.1029/92GL02627; ROBOCK A, 1995, J CLIMATE, V8, P1086, DOI 10.1175/1520-0442(1995)008<1086:TVSIST>2.0.CO;2; Robock A, 1996, SCIENCE, V272, P972, DOI 10.1126/science.272.5264.972; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; SCHOEBERL MR, 1993, GEOPHYS RES LETT, V20, P29, DOI 10.1029/92GL02637; Solomon S, 1996, J GEOPHYS RES-ATMOS, V101, P6713, DOI 10.1029/95JD03353; STENCHIKOV G, UNPUB; Stenchikov GL, 1998, J GEOPHYS RES-ATMOS, V103, P13837, DOI 10.1029/98JD00693; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; TIE XX, 1994, J GEOPHYS RES-ATMOS, V99, P20545, DOI 10.1029/94JD01488; VOGELMANN AM, 1992, NATURE, V359, P47, DOI 10.1038/359047a0; ZEREFOS CS, 1994, J GEOPHYS RES-ATMOS, V99, P25741, DOI 10.1029/94JD02142	24	101	104	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1242	1244		10.1126/science.1069903	http://dx.doi.org/10.1126/science.1069903			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847326				2022-12-28	WOS:000173926000026
J	Taatjes, DJ; Naar, AM; Andel, F; Nogales, E; Tjian, R				Taatjes, DJ; Naar, AM; Andel, F; Nogales, E; Tjian, R			Structure, function, and activator-induced conformations of the CRSP coactivator	SCIENCE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; COFACTOR COMPLEX; CHROMATIN; MEDIATOR; PROTEIN; DOMAIN; SMCC; SP1	The human cofactor complexes ARC (activator-recruited cofactor) and CRSP (cofactor required for Sp1 activation) mediate activator-dependent transcription in vitro. Although these complexes share several common subunits, their structural and functional relationships remain unknown. Here, we report that affinity-purified ARC consists of two distinct multisubunit complexes: a larger complex, denoted ARC-L, and a smaller coactivator, CRSP. Reconstituted in vitro transcription with biochemically separated ARC-L and CRSP reveals differential cofactor functions. The ARC-L complex is transcriptionally inactive, whereas the CRSP complex is highly active. Structural determination by electron microscopy (EM) and three-dimensional reconstruction indicate substantial differences in size and shape between ARC-L and CRSP. Moreover, EM analysis of independently derived CRSP complexes reveals distinct conformations induced by different activators. These results suggest that CRSP may potentiate transcription via specific activator-induced conformational changes.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 401 Barker Hall, Berkeley, CA 94720 USA.		Taatjes, Dylan J/G-2027-2011					Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; KAMAKAKA RT, 1993, GENE DEV, V7, P1779, DOI 10.1101/gad.7.9.1779; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; NAAR AM, UNPUB; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8	19	209	217	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1058	1062		10.1126/science.1065249	http://dx.doi.org/10.1126/science.1065249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834832				2022-12-28	WOS:000173793000062
J	Makse, HA; Kurchan, J				Makse, HA; Kurchan, J			Testing the thermodynamic approach to granular matter with a numerical model of a decisive experiment	NATURE			English	Article							MECHANICS; FLUCTUATIONS; FLOW; FOAM	Edwards has proposed(1-3) a thermodynamic description of dense, slowly flowing granular matter, in which the grains (the 'atoms' of the system) interact with inelastic forces and enduring contacts. In Edwards' ensemble-one of the very few generalizations of standard statistical mechanics-thermodynamic quantities are computed as flat averages over configurations in which the grains are static or jammed, leading to a natural definition of configurational temperature. But the approach is not justified from first principles and hence, in the absence of explicit tests of its validity, has not been widely accepted. Here we report a numerical experiment involving a realistic model of slowly sheared granular matter; our results strongly support the thermodynamic description. Considering particles of different sizes in a slowly sheared dense granular system, we extract an effective temperature from a relation connecting their diffusivity and mobility. We then perform an explicit computation to show that the effective temperature measured from this relation coincides with the Edwards configurational temperature. Our approach, which is specifically conceived to be reproducible in the laboratory, may thus render the Edwards temperature accessible to experiments.	CUNY City Coll, Levich Inst, New York, NY 10031 USA; CUNY City Coll, Dept Phys, New York, NY 10031 USA; Ecole Super Phys & Chim Ind Ville Paris, PMMH, F-75231 Paris, France	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite	Makse, HA (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.	makse@mailaps.org						Allen M.P., 1991, COMPUTER SIMULATION; Barrat A, 2000, PHYS REV LETT, V85, P5034, DOI 10.1103/PhysRevLett.85.5034; Brey JJ, 2000, PHYSICA A, V275, P310, DOI 10.1016/S0378-4371(99)00375-1; Cugliandolo LF, 1997, PHYS REV E, V55, P3898, DOI 10.1103/PhysRevE.55.3898; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; Dean DS, 2001, PHYS REV LETT, V86, P5639, DOI 10.1103/PhysRevLett86.5639; DRESCHER A, 1972, J MECH PHYS SOLIDS, V20, P337, DOI 10.1016/0022-5096(72)90029-4; Durian DJ, 1995, PHYS REV LETT, V75, P4780, DOI 10.1103/PhysRevLett.75.4780; Edwards S. F., 1994, GRANULAR MATTER INTE, P121; EDWARDS SF, 1991, DISORDER IN CONDENSED MATTER PHYSICS, P147; HERRMANN HJ, 1998, PHYSICS DRY GRANULAR; HOOVER WG, 1980, PHYS REV A, V22, P1690, DOI 10.1103/PhysRevA.22.1690; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Johnson KL, 1985, CONTACT MECH, DOI 10.1201/b17110-2; KURCHAN J, 2001, JAMMING RHEOLOGY CON, P72; Lacasse MD, 1996, PHYS REV LETT, V76, P3448, DOI 10.1103/PhysRevLett.76.3448; Langer SA, 2000, EUROPHYS LETT, V49, P68, DOI 10.1209/epl/i2000-00121-4; LIU CH, 1995, SCIENCE, V269, P513, DOI 10.1126/science.269.5223.513; Makse HA, 2000, PHYS REV LETT, V84, P4160, DOI 10.1103/PhysRevLett.84.4160; MEHTA A, 1989, PHYSICA A, V157, P1091, DOI 10.1016/0378-4371(89)90035-6; Nicodemi M, 1999, PHYS REV LETT, V82, P3734, DOI 10.1103/PhysRevLett.82.3734; Nowak ER, 1998, PHYS REV E, V57, P1971, DOI 10.1103/PhysRevE.57.1971; Ottino JM, 2000, ANNU REV FLUID MECH, V32, P55, DOI 10.1146/annurev.fluid.32.1.55; SAVAGE SB, 1984, ADV APPL MECH, V24, P289, DOI 10.1016/S0065-2156(08)70047-4; Schafer J, 1996, J PHYS I, V6, P5, DOI 10.1051/jp1:1996129; Sciortino F, 2001, PHYS REV LETT, V86, P107, DOI 10.1103/PhysRevLett.86.107	26	265	266	2	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					614	617		10.1038/415614a	http://dx.doi.org/10.1038/415614a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832938				2022-12-28	WOS:000173709100038
J	O'Shea, JC; Buller, CE; Cantor, WJ; Chandler, AB; Cohen, EA; Cohen, DJ; Gilchrist, IC; Kleiman, NS; Labinaz, M; Madan, M; Hafley, GE; Califf, RM; Kitt, MM; Strony, J; Tcheng, JE				O'Shea, JC; Buller, CE; Cantor, WJ; Chandler, AB; Cohen, EA; Cohen, DJ; Gilchrist, IC; Kleiman, NS; Labinaz, M; Madan, M; Hafley, GE; Califf, RM; Kitt, MM; Strony, J; Tcheng, JE		ESPRIT Investigators	Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	74th Annual Scientific Sessions of the American-Heart-Association	NOV   12, 2001	ANAHEIM, CALIFORNIA	Amer Heart Assoc			DIABETES-MELLITUS; TRIAL; OUTCOMES	Context In the Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) trial, treatment with eptifibatide, a platelet glycoprotein IIb/IIIa integrin blocker, was found to reduce the ischemic complications of nonurgent coronary stent implantation at 48 hours and 30 days. Objective To determine whether eptifibatide treatment continues to provide durable, long-term benefit after coronary stent intervention. Design and Setting The ESPRIT trial was a randomized, double-blind, placebo-controlled, parallel-group, crossover-permitted trial conducted from June 1999 through February 2000 at 92 tertiary care centers in the United States and Canada. Participants A total of 2064 patients scheduled to undergo nonurgent percutaneous coronary intervention with stent implantation. Intervention Patients were randomly assigned to receive placebo (n=1024) or eptifibatide (two 180-mug/kg boluses, 10 minutes apart, with a continuous infusion of 2.0 mug/kg per minute; n=1040), started immediately before stent implantation and continued for 18 to 24 hours. Patients also received aspirin, heparin, and a thienopyridine. Main Outcome Measures Composite rates of death or myocardial infarction (MI) and death, infarction, or target vessel revascularization during the 12 months after enrollment. Results Complete follow-up data were available for 988 patients given eptifibatide (95.0%) and 976 patients given placebo (95.3%). By 12 months, the composite of death or MI had occurred in 8.0% of eptifibatide-treated patients and in 12.4% of placebo-treated patients (hazard ratio [HR], 0.63; 95% confidence interval [CI] 0.48-0.83; P=.001). The composite rate of death, MI, or target vessel revascularization was 17.5% in eptifibatide-treated patients vs 22.1% in placebo-treated patients (HR, 0.76; 95% CI, 0.63-0.93; P=.007). Conclusions Long-term outcomes of nonurgent coronary stent implantation appear to be improved through blockade of the platelet glycoprotein IIb/IIIa integrin with eptifibatide.	Duke Clin Res Inst, Durham, NC 27705 USA; Vancouver Gen Hosp, Vancouver, BC, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Univ Hosp, Augusta, GA USA; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Penn State Univ, Hershey, PA USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; COR Therapeut Inc, San Francisco, CA USA; Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA	Duke University; University of British Columbia; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Beth Israel Deaconess Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Baylor College of Medicine; University of Ottawa; University of Ottawa Heart Institute; Merck & Company; Schering Plough Corporation	O'Shea, JC (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27705 USA.		Gilchrist, Ian/HCI-4187-2022	Gilchrist, Ian/0000-0001-8525-8454				CALIFF RM, 1994, NEW ENGL J MED, V330, P956, DOI 10.1056/nejm199404073301402; Hanrath P, 1997, CIRCULATION, V96, P1445; Kleiman NS, 1998, CIRCULATION, V97, P1912, DOI 10.1161/01.CIR.97.19.1912; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; Madan M, 1998, CIRCULATION, V98, P2629, DOI 10.1161/01.CIR.98.23.2629; NANNIZZIALAIMO L, IN PRESS CIRCULATION; O'Shea JC, 2000, AM HEART J, V140, P834, DOI 10.1067/mhj.2000.110458; Simoons ML, 1997, LANCET, V349, P1429; STEIN B, 1995, CIRCULATION, V91, P979, DOI 10.1161/01.CIR.91.4.979; *TARGET STEER COMM, 2001, TARGET 6 MONTH RES; Tcheng JE, 1997, LANCET, V349, P1422; Tcheng JE, 2000, LANCET, V356, P2037; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 1999, LANCET, V354, P2019, DOI 10.1016/S0140-6736(99)10018-7; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502	16	67	70	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					618	621		10.1001/jama.287.5.618	http://dx.doi.org/10.1001/jama.287.5.618			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829701				2022-12-28	WOS:000173686700031
J	Holmes, J				Holmes, J			All you need is cognitive behaviour therapy?	BRITISH MEDICAL JOURNAL			English	Article							DEPRESSION		Univ Exeter, N Devon Dist Hosp, Dept Mental Hlth, Barnstaple, England	University of Exeter	Holmes, J (corresponding author), Univ Exeter, N Devon Dist Hosp, Dept Mental Hlth, Barnstaple, England.							Adams Douglas, 1978, HITCHHIKERS GUIDE GA, P4; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bateman A., 2000, BRIT J PSYCHOTHERAPY, V17, P147, DOI [10.1111/j.1752-0118.2000.tb00571.x, DOI 10.1111/J.1752-0118.2000.TB00571.X]; *DEP HLTH, 2001, TREATM CHOIC PSYCH T; Department of Health, 2000, NAT PLAN; Elkin I, 1994, HDB PSYCHOTHERAPY BE, P114; FONAGY P, 1999, OPEN DOOR REV OUTCOM; FREIDLI K, 1996, PRIMARY CARE PSYCHIA, V2, P205; Hemmings A, 2000, BRIT J GUID COUNS, V28, P233, DOI 10.1080/03069880050013520; HOLMES J, IN PRESS PSYCHOTHERA; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Hutton W., 1996, STATE WERE; Leff J, 2000, BRIT J PSYCHIAT, V177, P95, DOI 10.1192/bjp.177.2.95; Linehan M., 1993, COGNITIVE BEHAV TREA; LUBORSKY L, 1975, ARCH GEN PSYCHIAT, V32, P995; MOLMES J, 2001, SEARCH SECURE BASE A; *NHS EX, 1996, PSYCH SERV ENGL; Roth A., 1996, WHAT WORKS WHOM; Service National Framework., 2000, NAT SERV FRAM MENT H; SHAPIRO D, 1996, PSYCHOTHER RES, V5, P1; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; YOUNG J, 1990, COGNITIVE BEHAV THER	22	62	67	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					288	290		10.1136/bmj.324.7332.288	http://dx.doi.org/10.1136/bmj.324.7332.288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	519LT	11823364	Green Published			2022-12-28	WOS:000173728300023
J	MacArthur, C; Winter, HR; Bick, DE; Knowles, H; Lilford, R; Henderson, C; Lancashire, RJ; Braunholtz, DA; Gee, H				MacArthur, C; Winter, HR; Bick, DE; Knowles, H; Lilford, R; Henderson, C; Lancashire, RJ; Braunholtz, DA; Gee, H			Effects of redesigned community postnatal care on womens' health 4 months after birth: a cluster randomised controlled trial	LANCET			English	Article							MATERNAL HEALTH; DEPRESSION; CHILDBIRTH; PREVENTION; SUPPORT	Background Much postpartum physical and psychological morbidity is not addressed by present care, which tends to focus on routine examinations. We undertook a cluster randomised controlled trial to assess community postnatal care that has been redesigned to identify and manage individual needs. Methods We randomly allocated 36 general practice clusters from the West Midlands health region of the UK to intervention (n=17) or control (19) care. Midwives from the practices recruited women and provided care. 1087 (53%) of 2064 women were in practices randomly assigned to the intervention group, with 977 (47%) women in practices assigned to the control group. Care was led by midwives, with no routine contact with general practitioners, and was extended to 3 months. Midwives used symptom checklists and the Edinburgh postnatal depression scale (EPDS) to identify health needs and guidelines for the management of these needs. Primary outcomes at 4 months were obtained by postal questionnaire and included the women's short form 36 physical (PCS) and mental (MCS) component summary scores and the EPDS. Secondary outcomes were women's views about care. Multilevel analysis accounted for possible cluster effects. Findings 801 (77%) of 1087 women in the intervention group and 702 (76%) of 977 controls responded at 4 months. Women's mental health measures were significantly better in the intervention group (MCS, 3.03 [95% CI 1.53-4.52]; EPDS -1.92 [-2.55 to -1.29]; EPDS 13+ odds ratio 0.57 [0.43-0.76]) than in controls, but the physical health score did not differ. Interpretation Redesign of care so that it is midwife-led, flexible, and tailored to needs, could help to improve women's mental health and reduce probable depression at 4 months' postpartum.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham, W Midlands, England; Radcliffe Infirm, RCN Inst, Oxford OX2 6HE, England; Bournemouth Univ, Inst Hlth, Poole BH12 5BB, Dorset, England; Univ Birmingham, Sch Hlth Sci Nursing, Birmingham, W Midlands, England; Birmingham Womens Hosp NHS Trust, Birmingham, W Midlands, England	University of Birmingham; Radcliffe Infirmary; Bournemouth University; University of Birmingham; Birmingham Women's Hospital	MacArthur, C (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham, W Midlands, England.		MacArthur, Christine/ABA-8601-2021; Bick, Debra/P-9575-2018	MacArthur, Christine/0000-0003-0434-2158; Bick, Debra/0000-0002-8557-7276				Altman D.G., 1991, PRACTICAL STAT MED R; [Anonymous], 1995, BR J MIDWIFE; Audit Commission, 1997, 1 CLASS DEL IMPR MAT; BICK DE, 2001, POSTNATAL CARE EVIDE; Brown S, 2000, BRIT J OBSTET GYNAEC, V107, P1194, DOI 10.1111/j.1471-0528.2000.tb11607.x; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Brugha TS, 2000, PSYCHOL MED, V30, P1273, DOI 10.1017/S0033291799002937; CLEMENT S, 1999, COMMUNITY BASED MAT, pCH18; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; *DEP HLTH, COMM MAT SERV SUMM I; Elliott SA, 2000, BRIT J CLIN PSYCHOL, V39, P223, DOI 10.1348/014466500163248; Expert Maternity Group Department of Health, 1993, CHANG CHILDB; GARCIA J, 1994, MIDWIFERY, V10, P40, DOI 10.1016/0266-6138(94)90007-8; GLAZENER CMA, 1995, BRIT J OBSTET GYNAEC, V102, P282, DOI 10.1111/j.1471-0528.1995.tb09132.x; Gunn J, 1998, BRIT J OBSTET GYNAEC, V105, P991, DOI 10.1111/j.1471-0528.1998.tb10263.x; *HOUS COMM SEL COM, 1992, WINT REP; MACARTHUR C, 1991, HLTH CHILDBIRTH; Marchant S, 1995, BRIT J MIDWIFERY, V3, P34; Marsh J, 1991, Midwifery, V7, P177, DOI 10.1016/S0266-6138(05)80196-2; Morrell CJ, 2000, BRIT MED J, V321, P593, DOI 10.1136/bmj.321.7261.593; OAKLEY A, 2000, EXPT KNOWING, P182; Oakley A., 1992, SOCIAL SUPPORT MOTHE; OAKLEY A, 1994, EUR J PUBLIC HEALTH, V4, P265; OKOUMUNNE OC, 1999, HEALTH TECHNOL ASSES, V3, P1; PREMARANTNE UN, THORAX, V52, pA18; Rasbash J., 2000, USERS GUIDE MLWIN MU; RAY KL, 2000, COCHRANE LIB, V4; REID M, 1999, 2 CTR PRAGMATIC RAND; *ROYAL COLL MIDW, 2000, LIF BIRTH REFL POSTN; Saurel-Cubizolles MJ, 2000, BRIT J OBSTET GYNAEC, V107, P1202, DOI 10.1111/j.1471-0528.2000.tb11608.x; SHARIF K, 1993, J OBSTET GYNAECOL, V13, P251; Shields N, 1997, J REPROD INFANT PSYC, V15, P91, DOI DOI 10.1080/02646839708404537; STAMP EE, 1995, BIRTH-ISS PERINAT C, V22, P138; Townsend PP., 1988, HLTH DEPRIVATION INE; Trevelyan J, 1994, Nurs Times, V90, P38; Turnbull D, 1996, LANCET, V348, P213; WARE JE, 1994, PHYSICAL MENTAL HLTH	37	164	165	2	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					378	385		10.1016/S0140-6736(02)07596-7	http://dx.doi.org/10.1016/S0140-6736(02)07596-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518UP	11844507				2022-12-28	WOS:000173686500007
J	Walraven, G				Walraven, G			Rural Africa	LANCET			English	Editorial Material									MRC Labs, Farafenni Field Stn, Farafenni, Gambia	MRC Laboratory Molecular Biology	Walraven, G (corresponding author), MRC Labs, Farafenni Field Stn, Farafenni, Gambia.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					401	401		10.1016/S0140-6736(02)07601-8	http://dx.doi.org/10.1016/S0140-6736(02)07601-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844512				2022-12-28	WOS:000173686500012
J	Triadafilopoulos, G				Triadafilopoulos, G			Clostridium difficile colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Palo Alto Vet Affairs Hlth Care Syst, Palo Alto, CA 94304 USA		Triadafilopoulos, G (corresponding author), Palo Alto Vet Affairs Hlth Care Syst, Palo Alto, CA 94304 USA.			Triadafilopoulos, George/0000-0002-4233-3773					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					333	333		10.1056/NEJMicm010069	http://dx.doi.org/10.1056/NEJMicm010069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821510				2022-12-28	WOS:000173545300006
J	Quayle, WC; Peck, LS; Peat, H; Ellis-Evans, JC; Harrigan, PR				Quayle, WC; Peck, LS; Peat, H; Ellis-Evans, JC; Harrigan, PR			Extreme responses to climate change in Antarctic lakes	SCIENCE			English	Article							AIR-TEMPERATURE; ICE		British Antarctic Survey, NERC, Cambridge CB3 0ET, England; BC Ctr Excellence, Vancouver, BC V6Z 1Y6, Canada	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; B.C. Centre for Excellence in HIV/AIDS	Peck, LS (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.		QUAYLE, WENDY/Q-3719-2016; Peat, Helen J/E-9666-2015; QUAYLE, Wendy/D-4634-2011	QUAYLE, WENDY/0000-0003-0622-1915; Peat, Helen/0000-0003-2017-8597				CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; HAWES I, 1985, HYDROBIOLOGIA, V123, P69, DOI 10.1007/BF00006616; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Roberts EC, 1999, FRESHWATER BIOL, V41, P737, DOI 10.1046/j.1365-2427.1999.00401.x; SMITH RIL, 1990, ANTARCTIC ECOSYSTEMS, P32; VINCENT WF, 1988, MICROBIAL ECOSYSTEMS	7	223	233	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					645	645		10.1126/science.1064074	http://dx.doi.org/10.1126/science.1064074			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809962				2022-12-28	WOS:000173560900034
J	Grimes, DA; Schulz, KF				Grimes, DA; Schulz, KF			Descriptive studies: what they can and cannot do	LANCET			English	Article							FUNCTIONAL OVARIAN CYSTS; IN-VITRO FERTILIZATION; MATERNAL MORTALITY; UNITED-STATES; ORAL-CONTRACEPTIVES; RUSSIAN-FEDERATION; MULTIPLE BIRTH; BREAST-CANCER; WOMEN; AGE	Descriptive studies often represent the first scientific toe in the water in new areas of inquiry. A fundamental element of descriptive reporting is a clear, specific, and measurable definition of the disease or condition in question. Like newspapers, good descriptive reporting answers the five basic W questions: who, what, why, when, where ... and a sixth: so what? Case reports, case-series reports, cross-sectional studies, and surveillance studies deal with Individuals, whereas ecological correlational studies examine populations. The case report Is the least-publishable unit in medical literature. Case-series reports aggregate individual cases in one publication. Clustering of unusual cases in a short period often heralds a new epidemic, as happened with AIDS. Cross-sectional (prevalence) studies describe the health of populations. Surveillance can be thought of as watchfulness over a community; feedback to those who need to know is an Integral component of surveillance. Ecological correlational studies look for associations between exposures and outcomes In populations-eg, per capita cigarette sales and,rates of coronary artery disease-rather than in Individuals. Three important uses of descriptive studies include trend analysis, health-care planning, and hypothesis generation. A frequent error In reports of descriptive studies is overstepping the data: studies without a comparison group allow no inferences to be drawn about associations, causal or otherwise. Hypotheses about causation from descriptive studies are often tested in rigorous analytical studies.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org						AINSLEIGH HG, 1993, PREV MED, V22, P132, DOI 10.1006/pmed.1993.1010; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Bider D, 1999, J ASSIST REPROD GEN, V16, P221, DOI 10.1023/A:1020351026364; Borisenko KK, 1999, INT J STD AIDS, V10, P665, DOI 10.1258/0956462991913240; BOUVIERCOLLE MH, 1991, INT J EPIDEMIOL, V20, P717, DOI 10.1093/ije/20.3.717; CAILLOUETTE JC, 1987, AM J OBSTET GYNECOL, V156, P1538, DOI 10.1016/0002-9378(87)90028-7; *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV C; CATES W, 1978, AM J EPIDEMIOL, V108, P200, DOI 10.1093/oxfordjournals.aje.a112612; Centers for Disease Control (CDC), 1986, COMPR PLAN EP SURV; CENTERWALL BS, 1992, JAMA-J AM MED ASSOC, V267, P3059; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Cohen C, 1998, INTRO LOGIC; Comas A, 1990, Bol Asoc Med P R, V82, P343; DiazBarriga F, 1997, ENVIRON RES, V74, P11, DOI 10.1006/enrs.1997.3741; Dunn A, 1996, ARCH DIS CHILD-FETAL, V75, pF10, DOI 10.1136/fn.75.1.F10; EBERS GC, 1993, NEUROEPIDEMIOLOGY, V12, P1, DOI 10.1159/000110293; FARA GM, 1979, LANCET, V2, P295; FEARS TR, 1976, AM J PUBLIC HEALTH, V66, P461, DOI 10.2105/AJPH.66.5.461; FLETCHER RH, 1979, NEW ENGL J MED, V301, P180, DOI 10.1056/NEJM197907263010403; Foege WH, 1998, B WORLD HEALTH ORGAN, V76, P233; FRIEDMAN GD, 1967, J CHRON DIS, V20, P769, DOI 10.1016/0021-9681(67)90089-6; Gabert T, 1993, Wis Med J, V92, P671; GRIMES DA, 1989, OBSTET GYNECOL, V73, P1037; HADGU A, 1986, AM J OBSTET GYNECOL, V155, P954, DOI 10.1016/0002-9378(86)90324-8; HAGER WD, 1983, OBSTET GYNECOL, V61, P113; HARRINGTON J, 1978, ARCH ENVIRON HEALTH, V33, P12, DOI 10.1080/00039896.1978.10667301; Hennekens C.H., 1987, EPIDEMIOLOGY MED; HOLT VL, 1992, OBSTET GYNECOL, V79, P529; Hulley SB., 2001, DESIGNING CLIN RES; Jaremin B, 1997, Int J Occup Med Environ Health, V10, P405; JONES EF, 1980, FAM PLANN PERSPECT, V12, P293, DOI 10.2307/2134660; Kao SY, 1997, ACTA OBSTET GYN SCAN, V76, P629, DOI 10.3109/00016349709024602; KRANE BD, 1988, AM SURGEON, V54, P471; LANES SF, 1992, AM J OBSTET GYNECOL, V166, P956, DOI 10.1016/0002-9378(92)91371-G; Last J., 1988, DICT EPIDEMIOLOGY; LEVINE RJ, 1990, NEW ENGL J MED, V323, P12, DOI 10.1056/NEJM199007053230103; LEVIT F, 1977, NEW ENGL J MED, V297, P1127; Lilienfeld AM, 1980, FDN EPIDEMIOLOGY; LOGEROTLEBRUN H, 1995, FERTIL STERIL, V64, P746; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Martinez F, 1997, Eur J Contracept Reprod Health Care, V2, P25; MCBRIDE DQ, 1985, NEW ENGL J MED, V312, P186; McNeill WilliamH., 1998, PLAGUES PEOPLES; Noller KL, 1996, AM J OBSTET GYNECOL, V174, P1192, DOI 10.1016/S0002-9378(96)70661-0; PARKO A, 1990, Proceedings of the Finnish Dental Society, V86, P103; PETERSON HB, 1981, AM J OBSTET GYNECOL, V140, P811, DOI 10.1016/0002-9378(81)90745-6; QUILLIGAN EJ, 1975, OBSTET GYNECOL, V45, P96; ROOKS JB, 1979, JAMA-J AM MED ASSOC, V242, P644, DOI 10.1001/jama.242.7.644; Rothman K, 1986, MODERN EPIDEMIOLOGY; SASCO AJ, 1993, INT J CANCER, V53, P538, DOI 10.1002/ijc.2910530403; SATTIN RW, 1984, PUBLIC HEALTH REP, V99, P504; SCHENKEN JR, 1976, JAMA-J AM MED ASSOC, V236, P559, DOI 10.1001/jama.1976.03270060013003; Schuitemaker N, 1997, OBSTET GYNECOL, V90, P78, DOI 10.1016/S0029-7844(97)00128-2; SEWARD PN, 1973, AM J OBSTET GYNECOL, V115, P335, DOI 10.1016/0002-9378(73)90587-5; SILVERMAN WA, 1991, CONTROL CLIN TRIALS, V12, P355, DOI 10.1016/0197-2456(91)90015-E; STEBBINGS JH, 1984, AM J IND MED, V5, P435, DOI 10.1002/ajim.4700050604; Steegers-Theunissen RPM, 1998, J REPROD MED, V43, P173; STEPHENSON P, 1992, AM J PUBLIC HEALTH, V82, P1328, DOI 10.2105/AJPH.82.10.1328; STEWART GK, 1971, OBSTET GYNECOL, V37, P510; THACKER SB, 1995, OBSTET GYNECOL, V86, P613, DOI 10.1016/0029-7844(95)00232-G; THOMAS DB, 1993, EPIDEMIOL REV, V15, P220, DOI 10.1093/oxfordjournals.epirev.a036108; Tichonova L, 1997, LANCET, V350, P210, DOI 10.1016/S0140-6736(97)01382-2; Tough SC, 2000, J PEDIATR-US, V136, P618, DOI 10.1067/mpd.2000.105132; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WAUGH RJL, 1977, NEW ENGL J MED, V296, P178; WIESENTHAL AM, 1985, AM J EPIDEMIOL, V122, P847, DOI 10.1093/oxfordjournals.aje.a114167; WINGO PA, 1994, EPIDEMIOLOGIC APPROA; YON J L JR, 1974, Gynecologic Oncology, V2, P508, DOI 10.1016/0090-8258(74)90061-4; Zinn J, 1999, Clin Lab Manage Rev, V13, P386; 1995, LANCET, V345, P137; 1997, MMWR MORB MORTAL WKL, V46, P165; 1981, MMWR MORB MORTAL WKL, V30, P250	73	246	258	12	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2002	359	9301					145	149		10.1016/S0140-6736(02)07373-7	http://dx.doi.org/10.1016/S0140-6736(02)07373-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809274				2022-12-28	WOS:000173212400031
J	Godeau, B; Chevret, S; Varet, B; Lefrere, F; Zini, JM; Bassompierre, F; Cheze, S; Legouffe, E; Hulin, C; Grange, MJ; Fain, O; Bierling, P				Godeau, B; Chevret, S; Varet, B; Lefrere, F; Zini, JM; Bassompierre, F; Cheze, S; Legouffe, E; Hulin, C; Grange, MJ; Fain, O; Bierling, P		French AITP Study Grp	Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial	LANCET			English	Article							GAMMA-GLOBULIN; IMMUNE GLOBULIN; CORTICOSTEROIDS; CHILDHOOD; THERAPY; GUIDELINE	Background Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies, We compared intravenous immunoglobulin with high-dose methylprednisolone in untreated adults with severe AITP and assessed efficacy of subsequent oral steroids compared with placebo. Primary outcome was number of days with platelet count greater than 50x10(9)/L within the first 21 days. Methods We did a randomised multicentre trial based on a 2x2 design. 122 adults with severe AITP (platelet count less than or equal to 20x10(9)/L) were randomly assigned to receive either intravenous immunoglobulin or high-dose methylprednisolone on days 1-3 (randomisation A), and then to receive either oral prednisone or placebo (randomisation B) on days 4-21. Analysis was by intention to treat. Findings Six patients were excluded from the analysis. The number of days ori-which platelet counts were above 50x10(9)/L was 18 in 56 patients receiving intravenous immunoglobulin and 14 in 60 receiving high-dose methylprednisolone (p=0.02). Percentage of patients who had platelet counts over 50x10(9)/L on days 2 and 5 was 7% and 79%, respectively, in the intravenous immunoglobulin group compared with 2% and 60%, respectively, in the high-dose methylprednisolone group (p=0.04). During the second treatment period, prednisone was more effective than placebo for all short-term endpoints. Patients who received intravenous immunoglobulin and prednisone had platelet count greater than 50x10(9)/L for 18.5 days (p=0.005), and those treated with high-dose methylprednisolone and prednisone had this count for 17.5 days. Interpretation Intravenous immunoglobulin and oral prednisone seems to be more effective than high-dose methylprednisolone and oral prednisone in adults with severe AITP, although the latter treatment is effective and well tolerated.	Hop Henri Mondor, Assistance Publ Hop Paris,EFS Ile France, Lab Immunol Leucoplaquettaire, Serv Med Interne, F-94000 Creteil, France; Hop St Louis, Assistance Publ Hop Paris, Dept Biostat & Informat Med, Paris, France; Hop Necker Enfants Malad, Assistance Publ Hop Paris, Hematol Serv, Paris, France; Hop Lariboisiere, Assistance Publ Hop Paris, Hematol Serv, F-75475 Paris, France; Hop St Louis, Assistance Publ Hop Paris, DRC, Paris, France; Hop Cote de Necre, Hematol Serv, Caen, France; Hop Lareyronie, Hematol Serv, Montpellier, France; Hop Brabois, Hematol Serv, Nancy, France; Hop Bichat Claude Bernard, Dept Hematol Biol, Assistance Publ Hop Paris, F-75877 Paris, France; Hop Jean Verdier, Assistance Publ Hop Paris, Serv Med Interne, Bondy, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Montpellier; CHU de Montpellier; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bierling, P (corresponding author), Hop Henri Mondor, Assistance Publ Hop Paris,EFS Ile France, Lab Immunol Leucoplaquettaire, Serv Med Interne, 51 Ave Marechal de Lattre de Tassigny, F-94000 Creteil, France.	philippe.bierling@efs.sante.fr		chevret, sylvie/0000-0001-6449-4730				ALBAYRAK D, 1994, J PEDIATR-US, V125, P1004, DOI 10.1016/S0022-3476(05)82024-4; Alpdogan O, 1998, BRIT J HAEMATOL, V103, P1061, DOI 10.1046/j.1365-2141.1998.01096.x; Altintop L, 1997, AM J HEMATOL, V56, P191, DOI 10.1002/(SICI)1096-8652(199711)56:3<191::AID-AJH12>3.0.CO;2-E; BARRIOS NJ, 1993, ACTA HAEMATOL-BASEL, V89, P6; BLANCHETTE VS, 1993, J PEDIATR-US, V123, P989, DOI 10.1016/S0022-3476(05)80400-7; BUSSEL JB, 1987, VOX SANG, V52, P206, DOI 10.1111/j.1423-0410.1987.tb03029.x; Cohen YC, 2000, ARCH INTERN MED, V160, P1630, DOI 10.1001/archinte.160.11.1630; Frederiksen H, 1999, BLOOD, V94, P909, DOI 10.1182/blood.V94.3.909.415k02_909_913; George JN, 1997, ANN INTERN MED, V126, P317, DOI 10.7326/0003-4819-126-4-199702150-00009; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; GEORGE JN, 1994, NEW ENGL J MED, V331, P1207, DOI 10.1056/NEJM199411033311807; GODEAU B, 1993, BLOOD, V82, P1415; Godeau B, 1999, BRIT J HAEMATOL, V107, P716, DOI 10.1046/j.1365-2141.1999.01766.x; GODEAU B, 1995, AM J HEMATOL, V48, P282, DOI 10.1002/ajh.2830480416; HORD JD, 1993, PEDIATR HEMAT ONCOL, V10, P323, DOI 10.3109/08880019309029509; Imbach P, 2000, LANCET, V356, P447, DOI 10.1016/S0140-6736(00)02549-6; IMBACH P, 1985, LANCET, V2, P464; JACOBS P, 1994, AM J MED, V97, P55, DOI 10.1016/0002-9343(94)90048-5; Karpatkin S, 1997, LANCET, V349, P1531, DOI 10.1016/S0140-6736(96)12118-8; OZSOYLU S, 1993, PEDIATR HEMAT ONCOL, V10, P317, DOI 10.3109/08880019309029508; Rosthoj S, 1996, ACTA PAEDIATR, V85, P910, DOI 10.1111/j.1651-2227.1996.tb14183.x; Schiavotto C, 1993, Haematologica, V78, P35; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; VONDEMBORNE AEGKR, 1988, BRIT MED J, V296, P249, DOI 10.1136/bmj.296.6617.249-a	24	180	189	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2002	359	9300					23	29		10.1016/S0140-6736(02)07275-6	http://dx.doi.org/10.1016/S0140-6736(02)07275-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809183				2022-12-28	WOS:000173143500012
J	McNamee, D				McNamee, D			Shameful UK Government loan to Tanzania	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		McNamee, D (corresponding author), Lancet, London WC1X 8RR, England.								0	0	0	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					8	8		10.1016/S0140-6736(02)07329-4	http://dx.doi.org/10.1016/S0140-6736(02)07329-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809179				2022-12-28	WOS:000173143500007
J	Pounder, RE				Pounder, RE			Helicobacter pylori and NSAIDs - the end of the debate?	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTROINTESTINAL TOXICITY; ACID SUPPRESSION; DUODENAL-ULCERS; ERADICATION; THERAPY; TRIAL		UCL Royal Free & Univ Coll Med Sch, Ctr Gastroenterol, London NW3 2QG, England	University of London; University College London; UCL Medical School	Pounder, RE (corresponding author), UCL Royal Free & Univ Coll Med Sch, Ctr Gastroenterol, London NW3 2QG, England.	r.pounder@rfc.ucl.ac.uk						Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; BURGET DW, 1990, GASTROENTEROLOGY, V99, P345, DOI 10.1016/0016-5085(90)91015-X; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Corleto VD, 2001, ALIMENT PHARM THERAP, V15, P1555, DOI 10.1046/j.1365-2036.2001.01085.x; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Hawkey CJ, 1999, ALIMENT PHARM THER, V13, P695, DOI 10.1046/j.1365-2036.1999.00550.x; Hawkey CJ, 1998, LANCET, V352, P1016, DOI 10.1016/S0140-6736(98)04206-8; LANAS A, 1992, GASTROENTEROLOGY, V103, P862, DOI 10.1016/0016-5085(92)90018-T; POUNDER RE, 1984, GUT, V25, P697, DOI 10.1136/gut.25.7.697; ROSTOM A, 2000, COCHRANE DATABASE SY, V4; Roy PK, 2001, MEDICINE, V80, P189, DOI 10.1097/00005792-200105000-00005; Savarino V, 2000, ALIMENT PHARM THER, V14, P291; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Toh BH, 1997, NEW ENGL J MED, V337, P1441, DOI 10.1056/NEJM199711133372007	14	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2002	359	9300					3	4		10.1016/S0140-6736(02)07267-7	http://dx.doi.org/10.1016/S0140-6736(02)07267-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809174				2022-12-28	WOS:000173143500003
J	Zhang, QH; Piston, DW; Goodman, RH				Zhang, QH; Piston, DW; Goodman, RH			Regulation of corepressor function by nuclear NADH	SCIENCE			English	Article							CELLULAR PHOSPHOPROTEIN; NEGATIVE MODULATION; PROTEIN SIR2; TRANSFORMATION; TRANSCRIPTION; METASTASIS; CARCINOMA; CELLS; CTBP	The corepressor CtBP (carboxyl-terminal binding protein) is involved in transcriptional pathways important for development, cell cycle regulation, and transformation. We demonstrate that CtBP binding to cellular and viral transcriptional repressors is regulated by the nicotinamide adenine dinucleotides NAD(+) and NADH, with NADH being two to three orders of magnitude more effective. Levels of free nuclear nicotinamide adenine dinucleotides, determined using two-photon microscopy, correspond to the levels required for half-maximal CtBP binding and are considerably tower than those previously reported. Agents capable of increasing NADH levels stimulate CtBP binding to its partners in vivo and potentiate CtBP-mediated repression. We propose that this ability to detect changes in nuclear NAD(+)/NADH ratio allows CtBP to serve as a redox sensor for transcription.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NATIONAL CANCER INSTITUTE [R01CA115468, K01CA096561] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA115468, K01 CA096561, R01 CA115468-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; French T, 1998, METHOD CELL BIOL, V56, P277, DOI 10.1016/S0091-679X(08)60431-8; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Meiners S, 1998, ONCOGENE, V16, P9, DOI 10.1038/sj.onc.1201486; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PHILIPPIDIS H, 1969, BIOCHEM J, V113, P651, DOI 10.1042/bj1130651; PISTON DW, 1992, P SOC PHOTO-OPT INS, V1640, P379, DOI 10.1117/12.58230; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Shigemori K, 1996, AM J PHYSIOL-LUNG C, V270, pL803, DOI 10.1152/ajplung.1996.270.5.L803; STUBBS M, 1972, BIOCHEM J, V126, P59, DOI 10.1042/bj1260059; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Zhang Q., UNPUB	22	474	485	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1895	1897						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11847309				2022-12-28	WOS:000174299500040
J	West, SA; Sheldon, BC				West, SA; Sheldon, BC			Constraints in the evolution of sex ratio adjustment	SCIENCE			English	Article							SELECTION; COMPETITION; ALLOCATION; MANIPULATION; PRECISE; MAMMALS; BIRDS	When the relative fitness of mate and female offspring varies with environmental conditions, evolutionary theory predicts that parents should adjust the sex of their offspring accordingly. Qualitative and even quantitative support for this prediction is striking in some taxa but much less convincing in others. Explaining such variation across taxa in the fit of sex ratio theory remains a major challenge. We use meta-analysis to test the role of two constraints in the evolution of sex ratios. Based on analysis of sex ratio skews in birds and wasps, we show that (i) mechanisms of sex determination do not necessarily constrain the evolution of sex ratio adjustment, and (ii) parental ability to predict their offsprings' environment influences the evolution of sex ratio patterns across taxa. More generally, our results show that multiple constraints may determine the precision of adaptation.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Edinburgh; University of Oxford	West, SA (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		West, Stuart A/M-3608-2014; Sheldon, Ben C/A-8056-2010	West, Stuart A/0000-0003-2152-3153; Sheldon, Ben C/0000-0002-5240-7828				Aviles L, 2000, P ROY SOC B-BIOL SCI, V267, P1445, DOI 10.1098/rspb.2000.1162; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Brown GR, 2001, ANIM BEHAV, V61, P683, DOI 10.1006/anbe.2000.1659; BULL J J, 1988, P96; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; BURLEY N, 1981, SCIENCE, V211, P721, DOI 10.1126/science.211.4483.721; CHARNOV E L, 1982; CHARNOV EL, 1981, NATURE, V289, P27, DOI 10.1038/289027a0; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; CLUTTONBROCK TH, 1986, IBIS, V128, P329; Creel S, 1998, ANIM REPROD SCI, V53, P315, DOI 10.1016/S0378-4320(98)00121-3; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; FRANK SA, 1987, THEOR POPUL BIOL, V31, P47, DOI 10.1016/0040-5809(87)90022-0; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GOWATY PA, 1985, AM NAT, V126, P347, DOI 10.1086/284421; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Herre Edward Allen, 2001, P191, DOI 10.1017/CBO9780511609084.007; Johnson CN, 2001, P ROY SOC B-BIOL SCI, V268, P2001, DOI 10.1098/rspb.2001.1723; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Krackow S., 1999, P 22 INT ORN C DURB, P425; Leimar O, 1996, BEHAV ECOL, V7, P316, DOI 10.1093/beheco/7.3.316; MADSEN T, 1992, EVOLUTION, V46, P1549, DOI 10.1111/j.1558-5646.1992.tb01144.x; MAYNARD SMITH J., 1978, EVOLUTION SEX; MAYNARDSMITH J, 1980, BEHAV ECOL SOCIOBIOL, V7, P247; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Nagelkerke CJ, 1998, J EVOLUTION BIOL, V11, P649, DOI 10.1007/s000360050112; Olsson M, 2001, J EVOLUTION BIOL, V14, P120, DOI 10.1046/j.1420-9101.2001.00255.x; Palmer AR, 2000, ANNU REV ECOL SYST, V31, P441, DOI 10.1146/annurev.ecolsys.31.1.441; Pen I, 1999, AM NAT, V153, P384, DOI 10.1086/303183; Pen I, 2000, P ROY SOC B-BIOL SCI, V267, P539, DOI 10.1098/rspb.2000.1034; Pen I, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P26, DOI 10.1017/CBO9780511542053.003; PEN I, 1987, NATURE, V329, P627; Pen I., 2000, SELECTION, V1, P59, DOI [DOI 10.1556/SELECT.1.2000.1-3.11, 10.1556/Select.1.2000.1-3.11]; Rosenthal R, 1991, METAANALYTIC PROCEDU; Sakisaka Y, 2000, MOL ECOL, V9, P1711, DOI 10.1046/j.1365-294x.2000.01038.x; Sheldon BC, 1998, HEREDITY, V80, P397, DOI 10.1046/j.1365-2540.1998.00374.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; West SA, 1998, EVOLUTION, V52, P475, DOI 10.1111/j.1558-5646.1998.tb01647.x; West SA, 2000, SCIENCE, V290, P288, DOI 10.1126/science.290.5490.288; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085; YAMAGUCHI Y, 1985, NATURE, V318, P460, DOI 10.1038/318460a0	42	367	378	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1685	1688		10.1126/science.1069043	http://dx.doi.org/10.1126/science.1069043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11823605	Green Submitted			2022-12-28	WOS:000174212900038
J	Mason, S; Nicholl, J; Lilford, R				Mason, S; Nicholl, J; Lilford, R			What to do about poor clinical performance in clinical trials	BRITISH MEDICAL JOURNAL			English	Article							SURGEONS		Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Sheffield, Med Care Res Unit, Sheffield S1 4DA, S Yorkshire, England; Univ Leeds, No & Yorkshire Clin Trials & Res Unit, Leeds LS2 9NG, W Yorkshire, England	University of Birmingham; University of Sheffield; University of Leeds	Lilford, R (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.		Nicholl, Jon/B-8257-2008					Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; DELEVAL MR, 1994, J THORAC CARDIOV SUR, V107, P914; ENGLISH TAH, 1984, BRIT MED J, V289, P1205, DOI 10.1136/bmj.289.6453.1205; Lilford RJ, 2000, BRIT MED J, V320, P43, DOI 10.1136/bmj.320.7226.43; McArdle C, 2000, BMJ-BRIT MED J, V321, P1121, DOI 10.1136/bmj.321.7269.1121; Medical Research Council, 1998, MRC GUID GOOD CLIN P; Rothwell PM, 1999, LANCET, V353, P1325, DOI 10.1016/S0140-6736(99)01000-4; Stark J, 2000, LANCET, V355, P1004, DOI 10.1016/S0140-6736(00)90001-1; Treasure T, 2000, LANCET, V355, P948, DOI 10.1016/S0140-6736(00)90010-2; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	10	5	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					419	420		10.1136/bmj.324.7334.419	http://dx.doi.org/10.1136/bmj.324.7334.419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850378	Green Accepted, Green Published			2022-12-28	WOS:000174006300026
J	Drake, MJ; Jakosky, BM				Drake, MJ; Jakosky, BM			Narrow horizons in astrobiology	NATURE			English	Editorial Material									Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Arizona; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Drake, MJ (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.							Gee H, 2001, NATURE, V409, P1079; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924	3	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					733	734		10.1038/415733a	http://dx.doi.org/10.1038/415733a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845181				2022-12-28	WOS:000173833900022
J	Rigotti, NA				Rigotti, NA			Treatment of tobacco use and dependence.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUSTAINED-RELEASE BUPROPION; SMOKING CESSATION; CONTROLLED TRIAL; NICOTINE REPLACEMENT; TRANSDERMAL NICOTINE; RANDOMIZED TRIAL; WEIGHT-GAIN; SMOKERS; THERAPY; PLACEBO		Massachusetts Gen Hosp, Dept Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Dept Med, Tobacco Res & Treatment Ctr, 50 Staniford St,9th Fl, Boston, MA 02114 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004440] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL04440] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ayanian JZ, 1999, JAMA-J AM MED ASSOC, V281, P1019, DOI 10.1001/jama.281.11.1019; Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X; Bohadana A, 2000, ARCH INTERN MED, V160, P3128, DOI 10.1001/archinte.160.20.3128; Cromwell J, 1997, JAMA-J AM MED ASSOC, V278, P1759, DOI 10.1001/jama.278.21.1759; Department of Health and Human Services, 1990, DHHS PUBL; Fiore MC, 1996, JAMA-J AM MED ASSOC, V275, P1270, DOI 10.1001/jama.1996.03530400058039; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; FIORE MC, 2000, TREATING TOBACCO USE; Garrett BE, 2001, EXPERT OPIN PHARMACO, V2, P1548; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033; Hall SM, 1998, ARCH GEN PSYCHIAT, V55, P683, DOI 10.1001/archpsyc.55.8.683; HALL SM, 1992, AM J PUBLIC HEALTH, V82, P799, DOI 10.2105/AJPH.82.6.799; Hall SM, 1996, J CONSULT CLIN PSYCH, V64, P1003, DOI 10.1037/0022-006X.64.5.1003; Hughes JR, 1999, JAMA-J AM MED ASSOC, V281, P72, DOI 10.1001/jama.281.1.72; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Joseph AM, 1996, NEW ENGL J MED, V335, P1792, DOI 10.1056/NEJM199612123352402; Kinnunen T, 1996, J CONSULT CLIN PSYCH, V64, P791, DOI 10.1037/0022-006X.64.4.791; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Marcus BH, 1999, ARCH INTERN MED, V159, P1229, DOI 10.1001/archinte.159.11.1229; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; *NAT COMM QUAL ASS, 2000, STAT MAN CAR QUAL 20, P28; Prochazka AV, 1998, ARCH INTERN MED, V158, P2035, DOI 10.1001/archinte.158.18.2035; Raw M, 1998, THORAX, V53, pS1, DOI 10.1136/thx.53.2008.S1; RENNARD S, 1994, ARCH INTERN MED, V154, P989; Rigotti NA, 1999, ARCH INTERN MED, V159, P1169, DOI 10.1001/archinte.159.11.1169; Rigotti NA, 2000, JAMA-J AM MED ASSOC, V284, P741, DOI 10.1001/jama.284.6.741; STAPLETON JA, 1995, ADDICTION, V90, P31, DOI 10.1046/j.1360-0443.1995.901316.x; Thorndike AN, 1998, JAMA-J AM MED ASSOC, V279, P604, DOI 10.1001/jama.279.8.604; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0; 1999, MMWR MORB MORTAL WKL, V48, P1027; 2001, AM J PREV MED S, V20, P10; 2001, MMWR MORB MORTAL WKL, V50, P869	39	232	237	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					506	512		10.1056/NEJMcp012279	http://dx.doi.org/10.1056/NEJMcp012279			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521AE	11844853				2022-12-28	WOS:000173815300008
J	Shinefield, H; Black, S; Fattom, A; Horwith, G; Rasgon, S; Ordonez, J; Yeoh, H; Law, D; Robbins, JB; Schneerson, R; Muenz, L; Naso, R				Shinefield, H; Black, S; Fattom, A; Horwith, G; Rasgon, S; Ordonez, J; Yeoh, H; Law, D; Robbins, JB; Schneerson, R; Muenz, L; Naso, R			Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMBINANT EXOPROTEIN-A; CAPSULAR POLYSACCHARIDES; ANTIBODIES; INFECTIONS; IMMUNOGENICITY; BACTEREMIA; TYPE-5; MICE	Background: In patients with decreased resistance to infection, Staphylococcus aureus is a major cause of bacteremia and its complications. The capsular polysaccharides are essential for the pathogenesis of and immunity to S. aureus infection and are targets for vaccines. Methods: In a double-blind trial involving patients with end-stage renal disease who were receiving hemodialysis, we evaluated the safety, immunogenicity, and efficacy of a vaccine with S. aureus type 5 and 8 capsular polysaccharides conjugated to nontoxic recombinant Pseudomonas aeruginosa exotoxin A. Between April 1998 and August 1999, 1804 adult patients at 73 hemodialysis centers were randomly assigned to receive a single intramuscular injection of either vaccine or saline. IgG antibodies to S. aureus type 5 and 8 capsular polysaccharides were measured for up to two years, and episodes of S. aureus bacteremia were recorded. Efficacy was estimated by comparing the incidence of S. aureus bacteremia in the patients who received the vaccine with the incidence in the control patients. Results: Reactions to the vaccine were generally mild to moderate, and most resolved within two days. The capsular polysaccharides elicited an antibody response of at least 80 microg per milliliter (the estimated minimal level conferring protection) in 80 percent of patients for type 5 and in 75 percent of patients for type 8. The efficacy during weeks 3 to 54 was only 26 percent (P=0.23). However, between weeks 3 and 40 after vaccination, S. aureus bacteremia developed in 11 of 892 patients in the vaccine group who could be evaluated for bacteremia, as compared with 26 of 906 patients in the control group (estimate of efficacy, 57 percent; 95 percent confidence interval, 10 to 81 percent; nominal P=0.02). Conclusions: In patients receiving hemodialysis, a conjugate vaccine can confer partial immunity against S. aureus bacteremia for approximately 40 weeks, after which protection wanes as antibody levels decrease. (N Engl J Med 2002;346:491-6.) Copyright (C) 2002 Massachusetts Medical Society.	Kaiser Permanente Vaccine Study Ctr, Oakland, CA 94612 USA; Nabi, Rockville, MD USA; So Calif Kaiser Permanente, Los Angeles, CA USA; NICHHD, Bethesda, MD 20892 USA; Larry Muenz & Associates, Rockville, MD USA; Total Renal Res, Minneapolis, MN USA	Kaiser Permanente; Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shinefield, H (corresponding author), Kaiser Permanente Vaccine Study Ctr, 1 Kaiser Plaza,16th Fl, Oakland, CA 94612 USA.							ARBEIT RD, 1984, DIAGN MICR INFEC DIS, V2, P85, DOI 10.1016/0732-8893(84)90002-6; Archer GL, 2001, NEW ENGL J MED, V344, P55, DOI 10.1056/NEJM200101043440110; Bloembergen W E, 1996, Adv Ren Replace Ther, V3, P201; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; CHOU MY, 1989, J FORMOS MED ASSOC, V88, P352; *CYT, 1998, SOFTW MAN STATX 4; Essawi T, 1998, TROP MED INT HEALTH, V3, P576, DOI 10.1046/j.1365-3156.1998.00265.x; FATTOM A, 1990, INFECT IMMUN, V58, P2367, DOI 10.1128/IAI.58.7.2367-2374.1990; FATTOM A, 1992, INFECT IMMUN, V60, P584, DOI 10.1128/IAI.60.2.584-589.1992; Fattom A, 1999, AM J VET RES, V60, P530; FATTOM A, 1993, INFECT IMMUN, V61, P1023, DOI 10.1128/IAI.61.3.1023-1032.1993; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Goetz A, 1999, INFECT CONT HOSP EP, V20, P689, DOI 10.1086/501567; HOEN B, 1996, 36 INT C ANT AG CHEM, P233; KARAKAWA WW, 1985, J CLIN MICROBIOL, V22, P445, DOI 10.1128/JCM.22.3.445-447.1985; KARAKAWA WW, 1988, INFECT IMMUN, V56, P1090, DOI 10.1128/IAI.56.5.1090-1095.1988; Karakawa WW., 1982, SEMIN INFECT DIS, V4, P285; KESSLER M, 1993, NEPHRON, V64, P95, DOI 10.1159/000187285; LANDESMAN SH, 1981, REV INFECT DIS, V3, pS184; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Na'was T, 1998, J CLIN MICROBIOL, V36, P414; QUARLES LD, 1985, AM J KIDNEY DIS, V6, P412, DOI 10.1016/S0272-6386(85)80104-9; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; ROBBINS JB, 1973, PEDIATR RES, V7, P103, DOI 10.1203/00006450-197303000-00001; ROBBINS JB, 1995, ANN NY ACAD SCI, V754, P68, DOI 10.1111/j.1749-6632.1995.tb44439.x; ROUBICEK C, 1995, NEPHROLOGIE, V16, P229; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Welch PG, 1996, J AM SOC NEPHROL, V7, P247	29	351	387	0	17	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					491	496		10.1056/NEJMoa011297	http://dx.doi.org/10.1056/NEJMoa011297			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844850				2022-12-28	WOS:000173815300005
J	Herlihy, J; Scragg, P; Turner, S				Herlihy, J; Scragg, P; Turner, S			Discrepancies in autobiographical memories - Implications for the assessment of asylum seekers: repeated interviews study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EYEWITNESS TESTIMONY	Objective To investigate the consistency of autobiographical memory of people seeking asylum, in light of the assumption that discrepancies in asylum seekers' accounts of persecution mean that they are fabricating their stories. Design Repeated interviews. Setting England, 1999 and 2000. Participants Community sample of 27 Kosovan and 12 Bosnian refugees. Main outcome measures Discrepancies in repeated descriptions of one traumatic and one non-traumatic event including specific details, rated as central or peripheral to the event. Self report measures of post-traumatic stress disorder and depression. Results Discrepancies between an individual's accounts were common. For participants with high levels of post-traumatic stress, the number of discrepancies increased with length of time between interviews. More discrepancies occurred in details peripheral to the account than in details that were central to the account. Conclusion The assumption that inconsistency of recall means that accounts have poor credibility is questionable. Discrepancies are likely to occur in repeated interviews. For refugees showing symptoms of high levels of post-traumatic stress, the length of the application process may also affect the number of discrepancies. Recall of details rated by the interviewee as peripheral to the account is more likely to be inconsistent than recall of details that are central to the account. Thus, such inconsistencies should not be relied on as indicating a lack of credibility.	Traumat Stress Clin, London W1T 4P1, England; UCL, London WC1E 6BT, England	University of London; University College London	Herlihy, J (corresponding author), Traumat Stress Clin, London W1T 4P1, England.	jane@herlihvj.treeserve.co.uk		Herlihy, Jane/0000-0001-8600-0236				Beck AT, 1996, PSYCHOL ASSESS; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Christianson S.-A., 1996, REMEMBERING OUR STUD, P218, DOI [10.1017/CBO9780511527913.009, DOI 10.1017/CBO9780511527913.009]; Fawzi MCS, 1997, ACTA PSYCHIAT SCAND, V95, P87, DOI 10.1111/j.1600-0447.1997.tb00379.x; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Heuer F., 1992, HDB EMOTION MEMORY R, P151; HOLLIN CR, 1983, J APPL SOC PSYCHOL, V13, P234, DOI 10.1111/j.1559-1816.1983.tb01737.x; LIPTON JP, 1977, J APPL PSYCHOL, V62, P90, DOI 10.1037/0021-9010.62.1.90; MCNALLY RJ, 1994, COGNITION EMOTION, V8, P351, DOI 10.1080/02699939408408946; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; United Nations High Commission for Refugees, 1992, HDB PROC CRIT DET RE; VANDERKOLK BA, 1995, J TRAUMA STRESS, V8, P505, DOI 10.1002/jts.2490080402; VanVelsen C, 1996, J TRAUMA STRESS, V9, P181, DOI 10.1002/jts.2490090203; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.; Williams JMG, 1988, COGNITION EMOTION, V2, P221, DOI 10.1080/02699938808410925	16	129	129	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2002	324	7333					324	327		10.1136/bmj.324.7333.324	http://dx.doi.org/10.1136/bmj.324.7333.324			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521XH	11834558	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000173866300016
J	Stewart, F				Stewart, F			Root causes of violent conflict in developing countries	BRITISH MEDICAL JOURNAL			English	Article									Queen Elizabeth House, Oxford OX1 3LA, England	University of Oxford	Stewart, F (corresponding author), Queen Elizabeth House, Oxford OX1 3LA, England.							ALEXANDER J, 2000, WAR HUNGER DISPLACEM, P305; ANDRE C, 1996, LAND TENURE UNENDURA, P49; Cohen Abner, 1974, 2 DIMENSIONAL MAN ES; COLLIER P, 2000, GREED GRIEVANCE CIVI, P42; CRAMER C, 2001, SCH ORIENTAL AFRICAN; ELBADAWI I, 2001, MUCH WAR WIL WE SEE; FAIRHEAD JAMES, 2000, WAR HUNGER DISPLACEM, P147; Gurr Ted R., 1993, MINORITIES RISK GLOB; HIRSHLEIFER J, 1994, ECON INQ, V32, P1, DOI 10.1111/j.1465-7295.1994.tb01309.x; HOMERDIXON TF, 1994, INT SECURITY, V19, P5, DOI 10.2307/2539147; Horowitz Donald., 1985, ETHNIC GROUPS CONFLI; KAPLAN RD, 1994, ATLANTIC MONTHLY FEB, P44; KEEN D, 2001, WAR UNDERDEVELOPMENT, P155; Keen David., 1991, BENEFITS FAMINE POLI; KOTOUC E, 2001, THESIS U OXFORD OXFO; LICHBACH MI, 1989, WORLD POLIT, V41, P431, DOI 10.2307/2010526; MORRISSON C, 2000, WAR HUNGER DISPLACEM, P207; Nafziger E. Waine, 2000, WAR HUNGER DISPLACEM; Nafziger EW, 2000, WAR HUNGER DISPLACEM, P91; Ranger Terence, 2003, INVENTION TRADITION, P211; Reno W., 1998, WARLORD POLITICS AFR; REYNALQUEROL M, IN PRESS J CONFLICT; Stewart F, 2001, WAR UNDERDEVELOPMENT; STEWART F, 2001, REACTION PREVENTION, P105; SWAIN A, 2000, WAR HUNGER DISPLACEM, P179; Turton D., 1997, OXFORD DEV STUDIES, V25, P77, DOI DOI 10.1080/13600819708424123	26	89	91	1	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					342	345		10.1136/bmj.324.7333.342	http://dx.doi.org/10.1136/bmj.324.7333.342			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521XH	11834564	Green Published			2022-12-28	WOS:000173866300022
J	McIntosh, K				McIntosh, K			Current concepts - Community-acquired pneumonia in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RESPIRATORY-TRACT INFECTION; C-REACTIVE PROTEIN; PNEUMOCOCCAL CONJUGATE VACCINE; ERYTHROCYTE SEDIMENTATION-RATE; WHITE BLOOD-CELL; CHLAMYDIA-PNEUMONIAE; ETIOLOGIC DIAGNOSIS; GAMBIAN CHILDREN; LUNG PUNCTURE; PARAPNEUMONIC EFFUSIONS		Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	McIntosh, K (corresponding author), Childrens Hosp, Div Infect Dis, Enders 609,300 Longwood Ave, Boston, MA 02115 USA.	kenneth.mcintosh@tch.harvard.edu						ALDOUS MB, 1992, J INFECT DIS, V166, P646, DOI 10.1093/infdis/166.3.646; [Anonymous], 1981, B WORLD HEALTH ORGAN, V59, P707; [Anonymous], 1993, Br J Hosp Med, V49, P346; Bachur R, 1999, ANN EMERG MED, V33, P166, DOI 10.1016/S0196-0644(99)70390-2; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BEEM MO, 1977, NEW ENGL J MED, V296, P306, DOI 10.1056/NEJM197702102960604; BERMAN S, 1985, REV INFECT DIS, V7, P674; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BLOCK S, 1995, PEDIATR INFECT DIS J, V14, P471, DOI 10.1097/00006454-199506000-00002; BULLA A, 1978, B WORLD HEALTH ORGAN, V56, P481; Choi EH, 1998, CLIN INFECT DIS, V26, P1346, DOI 10.1086/516340; CLAESSON BA, 1989, PEDIATR INFECT DIS J, V8, P856, DOI 10.1097/00006454-198912000-00006; COURTOY I, 1989, CLIN PEDIATR, V28, P261, DOI 10.1177/000992288902800604; Davies HD, 1996, PEDIATR INFECT DIS J, V15, P371, DOI 10.1097/00006454-199604000-00017; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; FOY HM, 1979, JAMA-J AM MED ASSOC, V241, P253, DOI 10.1001/jama.241.3.253; FOY HM, 1973, AM J EPIDEMIOL, V97, P93, DOI 10.1093/oxfordjournals.aje.a121493; Frank AL, 1999, CLIN INFECT DIS, V29, P935, DOI 10.1086/520463; FREIJ BJ, 1984, PEDIATR INFECT DIS J, V3, P578, DOI 10.1097/00006454-198411000-00021; FRIEDLAND IR, 1995, PEDIATR INFECT DIS J, V14, P885, DOI 10.1097/00006454-199510000-00013; Gendrel D, 1997, EUR J CLIN MICROBIOL, V16, P388, DOI 10.1007/BF01726370; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; GRISCOM NT, 1988, RADIOLOGY, V167, P297, DOI 10.1148/radiology.167.2.3357939; GROSSMAN LK, 1988, ANN EMERG MED, V17, P43, DOI 10.1016/S0196-0644(88)80502-X; GUCKEL C, 1989, PEDIATR RADIOL, V19, P499, DOI 10.1007/BF02389556; HALL CB, 1988, J PEDIATR-US, V113, P266; Halsey NA, 1997, PEDIATRICS, V99, P289, DOI 10.1542/peds.99.2.289; Hammerschlag M R, 1995, Adv Pediatr Infect Dis, V10, P1; Hardie WD, 1998, PEDIATRICS, V101, P388, DOI 10.1542/peds.101.3.388; HARRISON HR, 1978, NEW ENGL J MED, V298, P702, DOI 10.1056/NEJM197803302981303; Heiskanen-Kosma T, 1998, PEDIATR INFECT DIS J, V17, P986, DOI 10.1097/00006454-199811000-00004; Heiskanen-Kosma T, 1999, SCAND J INFECT DIS, V31, P255, DOI 10.1080/00365549950163536; HUGHES JR, 1969, PEDIATRICS, V44, P477; IKEOGU MO, 1988, ARCH DIS CHILD, V63, P1266, DOI 10.1136/adc.63.10.1266; ISAACS D, 1989, PEDIATR INFECT DIS J, V8, P143; Jadavji T, 1997, CAN MED ASSOC J, V156, pS703; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; KLEIN JO, 1969, PEDIATRICS, V44, P486; KORPPI M, 1993, SCAND J INFECT DIS, V25, P207, DOI 10.3109/00365549309008486; KORPPI M, 1989, PEDIATR INFECT DIS J, V8, P687, DOI 10.1097/00006454-198910000-00005; Korppi M, 1997, EUR RESPIR J, V10, P1125, DOI 10.1183/09031936.97.10051125; KORPPI M, 1993, EUR J PEDIATR, V152, P24, DOI 10.1007/BF02072512; KORPPI M, 1993, SCAND J INFECT DIS, V25, P435, DOI 10.3109/00365549309008524; KORPPI M, 1993, ACTA PAEDIATR, V82, P360, DOI 10.1111/j.1651-2227.1993.tb12697.x; Lankinen KS, 1999, SCAND J INFECT DIS, V31, P155, DOI 10.1080/003655499750006209; Markowitz RI, 1998, SEMIN ROENTGENOL, V33, P151, DOI 10.1016/S0037-198X(98)80019-9; MCCARTHY PL, 1978, J PEDIATR-US, V92, P454, DOI 10.1016/S0022-3476(78)80448-X; MCCARTHY PL, 1981, CLIN PEDIATR, V20, P686, DOI 10.1177/000992288102001101; MCCONNOCHIE KM, 1988, AM J PUBLIC HEALTH, V78, P34, DOI 10.2105/AJPH.78.1.34; MCINTOSH K, IN PRESS PRINCIPLES; MIMICA I, 1971, AM J DIS CHILD, V122, P278, DOI 10.1001/archpedi.1971.02110040062002; MURPHY TF, 1981, AM J EPIDEMIOL, V113, P12, DOI 10.1093/oxfordjournals.aje.a113061; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; NOHYNEK H, 1995, PEDIATR INFECT DIS J, V14, P484, DOI 10.1097/00006454-199506000-00004; NOHYNEK H, 1991, AM J DIS CHILD, V145, P618, DOI 10.1001/archpedi.1991.02160060036016; PAISLEY JW, 1984, PEDIATR INFECT DIS J, V3, P14, DOI 10.1097/00006454-198401000-00005; PALLARES R, 1995, NEW ENGL J MED, V333, P1655; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; PICKERING LK, 2000, 2000 RED BOOK REPORT; PONKA A, 1983, EUR J RESPIR DIS, V64, P360; RADKOWSKI MA, 1981, AM J ROENTGENOL, V137, P703, DOI 10.2214/ajr.137.4.703; RAMSEY BW, 1986, PEDIATRICS, V78, P1; RAPKIN RH, 1975, CLIN PEDIATR, V14, P130, DOI 10.1177/000992287501400203; RILEY I, 1983, PEDIATR RES, V17, P1041; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; SCHUTZE GE, 1992, PEDIATR INFECT DIS J, V11, P160, DOI 10.1097/00006454-199202000-00034; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; SHANN F, 1984, LANCET, V2, P537; Shann F, 1995, CLIN INFECT DIS, V21, pS218, DOI 10.1093/clind/21.Supplement_3.S218; Shinefield HR, 2000, PEDIATR INFECT DIS J, V19, P394, DOI 10.1097/00006454-200004000-00036; STAGNO S, 1981, PEDIATRICS, V68, P322; TIPPLE MA, 1979, PEDIATRICS, V63, P192; Toikka P, 1999, CLIN INFECT DIS, V29, P568, DOI 10.1086/598635; Toikka P, 1999, J CLIN MICROBIOL, V37, P633, DOI 10.1128/JCM.37.3.633-637.1999; TURNER RB, 1987, J PEDIATR-US, V111, P194; WALL RA, 1986, B WORLD HEALTH ORGAN, V64, P553; WILDIN SR, 1988, AM J DIS CHILD, V142, P43, DOI 10.1001/archpedi.1988.02150010053020; Wubbel L, 1999, PEDIATR INFECT DIS J, V18, P98, DOI 10.1097/00006454-199902000-00004; ZUKIN DD, 1986, ANN EMERG MED, V15, P792	84	383	429	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					429	437		10.1056/NEJMra011994	http://dx.doi.org/10.1056/NEJMra011994			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832532				2022-12-28	WOS:000173686400008
J	Steinbrook, R				Steinbrook, R			Physician-assisted suicide in Oregon - An uncertain future	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Angell M, 1999, NEW ENGL J MED, V341, P1923, DOI 10.1056/NEJM199912163412509; ASHCROFT J, 2001, COMMUNICATION   1106; BRADSHAW S, 2001, COMMUNICATION   0627; Burt RA, 1997, NEW ENGL J MED, V337, P1234, DOI 10.1056/NEJM199710233371712; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CHRISTIE T, 2000, KNIGHTRIDDER TR 1218; Douglas CD, 2001, MED J AUSTRALIA, V175, P511, DOI 10.5694/j.1326-5377.2001.tb143704.x; *DRUG ENF ADM, 1991, AUT REP CONS ORD SYS; EGAN T, 1997, NY TIMES        1119, pA16; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2001, JAMA-J AM MED ASSOC, V285, P2363, DOI 10.1001/jama.285.18.2363; GROOPMAN J, 2001, NY TIMES        1109, pA27; Hedberg K, 2002, NEW ENGL J MED, V346, P450, DOI 10.1056/NEJM200202073460614; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; *NHPCO, 2001, STATS RES RES NHPCO; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Sullivan AD, 2001, NEW ENGL J MED, V344, P605, DOI 10.1056/NEJM200102223440811; 2001, OREGONIAN       1107	19	19	19	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					460	464		10.1056/NEJM200202073460624	http://dx.doi.org/10.1056/NEJM200202073460624			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832544				2022-12-28	WOS:000173686400029
J	Gruber, CJ; Tschugguel, W; Schneeberger, C; Huber, JC				Gruber, CJ; Tschugguel, W; Schneeberger, C; Huber, JC			Mechanisms of disease - Production and actions of estrogens	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HORMONE REPLACEMENT THERAPY; ACTIVATED PROTEIN-KINASE; LIGAND-BINDING DOMAIN; RECEPTOR-ALPHA; POSTMENOPAUSAL WOMEN; GENE-EXPRESSION; GROWTH-FACTOR; ENDOTHELIAL-CELLS; STEROID-RECEPTORS; BLOOD PRODUCTION		Univ Vienna, Sch Med, Dept Gynecol Endocrinol & Reprod Med, A-1090 Vienna, Austria	University of Vienna	Gruber, CJ (corresponding author), Univ Vienna, Sch Med, Dept Gynecol Endocrinol & Reprod Med, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.							ADASHI EY, 1991, HUM REPROD, V6, P1213, DOI 10.1093/oxfordjournals.humrep.a137514; ADLERCREUTZ H, 1992, J STEROID BIOCHEM, V41, P331, DOI 10.1016/0960-0760(92)90359-Q; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x; ARONICA SM, 1991, ENDOCRINOLOGY, V128, P2045, DOI 10.1210/endo-128-4-2045; BAIRD DT, 1974, J CLIN ENDOCR METAB, V38, P1009, DOI 10.1210/jcem-38-6-1009; Bingham SA, 1998, BRIT J NUTR, V79, P393, DOI 10.1079/BJN19980068; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; BRODIE A, 1993, J STEROID BIOCHEM, V44, P549, DOI 10.1016/0960-0760(93)90258-X; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CALLE EE, 1995, J NATL CANCER I, V87, P517, DOI 10.1093/jnci/87.7.517; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; CHRISTIANSEN C, 1981, LANCET, V1, P459; Clarkson TB, 1996, BRIT J OBSTET GYNAEC, V103, P53; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; ElAshry D, 1996, J STEROID BIOCHEM, V59, P261, DOI 10.1016/S0960-0760(96)00118-5; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Feigelson HS, 1999, CANCER RES, V59, P3908; FLOOD C, 1976, J CLIN ENDOCR METAB, V42, P1; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; GOJI K, 1993, J CLIN ENDOCR METAB, V77, P1629, DOI 10.1210/jc.77.6.1629; Green PS, 1997, J NEUROSCI, V17, P511; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Gruber DM, 2001, MATURITAS, V37, P151, DOI 10.1016/S0378-5122(00)00169-9; Henderson VW, 1997, NEUROLOGY, V48, pS27, DOI 10.1212/WNL.48.5_Suppl_7.27S; HILLIER SG, 1987, J STEROID BIOCHEM, V27, P351, DOI 10.1016/0022-4731(87)90327-X; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; Hochberg RB, 1998, ENDOCR REV, V19, P331, DOI 10.1210/er.19.3.331; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lieberman S, 1996, GYNECOL OBSTET INVES, V41, P147, DOI 10.1159/000292262; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; LINDSAY R, 1980, LANCET, V2, P1151; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; MATSUMINE H, 1986, J CLIN ENDOCR METAB, V63, P717, DOI 10.1210/jcem-63-3-717; MILLER WR, 1991, J STEROID BIOCHEM, V39, P783, DOI 10.1016/0960-0760(91)90026-2; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; MULNARD RA, 2000, JAMA-J AM MED ASSOC, V284, P2597; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; NAFTOLIN F, 1990, BIOL REPROD, V42, P21, DOI 10.1095/biolreprod42.1.21; NAFTOLIN F, 1994, J REPROD MED, V39, P257; Naftolin F, 1975, Recent Prog Horm Res, V31, P295; NEWTON CJ, 1994, J STEROID BIOCHEM, V48, P481, DOI 10.1016/0960-0760(94)90197-X; ONATE SA, 1995, SCIENCE, V270, P1354; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; OURSLER MJ, 1991, P NATL ACAD SCI USA, V88, P6613, DOI 10.1073/pnas.88.15.6613; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PaganiniHill A, 1996, AM J OBSTET GYNECOL, V174, P897, DOI 10.1016/S0002-9378(96)70322-8; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x; PORTER JC, 1974, J INVEST DERMATOL, V63, P85, DOI 10.1111/1523-1747.ep12678099; RALSTON SH, 1994, J BONE MINER RES, V9, P883; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Sator MO, 1997, MATURITAS, V28, P55, DOI 10.1016/S0378-5122(97)00060-1; SCALLEN TJ, 1985, J BIOL CHEM, V260, P4733; Schlegel A, 1999, J BIOL CHEM, V274, P33551, DOI 10.1074/jbc.274.47.33551; Schmidt JB, 1996, INT J DERMATOL, V35, P669, DOI 10.1111/j.1365-4362.1996.tb03701.x; Shao DL, 1999, J CLIN INVEST, V103, P1617, DOI 10.1172/JCI7421; Shwaery GT, 1997, CIRCULATION, V95, P1378; Siegelmann-Danieli N, 1999, BRIT J CANCER, V79, P456, DOI 10.1038/sj.bjc.6690071; SIITERI PK, 1966, J CLIN ENDOCR METAB, V26, P751, DOI 10.1210/jcem-26-7-751; SMITH CL, 1993, P NATL ACAD SCI USA, V90, P6120, DOI 10.1073/pnas.90.13.6120; SMITH DF, 1993, MOL ENDOCRINOL, V7, P4, DOI 10.1210/me.7.1.4; SMITH EP, 1995, NEW ENGL J MED, V332, P131; SODERQVIST G, 1993, AM J OBSTET GYNECOL, V168, P874; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; Takimoto GS, 1999, J STEROID BIOCHEM, V69, P45, DOI 10.1016/S0960-0760(98)00148-4; Tang M, 1997, J LAB CLIN MED, V129, P447, DOI 10.1016/S0022-2143(97)90078-0; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; Venkov CD, 1996, CIRCULATION, V94, P727, DOI 10.1161/01.CIR.94.4.727; WALKER P, 1984, NUCLEIC ACIDS RES, V12, P8611, DOI 10.1093/nar/12.22.8611; Watson CS, 1999, STEROIDS, V64, P5, DOI 10.1016/S0039-128X(98)00107-X; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WEI HC, 1993, NUTR CANCER, V20, P1, DOI 10.1080/01635589309514265; Weigel NL, 1996, BIOCHEM J, V319, P657, DOI 10.1042/bj3190657; WHITE RE, 1995, CIRC RES, V77, P936, DOI 10.1161/01.RES.77.5.936; Witkowska HE, 1997, STEROIDS, V62, P621, DOI 10.1016/S0039-128X(97)00047-0; Woolley CS, 1997, J NEUROSCI, V17, P1848; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yue M, 1999, ENDOCR-RELAT CANCER, V6, P157, DOI 10.1677/erc.0.0060157	104	693	728	1	51	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					340	352		10.1056/NEJMra000471	http://dx.doi.org/10.1056/NEJMra000471			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821512				2022-12-28	WOS:000173545300008
J	Joly, P; Roujeau, JC; Benichou, J; Picard, C; Dreno, B; Delaporte, E; Vaillant, L; D'Incan, M; Plantin, P; Bedane, C; Young, P; Bernard, P				Joly, P; Roujeau, JC; Benichou, J; Picard, C; Dreno, B; Delaporte, E; Vaillant, L; D'Incan, M; Plantin, P; Bedane, C; Young, P; Bernard, P		Bullous Dis French Study Grp	A comparison of oral and topical corticosteroids in patients with bullous pemphigoid	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELDERLY PATIENTS; MYCOPHENOLATE-MOFETIL; COHORT ANALYSIS; SKIN DISEASES; AZATHIOPRINE; THERAPY; PROGNOSIS; DIAGNOSIS; AUTOANTIBODIES; PREDNISOLONE	Background: Bullous pemphigoid is the most common autoimmune blistering skin disease of the elderly. Because elderly people have low tolerance for standard regimens of oral corticosteroids, we studied whether highly potent topical corticosteroids could decrease mortality while controlling disease. Methods: A total of 341 patients with bullous pemphigoid were enrolled in a randomized, multicenter trial and stratified according to the severity of their disease (moderate or extensive). Patients were randomly assigned to receive either topical clobetasol propionate cream (40 g per day) or oral prednisone (0.5 mg per kilogram of body weight per day for those with moderate disease and 1 mg per kilogram per day for those with extensive disease). The primary end point was overall survival. Results: Among the 188 patients with extensive bullous pemphigoid, topical corticosteroids were superior to oral prednisone (P=0.02). The one-year survival rate was 76 percent in the topical-corticosteroid group and 58 percent in the oral-prednisone group. Disease was controlled at three weeks in 92 of the 93 patients in the topical-corticosteroid group (99 percent) and 86 of the 95 patients in the oral-prednisone group (91 percent, P=0.02). Severe complications occurred in 27 of the 93 patients in the topical-corticosteroid group (29 percent) and in 51 of the 95 patients in the oral-prednisone group (54 percent, P=0.006). Among the 153 patients with moderate bullous pemphigoid, there were no significant differences between the topical-corticosteroid group and the oral-prednisone group in terms of overall survival, the rate of control at three weeks, or the incidence of severe complications. Conclusions: Topical corticosteroid therapy is effective for both moderate and severe bullous pemphigoid and is superior to oral corticosteroid therapy for extensive disease. (N Engl J Med 2002;346:321-7.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Rouen, INSERM, U519, Dept Dermatol, Rouen, France; Univ Rouen, INSERM, U519, Dept Biostat, Rouen, France; Univ Paris 07, Dept Dermatol, Creteil, France; Bichat Univ, Paris, France; Univ Nantes, Nantes, France; Univ Lille, Lille, France; Univ Tours, Tours, France; Univ Clermont Ferrand, Clermont Ferrand, France; Gen Hosp Quimper, Quimper, France; Univ Limoges, Limoges, France; Univ Reims, Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; Universite de Lille - ISITE; Universite de Lille; Universite de Tours; Universite de Limoges; Universite de Reims Champagne-Ardenne	Joly, P (corresponding author), Hop Charles Nicolle, Dermatol Clin, 1 Rue Germont, F-76031 Rouen, France.							Bernard P, 1997, BRIT J DERMATOL, V136, P694, DOI 10.1046/j.1365-2133.1997.6581643.x; BERNARD P, 1995, ARCH DERMATOL, V131, P48, DOI 10.1001/archderm.131.1.48; Bernard P, 1995, ANN DERMATOL VENER, V122, P751; Bohm M, 1997, LANCET, V349, P541, DOI 10.1016/S0140-6736(97)80092-X; BURTON JL, 1978, BRIT MED J, V2, P1190, DOI 10.1136/bmj.2.6146.1190; Courville P, 2000, ANN PATHOL, V20, P564; CROOKS V, 1991, J GERONTOL, V46, pM139, DOI 10.1093/geronj/46.4.M139; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; FINE JD, 1995, NEW ENGL J MED, V333, P1475, DOI 10.1056/NEJM199511303332207; GAMMON WR, 1990, J AM ACAD DERMATOL, V22, P664, DOI 10.1016/0190-9622(90)70094-X; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; GREAVES MW, 1971, BRIT MED J, V1, P144, DOI 10.1136/bmj.1.5741.144; Grundmann-Kollmann M, 1999, J AM ACAD DERMATOL, V40, P957, DOI 10.1016/S0190-9622(99)70084-8; GUILLAUME JC, 1993, ARCH DERMATOL, V129, P49, DOI 10.1001/archderm.129.1.49; Joly P, 1997, ARCH DERMATOL, V133, P719, DOI 10.1001/archderm.133.6.719; Korman NJ, 1998, ARCH DERMATOL, V134, P1137, DOI 10.1001/archderm.134.9.1137; KRAIN LS, 1972, ARCH DERMATOL, V106, P657, DOI 10.1001/archderm.106.5.657; Lebrun-Vignes B, 1999, ARCH DERMATOL, V135, P89, DOI 10.1001/archderm.135.1.89; MILLIGAN A, 1990, J AM ACAD DERMATOL, V22, P796, DOI 10.1016/0190-9622(90)70111-T; PAQUET P, 1991, ACTA DERM-VENEREOL, V71, P534; PAUL MA, 1994, J AM ACAD DERMATOL, V31, P620, DOI 10.1016/S0190-9622(94)70227-6; Roujeau JC, 1998, ARCH DERMATOL, V134, P465, DOI 10.1001/archderm.134.4.465; SAVIN JA, 1981, BRIT J DERMATOL, V104, P415, DOI 10.1111/j.1365-2133.1981.tb15311.x; SAVIN JA, 1979, BRIT J DERMATOL, V101, P521, DOI 10.1111/j.1365-2133.1979.tb11881.x; SNOW JL, 1995, ARCH DERMATOL, V131, P193, DOI 10.1001/archderm.131.2.193; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; TANAKA T, 1991, J BIOL CHEM, V266, P12555; THIVOLET J, 1985, LANCET, V1, P334, DOI 10.1016/S0140-6736(85)91099-2; THOMAS TPL, 1984, GERONTOLOGY, V30, P60, DOI 10.1159/000212608; Vaillant L, 1998, ARCH DERMATOL, V134, P1075, DOI 10.1001/archderm.134.9.1075; VENNING VA, 1992, J AM ACAD DERMATOL, V26, P585, DOI 10.1016/0190-9622(92)70085-T; WESTERHOF W, 1989, J AM ACAD DERMATOL, V20, P458, DOI 10.1016/S0190-9622(89)70058-X; WHO Collaborating Centre for International Drug Monitoring Uppsala, 1992, INT MON ADV REACT DR; ZILLIKENS D, 1995, ARCH DERMATOL, V131, P957, DOI 10.1001/archderm.131.8.957; Zimmermann R, 1999, ANN DERMATOL VENER, V126, P13	35	399	406	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					321	327		10.1056/NEJMoa011592	http://dx.doi.org/10.1056/NEJMoa011592			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821508				2022-12-28	WOS:000173545300004
J	Palmer, TN; Ralsanen, J				Palmer, TN; Ralsanen, J			Quantifying the risk of extreme seasonal precipitation events in a changing climate	NATURE			English	Article							DECISION-MODEL ANALYSIS; MULTIMODEL ENSEMBLE; PROBABILITY; WEATHER	Increasing concentrations of atmospheric carbon dioxide will almost certainly lead to changes in global mean climate(1). But because-by definition-extreme events are rare, it is significantly more difficult to quantify the risk of extremes. Ensemble-based probabilistic predictions(2), as used in short- and medium-term forecasts of weather and climate, are more useful than deterministic forecasts using a 'best guess' scenario to address this sort of problem(3,4). Here we present a probabilistic analysis of 19 global climate model simulations with a generic binary decision model. We estimate that the probability of total boreal winter precipitation exceeding two standard deviations above normal will increase by a factor of five over parts of the UK over the next 100 years. We find similar increases in probability for the Asian monsoon region in boreal summer, with implications for flooding in Bangladesh. Further practical applications of our techniques would be helped by the use of larger ensembles (for a more complete sampling of model uncertainty) and a wider range of scenarios at a resolution adequate to analyse average-size river basins.	European Ctr Medium Range Weather Forecasts, Reading RG2 9AX, Berks, England; Swedish Meteorol & Hydrol Inst, Rossby Ctr, S-60176 Norrkoping, Sweden	European Centre for Medium-Range Weather Forecasts (ECMWF); Swedish Meteorological & Hydrological Institute	Palmer, TN (corresponding author), European Ctr Medium Range Weather Forecasts, Shinfield Pk, Reading RG2 9AX, Berks, England.		Räisänen, Jouni/A-8203-2011	Räisänen, Jouni/0000-0003-3657-1588; Palmer, Tim/0000-0002-7121-2196				Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kharin VV, 2000, J CLIMATE, V13, P3760, DOI 10.1175/1520-0442(2000)013<3760:CITEIA>2.0.CO;2; Marsh, 2001, WEATHER, V56, P343, DOI [10.1002/j.1477-8696.2001.tb06506.x, DOI 10.1002/J.1477-8696.2001.TB06506.X]; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Palmer TN, 2000, REP PROG PHYS, V63, P71, DOI 10.1088/0034-4885/63/2/201; Palmer TN, 2000, Q J ROY METEOR SOC, V126, P2013, DOI 10.1256/smsqj.56702; Palmer TN, 2001, Q J ROY METEOR SOC, V127, P279, DOI 10.1256/smsqj.57201; Raisanen J, 2001, J CLIMATE, V14, P3212, DOI 10.1175/1520-0442(2001)014<3212:APADMA>2.0.CO;2; Richardson DS, 2000, Q J ROY METEOR SOC, V126, P649, DOI 10.1002/qj.49712656313	10	422	438	8	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					512	514		10.1038/415512a	http://dx.doi.org/10.1038/415512a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823856				2022-12-28	WOS:000173564300042
J	[Anonymous]				[Anonymous]			Summits that matter	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					457	457						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823810				2022-12-28	WOS:000173564300001
J	Herzog, MH; Fahle, M				Herzog, MH; Fahle, M			Effects of grouping in contextual modulation	NATURE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL INTERACTIONS; RANGE INTERACTIONS; ALERT MONKEYS; CONTRAST; ORIENTATION; V1; PATTERNS; DISCRIMINATION; SEGMENTATION	Perception of a visual target and the responses of cortical neurons can be strongly influenced by a context surrounding the target(1-27). This observation relates to the fundamental issue of how cortical neurons code objects of the external world. In high-contrast regimes, embedding a target in an iso-oriented context reduces neural responses and deteriorates performance in psychophysical experiments. Performance from orthogonal surrounds is better than that from iso-oriented ones(1-17). This contextual interference is often postulated to be caused by long- or short-range interactions between neurons tuned to orientation. Here we show, using a new illusion called 'shine-through' as a sensitive psychophysical probe, that the orientation difference between target and context does not determine performance. Instead, contextual modulation depends on the overall spatial structure of the context. We propose that contextual suppression vanishes if the contextual elements are grouped to an independent and coherent object.	Univ Bremen, D-28211 Bremen, Germany; City Univ London, Dept Optometry & Visual Sci, London EC1V 0HB, England	University of Bremen; City University London	Herzog, MH (corresponding author), Univ Bremen, Argonnenstr 3, D-28211 Bremen, Germany.							BANKS WP, 1984, PERCEPT PSYCHOPHYS, V36, P285, DOI 10.3758/BF03206370; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; Caputo G, 1996, VISION RES, V36, P2815, DOI 10.1016/0042-6989(96)00045-4; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P9631, DOI 10.1073/pnas.86.23.9631; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Ernst UA, 2001, NAT NEUROSCI, V4, P431, DOI 10.1038/86089; Herzog MH, 2001, P NATL ACAD SCI USA, V98, P4271, DOI 10.1073/pnas.071047498; Herzog MH, 2001, VISION RES, V41, P2325, DOI 10.1016/S0042-6989(01)00122-5; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Kurylo DD, 1997, PERCEPT PSYCHOPHYS, V59, P142, DOI 10.3758/BF03206856; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li W, 2000, J NEUROPHYSIOL, V83, P941, DOI 10.1152/jn.2000.83.2.941; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Mareschal I, 2001, VISION RES, V41, P1915, DOI 10.1016/S0042-6989(01)00082-7; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; NOTHDURFT HC, 1991, VISION RES, V31, P1073, DOI 10.1016/0042-6989(91)90211-M; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Wehrhahn C, 1996, PERCEPTION, V25, P1053, DOI 10.1068/p251053; WEISSTEIN N, 1974, SCIENCE, V186, P752, DOI 10.1126/science.186.4165.752; Wolfson SS, 1999, VISION RES, V39, P933, DOI 10.1016/S0042-6989(98)00144-8; Yu C, 2000, NAT NEUROSCI, V3, P724, DOI 10.1038/76687; Zipser K, 1996, J NEUROSCI, V16, P7376	29	69	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					433	436		10.1038/415433a	http://dx.doi.org/10.1038/415433a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807555				2022-12-28	WOS:000173433600051
J	Rosenthal, MB; Berndt, ER; Donohue, JM; Frank, RG; Epstein, AM				Rosenthal, MB; Berndt, ER; Donohue, JM; Frank, RG; Epstein, AM			Promotion of prescription drugs to consumers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: Spending on prescription drugs is the fastest growing component of the health care budget. There is public concern about the possibility that direct-to-consumer advertising of prescription drugs will result in inappropriate prescribing and higher costs of care. Guidelines issued in 1997 by the Food and Drug Administration (FDA) regarding advertising to consumers through electronic media are considered by some to be responsible for unleashing a flood of direct-to-consumer advertising. Methods: Using data on spending for promotional purposes and sales of prescription drugs, we examined industrywide trends for various types of promotion. We also tracked the relation between promotional efforts and sales over time. Finally, we documented the variation in direct-to-consumer advertising among and within five therapeutic classes of drugs and compared the variation in the intensity of such advertising with variation in the intensity of promotion to health care professionals. Results: Annual spending on direct-to-consumer advertising for prescription drugs tripled between 1996 and 2000, when it reached nearly $2.5 billion. Despite this increase, such advertising accounts for only 15 percent of the money spent on drug promotion and is highly concentrated on a subgroup of products. Within a therapeutic class, there is marked variation in the intensity of direct-to-consumer advertising, and the amount of such advertising for specific products fluctuates over time. The initial surge in direct-to-consumer advertising preceded the 1997 FDA guidelines that clarified the rules for electronic direct-to-consumer advertising, and thus the 1997 guidelines may not have been the most important reason for the overall increase. Conclusions: Although the use of direct-to-consumer advertising has grown disproportionately to other forms of promotion, it continues to account for a small proportion of total promotional efforts. Nevertheless, physicians must assist patients in evaluating health-related information obtained through direct advertising. (N Engl J Med 2002;346:498-505.) Copyright (C) 2002 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184; Donohue, Julie/0000-0003-2418-6017				[Anonymous], 2001, PREVENTION MAGAZINE, P46; BERNDT ER, 2001, LONG SHADOW PATIENT; Heffler S, 2001, HEALTH AFFAIR, V20, P193, DOI 10.1377/hlthaff.20.2.193; *J KAIS FAM FDN, 2001, PRESCR DRUG TRENDS C; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; *NIH CAR MAN, 2001, PRESCR DRUG EXP 2000; PASTORE M, 2001, HEALTHCARE WEB ADVER; *PHARM RES MAN AM, 2000, IND PROF 2000; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110	10	282	287	0	18	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					498	505		10.1056/NEJMsa012075	http://dx.doi.org/10.1056/NEJMsa012075			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521AE	11844852				2022-12-28	WOS:000173815300007
J	Schwartz, LA; Woloshin, S				Schwartz, LA; Woloshin, S			Marketing medicine to the public: A reader's guide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUNG-CANCER		VA Outcomes Grp, White River Jct, VT 05001 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA	VA Outcomes Group; Dartmouth College	Schwartz, LA (corresponding author), VA Outcomes Grp, White River Jct, VT 05001 USA.				NCI NIH HHS [CA91052-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Black WC, 2000, J NATL CANCER I, V92, P1280, DOI 10.1093/jnci/92.16.1280; Frame PS, 2000, JAMA-J AM MED ASSOC, V284, P1980, DOI 10.1001/jama.284.15.1980; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Kramer BS, 2000, HEMATOL ONCOL CLIN N, V14, P831, DOI 10.1016/S0889-8588(05)70314-2; *NAT CTR HLTH STAT, 1978, DEATH RAT 282 SEL CA; *US BUR CENS, NAT POP EST 1990S; 2001, NY TIMES        0923, P47; 2000, NY TIMES        0618, P34	9	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					774	775		10.1001/jama.287.6.774	http://dx.doi.org/10.1001/jama.287.6.774			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851550				2022-12-28	WOS:000173809500039
J	Rich, TH; Vickers-Rich, P; Gangloff, RA				Rich, TH; Vickers-Rich, P; Gangloff, RA			Polar dinosaurs	SCIENCE			English	Editorial Material							VICTORIA		Museum Victoria, Melbourne, Vic 3001, Australia; Monash Univ, Dept Earth Sci, Clayton, Vic 3800, Australia; Univ Alaska Museum, Fairbanks, AK 99775 USA	Museum Victoria; Monash University; University of Alaska System; University of Alaska Fairbanks	Rich, TH (corresponding author), Museum Victoria, POB 666E, Melbourne, Vic 3001, Australia.							Case Judd A., 1998, Journal of Vertebrate Paleontology, V18, p32A; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CLEMENS WA, 1993, GEOLOGY, V21, P503, DOI 10.1130/0091-7613(1993)021<0503:PIOATV>2.3.CO;2; DELAPPARENT AF, 1962, NORSK POLARINST ARBO, V14; DOUGLAS JG, 1982, PALAEOGEOGR PALAEOCL, V39, P171, DOI 10.1016/0031-0182(82)90021-9; GANGLOFF RA, 1998, DAKOTERRA, V5, P79; Gasparini Zulma, 1996, Memoirs of the Queensland Museum, V39, P583; GREGORY RT, 1989, EARTH PLANET SC LETT, V92, P27, DOI 10.1016/0012-821X(89)90018-6; Hammer William R., 1999, National Science Museum Monographs, V15, P211; Hotton N., 1980, COLD LOOK WARM BLOOD, P311; Laplace P. S., 1798, TRAITE MECANIQUE CEL, V2; PARRISH JT, 1988, GEOLOGY, V16, P22, DOI 10.1130/0091-7613(1988)016<0022:LCTVAN>2.3.CO;2; Pasch Anne D., 2001, P219; RICH TH, 2000, DINOSAURS DARKNESS; RICH TH, 1997, DINOSAUR ENCY, P562; Warren Anne, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P1	16	75	79	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					979	980		10.1126/science.1068920	http://dx.doi.org/10.1126/science.1068920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834803				2022-12-28	WOS:000173793000030
J	Choudhry, NK; Stelfox, HT; Detsky, AS				Choudhry, NK; Stelfox, HT; Detsky, AS			Relationships between authors of clinical practice guidelines and the pharmaceutical industry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; CONFLICT-OF-INTEREST; MANAGEMENT; PHYSICIANS; SOCIETY; HYPERTENSION; COMMITTEE; DRUGS	Context Increasing contact has been reported between physicians and the pharmaceutical industry, although no data exist in the literature regarding potential financial conflicts of interest for authors of clinical practice guidelines (CPGs). These interactions may be particularly relevant since CPGs are designed to influence the practice of a large number of physicians. Objective To quantify the extent and nature of interactions between authors of CPGs and the pharmaceutical industry. Design, Setting, and Participants Cross-sectional survey of 192 authors of 44 CPGs endorsed by North American and European societies on common adult diseases published between 1991 and July 1999. One hundred authors (52%) provided usable responses representing 37 of 44 different CPGs that we identified. Main Outcome Measures Nature and extent of interactions of authors with drug manufacturers; disclosure of relationships in published guidelines; prior discussion among authors regarding relationships; beliefs regarding whether authors' own relationships or those of their colleagues influenced treatment recommendations in guidelines. Results Eighty-seven percent of authors had some form of interaction with the pharmaceutical industry. Fifty-eight percent had received financial support to perform research and 38% had served as employees or consultants for a pharmaceutical company. On average, CPG authors interacted with 10.5 different companies. Overall, an average of 81% (95% confidence interval, 70% -92%) of authors per CPG had interactions. Similarly, all of the CPGs for 7 of the 10 diseases included in our study had at least 1 author who had some interaction. Fifty-nine percent had relationships with companies whose drugs were considered in the guideline they authored, and of these authors, 96% had relationships that predated the guideline creation process. Fifty-five percent of respondents indicated that the guideline process with which they were involved had no formal process for declaring these relationships. In published versions of the CPGs, specific declarations regarding the personal financial interactions of individual authors with the pharmaceutical industry were made in only 2 cases. Seven percent thought that their own relationships with the pharmaceutical industry influenced the recommendations and 19% thought that their coauthors' recommendations were influenced by their relationships. Conclusions Although the response rate for this survey was low, there appears to be considerable interaction between CPG authors and the pharmaceutical industry. Our study highlights the need for appropriate disclosure of financial conflicts of interest for authors of CPGs and a formal process for discussing these conflicts prior to CPG development.	Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Hlth Network, Dept Med, Toronto, ON, Canada; Harvard Univ, Program Hlth Care Policy, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University	Detsky, AS (corresponding author), Mt Sinai Hosp, Room 427,600 Univ Ave, Toronto, ON M5G 1X5, Canada.			Stelfox, Henry/0000-0003-1231-1490				Adams P, 1996, BMJ-BRIT MED J, V312, P827; *AG HLTH CAR POL R, 1994, UNST ANG DIAGN MAN; *AG HLTH CAR POL R, 1994, HEART FAIL EV CAR PA; *AM PSYCH ASS, 1993, AM J PSYCHIAT S, V150, pS1; Anderson J, 1996, BMJ-BRIT MED J, V312, P762; [Anonymous], 1993, THORAX, V48, pS1; ANTSIFEROV M, 1993, DIABETIC MED, V10, P990; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; BETTERIDGE DJ, 1993, POSTGRAD MED J, V69, P359, DOI 10.1136/pgmj.69.811.359; Beveridge RC, 1996, CAN MED ASSOC J, V155, P25; Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; *BRIT DIAB ASS, 1993, J R COLL PHYSICIANS, V27, P259; *BRIT THOR SOC, 1993, BR J HOSP MED    MAR, P3; Campbell GD, 1996, AM J RESP CRIT CARE, V153, P1711; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; CHAPMAN KR, 1992, CAN MED ASSOC J, V147, P420; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; DEBONO DP, 1994, J ROY COLL PHYS LOND, V28, P312; DEVAULT KR, 1995, ARCH INTERN MED, V155, P2165, DOI 10.1001/archinte.155.20.2165; EVANS CE, 1993, CAN CONS C HYP MAN 1; FEIN AM, 1995, AM J RESP CRIT CARE, V152, P1149, DOI 10.1164/ajrccm.152.4.7551362; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; Frohlich J, 1998, CAN J CARDIOL, V14, p17A; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Gleason PP, 1997, JAMA-J AM MED ASSOC, V278, P32, DOI 10.1001/jama.278.1.32; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1535, DOI 10.1002/art.1780381103; HOLBROOK AM, 1999, MED TREATMENT GUIDEL; Huchon G, 1998, EUR RESPIR J, V11, P986, DOI 10.1183/09031936.98.11040986; Hunt R, 1998, CAN J GASTROENTEROL, V12, P31, DOI 10.1155/1998/170180; JOHNSTONE DE, 1994, CAN J CARDIOL, V10, P613; Mandell L, 1993, Can J Infect Dis, V4, P25; Mandell L A, 1993, Can J Infect Dis, V4, P317; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; MYERS MG, 1995, GUIDELINES TREATMENT; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; OGILVIE RI, 1993, CAN MED ASSOC J, V149, P575; *ONT ANT REV PAN, 1997, ANT GUID COMM ACQ IN; Pearson MG, 1997, THORAX, V52, pS1; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Ryan TJ, 1996, CIRCULATION, V94, P2341, DOI 10.1161/01.CIR.94.9.2341; Sandberg WS, 1997, ACAD MED, V72, P916, DOI 10.1097/00001888-199710000-00018; SEVER P, 1993, BMJ-BRIT MED J, V306, P983, DOI 10.1136/bmj.306.6883.983; Soll AH, 1996, JAMA-J AM MED ASSOC, V275, P622; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; TAN MH, 1992, CAN MED ASSOC J, V147, P697; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; WESTON CFM, 1994, BMJ-BRIT MED J, V308, P767, DOI 10.1136/bmj.308.6931.767; WILLIAMS JF, 1995, CIRCULATION, V92, P2764; ZANCHETTI A, 1993, BMJ-BRIT MED J, V307, P1541, DOI 10.1136/bmj.307.6918.1541; ZIEGLER MG, 1995, JAMA-J AM MED ASSOC, V273, P1296, DOI 10.1001/jama.273.16.1296; 1991, J ALLERGY CLIN IMMUN, V88, P425; 1997, ARCH INTERN MED, V157, P2413; 1995, ENDOCR PRACT, V1, P149; 1997, AM J HLTH SYST PHARM, V54, P299; 1995, J ALLERGY CLIN IMMUN, V96, P707	58	437	452	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					612	617		10.1001/jama.287.5.612	http://dx.doi.org/10.1001/jama.287.5.612			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829700	Bronze			2022-12-28	WOS:000173686700030
J	Hlatky, MA; Boothroyd, D; Vittinghoff, E; Sharp, P; Whooley, MA				Hlatky, MA; Boothroyd, D; Vittinghoff, E; Sharp, P; Whooley, MA		HERS Res Grp	Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy - Results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED TRIAL; HEALTH SURVEY; DISEASE; ESTROGEN; RISK; PREVENTION; MORTALITY; PROGESTIN; OUTCOMES	Context Postmenopausal hormone therapy is commonly used by women for disease prevention, but its effects on quality of life have not been well documented. Objective To determine the effect on quality of life of estrogen plus progestin therapy used as secondary prevention in women with coronary artery disease. Design, Setting, and Participants A total of 2763 postmenopausal women with documented coronary artery disease (mean age, 67 years) in the Heart and Estrogen/Progestin Replacement Study, a randomized, placebo-controlled, double-blind trial conducted from January 1993 to July 1998 at outpatient and community settings at 20 US clinical centers. Intervention Participants were randomly assigned to receive either 0.625 mg/d of conjugated equine estrogen plus 2.5 mg/d of medroxyprogesterone acetate (n = 1380) or placebo (n = 1383) for 36 months. Main Outcome Measures Physical activity, measured by the Duke Activity Status Index; energy/fatigue and mental health, measured by RAND scales; and depressive symptoms, measured on the Burnam screening scale, at 3 years of follow-up. Results In all patients, scores declined significantly over 3 years for physical function (-3.8; P<.001), mental health (-0.6; P = .05), and energy/fatigue (-3.8; P<.001), but depressive symptoms were not significantly changed (P = .20). The effect of hormone therapy on these measures depended on the presence (n = 434) or absence (n = 2325) of flushing at study entry. Women with flushing who were assigned to hormone therapy had improved mental health (+2.6 vs -0.5; P = .04) and fewer depressive symptoms (-0.5 vs +0.007; P = .01) over follow-up compared with those assigned to placebo. Women without flushing who were assigned to hormone therapy had greater declines in physical function (-4.2 vs -3.3; P = .04) and energy/fatigue (-4.6 vs -3.1; P = .03) over follow-up. Quality-of-life scores were significantly lower among patients with older age, diabetes, hypertension, chest pain, or heart failure. These differences in quality of life among women classified by clinical characteristics were much greater than the effects of hormone therapy. Conclusion Hormone therapy has mixed effects on quality of life among older women. The effects of hormone therapy depend on the presence of menopausal symptoms; women without flushing had greater declines in physical measures, while women with flushing had improvements in emotional measures of quality of life.	Stanford Univ, Sch Med, Stanford, CA 94305 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Dept Vet Affairs Med Ctr, San Francisco, CA USA	Stanford University; University of California System; University of California San Francisco; Wake Forest University; Wake Forest Baptist Medical Center	Hlatky, MA (corresponding author), Stanford Univ, Sch Med, HRP Redwood Bldg,Room 150, Stanford, CA 94305 USA.			Boothroyd, Derek Brian/0000-0001-5387-6995; Hlatky, Mark/0000-0003-4686-9441				Alderman EL, 1996, NEW ENGL J MED, V335, P217; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BURNAM MA, 1988, MED CARE, V26, P775, DOI 10.1097/00005650-198808000-00004; Cauley JA, 2001, AM J MED, V110, P442, DOI 10.1016/S0002-9343(01)00647-7; Col NF, 1997, JAMA-J AM MED ASSOC, V277, P1140, DOI 10.1001/jama.277.14.1140; CROOG SH, 1986, NEW ENGL J MED, V314, P1657, DOI 10.1056/NEJM198606263142602; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; GRADY D, 1995, OBSTET GYNECOL, V85, P304, DOI 10.1016/0029-7844(94)00383-O; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Greendale GA, 1998, OBSTET GYNECOL, V92, P982, DOI 10.1016/S0029-7844(98)00305-6; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; HILLNER BE, 1986, AM J MED, V80, P1115, DOI 10.1016/0002-9343(86)90674-1; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Hsia J, 2000, CIRCULATION, V102, P2228; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; LIMOUZINLAMOTHE MA, 1994, AM J OBSTET GYNECOL, V170, P618, DOI 10.1016/S0002-9378(94)70239-X; Manson JE, 2001, NEW ENGL J MED, V345, P34, DOI 10.1056/NEJM200107053450106; Pocock SJ, 1996, CIRCULATION, V94, P135, DOI 10.1161/01.CIR.94.2.135; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Simon JA, 2001, CIRCULATION, V103, P638, DOI 10.1161/01.cir.103.5.638; Simon JA, 2001, ANN INTERN MED, V135, P493, DOI 10.7326/0003-4819-135-7-200110020-00008; Sourander L, 1998, LANCET, V352, P1965, DOI 10.1016/S0140-6736(98)05066-1; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Ware J.E., 1993, SF 36 HLTH SURV MAN; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WIKLUND I, 1993, AM J OBSTET GYNECOL, V168, P824, DOI 10.1016/S0002-9378(12)90828-5; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; 2001, WISDOM WOMENS INT ST	35	214	222	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					591	597		10.1001/jama.287.5.591	http://dx.doi.org/10.1001/jama.287.5.591			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829697				2022-12-28	WOS:000173686700027
J	Rice, L; Attisha, WK; Drexler, A; Francis, JL				Rice, L; Attisha, WK; Drexler, A; Francis, JL			Delayed-onset heparin-induced thrombocytopenia	ANNALS OF INTERNAL MEDICINE			English	Article							UNFRACTIONATED HEPARIN; ANTICOAGULATION	Background: Heparin-induced thrombocytopenia presents 5 to 12 days after heparin exposure, with or without arterial or venous thromboemboli. Delayed recognition and treatment of heparin-induced thrombocytopenia contribute to poor patient outcomes. Objective: To describe and increase awareness of a clinical scenario in which the onset or manifestations of heparin-induced thrombocytopenia are delayed. Design: Retrospective case series. Setting: Three large urban hospitals (with active cardiovascular surgery programs). Patients: 14 patients seen over a 3-year period in whom heparin-induced thrombocytopenia became apparent on delayed presentation with thromboembolic complications. Measurements: Platelet counts, onset of objectively determined thromboembolism, results of heparin-induced platelet factor 4 antibody tests, and outcomes. Results: Patients went home after hospitalizations that had included heparin exposure in most cases, with no thrombocytopenia recognized-only to return to the hospital (median, day 14) with thromboembolic complications. Thromboemboli were venous (12 patients, 7 with pulmonary emboli) or arterial (4 patients) or both. Platelet counts were mildly decreased in all but 2 patients on second presentation. On readmission, 11 patients received therapeutic heparin, which worsened the patients' clinical condition and, in all 11 cases, decreased the platelet count (mean at readmission, 143 x 10(9) cells/L; mean nadir after heparin re-exposure, 39 x 10(9) cells/L). Results of serologic tests for heparin-induced antibodies were positive in all patients. Subsequent treatments included alternative anticoagulants (11 patients), thrombolytic drugs (3 patients), inferior vena cava filters (3 patients) and, eventually, warfarin (11 patients). Three patients died. Conclusions: Delayed-onset heparin-induced thrombocytopenia is increasingly being recognized. To avoid disastrous outcomes, physicians must consider heparin-induced thrombocytopenia whenever a recently hospitalized patient returns with thromboembolism; therapy with alternative anticoagulants, not heparin, should be initiated.	Baylor Coll Med, Methodist Hosp, Houston, TX 77030 USA; St Lukes Episcopal Hosp, Houston, TX 77030 USA; Florida Hosp Ctr Hemostasis & Thrombosis, Orlando, FL USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Saint Lukes Episcopal Hospital; Adventist Health Services; AdventHealth	Rice, L (corresponding author), Baylor Coll Med, Methodist Hosp, 6565 Fannin St,MS 902-Main,Suite 930, Houston, TX 77030 USA.	lrice@bcm.tmc.edu						CHONG BH, 1992, HAEMOSTASIS, V22, P85; Greinacher A, 1999, CIRCULATION, V99, P73, DOI 10.1161/01.CIR.99.1.73; Greinacher A, 1999, THROMB HAEMOSTASIS, V82, P457; HARMENING D, 1992, CLIN HEMATOLOGY FUND, P416; KELTON JG, 1992, BLOOD, V80, P2246; LASTER J, 1988, J VASC SURG, V7, P667, DOI 10.1067/mva.1988.avs0070667; Lewis BE, 1997, SEMIN THROMB HEMOST, V23, P197, DOI 10.1055/s-2007-996091; Olson JD, 1998, ARCH PATHOL LAB MED, V122, P782; RICE L, 2002, IN PRESS POSTGRAD ME; Rice L, 1986, BLOOD S, V68, p339A; Wallis DE, 1999, AM J MED, V106, P629, DOI 10.1016/S0002-9343(99)00124-2; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; Warkentin TE, 1999, ANNU REV MED, V50, P129; WARKENTIN TE, 1994, AM J MED, V97, P489, DOI 10.1016/0002-9343(94)90332-8; Warkentin TE, 1997, ANN INTERN MED, V127, P804, DOI 10.7326/0003-4819-127-9-199711010-00005; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; Warkentin TE, 2000, J THROMB THROMBOLYS, V9, pS29	17	172	178	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					210	215		10.7326/0003-4819-136-3-200202050-00009	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827497				2022-12-28	WOS:000173637400004
J	Drazen, JM				Drazen, JM			Allocating limited resources	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					368	368		10.1056/NEJM200201313460514	http://dx.doi.org/10.1056/NEJM200201313460514			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821518				2022-12-28	WOS:000173545300013
J	Salanoubat, M; Genin, S; Artiguenave, F; Gouzy, J; Mangenot, S; Arlat, M; Billault, A; Brottier, P; Camus, JC; Cattolico, L; Chandler, M; Choisne, N; Claudel-Renard, C; Cunnac, S; Demange, N; Gaspin, C; Lavie, M; Moisan, A; Robert, C; Saurin, W; Schiex, T; Siguier, P; Thebault, P; Whalen, M; Wincker, P; Levy, M; Weissenbach, J; Boucher, CA				Salanoubat, M; Genin, S; Artiguenave, F; Gouzy, J; Mangenot, S; Arlat, M; Billault, A; Brottier, P; Camus, JC; Cattolico, L; Chandler, M; Choisne, N; Claudel-Renard, C; Cunnac, S; Demange, N; Gaspin, C; Lavie, M; Moisan, A; Robert, C; Saurin, W; Schiex, T; Siguier, P; Thebault, P; Whalen, M; Wincker, P; Levy, M; Weissenbach, J; Boucher, CA			Genome sequence of the plant pathogen Ralstonia solanacearum	NATURE			English	Article							SYMBIONT SINORHIZOBIUM-MELILOTI; PSEUDOMONAS-SOLANACEARUM; SECRETION APPARATUS; ESCHERICHIA-COLI; PROTEINS; VIRULENCE; GENES; BACTERIA; HRP; IDENTIFICATION	Ralstonia solanacearum is a devastating, soil-borne plant pathogen with a global distribution and an unusually wide host range. It is a model system for the dissection of molecular determinants governing pathogenicity. We present here the complete genome sequence and its analysis of strain GMI1000. The 5.8-megabase (Mb) genome is organized into two replicons: a 3.7-Mb chromosome and a 2.1-Mb megaplasmid. Both replicons have a mosaic structure providing evidence for the acquisition of genes through horizontal gene transfer. Regions containing genetically mobile elements associated with the percentage of G+C bias may have an important function in genome evolution. The genome encodes many proteins potentially associated with a role in pathogenicity. In particular, many putative attachment factors were identified. The complete repertoire of type III secreted effector proteins can be studied. Over 40 candidates were identified. Comparison with other genomes suggests that bacterial plant pathogens and animal pathogens harbour distinct arrays of specialized type III-dependent effectors.	INRA, CNRS, Lab Biol Mol Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Fdn Jean Dausset, CEPH, F-75010 Paris, France; CNRS, LMGM, F-31062 Toulouse, France; INRA, URGV, F-91057 Evry, France; INRA, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; INRA, Unite Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Foundation Jean Dausset-CEPH; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Boucher, CA (corresponding author), INRA, CNRS, Lab Biol Mol Interact Plantes Microorganismes, BP27, F-31326 Castanet Tolosan, France.	boucher@toulouse.inra.fr	Gaspin, Christine/B-6756-2015; Gouzy, Jerome/AAH-4977-2020; Arlat, Matthieu/CAH-3310-2022; Thébault, Patricia/AAD-1105-2020	Gouzy, Jerome/0000-0001-5695-4557; Thébault, Patricia/0000-0003-2276-4573; Genin, Stephane/0000-0003-2498-2400; Cunnac, Sebastien/0000-0002-3695-491X; Lavie, Muriel/0000-0003-3308-811X; Chandler, Michael/0000-0002-0292-6662; CHOISNE, Nathalie/0000-0001-6024-1664; Arlat, Matthieu/0000-0001-6196-4856				Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 1996, PLANT CELL, V8, P1683, DOI 10.1105/tpc.8.10.1683; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bertolla F, 1997, APPL ENVIRON MICROB, V63, P4965, DOI 10.1128/AEM.63.12.4965-4968.1997; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BOUCHER C, 1986, MOL GEN GENET, V205, P270, DOI 10.1007/BF00430438; Boucher C. A., 1988, Molecular Plant-Microbe Interactions, V1, P282, DOI 10.1094/MPMI-1-282; BRUMBLEY SM, 1993, J BACTERIOL, V175, P5477, DOI 10.1128/JB.175.17.5477-5487.1993; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Ezra D, 2000, MOL PLANT MICROBE IN, V13, P683, DOI 10.1094/MPMI.2000.13.6.683; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; FISCHER RA, 1922, J R STAT SOC, V85, P87; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; GRANADA GA, 1983, CAN J MICROBIOL, V29, P433, DOI 10.1139/m83-070; Gueneron M, 2000, MOL MICROBIOL, V36, P261, DOI 10.1046/j.1365-2958.2000.01870.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HAYWARD A. C., 2000, ENCY MICROBIOLOGY, V4, P32; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karp PD, 1999, NUCLEIC ACIDS RES, V27, P55, DOI 10.1093/nar/27.1.55; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Leach JE, 1996, ANNU REV PHYTOPATHOL, V34, P153, DOI 10.1146/annurev.phyto.34.1.153; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Matthysse AG, 2000, BBA-GENE STRUCT EXPR, V1490, P208, DOI 10.1016/S0167-4781(99)00250-X; Merlin C, 1997, MOL GEN GENET, V253, P499; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; ROSENBERG C, 1982, J BACTERIOL, V150, P402, DOI 10.1128/JB.150.1.402-406.1982; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith E. F., 1896, US DEP AGR DIV VEG P, P1; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thebaut P, 2000, JOBIM C P, P361; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x	47	699	1401	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					497	502		10.1038/415497a	http://dx.doi.org/10.1038/415497a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823852	Bronze			2022-12-28	WOS:000173564300038
J	Johnstone, RW; Ruefli, AA; Lowe, SW				Johnstone, RW; Ruefli, AA; Lowe, SW			Apoptosis: A link between cancer genetics and chemotherapy	CELL			English	Review							NF-KAPPA-B; CELL-CYCLE; P53-DEPENDENT APOPTOSIS; DNA METHYLATION; CARCINOMA-CELLS; TRANSGENIC MICE; DOWN-REGULATION; BCL-2 PROTEIN; IN-VITRO; P53	Defects in apoptosis underpin both tumorigenesis and drug resistance, and because of these defects chemotherapy often fails. Understanding the molecular events that contribute to drug-induced apoptosis, and how tumors evade apoptotic death, provides a paradigm to explain the relationship between cancer genetics and treatment sensitivity and should enable a more rational approach to anticancer drug design and therapy.	Peter MacCallum Canc Inst, Canc Immunol Div, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Peter Maccallum Cancer Center; Cold Spring Harbor Laboratory	Johnstone, RW (corresponding author), Peter MacCallum Canc Inst, Canc Immunol Div, Trescowthick Res Labs, Smorgon Family Bldg,St Andrews Pl, Melbourne, Vic 3002, Australia.	r.johnstone@pmcl.unimelb.edu.au; lowe@cshl.org	Johnstone, Ricky w/H-3748-2014	Johnstone, Ricky w/0000-0001-7053-9237	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adams JM, 1999, ONCOGENE, V18, P5268, DOI 10.1038/sj.onc.1202997; Arango D, 2001, CANCER RES, V61, P4910; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Asselin E, 2001, CANCER RES, V61, P1862; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown JM, 1999, CANCER RES, V59, P1391; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chatterjee D, 2001, CANCER RES, V61, P7148; Chen YNP, 1999, P NATL ACAD SCI USA, V96, P4325, DOI 10.1073/pnas.96.8.4325; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Corbet SW, 1999, ONCOGENE, V18, P1537, DOI 10.1038/sj.onc.1202436; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; Cunningham CC, 2001, CANCER, V92, P1265, DOI 10.1002/1097-0142(20010901)92:5<1265::AID-CNCR1447>3.0.CO;2-5; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; El-Deiry Wafik S., 1997, Current Opinion in Oncology, V9, P79; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Fulda S, 2001, ONCOGENE, V20, P1063, DOI 10.1038/sj.onc.1204141; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Griffiths SD, 1997, ONCOGENE, V14, P523, DOI 10.1038/sj.onc.1200871; Guo Z, 2001, CANCER RES, V61, P8395; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; HOFFMAN WH, 2001, J BIOL CHEM, V19, P19; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; IHDE DC, 1997, CANC PRINCIPLES PRAC; Jansen B, 2000, LANCET, V356, P1728, DOI 10.1016/S0140-6736(00)03207-4; Jia L, 2001, BLOOD, V98, P414, DOI 10.1182/blood.V98.2.414; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2001, BIOCHEM PHARMACOL, V62, P657, DOI 10.1016/S0006-2952(01)00733-X; Komarova EA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P41; Kondo S, 2000, CANCER RES, V60, P4328; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Leone G, 1999, HAEMATOLOGICA, V84, P937; Liu R, 1999, AM J PATHOL, V155, P1861, DOI 10.1016/S0002-9440(10)65505-8; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; Ng SSW, 2000, CANCER RES, V60, P5451; Omer CA, 2000, CANCER RES, V60, P2680; Paulsen M, 2001, J PATHOL, V195, P97, DOI 10.1002/path.890; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Rose S, 2000, AM J GASTROENTEROL, V95, P1; Roymans D, 2001, EUR J BIOCHEM, V268, P487, DOI 10.1046/j.1432-1327.2001.01936.x; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Sasaki H, 2000, CANCER RES, V60, P5659; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shin MS, 2001, CANCER RES, V61, P4942; Sierra A, 2000, INT J CANCER, V89, P142, DOI 10.1002/(SICI)1097-0215(20000320)89:2<142::AID-IJC7>3.3.CO;2-2; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; Tai YT, 1999, CANCER RES, V59, P2121; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tamm I, 2001, LANCET, V358, P489, DOI 10.1016/S0140-6736(01)05629-X; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tepper CG, 1999, BLOOD, V94, P1727, DOI 10.1182/blood.V94.5.1727.417k03_1727_1737; Trapani JA, 2000, CURR OPIN IMMUNOL, V12, P323, DOI 10.1016/S0952-7915(00)00094-7; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Volm M, 1998, ANTICANCER RES, V18, P2905; Walczak H, 2000, CANCER RES, V60, P3051; Walker A, 1997, CANCER RES, V57, P1939; Wallace-Brodeur RR, 1999, CELL MOL LIFE SCI, V55, P64, DOI 10.1007/s000180050270; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang XD, 2001, GENE DEV, V15, P2922; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	101	1889	2011	11	259	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					153	164		10.1016/S0092-8674(02)00625-6	http://dx.doi.org/10.1016/S0092-8674(02)00625-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832206	Bronze			2022-12-28	WOS:000173521300003
J	Zhang, XY; Zhu, YX; Granick, S				Zhang, XY; Zhu, YX; Granick, S			Hydrophobicity at a Janus interface	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY; SURFACES; FILMS; RANGE; WATER; HYDRATION; APPARATUS; LIQUIDS; POLYMER	Water confined between adjoining hydrophobic and hydrophilic surfaces (a Janus interface) is found to form stable films of nanometer thickness whose responses to shear deformations are extraordinarily noisy. The power spectrum of this noise is quantified. In addition, the frequency dependence of the complex shear modulus is a power law with slope one-half, indicating a distribution of relaxation processes rather than any dominant one. The physical picture emerges that whereas surface energetics encourage water to dewet the hydrophobic side of the interface, the hydrophilic side constrains water to be present, resulting in a flickering, fluctuating complex.	Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Zhang, XY (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.		Zhu, Yingxi/B-8294-2011					Ben- Naim A., 1980, HYDROPHOBIC INTERACT; BINDER K, 1995, PHYS REV E, V51, P2823, DOI 10.1103/PhysRevE.51.2823; Bratko D, 2001, J CHEM PHYS, V115, P3873, DOI 10.1063/1.1386926; Cheng YK, 1999, BIOPOLYMERS, V50, P742, DOI 10.1002/(SICI)1097-0282(199912)50:7<742::AID-BIP7>3.0.CO;2-6; Considine RF, 2000, LANGMUIR, V16, P631, DOI 10.1021/la9904713; Ferry J.D., 1982, VISCOELASTIC PROPERT, Vthird; GRUNZE M, COMMUNICATION; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; Hummer G, 1996, P NATL ACAD SCI USA, V93, P8951, DOI 10.1073/pnas.93.17.8951; Hummer G, 2000, CHEM PHYS, V258, P349, DOI 10.1016/S0301-0104(00)00115-4; Ishida N, 2000, LANGMUIR, V16, P6377, DOI 10.1021/la000219r; Israelachvili J.N., 1991, INTERMOLECULAR SURFA; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kokkoli E, 2000, J COLLOID INTERF SCI, V230, P176, DOI 10.1006/jcis.2000.7089; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; PARRY AO, 1990, PHYS REV LETT, V64, P439, DOI 10.1103/PhysRevLett.64.439; PEACHEY J, 1991, REV SCI INSTRUM, V62, P463, DOI 10.1063/1.1142089; PEANASKY J, 1995, LANGMUIR, V11, P953, DOI 10.1021/la00003a044; PEANASKY J, 1994, LANGMUIR, V10, P3874, DOI 10.1021/la00022a078; PRATT LR, 1977, J CHEM PHYS, V67, P3683, DOI 10.1063/1.435308; RUCKENSTEIN E, 1983, J COLLOID INTERF SCI, V96, P488, DOI 10.1016/0021-9797(83)90050-4; SCHWARTZ DK, 1990, PHYS REV A, V41, P5687, DOI 10.1103/PhysRevA.41.5687; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; Tanford Ch., 1973, HYDROPHOBIC EFFECT F; THOMAS R, COMMUNICATION; TSAO YH, 1993, SCIENCE, V262, P547, DOI 10.1126/science.8211182; Tyrrell JWG, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.176104; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; WEISSMAN M, COMMUNICATION; WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853; Yamamoto R, 1998, PHYS REV E, V58, P3515, DOI 10.1103/PhysRevE.58.3515; Zhang XY, 2001, J AM CHEM SOC, V123, P6736, DOI 10.1021/ja015960f; Zhu YX, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.096104	33	140	146	0	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					663	666		10.1126/science.1066141	http://dx.doi.org/10.1126/science.1066141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809968				2022-12-28	WOS:000173560900040
J	Grimes, DA; Schulz, KF				Grimes, DA; Schulz, KF			An overview of clinical research: the lay of the land	LANCET			English	Article							PHYSICIAN PERFORMANCE; RANDOMIZED-TRIAL; OBSTETRICS; RISK; DISEASE	Many clinicians report that they cannot read the medical literature critically. To address this difficulty, we provide a primer of clinical research for clinicians and researchers alike. Clinical research falls Into two general categories: experimental and observational, based on whether the investigator assigns the exposures or not. Experimental trials can also be subdivided into two: randomised and non-randomised. Observational studies can be either analytical or descriptive. Analytical studies feature a comparison (control) group, whereas descriptive studies do not. Within analytical studies, cohort studies track people forward in time from exposure to outcome. By contrast, case-control studies work in reverse, tracing back from outcome to exposure. Cross-sectional studies are like a snapshot, which measures both exposure and outcome at one time point. Descriptive studies, such as case-series reports, do not have a comparison group. Thus, in this type of study, investigators cannot examine associations, a fact often forgotten or ignored. Measures of association, such as relative risk or odds ratio, are the preferred way of expressing results of dichotomous outcomes-eg, sick versus healthy. Confidence intervals around these measures Indicate the precision of these results. Measures of association with confidence intervals reveal the strength, direction, and a plausible range of an effect as well as the likelihood of chance occurrence. By contrast, p values address only chance. Testing null hypotheses at a p value of 0.05 has no basis in medicine and should be discouraged.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org						Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Berenson AB, 2000, AM J OBSTET GYNECOL, V182, P820, DOI 10.1016/S0002-9378(00)70331-0; *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV C; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Doll R, 2000, BRIT MED J, V320, P1097, DOI 10.1136/bmj.320.7242.1097; EVANS CE, 1986, JAMA-J AM MED ASSOC, V255, P501; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Funai EF, 2001, GYNECOL OBSTET INVES, V51, P8, DOI 10.1159/000052882; GARG SK, 1994, JAMA-J AM MED ASSOC, V271, P1099, DOI 10.1001/jama.271.14.1099; Grimes DA, 1998, OBSTET GYNECOL, V92, P877, DOI 10.1016/S0029-7844(98)00276-2; Hannaford PC, 1998, BRIT J GEN PRACT, V48, P1657; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Huang Z, 1999, AM J EPIDEMIOL, V150, P1316, DOI 10.1093/oxfordjournals.aje.a009963; Hulley SB., 2001, DESIGNING CLIN RES; Kelsey JL., 1996, METHODS OBSERVATIONA; KEYS TF, 1977, MAYO CLIN PROC, V52, P657; Kim KS, 2000, ANN EPIDEMIOL, V10, P424, DOI 10.1016/S1047-2797(00)00065-X; Last J., 1988, DICT EPIDEMIOLOGY; LEVENO KJ, 1986, NEW ENGL J MED, V315, P615, DOI 10.1056/NEJM198609043151004; LEW JF, 1991, AM J EPIDEMIOL, V134, P413, DOI 10.1093/oxfordjournals.aje.a116103; Lilienfeld AM, 1980, FDN EPIDEMIOLOGY; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; MCKENNA UG, 1980, MAYO CLIN PROC, V55, P663; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Nerlich AG, 2000, LANCET, V356, P2176, DOI 10.1016/S0140-6736(00)03507-8; Olatunbosun OA, 1998, BRIT MED J, V316, P365, DOI 10.1136/bmj.316.7128.365; RAMSEY PG, 1991, JAMA-J AM MED ASSOC, V266, P1103, DOI 10.1001/jama.266.8.1103; Rothman K, 1986, MODERN EPIDEMIOLOGY; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; SIBLEY JC, 1982, NEW ENGL J MED, V306, P511, DOI 10.1056/NEJM198203043060904; Silver RK, 1997, FERTIL STERIL, V67, P30, DOI 10.1016/S0015-0282(97)81851-1; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Tatum HJ, 1996, AM J OBSTET GYNECOL, V175, P1231, DOI 10.1016/S0002-9378(96)70033-9; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Zink A, 1999, ANTICANCER RES, V19, P4273	36	353	386	6	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2002	359	9300					57	61		10.1016/S0140-6736(02)07283-5	http://dx.doi.org/10.1016/S0140-6736(02)07283-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809203				2022-12-28	WOS:000173143500032
J	van Dam, MJ; de Groot, E; Clee, SM; Hovingh, GK; Roelants, R; Brooks-Wilson, A; Zwinderman, AH; Smit, AJ; Smelt, AHM; Groen, AK; Hayden, MR; Kastelein, JJP				van Dam, MJ; de Groot, E; Clee, SM; Hovingh, GK; Roelants, R; Brooks-Wilson, A; Zwinderman, AH; Smit, AJ; Smelt, AHM; Groen, AK; Hayden, MR; Kastelein, JJP			Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study	LANCET			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; INTIMA-MEDIA THICKNESS; BINDING CASSETTE TRANSPORTER-1; GROWTH EVALUATION STATIN; ATHEROSCLEROSIS RISK; TANGIER-DISEASE; HDL CHOLESTEROL; CAROTID-ARTERY; ABC1 GENE	Background Decreased concentrations of HDL cholesterol are associated with increased cardiovascular risk. These concentrations are directly related to cholesterol efflux from cells-the first step and a key process in reverse cholesterol transport. Cholesterol efflux is mediated by the ATP-binding cassette A1 transporter (ABCA1), the rate-limiting step in the production of HDL. We aimed to assess the relation between cholesterol efflux, HDL concentrations, and arterial-wall changes in individuals with impaired ABCA1 function. Methods We investigated 30 individuals from families with ABCA1 mutations, and 110 controls matched for age, sex, and ethnic origin. We measured concentrations of HDL cholesterol in plasma and intima-media thickness of the carotid arteries by B-mode ultrasonography in all participants, We also measured cholesterol efflux from skin fibroblasts in nine individuals with ABCA1 mutations and in ten controls. Findings Individuals with ABCA1 mutations had lower amounts of cholesterol efflux, lower HDL cholesterol concentrations, and-greater intima-media thicknesses than controls. An intima-media thickness at the upper limit of normal (0.80 mm) was reached by age 55 years in the ABCA1 heterozygotes, and at age 80 years in unaffected controls (p<0.0001). Additionally, strong positive correlations were seen between HDL cholesterol concentrations and cholesterol efflux (r=0.90, p=0.001), and negative correlations between apolipoprotein-Al-mediated (r=-0.61, p=0.030) and HDL-particle-mediated (r=-0.60, p=0.018) efflux and intima-media thickness in the ABCA1 mutation carriers. Interpretation These results show a direct relation between ABCA1-mediated cellular cholesterol efflux and arterial-wall thickness, and therefore suggest that increasing efflux could inhibit atherosclerosis progression before the manifestation of symptomatic cardiovascular disease.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med G1 146, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Expt Hematol, NL-1105 AZ Amsterdam, Netherlands; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; Xenon Genet, Vancouver, BC, Canada; Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Internal Med, NL-2300 RA Leiden, Netherlands; Univ Groningen Hosp, Dept Internal Med, NL-9713 EZ Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med G1 146, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Brooks-Wilson, Angela/E-9399-2012; Clee, Susanne/AAC-4278-2020; Kastelein, John/AAF-7950-2020; van Dam, Marjel/AFT-3071-2022; Clee, Susanne/F-7312-2010; Hayden, Michael R/D-8581-2011	Brooks-Wilson, Angela/0000-0003-1009-6408; Clee, Susanne/0000-0001-7946-688X; Hayden, Michael R/0000-0001-5159-1419; van Dam, Marjel/0000-0001-9802-7516				Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOTS ML, 1992, HYPERTENSION, V19, P717, DOI 10.1161/01.HYP.19.6.717; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chambless LE, 1996, ULTRASOUND MED BIOL, V22, P545, DOI 10.1016/0301-5629(96)00039-7; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Clee SM, 2001, CIRCULATION, V103, P1198; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; de Groot E, 1998, J AM COLL CARDIOL, V31, P1561, DOI 10.1016/S0735-1097(98)00170-3; de Groot E, 1998, ULTRASOUND MED BIOL, V24, P825, DOI 10.1016/S0301-5629(98)00037-4; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glomset J A, 1973, Adv Lipid Res, V11, P1; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; MILLER GJ, 1975, LANCET, V1, P16; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Owen JS, 1999, LANCET, V354, P1402, DOI 10.1016/S0140-6736(99)00297-4; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Smilde TJ, 2000, EUR J CLIN INVEST, V30, P473; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; STOK WJ, 2001, 3 C PULS WAV AN LOND; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Wang J, 2000, ARTERIOSCL THROM VAS, V20, P1983, DOI 10.1161/01.ATV.20.8.1983	31	169	172	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					37	41		10.1016/S0140-6736(02)07277-X	http://dx.doi.org/10.1016/S0140-6736(02)07277-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809185				2022-12-28	WOS:000173143500014
J	Dahl, M; Tybjaerg-Hansen, A; Lange, P; Vestbo, J; Nordestgaard, BG				Dahl, M; Tybjaerg-Hansen, A; Lange, P; Vestbo, J; Nordestgaard, BG			Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha(1)-antitrypsin MZ heterozygotes: A longitudinal study of the general population	ANNALS OF INTERNAL MEDICINE			English	Article							ALPHA-1-ANTITRYPSIN GENE; PIMZ PHENOTYPE; TAQ-I; DEFICIENCY; RISK; INTERMEDIATE; POLYMORPHISM; INDIVIDUALS; MUTATION; REGION	Background: A deteriorating effect of severe alpha(1)-antitrypsin deficiency (ZZ genotype) on lung function is well known, whereas the role of intermediate deficiency (MZ genotype) remains uncertain. Objective: To test the hypothesis that MZ intermediate alpha(1)-antitrypsin deficiency affects pulmonary function and disease. Design: Population-based cohort study with 21-year follow-up. Setting: Copenhagen, Denmark. Participants: 9187 adults randomly selected from the Danish general population. Measurements: Plasma alpha(1)-antitrypsin levels, annual decrease in FEV1, airway obstruction, and hospitalization and mortality from chronic obstructive pulmonary disease (COPD). Results: 451 participants (4.9%) carried the MZ genotype. Plasma alpha(1)-antitrypsin levels were 31% lower in MZ heterozygotes than in persons with the MM genotype (Student t-test, P < 0.001). Annual decrease in FEV1 was 25 mL in MZ heterozygotes and 21 mL in persons with the MM genotype (t-test, P = 0.048). Airway obstruction was found in 19% of MZ heterozygotes compared with 15% of MM carriers (chi-square test, P = 0.023); in a logistic regression analysis adjusted for age, sex, and tobacco consumption, the corresponding odds ratio was 1.3 (Cl, 1.0 to 1.7). The incidence of hospitalization and mortality from COPD was 32 cases per 10 000 person-years in persons with the MZ genotype and 22 cases per 10 000 person-years in those with the MM genotype (log-rank test, P = 0.063). In a Cox regression model adjusted for age, sex, tobacco use, and FEV1 at study entry, relative risk for COPD outcomes in persons with the MZ genotype versus persons with the MM genotype was 1.5 (Cl, 1.0 to 2.3). All these results were independent of the S and E alleles in this gene and were not affected by cystic fibrosis DeltaF508 heterozygosity. Conclusions: MZ heterozygotes had a slightly greater rate of decrease in FEV1 and were modestly over-represented among persons with airway obstruction and COPD. In the population at large, MZ heterozygosity may account for a fraction of COPD cases-on the order of 2%, similar to the percentage of persons with COPD who have the severe but rare ZZ genotype.	Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen Hosp, DK-2100 Copenhagen, Denmark; Bispebjerg Hosp, DK-2400 Copenhagen NV, Denmark; Hvidovre Univ Hosp, DK-2650 Hvidovre, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.	brno@herlevhosp.kbhamt.dk	Dahl, Morten/F-4219-2014; Vestbo, Jorgen/Y-2912-2019; Nordestgaard, Borge Gronne/ABF-1310-2020	Dahl, Morten/0000-0002-6686-312X; Vestbo, Jorgen/0000-0001-6355-6362				[Anonymous], 1984, Acta Med Scand Suppl, V682, P1; ARMITAGE P, 1987, STATISTICAL METHODS, P160; BARKER AF, 1996, LUNG BIOL HEALTH DIS, V88, P245; Benetazzo MG, 1999, RESP MED, V93, P648, DOI 10.1016/S0954-6111(99)90105-1; BRANTLY ML, 1991, CHEST, V100, P703, DOI 10.1378/chest.100.3.703; Buist AS, 1994, TXB RESP MED, P1259; COX DW, 1995, METABOLIC MOL BASES, P4125; Dahl M, 2001, CLIN CHEM, V47, P56; Dahl M, 2001, J ALLERGY CLIN IMMUN, V107, P818, DOI 10.1067/mai.2001.114117; DEHAMEL FA, 1981, NEW ZEAL MED J, V94, P407; ERIKSSON S, 1985, EUR J RESPIR DIS, V67, P279; Horton F O 3rd, 1980, Chest, V77, P261, DOI 10.1378/chest.77.2_Supplement.261-a; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P77; LANGE P, 1991, EUR RESPIR J, V4, P1080; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; MADISON R, 1981, AM REV RESPIR DIS, V124, P149; Mahadeva R, 1999, J CLIN INVEST, V103, P999, DOI 10.1172/JCI4874; Mahadeva R, 1998, EUR RESPIR J, V11, P873, DOI 10.1183/09031936.98.11040873; MITTMAN C, 1978, AM REV RESPIR DIS, V118, P649, DOI 10.1164/arrd.1978.118.4.649; Morgan K, 1997, INT J BIOCHEM CELL B, V29, P1501, DOI 10.1016/S1357-2725(97)00118-0; MORGAN K, 1993, HUM MOL GENET, V2, P253, DOI 10.1093/hmg/2.3.253; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; POLLER W, 1990, EUR J CLIN INVEST, V20, P1; Sandford AJ, 1997, J MED GENET, V34, P874, DOI 10.1136/jmg.34.10.874; Seersholm N, 2000, AM J RESP CRIT CARE, V161, P81, DOI 10.1164/ajrccm.161.1.9812131; SING CF, 1985, AM J HUM GENET, V37, P268; SPSS, 1996, SPSS BAS 7 0 WIND US; TARJAN E, 1994, EUR RESPIR J, V7, P2199, DOI 10.1183/09031936.94.07122199; World Health Organization, 1965, MAN INT STAT CLASS D; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; 1989, SCAND J SOC MED S, V41, P1; 1997, THORAX S2, V52, pS1	32	116	120	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					270	279		10.7326/0003-4819-136-4-200202190-00006	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FQ	11848724				2022-12-28	WOS:000173943700002
J	Norcini, JJ				Norcini, JJ			The death of the long case?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Amer Board Internal Med, Philadelphia, PA 19006 USA	American Board of Internal Medicine	Norcini, JJ (corresponding author), Amer Board Internal Med, Philadelphia, PA 19006 USA.	jnorcini@icemed.org		Norcini, John/0000-0002-8464-4115				Crocker L, 1986, INTRO CLASSICAL MODE; Elstein AS, 1978, MED PROBLEM SOLVING; HARDEN RM, 1979, MED EDUC, V13, P41; Kroboth F.J., 1990, J GEN INTERN MED, V5, P214; McKinley RK, 2000, MED EDUC, V34, P573, DOI 10.1046/j.1365-2923.2000.00490.x; MESKAUSKAS JA, 1983, EVALUATING SKILLS ME; NOEL GL, 1992, ANN INTERN MED, V117, P757, DOI 10.7326/0003-4819-117-9-757; Norchini JJ, 2001, MED EDUC, V35, P735; NORCINI JJ, 1986, EVAL HEALTH PROF, V9, P286, DOI 10.1177/016327878600900302; NORCINI JJ, 1995, ANN INTERN MED, V123, P795, DOI 10.7326/0003-4819-123-10-199511150-00008; WAAS V, 2001, MED EDUC, V35, P317; Wass V, 2001, MED EDUC, V35, P729, DOI 10.1046/j.1365-2923.2001.01012.x; YANG JC, 1983, J MED EDUC, V58, P864	13	60	62	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2002	324	7334					408	409		10.1136/bmj.324.7334.408	http://dx.doi.org/10.1136/bmj.324.7334.408			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850375	Green Published, Bronze			2022-12-28	WOS:000174006300023
J	Arakawa, H; Hauschild, J; Buerstedde, JM				Arakawa, H; Hauschild, J; Buerstedde, JM			Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion	SCIENCE			English	Article							GERMINAL-CENTERS; CELL-LINE; RECOMBINATION; HYPERMUTATION	Three phenotypically distinct processes-somatic hypermutation, gene conversion, and switch recombination-remodel the functionally rearranged immunoglobulin (Ig) loci in B cells. Somatic hypermutation and switch recombination have recently been shown to depend on the activation-induced deaminase (AID) gene product. Here, we show that the disruption of the AID gene in the chicken B cell line DT40 completely blocks Ig gene conversion and that this block can be complemented by reintroduction of the AID complementary DNA. This demonstrates that the AID master gene controls all B cell-specific modifications of vertebrate Ig genes.	Heinrich Pette Inst, Dept Cellular Immunol, D-20251 Hamburg, Germany	Heinrich Pette Institute	Buerstedde, JM (corresponding author), Heinrich Pette Inst, Dept Cellular Immunol, Martinistr 52, D-20251 Hamburg, Germany.							Arakawa H, 1996, EMBO J, V15, P2540, DOI 10.1002/j.1460-2075.1996.tb00611.x; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; ARAKAWA H, UNPUB; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Buerstedde JM, 2002, NUCLEIC ACIDS RES, V30, P230, DOI 10.1093/nar/30.1.230; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Diaz M, 1998, IMMUNOL REV, V162, P13, DOI 10.1111/j.1600-065X.1998.tb01425.x; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; LISKAY RM, 1983, CELL, V35, P157, DOI 10.1016/0092-8674(83)90218-0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; TAKEDA S, 1992, P NATL ACAD SCI USA, V89, P4023, DOI 10.1073/pnas.89.9.4023; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	17	360	373	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1301	1306		10.1126/science.1067308	http://dx.doi.org/10.1126/science.1067308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847344				2022-12-28	WOS:000173926000046
J	Sales, BC				Sales, BC			Thermoelectric materials - Smaller is cooler	SCIENCE			English	Editorial Material							FIGURE; MERIT		Oak Ridge Natl Lab, Div Solid State, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Sales, BC (corresponding author), Oak Ridge Natl Lab, Div Solid State, POB 2008, Oak Ridge, TN 37831 USA.							Caillat T, 1997, J PHYS CHEM SOLIDS, V58, P1119, DOI 10.1016/S0022-3697(96)00228-4; Chung DY, 2000, SCIENCE, V287, P1024, DOI 10.1126/science.287.5455.1024; Harman TC, 2000, J ELECTRON MATER, V29, pL1, DOI 10.1007/s11664-000-0117-1; HICKS LD, 1993, PHYS REV B, V47, P12727, DOI 10.1103/PhysRevB.47.12727; Mahan GD, 1998, SOLID STATE PHYS, V51, P81; Nolas G.S., 2001, THERMOELECTRICS BASI; Nolas GS, 2000, APPL PHYS LETT, V77, P1855, DOI 10.1063/1.1311597; Nolas GS, 2001, SEMICONDUCT SEMIMET, V69, P255; NOLAS GS, IN PRESS MAT RES SOC; Sales BC, 1996, SCIENCE, V272, P1325, DOI 10.1126/science.272.5266.1325; Sharp JW, 1999, APPL PHYS LETT, V74, P3794, DOI 10.1063/1.124182; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; Wolfing B, 2001, PHYS REV LETT, V86, P4350, DOI 10.1103/PhysRevLett.86.4350	13	386	403	6	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1248	1249		10.1126/science.1069895	http://dx.doi.org/10.1126/science.1069895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847329				2022-12-28	WOS:000173926000029
J	Shuchman, M				Shuchman, M			Journalists as change agents in medicine and health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shuchman, M (corresponding author), SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA.							ANGELL M, 1996, SCI TRIAL; Gottlieb Martin, 1997, N Y Times Web, P30; Hartz J., 1997, WORLDS APART DISTANC; KING RT, 1996, WALL STREET J   0425, pA1; NELSON D, 2000, WASHINGTON POST 0131, pA1; Ransohoff D F, 2001, Eff Clin Pract, V4, P185; *RR MCC TRIB FDN, 1999, CANT C SER ETH ISS P, P161; Shuchman M, 1997, ANN INTERN MED, V126, P976, DOI 10.7326/0003-4819-126-12-199706150-00008; SHUCHMAN M, 2000, GLOBE MAIL      0404, pR6; WHITAKER R, 1998, BOSTON GLOBE    1115, pA1; WILLMAN D, 2000, LOS ANGELES T A 1220, P1	11	17	18	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					776	776		10.1001/jama.287.6.776	http://dx.doi.org/10.1001/jama.287.6.776			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851551	hybrid			2022-12-28	WOS:000173809500040
J	Greenwood, B; Mutabingwa, T				Greenwood, B; Mutabingwa, T			Malaria in 2002	NATURE			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; PLASMODIUM-FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; HOME TREATMENT; KENYA; CHLOROQUINE; POPULATION; INFECTION; EPIDEMIC; EFFICACY	The burden of malaria is increasing, especially in sub-Saharan Africa, because of drug and insecticide resistance and social and environmental changes. Thus, there is an urgent need for vaccines, new drugs and insecticides. Parasite, mosquito and human genome projects are helping in the search for new control tools and international donors are developing new funding mechanisms that could make them available to poor countries. But these new tools will achieve their maximum impact only if additional resources are deployed to strengthen malaria research and control communities in countries where the new tools will be used.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Natl Inst Med Res, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.							Bloland PB, 2000, B WORLD HEALTH ORGAN, V78, P1378; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Brown V, 1998, LANCET, V352, P1356, DOI 10.1016/S0140-6736(05)60747-7; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Fryauff DJ, 1998, AM J TROP MED HYG, V59, P513, DOI 10.4269/ajtmh.1998.59.513; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; Gomes M, 1998, LSHTM PUBL HEAL FOR, P87; Holding PA, 2001, AM J TROP MED HYG, V64, P68, DOI 10.4269/ajtmh.2001.64.68; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; LENGELER C, 1998, INSECTICIDE TREATED; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Muentener P, 1999, B WORLD HEALTH ORGAN, V77, P560; Mutabingwa T, 2001, LANCET, V358, P1218, DOI 10.1016/S0140-6736(01)06344-9; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Pitt S, 1998, LANCET, V352, P1279, DOI 10.1016/S0140-6736(98)00040-3; Roberts DR, 2000, LANCET, V356, P330, DOI 10.1016/S0140-6736(00)02516-2; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; SHRETTA R, 1998, COMMUNITY BASED HEAL; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Trouiller P, 1998, Int J Infect Dis, V3, P61, DOI 10.1016/S1201-9712(99)90010-3; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; Yeboah-Antwi K, 2001, B WORLD HEALTH ORGAN, V79, P394	27	471	492	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					670	672		10.1038/415670a	http://dx.doi.org/10.1038/415670a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832954	Bronze			2022-12-28	WOS:000173709100055
J	Pollack, IF; Finkelstein, SD; Woods, J; Burnham, J; Holmes, EJ; Hamilton, RL; Yates, AJ; Boyett, JM; Finlay, JL; Sposto, R				Pollack, IF; Finkelstein, SD; Woods, J; Burnham, J; Holmes, EJ; Hamilton, RL; Yates, AJ; Boyett, JM; Finlay, JL; Sposto, R		Children's Canc Grp	Expression of p53 and prognosis in children with malignant gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-GRADE ASTROCYTOMAS; LONG-TERM SURVIVAL; GLIOBLASTOMA-MULTIFORME; CLINICAL-IMPLICATIONS; EGFR AMPLIFICATION; GENE AMPLIFICATION; CANCER-THERAPY; MUTATIONS; OVEREXPRESSION; DELETION	Background: The prognosis of children with high-grade gliomas is uncertain, even when clinical and histologic findings are considered. We investigated whether mutations in the TP53 gene or the degree of expression of p53 protein in high-grade gliomas is associated with progression-free survival in children with these tumors. Methods: Paraffin-embedded specimens of malignant gliomas from children treated in the Children's Cancer Group study CCG-945 were assessed by mutational analysis of TP53 (121 specimens) and immunohistochemical analysis of p53 (115 specimens). For mutational studies, areas of tissue that contained malignant glioma were isolated by microdissection, and the DNA was subjected to polymerase-chain-reaction-based amplification and sequencing of TP53 exons 5, 6, 7, and 8. Immunohistochemical analysis was performed with the use of a microwave-enhanced antigen retrieval and an antibody that bound both wild-type and mutant p53. Results: We found a significant association between overexpression of p53 and outcome; this association was independent of histologic features, age, sex, the extent of resection, and tumor location. The rate (+/-SE) of progression-free survival at five years was 44+/-6 percent in the group of 74 patients whose tumors had low levels of expression of p53 and 17+/-6 percent in the group of 41 patients whose tumors had overexpression of p53 (P<0.001). A nonsignificant association was observed between mutations in TP53 and outcome. Conclusions: Overexpression of p53 in malignant gliomas during childhood is strongly associated with an adverse outcome, independently of clinical prognostic factors and histologic findings.	Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; Childrens Oncol Grp, Arcadia, CA USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; NYU, Med Ctr, Dept Pediat, New York, NY 10016 USA; Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Oncology Group (COG); University System of Ohio; Ohio State University; St Jude Children's Research Hospital; New York University; University of Southern California	Pollack, IF (corresponding author), Childrens Hosp Pittsburgh, Dept Neurosurg, 3705 5th Ave, Pittsburgh, PA 15213 USA.	pollaci@chplink.chp.edu			NCI NIH HHS [CA13539, CA21765] Funding Source: Medline; NINDS NIH HHS [NS01810, NS37704] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, U10CA013539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037704] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boyett J., 1998, P ASCO, V17, p526a; Bredel M, 1999, CLIN CANCER RES, V5, P1786; Brown JM, 1999, CANCER RES, V59, P1391; Campbell JW, 1996, NEUROSURGERY, V38, P258, DOI 10.1097/00006123-199602000-00006; CHANDLER KL, 1993, NEUROSURGERY, V32, P716, DOI 10.1227/00006123-199305000-00003; Collins VP, 1999, SEMIN CANCER BIOL, V9, P267, DOI 10.1006/scbi.1999.0132; Cunningham JM, 1997, J NEUROSURG, V86, P121, DOI 10.3171/jns.1997.86.1.0121; DANKS RA, 1995, NEUROSURGERY, V37, P246, DOI 10.1227/00006123-199508000-00009; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Dixon W. J., 1969, INTRO STAT ANAL; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; FINLAY JL, 1995, J CLIN ONCOL, V13, P112, DOI 10.1200/JCO.1995.13.1.112; FULTS D, 1992, CANCER RES, V52, P674; FULTS D, 1993, GENE CHROMOSOME CANC, V7, P173, DOI 10.1002/gcc.2870070311; Galanis E, 1998, INT J ONCOL, V13, P717; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GOH HS, 1995, CANCER RES, V55, P5217; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HE J, 1995, CANCER RES, V55, P4833; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ichimura K, 2000, CANCER RES, V60, P417; Ichimura K, 1998, GENE CHROMOSOME CANC, V22, P9, DOI 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1; JAMES CD, 1988, CANCER RES, V48, P5546; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kim SH, 1999, J UROLOGY, V162, P1512, DOI 10.1016/S0022-5347(05)68350-4; KINZLER KW, 1994, NEW ENGL J MED, V331, P49, DOI 10.1056/NEJM199407073310113; KLEIHUES P, 1993, INT HISTOLOGICAL CLA, V21, P11; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LANG FF, 1994, ONCOGENE, V9, P949; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LITOFSKY NS, 1994, NEUROSURGERY, V34, P967, DOI 10.1227/00006123-199406000-00003; Liu WG, 1997, CANCER RES, V57, P5254; Louis DN, 1997, BRAIN PATHOL, V7, P755, DOI 10.1111/j.1750-3639.1997.tb01062.x; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; NAZZARO JM, 1990, J NEUROSURG, V73, P331, DOI 10.3171/jns.1990.73.3.0331; Newcomb EW, 2000, HUM PATHOL, V31, P115, DOI 10.1016/S0046-8177(00)80207-5; POLLACK IF, 1994, NEW ENGL J MED, V331, P1500, DOI 10.1056/NEJM199412013312207; Pollack IF, 1997, CANCER RES, V57, P304; Pollack IF, 2001, CANCER RES, V61, P7404; Quinn DI, 2000, CANCER RES, V60, P1585; Raffel C, 1999, CLIN CANCER RES, V5, P4085; RASHEED BKA, 1994, CANCER RES, V54, P1324; RASHEED BKA, 1995, ONCOGENE, V10, P2243; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; RUSCH V, 1995, CANCER RES, V55, P5038; SALCMAN M, 1994, NEUROSURGERY, V34, P213, DOI 10.1227/00006123-199402000-00002; SALFORD LG, 1988, J NEUROSURG, V69, P506, DOI 10.3171/jns.1988.69.4.0506; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SPOSTO R, 1989, J NEURO-ONCOL, V7, P165, DOI 10.1007/BF00165101; Sung T, 2000, BRAIN PATHOL, V10, P249, DOI 10.1111/j.1750-3639.2000.tb00258.x; Sure U, 1997, J NEUROPATH EXP NEUR, V56, P782; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; VONDEIMLING A, 1993, BRAIN PATHOL, V3, P19; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wu TT, 1996, MODERN PATHOL, V9, P199; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7	58	207	212	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					420	427		10.1056/NEJMoa012224	http://dx.doi.org/10.1056/NEJMoa012224			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832530	Bronze			2022-12-28	WOS:000173686400005
J	Armstrong, PW				Armstrong, PW			Coronary reperfusion: numerators searching for denominators	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; PHARMACOLOGICAL REPERFUSION; THROMBOLYTIC THERAPY; FIBRINOLYSIS; MORTALITY; HORIZONS		Univ Alberta, Dept Med, Edmonton, AB T6G 2H7, Canada	University of Alberta	Armstrong, PW (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2H7, Canada.	paul.armstrong@ualberta.ca		Armstrong, Paul/0000-0002-0460-3445				Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; [Anonymous], 1988, LANCET, V2, P349; Armstrong PW, 2001, CIRCULATION, V103, P2862; Armstrong PW, 2001, CIRCULATION, V103, P2987, DOI 10.1161/01.CIR.103.24.2987; JAH P, 1996, J AM COLL CARDIOL, V27, P1335; KLEIMAN NS, 1994, CIRCULATION, V90, P2658, DOI 10.1161/01.CIR.90.6.2658; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Ottesen MM, 2001, J AM COLL CARDIOL, V37, P1581, DOI 10.1016/S0735-1097(01)01198-6; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; Shine KI, 2000, CIRCULATION, V101, P2325, DOI 10.1161/01.CIR.101.19.2325; White HD, 2000, LANCET, V356, P2028, DOI 10.1016/S0140-6736(00)03397-3; Woods KL, 1996, LANCET, V347, P1203, DOI 10.1016/S0140-6736(96)90732-1	13	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					371	372		10.1016/S0140-6736(02)07588-8	http://dx.doi.org/10.1016/S0140-6736(02)07588-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844504				2022-12-28	WOS:000173686500004
J	Lando, D; Peet, DJ; Whelan, DA; Gorman, JJ; Whitelaw, ML				Lando, D; Peet, DJ; Whelan, DA; Gorman, JJ; Whitelaw, ML			Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; TRANSCRIPTION FACTOR; EXPRESSION; FACTOR-1-ALPHA; HOMEOSTASIS; HIF-1-ALPHA; PROTEIN-1; SUBUNIT; EPAS1	The hypoxia-inducible factors (HIFs) 1alpha and 2alpha are key mammalian transcription factors that exhibit dramatic increases in both protein stability and intrinsic transcriptional potency during low-oxygen stress. This increased stability is due to the absence of proline hydroxylation, which in normoxia promotes binding of HIF to the von Hippel-Lindau (VHL tumor suppressor) ubiquitin ligase. We now show that hypoxic induction of the COOH-terminal transactivation domain (CAD) of HIF occurs through abrogation of hydroxylation of a conserved asparagine in the CAD. Inhibitors of Fe(II)- and 2-oxoglutarate-dependent dioxygenases prevented hydroxylation of the Asn, thus allowing the CAD to interact with the p300 transcription coactivator. Replacement of the conserved Asn by Ala resulted in constitutive p300 interaction and strong transcriptional activity. Full induction of HIF-1alpha and -2alpha, therefore, relies on the abrogation of both Pro and Asn hydroxylation, which during normoxia occur at the degradation and COOH-terminal transactivation domains, respectively.	Univ Adelaide, Dept Mol Biosci Biochem, Adelaide, SA 5005, Australia; CSIRO Hlth Sci & Nutr, Parkville, Vic 3052, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Whitelaw, ML (corresponding author), Univ Adelaide, Dept Mol Biosci Biochem, Adelaide, SA 5005, Australia.		Lando, David/A-2546-2010; Lando, David/AAH-3052-2019; Peet, Daniel/AAE-6698-2020	Lando, David/0000-0001-5783-8769; Peet, Daniel/0000-0002-6085-8936				Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Dinchuk JE, 2000, J BIOL CHEM, V275, P39543, DOI 10.1074/jbc.M006753200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lopaticki S, 1998, J MASS SPECTROM, V33, P950, DOI 10.1002/(SICI)1096-9888(199810)33:10<950::AID-JMS704>3.3.CO;2-1; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2000, GENE DEV, V14, P1893; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Wallis TP, 2001, PROTEIN SCI, V10, P2251, DOI 10.1110/ps.15401; WANG QP, 1991, J BIOL CHEM, V266, P14004; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	28	1193	1279	4	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					858	861		10.1126/science.1068592	http://dx.doi.org/10.1126/science.1068592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823643				2022-12-28	WOS:000173733000046
J	Demarest, SJ; Martinez-Yamout, M; Chung, J; Chen, HW; Xu, W; Dyson, HJ; Evans, RM; Wright, PE				Demarest, SJ; Martinez-Yamout, M; Chung, J; Chen, HW; Xu, W; Dyson, HJ; Evans, RM; Wright, PE			Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators	NATURE			English	Article							J-COUPLINGS; PROTEINS; BINDING; NMR; CBP; SPECIFICITY; ACTIVATION; DYNAMICS; PROGRAMS; COMPLEX	Nuclear hormone receptors are ligand-activated transcription factors that regulate the expression of genes that are essential for development, reproduction and homeostasis(1). The hormone response is mediated through recruitment of p160 receptor coactivators and the general transcriptional coactivator CBP/p300, which function synergistically to activate transcription(2). These coactivators exhibit intrinsic histone acetyltransferase activity, function in the remodelling of chromatin, and facilitate the recruitment of RNA polymerase II and the basal transcription machinery(3). The activities of the p160 coactivators are dependent on CBP. Both coactivators are essential for proper cell-cycle control, differentiation and apoptosis, and are implicated in cancer and other diseases(4-7). To elucidate the molecular basis of assembling the multiprotein activation complex, we undertook a structural and thermodynamic analysis of the interaction domains of CBP and the activator for thyroid hormone and retinoid receptors(8). Here we show that although the isolated domains are intrinsically disordered, they combine with high affinity to form a cooperatively folded helical heterodimer. Our study uncovers a unique mechanism, called 'synergistic folding', through which p160 coactivators recruit CBP/p300 to allow transmission of the hormonal signal to the transcriptional machinery.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Howard Hughes Medical Institute	Wright, PE (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Dyson, Jane/D-4160-2011; Evans, Ronald/AAF-4001-2019	Dyson, Jane/0000-0001-6855-3398; Evans, Ronald/0000-0002-9986-5965; Wright, Peter/0000-0002-1368-0223				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BAX A, 1994, METHOD ENZYMOL, V239, P79; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Goodman RH, 2000, GENE DEV, V14, P1553; GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li C, 1997, P NATL ACAD SCI USA, V94, P2278, DOI 10.1073/pnas.94.6.2278; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	30	336	347	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					549	553		10.1038/415549a	http://dx.doi.org/10.1038/415549a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823864				2022-12-28	WOS:000173564300052
J	Williams, JH; Friedman, WE				Williams, JH; Friedman, WE			Identification of diploid endosperm in an early angiosperm lineage	NATURE			English	Article							3 GENOMIC COMPARTMENTS; EXTANT GYMNOSPERMS; PHYLOGENY; EMBRYOLOGY; GNETALES; ORIGIN; PLANTS; GENES; ROOT	In flowering plants, the developmental and genetic basis for the establishment of an embryo-nourishing tissue differs from all other lineages of seed plants. Among extant nonflowering seed plants (conifers, cycads, Ginkgo, Gnetales), a maternally derived haploid tissue (female gametophyte) is responsible for the acquisition of nutrients from the maternal diploid plant, and the ultimate provisioning of the embryo. In flowering plants, a second fertilization event, contemporaneous with the fusion of sperm and egg to yield a zygote, initiates a genetically biparental and typically triploid embryo-nourishing tissue called endosperm. For over a century, triploid biparental endosperm has been viewed as the ancestral condition in extant flowering plants(1-3). Here we report diploid biparental endosperm in Nuphar polysepalum, a basal angiosperm. We show that diploid endosperms are common among early angiosperm lineages and may represent the ancestral condition among flowering plants. If diploid endosperm is plesiomorphic, the triploid endosperms of the vast majority of flowering plants must have evolved from a diploid condition through the developmental modification of the unique fertilization process that initiates endosperm.	Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Friedman, WE (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.	ned@colorado.edu	Williams, Joseph Hill/E-2227-2011	Williams, Joseph/0000-0002-1206-5667; Friedman, William Edward/0000-0003-0374-3427				Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; Battaglia E, 1989, ANN BOT, V47, P7; BATYGINA T B, 1982, Botanicheskii Zhurnal (St. Petersburg), V67, P1179; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Endress PK, 2001, INT J PLANT SCI, V162, P1111, DOI 10.1086/321919; Feild TS, 2000, INT J PLANT SCI, V161, P705, DOI 10.1086/314293; FRIEDMAN WE, 1995, P NATL ACAD SCI USA, V92, P3913, DOI 10.1073/pnas.92.9.3913; Friedman WE, 2001, CURR OPIN PLANT BIOL, V4, P14, DOI 10.1016/S1369-5266(00)00129-1; Friedman WE, 2001, EVOLUTION, V55, P217; Galati BG, 1985, B SOC ARGENT BOT, V24, P9; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Johri B.M., 1992, COMP EMBRYOLOGY ANGI; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Orban I, 1998, BOT J LINN SOC, V126, P339, DOI 10.1006/bojl.1997.0157; PALSER BF, 1975, ANN MO BOT GARD, V62, P621, DOI 10.2307/2395269; Queller D. C., 1989, Oxford Surveys in Evolutionary Biology, V6, P73; Solntseva MP, 1981, COMP EMBRYOLOGY FLOW, P51; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Swamy BGL., 1964, J INDIAN BOT SOC, V43, P391; Tobe H, 2000, J PLANT RES, V113, P271, DOI 10.1007/PL00013935; VANMIEGROET F, 1992, CAN J BOT, V70, P1991; Wilson M. F., 1983, MATE CHOICE PLANTS T; Winter A. N., 1991, BOT ZH, V76, P1716; Winter AN, 1991, BOT ZH, V76; YOSHIDA OSAMU, 1962, J COLL ARTS SCI CHIBA UNIV NAT SCI SER, V3, P459; [No title captured]	30	116	123	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					522	526		10.1038/415522a	http://dx.doi.org/10.1038/415522a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823859				2022-12-28	WOS:000173564300046
J	Achmat, Z				Achmat, Z			Commentary: Most South Africans cannot afford anti-HIV drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material									Treatment Act Campaign, ZA-7793 Cape Town, South Africa		Achmat, Z (corresponding author), Treatment Act Campaign, ZA-7793 Cape Town, South Africa.							DORRINGTON R, 2001, IMPACT HIV AIDS ADUL, P6; *OXF, 2001, OXF BRIEF PAP PFIZ; Sidley, 2000, BMJ, V320, P1016, DOI 10.1136/bmj.320.7240.1016; *TREATM ACT CAMP, 2001, BRED CONS STAT IMP E; Yamey G, 2001, BRIT MED J, V322, P383, DOI 10.1136/bmj.322.7283.383	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					217	218						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11831204				2022-12-28	WOS:000173604800022
J	Pell, JP; MacIntyre, K; Walsh, D; Capewell, S; McMurray, JJV; Chalmers, JWT; Boyd, JH; Finlayson, AR; Stewart, S; Redpath, AD				Pell, JP; MacIntyre, K; Walsh, D; Capewell, S; McMurray, JJV; Chalmers, JWT; Boyd, JH; Finlayson, AR; Stewart, S; Redpath, AD			Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROFILE		Glasgow Royal Infirm Univ NHS Trust, Dept Med Cardiol, Glasgow G32 2ER, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Western Infirm, Gardiner Inst, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Glasgow; University of Glasgow; University of Liverpool	Pell, JP (corresponding author), Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland.	jill.pell@gghb.scot.nhs.uk	mcmurray, John/B-2467-2013; Stewart, Simon/M-3316-2016; Macintyre, Kate/J-7174-2014	mcmurray, John/0000-0002-6317-3975; Stewart, Simon/0000-0001-9032-8998; Macintyre, Kate/0000-0003-2741-0467; Pell, Jill/0000-0002-8898-7035; Boyd, James/0000-0002-8925-8811				BLACK N, 1994, BRIT HEART J, V72, P317; Carstairs V., 1991, DEPRIVATION HLTH SCO; Delecretaz E, 1998, EUR HEART J, V19, P1042, DOI 10.1053/euhj.1997.0801; HARAPHONGSE M, 1994, CAN J CARDIOL, V10, P71; Nishioka H, 1998, JPN CIRC J, V62, P665, DOI 10.1253/jcj.62.665	5	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2002	324	7331					201	202		10.1136/bmj.324.7331.201	http://dx.doi.org/10.1136/bmj.324.7331.201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809641	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000173604800016
J	Sykes, R				Sykes, R			Commentary: The reality of treating HIV and AIDS in poor countries	BRITISH MEDICAL JOURNAL			English	Editorial Material									GlaxoSmithKline, Greenford UB6 0NN, Middx, England	GlaxoSmithKline	Sykes, R (corresponding author), GlaxoSmithKline, Greenford UB6 0NN, Middx, England.							Brown P, 2001, BRIT MED J, V322, P1265, DOI 10.1136/bmj.322.7297.1265; 2001, INDEPENDENT     0623	2	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					216	217						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11831203				2022-12-28	WOS:000173604800021
J	Ernst, MO; Banks, MS				Ernst, MO; Banks, MS			Humans integrate visual and haptic information in a statistically optimal fashion	NATURE			English	Article							TEXTURE-PERCEPTION; IDEAL OBSERVERS; TOUCH; PSYCHOPHYSICS; DISCREPANCY; DOMINANCE; VISION; SLANT	When a person looks at an object while exploring it with their hand, vision and touch both provide information for estimating the properties of the object. Vision frequently dominates the integrated visual-haptic percept, for example when judging size, shape or position(1-3), but in some circumstances the percept is clearly affected by haptics(4-7). Here we propose that a general principle, which minimizes variance in the final estimate, determines the degree to which vision or haptics dominates. This principle is realized by using maximum-likelihood estimation(8-15) to combine the inputs. To investigate cue combination quantitatively, we first measured the variances associated with visual and haptic estimation of height. We then used these measurements to construct a maximum-likelihood integrator. This model behaved very similarly to humans in a visual-haptic task. Thus, the nervous system seems to combine visual and haptic information in a fashion that is similar to a maximum-likelihood integrator. Visual dominance occurs when the variance associated with visual estimation is lower than that associated with haptic estimation.	Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ernst, MO (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	marc.ernst@tuebingen.mpg.de		Ernst, Marc/0000-0003-4197-8569				Backus BT, 1999, PERCEPTION, V28, P217, DOI 10.1068/p2753; Banks MS, 1998, VISION RES, V38, P187, DOI 10.1016/S0042-6989(97)00179-X; BLAKE A, 1993, VISION RES, V33, P1723, DOI 10.1016/0042-6989(93)90037-W; Clark J.J., 1990, DATA FUSION SENSORY; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; FESTINGE.L, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024766; GHARAMANI Z, 1997, SELF ORG COMPUTATION, P117; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; HELLER MA, 1983, PERCEPTION, V12, P607, DOI 10.1068/p120607; HELLER MA, 1982, PERCEPT PSYCHOPHYS, V31, P339, DOI 10.3758/BF03202657; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; LEDERMAN SJ, 1981, J EXP PSYCHOL HUMAN, V7, P902, DOI 10.1037/0096-1523.7.4.902; MonWilliams M, 1997, P ROY SOC B-BIOL SCI, V264, P1007, DOI 10.1098/rspb.1997.0139; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; POWER RP, 1980, PERCEPTION, V9, P457, DOI 10.1068/p090457; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Schrater PR, 2000, INT J COMPUT VISION, V40, P73, DOI 10.1023/A:1026557704054; SINGER G, 1969, PERCEPT PSYCHOPHYS, V5, P315, DOI 10.3758/BF03209572; Tastevin J, 1937, ENCEPHALE, V32, P57; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Warren D. H., 1991, PSYCHOL TOUCH, P119; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638	25	2777	2809	22	375	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					429	433		10.1038/415429a	http://dx.doi.org/10.1038/415429a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514HR	11807554				2022-12-28	WOS:000173433600050
J	Grimes, DA; Schulz, KF				Grimes, DA; Schulz, KF			Bias and causal associations in observational research	LANCET			English	Article							PELVIC INFLAMMATORY DISEASE; INTRAUTERINE-DEVICE; ORAL-CONTRACEPTIVES; CONTROLLED TRIALS; WOMENS HEALTH; RISK-FACTORS; SAMPLE-SIZE; CANCER; QUALITY; BREAST	Readers of medical literature need to consider two types of validity, Internal and external. Internal validity means that the study measured what It set out to; external validity Is the ability to generalise from the study to the reader's patients. With respect to internal validity, selection bias, Information bias, and confounding are present to some degree in all observational research. Selection bias stems from an absence of comparability between groups being studied. Information bias results from Incorrect determination of exposure, outcome, or both. The effect of Information bias depends on Its type. If Information Is gathered differently for one group than for another, bias results. By contrast, non-differential misclassification tends to obscure real differences. Confounding Is a mixing or blurring of effects: a researcher attempts to relate an exposure to an outcome but actually measures the effect of a third factor (the confounding variable). Confounding can be controlled In several ways: restriction, matching, stratification, and more sophisticated multivariate techniques. If a reader cannot explain away study results on the basis of selection, information, or confounding bias, then chance might be another explanation. Chance should be examined last, however, since these biases can account for highly significant, though bogus results. Differentiation between spurious, Indirect, and causal associations can be difficult. Criteria such as temporal sequence, strength and consistency of an association, and evidence of a dose-response effect lend support to a causal link.	Family Hlth Int, Res Triangle Pk, NC 27709 USA		Grimes, DA (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.	dgrimes@fhi.org						ABRAMSON JH, 1988, MAKING SENSE DATA; Ahlbom A, 1990, INTRO MODERN EPIDEMI; [Anonymous], 1968, CIRCULATION, V37, P11; Bartholomew L L, 1998, Obstet Gynecol Surv, V53, P708, DOI 10.1097/00006254-199811000-00024; BURKMAN RT, 1981, OBSTET GYNECOL, V57, P269; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; FEINSTEIN AR, 1977, BRIT MED J, V2, P766, DOI 10.1136/bmj.2.6089.766-b; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; GRIMES DA, 1995, AM J OBSTET GYNECOL, V172, P227, DOI 10.1016/0002-9378(95)90125-6; GRIMES DA, 1993, JAMA-J AM MED ASSOC, V269, P3030, DOI 10.1001/jama.269.23.3030; GRIMES DA, 1992, OBSTET GYNECOL, V80, P865; Halbert JA, 1999, J AM GERIATR SOC, V47, P477, DOI 10.1111/j.1532-5415.1999.tb07242.x; HARRIS BML, 1989, BMJ-BRIT MED J, V299, P1430, DOI 10.1136/bmj.299.6713.1430; Hennekens C.H., 1987, EPIDEMIOLOGY MED; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hulley SB., 2001, DESIGNING CLIN RES; JAIN AK, 1976, AM J OBSTET GYNECOL, V126, P301, DOI 10.1016/0002-9378(76)90539-1; Kjellberg L, 2000, BRIT J CANCER, V82, P1332, DOI 10.1054/bjoc.1999.1100; KRONMAL RA, 1991, J CLIN EPIDEMIOL, V44, P109, DOI 10.1016/0895-4356(91)90259-C; Lacey JV, 1999, CANCER EPIDEM BIOMAR, V8, P1079; LANG TA, 1997, HOW REPORT STAT MED; Last J., 1988, DICT EPIDEMIOLOGY; LEE NC, 1988, OBSTET GYNECOL, V72, P1; LEE NC, 1991, OBSTET GYNECOL, V77, P425; LEE NC, 1983, OBSTET GYNECOL, V62, P1; LINDEFORSHARRIS BM, 1991, AM J EPIDEMIOL, V134, P1003, DOI 10.1093/oxfordjournals.aje.a116173; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCKEIGUE PM, 1994, TERATOLOGY, V50, P27, DOI 10.1002/tera.1420500105; Melbye M, 1997, NEW ENGL J MED, V336, P81, DOI 10.1056/NEJM199701093360201; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moinpour CM, 2000, J CLIN ONCOL, V18, P1942, DOI 10.1200/JCO.2000.18.9.1942; ORY HW, 1977, JAMA-J AM MED ASSOC, V237, P2619, DOI 10.1001/jama.237.24.2619; Rothman K, 1986, MODERN EPIDEMIOLOGY; ROTHMAN KJ, 1978, NEW ENGL J MED, V299, P1362; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; SCHLESSELMAN JJ, 1989, CONTRACEPTION, V40, P1, DOI 10.1016/0010-7824(89)90025-5; SCHULL WJ, 1969, J CHRON DIS, V22, P217, DOI 10.1016/0021-9681(69)90015-0; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; SELTZER CC, 1974, AM J EPIDEMIOL, V100, P453, DOI 10.1093/oxfordjournals.aje.a112057; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Streiner DS, 1989, PDQ EPIDEMIOLOGY; WINGO PA, 1984, EPIDEMIOLOGIC APPROA	46	851	870	1	79	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2002	359	9302					248	252		10.1016/S0140-6736(02)07451-2	http://dx.doi.org/10.1016/S0140-6736(02)07451-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812579				2022-12-28	WOS:000173350800034
J	Keenan, SP				Keenan, SP			Weaning protocols: here to stay	LANCET			English	Editorial Material							MECHANICAL VENTILATION; DURATION; TRIAL; TIME		Royal Columbian Hosp, Intens Care Unit, New Westminster, BC V3L 5E7, Canada		Keenan, SP (corresponding author), Royal Columbian Hosp, Intens Care Unit, New Westminster, BC V3L 5E7, Canada.							BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; COHEN IL, 1991, CRIT CARE MED, V19, P1278, DOI 10.1097/00003246-199110000-00010; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Henneman E, 2001, CRIT CARE MED, V29, P297, DOI 10.1097/00003246-200102000-00013; Horst HM, 1998, ARCH SURG-CHICAGO, V133, P483, DOI 10.1001/archsurg.133.5.483; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Vitacca M, 2001, AM J RESP CRIT CARE, V164, P225, DOI 10.1164/ajrccm.164.2.2008160; Wood G, 1995, Respir Care, V40, P219; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193	12	8	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					186	187		10.1016/S0140-6736(02)07465-2	http://dx.doi.org/10.1016/S0140-6736(02)07465-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812550				2022-12-28	WOS:000173350800006
J	Ma, RCW; Chan, WB; Chow, CC; Cockram, CS				Ma, RCW; Chan, WB; Chow, CC; Cockram, CS			A woman with vomiting and hyperamylasaemia	LANCET			English	Editorial Material							PHEOCHROMOCYTOMA		Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Ma, RCW (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.		Ma, Ronald/C-2788-2009	Ma, Ronald/0000-0002-1227-803X				BERK JE, 1977, AM J GASTROENTEROL, V68, P572; GAN TJ, 1994, CAN J ANAESTH, V41, P244, DOI 10.1007/BF03009839; JONES DJ, 1985, BRIT MED J, V291, P1267, DOI 10.1136/bmj.291.6504.1267; PERRIER NAD, 1994, MAYO CLIN PROC, V69, P366; YAMANISHI J, 1985, BRIT MED J, V291, P1171, DOI 10.1136/bmj.291.6503.1171	5	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					42	42		10.1016/S0140-6736(02)07278-1	http://dx.doi.org/10.1016/S0140-6736(02)07278-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809186				2022-12-28	WOS:000173143500015
J	Walker, GJ; Hayward, NK				Walker, GJ; Hayward, NK			p16INK4A and p14ARF tumour suppressors in melanoma: lessons from the mouse	LANCET			English	Editorial Material							GERMLINE MUTATIONS; INK4A LOCUS; CDK4; RAS		Royal Brisbane Hosp, Queensland Inst Med Res, Human Genet Lab, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Hayward, NK (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Human Genet Lab, Brisbane, Qld 4029, Australia.		hayward, nicholas k/C-1367-2015; Walker, Graeme J/C-2548-2012; hayward, nick/AAV-8802-2020	hayward, nicholas k/0000-0003-4760-1033; Walker, Graeme J/0000-0002-9392-8769; 				Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Pollock PM, 2000, CLIN LAB MED, V20, P667; Rizos H, 2001, ONCOGENE, V20, P5543, DOI 10.1038/sj.onc.1204728; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	15	9	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					7	8		10.1016/S0140-6736(02)07271-9	http://dx.doi.org/10.1016/S0140-6736(02)07271-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809177				2022-12-28	WOS:000173143500006
J	Austin, MJ; Muskett, P; Kahn, K; Feys, BJ; Jones, JDG; Parker, JE				Austin, MJ; Muskett, P; Kahn, K; Feys, BJ; Jones, JDG; Parker, JE			Regulatory role of SGT1 in early R gene-mediated plant defenses	SCIENCE			English	Article							DISEASE RESISTANCE; ESSENTIAL COMPONENT; ARABIDOPSIS; EDS1; DEGRADATION; EXPRESSION; PROTEINS	Animal SGT1 is a component of Skp1-Cullin-F-box protein (SCF) ubiquitin ligases that target regulatory proteins for degradation. Mutations in one (SGT1b) of two highly homologous Arabidopsis SGT1 genes disable early plant defenses conferred by multiple resistance (R) genes. Loss of SGT1b function in resistance is not compensated for by SGT1a. R genes differ in their requirements for SGT1b and a second resistance signaling gene, RAR1, that was previously implicated as an SGT1 interactor. Moreover, SGT1b and RAR1 contribute additively to RPP5-mediated pathogen recognition. These data imply both operationally distinct and cooperative functions of SGT1 and RAR1 in plant disease resistance.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society	Parker, JE (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	parker@mpiz-koeln.mpg.de	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X; Austin, Mark/0000-0003-4943-7265				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Andrade MA, 2001, PLANT MOL BIOL, V46, P603, DOI 10.1023/A:1010650809272; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Cohn J, 2001, CURR OPIN IMMUNOL, V13, P55, DOI 10.1016/S0952-7915(00)00182-5; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Inohara N, 2000, J BIOL CHEM, V275, P27823; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Jorgensen JH, 1996, GENOME, V39, P492, DOI 10.1139/g96-063; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MUSKETT P, IN PRESS PLANT CELL; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6	23	332	370	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2077	2080		10.1126/science.1067747	http://dx.doi.org/10.1126/science.1067747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11847308				2022-12-28	WOS:000174450500050
J	Squires, JE				Squires, JE			Artificial blood	SCIENCE			English	Editorial Material									Amer Red Cross, Biomed Serv, Arlington, VA 22307 USA	American Red Cross	Squires, JE (corresponding author), Amer Red Cross, Biomed Serv, Arlington, VA 22307 USA.	squiresj@usa.redcross.org	Badiger, Sharan/M-7727-2015	Badiger, Sharan/0000-0001-9752-9792				CHANG TMS, 1997, BLOOD SUBSTITUTES PR, V1; Creteur J, 2000, CRIT CARE MED, V28, P3025, DOI 10.1097/00003246-200008000-00058; Hill SE, 2001, CAN J ANAESTH, V48, pS32; MCCULLOUGH J, 1998, TRANSFUSION MED, P91; RABINER SF, 1970, ANN SURG, V171, P615, DOI 10.1097/00000658-197004000-00020; ROSSI EC, 1991, PRINCIPLES TRANSFUSI, P1; VANVAKAS E, 2001, EVIDENCE BASED PRACT, P101; Winslow R. M., 2000, SCI BASIS TRANSFUSIO, P588	8	119	131	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1002	+		10.1126/science.1068443	http://dx.doi.org/10.1126/science.1068443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834811				2022-12-28	WOS:000173793000039
J	Flower, R				Flower, R			A long engagement	NATURE			English	Article									William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Flower, R (corresponding author), William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.							Clark AJ, 1926, J PHYSIOL-LONDON, V61, P547, DOI 10.1113/jphysiol.1926.sp002315; Clark AJC, 1926, J PHYSIOL-LONDON, V61, P530, DOI 10.1113/jphysiol.1926.sp002314; Clarke WP, 1998, TRENDS PHARMACOL SCI, V19, P270, DOI 10.1016/S0165-6147(97)01138-3; DEJONGH DK, 1964, MOL PHARM; Langley JN, 1905, J PHYSIOL-LONDON, V33, P374; Parascandola J., 1986, DISCOVERIES PHARM, V3, P129	6	2	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					587	587		10.1038/415587a	http://dx.doi.org/10.1038/415587a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832920	Bronze			2022-12-28	WOS:000173709100022
J	Chapman, MR; Robinson, LS; Pinkner, JS; Roth, R; Heuser, J; Hammar, M; Normark, S; Hultgren, SJ				Chapman, MR; Robinson, LS; Pinkner, JS; Roth, R; Heuser, J; Hammar, M; Normark, S; Hultgren, SJ			Role of Escherichia coli curli operons in directing amyloid fiber formation	SCIENCE			English	Article							THIN AGGREGATIVE FIMBRIAE; FIBRONECTIN-BINDING CURLI; SALMONELLA-ENTERITIDIS; ALZHEIMERS-DISEASE; SURFACE ORGANELLES; PEPTIDES; CSGB	Amyloid is associated with debilitating human ailments including Alzheimer's and prion diseases. Biochemical, biophysical, and imaging analyses revealed that fibers produced by Escherichia coli called curli were amyloid. The CsgA curlin subunit, purified in the absence of the CsgB nucleator, adopted a soluble, unstructured form that upon prolonged incubation assembled into fibers that were indistinguishable from curli. In vivo, curli biogenesis was dependent on the nucleation-precipitation machinery requiring the CsgE and CsgF chaperone-like and nucleator proteins, respectively. Unlike eukaryotic amyloid formation, curli biogenesis is a productive pathway, requiring a specific assembly machinery.	Washington Univ, Sch Med, Dept Mol Microbiol & Microbial Pathogenesis, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Karolinska Inst, Dept Microbiol, S-171777 Stockholm, Sweden; Karolinska Inst, Tumorbiol Ctr, S-171777 Stockholm, Sweden	Washington University (WUSTL); Washington University (WUSTL); Karolinska Institutet; Karolinska Institutet	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol & Microbial Pathogenesis, Box 8230, St Louis, MO 63110 USA.		Hammar, Mats/R-7908-2019	Hammar, Mats/0000-0002-4593-7273; Chapman, Matthew/0000-0002-2645-1294	NIAID NIH HHS [F32 AI010502, AI29549, F32 AI010502-03, R01 AI029549, R01 AI048689, R37 AI029549, 1 F32 AI10502-01A1, AI48689] Funding Source: Medline; NIA NIH HHS [NIA P50 AG05681-17, P50 AG005681] Funding Source: Medline; NIDDK NIH HHS [R01 DK051406, DK51406] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010502, R01AI029549, R01AI048689, R37AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BenNasr A, 1996, MOL MICROBIOL, V20, P927; Bian Z, 1997, EMBO J, V16, P5827, DOI 10.1093/emboj/16.19.5827; CHAPMAN M, UNPUB; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; HUESER JE, 1987, J MUSCLE RES CELL M, V8, P303; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; OLSEN A, 1993, INFECT AGENT DIS, V2, P272; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998	17	903	940	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					851	855		10.1126/science.1067484	http://dx.doi.org/10.1126/science.1067484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823641	Green Accepted			2022-12-28	WOS:000173733000044
J	Koning, S; van Suijlekom-Smit, LWA; Nouwen, JL; Verduin, CM; Bernsen, RMD; Oranje, AP; Thomas, S; van der Wouden, JC				Koning, S; van Suijlekom-Smit, LWA; Nouwen, JL; Verduin, CM; Bernsen, RMD; Oranje, AP; Thomas, S; van der Wouden, JC			Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TOPICAL MUPIROCIN; ERYTHROMYCIN; STAPHYLOCOCCI; ANTIBIOTICS; RESISTANCE; OINTMENT; THERAPY	Objective To test the hypothesis that fusidic acid would not increase the treatment effect of disinfecting with povidone-iodine alone in children with impetigo. Design Randomised placebo controlled trial. Setting General practices in Greater Rotterdam. Participants 184 children aged 0-12 years with impetigo. Main outcome measures Clinical cure and bacterial cure after one week. Results After one week of treatment 55% of the patients in the fusidic acid group were clinically cured compared with 13% in the placebo group (odds ratio 12.6,95% confidence interval 5.0 to 31.5, number needed to treat 2.3). After two weeks and four weeks the differences in cure rates between the two groups had become smaller. More children in the placebo group were non-compliant (12 v 5) and received extra antibiotic treatment (I I v 3), and more children in the placebo group reported adverse effects (19 v 7). Staphylococcus aureus was found in 96% of the positive cultures; no strains were resistant to fusidic acid. Conclusions Fusidic acid is much more effective than placebo (when both are given in combination with povidone-iodine shampoo) in the treatment of impetigo. Because of the low rate of cure and high rate of adverse events in the placebo group, the value of povidone-iodine in impetigo can be questioned.	Erasmus Univ, Dept Gen Practice, NL-3000 DR Rotterdam, Netherlands; Univ Rotterdam Hosp, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Paediat, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Med Microbiol & Infect Dis, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Dermatovenereol, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam	van der Wouden, JC (corresponding author), Erasmus Univ, Dept Gen Practice, Room FF 325,POB 1738, NL-3000 DR Rotterdam, Netherlands.	vanderwouden@hag.fgg.eur.nl	van der Wouden, Johannes C/O-5109-2019; van der Wouden, Johannes C/C-2597-2009	van der Wouden, Johannes C/0000-0001-6639-6050; 				*AM SOC MICR, 1992, CLIN MICR PROC HDB; BALTIMORE RS, 1985, PEDIATR INFECT DIS J, V4, P597, DOI 10.1097/00006454-198509000-00061; Bass JW, 1997, PEDIATR INFECT DIS J, V16, P708, DOI 10.1097/00006454-199707000-00013; BOUKES FS, 1999, HUISARTS WET, V41, P427; BRIJNZEELS MA, 1993, CHILD GEN PRACTICE; BRITTON JW, 1990, J PEDIATR-US, V117, P827; Bruijnzeels MA, 1993, CHILD GEN PRACTICE; CARRUTHERS R, 1988, DRUGS, V36, P364, DOI 10.2165/00003495-198836030-00006; DAGAN R, 1992, ANTIMICROB AGENTS CH, V36, P287, DOI 10.1128/AAC.36.2.287; DAJANI AS, 1971, PEDIATRICS, V48, P83; de Neeling AJ, 1998, J ANTIMICROB CHEMOTH, V41, P93, DOI 10.1093/jac/41.1.93; Espersen F, 1998, BRIT J DERMATOL, V139, P4; Finlay JE, 1997, ANTIMICROB AGENTS CH, V41, P1137, DOI 10.1128/AAC.41.5.1137; GILBERT M, 1989, J AM ACAD DERMATOL, V20, P1083, DOI 10.1016/S0190-9622(89)70137-7; GODTFREDSEN W, 1962, Lancet, V1, P928, DOI 10.1016/S0140-6736(62)91968-2; HAY RJ, 1998, ROOK WILKINSON EBLIN, P1109; MERTZ PM, 1989, ARCH DERMATOL, V125, P1069, DOI 10.1001/archderm.125.8.1069; MORLEY PAR, 1988, CURR MED RES OPIN, V11, P142, DOI 10.1185/03007998809110457; *NAT COMM CLIN LAB, 2001, M100S11 NCCLS; National Committee for Clinical Laboratory Standards, 2000, M2A7 NCCLS; RESNICK DS, 2000, TXB PEDIAT DERMATOLO, P369; ROGERS M, 1987, MED J AUSTRALIA, V147, P63, DOI 10.5694/j.1326-5377.1987.tb133260.x; RUBY RJ, 1973, PEDIATRICS, V52, P854; VANAMSTEL L, 2000, HUISARTS WET, V43, P247; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999	25	57	61	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2002	324	7331					203	206A		10.1136/bmj.324.7331.203	http://dx.doi.org/10.1136/bmj.324.7331.203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809642	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000173604800017
J	Miller, RJ				Miller, RJ			The ups and downs of Down's syndrome	LANCET			English	Editorial Material									Northwestern Univ, Sch Med, Dept Mol Pharmacol, Chicago, IL 60603 USA	Northwestern University	Miller, RJ (corresponding author), Northwestern Univ, Sch Med, Dept Mol Pharmacol, Chicago, IL 60603 USA.							Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Griffith EC, 2001, NEURON, V31, P339, DOI 10.1016/S0896-6273(01)00386-5; Haydar TF, 2000, J NEUROSCI, V20, P4156; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174	4	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					275	276		10.1016/S0140-6736(02)07533-5	http://dx.doi.org/10.1016/S0140-6736(02)07533-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830189				2022-12-28	WOS:000173588100003
J	Jackson, BE; McInerney, MJ				Jackson, BE; McInerney, MJ			Anaerobic microbial metabolism can proceed close to thermodynamic limits	NATURE			English	Article							SYNTROPHIC ASSOCIATION; BENZOATE DEGRADATION; ENERGETICS; BACTERIUM; OXIDATION; GROWTH	Many fermentative bacteria obtain energy for growth by reactions in which the change in free energy (DeltaG') is less than that needed to synthesize ATP(1-4). These bacteria couple substrate metabolism directly to ATP synthesis, however, by classical phosphoryl transfer reactions(4,5). An explanation for the energy economy of these organisms is that biological systems conserve energy in discrete amounts(3,)4, with a minimum, biochemically convertible energy value of about -20 kJ mol(-1) (refs(1-3)). This concept predicts that anaerobic substrate decay ceases before the minimum free energy value is reached, and several studies support this prediction(1,6-9). Here we show that metabolism by syntrophic associations, in which the degradation of a substrate by one species is thermodynamically possible only through removal of the end product by another species(1), can occur at values close to thermodynamic equilibrium (DeltaG' approximate to0 kJ mol(-1)). The free energy remaining when substrate metabolism halts is not constant; it depends on the terminal electron-accepting reaction and the amount of energy required for substrate activation. Syntrophic associations metabolize near thermodynamic equilibrium, indicating that bacteria operate extremely efficient catabolic systems.	Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	McInerney, MJ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, 770 Van Vleet Oval, Norman, OK 73019 USA.	mcinerney@ou.edu	McInerney, Michael J/E-6215-2012					AUBURGER G, 1992, APPL MICROBIOL BIOT, V37, P789, DOI 10.1007/BF00174847; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Christensen TH, 2000, J CONTAM HYDROL, V45, P165, DOI 10.1016/S0169-7722(00)00109-1; COUTTS DAP, 1987, J APPL BACTERIOL, V62, P251, DOI 10.1111/j.1365-2672.1987.tb02406.x; Cramer W.A., 1990, ENERGY TRANSDUCTION; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; DWYER DF, 1988, APPL ENVIRON MICROB, V54, P1354, DOI 10.1128/AEM.54.6.1354-1359.1988; Elshahed MS, 2001, APPL ENVIRON MICROB, V67, P1728, DOI 10.1128/AEM.67.4.1728-1738.2001; Harwood CS, 1997, J BACTERIOL, V179, P301, DOI 10.1128/jb.179.2.301-309.1997; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; JACKSON BE, 1999, THESIS U OKLAHOMA; JETTEN MSM, 1991, FEMS MICROBIOL LETT, V84, P313, DOI 10.1111/j.1574-6968.1991.tb04616.x; KAISER JL, 1982, ARCH MICROBIOL, V133, P384; Kleerebezem R, 2000, BIOTECHNOL BIOENG, V67, P529, DOI 10.1002/(SICI)1097-0290(20000305)67:5<529::AID-BIT4>3.0.CO;2-Q; MALONEY PC, 1983, J BACTERIOL, V153, P1461, DOI 10.1128/JB.153.3.1461-1470.1983; McInerney M.J., 1981, BIOMASS CONVERS PROC, P277, DOI DOI 10.1007/978-1-4757-0301-6_15; MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schink B., 1988, NAT REV MICROBIOL, P5; Schocke L, 1997, MICROBIOL-UK, V143, P2345, DOI 10.1099/00221287-143-7-2345; Scholten JCM, 2000, APPL ENVIRON MICROB, V66, P2934, DOI 10.1128/AEM.66.7.2934-2942.2000; Seiler W., 1980, ATMOS TECHNOL, V12, P40; SEITZ HJ, 1990, ARCH MICROBIOL, V155, P82, DOI 10.1007/BF00291279; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Thauer R. K., 1984, S SOC GEN MICROBIOL, P123; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Warikoo V, 1996, APPL ENVIRON MICROB, V62, P26, DOI 10.1128/AEM.62.1.26-32.1996; WOFFORD NQ, 1986, J BACTERIOL, V167, P179, DOI 10.1128/jb.167.1.179-185.1986; [No title captured]	30	188	198	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					454	456		10.1038/415454a	http://dx.doi.org/10.1038/415454a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807560				2022-12-28	WOS:000173433600056
J	Zhou, W; Goodman, SN; Galizia, G; Lieto, E; Ferraraccio, F; Pignatelli, C; Purdie, CA; Piris, J; Morris, R; Harrison, DJ; Paty, PB; Culliford, A; Romans, KE; Montgomery, EA; Choti, MA; Kinzler, KW; Vogelstein, B				Zhou, W; Goodman, SN; Galizia, G; Lieto, E; Ferraraccio, F; Pignatelli, C; Purdie, CA; Piris, J; Morris, R; Harrison, DJ; Paty, PB; Culliford, A; Romans, KE; Montgomery, EA; Choti, MA; Kinzler, KW; Vogelstein, B			Counting alleles to predict recurrence of early-stage colorectal cancers	LANCET			English	Article							MICROSATELLITE INSTABILITY; CHROMOSOME 18Q; CARCINOMA; TUMOR; PROGNOSIS; SURVIVAL; HETEROZYGOSITY; LOSSES; COLON	Background Chromosome imbalances occur in many cancers and represent important biological properties of tumours. However, measurements of such imbalances are difficult. We used a new, quantitative approach to investigate the prognostic value of chromosome imbalances in early-stage colorectal cancers. Methods We studied 180 patients with no evidence of lymph-node or distant metastases at the time of surgery. DNA from paraffin-embedded tumours was tested for imbalances of chromosome 8p and 18q by digital SNP (single-nucleotide polymorphism)-a technique in which each allele in a sample is directly counted. Surviving patients had median follow-up of 68 months, and disease recurrence was used as the clinical endpoint. Findings Tumours were divided into three groups: "L" tumours (n=93) had allelic imbalances of chromosomes 8p and 18q, "L/R" tumours (n=60) had allelic imbalances of either chromosome 8p or 18q but not both, and "R" tumours (n=27) retained allelic balance for both chromosomes. 5-year disease-free survival was 100% (95% CI 80-100) for patients with R tumours, 74% (61-87) for patients with L/R tumours, and 58% (47-69) for those with L tumours. These differences were significant (p<0.0001) and were independent of other variables-eg, Duke's stage A tumours of class L were much more likely to recur than Duke's stage B tumours of class R (p=0.002). Interpretation In patients without metastasis, allelic imbalance is a better predictor of prognosis than histopathological stage.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA; Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; Univ Naples 2, Sch Med, Dept Surg Sci, Naples, Italy; Univ Edinburgh, Sch Med, Dept Pathol, Edinburgh, Midlothian, Scotland; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Emory University; Universita della Campania Vanvitelli; University of Edinburgh; Memorial Sloan Kettering Cancer Center	Vogelstein, B (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Howard Hughes Med Inst, 1650 Orleans St, Baltimore, MD 21231 USA.		Galizia, Gennaro/A-3924-2010	Goodman, Steven/0000-0002-3872-5723; Purdie, Colin/0000-0002-1258-4010; GALIZIA, Gennaro/0000-0002-6897-0391				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Arribas R, 1999, CLIN CANCER RES, V5, P3454; Bast RC, 2001, J CLIN ONCOL, V19, P1865, DOI 10.1200/JCO.2001.19.6.1865; Berney CR, 2000, INT J CANCER, V89, P1, DOI 10.1002/(SICI)1097-0215(20000120)89:1<1::AID-IJC1>3.0.CO;2-7; Bisgaard ML, 2001, SCAND J GASTROENTERO, V36, P405, DOI 10.1080/003655201300051252; Carethers JM, 1998, GASTROENTEROLOGY, V114, P1188, DOI 10.1016/S0016-5085(98)70424-X; Cosimelli M, 1998, ANTICANCER RES, V18, P1957; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; Font A, 2001, DIS COLON RECTUM, V44, P549, DOI 10.1007/BF02234328; Gonzalez-Garcia I, 2000, JNCI-J NATL CANCER I, V92, P544, DOI 10.1093/jnci/92.7.544; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Iniesta P, 2000, CANCER-AM CANCER SOC, V89, P1220, DOI 10.1002/1097-0142(20000915)89:6<1220::AID-CNCR5>3.0.CO;2-Z; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lindforss U, 2000, CANCER-AM CANCER SOC, V88, P2661, DOI 10.1002/1097-0142(20000615)88:12<2661::AID-CNCR3>3.0.CO;2-Q; Liu J, 1999, FEBS LETT, V462, P121, DOI 10.1016/S0014-5793(99)01523-9; Loukola A, 2001, CANCER RES, V61, P4545; Martinez-Lopez E, 1998, GASTROENTEROLOGY, V114, P1180, DOI 10.1016/S0016-5085(98)70423-8; Ogunbiyi OA, 1998, J CLIN ONCOL, V16, P427, DOI 10.1200/JCO.1998.16.2.427; Purdie CA, 2000, HISTOPATHOLOGY, V36, P121, DOI 10.1111/j.1365-2559.2000.00826.x; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; Risques RA, 2001, LAB INVEST, V81, P307, DOI 10.1038/labinvest.3780239; Shih IM, 2001, CANCER RES, V61, P818; Takanishi DM, 1997, MOL DIAGN, V2, P3, DOI 10.1016/S1084-8592(97)80003-3; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; WERSTO RP, 1991, HUM PATHOL, V22, P1085, DOI 10.1016/0046-8177(91)90260-V; Zhou W, 2001, NAT BIOTECHNOL, V19, P78, DOI 10.1038/83572	30	122	150	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					219	225		10.1016/S0140-6736(02)07448-2	http://dx.doi.org/10.1016/S0140-6736(02)07448-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812558				2022-12-28	WOS:000173350800014
J	Adams, D				Adams, D			Blast from the past: a cautionary tale	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					121	121		10.1136/bmj.324.7329.121	http://dx.doi.org/10.1136/bmj.324.7329.121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11808532	Green Published			2022-12-28	WOS:000173325400063
J	Barbour, V; Horton, R				Barbour, V; Horton, R			Mechanisms of disease	LANCET			English	Editorial Material							POLYMORPHISM		Lancet, London WC1X 8RR, England		Barbour, V (corresponding author), Lancet, London WC1X 8RR, England.			Barbour, Virginia/0000-0002-2358-2440				[Anonymous], 1999, NAT GENET, V22, P1; Arranz MJ, 2000, LANCET, V355, P1615, DOI 10.1016/S0140-6736(00)02221-2; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Horton R, 2000, LANCET, V356, P2, DOI 10.1016/S0140-6736(00)02420-X; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 5	2002	359	9300					2	3		10.1016/S0140-6736(02)07268-9	http://dx.doi.org/10.1016/S0140-6736(02)07268-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809173				2022-12-28	WOS:000173143500002
J	Roberts, CM; McClean, CJ; Veron, JEN; Hawkins, JP; Allen, GR; McAllister, DE; Mittermeier, CG; Schueler, FW; Spalding, M; Wells, F; Vynne, C; Werner, TB				Roberts, CM; McClean, CJ; Veron, JEN; Hawkins, JP; Allen, GR; McAllister, DE; Mittermeier, CG; Schueler, FW; Spalding, M; Wells, F; Vynne, C; Werner, TB			Marine biodiversity hotspots and conservation priorities for tropical reefs	SCIENCE			English	Article							RECRUITMENT; POPULATION; EXTINCTION	Coral reefs are the most biologically diverse of shallow water marine ecosystems but are being degraded worldwide by human activities and climate warming. Analyses of the geographic ranges of 3235 species of reef fish, corals, snails, and lobsters revealed that between 7.2% and 53.6% of each taxon have highly restricted ranges, rendering them vulnerable to extinction. Restricted-range species are clustered into centers of endemism, like those described for terrestrial taxa. The 10 richest centers of endemism cover 15.8% of the world's coral reefs (0.012% of the oceans) but include between 44.8 and 54.2% of the restricted-range species, Many occur in regions where reefs are being severely affected by people, potentially leading to numerous extinctions. Threatened centers of endemism are major biodiversity hotspots, and conservation efforts targeted toward them could help avert the loss of tropical reef biodiversity.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Australian Inst Marine Sci, Townsville MC, Qld 4810, Australia; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Ocean Voice Int, Perth, ON K7H 3M6, Canada; Eastern Ontario Biodivers Museum, Kemptville, ON, Canada; UNEP, WCMC, Cambridge CB3 0DL, England; Western Australian Museum, Perth, WA 6000, Australia; Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Harvard University; Australian Institute of Marine Science; Conservation International; Western Australian Museum; University of York - UK	Roberts, CM (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	cr10@york.ac.uk	Spalding, Mark/GVU-0739-2022	Spalding, Mark/0000-0001-9456-4533				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Birkeland C., 1997, LIFE DEATH CORAL REE; Bryant D., 1998, REEFS RISK MAP BASED; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Ginsburg RN, 1994, P C GLOB ASP COR REE; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; MCALLISTER DE, 1991, SEA WIND, V5, P14; McAllister Don E., 1994, P155; Miya M, 1997, NATURE, V389, P803, DOI 10.1038/39774; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nott M. Philip, 1997, P125; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Polunin NVC, 1996, REEF FISHERIES; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Robertson DR, 2001, P NATL ACAD SCI USA, V98, P5667, DOI 10.1073/pnas.091367798; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Veron J., 2000, CORALS WORLD, V1-3; WERNER TB, 1998, RAPID BODIVERSITY AS	24	1056	1095	22	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1280	1284		10.1126/science.1067728	http://dx.doi.org/10.1126/science.1067728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847338				2022-12-28	WOS:000173926000040
J	Friedman, JS; Walter, MA				Friedman, JS; Walter, MA			Under pressure	SCIENCE			English	Editorial Material							OPEN-ANGLE GLAUCOMA; LOCUS; IDENTIFICATION; LOCALIZATION; REGION		Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Friedman, JS (corresponding author), Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2S2, Canada.							Borras T, 2002, INVEST OPHTH VIS SCI, V43, P33; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709	10	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					983	984		10.1126/science.1069950	http://dx.doi.org/10.1126/science.1069950			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834805				2022-12-28	WOS:000173793000032
J	He, H; Bourges, P; Sidis, Y; Ulrich, C; Regnault, LP; Pailhes, S; Berzigiarova, NS; Kolesnikov, NN; Keimer, B				He, H; Bourges, P; Sidis, Y; Ulrich, C; Regnault, LP; Pailhes, S; Berzigiarova, NS; Kolesnikov, NN; Keimer, B			Magnetic resonant mode in the single-layer high-temperature superconductor Tl(2)Ba(2)CuO(6+delta)	SCIENCE			English	Article							T-C SUPERCONDUCTORS; NEUTRON-SCATTERING; SPIN FLUCTUATIONS; RAMAN-SCATTERING; ORDER-PARAMETER; PEAK; CONDUCTIVITY; BI2SR2CACU2O8+DELTA; YBA2CU3O6+X; SUSCEPTIBILITY	An unusual spin excitation mode observed by neutron scattering has inspired numerous theoretical studies of the interplay between charged quasiparticles and collective spin excitations in the copper oxide high-temperature superconductors. The mode has, thus far, only been observed in materials with crystal structures consisting of copper oxide bilayers, and it is absent in the single-layer compound La(2-x)Sr(x)CoO(4+delta). Neutron-scattering data now show that the mode is present in Tl(2)Ba(2)CuO(6+delta), a single-layer compound with a superconducting transition temperature of similar to90 kelvin, demonstrating that it is a generic feature of the copper oxide superconductors, independent of the layer sequence. This restricts the theoretical models for the origin of the resonant mode and its role in the mechanism of high-temperature superconductivity.	Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Ctr Etud Saclay, CNRS, CEA, Lab Leon Brillouin, F-91191 Gif Sur Yvette, France; CEA Grenoble, Dept Rech Fondamentale Mat Condensee, F-38054 Grenoble 9, France; Russian Acad Sci, Inst Solid State Phys, Chernogolovka 142432, Russia	Max Planck Society; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS	Keimer, B (corresponding author), Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany.	b.keimer@fkf.mpg.de	Ulrich, Clemens/M-6517-2017; pailhès, stéphane/AAA-5774-2021; Kolesnikov, Nikolai N/T-1911-2017; Regnault, Louis-Pierre/AAM-6840-2020	Ulrich, Clemens/0000-0002-6829-9374; pailhès, stéphane/0000-0002-9221-7092; Regnault, Louis-Pierre/0000-0002-4786-299X; Bourges, Philippe/0000-0001-9494-0789; Keimer, Bernhard/0000-0001-5220-9023				Abanov A, 1999, PHYS REV LETT, V83, P1652, DOI 10.1103/PhysRevLett.83.1652; Bourges P, 1998, NATO ADV SCI I B-PHY, V371, P349; Carbotte JP, 1999, NATURE, V401, P354, DOI 10.1038/43843; Dai PC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054525; Eschrig M, 2000, PHYS REV LETT, V85, P3261, DOI 10.1103/PhysRevLett.85.3261; Fong HF, 1999, NATURE, V398, P588, DOI 10.1038/19255; Fong HF, 1999, PHYS REV LETT, V82, P1939, DOI 10.1103/PhysRevLett.82.1939; Fong HF, 2000, PHYS REV B, V61, P14773, DOI 10.1103/PhysRevB.61.14773; Gasparov LV, 1997, PHYS REV B, V55, P1223, DOI 10.1103/PhysRevB.55.1223; He H, 2001, PHYS REV LETT, V86, P1610, DOI 10.1103/PhysRevLett.86.1610; Kastner MA, 1998, REV MOD PHYS, V70, P897, DOI 10.1103/RevModPhys.70.897; KOLESNIKOV NN, 1995, PHYSICA C, V242, P385, DOI 10.1016/0921-4534(94)02420-0; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; LIU DZ, 1995, PHYS REV LETT, V75, P4130, DOI 10.1103/PhysRevLett.75.4130; Manske D, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054517; MAZIN II, 1995, PHYS REV LETT, V75, P4134, DOI 10.1103/PhysRevLett.75.4134; Millis AJ, 1996, PHYS REV B, V54, P16172, DOI 10.1103/PhysRevB.54.16172; Munzar D, 1999, PHYSICA C, V317, P547, DOI 10.1016/S0921-4534(99)00126-4; Ozyuzer L, 1999, PHYSICA C, V320, P9, DOI 10.1016/S0921-4534(99)00324-X; Puchkov AV, 1996, PHYS REV LETT, V77, P1853, DOI 10.1103/PhysRevLett.77.1853; Sato NK, 2001, NATURE, V410, P340, DOI 10.1038/35066519; Schachinger E, 2000, PHYS REV B, V62, P9054, DOI 10.1103/PhysRevB.62.9054; Sidis Y, 2000, PHYS REV LETT, V84, P5900, DOI 10.1103/PhysRevLett.84.5900; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Tsuei CC, 1997, NATURE, V387, P481, DOI 10.1038/387481a0; Tsvetkov AA, 1998, NATURE, V395, P360, DOI 10.1038/26439; Venturini F, 2000, PHYS REV B, V62, P15204, DOI 10.1103/PhysRevB.62.15204; Zasadzinski JF, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067005; Zeyher R, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.140510; Zhang SC, 1997, SCIENCE, V275, P1089, DOI 10.1126/science.275.5303.1089	30	183	185	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1045	1047		10.1126/science.1067877	http://dx.doi.org/10.1126/science.1067877			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11809938	Green Submitted			2022-12-28	WOS:000173793000058
J	Monney, L; Sabatos, CA; Gaglia, JL; Ryu, A; Waldner, H; Chernova, T; Manning, S; Greenfield, EA; Coyle, AJ; Sobel, RA; Freeman, GJ; Kuchroo, VK				Monney, L; Sabatos, CA; Gaglia, JL; Ryu, A; Waldner, H; Chernova, T; Manning, S; Greenfield, EA; Coyle, AJ; Sobel, RA; Freeman, GJ; Kuchroo, VK			Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease	NATURE			English	Article							CHEMOKINE RECEPTOR EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CD4(+) T-CELLS; CUTTING EDGE; LYMPHOCYTES; TH1; ENCEPHALOMYELITIS; THERAPY; ANTIGEN; SUBSETS	Activation of naive CD4(+) T-helper cells results in the development of at least two distinct effector populations, Th1 and Th2 cells(1-3). Th1 cells produce cytokines (interferon (IFN)-gamma, interleukin (IL)-2, tumour-necrosis factor (TNF)-alpha and lymphotoxin) that are commonly associated with cell-mediated immune responses against intracellular pathogens, delayed-type hypersensitivity reactions 4, and induction of organ-specific autoimmune diseases(5). Th2 cells produce cytokines (IL-4, IL-10 and IL-13) that are crucial for control of extracellular helminthic infections and promote atopic and allergic diseases(4). Although much is known about the functions of these two subsets of T-helper cells, there are few known surface molecules that distinguish between them(6). We report here the identification and characterization of a transmembrane protein, Tim-3, which contains an immunoglobulin and a mucin-like domain and is expressed on differentiated Th1 cells. In vivo administration of antibody to Tim-3 enhances the clinical and pathological severity of experimental autoimmune encephalomyelitis (EAE), a Th1-dependent autoimmune disease, and increases the number and activation level of macrophages. Tim-3 may have an important role in the induction of autoimmune diseases by regulating macrophage activation and/or function.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 95305 USA; VA Hlth Care Syst, Palo Alto, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Stanford University	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.		Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Sobel, Raymond/0000-0002-0477-9002				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; GORDON EJ, 1995, J NEUROIMMUNOL, V62, P153, DOI 10.1016/0165-5728(95)00120-2; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Jourdan P, 1998, J IMMUNOL, V160, P4153; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LACK G, 1994, J IMMUNOL, V152, P2546; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; MCINTIRE JJ, 2001, NATURE IMMUNOL, V2, P1019; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; Tran EH, 1998, J IMMUNOL, V161, P3767; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Zingoni A, 1998, J IMMUNOL, V161, P547	24	1125	1310	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					536	541		10.1038/415536a	http://dx.doi.org/10.1038/415536a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823861				2022-12-28	WOS:000173564300049
J	Schwartz, MK; Mills, LS; McKelvey, KS; Ruggiero, LF; Allendorf, FW				Schwartz, MK; Mills, LS; McKelvey, KS; Ruggiero, LF; Allendorf, FW			DNA reveals high dispersal synchronizing the population dynamics of Canada lynx	NATURE			English	Article							GENE FLOW; MICROSATELLITE LOCI; DIFFERENTIATION; MIGRATION; PATTERNS	Population dynamics of Canada lynx (Lynx canadensis) have been of interest to ecologists for nearly sixty years(1-4). Two competing hypotheses concerning lynx population dynamics and large-scale spatial synchrony are currently debated. The first suggests that dispersal is substantial among lynx populations(5), and the second proposes that lynx at the periphery of their range exist in small, isolated patches that maintain cycle synchrony via correlation with extrinsic environmental factors(2). Resolving the nature of lynx population dynamics and dispersal is important both to ecological theory and to the conservation of threatened lynx populations: the lack of knowledge about connectivity between populations at the southern periphery of the lynx's geographic range delayed their legal listing in the United States(6). We test these competing hypotheses using microsatellite DNA markers and lynx samples from 17 collection sites in the core and periphery of the lynx's geographic range. Here we show high gene flow despite separation by distances greater than 3,100 km, supporting the dispersal hypothesis. We therefore suggest that management actions in the contiguous United States should focus on maintaining connectivity with the core of the lynx's geographic range.	Univ Montana, Sch Forestry, Wildlife Biol Program, Missoula, MT 59812 USA; USDA, USFS, Rocky Mt Res Stn, Missoula, MT 59801 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Schwartz, MK (corresponding author), Univ Montana, Sch Forestry, Wildlife Biol Program, Missoula, MT 59812 USA.		Mills, L. Scott/K-2458-2012; Schwartz, Michael K/C-3184-2014	Mills, L. Scott/0000-0001-8771-509X; Schwartz, Michael K/0000-0003-3521-3367				BERTHIER P, IN PRESS GENETICS; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cattadori IM, 2000, J ANIM ECOL, V69, P620, DOI 10.1046/j.1365-2656.2000.00421.x; Cornuet JM, 1999, GENETICS, V153, P1989; Ehrich D, 2001, MOL ECOL, V10, P481, DOI 10.1046/j.1365-294x.2001.01229.x; Elton C, 1942, J ANIM ECOL, V11, P215, DOI 10.2307/1358; Forbes SH, 1997, CONSERV BIOL, V11, P1226, DOI 10.1046/j.1523-1739.1997.96296.x; Greenman JV, 2001, OIKOS, V93, P343, DOI 10.1034/j.1600-0706.2001.930217.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; MANUEL S, IN PRESS CONS BIOL; McKelvey Kevin S., 2000, P207; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; MENOTTIRAYMOND MA, 1995, J HERED, V86, P319, DOI 10.1093/oxfordjournals.jhered.a111594; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mowat Garth, 2000, P265; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Predavec M, 2001, OECOLOGIA, V126, P216, DOI 10.1007/s004420000516; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Ruggiero Leonard F., 2000, P443; SCHWARTZ MK, UNPUB MOL ECOL; Slough BG, 1996, J WILDLIFE MANAGE, V60, P946, DOI 10.2307/3802397; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; 2000, FED REG, V65, P15051	28	124	128	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					520	522		10.1038/415520a	http://dx.doi.org/10.1038/415520a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823858	Green Published			2022-12-28	WOS:000173564300045
J	Witkowski, JA				Witkowski, JA			Mad hatters at the DNA tea party - A unique discovery brings fresh insight to the discovery of DNA's structure.	NATURE			English	Editorial Material									Cold Spring Harbor Lab, Banbury Ctr, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Witkowski, JA (corresponding author), Cold Spring Harbor Lab, Banbury Ctr, POB 534, Cold Spring Harbor, NY 11724 USA.		Witkowski, Jan/FHJ-8549-2022	Witkowski, Jan/0000-0002-8159-2874				Crick F, 1988, WHAT MAD PURSUIT PER; Judson Horace F., 1996, 8 DAY CREATION MAKER, Vsecond; Kohler Robert F., 1991, PARTNERS SCI FDN NAT; OLBY RC, 1994, PATH DOUBLE HELIX; Swann Brenda, 1999, JD BERNAL LIFE SCI P; Thomas J. M., 1990, LEGACY L BRAGG; Watson James, 1968, DOUBLE HELIX	7	0	1	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					473	474		10.1038/415473a	http://dx.doi.org/10.1038/415473a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823830				2022-12-28	WOS:000173564300020
J	De Weerdt, W; Feys, H				De Weerdt, W; Feys, H			Assessment of physiotherapy for patients with stroke	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; POSTSTROKE REHABILITATION; SINGLE-BLIND; FORCED USE; METAANALYSIS; INTENSITY; PROGRAM; THERAPY; GAIT		Katholieke Univ Leuven, Fac Phys Educ & Physiotherapy, Dept Rehabil Sci, B-3001 Heverlee, Belgium	KU Leuven	De Weerdt, W (corresponding author), Katholieke Univ Leuven, Fac Phys Educ & Physiotherapy, Dept Rehabil Sci, B-3001 Heverlee, Belgium.							Carr JH., 2000, MOVEMENT SCI FDN PHY; DAVIES PM, 2000, STEPS FOLLOW; Duncan P, 1998, STROKE, V29, P2055, DOI 10.1161/01.STR.29.10.2055; Duncan P W, 1997, Top Stroke Rehabil, V3, P1, DOI 10.1080/10749357.1997.11754126; Feys HM, 1998, STROKE, V29, P785, DOI 10.1161/01.STR.29.4.785; Glanz M, 1996, ARCH PHYS MED REHAB, V77, P549, DOI 10.1016/S0003-9993(96)90293-2; GLANZ M, 1995, ARCH PHYS MED REHAB, V76, P508, DOI 10.1016/S0003-9993(95)80503-6; Hanger HC, 2000, CLIN REHABIL, V14, P370, DOI 10.1191/0269215500cr339oa; Kwakkel G, 1997, STROKE, V28, P1550, DOI 10.1161/01.STR.28.8.1550; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Langhammer B, 2000, CLIN REHABIL, V14, P361, DOI 10.1191/0269215500cr338oa; Parry RH, 1999, CLIN REHABIL, V13, P187, DOI 10.1191/026921599676198929; Perfetti C, 2001, EXERCICE THERAPEUTIQ; Roper TA, 1999, AGE AGEING, V28, P9, DOI 10.1093/ageing/28.1.9; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Thaut MH, 1997, J NEUROL SCI, V151, P207, DOI 10.1016/S0022-510X(97)00146-9; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6	20	19	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					182	183		10.1016/S0140-6736(02)07461-5	http://dx.doi.org/10.1016/S0140-6736(02)07461-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812546				2022-12-28	WOS:000173350800002
J	Fugmann, SD; Schatz, DG				Fugmann, SD; Schatz, DG			Immunology - One AID to unite them all	SCIENCE			English	Editorial Material							CYTIDINE DEAMINASE AID; CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; DEFICIENCY		Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Fugmann, SD (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06510 USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; HARRIS RS, IN PRESS CURR BIOL; Kong QZ, 2001, GENETICS, V158, P369; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; PAPAVASILIOU FN, IN PRESS J EXP MED; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100	14	15	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1244	1245		10.1126/science.1070023	http://dx.doi.org/10.1126/science.1070023			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847327				2022-12-28	WOS:000173926000027
J	Bhutta, ZA				Bhutta, ZA			Children of war: the real casualties of the Afghan conflict	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; MOTHERS; EXPERIENCES		Aga Khan Univ, Karachi, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu						Ali HM, 2000, LANCET, V355, P1851, DOI 10.1016/S0140-6736(00)02289-3; ANDERSSON N, 1995, BRIT MED J, V311, P718, DOI 10.1136/bmj.311.7007.718; Bhutta ZA, 1998, BRIT MED J, V317, P363; Bhutta ZA, 2001, INT J EPIDEMIOL, V30, P712, DOI 10.1093/ije/30.4.712; BRYCE JW, 1989, SOC SCI MED, V28, P685, DOI 10.1016/0277-9536(89)90216-5; *CENTR INT AG, 2002, WORLD FACTB 2001 AFG; Coleridge P, 1999, DISABILITY AFGHANIST; FEROGH AA, 1990, CURRENT POLITICAL EC; FRIEDMAN T, 2001, NY TIMES        1113; GESSNER BD, 1994, JAMA-J AM MED ASSOC, V272, P382, DOI 10.1001/jama.272.5.382; *GLOB MOV CHILDR A, 2001, LOST CHANC CHANG SIT; Goldstein RD, 1997, PEDIATRICS, V100, P873, DOI 10.1542/peds.100.5.873; Gupta L., 1997, PSYCHOSOCIAL ASSESSM; HUSSAIN SA, 1998, HOME COUNTRY JOURNEY, P184; Locke CJ, 1996, ARCH PEDIAT ADOL MED, V150, P822, DOI 10.1001/archpedi.1996.02170330048008; LYKES MB, 1994, SOC SCI MED, V38, P543, DOI 10.1016/0277-9536(94)90250-X; MAGNUS RH, 1998, AFGHANISTAN MULLAH M; MILLER LC, 1994, ARCH PEDIAT ADOL MED, V148, P704, DOI 10.1001/archpedi.1994.02170070042007; *MIN FIN, EC SURV PAK 2000 200; Munczek DS, 1998, SOC SCI MED, V47, P1699, DOI 10.1016/S0277-9536(98)00252-4; Nayyar A.H, 1998, ED STATE 50 YEARS PA, P215; *RADD BARN SAV CHI, 1999, BAS STUD FUT SAV CHI; Rasekh Z, 1998, JAMA-J AM MED ASSOC, V280, P449, DOI 10.1001/jama.280.5.449; Sogan D, 1998, PEDIATRICS, V102, P1193, DOI 10.1542/peds.102.5.1193; *UN CHILDR FUND, 1994, ANT PERS LAND MIN SC, P6; Yousaf Mohammad, 1992, BEAR TRAP AFGHANISTA, P192	26	31	31	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2002	324	7333					349	352		10.1136/bmj.324.7333.349	http://dx.doi.org/10.1136/bmj.324.7333.349			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834566	Green Published			2022-12-28	WOS:000173866300025
J	Meisterernst, M				Meisterernst, M			Mediator meets morpheus	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; COMPLEX		Natl Res Ctr Environm & Hlth, GSF Inst Mol Immunol, Gene Express Dept, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Meisterernst, M (corresponding author), Natl Res Ctr Environm & Hlth, GSF Inst Mol Immunol, Gene Express Dept, Marchionini Str 25, D-81377 Munich, Germany.							Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249	12	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					984	985		10.1126/science.1069485	http://dx.doi.org/10.1126/science.1069485			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834806				2022-12-28	WOS:000173793000033
J	Rogers, DJ; Randolph, SE; Snow, RW; Hay, SI				Rogers, DJ; Randolph, SE; Snow, RW; Hay, SI			Satellite imagery in the study and forecast of malaria	NATURE			English	Review							TSETSE-FLIES; MORTALITY; AFRICA; MODEL; TRANSMISSION; CLIMATE; ABUNDANCE; VECTORS; SEASONS; FUTURE	More than 30 years ago, human beings looked back from the Moon to see the magnificent spectacle of Earth-rise. The technology that put us into space has since been used to assess the damage we are doing to our natural environment and is now being harnessed to monitor and predict diseases through space and time. Satellite sensor data promise the development of early-warning systems for diseases such as malaria, which kills between 1 and 2 million people each year.	Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Univ Oxford, Dept Zool, Oxford Tick Res Grp, Oxford OX1 3PS, England; Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford; Kenya Medical Research Institute; University of Oxford	Rogers, DJ (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.	david.rogers@zoo.ox.ac.uk	Hay, Simon Iain/F-8967-2015; Randolph, Sarah/AAR-9346-2021; Snow, Robert William/AFR-1436-2022	Hay, Simon Iain/0000-0002-0611-7272; Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [056642] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R M, 1991; [Anonymous], 1999, WORLD HLTH REPORT 19; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Butler RJ, 1959, ATLAS KENYA COMPREHE; CHRISTOPHERS SR, 1911, PALUDISM, V2, P17; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; GILL C. A., 1923, Indian Journal of Medical Research, V10, P1136; Goetz SJ, 2000, ADV PARASIT, V47, P289, DOI 10.1016/S0065-308X(00)47012-0; Green P.E., 1978, ANAL MULTIVARIATE DA; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hay SI, 1996, ANN TROP MED PARASIT, V90, P1; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3; Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335; HAY SI, IN PRESS NATURE; KOVATS RS, 1999, EL NINO HLTH; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; *MAPP MAL RISK AFR, 1998, 1 MARA ARMA; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; McGregor GR, 1998, TROPICAL CLIMATOLOGY; Myers MF, 2000, ADV PARASIT, V47, P309, DOI 10.1016/S0065-308X(00)47013-2; Najera JA., 1998, MALARIA EPIDEMICS DE; National Research Council, 2001, WEATH CLIM EC INF DI; ONORI E, 1980, B WORLD HEALTH ORGAN, V58, P91; Randolph SE, 1997, PARASITOLOGY, V115, P265, DOI 10.1017/S0031182097001315; ROGERS DJ, 1990, INSECT SCI APPL, V11, P331, DOI 10.1017/S1742758400012753; ROGERS DJ, 1988, PHILOS T R SOC B, V321, P513, DOI 10.1098/rstb.1988.0106; ROGERS DJ, 1991, NATURE, V351, P739, DOI 10.1038/351739a0; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Rogers DJ, 2000, ADV PARASIT, V47, P129, DOI 10.1016/S0065-308X(00)47008-9; ROGERS DJ, 1993, PARASITOL TODAY, V9, P266, DOI 10.1016/0169-4758(93)90074-P; ROGERS DJ, 1991, PREV VET MED, V11, P201, DOI 10.1016/S0167-5877(05)80005-4; Rogers DJ, 1994, LARGE SCALE ECOLOGY, P249; Shanks GD, 2000, T ROY SOC TROP MED H, V94, P253, DOI 10.1016/S0035-9203(00)90310-9; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Snow RW, 2001, TRENDS PARASITOL, V17, P593, DOI 10.1016/S1471-4922(01)02031-1; SNOW RW, 1995, PARASITOL TODAY, V11, P188, DOI 10.1016/0169-4758(95)80156-1; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; SWAROOP S, 1949, AM J TROP MED, V29, P1; WOLTER K, 1987, J CLIM APPL METEOROL, V26, P540, DOI 10.1175/1520-0450(1987)026<0540:TSOISC>2.0.CO;2; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; World Health Organization, 2001, MAL EARL WARN SYST F; YACOB KBM, 1945, J MALAR I INDIA, V6, P39	50	310	323	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					710	715		10.1038/415710a	http://dx.doi.org/10.1038/415710a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832960	Green Accepted			2022-12-28	WOS:000173709100061
J	Kolesnychenko, OY; de Kort, R; Katsnelson, MI; Lichtenstein, AI; van Kempen, H				Kolesnychenko, OY; de Kort, R; Katsnelson, MI; Lichtenstein, AI; van Kempen, H			Real-space imaging of an orbital Kondo resonance on the Cr(001) surface	NATURE			English	Article							ELECTRONIC-STRUCTURE; INFINITE DIMENSIONS; IMPURITY; SUPERCONDUCTIVITY; FIELD	The Kondo effect(1) is usually connected with the interaction between a localized spin moment and itinerant electrons. This interaction leads to the formation of a narrow resonance at the Fermi level, which is called the Abrikosov-Suhl or Kondo resonance(2). Scanning tunnelling microscopy is an ideal technique for real-space investigations of complicated electronic structures(3,4) and many-body phenomena, such as the formation of the Kondo resonance(5-8) or d-wave pairing in high-T-c superconductors(9). Theory has predicted that similar, Kondo-like many-electron resonances are possible for scattering centres with orbital instead of spin degrees of freedom-the quadruple momenta in uranium-based compounds or two-level systems in metallic glasses are examples of such 'pseudo-Kondo' scattering centres(10). Here we present evidence for the orbital Kondo resonance on a transition-metal surface. Investigations of an atomically clean Cr(001) surface at low temperature using scanning tunnelling microscopy reveal a very narrow resonance at 26 meV above the Fermi level, and enable us to visualize the orbital character of the corresponding state. The experimental data, together with many-body calculations, demonstrate that the observed resonance is an orbital Kondo resonance formed by two degenerate d(xz), d(yz) surface states.	Catholic Univ Nijmegen, Mat Res Inst, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	van Kempen, H (corresponding author), Catholic Univ Nijmegen, Mat Res Inst, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.		Lichtenstein, Alexander/K-8730-2012; Katsnelson, Mikhail I./D-4359-2012	Lichtenstein, Alexander/0000-0003-0152-7122; 				Balatsky AV, 2000, NATURE, V403, P717, DOI 10.1038/35001703; Cox DL, 1998, ADV PHYS, V47, P599, DOI 10.1080/000187398243500; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; FU CL, 1986, PHYS REV B, V33, P1755, DOI 10.1103/PhysRevB.33.1755; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Heinze S, 2000, SCIENCE, V288, P1805, DOI 10.1126/science.288.5472.1805; Hewson A C, 1993, KONDO PROBLEM HEAVY; JARRELL M, 1995, PHYS REV B, V51, P7429, DOI 10.1103/PhysRevB.51.7429; KLEBANOFF LE, 1985, PHYS REV B, V32, P1997, DOI 10.1103/PhysRevB.32.1997; Kleiber M, 2000, PHYS REV LETT, V85, P4606, DOI 10.1103/PhysRevLett.85.4606; KONDO J, 1964, PROG THEOR PHYS, V32, P37, DOI 10.1143/PTP.32.37; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Manoharan HC, 2000, NATURE, V403, P512, DOI 10.1038/35000508; Odom TW, 2000, SCIENCE, V290, P1549, DOI 10.1126/science.290.5496.1549; Pan SH, 2000, NATURE, V403, P746, DOI 10.1038/35001534; Schmid M, 1997, SURF SCI, V377, P1023, DOI 10.1016/S0039-6028(96)01539-7; STROSCIO JA, 1995, PHYS REV LETT, V75, P2960, DOI 10.1103/PhysRevLett.75.2960; vanderWielen MCMM, 1996, PHYS REV LETT, V76, P1075, DOI 10.1103/PhysRevLett.76.1075	19	62	63	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					507	509		10.1038/415507a	http://dx.doi.org/10.1038/415507a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823854				2022-12-28	WOS:000173564300040
J	Ferrara, A				Ferrara, A			Astronomy - Radio noise from dust grains	SCIENCE			English	Editorial Material									Osserv Astrofis Arcetri, I-50125 Florence, Italy	Istituto Nazionale Astrofisica (INAF)	Ferrara, A (corresponding author), Osserv Astrofis Arcetri, Largo E Fermi 5, I-50125 Florence, Italy.	ferrara@arcetri.astro.it						DEOLIVEIRACOSTA A, IN PRESS ASTROPHYS J; Draine BT, 1998, ASTROPHYS J, V508, P157, DOI 10.1086/306387; Draine BT, 1998, ASTROPHYS J, V494, pL19, DOI 10.1086/311167; ERICKSON WC, 1957, ASTROPHYS J, V126, P480, DOI 10.1086/146421; FERRARA A, 1994, ASTROPHYS J, V427, P155, DOI 10.1086/174128; FINKBEINER DP, IN PRESS ASTROPHYS J; HOYLE F, 1970, NATURE, V227, P473, DOI 10.1038/227473a0; Kogut A, 1996, ASTROPHYS J, V464, pL5, DOI 10.1086/310072; Leitch EM, 1997, ASTROPHYS J, V486, pL23, DOI 10.1086/310823; PURCELL EM, 1979, ASTROPHYS J, V231, P404, DOI 10.1086/157204; PURCELL EM, 1971, ASTROPHYS J, V167, P31, DOI 10.1086/151002	11	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					638	639		10.1126/science.1067917	http://dx.doi.org/10.1126/science.1067917			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809959				2022-12-28	WOS:000173560900031
J	Gomez, FJ; Waymouth, RM				Gomez, FJ; Waymouth, RM			Polymer synthesis - Catalysts rise to the challenge	SCIENCE			English	Editorial Material							ELASTOMERIC POLYPROPYLENE; COPOLYMERIZATION; COMPLEXES; STRATEGY; PROPENE		Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Gomez, FJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.			Waymouth, Robert/0000-0001-9862-9509				Chamberlain BM, 2001, J AM CHEM SOC, V123, P3229, DOI 10.1021/ja003851f; CHIEN JCW, 1991, J AM CHEM SOC, V113, P8569, DOI 10.1021/ja00022a080; COATES GW, 1995, SCIENCE, V267, P217, DOI 10.1126/science.267.5195.217; EWEN JA, 1988, J AM CHEM SOC, V110, P6255, DOI 10.1021/ja00226a056; Fan W, 2001, J AM CHEM SOC, V123, P9555, DOI 10.1021/ja0100773; Hoveyda AH, 2001, CHEM-EUR J, V7, P945, DOI 10.1002/1521-3765(20010302)7:5<945::AID-CHEM945>3.0.CO;2-3; Ittel SD, 2000, CHEM REV, V100, P1169, DOI 10.1021/cr9804644; Jayaratne KC, 2000, J AM CHEM SOC, V122, P10490, DOI 10.1021/ja002558c; Kuhl O, 2000, J ORGANOMET CHEM, V604, P116, DOI 10.1016/S0022-328X(00)00214-X; Nele M, 2001, MACROMOLECULES, V34, P3830, DOI 10.1021/ma0021186; Nguyen H, 2000, MACROMOLECULES, V33, P1508, DOI 10.1021/ma991797l; Nozaki K, 1997, J AM CHEM SOC, V119, P12779, DOI 10.1021/ja973199x; Resconi L, 2000, CHEM REV, V100, P1253, DOI 10.1021/cr9804691; Seiders TJ, 2001, ORG LETT, V3, P3225, DOI 10.1021/ol0165692; Tian J, 2001, J AM CHEM SOC, V123, P5134, DOI 10.1021/ja0157189; Vedejs E, 2001, J AM CHEM SOC, V123, P2428, DOI 10.1021/ja0035405	16	44	45	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					635	636		10.1126/science.1067919	http://dx.doi.org/10.1126/science.1067919			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809956				2022-12-28	WOS:000173560900028
J	He, L; Fong, J; von Zastrow, M; Whistler, JL				He, L; Fong, J; von Zastrow, M; Whistler, JL			Regulation of opioid receptor trafficking and morphine tolerance by receptor oligornerization	CELL			English	Article							RAT-BRAIN; G-PROTEINS; DOWN-REGULATION; UP-REGULATION; GABA RELEASE; MICE LACKING; NEURONS; DEPENDENCE; DESENSITIZATION; ENDOCYTOSIS	The utility of morphine for the treatment of chronic pain is hindered by the development of tolerance to the analgesic effects of the drug. Morphine is unique among opiates in its ability to activate the mu opioid receptor (MOR) without promoting its desensitization and endocytosis. Here we demonstrate that [D-Ala(2)-MePhe(4)-Gly(5)-ol] enkephalin (DAMGO) can facilitate the ability of morphine to stimulate MOR endocytosis. As a consequence, rats treated chronically with both drugs show reduced analgesic tolerance compared to rats treated with morphine alone. These results demonstrate that endocytosis of the MOR can reduce the development of tolerance, and hence suggest an approach for the development of opiate analogs with enhanced efficacy for the treatment of chronic pain.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Psychiat & Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	shooz2@itsa.ucsf.edu						Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; ABDELHAMID EE, 1991, EUR J PHARMACOL, V198, P157, DOI 10.1016/0014-2999(91)90615-W; ADVOKAT C, 1993, PHARMACOL BIOCHEM BE, V45, P871, DOI 10.1016/0091-3057(93)90134-F; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; Bernstein MA, 1998, MOL BRAIN RES, V55, P237, DOI 10.1016/S0169-328X(98)00005-9; Blake AD, 1997, J BIOL CHEM, V272, P782, DOI 10.1074/jbc.272.2.782; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bonci A, 1997, J NEUROSCI, V17, P796; BRADY LS, 1989, BRAIN RES, V477, P382, DOI 10.1016/0006-8993(89)91432-7; Chieng B, 1998, J NEUROSCI, V18, P7033; CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633; Connor M, 1999, BRIT J PHARMACOL, V126, P1553, DOI 10.1038/sj.bjp.0702457; DEVRIES TJ, 1993, LIFE SCI, V52, P1685, DOI 10.1016/0024-3205(93)90476-J; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; GOUARDERES C, 1990, PROG CLIN BIOL RES, V328, P175; HUGHES J, 1983, BRIT MED BULL, V39, P1; Jolas T, 2000, NEUROSCIENCE, V95, P433; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; MALMBERG AB, 1992, J PHARMACOL EXP THER, V263, P264; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mitchell JM, 2000, NAT NEUROSCI, V3, P47, DOI 10.1038/71120; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; REZVANI A, 1983, J PHARMACOL EXP THER, V225, P251; ROTHMAN RB, 1991, PEPTIDES, V12, P151, DOI 10.1016/0196-9781(91)90182-O; Selley DE, 1997, BRAIN RES, V746, P10, DOI 10.1016/S0006-8993(96)01125-0; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2000, J NEUROSCI, V20, P4555, DOI 10.1523/JNEUROSCI.20-12-04555.2000; SIMANTOV R, 1984, NEUROPEPTIDES, V5, P197, DOI 10.1016/0143-4179(84)90061-1; Stafford K, 2001, PHARMACOL BIOCHEM BE, V69, P233, DOI 10.1016/S0091-3057(01)00525-1; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; STEVENS CW, 1989, J PHARMACOL EXP THER, V250, P1; Tao PL, 1998, EUR J PHARMACOL, V344, P137, DOI 10.1016/S0014-2999(97)01596-3; Tejwani GA, 1998, BRAIN RES, V797, P305, DOI 10.1016/S0006-8993(98)00416-8; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Trafton JA, 2000, J NEUROSCI, V20, P8578; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; WERLING LL, 1989, P NATL ACAD SCI USA, V86, P6393, DOI 10.1073/pnas.86.16.6393; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yaksh TL, 1999, TRENDS PHARMACOL SCI, V20, P329, DOI 10.1016/S0165-6147(99)01370-X; YAKSH TL, 1986, PHARMACOL BIOCHEM BE, V25, P483, DOI 10.1016/0091-3057(86)90028-6; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	57	264	276	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					271	282		10.1016/S0092-8674(02)00613-X	http://dx.doi.org/10.1016/S0092-8674(02)00613-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832216	Bronze			2022-12-28	WOS:000173521300013
J	Anderson, GR; Brenner, BM				Anderson, GR; Brenner, BM			Molecular markers in colorectal cancer	LANCET			English	Editorial Material							GENOME		Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Anderson, GR (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.	garth.anderson@roswellpark.org						Anderson GR, 2001, BIOESSAYS, V23, P1037, DOI 10.1002/bies.1149; Anderson GR, 2001, CANCER RES, V61, P8274; De Angelis PM, 2001, INT J COLORECTAL DIS, V16, P38, DOI 10.1007/s003840000275; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Folkman J, 2000, NAT REV MOL CELL BIO, V1, P76, DOI 10.1038/35036100; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Hegde P, 2001, CANCER RES, V61, P7792; Houlston RS, 2001, J CLIN PATHOL-MOL PA, V54, P206, DOI 10.1136/mp.54.4.206; Martinez-Lopez E, 1998, GASTROENTEROLOGY, V114, P1180, DOI 10.1016/S0016-5085(98)70423-8; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Tarafa G, 2000, ONCOGENE, V19, P546, DOI 10.1038/sj.onc.1203353; Weber JC, 2001, ANN SURG, V234, P795, DOI 10.1097/00000658-200112000-00011; 2001, NCBI SNP DATABASE	14	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2002	359	9302					183	184		10.1016/S0140-6736(02)07462-7	http://dx.doi.org/10.1016/S0140-6736(02)07462-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812547				2022-12-28	WOS:000173350800003
J	Ashrafian, H; Taylor-Robinson, SD; Calam, J; Playford, RJ				Ashrafian, H; Taylor-Robinson, SD; Calam, J; Playford, RJ			Once you start, you can't stop	LANCET			English	Editorial Material							DIAGNOSIS		Hammersmith Hosp, Imperial Coll Sch Med, Gastroenterol Unit, London W12 0HS, England	Imperial College London	Playford, RJ (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Gastroenterol Unit, London W12 0HS, England.	r.playford@ic.ac.uk		Ashrafian, Houman/0000-0003-3988-378X; Playford, Raymond/0000-0003-1235-8504				Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; CADIOT G, 1995, GASTROEN CLIN BIOL, V19, P811; El-Nujumi A, 1998, GUT, V42, P159, DOI 10.1136/gut.42.2.159; JENSEN RT, IN PRESS SURG ENDOCR; WOLFE MM, 1987, NEW ENGL J MED, V317, P1200, DOI 10.1056/NEJM198711053171907	5	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 19	2002	359	9302					226	226		10.1016/S0140-6736(02)07449-4	http://dx.doi.org/10.1016/S0140-6736(02)07449-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812559				2022-12-28	WOS:000173350800015
J	Sousa, AB; Ferreira, G; Veiga, J; Carvalho, A				Sousa, AB; Ferreira, G; Veiga, J; Carvalho, A			Bowel infarction due to aspergillosis	LANCET			English	Editorial Material									Hosp Capuchos, Dept Hematol, Lisbon, Portugal; Hosp Curry Cabral, Dept Pathol, Lisbon, Portugal		Carvalho, A (corresponding author), Hosp Capuchos, Dept Hematol, Lisbon, Portugal.								0	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					210	210		10.1016/S0140-6736(02)07446-9	http://dx.doi.org/10.1016/S0140-6736(02)07446-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812556				2022-12-28	WOS:000173350800012
J	Drummond, C				Drummond, C			For and against - Cannabis control: costs outweigh the benefits - Against	BRITISH MEDICAL JOURNAL			English	Editorial Material									St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, London SW17 0RE, England	St Georges University London	Drummond, C (corresponding author), St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, London SW17 0RE, England.		Drummond, Colin/O-9141-2019	Drummond, Colin/0000-0001-9379-5452				Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Campbell FA, 2001, BMJ-BRIT MED J, V323, P13, DOI 10.1136/bmj.323.7303.13; *DEP ENV TRANSP RE, 1998, REP INC DRUGS ROAD A; Hall W, 2001, DRUG ALCOHOL DEPEN, V62, P163, DOI 10.1016/S0376-8716(00)00171-X; Hall W, 1994, NATL DRUG STRATEGY M, V25; HENRY J, 2000, TIMES           1028; House of Lords Select Committee on Science and Technology, 1998, CANN SCI MED EV; Johns A, 2001, BRIT J PSYCHIAT, V178, P116, DOI 10.1192/bjp.178.2.116; Raw M, 1998, THORAX, V53, pS1, DOI 10.1136/thx.53.2008.S1; *ROYAL COLL GEN PR, 1986, ALC BAL VIEW; Tramer MR, 2001, BMJ-BRIT MED J, V323, P16, DOI 10.1136/bmj.323.7303.16; *WHO PROGR SUBST A, 1997, CANN HLTH PERSP RES; Zhang ZF, 1999, CANCER EPIDEM BIOMAR, V8, P1071	13	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					107	108						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11808516				2022-12-28	WOS:000173325400028
J	Bahr, K; Simpson, F				Bahr, K; Simpson, F			Electrical anisotropy below slow- and fast-moving plates: Paleoflow in the upper mantle?	SCIENCE			English	Article							LITHOSPHERE; VELOCITIES; MODEL; FIELD	Upper mantle electrical conductivities can be explained by hydrogen diffusivity in hydrous olivine. Diffusivity enhances the conductivity of olivine anisotropically, making the a axis the most conductive of the three axes. Therefore, the hypothesis that plate motion induces lattice-preferred orientation of olivine can be tested with the use of long-period electromagnetic array measurements. Here, we compared electrical anisotropies below the stow-moving Fennoscandian and fast-moving Australian plates. The degree of olivine alignment is greater in the mantle below the Fennoscandian plate than below the Australian plate. This finding may indicate that convection rather than plate motion is the dominant deformation mechanism.	Univ Gottingen, Inst Geophys, D-37075 Gottingen, Germany; Inst Geol & Nucl Sci, Lower Hutt, New Zealand	University of Gottingen; GNS Science - New Zealand	Bahr, K (corresponding author), Univ Gottingen, Inst Geophys, D-37075 Gottingen, Germany.							Bahr K, 2000, PHYS EARTH PLANET IN, V119, P237, DOI 10.1016/S0031-9201(00)00134-5; Bahr K, 2000, EARTH PLANET SC LETT, V178, P87, DOI 10.1016/S0012-821X(00)00070-4; Debayle E, 2000, J GEOPHYS RES-SOL EA, V105, P25423, DOI 10.1029/2000JB900212; GATZEMEIER A, COMMUNICATION; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1109, DOI 10.1029/GL017i008p01109; Kaminski E, 2001, EARTH PLANET SC LETT, V189, P253, DOI 10.1016/S0012-821X(01)00356-9; KARATO S, 1990, NATURE, V347, P272, DOI 10.1038/347272a0; MACKWELL SJ, 1990, J GEOPHYS RES-SOLID, V95, P5079, DOI 10.1029/JB095iB04p05079; MARESCHAL M, 1995, NATURE, V375, P134, DOI 10.1038/375134a0; MONTAGNER JP, 1991, J GEOPHYS RES-SOL EA, V96, P20337, DOI 10.1029/91JB01890; OSIPOVA IL, 1989, PHYS EARTH PLANET IN, V53, P337, DOI 10.1016/0031-9201(89)90019-8; SCHMELING H, 1993, PHYS EARTH PLANET IN, V79, P241, DOI 10.1016/0031-9201(93)90150-8; Schmucker U., 1973, Physics of the Earth and Planetary Interiors, V7, P365, DOI 10.1016/0031-9201(73)90061-7; Simpson F, 2000, J GEOPHYS RES-SOL EA, V105, P19321, DOI 10.1029/2000JB900106; Simpson F, 2001, NATURE, V412, P632, DOI 10.1038/35088051; SUHADOLC P, 1990, TECTONOPHYSICS, V176, P123, DOI 10.1016/0040-1951(90)90262-7; VINNIK LP, 1992, GEOPHYS J INT, V111, P433, DOI 10.1111/j.1365-246X.1992.tb02102.x; Wang SM, 2001, EARTH PLANET SC LETT, V189, P133, DOI 10.1016/S0012-821X(01)00351-X; Xu YS, 2000, J GEOPHYS RES-SOL EA, V105, P27865, DOI 10.1029/2000JB900299	19	51	55	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1270	1272		10.1126/science.1066161	http://dx.doi.org/10.1126/science.1066161			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847335				2022-12-28	WOS:000173926000036
J	Knox, AL; Brown, NH				Knox, AL; Brown, NH			Rap1 GTPase regulation of adherens junction positioning and cell adhesion	SCIENCE			English	Article							DIRECT BINDING; DROSOPHILA; MORPHOGENESIS; PROTEINS; ZO-1; LOCALIZATION; EXPRESSION; EPITHELIA; POLARITY; MEMBERS	Cell-cell junctions are distributed evenly around the lateral circumference of cells within an epithelium. We find that the even distribution of adherens junctions is an active process that requires the small guanosine triphosphatase Rap1. Cells mutant for Rap1 condensed their adherens junctions to one side of the cell. This disrupted normal epithelial. cell behavior, and mutant cell clones dispersed into the surrounding wild-type tissue. Rap1 is enriched at adherens junctions, particularly between newly divided sister cells where it may reseal the adherens junction ring. The regulation of adherens junction positioning could play a role in cell mobility and cell division.	Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Anat, Cambridge CB2 1QR, England	University of Cambridge	Brown, NH (corresponding author), Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.			Knox, Andrea/0000-0002-3367-6678; Brown, Nicholas/0000-0002-8958-7017				Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; BOETTNER B, COMMUNICATION; BOKOCH GM, 1993, BIOCHEM J, V289, P17, DOI 10.1042/bj2890017; Chou TB, 1996, GENETICS, V144, P1673; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; KNOX AL, UNPUB; Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Muller HAJ, 2000, DEV DYNAM, V218, P52; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Takahisa M, 1996, GENE DEV, V10, P1783, DOI 10.1101/gad.10.14.1783; Wei XR, 2001, MECH DEVELOP, V100, P217, DOI 10.1016/S0925-4773(00)00550-5; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	26	192	195	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1285	1288		10.1126/science.1067549	http://dx.doi.org/10.1126/science.1067549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847339				2022-12-28	WOS:000173926000041
J	MacPhee, AG; Tate, MW; Powell, CF; Yue, Y; Renzi, MJ; Ercan, A; Narayanan, S; Fontes, E; Walther, J; Schaller, J; Gruner, SM; Wang, J				MacPhee, AG; Tate, MW; Powell, CF; Yue, Y; Renzi, MJ; Ercan, A; Narayanan, S; Fontes, E; Walther, J; Schaller, J; Gruner, SM; Wang, J			X-ray imaging of shock waves generated by high-pressure fuel sprays	SCIENCE			English	Article							PIXEL ARRAY DETECTOR; DIFFRACTION; INJECTION	Synchrotron x-radiography and a fast x-ray detector were used to record the time evolution of the transient fuel sprays from a high-pressure injector. A succession of 5.1-microsecond radiographs captured the propagation of the spray-induced shock waves in a gaseous medium and revealed the complex nature of the spray hydrodynamics. The monochromatic x-radiographs also allow quantitative analysis of the shock waves that has been difficult if not impossible with optical imaging. Under injection conditions similar to those found in operating engines, the fuel jets can exceed supersonic speeds and result in gaseous shock waves.	Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Argonne Natl Lab, Div Energy Syst, Argonne, IL 60439 USA; Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Robert Bosch GmbH, Corp Res, D-70049 Stuttgart, Germany	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; Cornell University; Bosch	Wang, J (corresponding author), Argonne Natl Lab, Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA.		Gruner, Sol/G-2924-2010	Gruner, Sol/0000-0002-1171-4426	PHS HHS [DMR-9713424] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; [Anonymous], 1971, COMPRESSIBLE FLUID D; Barna SL, 1997, IEEE T NUCL SCI, V44, P950, DOI 10.1109/23.603783; Cao ZM, 2000, JSME INT J B-FLUID T, V43, P582, DOI 10.1299/jsmeb.43.582; CHAR JM, 1990, J PROPUL POWER, V6, P544, DOI 10.2514/3.23254; CHIGIER N, 1991, PROG ENERG COMBUST, V17, P211, DOI 10.1016/0360-1285(91)90011-B; FIELD JE, 1977, PROC R SOC LON SER-A, V357, P143, DOI 10.1098/rspa.1977.0160; HECHT E., 1998, OPTICS; Hentschel W, 1996, OPT LASER ENG, V25, P401, DOI 10.1016/0143-8166(95)00091-7; Herman H, 1988, MRS BULL, V13, P60, DOI DOI 10.1557/S0883769400063715; Hurly JJ, 2000, INT J THERMOPHYS, V21, P739, DOI 10.1023/A:1006697620523; KUO K, 1996, RECENT ADV SPRAY COM, V1; KUO K, 1996, RECENT ADV SPRAY COM, V2; NAKAHIRA T, 1992, SHOCK WAVES, V2, P1271; OKEEFE JD, 1967, NATURE, V213, P23, DOI 10.1038/213023a0; Powell CF, 2000, J SYNCHROTRON RADIAT, V7, P356, DOI 10.1107/S0909049500013431; Rossi G, 1999, J SYNCHROTRON RADIAT, V6, P1096, DOI 10.1107/S0909049599009802; SHI HH, 1994, JSME INT J B-FLUID T, V37, P509, DOI 10.1299/jsmeb.37.509; Tikhomirov RA, 1992, HIGH PRESSURE JETCUT; Yule A. J., 1991, ATOMIZATION SPRAY, V1, P441; Zhang YY, 2000, APPL OPTICS, V39, P6221, DOI 10.1364/AO.39.006221	21	108	109	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1261	1263		10.1126/science.1068149	http://dx.doi.org/10.1126/science.1068149			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847333				2022-12-28	WOS:000173926000033
J	Vogelstein, B; Alberts, B; Shine, K				Vogelstein, B; Alberts, B; Shine, K			Genetics - Please don't call it cloning!	SCIENCE			English	Editorial Material									Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Kimmel Canc Ctr, Baltimore, MD 21231 USA; Natl Acad Sci, Washington, DC 20418 USA; CNR, Washington, DC 20418 USA; Natl Acad Sci, Inst Med, Washington, DC 20418 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	Vogelstein, B (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21231 USA.							Kennedy D, 2001, SCIENCE, V294, P745, DOI 10.1126/science.294.5543.745; National Research Council, 2001, STEM CELLS FUT REG M; National Research Council, 2002, SCI MED ASP HUM REPR	3	71	72	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1237	1237		10.1126/science.1070247	http://dx.doi.org/10.1126/science.1070247			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847324				2022-12-28	WOS:000173926000021
J	Lo, B; Ruston, D; Kates, LW; Arnold, RM; Cohen, CB; Faber-Langendoen, K; Pantilat, SZ; Puchalski, CM; Quill, TR; Rabow, MW; Schreiber, S; Sulmasy, DP; Tulsky, JA				Lo, B; Ruston, D; Kates, LW; Arnold, RM; Cohen, CB; Faber-Langendoen, K; Pantilat, SZ; Puchalski, CM; Quill, TR; Rabow, MW; Schreiber, S; Sulmasy, DP; Tulsky, JA		Working Grp Religious Spiritual Is	Discussing religious and spiritual issues at the end of life - A practical guide for physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FAMILY MEDICINE; CARE; ATTITUDES; BELIEFS; ETHICS; INTERVIEW; CANCER; PRAYER; ILL; ME	As patients near the end of life, their spiritual and religious concerns may be awakened or intensified. Many physicians, however, feel unskilled and uncomfortable discussing these concerns. This article suggests how physicians might respond when patients or families raise such concerns. First, some patients may explicitly base decisions about life-sustaining interventions on their spiritual or religious beliefs. Physicians need to explore those beliefs to help patients think through their preferences regarding specific interventions. Second, other patients may not bring up spiritual or religious concerns but are troubled by them. Physicians should identify such concerns and listen to them empathetically, without trying to alleviate the patient's spiritual suffering or offering premature reassurance. Third, some patients or families may have religious reasons for insisting on life-sustaining interventions that physicians advise against. The physician should listen and try to understand the patient's viewpoint. Listening respectfully does not require the physician to agree with the patient or misrepresent his or her own views. Patients and families who feel that the physician understands them and cares about them may be more willing to consider the physician's views on prognosis and treatment. By responding to patients' spiritual and religious concerns and needs, physicians may help them find comfort and closure near the end of life.	Univ Calif San Francisco, Div Gen Internal Med, Program Med Eth, San Francisco, CA 94143 USA; Univ Pittsburgh, Sch Med, Ctr Bioeth & Hlth Law, Div Gen Internal Med, Pittsburgh, PA USA; Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA; SUNY Upstate Med Univ, Ctr Bioeth & Humanities, Syracuse, NY USA; George Washington Univ, Sch Med, Inst Spiritual & Hlth, Div Aging Studies, St Louis, MO USA; Univ Rochester, Sch Med, Dept Med, Program Biopsychol Studies, Rochester, NY USA; Hackensack Univ Med Ctr, Hackensack, NJ USA; New York Med Coll, Bioeth Inst, St Vincents Manhattan, John J Conley Dept Eth, New York, NY USA; Duke Univ, Dept Med, Program Med Encounter & Palliat Care, Durham, NC USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; George Washington University; University of Rochester; Hackensack University Medical Center; New York Medical College; Duke University	Lo, B (corresponding author), Room C 126,521 Parnassus Ave, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu						*ASS CLIN PAST ED, 2001, OBJ CLIN PAST ED; Astrow AB, 2001, AM J MED, V110, P283; Baile WF, 1999, ONCOLOGY-NY, V13, P1021; BERNARDIN JC, 1998, GIFT PEACE PERSONAL; Byock I, 1997, DYING WELL PROSPECT; Clinebell H.J., 1984, BASIC TYPES PASTORAL; Cohen CB, 2000, HASTINGS CENT REP, V30, P40, DOI 10.2307/3528046; Cohen CB, 2001, HASTINGS CENT REP, V31, P29, DOI 10.2307/3527702; Coulehan JL, 2001, ANN INTERN MED, V135, P221, DOI 10.7326/0003-4819-135-3-200108070-00022; DAALEMAN TP, 1994, J FAM PRACTICE, V39, P564; Ehman JW, 1999, ARCH INTERN MED, V159, P1803, DOI 10.1001/archinte.159.15.1803; Ellis MR, 1999, J FAM PRACTICE, V48, P105; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Faber-Langendoen K, 2000, ANN INTERN MED, V132, P482, DOI 10.7326/0003-4819-132-6-200003210-00010; KING DE, 1994, J FAM PRACTICE, V39, P349; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; LO B, 2000, RESOLVING ETHICAL DI, P128; Maguire P, 1996, EUR J CANCER, V32A, P78, DOI 10.1016/0959-8049(95)00527-7; Maguire P., 2000, COMMUNICATION SKILLS; Matthews DA, 1998, ARCH FAM MED, V7, P118, DOI 10.1001/archfami.7.2.118; *N CUMM FDN, 1997, SPIR BELI DYING PROC; Oyama O, 1998, ARCH FAM MED, V7, P431, DOI 10.1001/archfami.7.5.431; Platt FW, 2001, ANN INTERN MED, V134, P1079, DOI 10.7326/0003-4819-134-11-200106050-00020; Post SG, 2000, ANN INTERN MED, V132, P578, DOI 10.7326/0003-4819-132-7-200004040-00010; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Puchalski C, 2000, J Palliat Med, V3, P129, DOI 10.1089/jpm.2000.3.129; Puchalski C., 1999, SUPPORT VOICE, V5, P12; Puchalski CM, 1999, SPIRITUAL LIFE, V45, P154; QUINN TE, 2001, ANN INTERN MED, V135, P51; Rabow MW, 1999, WESTERN J MED, V171, P260; Roter DL, 2000, ARCH INTERN MED, V160, P3477, DOI 10.1001/archinte.160.22.3477; Rushton C H, 1996, Pediatr Nurs, V22, P64; Savulescu J, 1998, J MED ETHICS, V24, P382, DOI 10.1136/jme.24.6.382; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Sloan RP, 2000, NEW ENGL J MED, V342, P1913, DOI 10.1056/NEJM200006223422513; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Speck P., 1998, OXFORD TXB PALLIATIV, P805; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; STONE D, 1999, DIFFICULT CONSERVATI; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; Sulmasy DP., 1997, HEALERS CALLING SPIR; Taylor EJ, 1999, PSYCHO-ONCOLOGY, V8, P386; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003	45	198	201	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					749	754		10.1001/jama.287.6.749	http://dx.doi.org/10.1001/jama.287.6.749			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520XR	11851542				2022-12-28	WOS:000173809500032
J	Reilley, B; Simpson, I; Ford, N; DuBois, M				Reilley, B; Simpson, I; Ford, N; DuBois, M			Conflict in Sri Lanka - Sri Lanka's health service is a casualty of 20 years of war	BRITISH MEDICAL JOURNAL			English	Letter									Med Sans Frontieres, Colombo, Sri Lanka; Med Sans Frontieres, London EC1R 5DJ, England; Med Sans Frontieres, Amsterdam, Netherlands	Doctors Without Borders; Doctors Without Borders	Reilley, B (corresponding author), Med Sans Frontieres, Colombo, Sri Lanka.								0	6	6	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					361	362						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834572				2022-12-28	WOS:000173866300033
J	Verweij, M; van den Hoven, M				Verweij, M; van den Hoven, M			Influenza vaccination rates and informed consent in Dutch nursing homes: Survey of nursing home physicians	BRITISH MEDICAL JOURNAL			English	Article									Univ Utrecht, Ctr Bioeth & Hlth Law, NL-3584 CS Utrecht, Netherlands	Utrecht University	Verweij, M (corresponding author), Univ Utrecht, Ctr Bioeth & Hlth Law, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands.			Verweij, Marcel/0000-0001-9169-1852				BEAUCHAMP H, 1994, PRINCIPLES BIOMEDICA; Drinka PJ, 1997, J FAM PRACTICE, V45, P509; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Nicholson KG, 2000, LANCET, V355, P83, DOI 10.1016/S0140-6736(99)00310-4; Verweij M, 2001, BIOETHICS, V15, P536, DOI 10.1111/1467-8519.00260	5	13	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					328	328		10.1136/bmj.324.7333.328	http://dx.doi.org/10.1136/bmj.324.7333.328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834559	Green Published, Bronze			2022-12-28	WOS:000173866300017
J	Helfand, SL				Helfand, SL			Neurobiology - Chaperones take flight	SCIENCE			English	Editorial Material							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; DROSOPHILA; MUTATION		Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Helfand, SL (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.				NATIONAL INSTITUTE ON AGING [R37AG016667] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG016667] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fortini ME, 2000, TRENDS GENET, V16, P161, DOI 10.1016/S0168-9525(99)01939-3; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045	8	17	18	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					809	810		10.1126/science.1069544	http://dx.doi.org/10.1126/science.1069544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823628				2022-12-28	WOS:000173733000030
J	Ploegh, HL				Ploegh, HL			Don Craig Wiley (1944-2001) - Obituary	NATURE			English	Biographical-Item									Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Ploegh, HL (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.								0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					492	492		10.1038/415492a	http://dx.doi.org/10.1038/415492a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823846	Bronze			2022-12-28	WOS:000173564300032
J	Provencio, I; Rollag, MD; Castrucci, AM				Provencio, I; Rollag, MD; Castrucci, AM			Anatomy: Photoreceptive net in the mammalian retina - This mesh of cells may explain how some blind mice can still tell day from night.	NATURE			English	Article									Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Circadian Res Ctr, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Provencio, I (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.		Castrucci, Ana Maria L/C-3296-2014	Castrucci, Ana Maria/0000-0002-2065-8198; Provencio, Ignacio/0000-0003-1175-920X				Berson DM, 2001, INVEST OPHTH VIS SCI, V42, pS113; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Rollag MD, 2000, METHOD ENZYMOL, V316, P291	7	340	355	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					493	493		10.1038/415493a	http://dx.doi.org/10.1038/415493a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823848	Bronze			2022-12-28	WOS:000173564300033
J	Traverso, G; Shuber, A; Levin, B; Johnson, C; Olsson, L; Schoetz, DJ; Hamilton, SR; Boynton, K; Kinzler, KW; Vogelstein, B				Traverso, G; Shuber, A; Levin, B; Johnson, C; Olsson, L; Schoetz, DJ; Hamilton, SR; Boynton, K; Kinzler, KW; Vogelstein, B			Detection of APC mutations in fecal DNA from patients with colorectal tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OCCULT-BLOOD-TEST; K-RAS MUTATIONS; ABERRANT CRYPT FOCI; SCREENING SIGMOIDOSCOPY; ADENOMATOUS POLYPOSIS; ASYMPTOMATIC ADULTS; CODON-12 MUTATIONS; CANCER MORTALITY; P53 GENE; STOOL	Background: Noninvasive methods for detecting colorectal tumors have the potential to reduce morbidity and mortality from this disease. The mutations in the adenomatous polyposis coli (APC) gene that initiate colorectal tumors theoretically provide an optimal marker for detecting colorectal tumors. The purpose of our study was to determine the feasibility of detecting APC mutations in fecal DNA with the use of newly developed methods. Methods: We purified DNA from routinely collected stool samples and screened for APC mutations with the use of a novel approach called digital protein truncation. Many different mutations could potentially be identified in a sensitive and specific manner with this technique. Results: Stool samples from 28 patients with nonmetastatic colorectal cancers, 18 patients with adenomas that were at least 1 cm in diameter, and 28 control patients without neoplastic disease were studied. APC mutations were identified in 26 of the 46 patients with neoplasia (57 percent; 95 percent confidence interval, 41 to 71 percent) and in none of the 28 control patients (0 percent; 95 percent confidence interval, 0 to 12 percent; P<0.001). In the patients with positive tests, mutant APC genes made up 0.4 to 14.1 percent of all APC genes in the stool. Conclusions APC: mutations can be detected in fecal DNA from patients with relatively early colorectal tumors. This feasibility study suggests a new approach for the early detection of colorectal neoplasms. (N Engl J Med 2002;346:311-20.) Copyright (C) 2002 Massachusetts Medical Society.	Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Sch Med, Howard Hughes Med Inst, Grad Program Human Genet, Baltimore, MD 21231 USA; Exact Sci, Maynard, MA USA; Univ Texas, MD Anderson Canc Ctr, Div Canc Prevent, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; Uppsala Univ, Clin Res Ctr, Uppsala, Sweden; Cent Hosp Vasteras, Dept Surg, Vasteras, Sweden; Lahey Clin Fdn, Dept Colon Rectal Surg, Burlington, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Uppsala University; Vasteras Central Hospital; Lahey Hospital & Medical Center	Vogelstein, B (corresponding author), Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	vogelbe@welch.jhu.edu			NCI NIH HHS [CA 43460, CA 62924, CA 57345] Funding Source: Medline; NIGMS NIH HHS [GM 07184] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA057345, R37CA043460, P50CA062924, R01CA057345, R01CA043460] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlquist DA, 2000, GASTROENTEROLOGY, V119, P1219, DOI 10.1053/gast.2000.19580; ALLISON JE, 1990, ANN INTERN MED, V112, P328, DOI 10.7326/0003-4819-112-5-328; BAKER SJ, 1990, CANCER RES, V50, P7717; Boland CR, 1997, HOSP PRACT, V32, P79, DOI 10.1080/21548331.1997.11443598; Bond JH, 2001, ENDOSCOPY, V33, P454, DOI 10.1055/s-2001-14266; Deuter R, 1998, HUM MUTAT, V11, P84, DOI 10.1002/(SICI)1098-1004(1998)11:1<84::AID-HUMU13>3.3.CO;2-W; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Doolittle BR, 2001, EXP MOL PATHOL, V70, P289, DOI 10.1006/exmp.2001.2364; Eguchi S, 1996, CANCER, V77, P1707, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1707::AID-CNCR43>3.3.CO;2-U; HASEGAWA Y, 1995, ONCOGENE, V10, P1441; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; JEN J, 1994, CANCER RES, V54, P5523; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohata Yoshiaki, 1996, Japanese Journal of Gastroenterology, V93, P391; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Nollau P, 1996, INT J CANCER, V66, P332, DOI 10.1002/(SICI)1097-0215(19960503)66:3<332::AID-IJC11>3.0.CO;2-D; Ore L, 2001, EUR J CANCER PREV, V10, P251, DOI 10.1097/00008469-200106000-00008; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; PRETLOW TP, 1995, GASTROENTEROLOGY, V108, P600, DOI 10.1016/0016-5085(95)90092-6; Puig P, 1999, LAB INVEST, V79, P617; Ratto C, 1996, DIS COLON RECTUM, V39, P1238, DOI 10.1007/BF02055116; Reese S, 2001, JAMA-J AM MED ASSOC, V285, P1570; Rengucci C, 2001, CLIN CANCER RES, V7, P590; Rozen P, 2000, CANCER-AM CANCER SOC, V89, P46; Scotiniotis Ilias, 1999, Current Opinion in Oncology, V11, P305, DOI 10.1097/00001622-199907000-00011; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Shields HM, 2001, AM J GASTROENTEROL, V96, P196; SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048; SMITH AJ, 1994, CANCER RES, V54, P5527; SMITHRAVIN J, 1995, GUT, V36, P81, DOI 10.1136/gut.36.1.81; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559; TSAO JI, 1994, AM J PATHOL, V145, P531; Ulvik Arve, 1995, Tidsskrift for den Norske Laegeforening, V115, P3266; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; Verne JECW, 1998, BRIT MED J, V317, P182, DOI 10.1136/bmj.317.7152.182; Villa E, 1996, GASTROENTEROLOGY, V110, P1346, DOI 10.1053/gast.1996.v110.pm8613038; Vogelstein B., 1998, GENETIC BASIS HUMAN	45	240	275	2	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2002	346	5					311	320		10.1056/NEJMoa012294	http://dx.doi.org/10.1056/NEJMoa012294			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	516GJ	11821507	Bronze			2022-12-28	WOS:000173545300003
J	Weeks, SJ; Currie, B; Bakun, A				Weeks, SJ; Currie, B; Bakun, A			Satellite imaging - Massive emissions of toxic gas in the Atlantic	NATURE			English	Article									Univ Cape Town, Ocean Space Ltd, ZA-7701 Rondebosch, South Africa; Univ Cape Town, IRD, IDYLE Project, Dept Oceanog, ZA-7701 Rondebosch, South Africa; Natl Marine Res & Informat Ctr, Swakopmund, Namibia	University of Cape Town; University of Cape Town	Weeks, SJ (corresponding author), Univ Cape Town, Ocean Space Ltd, ZA-7701 Rondebosch, South Africa.		Weeks, Scarla J/E-8632-2013	Weeks, Scarla J/0000-0002-0579-7069; Bakun, Andrew/0000-0002-4366-3846				BAILEY GW, 1985, S AFRICAN J MARINE S, V3, P197; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; MASRIERA J, 1990, MAR BIOL, V104, P175, DOI 10.1007/BF01313256; Tyrrell T, 1999, J GEOPHYS RES-OCEANS, V104, P3223, DOI 10.1029/1998JC900052; WOOSTER WS, 1963, SEA, V2, P253	5	92	95	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					493	494		10.1038/415493b	http://dx.doi.org/10.1038/415493b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823847				2022-12-28	WOS:000173564300034
J	Cremona, G; Asnaghi, R; Baderna, P; Brunetto, A; Brutsaert, T; Cavallaro, C; Clark, TM; Cogo, A; Donis, R; Lanfranchi, P; Luks, A; Novello, N; Panzetta, S; Perini, L; Putnam, M; Spagnolatti, L; Wagner, H; Wagner, PD				Cremona, G; Asnaghi, R; Baderna, P; Brunetto, A; Brutsaert, T; Cavallaro, C; Clark, TM; Cogo, A; Donis, R; Lanfranchi, P; Luks, A; Novello, N; Panzetta, S; Perini, L; Putnam, M; Spagnolatti, L; Wagner, H; Wagner, PD			Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study	LANCET			English	Article							ACUTE MOUNTAIN-SICKNESS; OPERATION EVEREST-II; LUNG LYMPH-FLOW; SIMULATED ALTITUDE; GAS-EXCHANGE; SEA-LEVEL; EXERCISE; EDEMA; HUMANS; SHEEP	Background High altitude pulmonary oedema (RAPE) that is severe enough to require urgent medical care is infrequent. We hypothesised that subclinical HAPE is far more frequent than suspected during even modest climbs of average effort. Methods We assessed 262 consecutive climbers of Monte Rosa (4559 m), before ascent and about 24 h later on the summit 1 h after arriving, by clinical examination, electrocardiography, oximetry, spirometry, carbon monoxide transfer, and closing volume. A chest radiograph was taken at altitude. Findings Only one climber was evacuated for HAPE, but 40 (15%) of 262 climbers had chest rales or interstitial oedema on radiograph after ascent. Of 37 of these climbers, 34 (92%) showed increased closing volume. Of the 197 climbers without oedema, 146 (74%) had an increase in closing volume at altitude. With no change in vital capacity, forced expiratory volume in 1 s and forced expiratory flow at 25-75% of forced vital capacity increased slightly at altitude, without evidence of oedema. If we assume that an increased closing volume at altitude indicates increased pulmonary extravascular fluid, our data suggest that three of every four healthy, recreational climbers have mild subclinical HAPE shortly after a modest climb. Interpretation The risk of HAPE might not be confined to a small group of genetically susceptible people, but likely exists for most climbers if the rate of ascent and degree of physical effort are great enough, especially if lung size is normal or low.	San Raffaele Univ Sci Inst, Resp Med Unit, I-20132 Milan, Italy; Univ Calif San Diego, Dept Med, Div Physiol, La Jolla, CA 92093 USA; Univ Ferrara, Club Alpino Italiano & Pulm Div, I-44100 Ferrara, Italy	Vita-Salute San Raffaele University; University of California System; University of California San Diego; University of Ferrara	Cremona, G (corresponding author), San Raffaele Univ Sci Inst, Resp Med Unit, Via Olgettina 60, I-20132 Milan, Italy.		Cremona, George/ABI-2752-2020	Asnaghi, Roberto/0000-0001-9746-6955	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007212, P01HL017731] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 07212, HL 17731] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COATES G, 1984, J CLIN INVEST, V74, P133, DOI 10.1172/JCI111393; DEAL EC, 1980, AM REV RESPIR DIS, V121, P621; DEMEDTS M, 1974, B PHYSIO-PATHOL RESP, V10, P11; Eldridge MW, 1996, J APPL PHYSIOL, V81, P911, DOI 10.1152/jappl.1996.81.2.911; FASULES JW, 1985, CIRCULATION, V72, P957, DOI 10.1161/01.CIR.72.5.957; GALE GE, 1985, J APPL PHYSIOL, V58, P978, DOI 10.1152/jappl.1985.58.3.978; GRAY GW, 1973, J APPL PHYSIOL, V35, P227, DOI 10.1152/jappl.1973.35.2.227; GUY HJ, 1976, AM REV RESPIR DIS, V113, P737; HACKETT PH, 1976, LANCET, V2, P1149; HARKEN AH, 1976, ANN SURG, V184, P183, DOI 10.1097/00000658-197608000-00009; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Maggiorini M, 1999, HYPOXIA NEXT MILLENN, P408; NEWMAN JH, 1988, J APPL PHYSIOL, V64, P2125, DOI 10.1152/jappl.1988.64.5.2125; OBRODOVICH H, 1986, AM REV RESPIR DIS, V134, P862, DOI 10.1164/arrd.1986.134.5.862; Podolsky A, 1996, J APPL PHYSIOL, V81, P922, DOI 10.1152/jappl.1996.81.2.922; Rahn H, 1955, GRAPHICAL ANAL RESP; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SCHAFFARTZIK W, 1992, J APPL PHYSIOL, V72, P1657, DOI 10.1152/jappl.1992.72.5.1657; Scherrer U, 1999, ADV EXP MED BIOL, V474, P93; SINGH I, 1965, LANCET, V1, P229; Steinacker JM, 1998, EUR RESPIR J, V11, P643; VISWANATHAN R, 1969, AM REV RESPIR DIS, V100, P334, DOI 10.1164/arrd.1969.100.3.334; VISWANATHAN R, 1978, RESPIRATION, V36, P216, DOI 10.1159/000193953; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WEST JB, 1995, EUR RESPIR J, V8, P523; WEST JB, 1992, INT J SPORTS MED, V13, P54; WEST JB, 1995, PULMONARY PATHOPHYSI	29	138	146	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					303	309		10.1016/S0140-6736(02)07496-2	http://dx.doi.org/10.1016/S0140-6736(02)07496-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830197				2022-12-28	WOS:000173588100011
J	Hector, A; Hooper, R				Hector, A; Hooper, R			Ecology - Darwin and the first ecological experiment	SCIENCE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Natl Inst Environm Studies, Wildlife Conservat Res Team, Tsukuba, Ibaraki 3050053, Japan	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); National Institute for Environmental Studies - Japan	Hector, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.		Hector, Andrew/H-4199-2011	Hector, Andrew/0000-0002-1309-7716				ACOT P, 1998, EUROPEAN ORIGINS SCI, V1; Browne J, 1980, J Hist Biol, V13, P53, DOI 10.1007/BF00125354; Darwin C., 1858, J P LINNEAN SOC LOND, V3, P45, DOI DOI 10.1111/J.1096-3642.1858.TB02500.X; Darwin Charles, 1985, ORIGIN SPECIES MEANS, P185; Davy H., 1821, ELEMENTS AGR CHEM; Ehrlich P.R., 1981, EXTINCTION; KIRA TATUO, 1953, JOUR INST POLYTECH [OSAKA CITY UNIV] SER D BIOL, V4, P1; KOHN D, 1975, DARWINIAN HERITAGE; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MCNAUGHTON SJ, 1993, BIODIVERSITY ECOSYST; SINCLAIR G, 1826, LOUDONS GARDENERS MA, V1, P14; Sinclair G, 1824, HORTUS GRAMINEUS WOB; Stauffer R. C., 1975, C DARWINS NATURAL SE	13	71	85	7	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					639	640		10.1126/science.1064815	http://dx.doi.org/10.1126/science.1064815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809960				2022-12-28	WOS:000173560900032
J	Suzuki, N; Nishiura, M; Wakatsuki, Y				Suzuki, N; Nishiura, M; Wakatsuki, Y			Isolation and structural characterization of 1-zirconacyclopent-3-yne, five-membered cyclic alkynes	SCIENCE			English	Article							ZIRCONOCENE COMPLEXES; MOLECULAR-STRUCTURE; BIS(ZIRCONOCENE) COMPLEX; CATALYZED DIMERIZATION; METAL-COMPLEXES; CYCLOALKYNES; CYCLOPENTYNE; CRYSTAL; ACETYLENE; CUMULENE	Stable five-membered cyclic alkynes were synthesized, isolated, and fully characterized. Divalent zirconium species, bis(cyctopentadienyt)zirconium(II) equivalent, reacted with (Z)-1,4-disubstituted 1,2,3-butatrienes [(Z)-R-CH=C=C=CH-R, 1a: R = (CH(3))(3)Si-, 1b: R = tert-C(4)H(9)-] to give 1-zirconacyclopent-3-yne compounds (2a-b) in good yields. X-ray diffraction analysis revealed their five-membered cyclic structure with a sufficiently short triple bond to regard this compound as a metallacyclopentyne.	RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan	RIKEN	Suzuki, N (corresponding author), RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan.	nsuzuki@postman.riken.go.jp	Suzuki, Noriyuki/C-5288-2012; Nishiura, Masayoshi/F-2919-2016	Nishiura, Masayoshi/0000-0003-2748-9814				Ahlers W, 1997, ORGANOMETALLICS, V16, P1440, DOI 10.1021/om960918s; ALLEN FH, 1987, J CHEM SOC P2, V11, P1; ALT HG, 1992, J ORGANOMET CHEM, V433, P107, DOI 10.1016/0022-328X(92)80133-I; ANDO W, 1992, ORGANOMETALLICS, V11, P1009, DOI 10.1021/om00039a002; [Anonymous], 1991, ADV STRAIN ORG CHEM; BARTSCH HH, 1981, Z KRISTALLOGR, V156, P10; BENNETT MA, 1989, ANGEW CHEM INT EDIT, V28, P1296, DOI 10.1002/anie.198912961; BOLSTER JM, 1981, J AM CHEM SOC, V103, P2868, DOI 10.1021/ja00400a066; BRIGHT D, 1971, J CHEM SOC A, P1979, DOI 10.1039/j19710001979; BUCHWALD SL, 1989, J AM CHEM SOC, V111, P9113, DOI 10.1021/ja00207a025; CHAPMAN OL, 1981, J AM CHEM SOC, V103, P7033, DOI 10.1021/ja00413a074; ERKER G, 1980, J AM CHEM SOC, V102, P6344, DOI 10.1021/ja00540a032; FITJER L, 1982, TETRAHEDRON LETT, V23, P1661, DOI 10.1016/S0040-4039(00)87184-1; Gilbert JC, 1998, ADV STRAIN THEOR INT, V4, P203; Gleiter R., 1995, MODERN ACETYLENE CHE, DOI DOI 10.1002/9783527615278.CH08; HAASE J, 1971, Z NATURFORSCH PT A, VA 26, P1190, DOI 10.1515/zna-1971-0716; HAASE J, 1972, Z NATURFORSCH PT A, VA 27, P624; HAGELEE L, 1979, J AM CHEM SOC, V101, P4888, DOI 10.1021/ja00511a017; HSU DP, 1993, J AM CHEM SOC, V115, P10394, DOI 10.1021/ja00075a079; HUNTER WE, 1983, ORGANOMETALLICS, V2, P750, DOI 10.1021/om00078a010; Jones WM, 1998, ADV ORGANOMET CHEM, V42, P147, DOI 10.1016/S0065-3055(08)60543-2; KREBS A, 1971, ANGEW CHEM INT EDIT, V10, P509, DOI 10.1002/anie.197105091; KREBS A, 1983, TOP CURR CHEM, V109, P189; LEFEBER C, 1995, J ORGANOMET CHEM, V501, P189, DOI 10.1016/0022-328X(95)05648-9; Montgomery LK, 1960, J AM CHEM SOC, V82, P4750, DOI DOI 10.1021/ja01502a081; NEGISHI E, 1986, TETRAHEDRON LETT, V27, P2829, DOI 10.1016/S0040-4039(00)84653-5; NEGISHI E, 1994, J AM CHEM SOC, V116, P9751, DOI 10.1021/ja00100a051; Pflug J, 1999, J CHEM SOC DALTON, P2551, DOI 10.1039/a903492g; ROSENTHAL U, 1995, Z ANORG ALLG CHEM, V621, P77, DOI 10.1002/zaac.19956210114; ROSENTHAL U, 1994, ANGEW CHEM INT EDIT, V33, P1605, DOI 10.1002/anie.199416051; Schulte P, 1997, J ORGANOMET CHEM, V530, P95, DOI 10.1016/S0022-328X(96)06605-3; SUZUKI N, 1994, J ORGANOMET CHEM, V473, P117, DOI 10.1016/0022-328X(94)80112-6; TYPKE V, 1979, J MOL STRUCT, V56, P77, DOI 10.1016/0022-2860(79)80139-8; WAKATSUKI Y, 1993, B CHEM SOC JPN, V66, P987, DOI 10.1246/bcsj.66.987; WAKATSUKI Y, 1991, J AM CHEM SOC, V113, P9604, DOI 10.1021/ja00025a027; WITTIG G, 1960, ANGEW CHEM INT EDIT, V72, P324, DOI 10.1002/ange.19600720914; YASUDA H, 1980, CHEM LETT, P519; YIN JG, 1993, J AM CHEM SOC, V115, P8859, DOI 10.1021/ja00072a057	38	108	108	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					660	663		10.1126/science.1067157	http://dx.doi.org/10.1126/science.1067157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809967				2022-12-28	WOS:000173560900039
J	Hibberd, JM; Quick, WP				Hibberd, JM; Quick, WP			Characteristics of C-4 photosynthesis in stems and petioles of C-3 flowering plants	NATURE			English	Article							DISSOLVED INORGANIC CARBON; PHOTORESPIRATORY ENZYMES; BUNDLE-SHEATH; METABOLISM; GROWTH; LOCALIZATION; RHIZOSPHERE; TOBACCO; LEAVES; CELLS	Most plants are known as C-3 plants because the first product of photosynthetic CO2 fixation is a three-carbon compound(1). C-4 plants, which use an alternative pathway in which the first product is a four-carbon compound, have evolved independently many times and are found in at least 18 families(2,3). In addition to differences in their biochemistry, photosynthetic organs of C-4 plants show alterations in their anatomy and ultrastructure(4). Little is known about whether the biochemical or anatomical characteristics of C-4 photosynthesis evolved first. Here we report that tobacco, a typical C-3 plant, shows characteristics of C-4 photosynthesis in cells of stems and petioles that surround the xylem and phloem, and that these cells are supplied with carbon for photosynthesis from the vascular system and not from stomata. These photosynthetic cells possess high activities of enzymes characteristic of C-4 photosynthesis, which allow the decarboxylation of four-carbon organic acids from the xylem and phloem, thus releasing CO2 for photosynthesis. These biochemical characteristics of C-4 photosynthesis in cells around the vascular bundles of stems of C-3 plants might explain why C-4 photosynthesis has evolved independently many times.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Sheffield, Robert Hill Inst, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Cambridge; University of Sheffield	Hibberd, JM (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	julian.hibberd@plantsci.cam.ac.uk						Ashton AR., 1990, METH PLANT BIOCH, V3, P39, DOI DOI 10.1016/B978-0-12-461013-2.50010-1; BENZIONI A, 1971, PHYSIOL PLANTARUM, V24, P288, DOI 10.1111/j.1399-3054.1971.tb03493.x; CALVIN M, 1951, SYM SOC EXP BIOL, V5, P284; Cramer MD, 1999, NEW PHYTOL, V142, P441, DOI 10.1046/j.1469-8137.1999.00415.x; Cramer MD, 1999, J EXP BOT, V50, P79, DOI 10.1093/jexbot/50.330.79; Esau K, 1965, PLANT ANATOMY, V2, P429; Gao ZF, 1996, PLANT PHYSIOL BIOCH, V34, P807; Gerendas J, 1999, J EXP BOT, V50, P1101, DOI 10.1093/jexbot/50.336.1101; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hibberd JM, 1998, PLANTA, V205, P506, DOI 10.1007/s004250050349; Hibberd JM, 1999, PLANT CELL ENVIRON, V22, P937, DOI 10.1046/j.1365-3040.1999.00462.x; KEELEY JE, 1984, NATURE, V310, P694, DOI 10.1038/310694a0; Keeley JE, 1998, BOT REV, V64, P121, DOI 10.1007/BF02856581; Kinsman EA, 1998, DEVELOPMENT, V125, P1815; Lea PJ., 1999, PLANT BIOCH MOL BIOL; Monson RK, 1999, C4 PLANT BIOL, P377, DOI [10.1016/B978-012614440-6/50012-4, DOI 10.1016/B978-012614440-6/50012-4]; MOORE PD, 1982, NATURE, V310, P696; Nilsen Erik T., 1995, P223, DOI 10.1016/B978-012276460-8/50012-6; Pate J.S., 1975, TRANSPORT PLANTS, P451, DOI 10.1007/978-3-642-66161-7_19; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P139, DOI 10.1111/j.1365-3040.1991.tb01330.x; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; RAWSTHORNE S, 1988, PLANTA, V173, P298, DOI 10.1007/BF00401016; RAWSTHORNE S, 1988, PLANTA, V176, P527, DOI 10.1007/BF00397660; RAWSTHORNE S, 1992, PLANT J, V2, P267, DOI 10.1111/j.1365-313X.1992.00267.x; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Sage R., 1999, C4 PLANT BIOL, P551, DOI DOI 10.1016/B978-012614440-6/50017-3; SCHAAF J, 1995, PLANT PHYSIOL, V108, P949, DOI 10.1104/pp.108.3.949; THOMAS JC, 1992, PLANT PHYSIOL, V98, P626, DOI 10.1104/pp.98.2.626; Vuorinen AH, 1995, J PLANT PHYSIOL, V147, P236, DOI 10.1016/S0176-1617(11)81510-5; WALKER RP, 1995, PLANTA, V196, P58, DOI 10.1007/BF00193217	30	297	334	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					451	454		10.1038/415451a	http://dx.doi.org/10.1038/415451a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807559	Green Accepted			2022-12-28	WOS:000173433600055
J	Moller, AM; Villebro, N; Pedersen, T; Tonnesen, H				Moller, AM; Villebro, N; Pedersen, T; Tonnesen, H			Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial	LANCET			English	Article							PULMONARY COMPLICATIONS; CIGARETTE-SMOKING; CESSATION; SMOKERS; REDUCE	Background Smokers are at higher risk of cardiopulmonary and wound-related postoperative complications than nonsmokers. Our aim was to investigate the effect of preoperative smoking intervention on the frequency of postoperative complications in patients undergoing hip and knee replacement. Methods We did a randomised trial in three hospitals in Denmark. 120 patients were randomly assigned 6-8 weeks before scheduled surgery to either the control (n=60) or smoking intervention (60) group. Smoking intervention was counselling and nicotine replacement therapy, and either smoking cessation or at least 50% smoking reduction. An assessor, who was masked to the intervention, registered the occurrence of cardiopulmonary, renal, neurological, or surgical complications and duration of hospital admittance. The main analysis was by intention to treat. Findings Eight controls and four patients from the intervention group were excluded from the final analysis because their operations were either postponed or cancelled. Thus, 52 and 56 patients, respectively, were analysed for outcome. The overall complication rate was 18% in the smoking intervention group and 52% in controls (p = 0.0003). The most significant effects of intervention were seen for wound-related complications (5% vs 31%, p = 0.001), cardiovascular complications (0% vs 10%, p = 0.08), and secondary surgery (4% vs 15%, p = 0.07). The median length of stay was 11 days (range 7-55) in the intervention group and 13 days (8-65) in the control group. Interpretation An effective smoking intervention programme 6-8 weeks before surgery reduces postoperative morbidity, and we recommend, on the basis of our results, this programme be adopted.	Bispebjerg Hosp, Dept Anaesthesiol, DK-2400 Copenhagen NV, Denmark; Bispebjerg Hosp, Clin Unit Prevent Med & Hlth Promot, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Moller, AM (corresponding author), Bispebjerg Hosp, Dept Anaesthesiol, DK-2400 Copenhagen NV, Denmark.	docamm@yahoo.com		Tonnesen, Hanne/0000-0002-7161-3416				AHMED SS, 1976, AM J CARDIOL, V37, P33, DOI 10.1016/0002-9149(76)90496-3; Beckers S, 1991, Acta Anaesthesiol Belg, V42, P45; Bluman LG, 1998, CHEST, V113, P883, DOI 10.1378/chest.113.4.883; BODE FR, 1975, AM J MED, V59, P43, DOI 10.1016/0002-9343(75)90320-4; BOUNAMEAUX H, 1988, CARDIOVASC RES, V22, P154, DOI 10.1093/cvr/22.2.154; BrooksBrunn JA, 1997, CHEST, V111, P564, DOI 10.1378/chest.111.3.564; BUIST AS, 1976, AM REV RESPIR DIS, V114, P115; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; FERSON M, 1979, INT J CANCER, V23, P603, DOI 10.1002/ijc.2910230504; Frick W G, 1994, Tex Dent J, V111, P21; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Jorgensen LN, 1998, SURGERY, V123, P450, DOI 10.1016/S0039-6060(98)70167-9; Kinsella JB, 1999, ANN OTO RHINOL LARYN, V108, P139, DOI 10.1177/000348949910800206; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Moller AM, 2001, ACTA ANAESTH SCAND, V45, P345, DOI 10.1034/j.1399-6576.2001.045003345.x; Morton HJV, 1944, LANCET, V1, P368; Padubidri AN, 2001, PLAST RECONSTR SURG, V107, P342, DOI 10.1097/00006534-200102000-00007; ROTH GM, 1960, ANN NY ACAD SCI, V90, P308, DOI 10.1111/j.1749-6632.1960.tb32645.x; SCHEIDEGGER D, 1976, EUR J INTEN CARE MED, V2, P35, DOI 10.1007/BF00571895; Schwilk B, 1997, ACTA ANAESTH SCAND, V41, P348, DOI 10.1111/j.1399-6576.1997.tb04697.x; Thomas D, 1993, Rev Prat, V43, P1218; Tonnesen H, 1999, BMJ-BRIT MED J, V318, P1311, DOI 10.1136/bmj.318.7194.1311; WARNER MA, 1989, MAYO CLIN PROC, V64, P609, DOI 10.1016/S0025-6196(12)65337-3; WARNER MA, 1984, ANESTHESIOLOGY, V60, P380, DOI 10.1097/00000542-198404000-00022; Wetterslev J, 2000, ACTA ANAESTH SCAND, V44, P9, DOI 10.1034/j.1399-6576.2000.440103.x; Zoutman D, 1998, INFECT CONT HOSP EP, V19, P254	27	670	683	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2002	359	9301					114	117		10.1016/S0140-6736(02)07369-5	http://dx.doi.org/10.1016/S0140-6736(02)07369-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809253				2022-12-28	WOS:000173212400010
J	Inoue, K; Horohisa, T; Yamada, T; Tsuchida, Y; Yoshikawa, T				Inoue, K; Horohisa, T; Yamada, T; Tsuchida, Y; Yoshikawa, T			Nasogastric tubes in patients with dysphagia	LANCET			English	Letter									Naka Cent Hosp, Frist Dept Internal Med, Naka, Ibaraki 3110134, Japan; Kyoto Prefectural Univ Med, Kyoto, Japan	Kyoto Prefectural University of Medicine	Inoue, K (corresponding author), Naka Cent Hosp, Frist Dept Internal Med, Naka, Ibaraki 3110134, Japan.							Dziewas R, 2001, LANCET, V358, P725, DOI 10.1016/S0140-6736(01)05902-5; Teramoto S, 1999, LANCET, V353, P1243, DOI 10.1016/S0140-6736(98)05844-9	2	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					81	81		10.1016/S0140-6736(02)07302-6	http://dx.doi.org/10.1016/S0140-6736(02)07302-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809224				2022-12-28	WOS:000173143500053
J	Petrovic, P; Kalso, E; Petersson, KM; Ingvar, M				Petrovic, P; Kalso, E; Petersson, KM; Ingvar, M			Placebo and opioid analgesia - Imaging a shared neuronal network	SCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; RECEPTOR-BINDING; ELECTRICAL-STIMULATION; THALAMIC-STIMULATION; CEREBRAL ACTIVATION; PERIAQUEDUCTAL GRAY; C-11 DIPRENORPHINE; MOTOR CORTEX; CHRONIC PAIN	It has been suggested that placebo analgesia involves both higher order cognitive networks and endogenous opioid systems. The rostral anterior cingulate cortex (rACC) and the brainstem are implicated in opioid analgesia, suggesting a similar role for these structures in placebo analgesia. Using positron emission tomography, we confirmed that both opioid and placebo analgesia are associated with increased activity in the rACC. We also observed a covariation between the activity in the rACC and the brainstem during both opioid and placebo analgesia, but not during the pain-only condition. These findings indicate a related neural mechanism in placebo and opioid analgesia.	Karolinska Inst, Dept Clin Neurosci, Cognit Neurophysiol Res Grp, S-17176 Stockholm, Sweden; Helsinki Univ Hosp, Dept Anaesthesia & Intens Care Med, Pain Clin, Helsinki, Finland	Karolinska Institutet; University of Helsinki; Helsinki University Central Hospital	Ingvar, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, Cognit Neurophysiol Res Grp, S-17176 Stockholm, Sweden.		GNC, GNC/B-5716-2013; Petersson, Karl Magnus/HDO-0143-2022; Petersson, Karl Magnus/E-8188-2012; Petrovic, Predrag/AAS-6736-2020	Petersson, Karl Magnus/0000-0002-8245-0392; Petersson, Karl Magnus/0000-0002-8245-0392; Petrovic, Predrag/0000-0002-5536-945X; Ingvar, Martin/0000-0002-9041-5714				Adler LJ, 1997, ANESTH ANALG, V84, P120, DOI 10.1097/00000539-199701000-00023; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Benedetti F, 1999, J NEUROSCI, V19, P3639; Casey KL, 2000, J NEUROPHYSIOL, V84, P525, DOI 10.1152/jn.2000.84.1.525; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Davis KD, 2000, J NEUROSURG, V92, P64, DOI 10.3171/jns.2000.92.1.0064; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duncan GH, 1998, J NEUROPHYSIOL, V80, P3326, DOI 10.1152/jn.1998.80.6.3326; Faymonville ME, 2000, ANESTHESIOLOGY, V92, P1257, DOI 10.1097/00000542-200005000-00013; FELDMAN PL, 1991, J MED CHEM, V34, P2202, DOI 10.1021/jm00111a041; Fields H., 1999, TXB PAIN; Firestone LL, 1996, ANESTH ANALG, V82, P1247, DOI 10.1097/00000539-199606000-00025; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Garcia-Larrea L, 1997, STEREOT FUNCT NEUROS, V68, P141, DOI 10.1159/000099915; Gyulai FE, 1997, ANESTHESIOLOGY, V86, P538, DOI 10.1097/00000542-199703000-00005; HARDY SGP, 1985, BRAIN RES, V339, P281; HARDY SGP, 1981, NEUROSCI LETT, V22, P97, DOI 10.1016/0304-3940(81)90070-7; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; JONES AKP, 1994, BRIT J RHEUMATOL, V33, P909; Jones AKP, 1999, J CEREBR BLOOD F MET, V19, P803, DOI 10.1097/00004647-199907000-00011; Kupers RC, 2000, PAIN, V87, P295, DOI 10.1016/S0304-3959(00)00295-5; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; OLESON TD, 1980, BRAIN RES, V194, P79, DOI 10.1016/0006-8993(80)91320-7; Petrovic P, 2000, PAIN, V85, P19, DOI 10.1016/S0304-3959(99)00232-8; PEYRON R, 1995, PAIN, V62, P275, DOI 10.1016/0304-3959(94)00211-V; PRICE D, 1999, PSYCHOL MECH PAIN AN, P155; PRICE D, 1999, PSYCHOL MECH PAIN AN, P137; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; ROYCE GJ, 1983, EXP BRAIN RES, V50, P157; Talairach J., 1988, COPLANAR STEREOTAXIC; Vogt B., 1993, NEUROBIOLOGY CINGULA, P313; Wagner KJ, 2001, ANESTHESIOLOGY, V94, P732, DOI 10.1097/00000542-200105000-00008; WALL PD, 1999, TXB PAIN, P1419; WESTMORELAND CL, 1993, ANESTHESIOLOGY, V79, P893, DOI 10.1097/00000542-199311000-00005; Willoch F, 1999, AM J NEURORADIOL, V20, P686; WILLOCH F, 2001, THESIS U OSLO; Zhang YQ, 1997, PAIN, V72, P127, DOI 10.1016/S0304-3959(97)00025-0; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	40	1002	1024	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1737	1740		10.1126/science.1067176	http://dx.doi.org/10.1126/science.1067176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11834781	Green Published			2022-12-28	WOS:000174212900053
J	Krot, AN; McKeegan, KD; Leshin, LA; MacPherson, GJ; Scott, ERD				Krot, AN; McKeegan, KD; Leshin, LA; MacPherson, GJ; Scott, ERD			Existence of an O-16-rich gaseous reservoir in the solar nebula	SCIENCE			English	Article							REFRACTORY INCLUSION; ORDINARY CHONDRITES; CHONDRULE FORMATION; CONSTRAINTS; SYSTEM; AL-26; CONDENSATION; METEORITES; ALLENDE; MODELS	Carbonaceous chondrite condensate olivine grains from two distinct petrographic settings, calcium-aluminum-rich inclusion (CAI) accretionary rims and amoeboid olivine aggregates (AOAs), are oxygen-16 (O-16) enriched at the level, previously observed inside CAIs. This requires that the gas in the nebular region where these grains condensed was O-16-rich. This contrasts with an O-16-poor gas present during the formation of chondrules, suggesting that CAIs and AOAs formed in a spatially restricted region of the solar nebula containing O-16-rich gas. The O-16-rich gas composition may have resulted either from mass-independent isotopic chemistry or from evaporation of regions with enhanced dust/gas ratios, possibly in an X-wind environment near the young Sun.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Smithsonian Inst, US Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA	University of Hawaii System; University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe; Smithsonian Institution; Smithsonian National Museum of Natural History	Krot, AN (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	sasha@higp.hawaii.edu	McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X; Scott, Edward/0000-0002-5137-3830				BREARLEY AJ, 1989, GEOCHIM COSMOCHIM AC, V53, P2081, DOI 10.1016/0016-7037(89)90326-8; Cassen P, 2001, METEORIT PLANET SCI, V36, P671, DOI 10.1111/j.1945-5100.2001.tb01908.x; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; DAVIS AM, 1994, METEORITICS, V29, P458; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; Fagan TJ, 2001, METEORIT PLANET SCI, V36, P223, DOI 10.1111/j.1945-5100.2001.tb01866.x; Guan Y, 2000, EARTH PLANET SC LETT, V181, P271, DOI 10.1016/S0012-821X(00)00218-1; Hewins R., 1996, CHONDRULES PROTOPLAN, P55; Hiyagon H, 1999, SCIENCE, V283, P828, DOI 10.1126/science.283.5403.828; IMAI H, 2001, LUNAR PLANET SCI, V32, P1580; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Komatsu M, 2001, METEORIT PLANET SCI, V36, P629, DOI 10.1111/j.1945-5100.2001.tb01905.x; Krot AN, 1999, METEORIT PLANET SCI, V34, pA68; Krot AN, 2001, METEORIT PLANET SCI, V36, P611, DOI 10.1111/j.1945-5100.2001.tb01904.x; LESHIN LA, 2000, LUNAR PLANET SCI, V31, P1918; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2267, DOI 10.1016/0016-7037(85)90227-3; MACPHERSON GJ, 1993, GEOCHIM COSMOCHIM AC, V57, P231, DOI 10.1016/0016-7037(93)90481-B; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; Petaev MI, 1998, METEORIT PLANET SCI, V33, P1123, DOI 10.1111/j.1945-5100.1998.tb01717.x; Rubin AE, 2000, EARTH-SCI REV, V50, P3, DOI 10.1016/S0012-8252(99)00067-7; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; RUZICKA A, 1995, METEORITICS, V30, P570; Scott ERD, 2001, METEORIT PLANET SCI, V36, P1307, DOI 10.1111/j.1945-5100.2001.tb01826.x; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Wark D. A., 1977, P 8 LUN SCI C, V8, P95; WOOD JA, 1981, EARTH PLANET SC LETT, V56, P32, DOI 10.1016/0012-821X(81)90115-1; Wood JA, 1998, ASTROPHYS J, V503, pL101, DOI 10.1086/311517; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; YURIMOTO H, 2001, METEORIT PLANET SCI, V36, pA230	33	96	97	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1051	1054		10.1126/science.1068200	http://dx.doi.org/10.1126/science.1068200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834830				2022-12-28	WOS:000173793000060
J	Gurney, KR; Law, RM; Denning, AS; Rayner, PJ; Baker, D; Bousquet, P; Bruhwiler, L; Chen, YH; Ciais, P; Fan, S; Fung, IY; Gloor, M; Heimann, M; Higuchi, K; John, J; Maki, T; Maksyutov, S; Masarie, K; Peylin, P; Prather, M; Pak, BC; Randerson, J; Sarmiento, J; Taguchi, S; Takahashi, T; Yuen, CW				Gurney, KR; Law, RM; Denning, AS; Rayner, PJ; Baker, D; Bousquet, P; Bruhwiler, L; Chen, YH; Ciais, P; Fan, S; Fung, IY; Gloor, M; Heimann, M; Higuchi, K; John, J; Maki, T; Maksyutov, S; Masarie, K; Peylin, P; Prather, M; Pak, BC; Randerson, J; Sarmiento, J; Taguchi, S; Takahashi, T; Yuen, CW			Towards robust regional estimates of CO2 sources and sinks using atmospheric transport models	NATURE			English	Article							CARBON-DIOXIDE; SYNTHESIS INVERSION; LAND; DELTA-C-13; EMISSIONS; FLUXES; BUDGET; CYCLE	Information about regional carbon sources and sinks can be derived from variations in observed atmospheric CO2 concentrations via inverse modelling with atmospheric tracer transport models. A consensus has not yet been reached regarding the size and distribution of regional carbon fluxes obtained using this approach, partly owing to the use of several different atmospheric transport models(1-9). Here we report estimates of surface- atmosphere CO2 fluxes from an intercomparison of atmospheric CO2 inversion models (the TransCom 3 project), which includes 16 transport models and model variants. We find an uptake of CO2 in the southern extratropical ocean less than that estimated from ocean measurements, a result that is not sensitive to transport models or methodological approaches. We also find a northern land carbon sink that is distributed relatively evenly among the continents of the Northern Hemisphere, but these results show some sensitivity to transport differences among models, especially in how they respond to seasonal terrestrial exchange of CO2. Overall, carbon fluxes integrated over latitudinal zones are strongly constrained by observations in the middle to high latitudes. Further significant constraints to our understanding of regional carbon fluxes will therefore require improvements in transport models and expansion of the CO2 observation network within the tropics.	Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; CSIRO Atmospher Res, Aspendale, Vic 3195, Australia; Natl Ctr Atmospher Res, Boulder, CO 80303 USA; LSCE, F-91198 Gif Sur Yvette, France; NOAA, Climate Monitoring & Diagnost Lab, Boulder, CO 80303 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02141 USA; Princeton Univ, AOS Program, Princeton, NJ 08544 USA; Univ Calif Berkeley, Ctr Atmospher Sci, Berkeley, CA 94720 USA; Max Planck Inst Biogeochem, D-07701 Jena, Germany; Environm Canada, Meteorol Serv Canada, Toronto, ON M3H 5T4, Canada; Japan Meteorol Agcy, Observ Dept, Div Atmospher Environm, Qual Assurance Sect,Chiyoda Ku, Tokyo 1008122, Japan; Frontier Res Syst Global Change, Inst Global Change Res, Yokohama, Kanagawa 2360001, Japan; Univ Calif Irvine, Irvine, CA 92697 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Colorado State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Center Atmospheric Research (NCAR) - USA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); National Oceanic Atmospheric Admin (NOAA) - USA; Massachusetts Institute of Technology (MIT); Princeton University; University of California System; University of California Berkeley; Max Planck Society; Environment & Climate Change Canada; Meteorological Service of Canada; Japan Meteorological Agency; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of California System; University of California Irvine; California Institute of Technology; California Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); Columbia University	Denning, AS (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.	denning@atmos.colostate.edu	Ciais, Philippe/A-6840-2011; Denning, Scott/F-4974-2011; Law, Rachel/A-1969-2012; Pak, Bernard C/F-4326-2015; Bruhwiler, Lori/AAQ-8502-2020; John, Jasmin G/F-8194-2012; Fan, Song-Miao/A-8004-2008; Maksyutov, Shamil S/G-6494-2011; Law, Rachel/AAV-1949-2020; Heimann, Martin/H-7807-2016; Randerson, James/Y-2550-2019	Ciais, Philippe/0000-0001-8560-4943; Denning, Scott/0000-0003-3032-7875; Law, Rachel/0000-0002-7346-0927; Pak, Bernard C/0000-0002-2137-8171; Bruhwiler, Lori/0000-0002-3554-9250; John, Jasmin G/0000-0003-2696-277X; Fan, Song-Miao/0000-0001-8352-8035; Maksyutov, Shamil S/0000-0002-1200-9577; Law, Rachel/0000-0002-7346-0927; Heimann, Martin/0000-0001-6296-5113; Randerson, James/0000-0001-6559-7387; Peylin, Philippe/0000-0001-9335-6994; Rayner, Peter/0000-0001-7707-6298; Bousquet, Philippe/0000-0002-4444-2703				Andres RJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P419, DOI 10.1029/96GB01523; Apps M.J., 1994, CARBON BALANCE WORLD, P14; BAKER DF, 2001, SOURCES SINKS ATMOSP; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Bousquet P, 1999, J GEOPHYS RES-ATMOS, V104, P26161, DOI 10.1029/1999JD900342; BRENKERT AL, 1995, CARBON DIOXIDE EMISS; DEFRIES RS, 1994, INT J REMOTE SENS, V15, P3567, DOI 10.1080/01431169408954345; Denning AS, 1999, TELLUS B, V51, P266, DOI 10.1034/j.1600-0889.1999.00012.x; DENNING AS, 1995, NATURE, V376, P240, DOI 10.1038/376240a0; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; ENTING IG, 1995, TELLUS B, V47, P35, DOI 10.1034/j.1600-0889.47.issue1.5.x; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Houghton RA, 1999, GLOB CHANGE BIOL, V5, P481, DOI 10.1046/j.1365-2486.1999.00244.x; Kaminski T, 1999, J GEOPHYS RES-ATMOS, V104, P18555, DOI 10.1029/1999JD900146; Kaminski T, 2001, J GEOPHYS RES-ATMOS, V106, P4703, DOI 10.1029/2000JD900581; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; METZL N, 2001, 6 INT CARB DIOX C SE, P685; *NOAA CMDL, 2000, GLOBALVIEW CO2 COOP; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; PEYLIN P, UNPUB J GEOPHYS RES; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; *SECR UN FRAM CONV, 2000, GREENH GAS INV DAT 1; Taguchi S, 2000, GEOPH MONOG SERIES, V114, P239; TAKAHASHI T, UNPUB DEEP SEA RES, V1; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TARANTOLA A, 1998, INVERSE PROBLEM THEO; TAYLOR KE, 1997, AMIP 2 SEA SURFACE T	30	853	885	18	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					626	630		10.1038/415626a	http://dx.doi.org/10.1038/415626a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832942	Green Published			2022-12-28	WOS:000173709100042
J	Seewald, MJ; Korner, C; Wittinghofer, A; Vetter, IR				Seewald, MJ; Korner, C; Wittinghofer, A; Vetter, IR			RanGAP mediates GTP hydrolysis without an arginine finger	NATURE			English	Article							ACTIVATING PROTEIN; CRYSTAL-STRUCTURE; TRANSITION-STATE; RAN/TC4 GTPASE; BINDING; TRANSPORT; COMPLEX; DOMAIN; GAP; RESIDUES	GTPase-activating proteins (GAPs) increase the rate of GTP hydrolysis on guanine nucleotide-binding proteins by many orders of magnitude. Studies with Ras and Rho have elucidated the mechanism of GAP action by showing that their catalytic machinery is both stabilized by GAP binding and complemented by the insertion of a so-called 'arginine finger' into the phosphate-binding pocket(1,2). This has been proposed as a universal mechanism for GAP-mediated GTP hydrolysis. Ran is a nuclear Ras-related protein that regulates both transport between the nucleus and cytoplasm during interphase, and formation of the mitotic spindle and/or nuclear envelope in dividing cells(3). RanGTP is hydrolysed by the combined action of Ran-binding proteins (RanBPs) and RanGAP(4). Here we present the three-dimensional structure of a Ran-RanBP1-RanGAP ternary complex in the ground state and in a transition-state mimic. The structure and biochemical experiments show that RanGAP does not act through an arginine finger, that the basic machinery for fast GTP hydrolysis is provided exclusively by Ran and that correct positioning of the catalytic glutamine is essential for catalysis.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44026 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Postfach 102664, D-44026 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Ding, Cheng-Qiang/B-6287-2011	Seewald, Michael/0000-0001-6967-8993				Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKER J, 1995, J BIOL CHEM, V270, P11860, DOI 10.1074/jbc.270.20.11860; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Haberland J, 1999, BIOCHEM J, V343, P653, DOI 10.1042/0264-6021:3430653; Haberland J, 1997, J BIOL CHEM, V272, P24717, DOI 10.1074/jbc.272.39.24717; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969	30	150	153	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					662	666		10.1038/415662a	http://dx.doi.org/10.1038/415662a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832950				2022-12-28	WOS:000173709100052
J	Meeker, WC; Haldeman, S				Meeker, WC; Haldeman, S			Chiropractic: A profession at the crossroads of mainstream and alternative medicine	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-BACK-PAIN; RANDOMIZED CLINICAL-TRIAL; SPINAL MANIPULATIVE THERAPY; CHRONIC NECK PAIN; BETA-ENDORPHIN LEVELS; PRIMARY-CARE; CERVICAL-SPINE; MANUAL THERAPY; FOLLOW-UP; CONSERVATIVE TREATMENT	Chiropractic is a large and well-established health care profession in the United States. In this overview, we briefly examine the development of chiropractic from humble and contentious beginnings to its current state at the crossroads of alternative and mainstream medicine. Chiropractic has taken on many of the attributes of an established profession, improving its educational and licensing systems and substantially increasing its market share in the past two decades. The public increasingly uses chiropractic largely for spinal pain syndromes and appears to be highly satisfied with the results. Of all the so-called alternative professions, chiropractic has made the largest inroads into private and public health care financing systems and is increasingly viewed as an effective specialty by many in the medical profession. Much of the positive evolution of chiropractic can be ascribed to a quarter century-long research effort focused on the core chiropractic procedure of spinal manipulation. This effort has helped bring spinal manipulation out of the investigational category to become one of the most studied forms of conservative treatment for spinal pain. Chiropractic theory is still controversial, but recent expansion in federal support of chiropractic research bodes well for further scientific development. The medical establishment has not yet fully accepted chiropractic as a mainstream form of care. The next decade should determine whether chiropractic maintains the trappings of an alternative health care profession or becomes fully integrated into all health care systems.	Palmer Ctr Chiropract Res, Davenport, IA 52803 USA; Univ Calif Irvine, Irvine, CA USA	University of California System; University of California Irvine	Meeker, WC (corresponding author), Palmer Ctr Chiropract Res, 741 Brady St, Davenport, IA 52803 USA.	Meeker_b@palmer.edu		haldeman, scott/0000-0002-8688-9562	NIAMS NIH HHS [U24 AR45166] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U24AR045166] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aker PD, 1996, BMJ-BRIT MED J, V313, P1291; ANDERSON R, 1992, J MANIP PHYSIOL THER, V15, P181; ANDERSON R, 1992, PRINCIPLES PRACTICE, P3; Andersson GBJ, 1999, NEW ENGL J MED, V341, P1426, DOI 10.1056/NEJM199911043411903; Arkuszewski Z., 1988, MANUAL MED, V3, P132; ARKUSZEWSKI Z, 1986, MANUAL MED, V2, P68; Assendelft WJJ, 1996, J FAM PRACTICE, V42, P475; ASSENDELFT WJJ, 1995, JAMA-J AM MED ASSOC, V274, P1942, DOI 10.1001/jama.274.24.1942; Astin JA, 1998, ARCH INTERN MED, V158, P2303, DOI 10.1001/archinte.158.21.2303; BAIRD R, 1996, J AM CHIROPRACTIC AS, V33, P36; Balon J, 1998, NEW ENGL J MED, V339, P1013, DOI 10.1056/NEJM199810083391501; Bergmann TF, 1993, CHIROPRACTIC TECHNIQ; BERGQUISTULLMAN M, 1977, ACTA ORTHOP SCAND S, V170, P1; Bigos S, 1994, AHCPR PUBLICATION; BLOMBERG S, 1994, SPINE, V19, P569, DOI 10.1097/00007632-199403000-00013; BOGDUK N, 1981, J ANAT, V132, P39; Bogduk N, 1985, MANUELLE MED, V23, P77; BOLINE PD, 1995, J MANIP PHYSIOL THER, V18, P148; Bolton PS, 2000, J MANIP PHYSIOL THER, V23, P101, DOI 10.1016/S0161-4754(00)90075-7; Borkan JM, 1998, SPINE, V23, P1992, DOI 10.1097/00007632-199809150-00016; Bove G, 1998, JAMA-J AM MED ASSOC, V280, P1576, DOI 10.1001/jama.280.18.1576; BRENNAN PC, 1992, J MANIP PHYSIOL THER, V15, P83; BRODIN H, 1982, MANUELLE MED, V20, P90; Bronfort G, 1996, J Manipulative Physiol Ther, V19, P570; Bronfort G, 1999, NEUROL CLIN, V17, P91, DOI 10.1016/S0733-8619(05)70116-X; Bronfort G., 1989, AM J CHIROPRACTIC ME, V2, P145; BRONFORT G, 1996, P 1996 INT C SPIN MA, P105; Budgell BS, 2000, J MANIP PHYSIOL THER, V23, P104, DOI 10.1016/S0161-4754(00)90076-9; Burton AK, 2000, EUR SPINE J, V9, P202, DOI 10.1007/s005869900113; CAREY TS, 1995, SPINE, V20, P312, DOI 10.1097/00007632-199502000-00009; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; Carey TS, 1996, SPINE, V21, P339, DOI 10.1097/00007632-199602010-00018; CARLSSON J, 1990, CEPHALALGIA, V10, P131, DOI 10.1046/j.1468-2982.1990.1003131.x; CASSIDY JD, 1992, J MANIP PHYSIOL THER, V15, P570; Chapman-Smith D, 2000, CHIROPRACTIC PROFESS; CHERKIN DC, 1989, WESTERN J MED, V150, P351; Cherkin DC, 1998, NEW ENGL J MED, V339, P1021, DOI 10.1056/NEJM199810083391502; Christensen MG, 2000, JOB ANAL CHIROPRACTI; Cooper RA, 1996, HEALTH AFFAIR, V15, P226, DOI 10.1377/hlthaff.15.3.226; COOPERSTEIN R, 1995, ADV CHIROPRATIC, V2, P437; COULEHAN JL, 1985, CULT MED PSYCHIAT, V9, P353; Coulter I, 1998, ALTERN THER HEALTH M, V4, P64; COULTER I, 1992, PRINCIPLES PRACTICE, P53; COULTER ID, 1995, ADV CHIROPRACTIC, V3, P431; COXHEAD CE, 1981, LANCET, V1, P1065; Cramer GD, 2000, J MANIP PHYSIOL THER, V23, P380, DOI 10.1067/mmt.2000.108145; Davis PT, 1998, J MANIP PHYSIOL THER, V21, P317; DELITTO A, 1993, PHYS THER, V73, P216, DOI 10.1093/ptj/73.4.216; DELITTO A, 1993, PHYS THER, V73, P226, DOI 10.1093/ptj/73.4.226; Dishman JD, 2000, SPINE, V25, P2519, DOI 10.1097/00007632-200010010-00015; DORAN DML, 1975, BRIT MED J, V2, P161, DOI 10.1136/bmj.2.5964.161; Dvorak J., 1985, MAN MED, V2, P1; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; EVANS DP, 1978, RHEUMATOL REHABIL, V17, P46, DOI 10.1093/rheumatology/17.1.46; FARRELL JP, 1982, MED J AUSTRALIA, V1, P160, DOI 10.5694/j.1326-5377.1982.tb132242.x; GATTERMAN MI, 1995, FDN CHIROPRACTIC SUB; GIBSON T, 1985, LANCET, V1, P1258; Giles LGF, 1999, J MANIP PHYSIOL THER, V22, P376, DOI 10.1016/S0161-4754(99)70082-5; GILES LGF, 1987, BRIT J RHEUMATOL, V26, P362; GLOVER JR, 1974, BRIT J IND MED, V31, P59; GODFREY CM, 1984, SPINE, V9, P301, DOI 10.1097/00007632-198404000-00015; GOLDSTEIN M, 1975, US PHS PUBLICATION; Gordon NP, 1998, WESTERN J MED, V169, P153; HADLER NM, 1987, SPINE, V12, P703, DOI 10.1097/00007632-198709000-00012; Haldeman S, 2000, J MANIP PHYSIOL THER, V23, P112, DOI 10.1016/S0161-4754(00)90078-2; Haldeman S, 1999, SPINE, V24, P785, DOI 10.1097/00007632-199904150-00010; HALDEMAN S, 1992, GUIDELINES CHIROPRAC; Hawk C, 2000, J AM GERIATR SOC, V48, P534, DOI 10.1111/j.1532-5415.2000.tb05000.x; Hawk C, 1997, J MANIP PHYSIOL THER, V20, P147; HAWK C, 1995, J MANIP PHYSIOL THER, V18, P57; Hawk C, 1999, ALTERN THER HEALTH M, V5, P56; HAWK C, 1996, ADV CHIROPRACTIC, V3, P287; Heikkila H, 2000, MANUAL THER, V5, P151, DOI 10.1054/math.2000.0357; Helliwell P S, 1989, Proc Inst Mech Eng H, V203, P187, DOI 10.1243/PIME_PROC_1989_203_037_01; Hemmila HM, 1997, ARCH PHYS MED REHAB, V78, P571, DOI 10.1016/S0003-9993(97)90420-2; HERZOG W, 1991, J MANIP PHYSIOL THER, V14, P104; HERZOG W, 1995, ADV CHIROPRACTIC, V3, P269; HOEHLER FK, 1981, JAMA-J AM MED ASSOC, V245, P1835, DOI 10.1001/jama.245.18.1835; Hondras MA, 1999, PAIN, V81, P105, DOI 10.1016/S0304-3959(99)00004-4; HONDRAS MA, 2001, COCHRANE DATABASE SY, V1; HOWE DH, 1983, J ROY COLL GEN PRACT, V33, P574; HOYT WH, 1979, J AM OSTEOPATH ASSOC, V78, P322; Hurwitz EL, 1998, AM J PUBLIC HEALTH, V88, P771, DOI 10.2105/AJPH.88.5.771; Hurwitz EL, 1996, SPINE, V21, P1746, DOI 10.1097/00007632-199608010-00007; JACKSON P, 2001, J AM CHIROPR ASS, V38, P27; JENSEN GA, 1997, AHCPR PUBLICATION, P39; JENSEN OK, 1990, CEPHALALGIA, V10, P241, DOI 10.1046/j.1468-2982.1990.1005241.x; Jordan A, 1998, SPINE, V23, P311, DOI 10.1097/00007632-199802010-00005; Kaptchuk TJ, 1998, ARCH INTERN MED, V158, P2215, DOI 10.1001/archinte.158.20.2215; Keller TS, 2000, J MANIP PHYSIOL THER, V23, P585, DOI 10.1067/mmt.2000.110947; KELNER M, 1980, CHIROPRACTORS DO THE; Kinalski R, 1989, J MANUAL MED, V4, P44; Kleynhans AM., 1992, PRINCIPLES PRACTICE, V2; Klougart N, 1996, J Manipulative Physiol Ther, V19, P371; Koes BW, 1996, SPINE, V21, P2860, DOI 10.1097/00007632-199612150-00013; KOES BW, 1992, SPINE, V17, P28, DOI 10.1097/00007632-199201000-00005; KOES BW, 1993, J MANIP PHYSIOL THER, V16, P211; KOKJOHN K, 1992, J MANIP PHYSIOL THER, V15, P279; LANTZ CA, 1995, FDN CHIROPRACTIC SUB, P149; LEE KP, 1995, NEUROLOGY, V45, P1213, DOI 10.1212/WNL.45.6.1213; MACDONALD RS, 1990, SPINE, V15, P364, DOI 10.1097/00007632-199005000-00005; Mainous AG, 2000, ARCH FAM MED, V9, P446, DOI 10.1001/archfami.9.5.446; Marchiori DM, 2014, CLIN IMAGING SKELETA; MATHEWS JA, 1987, BRIT J RHEUMATOL, V26, P416; MCKINNEY LA, 1989, BRIT MED J, V299, P1006, DOI 10.1136/bmj.299.6706.1006; MEADE TW, 1995, BRIT MED J, V311, P349, DOI 10.1136/bmj.311.7001.349; MEADE TW, 1990, BRIT MED J, V300, P1431, DOI 10.1136/bmj.300.6737.1431; MEALY K, 1986, BRIT MED J, V292, P656, DOI 10.1136/bmj.292.6521.656; Mierau D, 1988, MANUAL MED, V3, P135; MOORE JS, 1993, CHIROPRACTIC AM HIST; Mootz R, 1997, AHCPR PUBLICATION; Mootz RD, 1997, AHCPR PUBLICATION, P67; MORGAN JP, 1985, J AM OSTEOPATH ASSOC, V85, P308; Morley J, 2001, J ALTERN COMPLEM MED, V7, P65, DOI 10.1089/107555301300004547; NANSEL DD, 1989, J MANIP PHYSIOL THER, V12, P419; Nelson CF, 1998, J MANIP PHYSIOL THER, V21, P511; NIELSEN NH, 1995, CLIN EXP ALLERGY, V25, P80, DOI 10.1111/j.1365-2222.1995.tb01006.x; Nilsson N, 1997, J Manipulative Physiol Ther, V20, P326; NORDEMAR R, 1981, PAIN, V10, P93, DOI 10.1016/0304-3959(81)90050-6; NWUGA VCB, 1982, AM J PHYS MED REHAB, V61, P273; Nyiendo J, 2001, J MANIP PHYSIOL THER, V24, P92, DOI 10.1067/mmt.2001.112565; ONGLEY MJ, 1987, LANCET, V2, P143; OTHS K, 1994, CULT MED PSYCHIAT, V18, P83, DOI 10.1007/BF01384878; PARKER GB, 1978, AUST NZ J MED, V8, P589, DOI 10.1111/j.1445-5994.1978.tb04845.x; POPE MH, 1994, SPINE, V19, P2571, DOI 10.1097/00007632-199411001-00013; Postacchini F, 1988, NEURO-ORTHOPEDICS, V6, P28; Rasmussen G. G., 1979, MANUAL MED, V17, P8; REED WR, 1994, J MANIP PHYSIOL THER, V17, P596; Rupert RL, 2000, J MANIP PHYSIOL THER, V23, P10, DOI 10.1016/S0161-4754(00)90108-8; Rupert RL, 2000, J MANIP PHYSIOL THER, V23, P1, DOI 10.1016/S0161-4754(00)90107-6; RUPERT RL, 1985, ICA INT REV CHIR WIN, P58; SANDERS GE, 1990, J MANIP PHYSIOL THER, V13, P391; Senstad O, 1997, SPINE, V22, P435, DOI 10.1097/00007632-199702150-00017; Shekelle PG, 1998, NEW ENGL J MED, V339, P1074, DOI 10.1056/NEJM199810083391509; SHEKELLE PG, 1995, MED CARE, V33, P842, DOI 10.1097/00005650-199508000-00008; SHEKELLE PG, 1992, ANN INTERN MED, V117, P590, DOI 10.7326/0003-4819-117-7-590; Siehl D, 1971, J Am Osteopath Assoc, V70, P433; SIMSWILLIAMS H, 1978, BMJ-BRIT MED J, V2, P1338, DOI 10.1136/bmj.2.6148.1338; SIMSWILLIAMS H, 1979, BMJ-BRIT MED J, V2, P1318, DOI 10.1136/bmj.2.6201.1318; Skargren EI, 1998, SPINE, V23, P1875, DOI 10.1097/00007632-199809010-00016; Skargren EI, 1997, SPINE, V22, P2167, DOI 10.1097/00007632-199709150-00015; SLOOP PR, 1982, SPINE, V7, P532, DOI 10.1097/00007632-198211000-00003; SPITZER WO, 1995, SPINE, V20, pS1; Stano M, 1992, J Am Health Policy, V2, P39; Suter E, 2000, J MANIP PHYSIOL THER, V23, P76, DOI 10.1016/S0161-4754(00)90071-X; TAYLOR JAM, 1995, SPINE, V20, P1147, DOI 10.1097/00007632-199505150-00006; TERRETT ACJ, 1984, AM J PHYS MED REHAB, V63, P217; Triano J, 1997, SPINE, V22, P1955, DOI 10.1097/00007632-199709010-00003; TRIANO JJ, 1995, SPINE, V20, P948, DOI 10.1097/00007632-199504150-00013; Tuchin PJ, 2000, J MANIP PHYSIOL THER, V23, P91, DOI 10.1016/S0161-4754(00)90073-3; vanTulder MW, 1997, SPINE, V22, P2128, DOI 10.1097/00007632-199709150-00012; VERNON HT, 1986, J MANIP PHYSIOL THER, V9, P115; VERNON HT, 1990, J MANIP PHYSIOL THER, V13, P13; Vicenzino B, 1996, PAIN, V68, P69, DOI 10.1016/S0304-3959(96)03221-6; Von Kuster T, 1980, CHIROPRACTIC HLTH CA; Vroomen PCAJ, 2000, J SPINAL DISORD, V13, P463, DOI 10.1097/00002517-200012000-00001; Waagen GN, 1986, MANUAL MED, V2, P63; Walsh MJ, 1999, J MANIP PHYSIOL THER, V22, P582, DOI 10.1016/S0161-4754(99)70018-7; WARDWELL W, 1992, CHIROPRACTIC HIST EV; WATERWORTH RF, 1985, NEW ZEAL MED J, V98, P372; Wiberg JMM, 1999, J MANIP PHYSIOL THER, V22, P517, DOI 10.1016/S0161-4754(99)70003-5; Wreje Ullacarin, 1992, Scandinavian Journal of Primary Health Care, V10, P310, DOI 10.3109/02813439209014080; YATES RG, 1988, J MANIP PHYSIOL THER, V11, P484; ZYLBERGOLD RS, 1981, ARCH PHYS MED REHAB, V62, P176; 1999, FED REG, V64, P59380	165	163	164	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					216	227		10.7326/0003-4819-136-3-200202050-00010	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827498				2022-12-28	WOS:000173637400005
J	Bradley, F; Smith, M; Long, J; O'Dowd, T				Bradley, F; Smith, M; Long, J; O'Dowd, T			Reported frequency of domestic violence: cross sectional survey of women attending general practice	BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; ABUSE	Objectives To determine exposure to violence by a partner or spouse among women attending general practice and its association with respondents' demographic and personal characteristics; frequency of inquiry about violence by general practitioners; and women's views on routine questioning about domestic violence by general practitioners. Design Cross sectional, self administered, anonymous survey. Setting 22 volunteer Irish general practices. Participants 1871 women attending general practice. Main outcome measures Proportion who had experienced domestic violence, severity of such violence, and context in which violence occurred. Results Of the 1692 women who had ever had a sexual relationship, 651 (39%, 95% confidence interval 36% to 41%) had experienced violent behaviour by a partner. 78/651 (12%) women reported that their doctor had asked about domestic violence. 298/651 (46%,42% to 50%) women had been injured, 60 (20%) of whom reported that their doctor had asked about domestic violence. 1304/1692 (77%, 77% to 80%) were in favour of routine inquiry about domestic violence by their usual general practitioner. 1170 women (69%) reported controlling behaviour by their partner and 475 (28%) reported feeling afraid of their previous or current partner. Women who reported domestic violence were 32 times more likely to be afraid of their partner than women who did not report such violence. Conclusions Almost two fifths of women had experienced domestic violence but few recalled being asked about it. Most women favoured routine questioning by their practitioner about such violence. Asking women about fear of their partner and controlling behaviour may be a useful way of identifying those who have experienced domestic violence.	Adelaide & Meath Hosp, Trinity Coll, Ctr Hlth Sci, Dept Community Hlth & Gen Practice, Dublin 24, Ireland; Royal Coll Surgeons Ireland, Dept Psychol, Hlth Serv Res Ctr, Dublin 2, Ireland	Trinity College Dublin; Royal College of Surgeons - Ireland; University College Dublin	O'Dowd, T (corresponding author), Adelaide & Meath Hosp, Trinity Coll, Ctr Hlth Sci, Dept Community Hlth & Gen Practice, Dublin 24, Ireland.							ALPERT EJ, 1995, ANN INTERN MED, V123, P774, DOI 10.7326/0003-4819-123-10-199511150-00006; BROWN R, 1992, JAMA-J AM MED ASSOC, V267, P3184; DOBASH R, 1996, RES EVULATION PROGRA; DROSSMAN DA, 1995, ANN INTERN MED, V123, P782, DOI 10.7326/0003-4819-123-10-199511150-00007; Freund KM, 1996, J GEN INTERN MED, V11, P44, DOI 10.1007/BF02603485; Hamberger L K, 1992, Fam Med, V24, P283; Hegarty K, 1998, AUST NZ J PUBL HEAL, V22, P49, DOI 10.1111/j.1467-842X.1998.tb01144.x; JOHNSON H, 1995, CAN J CRIMINOL, V37, P281; KELLEHER P, 1995, MAKING LINKS INTEGRA; Marais A, 1999, S AFR MED J, V89, P635; Mazza D, 1996, MED J AUSTRALIA, V164, P14, DOI 10.5694/j.1326-5377.1996.tb94101.x; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; Mezey GC, 1997, BRIT MED J, V314, P1295, DOI 10.1136/bmj.314.7090.1295; Mooney J., 1993, HIDDEN FIGURE DOMEST; NEWBERGER EH, 1992, JAMA-J AM MED ASSOC, V267, P2370, DOI 10.1001/jama.267.17.2370; Richardson J, 1996, BRIT J GEN PRACT, V46, P239; Rosenberg Mark L., 1991, VIOLENCE AM PUBLIC H; SASSETTI MR, 1993, PRIMARY CARE, V20, P289; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	19	131	137	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					271	274		10.1136/bmj.324.7332.271	http://dx.doi.org/10.1136/bmj.324.7332.271			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	519LT	11823359	Bronze, Green Published			2022-12-28	WOS:000173728300018
J	Nepstad, D; McGrath, D; Alencar, A; Barros, AC; Carvalho, G; Santilli, M; Diaz, MDV				Nepstad, D; McGrath, D; Alencar, A; Barros, AC; Carvalho, G; Santilli, M; Diaz, MDV			Environment - Frontier governance in Amazonia	SCIENCE			English	Article							FOREST		Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; Fed Univ Para, BR-66059 Belem, Para, Brazil	Woods Hole Research Center; Universidade Federal do Para	Nepstad, D (corresponding author), Woods Hole Res Ctr, POB 296, Woods Hole, MA 02543 USA.		/AAX-3684-2020	/0000-0001-5605-7469				Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; *BRAZ I NAT STAT G, 2000, PROD AGR MUN 1999; Carvalho G, 2001, NATURE, V409, P131, DOI 10.1038/35051794; Costa MH, 2000, J CLIMATE, V13, P18, DOI [10.1175/1520-0442(2000)013<0018:CEODAD>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;0018:CEODAD&gt;2.0.CO;2]; *GOV EST M GROSS F, 2001, SIST CONTR AMB PROPR; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Schmink M., 1992, CONTESTED FRONTIERS; SCHNEIDER RR, 2000, PARTNERSHIP SERIES, V1; Webb Steven, 1999, 2121 WORLD BANK; Zimmer Kevin J., 1997, Ornithological Monographs, V48, P887; Zimmerman B, 2001, ENVIRON CONSERV, V28, P10, DOI 10.1017/S0376892901000029	12	145	151	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					629	+		10.1126/science.1067053	http://dx.doi.org/10.1126/science.1067053			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809955				2022-12-28	WOS:000173560900025
J	Stroock, AD; Dertinger, SKW; Ajdari, A; Mezic, I; Stone, HA; Whitesides, GM				Stroock, AD; Dertinger, SKW; Ajdari, A; Mezic, I; Stone, HA; Whitesides, GM			Chaotic mixer for microchannels	SCIENCE			English	Article							ADVECTION; DEVICE	It is difficult to mix solutions in microchannels. Under typical operating conditions, flows in these channels are laminar-the spontaneous fluctuations of velocity that tend to homogenize fluids in turbulent flows are absent, and molecular diffusion across the channels is slow. We present a passive method for mixing streams of steady pressure-driven flows in microchannels at low Reynolds number. Using this method, the length of the channel required for mixing grows only logarithmically with the Peclet number, and hydrodynamic dispersion along the channel is reduced relative to that in a simple, smooth channel. This method uses bas-relief structures on the floor of the channel that are easily fabricated with commonly used methods of planar lithography.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7083, Lab Physicochim Theor, Paris, France; Univ Calif Santa Barbara, Dept Mech & Environm Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Math, Santa Barbara, CA 93106 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University	Stroock, AD (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.		Stone, Howard A/B-6435-2008; Boroun, Shahab/E-4689-2015; Mezic, Igor/R-9659-2018	Mezic, Igor/0000-0002-2873-9013; Stroock, Abraham/0000-0002-8145-9977	NIGMS NIH HHS [GM51559] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051559] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ajdari A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016301; AJDARI A, 0101438 COND MAT; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11; Dunn DA, 2000, DRUG DISCOV TODAY, V5, pS84, DOI 10.1016/S1359-6446(00)80089-6; JOHNSON TJ, ANAL CHEM; JONES SW, 1989, J FLUID MECH, V209, P335, DOI 10.1017/S0022112089003137; JONES SW, 1994, J FLUID MECH, V280, P149, DOI 10.1017/S0022112094002880; Liu RH, 2000, J MICROELECTROMECH S, V9, P190, DOI 10.1109/84.846699; Losey MW, 2001, IND ENG CHEM RES, V40, P2555, DOI 10.1021/ie000523f; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mezic I, 1996, SIAM J APPL MATH, V56, P40, DOI 10.1137/S0036139994270449; Ottino JM., 1989, KINEMATICS MIXING ST; Probstein R.F., 1989, PHYSICOCHEMICAL HYDR; Sammarco TS, 1999, AICHE J, V45, P350, DOI 10.1002/aic.690450215; VOLPERT M, 2001, P 1 INT C HEAT TRANS	16	2590	2779	45	878	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					647	651		10.1126/science.1066238	http://dx.doi.org/10.1126/science.1066238			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809963				2022-12-28	WOS:000173560900035
J	Dawson, TM				Dawson, TM			Preconditioning-mediated neuroprotection through erythropoietin?	LANCET			English	Editorial Material									Johns Hopkins Univ, Sch Med, Inst Cellular Engn, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Inst Cellular Engn, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cellular Engn, Dept Neurol, Baltimore, MD 21287 USA.							Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Dame C, 2001, BIOL NEONATE, V79, P228; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Nandagopal K, 2001, J PHARMACOL EXP THER, V297, P474; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Siebenlist U, 2001, NATURE, V412, P601, DOI 10.1038/35088174; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Yoshimura A, 1998, Curr Opin Hematol, V5, P171, DOI 10.1097/00062752-199805000-00004	10	41	53	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					96	97		10.1016/S0140-6736(02)07335-X	http://dx.doi.org/10.1016/S0140-6736(02)07335-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809248				2022-12-28	WOS:000173212400005
J	Huang, JQ; Sridhar, S; Hunt, RH				Huang, JQ; Sridhar, S; Hunt, RH			Role of Helicobacter pylori infection and non-steroidal antiinflammatory drugs in peptic-ulcer disease: a meta-analysis	LANCET			English	Article							ANTI-INFLAMMATORY DRUGS; RHEUMATOID-ARTHRITIS PATIENTS; GASTRIC-MUCOSAL ADAPTATION; ABO BLOOD-GROUP; RISK-FACTORS; CAMPYLOBACTER-PYLORI; DUODENAL-ULCERS; NSAID USERS; OMEPRAZOLE; METAANALYSIS	Background The relation between H pylori infection and use of non-steroidal anti-inflammatory drugs (NSAIDs) in the pathogenesis of peptic-ulcer disease is controversial. We undertook a meta-analysis to address this issue. Methods By computer and manually we sought observational studies on the prevalence of peptic-ulcer disease in adult NSAID takers or the prevalence of H pylori infection and NSAID use in patients with peptic-ulcer bleeding. Summary odds ratios were calculated from the raw data. Tests for homogeneity were done. Findings Of 463 citations identified, 25 studies met inclusion criteria. In 16 studies of 1625 NSAID takers, uncomplicated peptic-ulcer disease was significantly more common in patients positive than in those negative for H pylori (341/817 [41.7%] vs 209/808 [25.9%]; odds ratio 2.12 [95% CI 1.68-2.67]), In five controlled studies, peptic-ulcer disease was significantly more common in NSAID takers (138/385 [35.8%]) than in controls (23/276 [8.3%]), irrespective of H pylori infection. Compared with H pylori negative individuals not taking NSAIDs, the risk of ulcer in H pylori infected NSAID takers was 61.1 (9.98-373). H pylori infection increased the risk of peptic-ulcer disease in NSAID takers 3.53-fold in addition to the risk associated with NSAID use (odds ratio 19.4). Similarly, in the presence of risk of peptic-ulcer disease associated with H pylori infection (18.1), use of NSAIDs increased the risk of peptic-ulcer disease 3.55-fold. H pylori infection and NSAID use increased the risk of ulcer bleeding 1.79-fold and 4.85-fold, respectively. However, the risk of ulcer bleeding increased to 6.13 when both factors were present. Interpretation Both H pylori infection and NSAID use independently and significantly increase the risk of peptic ulcer and ulcer bleeding. There is synergism for the development of peptic ulcer and ulcer bleeding between H pylori infection and NSAID use. Peptic-ulcer disease is rare in H pylori negative non-NSAID takers.	McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z8, Canada	McMaster University	Hunt, RH (corresponding author), McMaster Univ, Med Ctr, Dept Med, Div Gastroenterol, 1200 Main St W,Room 4W8, Hamilton, ON L8N 3Z8, Canada.							Aalykke C, 1999, GASTROENTEROLOGY, V116, P1305, DOI 10.1016/S0016-5085(99)70494-4; AlAssi MT, 1996, ENDOSCOPY, V28, P229, DOI 10.1055/s-2007-1005433; BERLIN JA, 1995, AM J EPIDEMIOL, V142, P383, DOI 10.1093/oxfordjournals.aje.a117645; BLAIR A, 1995, REGUL TOXICOL PHARM, V22, P189, DOI 10.1006/rtph.1995.1084; CASELLI M, 1989, DIGESTION, V44, P101, DOI 10.1159/000199898; Chan FKL, 1998, ALIMENT PHARM THER, V12, P1201; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Chan FKL, 1997, LANCET, V350, P975, DOI 10.1016/S0140-6736(97)04523-6; Chan FKL, 2000, BEST PRACT RES CL GA, V14, P161, DOI 10.1053/bega.1999.0066; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Colin R, 2000, GASTROEN CLIN BIOL, V24, P31; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P167, DOI 10.1016/0895-4356(94)00172-M; Cullen DJE, 1997, GUT, V41, P459, DOI 10.1136/gut.41.4.459; Ekstrom P, 1996, SCAND J GASTROENTERO, V31, P753, DOI 10.3109/00365529609010347; Gillen D, 1999, GUT, V44, P468, DOI 10.1136/gut.44.4.468; GOGGIN PM, 1993, GUT, V34, P1677, DOI 10.1136/gut.34.12.1677; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1653, DOI 10.1016/0016-5085(91)90665-8; Graham DY, 2000, HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, P453; GUBBINS GP, 1992, AM J MED, V93, P412, DOI 10.1016/0002-9343(92)90171-7; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HAWKEY CJ, 1990, BMJ-BRIT MED J, V300, P278, DOI 10.1136/bmj.300.6720.278; Hawkey CJ, 2000, HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, P461; Hawkey CJ, 1998, LANCET, V352, P1016, DOI 10.1016/S0140-6736(98)04206-8; Hawkey CJ, 2000, GASTROENTEROLOGY, V119, P521, DOI 10.1053/gast.2000.9561; Henriksson AE, 1998, SCAND J GASTROENTERO, V33, P1030, DOI 10.1080/003655298750026705; HENRIKSSON K, 1993, DIGEST DIS SCI, V38, P1688, DOI 10.1007/BF01303179; HERESBACH D, 1992, GUT, V33, P1608, DOI 10.1136/gut.33.12.1608; Huang J., 1996, Inflammopharmacology, V4, P17, DOI 10.1007/BF02735556; HUANG JQ, 2000, THERAPY DIGESTIVE DI, P113; HUDSON N, 1993, GUT, V34, P748, DOI 10.1136/gut.34.6.748; HUNT RH, 1990, CAN J GASTROENTEROL, V4, P89; Hyvarinen H, 1996, DIGESTION, V57, P305, DOI 10.1159/000201350; IGLEHART IW, 1989, J RHEUMATOL, V16, P599; JONES STM, 1991, BRIT J RHEUMATOL, V30, P16; Kim Jong G., 1994, American Journal of Gastroenterology, V89, P203; Kordecki H, 1997, J Physiol Pharmacol, V48 Suppl 4, P85; Kulkarni S G, 1996, Indian J Gastroenterol, V15, P118; Kurata JH, 1997, J CLIN GASTROENTEROL, V24, P2, DOI 10.1097/00004836-199701000-00002; Kuyvenhoven JP, 1999, SCAND J GASTROENTERO, V34, P1082, DOI 10.1080/003655299750024869; Labenz J, 1999, ITAL J GASTROENTEROL, V31, P110; LAINE L, 1995, ALIMENT PHARM THERAP, V9, P127; LAINE L, 1992, AM J GASTROENTEROL, V87, P1398; LANZA FL, 1991, AM J GASTROENTEROL, V86, P735; Li EKM, 1996, SCAND J RHEUMATOL, V25, P42, DOI 10.3109/03009749609082667; LICHTENSTEIN MJ, 1987, J CHRON DIS, V40, P893, DOI 10.1016/0021-9681(87)90190-1; Lipscomb GR, 1996, DIGEST DIS SCI, V41, P1583, DOI 10.1007/BF02087904; Lipscomb GR, 1997, ALIMENT PHARM THERAP, V11, P907, DOI 10.1046/j.1365-2036.1997.00222.x; LOEB DS, 1992, GASTROENTEROLOGY, V102, P1899, DOI 10.1016/0016-5085(92)90311-L; MARTIN DF, 1989, AM J GASTROENTEROL, V84, P1268; MAXTON DG, 1990, POSTGRAD MED J, V66, P717, DOI 10.1136/pgmj.66.779.717; MIZOKAMI Y, 1994, EUR J GASTROEN HEPAT, V6, pS109; Ng EKW, 1996, BRIT J SURG, V83, P1779, DOI 10.1002/bjs.1800831237; Ng TM, 2000, ALIMENT PHARM THERAP, V14, P203; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; PETERSON WL, 1988, GASTROENTEROLOGY, V95, P1185, DOI 10.1016/0016-5085(88)90349-6; Pilotto A, 1997, EUR J GASTROEN HEPAT, V9, P951, DOI 10.1097/00042737-199710000-00006; Pilotto A, 1997, DIGEST DIS SCI, V42, P586, DOI 10.1023/A:1018807412030; Porro GB, 1996, GUT, V39, P22, DOI 10.1136/gut.39.1.22; PUBLIG W, 1994, WIEN KLIN WOCHENSCHR, V106, P276; Santolaria S, 1999, ALIMENT PHARM THERAP, V13, P1511; SANTUCCI L, 1995, DIGEST DIS SCI, V40, P2074, DOI 10.1007/BF02208681; SCHUBERT TT, 1993, AM J MED, V94, P413, DOI 10.1016/0002-9343(93)90153-G; SEPPALA K, 1995, GUT, V36, P834, DOI 10.1136/gut.36.6.834; SHALLCROSS TM, 1990, ALIMENT PHARM THERAP, V4, P515; TAHA AS, 1995, GUT, V36, P334, DOI 10.1136/gut.36.3.334; Taha AS, 1999, GASTROENTEROLOGY, V116, P254, DOI 10.1016/S0016-5085(99)70120-4; TAHA AS, 1993, GUT, V34, P1162, DOI 10.1136/gut.34.9.1162; TAHA AS, 1992, J CLIN PATHOL, V45, P135, DOI 10.1136/jcp.45.2.135; TAHA AS, 1992, AM J GASTROENTEROL, V87, P1732; TAHA AS, 1993, GUT, V34, P580, DOI 10.1136/gut.34.5.580; TAHA AS, 1993, ALIMENT PHARM THERAP, V7, P41; THILLAINAYAGAM AV, 1994, DIGEST DIS SCI, V39, P1085, DOI 10.1007/BF02087562; Tseng GY, 1999, HEPATO-GASTROENTEROL, V46, P1000; Tu TC, 1999, GASTROINTEST ENDOSC, V49, P302, DOI 10.1016/S0016-5107(99)70005-2; UPADHYAY R, 1988, BRIT J RHEUMATOL, V27, P113; VEEV A, 1998, ACTA MED CROATICA, V52, P27; VERDU EF, 1995, GUT, V36, P539, DOI 10.1136/gut.36.4.539; Voutilainen M, 1998, SCAND J GASTROENTERO, V33, P811; Wu CY, 1999, SCAND J GASTROENTERO, V34, P234, DOI 10.1080/00365529950173618; Yeomans ND, 2000, GASTROENTEROL CLIN N, V29, P791, DOI 10.1016/S0889-8553(05)70147-3; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104	82	529	583	4	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					14	22		10.1016/S0140-6736(02)07273-2	http://dx.doi.org/10.1016/S0140-6736(02)07273-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809181				2022-12-28	WOS:000173143500010
J	Newland, AC				Newland, AC			Treatment of adults with autoimmune thrombocytopenic purpura	LANCET			English	Editorial Material							CHILDREN; THERAPY		Barts & London Sch Med & Dent, Dept Haematol, London E1 1BB, England	University of London; Queen Mary University London	Newland, AC (corresponding author), Barts & London Sch Med & Dent, Dept Haematol, London E1 1BB, England.							AKOGLU T, 1991, LANCET, V337, P56, DOI 10.1016/0140-6736(91)93379-N; BELLUCCI S, 1988, BLOOD, V71, P1165; Blanchette V, 1998, SEMIN HEMATOL, V35, P36; Cohen YC, 2000, ARCH INTERN MED, V160, P1630, DOI 10.1001/archinte.160.11.1630; Djulbegovic B, 2001, BLOOD, V98, P2282, DOI 10.1182/blood.V98.7.2282; George JN, 1996, BLOOD, V88, P3, DOI 10.1182/blood.V88.1.3.3; Medeiros D, 1998, J PEDIATR-US, V133, P334, DOI 10.1016/S0022-3476(98)70265-3; Portielje JEA, 2001, BLOOD, V97, P2549, DOI 10.1182/blood.V97.9.2549; SCHIAVOTTO C, 1995, ANN HEMATOL, V70, P89, DOI 10.1007/BF01834386; Stasi R, 2001, BLOOD, V98, P952, DOI 10.1182/blood.V98.4.952; Willis F, 2001, BRIT J HAEMATOL, V114, P891, DOI 10.1046/j.1365-2141.2001.03039.x	11	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					4	5		10.1016/S0140-6736(02)07269-0	http://dx.doi.org/10.1016/S0140-6736(02)07269-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809175				2022-12-28	WOS:000173143500004
J	Hendry, JH; Booth, C; Potten, CS				Hendry, JH; Booth, C; Potten, CS			Endothelial cells and radiation gastrointestinal syndrome	SCIENCE			English	Editorial Material							FIBROBLAST GROWTH-FACTOR; INTESTINAL CRYPTS; CLONOGEN CONTENT; IN-VIVO; DEDUCTION; SURVIVAL; DEATH; ASSAY; MICE		Christie Hosp, Paterson Inst Canc Res, Manchester, Lancs, England; EpiStem Ltd, Manchester, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Hendry, JH (corresponding author), Christie Hosp, Paterson Inst Canc Res, Manchester, Lancs, England.							FUKS Z, 1994, CANCER RES, V54, P2582; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; ROBERTS SA, 1995, RADIAT RES, V141, P303, DOI 10.2307/3579007; ROBERTS SA, 1994, INT J RADIAT BIOL, V65, P477, DOI 10.1080/09553009414550551; TEE PG, 1995, CANCER RES, V55, P298; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; WITHERS HR, 1993, RADIOTHER ONCOL, V26, P238	11	12	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1411A	1411A						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11826850				2022-12-28	WOS:000172240500002
